data_2k74_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k74 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.8 mm? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -54.25 -36.42 63.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLN . 43.2 m-85 -72.25 -44.31 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.57 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -45.69 -42.9 12.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 110.095 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -68.33 -25.4 65.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.19 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.4 tp-100 -78.79 -48.77 14.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.42 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 11' ' ' GLY . 39.1 p -76.7 -41.02 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -69.03 6.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.139 0.495 . . . . 0.0 110.304 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.21 140.8 15.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -68.9 -49.2 60.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.846 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.95 -46.07 6.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.12 85.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.114 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -56.88 -47.1 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.55 -27.94 68.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.14 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.24 -36.41 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 mmt -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.202 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.11 73.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.909 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.08 -34.14 73.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.978 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 m -59.68 -58.98 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.626 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.17 -25.67 65.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -42.11 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.279 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' O ' ' CG2' ' A' ' 28' ' ' THR . . . -61.39 -24.34 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.19 -45.4 10.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.454 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.0 -37.74 88.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.756 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.69 -51.42 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.925 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 5.6 p -47.25 -37.15 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.91 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.815 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.1 -15.83 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -94.46 -33.4 13.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.545 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -38.45 79.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.482 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -72.13 -39.2 68.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.579 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -8.42 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.9 t -108.99 -46.48 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 mmt -96.2 14.43 24.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.744 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt 43.01 42.63 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.7 mt -70.01 154.98 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.115 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -111.56 103.28 54.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.108 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -52.1 167.84 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.154 1.903 . . . . 0.0 111.545 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.8 175.4 9.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.5 t -61.7 -48.31 89.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 9.8 mp -61.34 -45.51 94.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.14 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -49.09 -44.73 42.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.429 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.45 -43.82 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.094 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -47.11 73.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.597 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.397 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' NH2' ' CD1' ' A' ' 52' ' ' PHE . 3.8 tmt_? -62.63 -37.66 87.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.548 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.34 78.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.13 -48.36 81.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.817 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.8 tp -79.56 -50.3 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CD1' ' NH2' ' A' ' 48' ' ' ARG . 66.2 t80 -46.23 -41.48 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.759 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.93 -44.2 89.47 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.61 -47.3 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.3 tp -44.62 -48.09 10.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.523 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.08 92.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.86 63.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.446 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.72 76.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.352 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.0 -27.09 54.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.45 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 60' ' ' ILE . 95.9 mt -81.8 -43.48 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.397 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.79 -32.94 78.85 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.85 4.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.715 0.293 . . . . 0.0 110.944 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.7 mt -83.33 -26.49 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.67 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -173.23 65.48 0.33 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.433 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.16 11.14 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.648 2.232 . . . . 0.0 112.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 64' ' ' ALA . 15.5 pttp -111.04 -6.47 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.243 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.25 161.89 24.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.639 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -38.16 -16.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.554 2.169 . . . . 0.0 112.287 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.4 tp -43.22 -31.47 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -40.79 -65.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -55.69 -29.89 60.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.557 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.2 t -67.6 -43.11 87.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.639 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -29.06 30.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.275 0.559 . . . . 0.0 109.955 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.7 ttt -65.25 -12.97 57.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 30.3 m -59.71 -37.15 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.524 0.678 . . . . 0.0 110.537 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.27 -30.05 5.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.215 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.472 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 2.5 t-105 -68.6 -49.72 57.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.995 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 81' ' ' ALA . 3.9 tt -66.53 -50.61 62.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.0 m-85 -43.69 -39.98 3.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -79.71 -23.81 42.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.75 -61.77 2.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.804 0.335 . . . . 0.0 111.159 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -51.95 12.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.085 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -68.51 -47.87 65.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.92 -46.11 92.87 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.41 -37.69 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.796 -0.238 . . . . 0.0 111.472 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -67.98 -25.41 65.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -90.21 -35.36 15.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.892 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.6 p -57.33 -52.53 64.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.911 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 92' ' ' THR . 19.4 m-85 -48.93 -49.85 38.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.376 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -51.91 -42.73 62.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -67.04 -34.49 77.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 74.8 p -74.48 -29.92 61.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.4 mmt -64.24 -41.18 97.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.356 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.72 -51.15 61.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.431 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.572 0.225 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -125.22 -5.7 7.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.653 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -123.02 81.58 50.88 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 36.1 Cg_exo -56.55 15.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.351 . . . . 0.0 112.671 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.653 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -76.28 -32.35 58.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.013 0.435 . . . . 0.0 110.253 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 1.1 m-20 -98.4 -40.28 8.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.347 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.24 -45.35 63.44 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.018 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 9.9 t-105 -76.76 -10.37 59.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.39 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.02 68.99 35.47 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.75 -15.44 12.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.867 2.378 . . . . 0.0 111.668 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -53.08 -32.15 45.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.627 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 44.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.432 ' CZ ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -148.57 -36.87 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.436 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.73 127.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.694 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.27 152.91 18.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.31 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -155.08 102.39 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.14 -168.07 19.38 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.3 154.1 19.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 36.3 m -99.01 138.78 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 111.204 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 101.04 -5.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.634 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.84 149.22 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -98.86 122.58 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.735 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.55 -29.76 9.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -173.68 146.54 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.46 158.08 44.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.293 0.568 . . . . 0.0 112.106 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 13.4 m-85 -112.89 137.71 50.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.175 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.7 mm? 48.61 17.44 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.425 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 92.61 22.3 29.18 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.223 -0.513 . . . . 0.0 111.995 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 5.2 mp0 -72.41 146.56 46.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.3 mtt -47.24 -56.42 12.43 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -40.95 -38.58 2.94 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.565 2.176 . . . . 0.0 112.672 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -70.14 -51.8 28.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.9 m95 -58.79 -56.64 19.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.9 tp -43.69 -38.29 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.54 -36.82 76.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.98 -46.48 94.5 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.7 mt -75.09 -25.63 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.015 0.436 . . . . 0.0 110.061 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -63.36 -44.03 95.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.765 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 4.8 tt -70.23 -36.83 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.578 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.75 75.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.187 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.55 -40.42 94.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.686 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 86.7 mt -64.36 -32.42 74.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.41 -29.65 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.38 -40.14 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.34 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -70.08 -50.03 45.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -51.62 -39.25 23.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.1 tp -81.18 -37.35 28.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.14 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.5 t -71.0 -22.48 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.795 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.12 -48.29 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.0 110.24 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 81.5 mt -69.16 -14.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.385 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 tp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.821 0.343 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -49.64 -48.91 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.404 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -52.83 -45.6 67.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.277 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tp -48.78 -43.76 38.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.126 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -69.56 -26.36 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.076 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -75.96 -50.49 14.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.28 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.81 70.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' A' ' 10' ' ' GLN . 50.4 p -76.85 -41.57 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.553 ' N ' ' HG ' ' A' ' 9' ' ' SER . 2.6 tp60 -68.28 5.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.419 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.75 140.98 15.12 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -70.19 -49.9 45.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.615 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.73 -46.42 5.91 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.45 89.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -61.58 -37.17 82.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.05 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.1 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.138 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.31 -30.0 66.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.752 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.423 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.2 mtp -73.41 -33.69 65.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.89 -55.3 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.53 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -47.03 -47.92 22.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 18' ' ' MET . 31.5 p -53.48 -58.02 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.379 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.14 -34.65 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.8 tp -76.32 -41.97 46.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.14 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.293 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.57 -37.32 42.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.13 -52.84 62.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.821 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.26 -50.24 74.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.747 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.1 p -48.59 -44.06 36.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.861 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.34 -46.21 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.034 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -19.57 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.534 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -92.27 -39.41 11.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.61 -30.85 14.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -83.77 -42.1 16.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.011 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -69.09 -14.49 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.074 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 36' ' ' MET . 9.2 p -109.11 -39.22 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.899 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.411 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 1.1 tpt -97.23 11.55 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.867 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.517 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.2 mp 43.85 44.97 6.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.199 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp -77.6 153.0 33.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -108.78 129.85 23.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.691 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.27 169.17 21.8 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.468 2.112 . . . . 0.0 112.184 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.95 159.57 38.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.561 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -50.82 -42.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.155 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.88 -45.13 87.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -51.08 -42.83 60.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 mt -66.21 -43.1 92.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.241 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -58.85 -44.91 91.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.757 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.07 -49.7 76.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -59.11 -30.09 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.131 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.98 82.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.347 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.43 -49.73 75.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.649 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.07 -49.27 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -46.1 -41.34 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.98 -42.39 92.68 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.5 t -64.97 -47.61 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 109.975 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 tt -45.21 -44.87 11.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.654 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -37.01 94.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -63.97 -37.88 89.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.2 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.73 -34.17 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.31 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -75.72 -27.14 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.186 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 60' ' ' ILE . 95.6 mt -80.39 -40.43 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.471 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.64 -26.81 73.46 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.96 9.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.662 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.2 mt -82.08 -39.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.63 74.38 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 0.0 110.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.31 26.8 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.701 2.267 . . . . 0.0 112.086 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 64' ' ' ALA . 52.2 tttm -108.13 -9.02 15.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.309 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.591 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.8 175.85 1.71 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.686 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.65 -4.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.239 1.96 . . . . 0.0 112.047 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.591 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.8 mt -47.98 -35.45 10.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 58.8 mtt180 -40.83 -70.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -49.61 -20.22 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.171 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 69' ' ' LEU . 9.8 t -83.38 -46.56 18.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.806 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.85 -38.85 64.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 110.928 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -61.16 -9.51 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.86 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 8.0 t -57.87 -41.4 79.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.323 0.582 . . . . 0.0 109.989 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.7 -32.62 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.505 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 2.2 t-105 -65.15 -51.68 59.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.7 tp -65.73 -47.52 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -44.07 -43.58 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.231 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 p -78.74 -21.0 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.718 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.46 -60.51 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.853 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -73.75 -55.12 6.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.178 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -65.57 -44.71 85.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.408 ' O ' ' CG2' ' A' ' 88' ' ' THR . . . -61.48 -45.49 96.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.426 -0.892 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.1 t -73.18 -44.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.692 0.282 . . . . 0.0 111.622 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -41.62 96.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.305 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.2 -45.37 48.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 84' ' ' GLY . 8.7 p -48.68 -49.36 38.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.659 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.423 ' O ' ' OG1' ' A' ' 92' ' ' THR . 57.0 t80 -52.0 -38.5 57.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.291 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -56.88 -42.23 79.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -68.01 -37.55 81.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.434 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 64.3 p -67.27 -41.44 85.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.347 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ttt -53.48 -48.45 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.12 -46.85 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.142 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.132 179.724 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -110.26 -0.21 17.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.612 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 tp -126.46 77.49 72.91 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.139 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 42.2 Cg_exo -53.03 4.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.787 2.325 . . . . 0.0 112.436 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.612 ' H ' ' C ' ' A' ' 114' ' ' LEU . 7.8 tp -61.38 -33.61 73.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.174 0.511 . . . . 0.0 109.978 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.53 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.3 OUTLIER -97.33 -43.88 7.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.528 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -66.95 -45.43 77.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.773 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -75.52 -11.75 60.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 70.51 46.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.7 -17.83 10.87 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.85 2.367 . . . . 0.0 111.884 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -57.44 -35.79 70.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.054 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.28 50.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.647 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.53 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -159.54 -35.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -54.58 127.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.501 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.8 149.12 21.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -164.19 117.67 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.703 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.93 -169.28 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 11.9 t70 -93.94 163.29 13.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 61.5 m -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.53 -4.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.56 128.52 36.76 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.759 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.463 ' N ' ' CD ' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -62.24 111.8 2.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.196 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -111.53 -31.31 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.823 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -172.73 141.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.055 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -146.9 160.99 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.225 0.535 . . . . 0.0 111.897 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -122.84 139.51 53.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.942 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.08 17.52 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.823 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 22.61 51.01 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.26 135.41 52.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.837 0.351 . . . . 0.0 110.108 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.22 148.42 49.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.409 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 6.5 mtt -45.64 -60.33 3.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.35 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.5 Cg_exo -35.98 -37.62 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.68 2.253 . . . . 0.0 112.5 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -70.94 -50.46 34.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.014 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.596 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.8 m95 -60.81 -56.85 16.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.842 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.35 -35.6 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.248 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 tp -65.4 -33.87 76.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.46 -46.78 93.71 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.18 -38.8 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -50.88 -44.06 59.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.733 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.21 -40.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.72 -47.77 76.33 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.693 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.24 -46.2 88.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.04 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.489 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 83.1 mt -61.7 -40.25 94.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.51 -40.38 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.464 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.6 t -52.46 -43.29 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.397 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.81 -45.35 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 74.7 t -48.82 -36.78 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.937 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.09 -33.11 33.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.983 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.7 t -76.32 -26.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.917 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.64 -50.54 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.68 -22.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.786 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.789 0.328 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -58.32 -38.74 77.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 7' ' ' GLN . 32.9 t80 -69.42 -47.58 63.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.12 -40.03 10.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.338 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.14 -22.11 63.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.211 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.6 tp-100 -80.03 -47.4 14.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.58 88.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 11' ' ' GLY . 92.5 p -76.82 -38.89 53.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.509 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 6.5 tt0 -64.94 2.5 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.93 146.63 18.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -67.89 -48.33 66.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.559 0.219 . . . . 0.0 110.61 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -45.73 6.07 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.09 -47.53 84.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -59.79 -39.26 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.091 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.029 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -70.05 -33.22 71.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.714 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.2 mtt -70.68 -33.93 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.6 -51.6 40.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.581 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.94 -34.21 62.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.7 m -63.34 -57.0 11.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.703 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -22.95 63.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.75 -42.06 16.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.417 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -51.27 -41.71 60.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.838 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.9 mp -72.06 -33.69 68.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -62.05 -42.83 99.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.428 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.21 -40.9 51.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 28.4 m -54.68 -45.88 74.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.585 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.86 64.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.547 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 tp -65.49 -20.69 66.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.729 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.62 -41.41 11.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -51.35 -38.41 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -71.16 -38.85 72.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.324 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.98 -6.79 52.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.848 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.34 -47.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.0 mtt -97.52 11.62 36.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 tp 46.48 48.25 13.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.616 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.1 mt -84.56 152.9 23.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -117.32 133.08 23.24 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.82 176.88 9.48 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 111.953 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.457 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 8.3 t -131.9 177.79 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.68 -46.07 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.95 -48.82 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.373 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -48.78 -48.33 41.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.657 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.64 -41.46 90.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -55.17 -47.73 74.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -63.08 -38.24 90.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -63.69 -36.77 84.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -40.59 77.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.35 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 tp -73.31 -53.08 11.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.05 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -45.06 -38.69 5.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.813 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.84 -42.55 94.98 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 43.5 t -60.61 -46.97 94.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.98 -46.68 11.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.62 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.2 -28.76 72.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.63 -38.8 70.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.299 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.73 76.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.019 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.418 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 4.3 mt -73.76 -28.11 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.14 -39.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.12 -21.44 78.41 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.48 7.79 5.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.715 0.293 . . . . 0.0 110.892 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.3 mp -84.03 -35.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -175.57 71.61 0.27 Allowed Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.601 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.07 13.53 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.514 2.143 . . . . 0.0 111.827 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 64' ' ' ALA . 80.7 tttt -106.68 -8.86 16.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.05 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.99 161.94 25.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.607 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -39.9 -14.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.479 2.12 . . . . 0.0 112.207 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -42.39 -34.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.639 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtt180 -37.94 -63.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -51.63 -31.12 24.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.842 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 69' ' ' LEU . 11.3 t -69.32 -45.44 79.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.947 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.89 -33.2 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.196 0.522 . . . . 0.0 110.317 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.467 ' O ' ' SD ' ' A' ' 74' ' ' MET . 2.8 tmm? -63.21 -14.52 50.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.026 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.52 -39.11 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.52 0.676 . . . . 0.0 110.524 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.36 -31.49 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.4 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 9.0 t-105 -65.94 -54.33 27.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.174 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' ALA . 14.9 tp -63.67 -47.68 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -42.79 -42.94 3.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.381 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.8 p -78.11 -23.21 47.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -61.12 -60.03 4.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.361 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -49.97 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.681 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -39.0 69.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.703 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.13 -48.29 86.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' ' OG1' ' A' ' 88' ' ' THR . 14.2 m -72.85 -48.33 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.595 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.453 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 14.6 tm0? -48.46 -29.06 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.09 -42.1 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.254 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 62.9 p -50.94 -31.03 16.44 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.38 -51.5 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.873 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.07 -36.76 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -71.63 -39.27 70.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -73.44 -52.17 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ttp -51.96 -52.94 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.12 -48.74 75.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.217 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.52 0.2 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' A' ' 113' ' ' TRP . 2.1 p-90 -122.09 9.87 9.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.602 ' C ' ' H ' ' A' ' 116' ' ' LEU . 50.1 mt -122.01 81.04 42.95 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.271 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.1 Cg_exo -51.94 0.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.233 . . . . 0.0 112.267 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.602 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 mt -60.69 -32.23 71.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.429 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 27.9 p-10 -96.82 -41.3 8.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.625 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 35.4 tttm -71.69 -45.19 62.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.732 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -74.27 -16.79 60.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.532 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.8 71.96 29.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.983 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.1 -18.37 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.683 2.255 . . . . 0.0 111.861 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -50.14 -52.52 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.83 54.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.565 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -154.97 -40.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.322 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.2 130.5 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.642 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.87 149.53 21.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -161.27 99.86 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.401 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.75 -177.32 20.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.457 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 44.4 t0 -91.4 157.05 17.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.54 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 5.7 m -103.51 131.25 50.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.123 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 97.02 -5.36 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.197 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.03 151.7 45.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.045 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -89.69 147.59 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -133.88 -31.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.459 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -174.89 143.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -132.97 164.15 27.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.769 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.21 118.01 9.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.283 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.81 16.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.4 10.63 79.56 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.1 mt -119.5 138.03 53.42 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.867 0.365 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.83 154.0 42.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.6 mtp -55.72 -50.25 88.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.568 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 55.4 Cg_exo -48.32 -38.8 34.71 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.446 2.098 . . . . 0.0 112.088 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.687 HE21 ' N ' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -70.03 -42.51 72.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.524 0.678 . . . . 0.0 109.87 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.687 ' N ' HE21 ' A' ' 144' ' ' GLN . 47.6 m95 -60.03 -56.15 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.222 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.9 tp -43.39 -42.76 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 143' ' ' PRO . 1.1 mt -56.91 -35.54 69.12 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.6 -44.28 96.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.835 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.81 -29.67 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.337 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 -44.78 88.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.987 0.422 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.4 -39.83 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.07 64.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.482 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.3 m-85 -52.91 -42.84 65.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.446 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -75.06 -29.43 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.247 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mt -70.83 -31.21 44.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.322 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.25 -38.71 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.735 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.551 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.27 -54.23 40.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.68 -45.22 79.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 tp -63.23 -37.8 88.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.49 -30.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.9 -50.16 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.999 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.18 -31.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.408 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -56.68 -38.58 72.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.298 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLN . 8.6 t80 -66.13 -47.36 74.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.176 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.44 -38.03 8.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.86 -21.28 65.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.068 0.461 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' PHE . 30.9 tt0 -81.71 -46.45 14.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.26 84.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.2 m -76.95 -34.43 57.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 20.6 tt0 -67.95 3.16 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.54 146.87 18.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -69.97 -48.82 56.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.739 0.304 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.23 -45.84 6.47 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.83 -48.07 80.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -56.26 -47.86 77.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -27.32 68.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -29.24 66.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.625 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.73 -34.09 60.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.232 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.9 26.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.887 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -54.45 -49.02 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -46.58 -58.65 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.553 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.31 -29.39 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.31 -39.44 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.711 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.6 -34.81 62.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.638 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.1 mt -74.11 -37.92 64.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.63 -50.54 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -57.93 -43.84 86.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 25.3 m -59.47 -43.64 93.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.39 -29.26 62.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -67.95 -21.62 65.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.688 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -88.0 -42.38 12.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -51.59 -39.94 58.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.124 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -71.51 -37.23 71.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 39.3 m80 -75.85 -10.55 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.18 -47.96 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -94.08 11.9 28.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.896 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tp 44.65 44.26 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.14 148.18 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.472 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -109.67 130.33 22.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.8 Cg_endo -76.35 174.36 12.95 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.288 1.992 . . . . 0.0 111.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -131.85 -178.5 4.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.93 -45.22 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.917 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 8.6 mp -76.07 -42.8 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.844 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 m -58.84 -51.9 68.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.81 -36.07 76.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.996 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.07 -46.68 85.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.788 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.67 -37.14 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.294 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.3 -33.83 74.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.319 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.55 76.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.493 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.81 73.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.92 -45.45 58.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.38 -40.27 11.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.688 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.39 79.91 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.3 t -62.25 -47.99 90.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.078 0.466 . . . . 0.0 109.937 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -45.11 -44.63 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.83 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -29.62 75.81 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.17 -37.42 87.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.11 -27.18 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.736 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.12 -39.94 75.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.596 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 pt -82.49 -31.94 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.14 -31.44 69.23 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.86 7.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.4 mp -83.8 -26.98 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.76 71.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -68.35 17.44 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.338 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 64' ' ' ALA . 59.6 mttt -112.2 -4.14 14.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.41 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -112.06 160.46 29.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.611 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -37.72 -16.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.556 2.171 . . . . 0.0 112.048 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.6 tp -43.13 -33.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -40.12 -67.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.522 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.64 -33.05 53.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.466 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 7.5 t -65.89 -55.85 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.617 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.93 74.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.236 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.9 mmt -61.79 -12.19 15.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.26 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 2.0 p -63.15 -31.51 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.469 0.652 . . . . 0.0 110.069 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.08 -30.64 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.606 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.487 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.3 t-105 -65.68 -49.68 67.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.806 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.72 -44.36 77.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.418 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -46.92 -45.28 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.4 p -78.17 -21.96 49.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.02 -59.5 5.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.016 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.5 -53.07 10.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.6 ttt85 -66.89 -45.68 77.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.64 -47.1 91.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' O ' ' OG1' ' A' ' 88' ' ' THR . 59.8 t -69.81 -47.26 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -52.98 -21.46 4.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.151 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -40.53 12.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.454 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 24.5 p -53.07 -26.01 14.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.532 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.72 -44.79 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.469 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 5.2 mp0 -56.22 -46.64 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.395 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -61.51 -50.06 74.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.363 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.7 p -59.3 -50.56 73.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.5 ttt -53.95 -49.36 68.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.54 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -48.0 82.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.738 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.556 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.73 0.01 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.238 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 mt -117.63 83.54 17.73 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.256 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -50.38 -0.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.688 2.258 . . . . 0.0 112.403 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.2 mp -62.66 -30.41 71.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 -39.82 9.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.672 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.67 -45.46 52.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.424 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 10.3 t-105 -73.64 -17.95 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.449 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.63 72.57 24.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.783 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.84 -17.54 12.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.662 2.241 . . . . 0.0 111.688 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -54.32 -52.59 61.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.863 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.07 55.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.745 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.93 -41.1 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.363 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -60.61 131.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 0.0 110.775 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.17 157.91 16.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' PRO . 47.9 p -164.87 99.82 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.564 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.12 -176.93 21.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 23.8 m-20 -84.55 156.57 21.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.798 0.332 . . . . 0.0 110.381 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 5.4 m -105.09 130.25 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.792 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.55 -6.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.889 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.71 151.97 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.896 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.685 ' HE ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -91.6 135.73 33.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 0.0 110.997 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -126.73 -24.4 3.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.25 141.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.7 163.35 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 112.23 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -130.83 139.61 50.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.8 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.3 17.13 3.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.5 19.95 61.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mt -122.7 134.48 54.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.922 0.391 . . . . 0.0 110.364 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.58 150.98 45.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.514 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.9 mtt -48.81 -55.18 21.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.765 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -40.94 -37.98 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.379 2.052 . . . . 0.0 112.028 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.53 -50.91 32.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.253 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.0 m95 -59.66 -57.25 13.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.487 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 146' ' ' LEU . 3.0 tm? -43.53 -41.76 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.53 -36.86 67.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.96 -40.83 93.85 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.728 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.2 mp -79.61 -26.55 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.192 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.14 -50.2 71.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.273 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.7 tt -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.593 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.28 -47.29 55.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.237 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.65 -45.91 73.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.5 mt -58.2 -30.54 66.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.832 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.54 -27.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.706 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 95.8 t -71.45 -36.19 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.976 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.487 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.25 -52.74 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.544 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.75 -38.76 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.627 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 3.7 mm? -81.71 -32.35 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.118 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 38.3 t -76.5 -22.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.63 -50.56 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 109.945 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -68.81 -17.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.55 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 90.8 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -46.8 -36.42 7.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.561 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -39.72 75.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.34 -44.16 54.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.305 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.84 -25.78 66.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.191 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -78.69 -46.78 18.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.8 76.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -76.62 -31.62 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.956 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -75.15 7.68 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.015 0.436 . . . . 0.0 110.462 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.17 145.58 17.02 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.06 -20.35 65.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.312 . . . . 0.0 110.601 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.59 58.48 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.43 67.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -55.98 -46.15 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.225 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.17 -31.66 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.523 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -32.45 71.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.3 mtt -69.85 -34.57 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.459 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.87 59.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.733 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -50.23 -51.05 47.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -52.32 -56.66 13.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.04 -31.24 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.88 -40.85 24.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.803 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.44 -44.56 17.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.706 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.4 mp -68.14 -25.4 65.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.02 -39.48 75.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.801 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -77.95 -47.34 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -50.23 -45.94 54.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.96 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.65 -20.99 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.829 0.347 . . . . 0.0 110.697 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -90.12 -22.14 21.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.5 -38.22 71.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.244 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 0.36 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.224 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -120.84 -49.35 2.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.46 -37.59 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.894 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.528 ' SD ' ' CZ3' ' A' ' 135' ' ' TRP . 15.8 ttt -109.81 13.54 23.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.6 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 37' ' ' LEU . 6.5 mp 42.36 37.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.51 149.69 43.88 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -110.34 125.76 30.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.668 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.15 145.99 19.69 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.429 2.086 . . . . 0.0 111.891 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -101.06 -174.99 2.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.708 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.77 -46.73 91.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.08 -47.03 88.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -51.49 -44.49 62.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.3 mt -61.42 -48.13 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.487 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 11.1 t80 -54.65 -44.99 73.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.728 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.52 -48.19 73.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.663 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -60.04 -38.21 82.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.73 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.2 90.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.507 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.03 76.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.405 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -73.41 -48.39 34.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.13 -42.24 19.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.8 -45.65 81.96 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 57' ' ' ALA . 56.1 t -62.24 -45.81 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.135 0.493 . . . . 0.0 109.749 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 tp -44.2 -48.59 9.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.352 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.95 97.52 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -56.54 -37.87 71.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.46 . . . . 0.0 110.295 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.54 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.327 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -70.23 -44.73 67.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -73.52 -35.32 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -31.08 68.27 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.75 5.5 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.694 0.283 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 63' ' ' ILE . 90.2 mt -79.18 -42.57 23.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.07 77.23 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.343 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.88 30.87 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.718 2.279 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -110.54 -9.82 14.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.127 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -108.83 176.21 1.66 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.889 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -6.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.126 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 67' ' ' THR . 37.7 mt -53.47 -28.1 28.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' NH1' ' HH ' ' A' ' 71' ' ' TYR . 10.1 ttm180 -40.76 -70.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.427 ' HH ' ' NH1' ' A' ' 70' ' ' ARG . 91.8 m-85 -54.95 -30.52 59.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.413 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.468 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 9.3 t -67.02 -54.48 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.785 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.66 63.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.264 0.554 . . . . 0.0 110.222 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 74' ' ' MET . 6.6 tmm? -59.13 -12.23 4.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.961 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 2.2 p -62.7 -32.46 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.379 0.609 . . . . 0.0 110.355 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.29 -32.95 5.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.039 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.56 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -66.06 -48.81 69.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.864 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.1 tp -65.9 -48.63 70.83 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -42.42 -42.52 3.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.125 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 84' ' ' GLY . 18.2 p -79.4 -21.38 45.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.89 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.27 -61.51 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.069 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -71.48 -45.59 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.555 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.487 ' CZ ' ' OH ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -77.54 -41.96 37.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 80' ' ' SER . . . -57.6 -49.63 72.05 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.385 -0.912 . . . . 0.0 110.825 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.514 ' O ' ' OG1' ' A' ' 88' ' ' THR . 28.2 m -68.3 -43.25 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.002 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -56.64 -31.36 64.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.506 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -43.42 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 110.32 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 33.5 p -52.32 -26.69 12.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.288 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.49 -50.02 64.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.641 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -52.19 -41.26 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -62.43 -48.97 77.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.2 p -66.77 -48.95 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.5 ttt -49.96 -49.96 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.02 -47.5 77.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.681 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 2.4 pm0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.63 0.252 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -124.71 27.16 6.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.594 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.1 mm? -122.58 78.15 46.92 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.852 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.24 -3.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.732 2.288 . . . . 0.0 112.266 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.5 mp -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 110.368 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -96.73 -42.98 7.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -70.24 -45.5 66.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.642 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -73.88 -17.14 61.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.17 71.78 33.57 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.26 -17.41 10.38 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.9 2.4 . . . . 0.0 111.785 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -51.89 -52.57 48.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.627 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.8 53.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.558 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -155.4 -40.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.452 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 p -55.75 128.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.13 151.0 19.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -169.94 100.59 0.3 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.43 177.88 18.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 11.8 t70 -86.53 138.22 31.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.094 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.571 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 37.3 m -92.96 130.66 38.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 92.45 -7.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.85 147.83 52.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -80.99 132.18 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.422 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.38 -26.33 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.627 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.528 ' CZ3' ' SD ' ' A' ' 36' ' ' MET . 0.6 OUTLIER -175.69 135.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -139.01 167.17 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.158 0.504 . . . . 0.0 111.606 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.26 120.09 10.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.474 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.1 16.91 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.71 16.8 72.12 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 mp -120.85 136.29 54.96 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.76 154.6 41.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.594 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -55.42 -51.57 78.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 142' ' ' MET . 75.5 Cg_exo -45.84 -37.78 17.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.384 2.056 . . . . 0.0 111.785 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.88 -48.48 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.819 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 50.2 m95 -57.24 -57.19 13.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.0 tp -44.26 -38.88 4.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.11 -37.54 67.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.21 -45.56 95.84 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.597 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.7 mp -75.63 -25.67 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 109.908 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.97 -46.32 85.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.5 pt -67.88 -35.77 73.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.385 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.98 -49.48 77.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.343 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.39 -48.37 71.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.717 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.487 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 31.1 mt -62.56 -34.32 76.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.073 0.463 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.9 mt -71.03 -35.56 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.611 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.57 -42.1 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.321 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.56 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -62.37 -34.21 76.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.3 t -73.35 -25.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.216 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.448 ' O ' ' OG ' ' A' ' 163' ' ' SER . 13.4 mt -84.83 -40.01 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.335 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.97 -25.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.89 -49.37 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.778 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.1 mm -72.02 -8.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.306 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 2.7 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.473 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -52.26 -31.91 34.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 7' ' ' GLN . 10.6 t80 -76.26 -42.07 46.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.374 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -46.42 -39.67 10.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 10' ' ' GLN . 8.3 t-20 -66.57 -24.05 66.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.259 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' PHE . 41.9 tt0 -81.02 -45.89 15.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.54 89.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.503 ' C ' ' H ' ' A' ' 11' ' ' GLY . 57.4 p -76.29 -37.37 57.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.638 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 6' ' ' ASN . 64.8 mt-30 -67.03 5.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.7 145.59 17.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.45 -48.48 60.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.34 6.05 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.94 81.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.144 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -58.25 -47.36 83.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.29 -28.33 68.01 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.55 -29.46 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -32.97 61.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.41 17.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 -52.83 39.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.678 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.0 p -48.26 -57.91 5.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.755 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.31 27.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 tt -81.45 -38.85 25.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.68 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.933 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.0 mp -69.0 -33.14 73.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.715 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -63.38 -41.37 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.1 -50.04 21.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.931 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -47.76 -47.2 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.665 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.95 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.34 -20.44 66.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -88.27 -42.77 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -51.61 -46.63 63.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.165 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' C ' ' OE1' ' A' ' 33' ' ' GLN . 0.5 OUTLIER -70.11 -29.01 65.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -68.04 -26.89 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.7 t -104.8 -53.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.162 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.0 mtt -75.4 3.51 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.17 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt 44.53 47.22 8.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.563 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.54 154.67 32.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.569 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -116.1 126.33 27.74 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 174.72 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.246 1.964 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.7 t -131.85 -175.82 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.765 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 40.5 t -64.44 -44.44 97.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.722 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.21 -49.96 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.54 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -49.14 -50.19 38.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.526 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.59 -41.36 89.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.918 0.39 . . . . 0.0 110.186 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -45.26 76.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.742 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -63.93 -35.96 82.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.044 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -65.27 -41.51 94.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.233 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.59 78.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.42 74.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.055 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.3 tp -77.41 -45.91 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.993 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -38.66 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.46 80.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 57' ' ' ALA . 38.0 t -62.81 -47.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.241 0.543 . . . . 0.0 109.71 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.8 tp -42.87 -47.2 5.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.562 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.4 92.38 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -55.87 -43.57 77.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.17 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.75 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.227 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.68 -43.23 94.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.449 HD12 HG23 ' A' ' 60' ' ' ILE . 19.6 mm -74.38 -43.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.623 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.13 68.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.34 4.36 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 63' ' ' ILE . 96.8 mt -79.43 -44.74 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.537 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -174.04 74.73 0.36 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.97 18.34 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.666 2.244 . . . . 0.0 112.407 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 64' ' ' ALA . 12.2 pttp -104.9 -7.66 19.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.639 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.98 176.85 1.33 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.446 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.5 1.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 0.0 111.878 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.639 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.3 tp -54.71 -34.89 63.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.639 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' SD ' ' A' ' 74' ' ' MET . 30.9 mtm105 -38.24 -66.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -53.64 -22.1 8.12 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.176 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.0 t -78.99 -48.26 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.336 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.16 -35.04 56.35 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 110.167 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.611 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.1 OUTLIER -64.83 -9.73 22.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.167 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 6.3 p -62.67 -35.38 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.1 mm -87.93 -33.74 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.831 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.574 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 16.7 t-105 -61.1 -50.42 73.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.046 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.93 -45.03 79.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -45.19 -44.87 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -79.89 -23.36 41.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.3 -60.45 3.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.631 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -71.76 -56.32 6.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.169 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -66.39 -51.05 61.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.85 -47.73 52.77 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.455 ' O ' ' OG1' ' A' ' 88' ' ' THR . 70.0 t -65.28 -32.05 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.266 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.54 -33.28 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.43 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.96 -40.65 38.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.542 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 46.6 p -52.77 -35.25 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.737 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.42 -52.14 24.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -46.1 -31.05 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.35 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -75.91 -45.56 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.652 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.1 p -67.5 -49.73 62.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.691 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -53.11 28.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.056 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.75 -49.62 72.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.464 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.323 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.758 0.313 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -4.18 58.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.395 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.652 ' C ' ' H ' ' A' ' 116' ' ' LEU . 19.9 mt -128.44 80.77 71.88 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.1 Cg_exo -50.71 3.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.815 2.344 . . . . 0.0 112.269 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.652 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.2 mm? -57.72 -33.24 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 0.0 109.975 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.556 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -96.73 -45.35 6.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.531 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -65.73 -45.46 82.56 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.331 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 32.6 t-105 -73.75 -14.35 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.83 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 t -142.04 74.87 21.23 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.79 -17.12 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.849 2.366 . . . . 0.0 111.696 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -54.84 -53.76 51.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.484 ' O ' ' CG2' ' A' ' 123' ' ' VAL . 3.5 p -105.63 60.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.585 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.556 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -164.77 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.385 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.6 p -62.4 130.22 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.1 157.98 15.98 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.8 p -162.73 99.66 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.499 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 142.84 -173.45 24.03 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 20.8 t70 -93.24 152.99 18.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.892 0.377 . . . . 0.0 110.172 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 5.4 m -104.68 128.59 52.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 99.54 -10.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.852 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -67.92 147.9 51.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 40.8 ttp180 -89.57 132.81 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.347 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -129.94 -21.47 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.503 ' CE3' ' SD ' ' A' ' 142' ' ' MET . 24.6 t90 -174.05 134.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.976 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -140.94 160.68 39.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.22 0.533 . . . . 0.0 111.914 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.77 140.46 50.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.085 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.68 17.44 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.49 21.82 46.44 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.86 137.93 54.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -71.9 146.95 47.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.561 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.503 ' SD ' ' CE3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -47.39 -57.57 9.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.539 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.1 Cg_exo -38.28 -38.41 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.586 2.191 . . . . 0.0 112.568 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -73.28 -52.23 14.72 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.149 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.572 ' O ' ' N ' ' A' ' 148' ' ' GLY . 66.9 m95 -55.53 -58.0 9.58 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.823 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.1 tp -44.01 -39.36 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 tt -54.96 -36.86 65.77 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.86 -43.37 99.3 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.643 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.94 -25.48 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -65.4 -43.56 90.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.401 HD13 HG23 ' A' ' 151' ' ' ILE . 18.6 pt -67.55 -37.8 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.286 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.88 -50.34 73.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.325 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.463 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 m-85 -54.33 -45.16 72.6 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.859 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.474 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 0.5 OUTLIER -75.86 -29.72 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.881 -179.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.12 -35.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.24 -35.86 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.75 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.574 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.81 -50.34 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.637 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.87 -48.03 78.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.67 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.527 ' C ' ' HG ' ' A' ' 163' ' ' SER . 16.6 t -69.23 -27.12 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.72 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.1 t -80.98 -46.13 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.427 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.6 mm -75.7 -13.99 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.527 ' HG ' ' C ' ' A' ' 160' ' ' VAL . 9.6 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.604 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.845 0.355 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.427 ' H ' HD23 ' A' ' 2' ' ' LEU . 64.9 mtm-85 -55.62 -40.47 72.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.305 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.37 -44.28 91.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.64 -42.16 44.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.309 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 10' ' ' GLN . 49.6 t30 -67.61 -28.14 67.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.915 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -73.04 -50.37 23.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.34 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.3 p -75.99 -35.36 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.588 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.519 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 38.3 mt-30 -74.32 12.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.966 0.413 . . . . 0.0 110.388 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.63 147.94 16.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -70.74 -49.89 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.32 -46.11 6.67 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.44 90.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.23 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.0 -32.03 69.33 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.942 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -27.94 60.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.69 -36.37 73.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 18' ' ' MET . 1.4 ppp? -72.58 -31.22 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.2 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.2 -47.45 46.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.724 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.8 p -54.6 -62.16 1.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.23 -39.75 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.55 -41.47 75.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.07 -36.66 30.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.3 mp -71.71 -36.41 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.77 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.97 -46.29 89.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.116 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.16 -48.85 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.09 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 40.8 m -46.2 -43.06 14.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.694 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.18 53.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.494 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.43 -18.61 64.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.605 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.15 -44.67 52.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.52 -28.02 62.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -70.9 -24.78 62.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.52 -45.07 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.158 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.2 mtt -83.96 5.07 26.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 mt 44.82 42.24 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.706 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.9 mt -80.42 153.73 28.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -117.84 130.32 24.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.79 179.39 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.249 1.966 . . . . 0.0 111.759 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.4 t -131.73 -175.49 3.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.402 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.918 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -68.05 -50.12 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -49.41 -50.94 38.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.691 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.96 -41.08 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -54.61 -45.73 73.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.96 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.51 -40.21 86.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.161 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.6 ttp85 -57.89 -35.94 71.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.3 -38.31 78.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.472 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -76.41 -51.07 12.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.339 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -46.99 -39.4 12.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -43.83 91.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' CG2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t -65.32 -41.58 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 110.037 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 tp -50.8 -50.44 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.842 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.99 92.7 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.23 -37.29 34.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.975 -0.612 . . . . 0.0 110.218 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.53 -25.45 60.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.23 -43.42 64.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.579 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mm -73.64 -30.61 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.04 -26.46 48.78 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.58 -2.96 21.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.66 -20.8 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.502 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 178.86 68.87 0.12 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.75 25.79 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.875 2.384 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -110.27 -6.33 15.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.55 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.555 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.13 174.41 2.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.83 -9.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.226 1.95 . . . . 0.0 112.175 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.555 ' H ' ' C ' ' A' ' 67' ' ' THR . 11.7 mt -51.32 -30.04 17.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -41.67 -69.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.53 -38.61 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.004 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.45 -54.04 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.45 70.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.399 0.619 . . . . 0.0 110.046 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.6 ttp -61.21 -25.24 66.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.612 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -51.56 -37.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.242 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -85.38 -37.37 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.404 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -57.68 -49.47 76.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.68 -46.89 77.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -46.97 -47.57 21.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.426 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 59.6 p -79.28 -25.61 42.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.35 4.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -52.89 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -65.57 -42.46 91.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.0 93.05 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 88' ' ' THR . 68.3 t -69.89 -54.24 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 111.12 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -47.7 -29.13 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.328 . . . . 0.0 110.743 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tp -85.16 -39.48 17.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.713 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 40.7 p -53.18 -23.15 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.3 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -76.15 -40.48 52.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.506 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.35 -39.91 73.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.387 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.1 m170 -69.18 -49.53 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -61.96 -49.92 74.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 17.3 ttt -47.53 -46.71 27.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.635 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.52 -44.29 74.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.671 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.58 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.648 0.261 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.459 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 8.5 p-90 -124.99 -2.95 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.709 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.64 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.82 86.3 19.03 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.873 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.3 Cg_exo -53.76 8.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.646 2.231 . . . . 0.0 112.483 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.64 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.5 mm? -73.63 -27.61 61.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.05 0.452 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -96.36 -41.02 8.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -70.59 -45.15 65.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.314 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 3.2 t90 -73.29 -18.1 61.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.54 73.71 20.12 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.06 -18.09 13.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.669 2.246 . . . . 0.0 111.802 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.69 -11.22 60.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.867 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.41 45.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -38.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.29 129.74 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.648 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.48 152.93 17.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.525 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 t -166.01 100.32 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.656 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.67 -176.15 21.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.454 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 31.3 t70 -87.12 147.88 25.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.336 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 11.9 m -99.61 130.09 45.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.814 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.0 -4.56 0.34 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.16 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.98 129.65 40.58 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -66.39 128.72 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -126.03 -25.27 3.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.708 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -174.86 136.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -139.94 161.15 38.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.085 0.469 . . . . 0.0 111.412 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -137.05 119.83 16.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.29 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 2.1 tp 78.63 16.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.24 14.84 73.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.83 133.19 55.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.746 0.308 . . . . 0.0 110.262 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.51 ' N ' ' OE2' ' A' ' 141' ' ' GLU . 2.1 mp0 -74.82 156.55 36.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.407 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 6.4 mtm -48.38 -61.39 3.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.6 Cg_exo -35.55 -41.05 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.57 2.18 . . . . 0.0 112.49 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.17 -44.22 60.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.608 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.4 m95 -66.13 -57.89 6.67 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.927 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.65 -38.56 3.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.1 tp -62.36 -34.3 76.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.04 -49.11 69.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.562 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.8 mp -66.35 -27.11 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -39.12 90.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.49 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 152' ' ' ALA . 2.4 tt -66.62 -36.58 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 151' ' ' ILE . . . -54.38 -48.89 71.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.75 -41.45 81.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 10.2 tp -53.96 -30.9 48.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 0.0 109.927 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 40.1 mm -79.63 -32.3 14.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.013 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.63 -45.86 91.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.924 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.18 -46.76 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.138 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 159' ' ' LEU . 3.3 p -51.79 -40.61 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.544 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.409 ' O ' ' OG ' ' A' ' 163' ' ' SER . 15.7 mt -80.11 -33.13 38.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.171 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.29 -24.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.957 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.2 t -80.66 -50.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.103 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 39.5 mm -71.25 -10.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.483 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 23.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.236 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.422 ' H ' HD13 ' A' ' 2' ' ' LEU . 4.6 mp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.861 0.362 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -52.02 -41.41 62.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.193 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' GLN . 22.3 m-85 -63.86 -44.43 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.074 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -45.93 -41.75 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.42 ' OD1' ' OG ' ' A' ' 163' ' ' SER . 46.5 t30 -67.9 -28.68 67.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.003 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' PHE . 5.9 tp-100 -76.03 -50.82 13.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.428 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.86 73.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.2 m -76.64 -42.27 42.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -66.52 3.3 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.387 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.94 145.07 17.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -68.8 -49.56 57.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.577 0.227 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.54 -46.3 5.69 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.56 85.44 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -58.36 -47.97 82.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.46 -29.36 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -30.93 68.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.47 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 tpt -72.08 -33.56 67.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.154 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.48 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -52.73 -51.35 60.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.667 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 p -51.56 -49.71 61.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.23 72.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.649 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.41 -38.02 77.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.482 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' ' CG2' ' A' ' 28' ' ' THR . . . -52.69 -35.27 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.565 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.9 mt -74.42 -41.21 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.57 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -67.18 -55.48 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.761 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.86 -53.38 56.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 16.9 p -49.31 -45.16 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.07 -43.24 65.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.735 0.302 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.76 -20.25 5.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.646 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -91.88 -39.49 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.542 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -48.86 -38.1 21.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.971 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -68.82 -38.58 79.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.77 -5.26 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.3 -46.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.891 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 30.6 mtt -100.81 10.01 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.926 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.95 42.61 28.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -87.69 154.06 20.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -121.09 141.43 32.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.864 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 127' ' ' SER . 88.0 Cg_endo -78.25 171.52 16.88 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 112.283 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.575 ' H ' ' HG ' ' A' ' 44' ' ' SER . 7.6 t -131.95 -173.67 3.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.405 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.9 t -64.3 -48.77 84.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 4.1 mm? -60.35 -46.88 88.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.575 ' HG ' ' H ' ' A' ' 41' ' ' CYS . 75.5 p -48.43 -43.97 34.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.333 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 45' ' ' ILE . 38.2 mm -61.54 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.919 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.53 -48.45 74.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.153 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 43' ' ' LEU . 2.5 mp0 -61.01 -42.73 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 52' ' ' PHE . 33.7 ttt-85 -64.3 -38.31 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.313 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.46 77.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.52 74.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.35 -51.61 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.406 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 59.8 t80 -43.97 -40.08 4.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.667 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.46 74.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.5 -47.64 90.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.915 0.388 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.9 tp -44.53 -50.53 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.84 -49.37 75.1 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -32.7 18.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.37 -36.01 80.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.205 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.51 -32.03 69.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.595 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.03 -38.49 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.585 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.76 -19.06 66.49 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.5 27.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.288 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.77 -25.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 177.37 73.52 0.1 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.575 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.23 26.31 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.591 2.194 . . . . 0.0 111.96 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 64' ' ' ALA . 1.2 mmmp? -104.66 -8.34 18.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.591 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.19 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.666 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.02 -2.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.264 1.976 . . . . 0.0 112.106 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.591 ' H ' ' C ' ' A' ' 67' ' ' THR . 42.9 mt -53.45 -33.85 55.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.549 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.561 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.8 ptp180 -40.89 -63.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.642 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.561 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 1.7 t80 -56.59 -29.85 62.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.458 0.572 . . . . 0.0 110.182 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' LEU . 12.5 t -68.22 -45.08 83.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.849 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.79 -32.59 46.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.51 . . . . 0.0 110.174 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttp -65.43 -19.4 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.751 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.2 -37.25 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.373 0.606 . . . . 0.0 110.419 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.4 mt -88.72 -31.55 5.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.713 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.548 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -66.76 -46.88 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.3 OUTLIER -66.5 -48.54 69.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.47 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -44.78 -43.91 8.96 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 p -75.91 -24.15 55.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.99 -60.25 4.13 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.269 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -73.9 -53.4 10.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -67.91 -43.66 78.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.76 -46.05 95.24 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.955 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.91 -41.11 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.97 -45.18 93.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.528 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.98 -42.84 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.038 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.2 p -48.8 -47.75 41.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.616 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -51.41 -32.37 26.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.404 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -71.01 -36.29 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.66 -36.99 73.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -74.2 -31.87 62.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.492 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 tpt -62.26 -43.14 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.421 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tp -64.2 -49.15 73.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.516 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' CD ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.601 0.238 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.511 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 3.8 p-90 -125.01 30.08 5.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 110.745 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.5 tp -125.63 68.96 62.23 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.409 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 119' ' ' TRP . 56.5 Cg_exo -46.51 -8.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 112.285 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.7 tp -53.31 -33.7 54.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 110.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.46 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 4.5 m-20 -96.45 -43.76 7.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.209 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.14 -45.28 67.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.415 ' N ' ' O ' ' A' ' 115' ' ' PRO . 12.0 t-105 -73.2 -18.87 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.568 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.56 72.31 25.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.179 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.77 -15.25 9.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.837 2.358 . . . . 0.0 111.538 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -49.22 -48.14 45.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.77 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.91 53.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.46 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 5.7 t80 -156.11 -39.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.86 130.0 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.66 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.97 150.54 20.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' PRO . 6.4 t -161.52 99.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.53 -172.45 23.02 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.529 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -88.41 151.52 22.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 12.9 m -103.19 130.3 50.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 97.21 -9.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.05 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 150.72 47.87 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.976 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -85.9 136.1 33.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.461 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -127.39 -17.62 4.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -172.92 120.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 7.7 t0 -115.04 148.96 38.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.344 0.593 . . . . 0.0 112.28 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.533 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 7.3 t80 -128.57 136.73 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.737 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp 54.27 17.44 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.439 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.14 13.02 64.73 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.665 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.523 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 9.1 mp -121.11 146.82 46.35 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -76.72 151.26 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.44 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 4.0 mmt -48.04 -63.36 1.55 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.3 Cg_exo -32.18 -38.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.938 2.425 . . . . 0.0 112.449 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -69.45 -53.75 17.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.277 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 76.8 m95 -60.17 -57.02 14.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.0 tp -43.73 -37.67 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.88 -34.97 76.98 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.3 -44.57 96.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.9 mp -76.28 -25.89 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -62.45 -45.64 92.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.514 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 pt -68.82 -38.7 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.73 -48.19 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.362 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.34 -41.67 94.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.463 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 37.6 mt -69.29 -30.62 68.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.83 -27.34 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.7 t -73.85 -35.45 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.645 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -69.99 -52.36 24.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.107 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.86 -33.93 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.932 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.27 -43.55 23.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.4 t -69.14 -26.86 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.888 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.6 t -75.01 -45.44 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.328 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.64 -21.23 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' A' ' 6' ' ' ASN . 17.7 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.897 0.38 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -54.13 -42.89 70.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -45.38 87.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -50.34 -42.18 52.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.3 -29.48 69.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -78.53 -49.42 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.514 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.38 -33.34 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.69 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' GLY . 41.3 p -76.33 -34.22 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -74.28 10.03 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -107.29 142.06 15.7 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -62.55 -18.38 61.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 0.0 110.294 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.51 -48.29 51.78 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.61 -51.43 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -52.76 -40.17 62.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.029 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.26 -30.11 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.416 ' O ' ' OG1' ' A' ' 21' ' ' THR . 7.1 tp -69.17 -34.28 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.403 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 mtt -74.85 -33.16 62.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.84 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.82 32.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.775 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.35 -30.92 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 17' ' ' LEU . 96.8 m -61.53 -61.99 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.43 -23.84 41.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.09 -39.92 40.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.03 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -78.8 -29.71 45.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.736 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.77 -47.09 64.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.01 -46.4 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 p -50.13 -46.33 53.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -73.19 -38.41 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.941 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -17.93 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.219 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -97.28 -25.87 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -46.62 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.773 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 19.4 mp0 -83.68 -30.1 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.008 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -60.38 -26.21 66.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.251 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.66 -38.11 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.805 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.5 mmt -74.96 1.96 11.59 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.27 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 tp 55.83 50.48 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.722 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.84 156.17 18.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -117.01 142.27 29.65 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.659 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 127' ' ' SER . 65.7 Cg_endo -74.39 173.68 13.83 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.51 2.14 . . . . 0.0 111.918 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -131.94 178.43 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.46 -43.93 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.421 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.22 -48.93 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.468 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -51.8 -50.73 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.891 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 45' ' ' ILE . 96.7 mt -62.62 -38.62 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.215 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -54.46 -47.29 73.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.559 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -61.38 -43.85 98.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.265 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.32 60.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.091 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.23 80.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.88 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 mt -76.78 -53.33 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.997 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -45.81 -40.61 9.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.44 -45.35 86.29 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.1 t -61.84 -45.16 99.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.87 -44.0 19.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.566 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.28 -28.22 73.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.575 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.76 -26.84 57.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.56 -42.91 77.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.15 -29.93 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -12.74 83.08 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.81 1.78 51.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.529 0.204 . . . . 0.0 111.25 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 pt -87.22 -27.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.963 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.8 72.46 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.83 0.347 . . . . 0.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.78 24.75 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.951 2.434 . . . . 0.0 112.177 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -104.9 -8.7 18.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.601 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.82 176.74 1.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.481 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -47.81 -4.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.321 2.014 . . . . 0.0 112.26 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.601 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 mm? -52.8 -31.22 37.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.139 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.496 ' NH1' ' OG ' ' A' ' 163' ' ' SER . 67.0 mtt180 -40.85 -69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.622 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.27 -35.73 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.437 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.4 t -62.27 -44.07 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.673 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.81 -33.13 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 109.483 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.62 -11.85 5.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.33 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.34 -42.85 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.288 0.566 . . . . 0.0 110.839 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.1 mt -87.06 -29.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.083 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.7 t-105 -60.74 -50.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.288 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 tp -70.07 -45.95 65.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.434 ' O ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -45.37 -50.41 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.015 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -71.12 -29.41 65.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.409 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -60.64 -58.92 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.425 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -70.85 -49.8 42.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -78.09 -33.8 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' A' ' 83' ' ' ARG . . . -65.3 -46.93 84.85 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' O ' ' OG1' ' A' ' 88' ' ' THR . 19.8 m -68.67 -44.72 82.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.766 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.402 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 2.9 tp-100 -50.13 -24.46 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.69 -41.1 16.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 69.8 p -49.0 -34.1 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.396 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.53 -52.0 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -49.1 -31.88 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -75.45 -50.18 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.013 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 p -68.97 -54.17 16.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.985 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 30.6 ttm -50.08 -49.14 52.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.3 tp -67.49 -39.25 85.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 131' ' ' ALA . 6.5 tp-100 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.723 0.297 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.499 ' CD1' ' C ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -88.53 9.06 25.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.211 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.655 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.1 tp -116.39 86.51 18.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.92 8.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.823 2.349 . . . . 0.0 113.003 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.655 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.5 tp -74.79 -28.12 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 124' ' ' PHE . 66.6 m-20 -95.76 -40.42 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.69 -33.99 76.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -86.93 -19.23 29.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.837 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.98 79.3 10.07 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.51 -16.08 12.08 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.605 2.203 . . . . 0.0 112.096 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -79.86 -4.85 54.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.743 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.77 45.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.194 0.521 . . . . 0.0 110.448 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.507 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 10.4 t80 -172.23 -39.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.336 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.75 125.18 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.483 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.07 157.69 15.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 40' ' ' PRO . 42.1 t -173.39 103.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.533 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.45 -172.62 24.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.4 m-20 -92.18 143.94 25.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.557 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.3 m -93.95 134.49 36.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 86.79 -0.05 0.57 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.06 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -67.73 155.66 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.245 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.59 145.69 25.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -133.66 -29.23 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.75 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -174.41 145.54 0.99 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.194 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -138.91 167.72 21.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.082 0.467 . . . . 0.0 111.482 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 63.9 t80 -143.51 119.0 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.717 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.9 OUTLIER 78.27 17.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -177.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.05 15.93 75.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 mp -119.51 131.27 55.53 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.3 152.18 44.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.373 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -50.75 -52.34 57.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 142' ' ' MET . 82.9 Cg_exo -44.28 -38.92 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.159 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.87 -49.14 31.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 148' ' ' GLY . 48.7 m95 -56.71 -57.32 12.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.6 tp -42.83 -42.14 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.548 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.66 -35.75 63.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.94 -39.98 97.74 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.615 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.41 -30.71 11.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -47.72 84.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.3 -41.08 83.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.564 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.93 -49.57 75.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.106 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -51.46 -46.76 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 37.7 tp -52.8 -36.98 59.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.568 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 27.3 mm -68.78 -41.72 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.5 -37.66 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -75.47 -31.21 60.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.44 -27.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.351 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.15 -42.11 16.36 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.156 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 163' ' ' SER . 9.3 p -73.1 -31.87 36.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.195 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 157' ' ' ALA . 54.0 t -73.25 -50.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.96 -22.96 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.496 ' OG ' ' NH1' ' A' ' 70' ' ' ARG . 24.1 p . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.49 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.442 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -60.46 -43.69 96.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 7' ' ' GLN . 42.4 t80 -62.21 -50.16 72.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -46.96 -37.24 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.245 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 38.2 t-20 -69.82 -25.91 63.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.311 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PHE . 85.9 mm-40 -82.4 -50.07 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.63 73.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.653 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' GLY . 88.7 p -76.24 -34.57 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -71.24 8.54 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.552 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.72 141.62 15.56 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -69.9 -50.1 45.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.769 0.319 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.12 5.7 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.06 86.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -60.63 -46.9 88.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.4 -30.27 68.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.37 -30.27 68.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.398 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.1 mmt -73.45 -31.16 63.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.73 -53.47 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.17 -32.69 64.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.928 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -65.99 -61.81 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.09 -23.86 62.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -81.82 -42.1 20.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.429 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -49.53 -50.97 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.648 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.2 mp -61.48 -33.88 74.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.599 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.88 -41.89 88.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.713 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.2 mm? -79.81 -52.13 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -42.11 -40.53 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.04 -41.72 34.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -55.36 -17.6 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.932 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -94.33 -35.34 12.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.607 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.82 -38.63 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.54 -35.29 60.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.555 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 1.5 t-80 -74.73 -10.12 59.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.294 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -109.18 -51.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.787 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.9 mtt -91.18 14.18 14.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.803 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.18 40.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.775 0.321 . . . . 0.0 110.721 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.31 152.11 46.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -108.66 115.93 56.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.87 147.73 21.7 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.272 1.981 . . . . 0.0 112.188 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 5.7 t -98.08 172.2 7.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.301 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 8.3 p -59.46 -41.26 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.944 0.402 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.427 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 76.4 mt -63.2 -45.27 92.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.056 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -48.84 -38.49 22.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.394 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 51.5 mt -69.49 -44.5 79.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.168 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -45.59 92.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.818 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -57.79 -44.34 86.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.386 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -61.33 -29.01 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -39.76 77.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.22 74.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 tp -76.59 -51.85 10.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -45.05 -39.96 6.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.25 -40.7 94.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 41.5 t -64.02 -17.71 21.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.699 0.762 . . . . 0.0 109.273 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -45.17 47.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.426 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.81 83.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.38 -40.06 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.351 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.87 -31.45 69.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.94 -29.52 50.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.145 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -79.08 -39.91 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.557 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.74 -33.19 79.71 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.18 9.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.697 0.284 . . . . 0.0 110.652 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 ' H ' ' C ' ' A' ' 61' ' ' GLY . 66.0 mt -78.41 -54.92 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.288 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -168.1 75.36 0.89 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 21.5 Cg_exo -61.67 14.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.974 2.449 . . . . 0.0 112.485 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.591 ' H ' ' C ' ' A' ' 64' ' ' ALA . 13.8 ptpt -109.78 -3.58 16.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.84 161.03 31.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.685 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -39.4 -15.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.484 2.123 . . . . 0.0 112.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.2 mp -43.25 -35.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.721 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.4 mtm-85 -40.24 -65.57 0.39 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.13 -15.87 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.619 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 69' ' ' LEU . 19.3 t -82.1 -46.37 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.722 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.23 -34.05 59.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.045 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.82 -8.55 2.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.329 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 32.7 m -59.25 -42.7 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.1 mt -87.76 -29.77 5.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.23 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.54 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.9 t-105 -63.77 -53.58 48.8 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.777 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.04 -43.89 90.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.508 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -47.32 -46.88 25.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.5 p -80.44 -21.63 41.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.67 -61.98 2.22 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.909 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -73.99 -44.08 55.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.541 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -75.17 -42.11 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.076 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.426 ' O ' ' OG1' ' A' ' 88' ' ' THR . . . -59.29 -48.61 85.12 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.04 -38.31 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.128 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -72.84 -36.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.32 -49.32 19.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 84' ' ' GLY . 11.3 p -51.17 -49.1 61.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.573 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.53 -39.48 34.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 110.085 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -58.96 -41.69 88.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.379 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -66.78 -39.07 87.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.589 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -68.68 -35.02 76.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ttt -59.05 -44.13 91.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -49.34 78.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.114 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.179 179.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -103.83 -1.56 27.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.635 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -119.68 81.64 25.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 43.9 Cg_exo -53.24 4.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.547 2.165 . . . . 0.0 112.246 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.635 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.9 mm? -66.87 -30.18 70.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.06 0.457 . . . . 0.0 110.248 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -96.78 -41.53 8.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.179 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -71.12 -45.0 64.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.749 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 20.4 t-105 -75.26 -15.15 60.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.8 69.17 65.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.86 -20.23 9.16 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.734 2.289 . . . . 0.0 111.256 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -52.22 -53.89 37.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.504 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.92 55.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.732 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.528 ' CZ ' ' OD1' ' A' ' 117' ' ' ASP . 2.1 t80 -157.89 -41.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.53 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.43 128.36 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.53 155.36 17.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.1 m -165.24 99.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.38 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.46 -173.37 23.1 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 9.1 m-20 -97.26 165.15 12.17 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.3 m -116.19 127.68 54.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.78 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 100.03 -8.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.94 143.15 55.77 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.01 128.05 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -132.82 -23.36 2.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -173.17 127.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.23 163.65 29.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.297 0.57 . . . . 0.0 112.164 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.02 137.92 54.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.156 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.84 16.69 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.92 13.43 53.09 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.365 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.3 mt -123.83 145.09 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.176 0.488 . . . . 0.0 109.955 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.35 150.82 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.699 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.432 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.4 mtp -47.53 -54.44 22.5 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.679 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 142' ' ' MET . 79.8 Cg_exo -40.21 -37.78 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.98 -47.18 60.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.947 0.403 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.9 m95 -65.79 -57.98 6.72 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.49 -36.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.947 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.2 tp -66.49 -34.74 78.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.35 -35.86 73.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mm -69.76 -44.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.21 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -44.15 69.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.77 -46.37 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.779 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.39 -50.22 74.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -61.95 -47.17 86.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.912 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 7.9 tt -53.57 -30.98 44.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.66 -27.68 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.147 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 70.2 t -75.0 -28.58 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.913 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.54 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.65 -39.63 26.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.785 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.21 -31.5 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.557 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.7 -42.77 27.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.31 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 163' ' ' SER . 28.4 m -71.26 -22.94 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.812 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.68 -50.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.62 -15.73 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.821 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 91.7 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.528 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 25.2 mtt85 -53.55 -28.86 34.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.06 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' GLN . 35.2 m-85 -76.94 -42.91 37.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.405 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -46.8 -42.73 17.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 7' ' ' GLN . 24.5 p30 -72.61 -23.0 60.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.5 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 48.4 tp60 -79.93 -48.51 13.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.554 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.42 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 11' ' ' GLY . 19.7 m -76.53 -36.05 57.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -67.55 4.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.4 141.46 15.24 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.46 -46.2 87.34 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.99 -44.92 5.9 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.1 77.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -58.44 -43.28 88.72 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.196 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.04 -28.46 68.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.1 tp -69.34 -31.96 70.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.377 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 21' ' ' THR . 39.9 mtt -73.45 -32.87 64.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.02 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.4 -52.99 26.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.536 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.05 -49.63 50.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.2 p -53.42 -42.49 67.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.499 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.11 67.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.642 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.5 mt -87.79 -42.11 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -58.11 -25.02 60.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.536 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.14 -38.45 36.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.78 -47.07 64.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.54 -48.99 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.672 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 51.0 m -49.7 -47.64 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.566 ' O ' ' NE2' ' A' ' 33' ' ' GLN . . . -73.47 -28.25 61.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.538 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.56 -20.53 66.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.978 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -91.45 -32.26 15.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.6 m-85 -58.23 -46.92 85.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.285 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 29' ' ' ALA . 1.0 OUTLIER -62.68 -49.41 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.78 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -24.04 18.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.23 -18.94 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' PHE . 33.0 mmm -98.43 -3.17 37.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.85 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.88 39.81 30.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.93 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.92 158.06 16.27 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -121.43 144.03 39.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.03 152.71 51.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.575 2.183 . . . . 0.0 112.2 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.7 t -115.81 -172.21 2.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.541 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.423 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 12.6 t -63.81 -47.86 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.034 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.26 -49.1 77.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.436 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 t -48.53 -46.42 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.2 mt -61.63 -43.11 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.366 . . . . 0.0 110.036 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -47.48 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.05 -39.29 93.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.83 -37.3 86.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.356 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.49 76.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.36 74.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tt -76.67 -51.92 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.214 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -45.68 -38.69 7.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.33 -43.91 91.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 25.5 t -61.47 -46.47 96.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -43.24 -47.67 6.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.312 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.08 -32.79 83.57 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.35 -31.45 70.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.53 68.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.391 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.469 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 15.8 mt -76.63 -31.08 57.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -80.16 -36.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.848 0.356 . . . . 0.0 110.053 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.36 -23.0 78.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.22 6.93 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.611 0.243 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -77.78 -51.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.131 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -172.84 74.82 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.444 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 23.03 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.739 2.293 . . . . 0.0 112.14 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -102.59 -10.37 19.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.233 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 2.6 p -113.9 155.83 44.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.13 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -37.31 -17.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.808 2.338 . . . . 0.0 112.834 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.2 mm? -44.98 -31.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' C ' ' O ' ' A' ' 69' ' ' LEU . 3.5 mmp_? -34.32 -55.16 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -53.13 -36.31 60.65 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.951 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 ' N ' ' A' ' 73' ' ' ALA . 3.4 m -65.16 -39.86 86.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.816 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' N ' HG21 ' A' ' 72' ' ' VAL . . . -76.24 -37.39 57.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.0 ttt -58.56 -14.36 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.8 t -55.08 -42.93 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.28 -31.14 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.644 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.439 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.2 t-105 -63.49 -55.4 24.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.113 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.0 tt -65.57 -48.41 72.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -42.84 -43.27 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.089 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 p -79.84 -22.43 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.791 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.45 -60.27 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.733 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.15 -55.08 6.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -65.95 -50.25 65.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.44 61.18 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.49 ' O ' ' OG1' ' A' ' 88' ' ' THR . 77.0 t -66.42 -45.42 89.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.895 0.379 . . . . 0.0 110.654 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.33 -31.86 67.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.58 -44.98 61.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -53.5 -27.0 23.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -70.97 -51.51 25.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -48.47 -34.24 10.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.25 -55.21 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -55.32 -46.69 76.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.1 ttt -56.73 -43.03 80.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tp -66.57 -22.99 66.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.059 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.993 0.425 . . . . 0.0 109.857 179.635 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.647 0.261 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -108.13 18.54 21.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.734 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.607 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -120.97 83.33 37.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.4 Cg_exo -53.03 2.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.647 2.231 . . . . 0.0 112.102 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.0 mp -63.63 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.638 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -97.02 -44.05 7.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -70.34 -45.58 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.471 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 15.7 t-105 -73.13 -15.05 61.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.98 74.89 11.96 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.46 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -12.62 13.82 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.907 2.405 . . . . 0.0 112.092 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -53.93 -54.12 43.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.839 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.436 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 8.5 t -106.94 60.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.72 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.7 m-85 -164.68 -41.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.07 125.13 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.442 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.57 152.01 21.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 m -162.95 99.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.642 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.25 179.45 17.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.442 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.8 OUTLIER -80.37 143.49 33.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.551 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 30.2 m -93.52 131.85 38.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 85.89 0.56 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.208 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' OE1' ' OD1' ' A' ' 129' ' ' ASP . 39.9 tt0 -68.31 128.65 37.36 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.216 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.72 116.49 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.344 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -104.19 -29.6 10.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.662 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -173.8 147.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.21 161.6 37.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.362 0.601 . . . . 0.0 112.054 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.25 138.59 54.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.84 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.44 17.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.94 22.82 40.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 mt -124.72 136.0 53.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.42 148.81 50.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.743 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.413 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.5 mtt -48.74 -52.74 42.99 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.67 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 142' ' ' MET . 81.8 Cg_exo -43.51 -35.96 6.48 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.286 1.99 . . . . 0.0 112.033 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.65 -46.55 58.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.321 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.0 m95 -64.52 -57.7 8.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.2 tp -43.53 -39.26 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.104 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.9 -33.75 74.79 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.63 -40.6 94.91 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.9 mp -72.68 -31.76 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 110.632 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.05 -39.62 86.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.502 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 152' ' ' ALA . 1.2 tp -70.94 -37.05 66.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.139 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.406 ' N ' HG22 ' A' ' 151' ' ' ILE . . . -65.16 -53.33 46.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -60.43 -38.52 84.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.224 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.443 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 7.2 tt -54.53 -37.84 65.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.4 mt -75.55 -40.64 41.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.8 t -48.96 -39.34 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.535 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.01 -43.63 43.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.963 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.58 -36.02 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.113 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.14 -32.72 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 163' ' ' SER . 54.2 t -77.76 -25.01 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.259 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.33 -50.75 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.32 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.43 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.4 mp -66.84 -22.54 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.716 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.1 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.517 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.888 0.375 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -47.92 -34.66 9.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.41 -38.21 74.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.991 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.9 tp -50.97 -40.17 57.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -66.62 -29.39 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.019 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.95 -49.82 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.39 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.799 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 11' ' ' GLY . 54.1 p -75.52 -33.94 60.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.643 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.493 ' N ' ' HG ' ' A' ' 9' ' ' SER . 15.4 mt-30 -75.17 14.98 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.57 150.26 17.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.6 ttm105 -67.9 -20.7 65.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.392 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.75 86.88 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.36 -51.56 59.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.355 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.465 ' NE1' ' O ' ' A' ' 9' ' ' SER . 19.4 m0 -54.08 -42.55 69.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.375 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.5 -30.89 64.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tp -68.55 -32.59 72.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.04 -33.87 61.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -51.99 48.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.723 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -53.87 -52.05 61.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.1 m -46.03 -61.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.8 -30.39 14.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.569 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.97 -40.8 53.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.04 -40.84 46.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.5 mp -69.21 -36.75 77.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.581 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.36 -49.37 69.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.65 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.72 -50.95 70.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -53.65 -42.34 67.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.33 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.035 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -20.86 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.95 -41.63 15.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.135 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -50.97 -43.67 60.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.0 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -77.43 -40.52 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.528 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -71.07 -16.59 62.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.772 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 31' ' ' TRP . 66.1 t -109.34 -50.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.18 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mtt -90.75 14.71 12.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp 41.16 37.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tp -63.43 155.58 28.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -120.25 90.93 45.62 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.967 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.11 147.52 19.95 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.567 2.178 . . . . 0.0 112.083 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 6.4 t -99.0 -173.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.779 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -67.19 -46.75 83.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.628 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.99 -47.02 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.216 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 m -49.19 -47.19 46.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.17 -39.95 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.235 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -54.67 -49.69 70.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.738 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -58.8 -39.71 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.435 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -58.68 -38.93 79.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.119 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.21 -39.52 94.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.506 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.91 82.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.9 tp -76.57 -50.4 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -44.11 -42.85 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.33 -41.41 96.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.47 -17.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.352 0.596 . . . . 0.0 109.901 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tp -81.79 -41.42 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.052 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -30.89 76.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.28 -35.15 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.151 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.78 97.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.1 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.61 -38.86 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.538 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.04 -21.0 78.29 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.68 3.64 32.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.279 . . . . 0.0 110.669 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -82.13 -49.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 179.15 77.09 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.25 21.35 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.892 2.395 . . . . 0.0 112.323 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -96.7 -8.37 31.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.116 0.484 . . . . 0.0 109.939 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -109.82 177.91 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.532 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 56.1 Cg_exo -50.49 -0.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.258 1.972 . . . . 0.0 112.278 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.616 ' H ' ' C ' ' A' ' 67' ' ' THR . 17.2 mt -62.33 -28.33 69.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -41.76 -64.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.573 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -55.5 -38.69 69.51 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.714 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -57.85 -54.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.546 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.03 -33.62 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.208 0.527 . . . . 0.0 110.314 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.1 ttt -64.56 -25.48 68.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.1 t -52.56 -32.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.457 0.646 . . . . 0.0 110.718 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -88.88 -31.56 5.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.097 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -65.98 -49.08 69.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.33 -43.51 77.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -46.87 -46.28 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.298 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -79.61 -21.48 44.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.742 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.61 -60.47 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.032 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -76.14 -48.47 20.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -67.77 -43.83 78.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.6 -47.64 90.14 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.87 -32.39 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.217 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.58 -28.6 65.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.39 -41.35 13.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 p -51.93 -51.88 53.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.727 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' O ' ' OG1' ' A' ' 92' ' ' THR . 8.2 m-85 -51.84 -48.36 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.137 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.09 -44.28 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.908 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' A' ' 91' ' ' HIS . 2.0 m-70 -62.82 -44.8 95.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.327 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 32.3 p -61.29 -47.75 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.3 tpt -45.5 -45.51 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.264 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.9 tp -64.94 -43.65 92.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.162 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.407 ' OE1' ' OE1' ' A' ' 141' ' ' GLU . 6.7 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -99.7 2.26 44.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.251 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.664 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.0 tp -119.88 85.09 33.49 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.2 Cg_exo -56.14 16.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.668 2.245 . . . . 0.0 112.638 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.664 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.1 tp -77.14 -30.85 55.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.029 0.442 . . . . 0.0 110.312 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -97.75 -40.28 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.098 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -70.61 -45.32 65.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.6 t90 -76.19 -11.64 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.334 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.46 71.19 17.75 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.831 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.77 -14.91 15.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.763 2.308 . . . . 0.0 111.766 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -57.33 -53.27 59.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.827 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 53.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -158.14 -39.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.287 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.2 t -54.97 123.92 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.18 158.17 15.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.648 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.56 104.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.501 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.04 -177.06 20.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 t70 -89.33 139.69 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 110.284 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.615 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 54.6 m -91.47 134.65 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 86.52 -1.09 0.64 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.095 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -68.0 153.2 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 119.01 37.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -122.68 -12.61 8.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.719 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -173.3 127.92 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.796 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.32 160.97 38.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.266 0.555 . . . . 0.0 112.179 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.66 137.31 53.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.862 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt 50.64 17.19 0.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.44 21.5 37.52 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.46 134.5 54.58 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.407 ' OE1' ' OE1' ' A' ' 95' ' ' GLN . 8.1 mt-10 -69.16 148.6 49.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.669 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.434 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -49.18 -51.93 52.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 142' ' ' MET . 89.4 Cg_exo -44.01 -38.74 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.426 2.084 . . . . 0.0 112.119 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.32 -49.6 47.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.3 m95 -60.85 -57.11 14.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.291 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.4 tp -43.03 -39.9 2.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.178 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.84 -34.82 75.15 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.91 -45.12 95.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.9 -34.45 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.955 0.407 . . . . 0.0 110.131 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -54.71 -47.58 73.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.75 -42.88 96.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.491 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.33 -45.95 24.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.403 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -64.02 -42.97 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.936 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.4 mp -51.97 -32.89 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.94 -27.78 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.639 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 55.2 t -63.45 -33.35 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.0 110.235 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.54 -49.98 10.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.308 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 65.3 t -53.79 -37.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.547 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 163' ' ' SER . 4.0 mm? -84.87 -33.68 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.128 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 17.4 t -70.07 -29.3 39.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.422 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.09 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.578 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 10.0 mt -71.73 -8.87 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.53 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 4.4 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.627 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -53.58 -34.52 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -72.31 -41.62 66.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.01 -43.81 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.385 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -64.83 -29.2 70.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.003 0.43 . . . . 0.0 110.277 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -78.5 -47.76 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.63 88.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.806 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.8 p -76.63 -35.39 58.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.673 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 6.4 tt0 -68.83 4.9 1.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.05 0.452 . . . . 0.0 110.405 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.79 146.99 17.31 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 63' ' ' ILE . 65.1 mtt180 -69.47 -48.84 59.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.667 0.27 . . . . 0.0 110.81 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.05 -46.32 6.26 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.93 -46.99 86.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.13 -42.17 89.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.82 -28.08 69.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -70.0 -27.71 64.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . 23.0 mmt -76.47 -33.91 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.161 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.12 -54.48 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.604 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -52.13 -51.83 55.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.654 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 18' ' ' MET . 11.0 p -45.41 -61.7 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.49 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.65 -40.04 80.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.91 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.6 mp -75.5 -38.53 59.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.16 -46.47 83.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.82 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.63 -55.15 14.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.4 p -45.45 -40.81 8.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.71 -42.25 51.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.821 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -18.57 3.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -88.92 -35.32 16.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.554 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -32.22 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.171 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.604 HE21 ' CB ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.44 -47.65 39.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 34' ' ' HIS . 20.8 t60 -70.89 -7.38 45.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.941 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.14 -42.18 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.029 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.7 mtp -99.85 12.46 36.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 9.3 mp 42.9 38.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.604 ' CB ' HE21 ' A' ' 33' ' ' GLN . 23.8 mt -74.59 156.29 36.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.894 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 126.51 27.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.05 137.43 17.32 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.234 1.956 . . . . 0.0 111.836 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.7 t -92.25 -178.05 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.565 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.07 -46.43 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.05 -48.32 82.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -48.65 -45.76 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.518 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.2 mt -61.38 -43.41 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.051 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -48.16 73.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -63.22 -36.4 83.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.721 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -68.24 -38.27 81.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.74 79.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.19 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.69 -50.45 13.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.199 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -46.47 -39.92 11.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.96 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -44.29 89.4 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.59 -47.35 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.986 0.422 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tt -45.41 -49.73 12.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.537 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.34 -49.71 75.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.83 -34.92 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.366 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.63 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.278 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -36.91 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.718 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -73.55 -35.88 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.447 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -15.32 79.3 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 3.59 32.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.605 0.24 . . . . 0.0 111.199 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.439 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 2.8 pt -91.19 -23.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.813 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.08 67.5 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.79 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.87 15.67 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.82 2.347 . . . . 0.0 112.027 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -102.38 -8.96 20.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.668 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.98 163.37 17.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.066 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.04 3.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.574 2.182 . . . . 0.0 112.607 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.668 ' H ' ' C ' ' A' ' 67' ' ' THR . 6.7 mp -67.06 -30.19 70.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.291 . . . . 0.0 110.918 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HD3' ' H ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -38.66 -42.82 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.608 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.477 ' CZ ' ' CG1' ' A' ' 75' ' ' VAL . 75.7 t80 -59.69 -37.95 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.672 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.2 m -59.62 -38.15 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.253 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -86.09 -30.51 22.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.716 -0.615 . . . . 0.0 110.114 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.8 ttp -67.75 -33.14 74.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.911 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 1.3 m -50.03 -28.57 4.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.562 0.696 . . . . 0.0 110.578 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.23 -31.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.976 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.439 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 13.8 t-105 -66.51 -47.6 72.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.81 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 tp -68.51 -47.85 65.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.439 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -43.98 -42.14 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.345 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -79.19 -24.28 43.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.583 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.37 -58.89 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.282 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CE2' ' NE2' ' A' ' 86' ' ' GLN . 73.5 t80 -74.2 -52.35 12.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.392 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -66.66 -40.86 88.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.25 93.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.427 ' O ' ' OG1' ' A' ' 88' ' ' THR . 95.2 t -72.84 -36.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.467 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 82' ' ' PHE . 7.6 tt0 -67.48 -45.95 74.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 tp -65.15 -42.96 93.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.568 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 6.6 p -51.46 -47.63 63.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.401 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -48.07 -41.81 27.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -59.82 -38.51 82.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.578 ' C ' ' HD1' ' A' ' 91' ' ' HIS . 1.7 t-80 -69.41 -56.07 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.387 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.4 p -55.72 -52.14 64.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.706 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 35.4 tpp -48.76 -45.23 39.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.44 -44.77 90.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.393 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.553 0.216 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.15 -5.96 7.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.432 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.654 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 mp -119.8 84.42 31.53 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.3 Cg_exo -55.15 11.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.568 2.179 . . . . 0.0 112.264 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.8 mm? -71.04 -32.74 69.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.086 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.0 p30 -97.63 -39.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 21.3 tttm -72.08 -45.26 61.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.8 t90 -76.34 -11.65 59.94 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.17 68.86 48.57 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -17.03 11.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.64 -33.99 35.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.28 45.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.586 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.55 -36.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.46 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.8 124.32 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.438 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.95 23.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t -164.98 101.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.584 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.66 -175.24 21.15 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -92.33 150.88 20.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.683 0.278 . . . . 0.0 110.323 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 11.9 m -100.74 132.07 46.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 95.56 -4.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.01 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.97 150.58 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.057 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -96.11 133.2 40.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.647 ' NE2' ' N ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -128.52 -22.5 3.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.732 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.647 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 21.6 t-105 -173.17 136.42 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.004 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 5.3 p30 -140.77 157.25 45.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 111.964 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.08 138.43 50.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.33 17.07 0.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.77 21.71 35.81 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.808 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.0 mt -124.86 137.27 54.3 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.33 148.86 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.402 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.9 mtt -47.89 -53.15 34.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -43.49 -37.35 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.419 2.079 . . . . 0.0 112.352 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -71.29 -50.33 33.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.993 0.425 . . . . 0.0 110.113 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 74.0 m95 -60.28 -57.84 11.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.09 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.7 tp -43.49 -37.8 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.062 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.7 tp -61.13 -34.94 75.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.72 -45.34 94.95 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.61 -31.88 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.12 -49.17 76.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.143 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.42 -46.68 94.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.537 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.42 -46.5 56.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.369 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -55.25 -43.24 74.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.2 mt -61.08 -30.58 70.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.869 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.62 -32.03 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 70.3 t -64.55 -37.6 80.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.439 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.29 -46.32 16.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.147 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.88 -44.01 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.37 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.42 -33.0 48.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 42.0 t -74.79 -22.97 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.882 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 46.2 t -82.17 -50.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.098 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.67 -17.34 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.796 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.7 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 -179.48 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -54.41 -31.59 55.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 12.6 t80 -74.89 -42.77 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.193 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.409 ' O ' ' OG ' ' A' ' 9' ' ' SER . 6.1 tp -47.97 -38.49 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.354 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -70.75 -27.05 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.448 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 7.1 tm0? -75.55 -49.94 17.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.23 -27.52 69.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 0.0 110.308 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' GLY . 23.0 m -76.51 -42.66 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.254 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -70.15 5.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.99 0.424 . . . . 0.0 110.684 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.69 142.66 16.2 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -69.0 -49.84 54.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.586 0.231 . . . . 0.0 110.713 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.86 -45.72 5.91 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -47.09 87.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -61.03 -37.07 81.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.26 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -32.34 70.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.95 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.82 -36.61 75.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.469 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.478 ' C ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -66.44 -34.79 78.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 -49.94 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.76 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.65 -41.87 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.9 m -64.39 -46.62 82.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.656 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.59 72.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.82 -42.08 20.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.91 -26.92 49.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -77.35 -39.82 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.542 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.2 -54.54 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -56.23 -50.48 71.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 p -49.91 -43.69 49.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.999 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.75 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.144 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -17.29 19.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -93.4 -37.63 11.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.702 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.78 -46.22 78.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.404 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -73.3 -36.21 66.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.63 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -61.25 -22.44 64.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.652 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.1 t -107.88 -28.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.805 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.6 mmt -92.03 3.27 55.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.999 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt 47.4 48.54 16.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.13 155.04 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.829 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -117.19 127.17 26.88 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.075 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.84 148.82 28.78 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.296 1.997 . . . . 0.0 112.368 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.654 ' H ' ' HG ' ' A' ' 44' ' ' SER . 10.2 t -94.58 173.57 7.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.32 -35.87 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 110.076 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -45.55 86.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.654 ' HG ' ' H ' ' A' ' 41' ' ' CYS . 19.0 m -48.94 -47.53 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.733 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.43 HG12 ' N ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -61.4 -38.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.43 ' N ' HG12 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -61.35 -46.19 91.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.838 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -65.1 -51.77 59.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.526 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -35.51 72.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.35 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.38 85.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.564 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.56 70.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.148 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' CD2' ' C ' ' A' ' 51' ' ' LEU . 7.0 tt -71.26 -53.71 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.026 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -44.84 -40.2 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.27 93.44 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 57' ' ' ALA . 60.2 t -59.91 -47.53 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 109.872 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.6 -45.39 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.329 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.79 -27.59 71.37 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -70.53 -37.68 74.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.059 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.42 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.952 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.385 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.51 -36.59 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.651 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -72.87 -34.3 59.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.49 2.93 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.716 0.293 . . . . 0.0 110.755 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.43 ' H ' ' C ' ' A' ' 61' ' ' GLY . 88.7 mt -77.97 -47.42 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.512 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.06 78.37 0.28 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.493 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.06 25.82 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.548 ' HZ3' ' CB ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -102.82 -10.93 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.175 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.624 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.48 176.46 1.48 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.485 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.96 -2.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.258 1.972 . . . . 0.0 111.874 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.2 tt -47.79 -37.17 13.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mmp_? -38.8 -67.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.827 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -52.49 -28.46 20.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.82 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.6 t -71.77 -47.04 58.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.715 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.51 53.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 110.484 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.55 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -63.2 -11.54 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.678 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.536 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 3.0 t -58.39 -38.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.372 0.606 . . . . 0.0 110.027 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -87.65 -32.54 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.309 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 12.4 t-105 -64.63 -53.69 43.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.169 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.0 tp -64.85 -47.22 78.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.832 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -44.16 -42.2 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.4 p -78.95 -22.36 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.75 -59.99 4.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.927 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -73.76 -55.02 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.218 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -66.35 -45.73 79.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.58 -46.57 91.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.483 ' O ' ' OG1' ' A' ' 88' ' ' THR . 86.7 t -70.77 -52.51 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -52.06 -29.41 21.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 tp -80.16 -43.6 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.359 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 61.5 p -52.44 -22.21 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.196 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -73.48 -51.7 16.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.36 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -50.13 -36.27 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -72.72 -36.51 67.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -74.99 -43.8 51.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.719 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 39.4 ttm -52.57 -52.05 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.711 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.66 -40.91 92.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.557 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.498 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 1.4 p-90 -124.29 -2.47 8.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.644 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.2 tp -115.19 88.83 18.83 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.77 10.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.832 2.355 . . . . 0.0 113.198 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.644 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -80.02 -22.59 42.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.128 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -95.28 -46.83 6.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.819 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -24.92 64.78 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.209 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -93.23 -19.92 20.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.088 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.82 70.94 19.55 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.93 -15.85 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.949 2.432 . . . . 0.0 112.247 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -52.76 -35.9 57.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.368 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.41 22.2 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.71 0.291 . . . . 0.0 110.913 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.48 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 2.4 t80 -131.4 -6.08 3.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.66 129.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.85 135.9 33.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.3 m -164.7 116.16 1.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.523 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.25 -168.44 16.39 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -96.12 158.08 15.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.694 0.283 . . . . 0.0 110.241 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -109.19 130.05 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.776 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 95.98 -3.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.791 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.78 150.54 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.027 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.7 145.39 24.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.941 0.4 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -135.17 -31.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.1 t-105 -174.95 144.77 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -141.5 167.05 23.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 111.402 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -141.39 120.35 12.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.379 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.28 16.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.18 15.0 75.6 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.48 133.69 55.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.811 0.339 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.77 152.87 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.425 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -51.17 -51.64 66.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 142' ' ' MET . 70.9 Cg_exo -45.39 -37.87 14.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.3 2.0 . . . . 0.0 112.034 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.99 -42.54 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.205 0.526 . . . . 0.0 109.982 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.606 ' O ' ' N ' ' A' ' 148' ' ' GLY . 59.9 m95 -65.64 -57.14 8.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.0 tp -43.33 -39.01 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.066 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.23 -34.59 76.8 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.92 -42.91 96.98 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.6 mt -67.68 -39.53 82.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 0.0 110.146 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -55.25 -45.31 76.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.5 mt -57.2 -43.93 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.61 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.44 62.27 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.518 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.7 m-85 -53.76 -43.48 69.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.087 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.455 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 1.1 pp -75.01 -29.7 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.309 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.9 mt -69.97 -36.74 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.201 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.3 m -73.36 -38.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.989 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.29 -51.16 62.55 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.844 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.3 t -55.19 -50.96 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.01 -33.9 73.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.4 t -67.07 -28.99 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.794 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.94 -45.92 62.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.146 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.64 -27.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 179.83 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.3 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.865 0.364 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.4 ptt-85 -58.74 -40.62 84.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -59.37 -47.63 84.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -51.19 -38.68 53.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -68.41 -31.26 70.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.348 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -77.06 -50.95 11.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.681 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.89 77.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 11' ' ' GLY . 85.3 p -76.96 -37.9 54.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.733 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.747 HE22 HH21 ' A' ' 70' ' ' ARG . 16.6 mm-40 -67.51 2.02 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.42 147.49 18.56 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -71.78 -49.68 36.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.685 0.278 . . . . 0.0 110.65 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.91 -45.05 5.85 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.19 84.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -58.41 -41.41 84.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.154 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -28.89 69.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.022 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.5 -30.48 67.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.308 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.433 ' O ' ' OG1' ' A' ' 21' ' ' THR . 0.4 OUTLIER -73.19 -33.09 65.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.02 7.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -47.97 -40.85 23.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -63.72 -50.17 70.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.377 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.13 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -37.27 41.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.92 -36.96 63.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.53 -37.93 65.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.46 -43.48 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.98 -48.31 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.508 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -54.47 -40.95 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.73 67.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.776 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 -20.4 63.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' NE1' ' CG2' ' A' ' 35' ' ' VAL . 32.1 t90 -88.95 -39.36 13.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.65 -43.61 57.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.43 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 4.5 tm0? -73.61 -29.56 62.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.02 -26.35 66.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' NE1' ' A' ' 31' ' ' TRP . 56.0 t -109.29 -53.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.924 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.68 1.13 8.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.96 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mt 48.54 41.36 17.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.43 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 1.4 tp -76.24 147.71 38.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -111.66 127.04 27.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.596 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.06 154.66 33.19 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 111.775 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 6.5 t -118.0 -171.98 2.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.787 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.23 -48.05 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.075 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.83 -50.1 70.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.442 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.7 p -53.08 -48.97 67.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mm -61.34 -45.23 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.327 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -58.41 -46.12 87.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.307 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -60.78 -38.32 84.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -64.59 -36.38 84.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.38 84.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.96 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.346 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.78 -49.58 15.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.049 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -46.32 -38.03 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.76 -44.25 81.29 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.9 -47.65 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -43.9 -48.62 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.6 -48.24 86.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.19 -33.02 25.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.27 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.77 -35.54 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.404 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.88 -37.26 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.223 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' N ' ' CD1' ' A' ' 60' ' ' ILE . 1.6 mp -75.24 -40.32 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.0 -28.67 73.34 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.77 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.705 0.288 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.1 mt -82.63 -32.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.46 73.36 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.442 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.75 24.58 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.518 2.145 . . . . 0.0 111.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.3 mttm -111.86 -7.56 14.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.13 162.44 21.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.655 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -38.91 -15.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.592 2.195 . . . . 0.0 112.304 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.4 mp -41.58 -33.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.747 HH21 HE22 ' A' ' 10' ' ' GLN . 71.9 mtt85 -39.22 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -51.95 -31.48 29.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.62 -45.94 80.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.97 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.46 -34.26 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.6 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -64.7 -19.66 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.678 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.413 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 2.1 t -54.09 -34.46 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 0.0 109.958 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 84.0 mt -89.15 -33.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.2 t-105 -65.87 -49.86 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.003 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -66.06 -49.58 67.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.3 m-85 -42.92 -42.61 3.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.8 p -78.11 -22.18 49.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.768 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.8 -59.86 4.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.281 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.3 -51.13 13.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.646 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -40.5 78.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 88' ' ' THR . . . -63.08 -47.14 90.98 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 81' ' ' ALA . 11.1 m -77.53 -32.73 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.336 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.04 -42.87 59.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.663 0.268 . . . . 0.0 111.191 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tp -73.72 -38.47 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.047 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 84' ' ' GLY . 7.9 p -59.56 -44.45 93.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.208 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -52.32 -52.13 54.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.522 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -50.84 -46.35 60.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -64.55 -33.16 75.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.9 m -70.97 -37.14 72.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.413 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.4 tpt -62.21 -33.01 73.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.115 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.2 -47.47 70.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.115 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 179.842 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.708 0.289 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -99.22 -5.38 30.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.426 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 116' ' ' LEU . 10.4 mp -113.09 82.81 5.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.31 12.11 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.041 1.827 . . . . 0.0 111.756 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.9 mt -80.13 -28.42 38.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.013 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 1.4 p30 -97.31 -40.83 8.55 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.975 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 3.3 ttmm -69.27 -45.16 70.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.658 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 16.0 t-105 -76.85 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.405 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.17 71.13 22.81 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.761 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.74 -16.11 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.748 2.299 . . . . 0.0 111.805 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -52.29 -32.63 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.785 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -133.37 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.536 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -152.3 -40.53 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.239 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.7 128.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.99 155.47 17.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.4 p -158.17 102.8 1.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.599 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.58 -177.27 19.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 33.9 t70 -86.06 150.02 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.58 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 9.7 m -101.74 127.23 48.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 98.87 -8.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.87 128.82 37.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.733 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.19 136.22 51.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -130.16 -29.35 2.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -174.56 145.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.722 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -144.73 159.64 42.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.256 0.551 . . . . 0.0 112.102 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.408 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -115.09 138.13 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.705 178.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp 50.24 16.85 0.28 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.73 22.64 33.01 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.36 136.23 53.93 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 135' ' ' TRP . 6.0 mm-40 -69.33 146.73 51.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.315 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.442 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 9.5 mtt -44.94 -62.7 1.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.144 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 85.8 Cg_exo -33.78 -37.63 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.848 2.366 . . . . 0.0 112.639 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 144' ' ' GLN . 4.8 mp0 -72.34 -52.0 18.08 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.0 m95 -59.47 -57.28 13.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.848 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.5 tp -44.57 -35.55 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.9 -33.96 76.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.51 -46.19 94.83 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.8 mp -75.14 -25.88 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -64.54 -44.37 91.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.743 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.9 tt -69.24 -37.39 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.79 -46.99 71.21 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.054 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.79 -44.47 96.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.686 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 52.3 mt -65.19 -30.95 71.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.9 -33.35 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.321 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 41.5 t -64.95 -31.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.52 -47.5 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.7 t -55.41 -42.21 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -28.58 56.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.903 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 31.1 t -78.26 -20.33 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.8 -50.03 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.83 -25.96 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.76 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.548 -179.873 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.987 0.422 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.6 -31.84 66.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 7' ' ' GLN . 23.3 t80 -73.48 -44.94 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -47.17 -39.88 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.003 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -68.46 -28.15 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.421 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 4' ' ' PHE . 24.4 tt0 -80.33 -49.45 11.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.36 72.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' GLY . 37.4 m -76.66 -34.99 58.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.754 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -72.76 7.41 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.07 142.08 15.87 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -68.44 -21.4 64.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 110.648 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.83 -46.06 61.94 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.83 76.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.327 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -58.17 -43.12 87.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.42 -33.06 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.323 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.48 -30.37 70.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . 60.3 mtp -73.66 -33.0 64.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.417 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.89 71.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.46 -51.83 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 18' ' ' MET . 12.7 p -41.65 -50.42 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.92 85.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.62 -39.67 80.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.306 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.71 -41.67 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.354 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.3 -33.78 63.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.543 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.76 -45.91 77.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.03 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -71.89 -46.55 57.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.92 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 87.5 m -46.8 -43.01 18.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.81 -21.45 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -68.49 -22.39 64.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.23 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.442 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 2.4 t-105 -97.68 -29.39 13.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.4 -39.86 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.51 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -78.8 -51.6 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.992 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -54.74 -53.41 55.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 31' ' ' TRP . 4.3 p -61.01 -18.19 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.0 ttt -106.3 10.56 31.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.589 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.2 mp 52.24 54.44 10.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.99 157.18 17.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.283 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -125.37 141.48 38.95 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.432 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.76 175.93 10.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 112.318 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.486 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 12.8 t -131.88 -179.34 5.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 39.6 t -56.06 -49.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.599 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.94 -38.24 87.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -54.23 -40.93 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.584 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.98 -37.59 78.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.428 . . . . 0.0 110.053 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -60.73 -48.2 82.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.038 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.94 -39.95 95.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -65.82 -36.16 82.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.366 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.11 86.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.05 -49.03 78.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 tp -76.04 -52.2 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.223 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -45.89 -42.59 12.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.53 89.47 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' ALA . 26.0 t -59.15 -46.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.298 0.571 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.09 -46.59 11.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.535 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.81 -27.42 71.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.04 -42.13 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.91 -21.51 62.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -43.93 19.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.34 -33.23 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -73.16 -31.38 61.63 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.44 6.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.798 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 61' ' ' GLY . 95.0 mt -82.81 -29.79 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.76 69.03 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.25 23.78 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.754 2.302 . . . . 0.0 111.654 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -102.29 -10.25 19.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.087 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.84 175.21 1.96 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.513 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.39 -9.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.281 1.987 . . . . 0.0 112.052 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -47.89 -31.43 5.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.126 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -40.33 -67.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.62 -26.08 63.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.43 -45.48 74.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.248 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.66 -36.48 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.47 0.653 . . . . 0.0 109.574 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -12.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.062 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.5 t -55.27 -44.21 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.306 0.574 . . . . 0.0 110.443 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.89 -31.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.627 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.493 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 10.0 t-105 -62.67 -55.79 23.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.129 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.1 tp -65.3 -48.17 74.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -43.58 -45.66 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.084 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 p -78.99 -21.14 47.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.43 -60.38 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.053 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.52 -51.27 17.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.09 -48.1 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -55.38 -48.42 69.76 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 66.1 t -69.29 -47.23 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.531 ' C ' HE21 ' A' ' 86' ' ' GLN . 0.0 OUTLIER -55.48 -23.48 25.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.292 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.39 -42.67 14.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.214 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 39.7 p -51.29 -26.38 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' O ' ' OG1' ' A' ' 92' ' ' THR . 5.5 m-85 -69.18 -46.53 67.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.246 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -55.38 -31.23 61.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.274 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 10.7 t-80 -70.09 -49.64 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.349 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 31.1 p -54.87 -56.36 20.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 110.199 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 40.8 mtt -48.01 -50.68 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.028 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.72 -36.8 7.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.412 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.525 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.793 0.33 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.85 -5.21 59.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.2 mp -119.68 81.85 25.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -52.67 -2.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.566 2.178 . . . . 0.0 112.016 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.569 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tt -59.53 -32.31 70.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -41.03 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.604 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -71.9 -45.28 61.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.721 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -73.71 -17.29 61.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.456 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.0 t -141.34 72.32 26.31 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.75 -16.48 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.895 2.396 . . . . 0.0 111.804 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -50.2 -49.11 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.816 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.97 53.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -154.57 -39.76 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -55.57 130.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.47 150.24 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.535 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.9 m -159.69 102.97 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.695 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.59 -176.7 20.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.3 m-20 -87.55 157.19 19.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 3.7 m -106.79 128.97 54.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.711 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 93.94 -7.87 0.13 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.429 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 8.1 mp0 -68.21 129.1 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.857 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.51 116.21 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.096 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -109.11 -31.04 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.84 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -174.06 143.26 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.794 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.96 156.45 44.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.295 0.569 . . . . 0.0 112.167 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -112.41 138.76 48.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.786 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.44 17.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 91.29 22.8 31.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.03 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.53 137.86 53.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.38 149.42 50.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.422 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 2.6 mtt -48.62 -52.74 42.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 142' ' ' MET . 86.5 Cg_exo -43.34 -34.21 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.396 2.064 . . . . 0.0 112.17 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.74 -52.66 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 148' ' ' GLY . 95.0 m95 -58.81 -58.3 9.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -43.83 -36.98 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.15 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.17 -34.6 75.29 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.67 -47.63 89.24 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.65 -25.57 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.049 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -64.85 -43.08 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.694 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 5.5 tp -68.27 -36.81 76.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.359 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.015 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -58.71 -33.74 70.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.9 mt -82.43 -34.26 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.484 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 91.6 t -60.48 -40.3 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.625 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.47 -50.58 13.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.13 -50.61 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.442 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.8 OUTLIER -66.54 -31.17 71.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.013 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 11.1 t -70.87 -28.77 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.18 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.29 -49.42 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.222 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 39.7 mm -68.92 -11.14 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.569 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 6.9 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.59 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.807 0.337 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.47 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -50.09 -45.69 52.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' GLN . 26.2 m-85 -63.03 -43.6 98.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.277 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.01 -42.36 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.8 -24.05 64.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 4' ' ' PHE . 52.1 tt0 -77.98 -48.19 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.55 87.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 11' ' ' GLY . 8.2 m -76.72 -37.32 56.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 6.2 tt0 -66.24 1.87 1.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.12 149.5 19.05 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -70.92 -49.03 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.681 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.83 -45.63 5.87 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.41 83.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.096 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -59.46 -47.17 86.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.058 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.27 -28.22 66.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -27.73 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.439 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.5 mmt -74.24 -34.44 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 -53.61 22.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.712 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.13 -52.71 57.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.485 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 p -44.74 -54.12 6.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.727 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.29 -22.2 62.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.7 tp -85.73 -41.26 15.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.634 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.28 -39.92 64.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.0 mm? -73.11 -27.78 61.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.835 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.44 -38.74 90.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.589 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 mt -79.18 -41.4 28.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 2.5 m -48.06 -43.33 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.49 -32.28 32.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.104 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tp -57.06 -21.33 30.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -90.22 -38.94 13.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.08 -45.54 43.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.25 -25.26 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 -21.24 51.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.393 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.19 -38.67 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.483 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.4 mtp -98.68 5.73 47.47 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.107 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 3.4 mm? 47.22 45.0 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.9 mt -80.01 153.28 28.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.503 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -121.2 126.86 26.41 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.415 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 153.4 32.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.218 1.945 . . . . 0.0 111.934 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.8 t -100.15 -174.77 2.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.6 t -65.98 -41.74 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 110.822 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.65 -36.47 65.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t -57.69 -47.73 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 124' ' ' PHE . 25.5 pt -66.72 -36.36 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.089 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -55.06 -48.29 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.27 -36.15 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.87 84.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.504 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.92 -47.9 83.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -77.72 -49.71 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -46.6 -43.32 17.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 109.851 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.44 93.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' ALA . 55.1 t -58.31 -46.7 88.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.006 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.0 -42.95 29.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.543 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -24.15 72.45 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.87 -32.05 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.584 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -23.09 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 tp -79.63 -42.3 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.388 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.72 -36.9 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.679 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -69.71 -33.7 71.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.19 6.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.655 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.52 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.9 mt -79.64 -25.56 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.76 68.38 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.85 14.42 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.674 2.249 . . . . 0.0 111.995 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -8.81 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.197 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.27 162.47 20.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.813 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -42.04 -12.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.418 2.079 . . . . 0.0 112.246 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mp -50.35 -29.3 9.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.481 ' CG ' ' H ' ' A' ' 71' ' ' TYR . 26.7 ptt180 -37.9 -57.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.715 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.481 ' H ' ' CG ' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -52.72 -35.01 55.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.108 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' LEU . 18.2 t -64.02 -44.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.58 -33.89 47.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.203 0.525 . . . . 0.0 110.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.3 mmt -62.59 -20.06 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -51.78 -39.03 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.457 0.646 . . . . 0.0 110.342 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 76' ' ' ILE . 97.0 mt -88.74 -30.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.766 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.499 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 15.0 t-105 -66.95 -51.16 58.63 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.123 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.2 tp -67.29 -50.31 60.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.617 ' CE2' ' NE ' ' A' ' 83' ' ' ARG . 63.6 t80 -42.36 -42.49 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 110.267 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 p -79.12 -23.23 44.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.803 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.05 -58.95 6.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.256 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -74.71 -51.87 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.617 ' NE ' ' CE2' ' A' ' 79' ' ' TYR . 47.5 ttp85 -65.56 -42.33 91.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.77 -46.53 93.46 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.7 t -66.8 -36.68 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.647 0.261 . . . . 0.0 111.057 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -72.09 -29.18 63.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.774 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.53 -48.2 9.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.391 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.7 p -50.85 -54.6 22.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' O ' ' OG1' ' A' ' 92' ' ' THR . 50.0 t80 -51.69 -34.74 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.385 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -57.98 -39.8 79.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -68.09 -38.51 82.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.408 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 52.0 p -65.08 -50.57 65.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.44 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 ttm -50.09 -39.58 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -45.44 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.492 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 19.0 tt0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.712 0.291 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -100.6 12.24 37.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.9 mt -121.69 79.39 39.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.062 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 119' ' ' TRP . 53.4 Cg_exo -48.66 -5.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.534 2.156 . . . . 0.0 111.968 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.589 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 tp -54.19 -31.8 53.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.32 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 32.3 p-10 -97.0 -42.79 7.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.268 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 26.0 ttpp -72.29 -45.78 58.58 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.895 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' PRO . 57.9 t-105 -71.1 -18.82 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.182 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -133.26 75.14 71.25 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.4 -26.65 3.93 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.779 2.319 . . . . 0.0 111.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -61.62 -54.35 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.013 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 t -98.09 59.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.748 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -169.37 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.96 127.47 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.418 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.4 160.58 14.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -166.14 99.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.79 -174.99 22.82 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.421 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -88.55 154.06 20.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.421 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 5.4 m -101.4 133.16 46.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 88.12 -4.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.928 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 12.4 tm-20 -67.93 150.95 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 19.6 ttm180 -85.82 126.84 34.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 110.538 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.25 -26.09 5.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -175.55 135.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 4.1 p30 -135.43 159.55 41.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.366 0.603 . . . . 0.0 112.135 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -123.54 137.79 54.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.062 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mp 54.38 17.1 1.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.521 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.35 13.78 61.16 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.72 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.409 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 13.8 mt -119.12 145.0 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 4.0 mp0 -75.9 148.09 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.4 mtt -50.18 -57.28 13.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.1 Cg_exo -37.34 -38.67 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.351 2.034 . . . . 0.0 111.923 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -73.07 -46.81 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.204 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.5 m95 -60.77 -57.52 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 tt -43.55 -41.01 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tt -57.38 -34.95 69.39 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.35 -43.66 95.56 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.612 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.9 mp -72.85 -38.35 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -46.98 64.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 0.0 109.707 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.48 -49.49 83.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.72 -48.82 78.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.43 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.0 m-85 -59.15 -44.65 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.444 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.525 ' C ' ' CD1' ' A' ' 154' ' ' LEU . 0.3 OUTLIER -69.64 -30.71 68.48 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.298 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.24 -36.69 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.722 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.2 t -62.12 -43.31 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.499 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -61.71 -48.42 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 83.3 t -52.17 -39.24 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.038 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.18 -41.42 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.26 -27.52 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 0.0 110.91 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.86 -44.66 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.17 -8.92 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.509 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.616 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.874 0.369 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -38.86 70.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.401 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.38 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.281 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.22 -42.0 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.663 HD22 ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -65.37 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.238 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -74.29 -50.08 20.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.89 71.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' GLY . 31.8 m -76.8 -37.36 55.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.663 ' NE2' HD22 ' A' ' 6' ' ' ASN . 0.7 OUTLIER -73.22 6.94 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.45 144.65 16.0 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -69.71 -49.15 56.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.732 0.301 . . . . 0.0 110.727 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.16 -46.12 6.42 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.26 85.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -59.19 -42.31 90.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.84 -28.95 69.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.051 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.54 -33.99 71.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.623 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.3 mtt -69.96 -33.35 71.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -51.8 35.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.669 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -50.05 -44.05 51.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.851 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -60.25 -62.0 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' O ' ' OE1' ' A' ' 26' ' ' GLU . . . -50.56 -29.45 10.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -37.5 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.418 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.38 -36.2 61.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.68 -37.37 84.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.716 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 3.1 mp0 -66.45 -46.02 77.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.497 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.45 -56.73 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.3 p -46.97 -44.81 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.722 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.71 -42.79 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.961 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.38 -19.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.953 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -92.36 -36.25 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.748 0.309 . . . . 0.0 110.48 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -44.07 58.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.133 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.93 -29.98 70.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -76.69 -13.02 60.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.587 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.03 -51.82 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.3 mmt -89.36 8.91 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.95 49.06 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.254 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 mt -82.45 155.25 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -124.34 95.58 43.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.36 140.02 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.389 2.059 . . . . 0.0 112.08 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.9 t -95.78 -168.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.67 -44.86 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.98 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -70.84 -50.13 38.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.745 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 41' ' ' CYS . 31.6 p -50.05 -51.17 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.46 -39.27 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.308 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -57.2 -45.36 83.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.85 -36.86 75.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.168 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -64.01 -33.81 76.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.022 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.66 80.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.89 77.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.383 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -76.51 -49.21 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.056 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -46.31 -40.1 11.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.496 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.61 -45.36 85.43 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.17 -45.45 98.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.187 0.518 . . . . 0.0 109.729 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.7 -46.73 10.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.586 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.15 -36.72 93.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.91 96.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.629 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tp -78.17 -29.9 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.5 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -83.3 -40.18 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.77 -34.19 66.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.72 4.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.9 mt -87.46 -25.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -175.51 67.45 0.26 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.39 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.2 15.92 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.679 2.253 . . . . 0.0 112.116 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 64' ' ' ALA . 21.7 pttt -115.65 -4.05 12.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.111 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.12 163.17 19.71 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -39.97 -15.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.505 2.136 . . . . 0.0 112.255 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 mm? -41.81 -34.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.79 -70.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.536 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -48.35 -36.21 14.03 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.792 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -65.65 -45.7 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.63 -33.36 41.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.265 0.555 . . . . 0.0 110.295 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 mmt -65.62 -20.51 66.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.36 -34.67 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.0 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.415 HD11 HG21 ' A' ' 76' ' ' ILE . 69.3 mt -89.31 -32.25 5.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.205 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.517 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.3 t-105 -63.64 -51.41 65.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.997 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tp -69.11 -44.54 72.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HH ' ' NH2' ' A' ' 83' ' ' ARG . 68.5 t80 -45.79 -46.51 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.174 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.8 p -78.5 -19.72 52.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.669 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -60.75 -59.45 5.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -74.72 -49.76 19.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.618 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.402 ' NH2' ' HH ' ' A' ' 79' ' ' TYR . 27.3 mmm-85 -71.83 -40.23 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.814 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.47 -49.16 81.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.463 ' O ' ' OG1' ' A' ' 88' ' ' THR . 33.5 m -72.74 -47.4 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.746 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -50.72 -24.9 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 0.0 109.945 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 tt -81.44 -40.56 23.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.434 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 66.7 p -53.95 -25.64 21.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 110.085 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -52.07 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -56.95 -32.82 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.462 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 7.2 t-80 -71.73 -44.58 63.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -65.99 -52.22 51.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.408 ' N ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -57.45 -50.9 71.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -53.59 -33.4 54.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.823 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 109.911 179.624 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.8 pm0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.637 0.256 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -101.21 -6.27 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.645 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.608 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.2 mt -123.61 78.91 55.56 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.986 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 45.5 Cg_exo -52.22 1.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.612 2.208 . . . . 0.0 112.194 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.608 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.0 tp -62.4 -29.31 70.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.551 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.4 OUTLIER -97.43 -41.18 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.443 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -75.29 -45.73 37.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.473 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.7 t90 -68.62 -17.67 64.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.203 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.13 79.42 2.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.996 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.02 -2.05 11.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.043 2.495 . . . . 0.0 111.785 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -49.05 -47.96 44.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.776 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.96 54.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -157.15 -41.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.408 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 p -54.43 128.9 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.66 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.78 150.41 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.776 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.4 t -167.82 110.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.476 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.02 -172.81 21.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.2 m-20 -87.08 139.1 30.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.211 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.523 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 28.6 m -93.16 131.09 38.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 87.38 -1.9 0.56 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.326 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.01 128.48 36.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.035 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -80.17 129.23 34.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -122.49 -15.49 7.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.62 144.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.02 159.26 42.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.553 . . . . 0.0 112.0 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.418 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.9 t80 -112.23 136.85 51.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.82 16.84 0.12 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.38 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 92.71 22.52 28.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.89 133.83 54.4 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 109.977 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.85 146.37 54.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.406 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.5 mtt -46.96 -52.65 31.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.722 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 142' ' ' MET . 77.0 Cg_exo -44.45 -35.63 8.83 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.329 2.019 . . . . 0.0 112.232 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.411 ' N ' HE21 ' A' ' 144' ' ' GLN . 0.0 OUTLIER -70.51 -52.51 21.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.457 . . . . 0.0 109.995 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.632 ' O ' ' N ' ' A' ' 148' ' ' GLY . 83.0 m95 -59.35 -56.97 15.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.125 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tt -43.26 -38.21 2.48 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -34.06 73.49 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.96 -41.9 98.07 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.437 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.07 -27.93 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.086 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -61.49 -48.47 80.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 tp -69.15 -37.2 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.26 67.34 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.025 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.1 -41.17 99.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.864 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 mp -51.93 -32.41 32.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.1 mm -82.08 -38.7 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.464 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 79.0 t -52.11 -36.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.319 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.517 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.27 -47.16 15.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.67 -37.67 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.097 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.01 -40.23 28.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 45.3 t -68.48 -26.26 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.855 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.32 -49.0 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.7 mt -65.8 -13.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.275 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 -179.845 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 19.1 ttp180 -57.49 -27.93 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.202 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.4 -42.64 58.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.074 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -50.76 -41.19 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.498 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.509 ' ND2' ' C ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -71.98 -26.41 62.23 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.512 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.77 -49.46 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.623 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.03 77.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -76.74 -32.63 57.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -70.1 2.25 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.88 149.75 19.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -71.98 -49.72 34.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.448 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.15 -45.49 6.27 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -58.82 -45.32 90.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.026 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.7 -28.28 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.99 -30.75 68.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.433 ' O ' ' OG1' ' A' ' 21' ' ' THR . 27.2 tpp -72.13 -33.56 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.906 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -51.81 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -51.41 -52.03 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -49.66 -47.76 49.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -43.31 86.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.34 -41.3 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.89 -35.32 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.378 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' OG1' ' A' ' 28' ' ' THR . 35.4 mt -75.71 -39.6 57.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.487 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -64.82 -52.73 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -57.33 -42.04 81.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.644 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 25' ' ' LEU . 11.7 p -60.67 -42.25 96.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.124 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.95 -19.82 65.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.294 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -94.46 -37.7 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 110.843 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -55.41 -46.7 76.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.404 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -71.62 -40.45 69.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.693 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.539 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 45.7 t-80 -61.38 -15.02 32.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.1 t -108.84 -44.77 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.42 5.34 27.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.98 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt 48.34 48.98 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.715 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.4 mt -85.06 154.83 21.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.574 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -116.15 119.15 37.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.245 1.964 . . . . 0.0 112.022 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.447 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 3.9 t -127.19 -177.21 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.527 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 p -66.57 -34.93 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 0.0 110.401 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.52 -48.5 55.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.306 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 p -48.46 -50.77 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.1 mt -61.56 -38.43 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -60.52 -44.3 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.838 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.75 -47.88 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 -50.6 -42.79 56.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.917 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.92 74.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.26 -44.62 79.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.928 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.41 -50.83 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.043 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -39.49 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.25 -45.4 80.85 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.32 -43.74 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.559 . . . . 0.0 109.533 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.03 -49.42 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.362 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.12 92.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -29.3 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.5 -37.29 71.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.479 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -74.06 -23.76 59.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.357 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -84.19 -46.81 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.39 73.82 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.05 5.42 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.726 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.8 mt -80.44 -32.86 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.69 72.95 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.63 27.6 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.547 2.165 . . . . 0.0 111.68 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 64' ' ' ALA . 16.5 tttm -113.34 -10.71 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.933 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.42 162.6 19.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.654 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -39.05 -14.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.705 2.27 . . . . 0.0 112.665 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' THR . 44.4 mt -45.07 -28.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.699 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.2 OUTLIER -40.87 -70.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.547 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -51.03 -33.26 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.909 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.22 -45.45 89.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -36.13 26.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.625 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -62.73 -23.68 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.402 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.01 -31.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.407 0.622 . . . . 0.0 109.873 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.2 mt -88.86 -34.32 6.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.9 t-105 -65.34 -53.15 47.87 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 81' ' ' ALA . 4.8 mt -63.2 -47.96 80.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.666 0.27 . . . . 0.0 110.607 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -42.73 -43.31 3.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.256 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.0 p -77.66 -21.27 52.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.831 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.7 -60.61 3.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.45 -53.66 15.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.01 -48.41 53.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.453 ' O ' ' OG1' ' A' ' 88' ' ' THR . . . -55.89 -47.26 80.51 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.97 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.88 -32.43 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.542 0.211 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -72.06 -47.07 54.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.062 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.48 -49.91 43.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.674 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 84' ' ' GLY . 13.2 p -46.39 -48.42 18.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.441 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' THR . 50.4 t80 -57.29 -44.94 84.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.296 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -43.71 -42.06 5.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 109.987 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.02 -34.68 73.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.97 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 89' ' ' TYR . 10.1 m -62.24 -50.1 73.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.302 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ttt -56.48 -36.78 69.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.933 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -70.13 -36.9 75.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.52 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 48.5 tt0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.509 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.651 0.262 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.59 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -124.62 -1.01 8.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.624 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.642 ' C ' ' H ' ' A' ' 116' ' ' LEU . 53.3 mt -126.59 85.58 60.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.46 5.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.872 2.381 . . . . 0.0 112.745 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.642 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.0 mt -58.04 -31.41 66.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.78 -40.08 8.72 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.997 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.5 -45.54 90.24 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.39 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -79.6 -13.01 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.856 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.81 68.93 24.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.907 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -69.98 -20.04 34.29 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.813 2.342 . . . . 0.0 111.508 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.64 -53.49 57.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.344 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.54 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 4.0 t -101.94 54.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 6.3 m-85 -161.22 -46.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.32 129.44 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.74 152.18 19.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.662 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 101.78 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.733 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.79 176.41 14.92 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -83.13 160.47 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.8 m -107.84 128.96 55.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 97.4 -8.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.726 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE2' ' N ' ' A' ' 129' ' ' ASP . 8.0 pt-20 -67.87 148.91 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.933 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -85.54 136.51 33.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -125.59 -31.17 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.407 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 39.8 t-105 -174.82 141.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 135' ' ' TRP . 3.6 m-20 -134.62 161.28 35.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.325 0.583 . . . . 0.0 112.161 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.415 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -118.98 136.67 53.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.517 178.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 49.13 16.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.479 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.415 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 93.85 19.75 33.25 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.227 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.1 144.05 51.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.06 0.43 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.52 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 50.8 mt-10 -70.38 145.95 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.424 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mmt -44.03 -61.93 1.76 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -34.97 -36.45 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.618 2.212 . . . . 0.0 112.238 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -69.57 -58.32 4.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.045 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.9 m95 -55.31 -57.38 12.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.6 tt -43.45 -35.52 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.126 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.37 -35.13 78.19 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.57 -48.27 85.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.484 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.9 mp -71.87 -33.28 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.02 -44.08 87.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.46 -43.33 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.47 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.65 -49.99 75.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.11 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -57.37 -48.24 79.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 0.0 111.058 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.461 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 4.5 mm? -66.98 -34.93 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.607 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 -36.73 37.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.199 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.9 t -54.66 -48.74 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.177 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -61.19 -48.69 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.7 t -48.9 -39.43 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 33.5 mt -78.38 -24.6 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.04 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.92 -22.7 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 110.718 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.24 -49.59 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.48 -25.69 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.72 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 0.0 110.403 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.845 0.355 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -51.3 -39.34 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.391 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -66.1 -44.92 82.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.2 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -39.65 12.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -69.45 -24.96 63.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.315 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tm0? -80.39 -48.22 13.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.56 69.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.522 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 11' ' ' GLY . 66.9 p -76.79 -34.48 57.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.418 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 1.9 tp-100 -70.96 6.37 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.99 141.08 15.15 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.75 -20.64 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.738 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.43 -44.2 74.59 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -51.33 66.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -53.76 -43.9 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mt -70.26 -30.28 67.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.05 -36.64 77.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.604 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.58 -34.49 75.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.27 37.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.394 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -50.63 -36.87 37.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.728 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.11 -56.72 14.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.778 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.71 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.658 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -84.21 -42.39 15.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.27 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.55 -34.61 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.35 -52.84 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.83 -52.28 60.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 p -51.23 -38.9 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.15 -34.14 68.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.46 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.28 -22.75 67.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.756 0.312 . . . . 0.0 110.426 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -85.03 -28.81 25.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -45.56 94.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.99 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -66.95 -27.46 67.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -83.17 -13.34 55.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.981 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.32 -33.13 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.132 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' MET . 14.3 ttm -109.21 6.63 24.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.153 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 mt 48.92 51.35 16.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.046 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mt -81.81 154.54 25.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.509 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 127' ' ' SER . 42.3 mttp -120.24 93.76 48.28 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.5 131.11 27.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.509 2.139 . . . . 0.0 112.022 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -89.8 -171.14 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 8.6 p -62.22 -41.65 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 2.8 mp -58.89 -45.44 90.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.507 ' HG ' ' H ' ' A' ' 41' ' ' CYS . 11.5 m -48.45 -42.54 32.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -62.48 -42.22 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 110.12 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -65.83 -46.45 78.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.503 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -50.36 67.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.366 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -58.76 -30.77 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.72 68.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.81 80.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.62 -52.78 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.246 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -44.66 -40.19 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.74 87.93 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.44 -46.36 93.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mt -44.05 -46.09 8.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.427 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.19 -41.64 98.26 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.31 -44.38 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.512 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.3 -32.61 73.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 8.6 mt -73.33 -26.45 61.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mm -82.08 -35.33 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.351 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.16 80.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.81 5.71 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.695 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.5 mp -82.85 -35.12 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.426 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -179.83 73.23 0.18 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.206 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 53.0 Cg_endo -72.56 23.3 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.533 2.155 . . . . 0.0 112.055 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 64' ' ' ALA . 12.1 ttpt -113.8 -6.49 13.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -114.12 159.44 36.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.894 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -38.15 -18.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.628 2.219 . . . . 0.0 112.442 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.5 mp -41.34 -32.6 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.572 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.579 ' NH2' ' HG ' ' A' ' 163' ' ' SER . 34.8 mtp180 -39.76 -65.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.663 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.02 -32.49 46.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -66.0 -45.23 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.819 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' VAL . . . -74.51 -34.29 63.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.657 0.742 . . . . 0.0 109.129 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.533 ' O ' ' SD ' ' A' ' 74' ' ' MET . 11.0 tmm? -56.96 -11.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 73' ' ' ALA . 47.0 t -63.14 -44.17 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.29 0.567 . . . . 0.0 111.394 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.05 -32.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.442 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.477 ' CE3' ' N ' ' A' ' 78' ' ' LEU . 9.9 t90 -61.22 -53.17 60.31 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.588 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' CE3' ' A' ' 77' ' ' TRP . 20.9 tp -58.31 -53.67 55.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -43.82 -46.07 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.667 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -80.71 -27.31 36.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.01 -60.84 3.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.004 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -73.47 -55.69 6.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -66.93 -45.48 77.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.04 93.51 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 88' ' ' THR . 80.8 t -69.91 -53.18 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.531 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -47.6 -25.71 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 109.948 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 tp -78.09 -39.67 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.32 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 73.4 p -54.58 -29.52 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.355 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.44 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.5 OUTLIER -70.77 -52.46 20.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.856 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.09 -32.61 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -75.22 -34.97 61.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.772 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 17.6 p -72.05 -47.75 49.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.542 ' N ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -53.62 -53.87 45.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.554 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.72 -43.97 97.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.617 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.203 179.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.597 0.237 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.653 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -85.09 -6.21 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 110.36 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.65 ' C ' ' H ' ' A' ' 116' ' ' LEU . 12.0 mt -120.35 83.41 33.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.41 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 39.1 Cg_exo -54.0 11.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.79 2.326 . . . . 0.0 112.802 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.65 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.1 mt -75.16 -29.15 60.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.542 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 1.1 t70 -96.24 -40.22 9.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.805 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -67.87 -40.61 83.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.41 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.4 t90 -81.67 -16.02 52.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.45 74.15 20.2 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.68 -17.27 11.22 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.856 2.371 . . . . 0.0 111.841 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -51.71 -52.44 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 m -112.66 60.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.641 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.542 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 2.0 t80 -164.92 -40.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.329 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.4 125.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.81 146.56 23.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' LYS . 16.2 p -155.1 144.79 21.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.88 -175.71 38.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.477 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.1 m-20 -84.64 144.76 28.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.744 0.307 . . . . 0.0 110.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.59 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 32.8 m -92.72 132.65 36.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.963 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 89.88 -3.27 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.452 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.92 128.3 36.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.826 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -76.93 134.95 38.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -128.06 -19.63 3.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TRP . . . . . 0.586 ' NE1' ' SD ' ' A' ' 142' ' ' MET . 6.7 p90 -172.95 149.6 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.228 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.11 166.89 24.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.28 0.562 . . . . 0.0 111.87 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -122.8 138.41 54.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.38 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.57 17.04 0.51 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.411 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.2 21.65 44.51 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.0 mt -126.34 137.67 53.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 143.7 55.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.25 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.586 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -48.1 -53.36 33.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.3 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.3 Cg_exo -40.95 -35.81 1.85 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.33 2.02 . . . . 0.0 111.863 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -71.71 -49.64 37.6 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.619 ' O ' ' N ' ' A' ' 148' ' ' GLY . 79.5 m95 -59.17 -56.73 18.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.908 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -43.91 -38.54 3.45 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -35.19 72.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.08 -47.04 93.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.7 mp -65.96 -43.67 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.04 -40.27 30.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.3 mt -65.38 -38.51 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.715 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.99 -49.71 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.991 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.08 -45.71 93.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.563 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 13.2 tp -47.97 -32.64 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.391 0.615 . . . . 0.0 109.844 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.0 mt -83.0 -37.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.292 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 53.0 t -52.61 -46.35 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.458 ' CB ' ' CE2' ' A' ' 77' ' ' TRP . . . -79.88 -44.17 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.548 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 43.0 t -50.16 -40.66 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.11 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.24 -42.15 14.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.477 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 163' ' ' SER . 55.6 t -64.68 -38.26 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.208 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.539 ' O ' ' NH2' ' A' ' 70' ' ' ARG . 63.8 t -71.75 -53.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 109.945 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.502 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -66.46 -5.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.579 ' HG ' ' NH2' ' A' ' 70' ' ' ARG . 66.7 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.185 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 2' ' ' LEU . 3.8 mm? -63.95 -39.27 93.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.205 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -54.25 -36.42 63.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLN . 43.2 m-85 -72.25 -44.31 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.57 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -45.69 -42.9 12.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 110.095 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -68.33 -25.4 65.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.19 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.4 tp-100 -78.79 -48.77 14.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.42 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 11' ' ' GLY . 39.1 p -76.7 -41.02 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -69.03 6.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.139 0.495 . . . . 0.0 110.304 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.21 140.8 15.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -68.9 -49.2 60.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.846 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.95 -46.07 6.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.12 85.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.114 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -56.88 -47.1 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.55 -27.94 68.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.14 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.24 -36.41 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 mmt -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.202 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.11 73.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.909 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.08 -34.14 73.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.978 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 m -59.68 -58.98 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.626 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.17 -25.67 65.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.33 -42.11 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.279 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' O ' ' CG2' ' A' ' 28' ' ' THR . . . -61.39 -24.34 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.19 -45.4 10.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.454 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.0 -37.74 88.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.756 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.69 -51.42 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.925 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 5.6 p -47.25 -37.15 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.91 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.815 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.1 -15.83 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -94.46 -33.4 13.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.545 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -38.45 79.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.482 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -72.13 -39.2 68.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.579 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -8.42 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.9 t -108.99 -46.48 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 mmt -96.2 14.43 24.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.744 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt 43.01 42.63 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.7 mt -70.01 154.98 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.115 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -111.56 103.28 54.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.108 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -52.1 167.84 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.154 1.903 . . . . 0.0 111.545 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.8 175.4 9.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.5 t -61.7 -48.31 89.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 9.8 mp -61.34 -45.51 94.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.14 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -49.09 -44.73 42.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.429 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.6 mt -61.45 -43.82 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.094 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -47.11 73.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.597 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.397 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' NH2' ' CD1' ' A' ' 52' ' ' PHE . 3.8 tmt_? -62.63 -37.66 87.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.548 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.34 78.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.13 -48.36 81.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.817 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.8 tp -79.56 -50.3 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CD1' ' NH2' ' A' ' 48' ' ' ARG . 66.2 t80 -46.23 -41.48 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.759 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.93 -44.2 89.47 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.5 t -62.61 -47.3 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.3 tp -44.62 -48.09 10.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.523 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.08 92.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.86 63.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.446 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.72 76.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.352 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.0 -27.09 54.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.45 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 60' ' ' ILE . 95.9 mt -81.8 -43.48 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.397 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.79 -32.94 78.85 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.85 4.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.715 0.293 . . . . 0.0 110.944 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.7 mt -83.33 -26.49 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.67 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -173.23 65.48 0.33 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.433 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.16 11.14 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.648 2.232 . . . . 0.0 112.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 64' ' ' ALA . 15.5 pttp -111.04 -6.47 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.243 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.25 161.89 24.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.639 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -38.16 -16.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.554 2.169 . . . . 0.0 112.287 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.4 tp -43.22 -31.47 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -40.79 -65.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -55.69 -29.89 60.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.557 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.2 t -67.6 -43.11 87.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.639 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -29.06 30.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.275 0.559 . . . . 0.0 109.955 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.7 ttt -65.25 -12.97 57.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 30.3 m -59.71 -37.15 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.524 0.678 . . . . 0.0 110.537 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.27 -30.05 5.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.215 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.472 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 2.5 t-105 -68.6 -49.72 57.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.995 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 81' ' ' ALA . 3.9 tt -66.53 -50.61 62.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.0 m-85 -43.69 -39.98 3.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -79.71 -23.81 42.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.75 -61.77 2.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.804 0.335 . . . . 0.0 111.159 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -51.95 12.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.085 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -68.51 -47.87 65.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.92 -46.11 92.87 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.41 -37.69 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.796 -0.238 . . . . 0.0 111.472 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -67.98 -25.41 65.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -90.21 -35.36 15.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.892 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.6 p -57.33 -52.53 64.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.911 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.442 ' O ' ' OG1' ' A' ' 92' ' ' THR . 19.4 m-85 -48.93 -49.85 38.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.376 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -51.91 -42.73 62.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -67.04 -34.49 77.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 74.8 p -74.48 -29.92 61.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.571 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.4 mmt -64.24 -41.18 97.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.356 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.72 -51.15 61.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.431 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 0.4 OUTLIER -57.2 -48.02 79.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.171 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -74.26 -22.67 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.416 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 98' ' ' PRO . 17.2 t80 -138.56 70.02 45.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 97' ' ' TYR . 42.8 Cg_exo -53.6 -159.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.826 2.351 . . . . 0.0 112.228 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p 175.09 152.5 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.16 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 102' ' ' ALA . 85.9 Cg_exo -37.77 154.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.694 2.263 . . . . 0.0 112.372 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.58 37.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 100' ' ' PRO . . . -77.3 -45.34 26.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.537 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.477 ' O ' ' OG ' ' A' ' 104' ' ' SER . 20.4 m -47.98 -21.49 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 103' ' ' THR . 49.4 p 58.81 129.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.11 142.78 18.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CD2' ' N ' ' A' ' 107' ' ' MET . 5.6 p90 -159.33 -142.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.573 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 33.0 mtt -56.08 134.62 52.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.18 131.99 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.624 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -86.03 99.85 11.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.249 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.64 150.31 94.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.64 160.18 50.72 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.732 2.288 . . . . 0.0 111.907 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -108.07 8.45 28.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -125.22 -5.7 7.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.653 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -123.02 81.58 50.88 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 36.1 Cg_exo -56.55 15.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.351 . . . . 0.0 112.671 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.653 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -76.28 -32.35 58.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.013 0.435 . . . . 0.0 110.253 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 1.1 m-20 -98.4 -40.28 8.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.347 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.24 -45.35 63.44 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.018 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 9.9 t-105 -76.76 -10.37 59.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.39 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.02 68.99 35.47 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.75 -15.44 12.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.867 2.378 . . . . 0.0 111.668 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -53.08 -32.15 45.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.627 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 44.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.432 ' CZ ' ' OD1' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -148.57 -36.87 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.436 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -58.73 127.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.694 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.27 152.91 18.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.31 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -155.08 102.39 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.14 -168.07 19.38 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.3 154.1 19.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 36.3 m -99.01 138.78 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 111.204 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 101.04 -5.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.634 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.84 149.22 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -98.86 122.58 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.735 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.55 -29.76 9.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -173.68 146.54 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.46 158.08 44.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.293 0.568 . . . . 0.0 112.106 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 13.4 m-85 -112.89 137.71 50.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.175 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.7 mm? 48.61 17.44 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.425 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 92.61 22.3 29.18 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.223 -0.513 . . . . 0.0 111.995 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 5.2 mp0 -72.41 146.56 46.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.3 mtt -47.24 -56.42 12.43 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -40.95 -38.58 2.94 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.565 2.176 . . . . 0.0 112.672 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -70.14 -51.8 28.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.9 m95 -58.79 -56.64 19.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.9 tp -43.69 -38.29 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.54 -36.82 76.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.98 -46.48 94.5 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.7 mt -75.09 -25.63 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.015 0.436 . . . . 0.0 110.061 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -63.36 -44.03 95.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.765 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 4.8 tt -70.23 -36.83 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.578 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.75 75.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.187 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.55 -40.42 94.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.686 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 86.7 mt -64.36 -32.42 74.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.41 -29.65 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.38 -40.14 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.34 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -70.08 -50.03 45.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 92.4 t -51.62 -39.25 23.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.1 tp -81.18 -37.35 28.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.14 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.5 t -71.0 -22.48 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.795 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.12 -48.29 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.0 110.24 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 164' ' ' GLN . 81.5 mt -69.16 -14.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.9 m -52.91 -14.27 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.629 ' C ' ' H ' ' A' ' 166' ' ' PHE . 61.7 tt0 -40.07 104.04 0.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.59 2.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.234 1.956 . . . . 0.0 112.276 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.629 ' H ' ' C ' ' A' ' 164' ' ' GLN . 62.5 m-85 56.73 -95.2 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.434 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -163.61 -11.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.643 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.69 66.29 9.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -76.06 -143.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.746 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 172' ' ' ASP . 16.3 pttm -158.51 -1.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.536 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 65.08 -68.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.51 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 170' ' ' LYS . 5.5 m-20 -158.06 168.72 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.691 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 3.5 mm? -75.41 158.36 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -83.39 138.6 33.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.32 79.51 0.29 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -91.95 -76.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.365 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -99.18 -51.33 1.35 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.667 ' CD2' ' H ' ' A' ' 179' ' ' HIS . 45.1 t60 59.45 -136.69 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 110.574 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.667 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 34.4 t-80 -81.45 99.03 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.638 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -161.47 91.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -58.7 -176.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 32.4 m170 54.24 82.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.518 ' O ' ' ND1' ' A' ' 183' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.491 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.7 -47.81 81.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -49.64 -48.91 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.404 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -52.83 -45.6 67.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.277 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tp -48.78 -43.76 38.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.126 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -69.56 -26.36 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.076 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -75.96 -50.49 14.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.28 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.81 70.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' A' ' 10' ' ' GLN . 50.4 p -76.85 -41.57 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.553 ' N ' ' HG ' ' A' ' 9' ' ' SER . 2.6 tp60 -68.28 5.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.419 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.75 140.98 15.12 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -70.19 -49.9 45.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.615 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.73 -46.42 5.91 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.45 89.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -61.58 -37.17 82.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.05 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.1 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.138 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 tp -70.31 -30.0 66.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.752 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.423 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.2 mtp -73.41 -33.69 65.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.89 -55.3 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.53 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -47.03 -47.92 22.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 18' ' ' MET . 31.5 p -53.48 -58.02 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.379 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.14 -34.65 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.8 tp -76.32 -41.97 46.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.21 -32.14 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.293 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.57 -37.32 42.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.13 -52.84 62.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.821 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.26 -50.24 74.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.747 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.1 p -48.59 -44.06 36.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.861 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.34 -46.21 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.034 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.15 -19.57 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.534 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -92.27 -39.41 11.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.61 -30.85 14.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -83.77 -42.1 16.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.011 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -69.09 -14.49 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.074 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 36' ' ' MET . 9.2 p -109.11 -39.22 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.899 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.411 ' N ' ' CG1' ' A' ' 35' ' ' VAL . 1.1 tpt -97.23 11.55 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.867 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.517 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.2 mp 43.85 44.97 6.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.199 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 tp -77.6 153.0 33.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -108.78 129.85 23.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.691 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.27 169.17 21.8 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.468 2.112 . . . . 0.0 112.184 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.95 159.57 38.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.561 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -50.82 -42.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.155 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.88 -45.13 87.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -51.08 -42.83 60.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 mt -66.21 -43.1 92.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.241 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -58.85 -44.91 91.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.757 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.07 -49.7 76.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -59.11 -30.09 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.131 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.98 82.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.347 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.43 -49.73 75.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.649 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.07 -49.27 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -46.1 -41.34 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.98 -42.39 92.68 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.5 t -64.97 -47.61 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 109.975 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 tt -45.21 -44.87 11.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.654 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -37.01 94.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -63.97 -37.88 89.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.2 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.73 -34.17 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.31 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -75.72 -27.14 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.186 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 60' ' ' ILE . 95.6 mt -80.39 -40.43 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.471 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.64 -26.81 73.46 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.96 9.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.662 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' H ' ' C ' ' A' ' 61' ' ' GLY . 96.2 mt -82.08 -39.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.63 74.38 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 0.0 110.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.31 26.8 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.701 2.267 . . . . 0.0 112.086 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 64' ' ' ALA . 52.2 tttm -108.13 -9.02 15.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.309 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.591 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.8 175.85 1.71 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.686 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.65 -4.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.239 1.96 . . . . 0.0 112.047 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.591 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.8 mt -47.98 -35.45 10.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 58.8 mtt180 -40.83 -70.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -49.61 -20.22 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.171 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 69' ' ' LEU . 9.8 t -83.38 -46.56 18.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.806 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.85 -38.85 64.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 110.928 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -61.16 -9.51 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.86 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 8.0 t -57.87 -41.4 79.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.323 0.582 . . . . 0.0 109.989 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.7 -32.62 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.505 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 2.2 t-105 -65.15 -51.68 59.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.7 tp -65.73 -47.52 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -44.07 -43.58 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.231 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 p -78.74 -21.0 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.718 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.46 -60.51 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.853 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -73.75 -55.12 6.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.178 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -65.57 -44.71 85.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.408 ' O ' ' CG2' ' A' ' 88' ' ' THR . . . -61.48 -45.49 96.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.426 -0.892 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.1 t -73.18 -44.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.692 0.282 . . . . 0.0 111.622 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -41.62 96.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.305 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.2 -45.37 48.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 84' ' ' GLY . 8.7 p -48.68 -49.36 38.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.659 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.423 ' O ' ' OG1' ' A' ' 92' ' ' THR . 57.0 t80 -52.0 -38.5 57.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.291 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -56.88 -42.23 79.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -68.01 -37.55 81.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.434 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 64.3 p -67.27 -41.44 85.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.347 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' TYR . 13.0 ttt -53.48 -48.45 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.12 -46.85 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.142 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -50.71 -41.32 56.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.132 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 96' ' ' LEU . 4.0 mm? -91.17 -13.95 31.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' PRO . 80.1 t80 -121.48 85.48 43.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.407 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 97' ' ' TYR . 50.8 Cg_exo -52.94 -140.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.746 2.297 . . . . 0.0 112.247 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 98' ' ' PRO . 14.2 p 60.88 58.28 3.64 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.66 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.804 2.336 . . . . 0.0 112.041 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 73.21 99.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.361 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.5 114.89 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.7 m -96.58 -60.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.697 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.1 t -120.0 -65.45 1.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 24.2 t0 60.87 -172.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.448 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.538 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 27.7 m-85 -147.5 76.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.571 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.599 ' C ' ' H ' ' A' ' 109' ' ' ARG . 7.9 mmt -85.9 128.8 34.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.7 t 61.39 -5.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.599 ' H ' ' C ' ' A' ' 107' ' ' MET . 76.0 mtt85 -97.52 99.73 11.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.575 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 164.06 15.71 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -40.96 151.95 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.687 2.258 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.12 -9.71 14.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.555 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -110.26 -0.21 17.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.612 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 tp -126.46 77.49 72.91 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.139 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 42.2 Cg_exo -53.03 4.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.787 2.325 . . . . 0.0 112.436 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.612 ' H ' ' C ' ' A' ' 114' ' ' LEU . 7.8 tp -61.38 -33.61 73.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.174 0.511 . . . . 0.0 109.978 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.53 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.3 OUTLIER -97.33 -43.88 7.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.528 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -66.95 -45.43 77.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.773 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -75.52 -11.75 60.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 70.51 46.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.7 -17.83 10.87 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.85 2.367 . . . . 0.0 111.884 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -57.44 -35.79 70.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.054 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.28 50.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.647 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.53 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -159.54 -35.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -54.58 127.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.501 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.8 149.12 21.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -164.19 117.67 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.703 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.93 -169.28 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 11.9 t70 -93.94 163.29 13.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 61.5 m -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.53 -4.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.56 128.52 36.76 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.759 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.463 ' N ' ' CD ' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -62.24 111.8 2.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.196 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -111.53 -31.31 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.823 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -172.73 141.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.055 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -146.9 160.99 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.225 0.535 . . . . 0.0 111.897 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -122.84 139.51 53.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.942 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.08 17.52 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.823 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 22.61 51.01 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.26 135.41 52.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.837 0.351 . . . . 0.0 110.108 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.22 148.42 49.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.409 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 6.5 mtt -45.64 -60.33 3.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.35 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.5 Cg_exo -35.98 -37.62 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.68 2.253 . . . . 0.0 112.5 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -70.94 -50.46 34.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.014 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.596 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.8 m95 -60.81 -56.85 16.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.842 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.35 -35.6 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.248 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 tp -65.4 -33.87 76.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.46 -46.78 93.71 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.18 -38.8 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -50.88 -44.06 59.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.733 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.21 -40.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -55.72 -47.77 76.33 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.693 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.24 -46.2 88.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.04 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.489 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 83.1 mt -61.7 -40.25 94.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.51 -40.38 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.464 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.6 t -52.46 -43.29 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.397 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.81 -45.35 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 74.7 t -48.82 -36.78 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.937 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.09 -33.11 33.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.983 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.7 t -76.32 -26.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.917 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.64 -50.54 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.534 ' C ' ' H ' ' A' ' 164' ' ' GLN . 2.1 pp -65.68 -22.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.8 p -54.19 -4.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.65 ' NE2' ' N ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -117.56 148.19 42.4 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.477 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.625 ' N ' HE21 ' A' ' 164' ' ' GLN . 56.2 Cg_endo -70.64 52.52 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.413 2.076 . . . . 0.0 111.96 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.65 ' N ' ' NE2' ' A' ' 164' ' ' GLN . 57.8 t80 41.26 -109.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.722 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 66.6 tttt -169.76 98.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.674 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.44 -56.65 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -179.2 23.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -82.14 87.49 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.587 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -93.96 128.31 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -65.68 157.53 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.636 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.14 -168.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.546 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.55 143.8 49.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.511 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -85.27 -122.35 1.15 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 54.26 170.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.767 0.318 . . . . 0.0 110.538 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.19 7.8 77.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.7 m170 58.9 42.41 19.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.43 132.38 53.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.38 -56.03 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.532 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 62.33 150.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 51.32 66.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.587 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.3 -38.64 88.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.383 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -58.32 -38.74 77.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' A' ' 7' ' ' GLN . 32.9 t80 -69.42 -47.58 63.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.12 -40.03 10.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.338 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.14 -22.11 63.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.211 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.6 tp-100 -80.03 -47.4 14.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.58 88.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 11' ' ' GLY . 92.5 p -76.82 -38.89 53.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.509 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 6.5 tt0 -64.94 2.5 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.93 146.63 18.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -67.89 -48.33 66.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.559 0.219 . . . . 0.0 110.61 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -45.73 6.07 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.09 -47.53 84.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -59.79 -39.26 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.091 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.029 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -70.05 -33.22 71.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.714 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.2 mtt -70.68 -33.93 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.6 -51.6 40.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.581 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.94 -34.21 62.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.7 m -63.34 -57.0 11.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.703 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -22.95 63.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.75 -42.06 16.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.417 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -51.27 -41.71 60.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.838 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 7.9 mp -72.06 -33.69 68.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -62.05 -42.83 99.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.428 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.21 -40.9 51.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 28.4 m -54.68 -45.88 74.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.585 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.86 64.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.547 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 tp -65.49 -20.69 66.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.729 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.62 -41.41 11.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -51.35 -38.41 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.467 ' NE2' ' O2 ' ' A' ' 201' ' ' UQ2 . 1.7 tt0 -71.16 -38.85 72.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.324 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.98 -6.79 52.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.848 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.34 -47.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.0 mtt -97.52 11.62 36.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 tp 46.48 48.25 13.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.616 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.1 mt -84.56 152.9 23.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -117.32 133.08 23.24 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.82 176.88 9.48 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 111.953 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.457 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 8.3 t -131.9 177.79 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.68 -46.07 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.95 -48.82 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.373 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -48.78 -48.33 41.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.657 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.64 -41.46 90.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -55.17 -47.73 74.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -63.08 -38.24 90.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -63.69 -36.77 84.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -40.59 77.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.35 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 tp -73.31 -53.08 11.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.05 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -45.06 -38.69 5.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.813 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.84 -42.55 94.98 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 43.5 t -60.61 -46.97 94.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.98 -46.68 11.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.62 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.2 -28.76 72.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.63 -38.8 70.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.299 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.73 76.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.019 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 4.3 mt -73.76 -28.11 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.14 -39.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.12 -21.44 78.41 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.48 7.79 5.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.715 0.293 . . . . 0.0 110.892 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.3 mp -84.03 -35.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -175.57 71.61 0.27 Allowed Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.601 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.07 13.53 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.514 2.143 . . . . 0.0 111.827 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 64' ' ' ALA . 80.7 tttt -106.68 -8.86 16.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.05 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.99 161.94 25.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.607 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -39.9 -14.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.479 2.12 . . . . 0.0 112.207 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -42.39 -34.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.639 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtt180 -37.94 -63.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -51.63 -31.12 24.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.842 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 69' ' ' LEU . 11.3 t -69.32 -45.44 79.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.947 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.89 -33.2 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.196 0.522 . . . . 0.0 110.317 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.467 ' O ' ' SD ' ' A' ' 74' ' ' MET . 2.8 tmm? -63.21 -14.52 50.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.026 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.3 t -57.52 -39.11 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.52 0.676 . . . . 0.0 110.524 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.36 -31.49 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.4 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 9.0 t-105 -65.94 -54.33 27.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.174 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' ALA . 14.9 tp -63.67 -47.68 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -42.79 -42.94 3.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.381 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.8 p -78.11 -23.21 47.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -61.12 -60.03 4.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.361 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -49.97 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.681 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -39.0 69.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.703 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.13 -48.29 86.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.555 ' O ' ' OG1' ' A' ' 88' ' ' THR . 14.2 m -72.85 -48.33 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.595 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.453 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 14.6 tm0? -48.46 -29.06 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.09 -42.1 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.254 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 62.9 p -50.94 -31.03 16.44 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.38 -51.5 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.873 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.07 -36.76 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -71.63 -39.27 70.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -73.44 -52.17 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.5 ttp -51.96 -52.94 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.12 -48.74 75.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -54.76 -36.06 64.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.217 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -92.33 -15.96 26.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.55 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 93' ' ' MET . 51.9 m-85 -139.36 68.43 39.48 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.449 ' O ' ' OG ' ' A' ' 99' ' ' SER . 54.2 Cg_exo -48.85 163.87 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.718 2.279 . . . . 0.0 111.874 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 98' ' ' PRO . 44.0 m -171.56 67.77 0.44 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.727 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.88 114.03 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.693 2.262 . . . . 0.0 111.963 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 102' ' ' ALA . 2.1 t80 -150.44 64.22 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.434 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . 44.84 -171.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 m 52.78 19.49 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -64.63 -16.82 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 54.98 47.03 23.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.46 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -43.43 -31.32 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.623 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmm -79.55 178.35 8.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.3 99.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.44 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -106.07 99.64 9.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -101.04 159.79 28.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.175 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.39 160.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.441 2.094 . . . . 0.0 111.931 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.52 20.03 16.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.003 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' A' ' 113' ' ' TRP . 2.1 p-90 -122.09 9.87 9.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.602 ' C ' ' H ' ' A' ' 116' ' ' LEU . 50.1 mt -122.01 81.04 42.95 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.271 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.1 Cg_exo -51.94 0.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.233 . . . . 0.0 112.267 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.602 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 mt -60.69 -32.23 71.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.429 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 27.9 p-10 -96.82 -41.3 8.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.625 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 35.4 tttm -71.69 -45.19 62.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.732 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -74.27 -16.79 60.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.532 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.8 71.96 29.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.983 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.1 -18.37 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.683 2.255 . . . . 0.0 111.861 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -50.14 -52.52 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.83 54.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.565 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -154.97 -40.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.322 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.2 130.5 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.642 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.87 149.53 21.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -161.27 99.86 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.401 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.75 -177.32 20.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 44.4 t0 -91.4 157.05 17.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.54 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.578 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 5.7 m -103.51 131.25 50.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.123 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 97.02 -5.36 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.197 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.03 151.7 45.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.045 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -89.69 147.59 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.4 HE22 ' CM3' ' A' ' 201' ' ' UQ2 . 28.9 mt-30 -133.88 -31.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.459 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -174.89 143.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -132.97 164.15 27.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.769 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.21 118.01 9.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.283 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.81 16.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.4 10.63 79.56 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.1 mt -119.5 138.03 53.42 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.867 0.365 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.83 154.0 42.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.6 mtp -55.72 -50.25 88.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.568 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 55.4 Cg_exo -48.32 -38.8 34.71 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.446 2.098 . . . . 0.0 112.088 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.687 HE21 ' N ' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -70.03 -42.51 72.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.524 0.678 . . . . 0.0 109.87 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.687 ' N ' HE21 ' A' ' 144' ' ' GLN . 47.6 m95 -60.03 -56.15 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.222 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.9 tp -43.39 -42.76 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 143' ' ' PRO . 1.1 mt -56.91 -35.54 69.12 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.6 -44.28 96.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.835 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.81 -29.67 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.337 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 -44.78 88.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.987 0.422 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.4 -39.83 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.07 64.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.482 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.3 m-85 -52.91 -42.84 65.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.446 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 0.8 OUTLIER -75.06 -29.43 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.247 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mt -70.83 -31.21 44.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.322 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.0 m -78.25 -38.71 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.735 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.551 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.27 -54.23 40.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -55.68 -45.22 79.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 tp -63.23 -37.8 88.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.49 -30.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.9 -50.16 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.999 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.18 -31.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.0 m -53.13 -18.82 2.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.408 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -104.12 110.65 64.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.363 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -43.92 85.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.175 1.917 . . . . 0.0 111.968 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' GLN . 18.4 p90 -44.21 162.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -42.98 125.0 3.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.492 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -122.36 -47.73 2.11 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -86.29 101.94 13.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.666 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 172' ' ' ASP . 2.2 ptpp? -96.98 165.87 11.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.526 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 55.09 -81.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.56 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 170' ' ' LYS . 22.7 t0 64.01 124.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.638 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.6 mt -83.0 -162.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -145.79 165.6 28.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -79.97 -75.17 1.06 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -154.08 -33.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.52 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -160.4 17.45 0.21 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.418 ' C ' ' N ' ' A' ' 180' ' ' HIS . 5.0 m80 -68.64 -62.15 1.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.426 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 179' ' ' HIS . 46.0 t-80 45.92 21.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.418 ' N ' ' C ' ' A' ' 178' ' ' HIS . 5.1 t60 -41.36 123.06 2.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.733 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.426 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 3.2 t-80 -110.19 -15.02 14.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 1.5 t-80 64.84 -144.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.528 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.671 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.561 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.467 ' O2 ' ' NE2' ' A' ' 33' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -76.84 -47.2 22.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.389 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -56.68 -38.58 72.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.298 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLN . 8.6 t80 -66.13 -47.36 74.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.176 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.44 -38.03 8.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.86 -21.28 65.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.068 0.461 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' PHE . 30.9 tt0 -81.71 -46.45 14.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.26 84.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.2 m -76.95 -34.43 57.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 20.6 tt0 -67.95 3.16 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.54 146.87 18.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -69.97 -48.82 56.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.739 0.304 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.23 -45.84 6.47 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.83 -48.07 80.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -56.26 -47.86 77.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -27.32 68.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -29.24 66.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.625 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.73 -34.09 60.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.232 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.9 26.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.887 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -54.45 -49.02 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -46.58 -58.65 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.553 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.31 -29.39 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.31 -39.44 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.711 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -54.6 -34.81 62.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.638 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.1 mt -74.11 -37.92 64.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.63 -50.54 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -57.93 -43.84 86.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 25.3 m -59.47 -43.64 93.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.39 -29.26 62.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -67.95 -21.62 65.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.688 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -88.0 -42.38 12.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -51.59 -39.94 58.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.124 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -71.51 -37.23 71.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 39.3 m80 -75.85 -10.55 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.18 -47.96 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -94.08 11.9 28.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.896 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tp 44.65 44.26 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.14 148.18 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.472 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -109.67 130.33 22.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.8 Cg_endo -76.35 174.36 12.95 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.288 1.992 . . . . 0.0 111.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -131.85 -178.5 4.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.93 -45.22 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.917 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 43' ' ' LEU . 8.6 mp -76.07 -42.8 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.844 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 m -58.84 -51.9 68.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 tt -64.81 -36.07 76.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.996 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.07 -46.68 85.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.788 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.67 -37.14 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.294 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.3 -33.83 74.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.319 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.55 76.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.493 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.81 73.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.92 -45.45 58.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.38 -40.27 11.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.688 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.39 79.91 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.3 t -62.25 -47.99 90.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.078 0.466 . . . . 0.0 109.937 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -45.11 -44.63 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.83 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -29.62 75.81 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.17 -37.42 87.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.11 -27.18 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.736 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.12 -39.94 75.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.596 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.7 pt -82.49 -31.94 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.14 -31.44 69.23 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.86 7.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.4 mp -83.8 -26.98 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.76 71.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -68.35 17.44 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.338 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 64' ' ' ALA . 59.6 mttt -112.2 -4.14 14.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.41 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -112.06 160.46 29.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.611 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -37.72 -16.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.556 2.171 . . . . 0.0 112.048 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.6 tp -43.13 -33.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -40.12 -67.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.522 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.64 -33.05 53.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.466 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 7.5 t -65.89 -55.85 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.617 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.93 74.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.236 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.9 mmt -61.79 -12.19 15.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.26 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 2.0 p -63.15 -31.51 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.469 0.652 . . . . 0.0 110.069 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.08 -30.64 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.606 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.487 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.3 t-105 -65.68 -49.68 67.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.806 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.72 -44.36 77.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.418 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -46.92 -45.28 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.4 p -78.17 -21.96 49.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.02 -59.5 5.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.016 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.5 -53.07 10.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.6 ttt85 -66.89 -45.68 77.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.64 -47.1 91.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' O ' ' OG1' ' A' ' 88' ' ' THR . 59.8 t -69.81 -47.26 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -52.98 -21.46 4.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.151 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -40.53 12.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.454 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 24.5 p -53.07 -26.01 14.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.532 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.72 -44.79 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.469 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 5.2 mp0 -56.22 -46.64 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.395 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -61.51 -50.06 74.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.363 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.7 p -59.3 -50.56 73.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.55 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.5 ttt -53.95 -49.36 68.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.54 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -48.0 82.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.264 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -49.98 -41.8 47.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.4 mt -96.71 -6.62 35.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.422 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.55 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.4 t80 -126.08 80.85 67.44 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.633 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 99' ' ' SER . 65.9 Cg_endo -77.43 -158.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.512 2.141 . . . . 0.0 112.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER 82.17 66.78 0.12 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.466 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.19 157.94 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 112.207 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 101' ' ' PHE . 34.7 t80 -165.27 -25.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -125.56 -19.87 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.377 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.1 m -80.85 64.29 5.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.483 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.3 p -77.84 122.89 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.622 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 51.84 93.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -48.84 107.71 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.187 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.4 ttt -160.22 125.23 3.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.598 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -70.29 142.71 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.427 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -150.04 100.0 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.04 149.56 42.75 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.188 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.82 130.58 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.53 2.153 . . . . 0.0 112.224 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -71.96 -0.05 10.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.226 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.556 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.73 0.01 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.238 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.611 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 mt -117.63 83.54 17.73 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.256 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -50.38 -0.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.688 2.258 . . . . 0.0 112.403 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.2 mp -62.66 -30.41 71.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 -39.82 9.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.672 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.67 -45.46 52.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.424 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 10.3 t-105 -73.64 -17.95 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.449 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.63 72.57 24.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.783 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.84 -17.54 12.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.662 2.241 . . . . 0.0 111.688 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -54.32 -52.59 61.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.863 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.07 55.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.745 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.93 -41.1 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.363 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -60.61 131.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 0.0 110.775 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.17 157.91 16.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' PRO . 47.9 p -164.87 99.82 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.564 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.12 -176.93 21.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 23.8 m-20 -84.55 156.57 21.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.798 0.332 . . . . 0.0 110.381 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 5.4 m -105.09 130.25 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.792 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.55 -6.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.889 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.71 151.97 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.896 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.685 ' HE ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -91.6 135.73 33.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 0.0 110.997 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -126.73 -24.4 3.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.25 141.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.7 163.35 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 112.23 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -130.83 139.61 50.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.8 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.3 17.13 3.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.5 19.95 61.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mt -122.7 134.48 54.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.922 0.391 . . . . 0.0 110.364 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.58 150.98 45.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.514 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.9 mtt -48.81 -55.18 21.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.765 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -40.94 -37.98 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.379 2.052 . . . . 0.0 112.028 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.53 -50.91 32.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.253 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.0 m95 -59.66 -57.25 13.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.487 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 146' ' ' LEU . 3.0 tm? -43.53 -41.76 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.53 -36.86 67.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.96 -40.83 93.85 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.728 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.2 mp -79.61 -26.55 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.192 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.14 -50.2 71.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.273 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.7 tt -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.593 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.28 -47.29 55.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.237 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.65 -45.91 73.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.5 mt -58.2 -30.54 66.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.832 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.54 -27.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.706 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 95.8 t -71.45 -36.19 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.976 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.487 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.25 -52.74 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.544 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.2 t -52.75 -38.76 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.627 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 3.7 mm? -81.71 -32.35 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.118 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 38.3 t -76.5 -22.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.8 t -80.63 -50.56 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 109.945 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.511 ' C ' ' H ' ' A' ' 164' ' ' GLN . 68.2 mt -68.81 -17.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.55 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 90.8 p -52.72 -8.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.586 ' C ' ' H ' ' A' ' 166' ' ' PHE . 2.7 mm100 -76.02 147.05 79.84 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.516 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 166' ' ' PHE . 54.0 Cg_exo -47.92 -4.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.434 2.09 . . . . 0.0 112.49 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 164' ' ' GLN . 51.7 t80 -31.41 -82.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.234 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -45.14 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -141.48 -149.03 0.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 168' ' ' ALA . 26.5 mttm 57.1 117.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.529 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -151.54 35.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.434 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 63.09 91.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.589 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -173.68 171.56 3.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.628 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.92 158.93 33.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -85.43 -108.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 170.48 128.91 1.06 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -161.57 23.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.623 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.07 160.1 9.9 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -114.1 103.13 10.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.875 0.369 . . . . 0.0 110.393 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -85.31 -49.87 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 9.8 p-80 -72.5 170.93 13.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.605 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 12.7 m-70 -145.46 171.06 15.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -79.04 47.6 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.539 ' OXT' ' CD2' ' A' ' 183' ' ' HIS . 79.0 t60 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mmt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tt -61.13 -55.66 29.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -46.8 -36.42 7.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.561 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -39.72 75.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.34 -44.16 54.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.305 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.84 -25.78 66.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.191 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -78.69 -46.78 18.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.8 76.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -76.62 -31.62 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.956 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -75.15 7.68 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.015 0.436 . . . . 0.0 110.462 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.17 145.58 17.02 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.06 -20.35 65.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.312 . . . . 0.0 110.601 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.59 58.48 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.43 67.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -55.98 -46.15 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.225 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.17 -31.66 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.523 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -32.45 71.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.3 mtt -69.85 -34.57 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.459 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.87 59.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.733 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -50.23 -51.05 47.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -52.32 -56.66 13.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.04 -31.24 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.88 -40.85 24.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.803 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.44 -44.56 17.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.706 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.4 mp -68.14 -25.4 65.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.02 -39.48 75.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.801 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -77.95 -47.34 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -50.23 -45.94 54.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.96 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.65 -20.99 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.829 0.347 . . . . 0.0 110.697 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -90.12 -22.14 21.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.5 -38.22 71.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.244 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 0.36 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.224 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -120.84 -49.35 2.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.46 -37.59 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.894 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.528 ' SD ' ' CZ3' ' A' ' 135' ' ' TRP . 15.8 ttt -109.81 13.54 23.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.6 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 37' ' ' LEU . 6.5 mp 42.36 37.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.51 149.69 43.88 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -110.34 125.76 30.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.668 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.15 145.99 19.69 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.429 2.086 . . . . 0.0 111.891 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -101.06 -174.99 2.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.708 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.77 -46.73 91.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.08 -47.03 88.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -51.49 -44.49 62.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 71.3 mt -61.42 -48.13 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.487 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 11.1 t80 -54.65 -44.99 73.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.728 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.52 -48.19 73.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.663 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -60.04 -38.21 82.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.73 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.2 90.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.507 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.03 76.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.405 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -73.41 -48.39 34.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.13 -42.24 19.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.8 -45.65 81.96 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 57' ' ' ALA . 56.1 t -62.24 -45.81 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.135 0.493 . . . . 0.0 109.749 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 tp -44.2 -48.59 9.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.352 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.95 97.52 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -56.54 -37.87 71.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.46 . . . . 0.0 110.295 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.54 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.327 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -70.23 -44.73 67.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -73.52 -35.32 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -31.08 68.27 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.75 5.5 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.694 0.283 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 63' ' ' ILE . 90.2 mt -79.18 -42.57 23.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 177.07 77.23 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.343 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.88 30.87 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.718 2.279 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -110.54 -9.82 14.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.127 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -108.83 176.21 1.66 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.889 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -6.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.126 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 67' ' ' THR . 37.7 mt -53.47 -28.1 28.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' NH1' ' HH ' ' A' ' 71' ' ' TYR . 10.1 ttm180 -40.76 -70.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.427 ' HH ' ' NH1' ' A' ' 70' ' ' ARG . 91.8 m-85 -54.95 -30.52 59.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.413 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.468 ' O ' ' CG1' ' A' ' 75' ' ' VAL . 9.3 t -67.02 -54.48 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.785 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.66 63.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.264 0.554 . . . . 0.0 110.222 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 74' ' ' MET . 6.6 tmm? -59.13 -12.23 4.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.961 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 2.2 p -62.7 -32.46 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.379 0.609 . . . . 0.0 110.355 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.29 -32.95 5.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.039 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.56 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -66.06 -48.81 69.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.864 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.1 tp -65.9 -48.63 70.83 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -42.42 -42.52 3.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.125 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 84' ' ' GLY . 18.2 p -79.4 -21.38 45.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.89 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.27 -61.51 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.069 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -71.48 -45.59 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.555 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.487 ' CZ ' ' OH ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -77.54 -41.96 37.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 80' ' ' SER . . . -57.6 -49.63 72.05 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.385 -0.912 . . . . 0.0 110.825 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.514 ' O ' ' OG1' ' A' ' 88' ' ' THR . 28.2 m -68.3 -43.25 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.002 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -56.64 -31.36 64.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.506 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -43.42 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 110.32 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 33.5 p -52.32 -26.69 12.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.288 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.49 -50.02 64.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.641 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -52.19 -41.26 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -62.43 -48.97 77.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.2 p -66.77 -48.95 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 97' ' ' TYR . 15.5 ttt -49.96 -49.96 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.67 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.02 -47.5 77.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.681 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -53.92 -37.86 64.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -11.14 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.584 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' MET . 29.2 t80 -145.41 81.19 10.42 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.686 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.4 136.09 9.73 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.733 2.289 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -124.76 151.3 67.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.292 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.22 -59.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.408 2.072 . . . . 0.0 112.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -57.75 104.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.36 150.46 22.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.53 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 104' ' ' SER . 63.8 p -48.9 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 103' ' ' THR . 3.2 m 179.58 12.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.4 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.42 58.58 3.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.42 -22.06 60.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.343 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' ARG . 75.6 mtm -149.0 162.63 39.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.652 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -52.87 84.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 107' ' ' MET . 2.9 tpp180 -84.77 101.67 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 111' ' ' PRO . 44.9 m-85 -122.01 153.22 60.78 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 110' ' ' PHE . 90.9 Cg_exo -36.46 160.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.584 2.189 . . . . 0.0 112.117 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 2.4 pm0 -95.05 6.58 48.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.813 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -124.71 27.16 6.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.594 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.1 mm? -122.58 78.15 46.92 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.852 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.24 -3.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.732 2.288 . . . . 0.0 112.266 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.5 mp -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 110.368 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -96.73 -42.98 7.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -70.24 -45.5 66.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.642 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -73.88 -17.14 61.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.17 71.78 33.57 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.26 -17.41 10.38 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.9 2.4 . . . . 0.0 111.785 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -51.89 -52.57 48.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.627 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.8 53.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.558 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -155.4 -40.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.452 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 p -55.75 128.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.13 151.0 19.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -169.94 100.59 0.3 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.43 177.88 18.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 11.8 t70 -86.53 138.22 31.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.094 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.571 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 37.3 m -92.96 130.66 38.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 92.45 -7.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.85 147.83 52.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -80.99 132.18 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.422 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.38 -26.33 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.627 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.528 ' CZ3' ' SD ' ' A' ' 36' ' ' MET . 0.6 OUTLIER -175.69 135.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -139.01 167.17 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.158 0.504 . . . . 0.0 111.606 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.26 120.09 10.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.474 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.1 16.91 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.71 16.8 72.12 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.7 mp -120.85 136.29 54.96 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.76 154.6 41.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.594 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -55.42 -51.57 78.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 142' ' ' MET . 75.5 Cg_exo -45.84 -37.78 17.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.384 2.056 . . . . 0.0 111.785 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.88 -48.48 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.819 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 50.2 m95 -57.24 -57.19 13.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.0 tp -44.26 -38.88 4.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.11 -37.54 67.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.21 -45.56 95.84 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.597 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.7 mp -75.63 -25.67 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 109.908 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.97 -46.32 85.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.5 pt -67.88 -35.77 73.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.385 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.98 -49.48 77.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.343 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.39 -48.37 71.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.717 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.487 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 31.1 mt -62.56 -34.32 76.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.073 0.463 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.9 mt -71.03 -35.56 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.611 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.57 -42.1 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.321 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.56 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -62.37 -34.21 76.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.3 t -73.35 -25.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.216 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.448 ' O ' ' OG ' ' A' ' 163' ' ' SER . 13.4 mt -84.83 -40.01 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.335 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.97 -25.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 31.6 m -82.89 -49.37 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.778 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 35.1 mm -72.02 -8.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.306 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 2.7 m -56.29 -25.32 48.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -173.68 78.97 0.38 Allowed Pre-proline 0 CA--C 1.528 0.129 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 166' ' ' PHE . 86.2 Cg_endo -85.2 19.65 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.973 2.449 . . . . 0.0 112.09 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 165' ' ' PRO . 6.0 m-85 55.23 165.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -64.38 -92.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.645 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 169' ' ' LYS . . . -176.6 -45.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 168' ' ' ALA . 37.9 pttt 31.59 55.62 0.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -70.1 135.44 49.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.174 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -50.66 -178.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.786 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 60.32 122.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.91 25.08 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 t80 54.17 90.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.687 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 47.49 -139.48 9.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -140.49 98.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.37 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -158.17 43.08 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.663 ' H ' ' ND1' ' A' ' 178' ' ' HIS . 3.3 p-80 -53.11 -79.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.318 . . . . 0.0 110.456 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.621 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 97.4 m-70 45.67 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.464 ' HD1' ' CD2' ' A' ' 181' ' ' HIS . 0.7 OUTLIER -57.24 162.35 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.464 ' CD2' ' HD1' ' A' ' 180' ' ' HIS . 8.7 m170 59.4 83.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.681 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -49.62 164.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.502 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.8 m80 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.488 -179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.464 ' O2 ' H3M1 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.8 mtp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.473 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 0.1 OUTLIER -77.44 -46.17 23.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.48 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -52.26 -31.91 34.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 7' ' ' GLN . 10.6 t80 -76.26 -42.07 46.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.374 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -46.42 -39.67 10.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 10' ' ' GLN . 8.3 t-20 -66.57 -24.05 66.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.259 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' PHE . 41.9 tt0 -81.02 -45.89 15.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.54 89.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.503 ' C ' ' H ' ' A' ' 11' ' ' GLY . 57.4 p -76.29 -37.37 57.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.638 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 6' ' ' ASN . 64.8 mt-30 -67.03 5.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.7 145.59 17.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.45 -48.48 60.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.34 6.05 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.94 81.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.144 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -58.25 -47.36 83.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.29 -28.33 68.01 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.55 -29.46 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -32.97 61.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.41 17.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 -52.83 39.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.678 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.0 p -48.26 -57.91 5.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.755 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.31 27.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 tt -81.45 -38.85 25.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.68 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.933 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.0 mp -69.0 -33.14 73.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.715 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -63.38 -41.37 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.1 -50.04 21.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.931 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -47.76 -47.2 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.665 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.95 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.34 -20.44 66.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -88.27 -42.77 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -51.61 -46.63 63.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.165 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' C ' ' OE1' ' A' ' 33' ' ' GLN . 0.5 OUTLIER -70.11 -29.01 65.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -68.04 -26.89 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.7 t -104.8 -53.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.162 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.0 mtt -75.4 3.51 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.17 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt 44.53 47.22 8.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.563 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.54 154.67 32.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.569 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -116.1 126.33 27.74 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 174.72 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.246 1.964 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.7 t -131.85 -175.82 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.765 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 40.5 t -64.44 -44.44 97.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.722 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.21 -49.96 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.54 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t -49.14 -50.19 38.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.526 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.59 -41.36 89.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.918 0.39 . . . . 0.0 110.186 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -45.26 76.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.742 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -63.93 -35.96 82.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.044 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -65.27 -41.51 94.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.233 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.59 78.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.42 74.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.055 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.3 tp -77.41 -45.91 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.993 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -38.66 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.46 80.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 57' ' ' ALA . 38.0 t -62.81 -47.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.241 0.543 . . . . 0.0 109.71 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.8 tp -42.87 -47.2 5.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.562 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.4 92.38 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -55.87 -43.57 77.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.17 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.75 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.227 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.68 -43.23 94.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.449 HD12 HG23 ' A' ' 60' ' ' ILE . 19.6 mm -74.38 -43.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.623 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.13 68.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.34 4.36 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 63' ' ' ILE . 96.8 mt -79.43 -44.74 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.537 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -174.04 74.73 0.36 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.97 18.34 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.666 2.244 . . . . 0.0 112.407 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 64' ' ' ALA . 12.2 pttp -104.9 -7.66 19.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.639 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.98 176.85 1.33 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.446 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.5 1.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 0.0 111.878 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.639 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.3 tp -54.71 -34.89 63.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.639 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' SD ' ' A' ' 74' ' ' MET . 30.9 mtm105 -38.24 -66.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -53.64 -22.1 8.12 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.176 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.0 t -78.99 -48.26 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.336 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.16 -35.04 56.35 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 110.167 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.611 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.1 OUTLIER -64.83 -9.73 22.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.167 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 72' ' ' VAL . 6.3 p -62.67 -35.38 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.1 mm -87.93 -33.74 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.831 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.574 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 16.7 t-105 -61.1 -50.42 73.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.046 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.93 -45.03 79.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -45.19 -44.87 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -79.89 -23.36 41.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.3 -60.45 3.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.631 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -71.76 -56.32 6.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.169 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -66.39 -51.05 61.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.85 -47.73 52.77 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.455 ' O ' ' OG1' ' A' ' 88' ' ' THR . 70.0 t -65.28 -32.05 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.266 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.54 -33.28 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.43 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.96 -40.65 38.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.542 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 46.6 p -52.77 -35.25 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.737 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.42 -52.14 24.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -46.1 -31.05 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.35 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -75.91 -45.56 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.652 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.1 p -67.5 -49.73 62.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.691 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -49.9 -53.11 28.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.056 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.75 -49.62 72.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.464 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -49.84 -35.78 24.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.323 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 tp -100.16 -8.83 23.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' MET . 34.8 t80 -128.32 75.6 78.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.609 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.63 118.67 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.719 2.279 . . . . 0.0 112.016 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.09 154.39 74.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.25 88.53 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.493 2.129 . . . . 0.0 112.003 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.92 163.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -80.14 161.73 25.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.619 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.6 p -79.11 38.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 102' ' ' ALA . 52.5 p -119.13 -12.36 9.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' PHE . 4.1 p30 -53.37 -53.8 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.605 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 67.6 m-85 -41.33 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.735 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 30.6 mtm -95.23 112.75 24.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.549 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 33.3 m -72.97 121.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -78.14 99.79 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.255 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -90.27 150.35 42.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.539 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.03 150.24 88.27 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.581 2.188 . . . . 0.0 111.879 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -99.39 -15.19 18.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -4.18 58.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.395 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.652 ' C ' ' H ' ' A' ' 116' ' ' LEU . 19.9 mt -128.44 80.77 71.88 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.1 Cg_exo -50.71 3.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.815 2.344 . . . . 0.0 112.269 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.652 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.2 mm? -57.72 -33.24 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 0.0 109.975 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.556 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -96.73 -45.35 6.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.531 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -65.73 -45.46 82.56 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.331 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 32.6 t-105 -73.75 -14.35 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.83 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 t -142.04 74.87 21.23 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.79 -17.12 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.849 2.366 . . . . 0.0 111.696 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -54.84 -53.76 51.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.484 ' O ' ' CG2' ' A' ' 123' ' ' VAL . 3.5 p -105.63 60.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.585 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.556 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -164.77 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.385 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.6 p -62.4 130.22 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.1 157.98 15.98 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.8 p -162.73 99.66 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.499 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 142.84 -173.45 24.03 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.484 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 20.8 t70 -93.24 152.99 18.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.892 0.377 . . . . 0.0 110.172 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 5.4 m -104.68 128.59 52.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 99.54 -10.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.852 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -67.92 147.9 51.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 40.8 ttp180 -89.57 132.81 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.347 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -129.94 -21.47 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.503 ' CE3' ' SD ' ' A' ' 142' ' ' MET . 24.6 t90 -174.05 134.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.976 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -140.94 160.68 39.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.22 0.533 . . . . 0.0 111.914 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.77 140.46 50.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.085 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.68 17.44 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.49 21.82 46.44 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.86 137.93 54.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -71.9 146.95 47.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.561 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.503 ' SD ' ' CE3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -47.39 -57.57 9.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.539 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.1 Cg_exo -38.28 -38.41 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.586 2.191 . . . . 0.0 112.568 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -73.28 -52.23 14.72 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.149 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.572 ' O ' ' N ' ' A' ' 148' ' ' GLY . 66.9 m95 -55.53 -58.0 9.58 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.823 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.1 tp -44.01 -39.36 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 tt -54.96 -36.86 65.77 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.86 -43.37 99.3 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.643 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.94 -25.48 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -65.4 -43.56 90.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.401 HD13 HG23 ' A' ' 151' ' ' ILE . 18.6 pt -67.55 -37.8 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.286 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.88 -50.34 73.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.325 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.463 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 m-85 -54.33 -45.16 72.6 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.859 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.474 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 0.5 OUTLIER -75.86 -29.72 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.881 -179.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.12 -35.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.24 -35.86 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.75 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.574 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.81 -50.34 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.637 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.87 -48.03 78.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.67 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.527 ' C ' ' HG ' ' A' ' 163' ' ' SER . 16.6 t -69.23 -27.12 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.72 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.1 t -80.98 -46.13 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.427 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.6 mm -75.7 -13.99 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.527 ' HG ' ' C ' ' A' ' 160' ' ' VAL . 9.6 p -67.61 -14.54 63.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.604 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.615 ' NE2' ' N ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -67.06 -64.77 1.92 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.569 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 25.0 Cg_endo -61.79 -35.42 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.466 2.11 . . . . 0.0 111.838 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER 55.67 150.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.729 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -175.86 -2.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.588 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 60.57 119.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -52.84 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -156.45 164.47 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 70.72 124.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 0.5 OUTLIER -80.26 -140.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 174' ' ' PHE . 3.5 mp -102.75 -57.48 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 173' ' ' LEU . 73.4 m-85 54.23 107.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -141.97 140.81 10.37 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.529 ' O ' ' NE ' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -82.59 -54.82 4.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.519 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 61.33 75.48 0.29 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -82.44 133.54 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.0 110.78 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.552 ' CD2' ' H ' ' A' ' 179' ' ' HIS . 5.7 p80 -84.33 -173.96 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -120.43 171.77 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.439 ' H ' ' CD2' ' A' ' 181' ' ' HIS . 6.1 p80 -60.35 178.1 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.563 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -75.12 -74.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.4 m80 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.536 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mmt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 1.9 pt? -59.35 -35.54 74.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.452 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.427 ' H ' HD23 ' A' ' 2' ' ' LEU . 64.9 mtm-85 -55.62 -40.47 72.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.305 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.37 -44.28 91.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.64 -42.16 44.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.309 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 10' ' ' GLN . 49.6 t30 -67.61 -28.14 67.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.915 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -73.04 -50.37 23.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.34 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.3 p -75.99 -35.36 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.588 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 38.3 mt-30 -74.32 12.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.966 0.413 . . . . 0.0 110.388 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.63 147.94 16.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -70.74 -49.89 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.32 -46.11 6.67 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.44 90.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.23 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.0 -32.03 69.33 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.942 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.29 -27.94 60.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.69 -36.37 73.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 18' ' ' MET . 1.4 ppp? -72.58 -31.22 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.2 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.2 -47.45 46.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.724 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.8 p -54.6 -62.16 1.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.23 -39.75 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.55 -41.47 75.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.07 -36.66 30.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.3 mp -71.71 -36.41 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.77 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.97 -46.29 89.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.116 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.16 -48.85 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.09 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 40.8 m -46.2 -43.06 14.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.694 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.18 53.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.494 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.43 -18.61 64.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.605 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.15 -44.67 52.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.52 -28.02 62.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -70.9 -24.78 62.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.52 -45.07 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.158 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.2 mtt -83.96 5.07 26.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 mt 44.82 42.24 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.706 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.9 mt -80.42 153.73 28.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -117.84 130.32 24.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.79 179.39 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.249 1.966 . . . . 0.0 111.759 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.4 t -131.73 -175.49 3.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.402 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.918 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -68.05 -50.12 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -49.41 -50.94 38.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.691 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.96 -41.08 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -54.61 -45.73 73.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.96 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.51 -40.21 86.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.161 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.6 ttp85 -57.89 -35.94 71.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.3 -38.31 78.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.472 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -76.41 -51.07 12.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.339 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -46.99 -39.4 12.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -43.83 91.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' CG2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t -65.32 -41.58 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 110.037 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 tp -50.8 -50.44 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.842 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.99 92.7 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.23 -37.29 34.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.975 -0.612 . . . . 0.0 110.218 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.53 -25.45 60.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.23 -43.42 64.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.579 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mm -73.64 -30.61 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.04 -26.46 48.78 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.58 -2.96 21.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.66 -20.8 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.502 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 178.86 68.87 0.12 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.75 25.79 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.875 2.384 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -110.27 -6.33 15.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.55 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.555 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.13 174.41 2.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.83 -9.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.226 1.95 . . . . 0.0 112.175 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.555 ' H ' ' C ' ' A' ' 67' ' ' THR . 11.7 mt -51.32 -30.04 17.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -41.67 -69.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.53 -38.61 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.004 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.45 -54.04 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.45 70.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.399 0.619 . . . . 0.0 110.046 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.6 ttp -61.21 -25.24 66.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.612 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -51.56 -37.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.242 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -85.38 -37.37 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.404 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -57.68 -49.47 76.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.68 -46.89 77.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -46.97 -47.57 21.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.426 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 59.6 p -79.28 -25.61 42.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.35 4.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -52.89 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -65.57 -42.46 91.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.72 -46.0 93.05 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 88' ' ' THR . 68.3 t -69.89 -54.24 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 111.12 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -47.7 -29.13 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.328 . . . . 0.0 110.743 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tp -85.16 -39.48 17.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.713 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 40.7 p -53.18 -23.15 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.3 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -76.15 -40.48 52.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.506 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.35 -39.91 73.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.387 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.1 m170 -69.18 -49.53 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -61.96 -49.92 74.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.3 ttt -47.53 -46.71 27.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.635 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 98' ' ' PRO . 19.7 mt -68.52 -44.29 74.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.671 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -59.17 -47.14 86.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.58 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.87 -25.81 37.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.46 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 t80 -143.81 68.62 16.47 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . 51.6 Cg_exo -50.95 154.22 7.53 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.711 2.274 . . . . 0.0 112.003 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.516 ' O ' ' CZ ' ' A' ' 101' ' ' PHE . 15.1 m -153.27 59.21 2.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.43 159.12 47.11 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.757 2.305 . . . . 0.0 111.921 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.516 ' CZ ' ' O ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -131.75 -172.27 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.429 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.78 19.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 101' ' ' PHE . 3.8 p -132.92 -170.2 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -169.75 65.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.674 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -80.12 -167.23 1.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 51.83 69.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 107' ' ' MET . 5.4 ppp? -154.32 127.88 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.298 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 t 45.56 64.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -143.92 113.6 7.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.76 156.12 59.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.33 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 150.3 87.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.619 2.213 . . . . 0.0 112.042 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -101.37 12.85 36.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.459 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 8.5 p-90 -124.99 -2.95 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.709 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.64 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.82 86.3 19.03 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.873 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.3 Cg_exo -53.76 8.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.646 2.231 . . . . 0.0 112.483 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.64 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.5 mm? -73.63 -27.61 61.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.05 0.452 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -96.36 -41.02 8.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -70.59 -45.15 65.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.314 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 3.2 t90 -73.29 -18.1 61.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.54 73.71 20.12 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -78.06 -18.09 13.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.669 2.246 . . . . 0.0 111.802 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.69 -11.22 60.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.867 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.41 45.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -38.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.29 129.74 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.648 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -95.48 152.93 17.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.525 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 t -166.01 100.32 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.656 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.67 -176.15 21.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.454 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 31.3 t70 -87.12 147.88 25.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.336 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 11.9 m -99.61 130.09 45.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.814 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 90.0 -4.56 0.34 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.16 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.98 129.65 40.58 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -66.39 128.72 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -126.03 -25.27 3.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.708 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -174.86 136.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -139.94 161.15 38.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.085 0.469 . . . . 0.0 111.412 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -137.05 119.83 16.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.29 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 2.1 tp 78.63 16.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.24 14.84 73.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.3 mp -119.83 133.19 55.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.746 0.308 . . . . 0.0 110.262 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.51 ' N ' ' OE2' ' A' ' 141' ' ' GLU . 2.1 mp0 -74.82 156.55 36.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.407 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 6.4 mtm -48.38 -61.39 3.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.6 Cg_exo -35.55 -41.05 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.57 2.18 . . . . 0.0 112.49 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.17 -44.22 60.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.608 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.4 m95 -66.13 -57.89 6.67 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.927 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.65 -38.56 3.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.1 tp -62.36 -34.3 76.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.04 -49.11 69.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.562 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.8 mp -66.35 -27.11 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -39.12 90.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.49 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.4 HG23 ' N ' ' A' ' 152' ' ' ALA . 2.4 tt -66.62 -36.58 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.4 ' N ' HG23 ' A' ' 151' ' ' ILE . . . -54.38 -48.89 71.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.75 -41.45 81.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 10.2 tp -53.96 -30.9 48.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 0.0 109.927 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 40.1 mm -79.63 -32.3 14.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.013 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.3 t -65.63 -45.86 91.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.924 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -79.18 -46.76 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.138 -178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 159' ' ' LEU . 3.3 p -51.79 -40.61 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.544 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.409 ' O ' ' OG ' ' A' ' 163' ' ' SER . 15.7 mt -80.11 -33.13 38.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.171 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.2 t -73.29 -24.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.957 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.2 t -80.66 -50.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.103 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 39.5 mm -71.25 -10.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.483 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 23.2 m -52.6 -19.45 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.236 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.513 ' C ' ' H ' ' A' ' 166' ' ' PHE . 35.8 mt-30 45.8 56.43 15.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 164' ' ' GLN . 39.9 Cg_endo -68.74 14.52 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.639 2.226 . . . . 0.0 111.71 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.513 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.4 OUTLIER -145.95 133.31 20.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -73.1 -48.18 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.799 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 170' ' ' LYS . . . -65.69 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.549 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 tttp 68.36 -1.44 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 168' ' ' ALA . 54.0 tttp -93.26 -32.8 14.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.542 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -156.95 -165.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 29.5 t70 -152.8 175.79 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.488 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 2.4 pp -51.75 144.03 11.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -82.16 -69.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.91 -134.23 31.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -171.31 59.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.594 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -45.17 -49.11 10.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 32.0 m170 52.82 -115.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.752 0.31 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.628 ' CG ' ' H ' ' A' ' 180' ' ' HIS . 0.7 OUTLIER -83.07 -129.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.508 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.628 ' H ' ' CG ' ' A' ' 179' ' ' HIS . 65.6 m80 -144.35 74.48 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.488 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 52.15 -129.92 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -170.3 -20.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.535 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.539 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.433 H102 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.422 ' H ' HD13 ' A' ' 2' ' ' LEU . 4.6 mp -68.34 -41.84 80.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.289 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -52.02 -41.41 62.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.193 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' GLN . 22.3 m-85 -63.86 -44.43 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.074 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -45.93 -41.75 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.42 ' OD1' ' OG ' ' A' ' 163' ' ' SER . 46.5 t30 -67.9 -28.68 67.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.003 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' PHE . 5.9 tp-100 -76.03 -50.82 13.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.428 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.86 73.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.2 m -76.64 -42.27 42.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -66.52 3.3 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.387 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.94 145.07 17.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -68.8 -49.56 57.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.577 0.227 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.54 -46.3 5.69 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.56 85.44 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -58.36 -47.97 82.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.46 -29.36 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -30.93 68.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.47 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 tpt -72.08 -33.56 67.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.154 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.48 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -52.73 -51.35 60.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.667 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 p -51.56 -49.71 61.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.23 72.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.649 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.41 -38.02 77.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.482 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' O ' ' CG2' ' A' ' 28' ' ' THR . . . -52.69 -35.27 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.565 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.9 mt -74.42 -41.21 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.57 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -67.18 -55.48 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.761 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.86 -53.38 56.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 16.9 p -49.31 -45.16 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.07 -43.24 65.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.735 0.302 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.76 -20.25 5.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.646 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -91.88 -39.49 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.542 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -48.86 -38.1 21.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.971 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -68.82 -38.58 79.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.77 -5.26 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.3 -46.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.891 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 30.6 mtt -100.81 10.01 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.926 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.95 42.61 28.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -87.69 154.06 20.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -121.09 141.43 32.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.864 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 127' ' ' SER . 88.0 Cg_endo -78.25 171.52 16.88 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 112.283 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.575 ' H ' ' HG ' ' A' ' 44' ' ' SER . 7.6 t -131.95 -173.67 3.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.405 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.9 t -64.3 -48.77 84.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 4.1 mm? -60.35 -46.88 88.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.575 ' HG ' ' H ' ' A' ' 41' ' ' CYS . 75.5 p -48.43 -43.97 34.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.333 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 45' ' ' ILE . 38.2 mm -61.54 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.919 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.53 -48.45 74.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.153 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 43' ' ' LEU . 2.5 mp0 -61.01 -42.73 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 52' ' ' PHE . 33.7 ttt-85 -64.3 -38.31 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.313 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.46 77.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.52 74.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tt -78.35 -51.61 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.406 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 59.8 t80 -43.97 -40.08 4.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.667 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.46 74.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.5 -47.64 90.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.915 0.388 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.9 tp -44.53 -50.53 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.84 -49.37 75.1 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -32.7 18.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.37 -36.01 80.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.205 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.51 -32.03 69.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.595 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.03 -38.49 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.585 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.76 -19.06 66.49 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.5 27.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.288 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.77 -25.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.712 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 177.37 73.52 0.1 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.575 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.23 26.31 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.591 2.194 . . . . 0.0 111.96 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 64' ' ' ALA . 1.2 mmmp? -104.66 -8.34 18.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.591 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.19 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.666 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.02 -2.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.264 1.976 . . . . 0.0 112.106 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.591 ' H ' ' C ' ' A' ' 67' ' ' THR . 42.9 mt -53.45 -33.85 55.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.549 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.561 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.8 ptp180 -40.89 -63.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.642 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.561 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 1.7 t80 -56.59 -29.85 62.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.458 0.572 . . . . 0.0 110.182 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' LEU . 12.5 t -68.22 -45.08 83.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.849 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.79 -32.59 46.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.51 . . . . 0.0 110.174 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttp -65.43 -19.4 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.751 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.2 -37.25 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.373 0.606 . . . . 0.0 110.419 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.4 mt -88.72 -31.55 5.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.713 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.548 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -66.76 -46.88 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 81' ' ' ALA . 0.3 OUTLIER -66.5 -48.54 69.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.47 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -44.78 -43.91 8.96 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 p -75.91 -24.15 55.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.99 -60.25 4.13 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.269 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -73.9 -53.4 10.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -67.91 -43.66 78.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.76 -46.05 95.24 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.955 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.91 -41.11 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.97 -45.18 93.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.528 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.98 -42.84 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.038 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.2 p -48.8 -47.75 41.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.616 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -51.41 -32.37 26.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.404 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -71.01 -36.29 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.66 -36.99 73.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -74.2 -31.87 62.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.492 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.535 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.7 tpt -62.26 -43.14 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.421 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tp -64.2 -49.15 73.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.516 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -56.46 -46.92 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.82 -14.79 43.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.763 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' MET . 21.1 t80 -152.12 76.84 7.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.51 121.3 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.661 2.24 . . . . 0.0 112.004 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 101' ' ' PHE . 1.8 t -55.86 150.16 29.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 101' ' ' PHE . 77.1 Cg_exo -43.06 78.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.659 2.24 . . . . 0.0 112.589 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 99' ' ' SER . 0.3 OUTLIER 36.37 94.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.879 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . -158.9 176.65 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 20.5 p 50.07 77.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.691 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m -85.5 152.93 22.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.398 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.17 158.78 38.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.714 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -155.99 -72.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.374 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.5 mtp -85.07 130.31 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.68 128.86 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.484 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 mtt85 -112.9 102.15 10.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.621 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -107.89 161.88 21.76 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.313 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' PHE . 90.7 Cg_exo -36.91 160.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.843 2.362 . . . . 0.0 112.307 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' CD ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -96.52 2.73 52.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.925 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.511 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 3.8 p-90 -125.01 30.08 5.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 110.745 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.5 tp -125.63 68.96 62.23 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.409 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 119' ' ' TRP . 56.5 Cg_exo -46.51 -8.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 112.285 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.7 tp -53.31 -33.7 54.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 110.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.46 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 4.5 m-20 -96.45 -43.76 7.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.209 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.14 -45.28 67.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.415 ' N ' ' O ' ' A' ' 115' ' ' PRO . 12.0 t-105 -73.2 -18.87 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.568 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.56 72.31 25.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.179 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.77 -15.25 9.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.837 2.358 . . . . 0.0 111.538 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -49.22 -48.14 45.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.77 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.91 53.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.46 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 5.7 t80 -156.11 -39.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.86 130.0 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.66 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.97 150.54 20.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' PRO . 6.4 t -161.52 99.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.53 -172.45 23.02 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.529 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -88.41 151.52 22.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 12.9 m -103.19 130.3 50.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.588 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 97.21 -9.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.05 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 150.72 47.87 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.976 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -85.9 136.1 33.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.461 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -127.39 -17.62 4.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -172.92 120.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 7.7 t0 -115.04 148.96 38.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.344 0.593 . . . . 0.0 112.28 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.533 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 7.3 t80 -128.57 136.73 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.737 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp 54.27 17.44 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.439 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.14 13.02 64.73 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.665 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.523 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 9.1 mp -121.11 146.82 46.35 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -76.72 151.26 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.44 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 4.0 mmt -48.04 -63.36 1.55 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.3 Cg_exo -32.18 -38.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.938 2.425 . . . . 0.0 112.449 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -69.45 -53.75 17.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.277 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 76.8 m95 -60.17 -57.02 14.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.0 tp -43.73 -37.67 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.88 -34.97 76.98 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.3 -44.57 96.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.9 mp -76.28 -25.89 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -62.45 -45.64 92.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.514 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 pt -68.82 -38.7 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.73 -48.19 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.362 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.34 -41.67 94.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.463 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 37.6 mt -69.29 -30.62 68.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.83 -27.34 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 54.7 t -73.85 -35.45 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.645 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -69.99 -52.36 24.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.107 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.86 -33.93 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.932 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.27 -43.55 23.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 52.4 t -69.14 -26.86 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.888 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.6 t -75.01 -45.44 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.328 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.489 ' C ' ' H ' ' A' ' 164' ' ' GLN . 72.5 mt -66.64 -21.23 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' A' ' 6' ' ' ASN . 17.7 p -58.4 -4.25 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 166' ' ' PHE . 1.7 pt20 -45.74 152.46 0.72 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.409 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -37.85 -22.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.614 2.21 . . . . 0.0 112.29 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' GLN . 9.6 t80 71.78 31.79 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 43.42 25.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.09 134.64 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.448 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' LYS . 9.9 tptp -100.12 -78.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 169' ' ' LYS . 13.5 mmmt 48.63 179.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.583 ' CA ' ' HE ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 41.11 77.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -170.88 34.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.511 ' CG ' ' H ' ' A' ' 174' ' ' PHE . 4.2 tp 63.56 -137.76 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.511 ' H ' ' CG ' ' A' ' 173' ' ' LEU . 3.5 m-85 47.08 61.37 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -55.4 -76.41 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -86.78 -51.24 6.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.7 -167.56 24.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -176.62 -178.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.534 ' C ' ' H ' ' A' ' 181' ' ' HIS . 2.8 m-70 -45.28 -56.24 5.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.672 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 8.2 t60 69.83 -38.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.534 ' H ' ' C ' ' A' ' 179' ' ' HIS . 23.3 t60 -52.27 -61.86 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.558 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -62.22 -139.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.452 ' ND1' ' OXT' ' A' ' 183' ' ' HIS . 65.3 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.538 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.57 ' O1 ' H2M3 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 mt -61.82 -42.68 99.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.311 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -54.13 -42.89 70.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -45.38 87.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -50.34 -42.18 52.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.3 -29.48 69.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -78.53 -49.42 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.514 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.38 -33.34 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.69 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 11' ' ' GLY . 41.3 p -76.33 -34.22 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -74.28 10.03 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -107.29 142.06 15.7 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -62.55 -18.38 61.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 0.0 110.294 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.51 -48.29 51.78 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.61 -51.43 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -52.76 -40.17 62.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.029 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.26 -30.11 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.416 ' O ' ' OG1' ' A' ' 21' ' ' THR . 7.1 tp -69.17 -34.28 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.403 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 mtt -74.85 -33.16 62.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.84 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.82 32.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.775 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.35 -30.92 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 17' ' ' LEU . 96.8 m -61.53 -61.99 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.43 -23.84 41.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.09 -39.92 40.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.63 -31.03 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -78.8 -29.71 45.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.736 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.77 -47.09 64.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.01 -46.4 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 p -50.13 -46.33 53.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -73.19 -38.41 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.941 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -17.93 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.219 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -97.28 -25.87 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -46.62 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.773 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.492 ' NE2' ' O4 ' ' A' ' 201' ' ' UQ2 . 19.4 mp0 -83.68 -30.1 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.008 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -60.38 -26.21 66.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.251 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.66 -38.11 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.805 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.5 mmt -74.96 1.96 11.59 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.27 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 tp 55.83 50.48 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.722 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.84 156.17 18.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -117.01 142.27 29.65 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.659 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 127' ' ' SER . 65.7 Cg_endo -74.39 173.68 13.83 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.51 2.14 . . . . 0.0 111.918 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -131.94 178.43 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.46 -43.93 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.421 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.22 -48.93 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.468 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -51.8 -50.73 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.891 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.433 HG22 HD13 ' A' ' 45' ' ' ILE . 96.7 mt -62.62 -38.62 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.215 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -54.46 -47.29 73.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.559 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -61.38 -43.85 98.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.265 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.32 60.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.091 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.23 80.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.88 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 mt -76.78 -53.33 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.997 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -45.81 -40.61 9.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.44 -45.35 86.29 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 57' ' ' ALA . 8.1 t -61.84 -45.16 99.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.87 -44.0 19.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.566 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.28 -28.22 73.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.575 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.76 -26.84 57.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.56 -42.91 77.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.15 -29.93 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -12.74 83.08 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.81 1.78 51.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.529 0.204 . . . . 0.0 111.25 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 pt -87.22 -27.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.963 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.8 72.46 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.83 0.347 . . . . 0.0 110.628 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.78 24.75 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.951 2.434 . . . . 0.0 112.177 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -104.9 -8.7 18.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.601 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.82 176.74 1.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.481 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -47.81 -4.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.321 2.014 . . . . 0.0 112.26 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.601 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 mm? -52.8 -31.22 37.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.139 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.496 ' NH1' ' OG ' ' A' ' 163' ' ' SER . 67.0 mtt180 -40.85 -69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.622 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.27 -35.73 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.437 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.4 t -62.27 -44.07 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.673 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.81 -33.13 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 109.483 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.62 -11.85 5.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.33 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.34 -42.85 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.288 0.566 . . . . 0.0 110.839 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.1 mt -87.06 -29.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.083 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.7 t-105 -60.74 -50.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.288 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 tp -70.07 -45.95 65.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.434 ' O ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -45.37 -50.41 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.015 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -71.12 -29.41 65.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.409 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -60.64 -58.92 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.425 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -70.85 -49.8 42.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -78.09 -33.8 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' A' ' 83' ' ' ARG . . . -65.3 -46.93 84.85 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' O ' ' OG1' ' A' ' 88' ' ' THR . 19.8 m -68.67 -44.72 82.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.766 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 2.9 tp-100 -50.13 -24.46 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.69 -41.1 16.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 69.8 p -49.0 -34.1 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.396 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.53 -52.0 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -49.1 -31.88 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -75.45 -50.18 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.013 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 p -68.97 -54.17 16.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.985 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.537 ' O ' ' N ' ' A' ' 97' ' ' TYR . 30.6 ttm -50.08 -49.14 52.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.3 tp -67.49 -39.25 85.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 131' ' ' ALA . 6.5 tp-100 -63.08 -37.69 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.6 tp -97.44 -20.16 17.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' A' ' 93' ' ' MET . 8.8 t80 -127.93 79.58 73.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.797 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.91 155.17 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.619 2.213 . . . . 0.0 112.123 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 m -147.36 153.13 43.87 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.36 -1.59 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.555 2.17 . . . . 0.0 112.205 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -162.11 142.75 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.811 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -172.69 -0.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.556 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.3 m 46.26 92.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.587 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.1 m -72.22 -78.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.671 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -173.57 -1.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.683 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 107' ' ' MET . 17.0 m-85 44.05 80.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.522 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.425 ' O ' ' O ' ' A' ' 106' ' ' PHE . 44.7 mtm 58.46 151.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -60.56 123.62 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.624 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -150.14 100.6 2.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.509 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -137.03 153.93 75.63 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.254 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 113' ' ' TRP . 88.8 Cg_exo -37.4 122.7 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.645 2.23 . . . . 0.0 112.195 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -75.97 20.05 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.499 ' CD1' ' C ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -88.53 9.06 25.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.211 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.655 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.1 tp -116.39 86.51 18.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.92 8.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.823 2.349 . . . . 0.0 113.003 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.655 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.5 tp -74.79 -28.12 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 124' ' ' PHE . 66.6 m-20 -95.76 -40.42 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.69 -33.99 76.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -86.93 -19.23 29.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.837 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.98 79.3 10.07 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.51 -16.08 12.08 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.605 2.203 . . . . 0.0 112.096 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -79.86 -4.85 54.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.743 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.77 45.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.194 0.521 . . . . 0.0 110.448 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.507 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 10.4 t80 -172.23 -39.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.336 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.6 t -54.75 125.18 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.483 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.07 157.69 15.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 40' ' ' PRO . 42.1 t -173.39 103.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.533 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.45 -172.62 24.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.4 m-20 -92.18 143.94 25.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.557 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 27.3 m -93.95 134.49 36.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 86.79 -0.05 0.57 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.06 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -67.73 155.66 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.245 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.59 145.69 25.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.411 ' OE1' ' O4 ' ' A' ' 201' ' ' UQ2 . 64.9 mt-30 -133.66 -29.23 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.75 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -174.41 145.54 0.99 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.194 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -138.91 167.72 21.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.082 0.467 . . . . 0.0 111.482 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 63.9 t80 -143.51 119.0 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.717 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.9 OUTLIER 78.27 17.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -177.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.05 15.93 75.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 8.1 mp -119.51 131.27 55.53 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.3 152.18 44.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.373 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -50.75 -52.34 57.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 142' ' ' MET . 82.9 Cg_exo -44.28 -38.92 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.159 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.87 -49.14 31.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 148' ' ' GLY . 48.7 m95 -56.71 -57.32 12.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.6 tp -42.83 -42.14 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.548 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.66 -35.75 63.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.94 -39.98 97.74 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.615 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.41 -30.71 11.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -47.72 84.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.3 -41.08 83.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.564 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -56.93 -49.57 75.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.106 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -51.46 -46.76 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 37.7 tp -52.8 -36.98 59.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.568 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 27.3 mm -68.78 -41.72 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.5 -37.66 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -75.47 -31.21 60.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.44 -27.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.351 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.15 -42.11 16.36 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.156 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 163' ' ' SER . 9.3 p -73.1 -31.87 36.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.195 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 157' ' ' ALA . 54.0 t -73.25 -50.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.6 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.3 mp -62.96 -22.96 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.998 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.496 ' OG ' ' NH1' ' A' ' 70' ' ' ARG . 24.1 p -57.2 -0.09 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.49 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.6 ' H ' ' C ' ' A' ' 162' ' ' ILE . 8.3 mt-30 -38.34 160.42 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -40.77 -13.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.751 2.301 . . . . 0.0 112.553 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.592 ' N ' ' O ' ' A' ' 164' ' ' GLN . 16.7 t80 58.27 109.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -101.14 -35.42 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -176.74 145.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -168.81 -44.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.409 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -97.31 -43.91 7.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.56 92.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.618 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -53.81 -178.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.65 -127.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.5 t80 45.43 93.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.452 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -78.38 140.96 24.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -79.46 63.73 4.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 52.49 40.78 55.04 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 77.9 m80 50.76 -106.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.485 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.505 ' O ' ' CD2' ' A' ' 180' ' ' HIS . 0.4 OUTLIER 172.77 168.11 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 179' ' ' HIS . 18.4 m-70 -148.58 155.08 40.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.311 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.657 ' CG ' ' H ' ' A' ' 182' ' ' HIS . 12.2 p80 -175.57 -61.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.657 ' H ' ' CG ' ' A' ' 181' ' ' HIS . 8.7 t60 -96.0 -88.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.414 ' CD2' ' N ' ' A' ' 183' ' ' HIS . 26.9 m170 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.596 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.492 ' O4 ' ' NE2' ' A' ' 33' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.442 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -78.34 -36.53 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.078 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -60.46 -43.69 96.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 7' ' ' GLN . 42.4 t80 -62.21 -50.16 72.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -46.96 -37.24 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.245 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 38.2 t-20 -69.82 -25.91 63.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.311 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PHE . 85.9 mm-40 -82.4 -50.07 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.63 73.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.653 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' GLY . 88.7 p -76.24 -34.57 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -71.24 8.54 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.552 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.72 141.62 15.56 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -69.9 -50.1 45.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.769 0.319 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.12 5.7 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.06 86.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -60.63 -46.9 88.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.4 -30.27 68.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.37 -30.27 68.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.398 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.1 mmt -73.45 -31.16 63.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.73 -53.47 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.17 -32.69 64.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.928 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -65.99 -61.81 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.09 -23.86 62.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -81.82 -42.1 20.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.429 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -49.53 -50.97 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.648 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.2 mp -61.48 -33.88 74.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.599 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.88 -41.89 88.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.713 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.455 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.2 mm? -79.81 -52.13 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -42.11 -40.53 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.04 -41.72 34.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -55.36 -17.6 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.932 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -94.33 -35.34 12.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.607 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.82 -38.63 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.54 -35.29 60.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.555 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 1.5 t-80 -74.73 -10.12 59.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.294 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -109.18 -51.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.787 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.9 mtt -91.18 14.18 14.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.803 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.18 40.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.775 0.321 . . . . 0.0 110.721 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.31 152.11 46.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -108.66 115.93 56.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.87 147.73 21.7 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.272 1.981 . . . . 0.0 112.188 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 5.7 t -98.08 172.2 7.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.301 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 8.3 p -59.46 -41.26 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.944 0.402 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.427 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 76.4 mt -63.2 -45.27 92.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.056 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -48.84 -38.49 22.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.394 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 51.5 mt -69.49 -44.5 79.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.168 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -45.59 92.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.818 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -57.79 -44.34 86.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.386 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -61.33 -29.01 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -39.76 77.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.22 74.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 tp -76.59 -51.85 10.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -45.05 -39.96 6.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.25 -40.7 94.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 41.5 t -64.02 -17.71 21.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.699 0.762 . . . . 0.0 109.273 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -45.17 47.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.426 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.81 83.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.38 -40.06 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.351 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.87 -31.45 69.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.94 -29.52 50.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.145 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -79.08 -39.91 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.557 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.74 -33.19 79.71 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.18 9.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.697 0.284 . . . . 0.0 110.652 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 ' H ' ' C ' ' A' ' 61' ' ' GLY . 66.0 mt -78.41 -54.92 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.288 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -168.1 75.36 0.89 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 21.5 Cg_exo -61.67 14.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.974 2.449 . . . . 0.0 112.485 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.591 ' H ' ' C ' ' A' ' 64' ' ' ALA . 13.8 ptpt -109.78 -3.58 16.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.84 161.03 31.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.685 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -39.4 -15.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.484 2.123 . . . . 0.0 112.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.2 mp -43.25 -35.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.721 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.4 mtm-85 -40.24 -65.57 0.39 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.13 -15.87 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.619 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 69' ' ' LEU . 19.3 t -82.1 -46.37 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.722 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.23 -34.05 59.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.045 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.82 -8.55 2.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.329 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 32.7 m -59.25 -42.7 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.1 mt -87.76 -29.77 5.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.23 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.54 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.9 t-105 -63.77 -53.58 48.8 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.777 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.04 -43.89 90.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.508 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -47.32 -46.88 25.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.5 p -80.44 -21.63 41.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.67 -61.98 2.22 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.909 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -73.99 -44.08 55.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.541 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -75.17 -42.11 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.076 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.426 ' O ' ' OG1' ' A' ' 88' ' ' THR . . . -59.29 -48.61 85.12 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -71.04 -38.31 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.128 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -72.84 -36.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.32 -49.32 19.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 84' ' ' GLY . 11.3 p -51.17 -49.1 61.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.573 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.53 -39.48 34.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 110.085 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -58.96 -41.69 88.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.379 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -66.78 -39.07 87.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.589 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -68.68 -35.02 76.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 97' ' ' TYR . 12.9 ttt -59.05 -44.13 91.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -59.59 -49.34 78.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.114 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -50.81 -49.24 58.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.179 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 96' ' ' LEU . 4.1 mm? -82.91 -14.3 54.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.062 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.535 ' CE2' ' OG ' ' A' ' 99' ' ' SER . 30.9 t80 -141.89 70.75 24.26 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.37 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.44 ' N ' ' O ' ' A' ' 94' ' ' LEU . 76.5 Cg_exo -44.73 -71.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.785 2.324 . . . . 0.0 112.467 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.535 ' OG ' ' CE2' ' A' ' 97' ' ' TYR . 29.0 m 42.99 77.52 0.44 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.478 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.66 -158.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.582 2.188 . . . . 0.0 112.062 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.0 t80 72.89 159.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.66 14.42 8.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.67 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -157.62 -69.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.412 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 103' ' ' THR . 46.9 t 54.25 108.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.88 132.11 22.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.669 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -161.41 79.68 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 6.7 ttm 60.72 -147.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.346 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -152.04 135.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.723 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -99.52 99.55 10.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.888 0.375 . . . . 0.0 110.383 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.07 155.7 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.158 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.56 158.31 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.479 2.119 . . . . 0.0 111.671 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.66 -1.33 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.667 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -103.83 -1.56 27.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.635 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -119.68 81.64 25.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 43.9 Cg_exo -53.24 4.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.547 2.165 . . . . 0.0 112.246 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.635 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.9 mm? -66.87 -30.18 70.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.06 0.457 . . . . 0.0 110.248 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -96.78 -41.53 8.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.179 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -71.12 -45.0 64.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.749 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 20.4 t-105 -75.26 -15.15 60.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.8 69.17 65.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.86 -20.23 9.16 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.734 2.289 . . . . 0.0 111.256 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -52.22 -53.89 37.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.504 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.92 55.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.732 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.528 ' CZ ' ' OD1' ' A' ' 117' ' ' ASP . 2.1 t80 -157.89 -41.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.53 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.43 128.36 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.53 155.36 17.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.1 m -165.24 99.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.38 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.46 -173.37 23.1 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 9.1 m-20 -97.26 165.15 12.17 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.3 m -116.19 127.68 54.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.78 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 100.03 -8.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.94 143.15 55.77 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.01 128.05 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -132.82 -23.36 2.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -173.17 127.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.23 163.65 29.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.297 0.57 . . . . 0.0 112.164 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.02 137.92 54.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.156 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.84 16.69 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.92 13.43 53.09 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.365 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.3 mt -123.83 145.09 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.176 0.488 . . . . 0.0 109.955 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.35 150.82 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.699 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.432 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.4 mtp -47.53 -54.44 22.5 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.679 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 142' ' ' MET . 79.8 Cg_exo -40.21 -37.78 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.98 -47.18 60.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.947 0.403 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.9 m95 -65.79 -57.98 6.72 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.49 -36.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.947 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.2 tp -66.49 -34.74 78.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.35 -35.86 73.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mm -69.76 -44.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.21 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -44.15 69.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.77 -46.37 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.779 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.39 -50.22 74.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -61.95 -47.17 86.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.912 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 7.9 tt -53.57 -30.98 44.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.66 -27.68 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.147 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 70.2 t -75.0 -28.58 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.913 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.54 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.65 -39.63 26.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.785 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.21 -31.5 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.557 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.7 -42.77 27.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.31 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' A' ' 163' ' ' SER . 28.4 m -71.26 -22.94 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.812 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.68 -50.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 164' ' ' GLN . 77.3 mt -64.62 -15.73 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.821 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 91.7 p -52.87 -6.21 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.528 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.57 ' H ' ' C ' ' A' ' 162' ' ' ILE . 8.1 tt0 -144.05 83.1 10.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.382 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 167' ' ' LYS . 60.7 Cg_endo -77.52 25.02 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.37 2.046 . . . . 0.0 112.085 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 164' ' ' GLN . 50.7 m-85 43.71 16.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . 81.5 tttt -90.48 134.46 34.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.545 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -44.7 153.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.535 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -139.18 22.24 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -74.87 -122.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 56.14 -155.44 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.591 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' CE1' ' A' ' 174' ' ' PHE . 14.2 t70 -154.89 81.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 174' ' ' PHE . 12.9 mt -76.42 2.67 12.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.583 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.445 ' CE1' ' OD2' ' A' ' 172' ' ' ASP . 53.1 m-85 58.14 119.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -76.73 -153.34 5.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -146.25 -138.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 178' ' ' HIS . . . 173.56 -120.79 0.82 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.436 ' CG ' ' O ' ' A' ' 177' ' ' GLY . 57.1 m80 -157.01 140.83 16.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.318 . . . . 0.0 110.521 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -103.49 64.67 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.527 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.608 ' H ' ' HD1' ' A' ' 180' ' ' HIS . 0.5 OUTLIER -88.38 117.6 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.629 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.601 ' CG ' ' H ' ' A' ' 182' ' ' HIS . 0.1 OUTLIER -101.8 -102.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 181' ' ' HIS . 4.2 m-70 -103.73 133.99 47.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.524 ' ND1' ' OXT' ' A' ' 183' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mmt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.88 -44.43 49.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.37 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 25.2 mtt85 -53.55 -28.86 34.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.06 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' GLN . 35.2 m-85 -76.94 -42.91 37.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.405 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -46.8 -42.73 17.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 7' ' ' GLN . 24.5 p30 -72.61 -23.0 60.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.5 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 48.4 tp60 -79.93 -48.51 13.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.554 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.42 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 11' ' ' GLY . 19.7 m -76.53 -36.05 57.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -67.55 4.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.4 141.46 15.24 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.46 -46.2 87.34 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.99 -44.92 5.9 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.1 77.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -58.44 -43.28 88.72 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.196 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.04 -28.46 68.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.1 tp -69.34 -31.96 70.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.377 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 21' ' ' THR . 39.9 mtt -73.45 -32.87 64.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.02 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.4 -52.99 26.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.536 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.05 -49.63 50.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.2 p -53.42 -42.49 67.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.499 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.11 67.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.642 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.5 mt -87.79 -42.11 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -58.11 -25.02 60.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.536 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.14 -38.45 36.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.78 -47.07 64.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.54 -48.99 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.672 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 51.0 m -49.7 -47.64 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.566 ' O ' ' NE2' ' A' ' 33' ' ' GLN . . . -73.47 -28.25 61.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.538 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.56 -20.53 66.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.978 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -91.45 -32.26 15.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.6 m-85 -58.23 -46.92 85.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.285 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 29' ' ' ALA . 1.0 OUTLIER -62.68 -49.41 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.78 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -24.04 18.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.23 -18.94 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' PHE . 33.0 mmm -98.43 -3.17 37.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.85 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.88 39.81 30.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.93 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.92 158.06 16.27 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -121.43 144.03 39.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.03 152.71 51.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.575 2.183 . . . . 0.0 112.2 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.7 t -115.81 -172.21 2.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.541 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.423 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 12.6 t -63.81 -47.86 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.034 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.26 -49.1 77.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.436 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 t -48.53 -46.42 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.2 mt -61.63 -43.11 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.366 . . . . 0.0 110.036 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -47.48 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.05 -39.29 93.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.83 -37.3 86.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.356 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.49 76.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.36 74.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tt -76.67 -51.92 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.214 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -45.68 -38.69 7.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.33 -43.91 91.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 25.5 t -61.47 -46.47 96.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -43.24 -47.67 6.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.312 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.08 -32.79 83.57 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.35 -31.45 70.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.53 68.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.391 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.469 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 15.8 mt -76.63 -31.08 57.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -80.16 -36.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.848 0.356 . . . . 0.0 110.053 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.36 -23.0 78.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.22 6.93 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.611 0.243 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -77.78 -51.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.131 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -172.84 74.82 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.444 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 23.03 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.739 2.293 . . . . 0.0 112.14 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -102.59 -10.37 19.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.233 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 2.6 p -113.9 155.83 44.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.13 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -37.31 -17.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.808 2.338 . . . . 0.0 112.834 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.2 mm? -44.98 -31.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' C ' ' O ' ' A' ' 69' ' ' LEU . 3.5 mmp_? -34.32 -55.16 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -53.13 -36.31 60.65 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.951 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 ' N ' ' A' ' 73' ' ' ALA . 3.4 m -65.16 -39.86 86.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.816 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' N ' HG21 ' A' ' 72' ' ' VAL . . . -76.24 -37.39 57.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.0 ttt -58.56 -14.36 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.468 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.8 t -55.08 -42.93 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.28 -31.14 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.644 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.439 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.2 t-105 -63.49 -55.4 24.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.113 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.0 tt -65.57 -48.41 72.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -42.84 -43.27 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.089 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 p -79.84 -22.43 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.791 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.45 -60.27 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.733 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.15 -55.08 6.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -65.95 -50.25 65.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.44 61.18 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.49 ' O ' ' OG1' ' A' ' 88' ' ' THR . 77.0 t -66.42 -45.42 89.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.895 0.379 . . . . 0.0 110.654 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.33 -31.86 67.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.58 -44.98 61.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -53.5 -27.0 23.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -70.97 -51.51 25.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -48.47 -34.24 10.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.25 -55.21 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -55.32 -46.69 76.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 97' ' ' TYR . 18.1 ttt -56.73 -43.03 80.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tp -66.57 -22.99 66.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.059 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -80.6 -32.97 36.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.993 0.425 . . . . 0.0 109.857 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 96' ' ' LEU . 4.1 mm? -98.67 -15.54 19.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.097 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.6 t80 -137.6 71.78 50.95 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.717 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.453 ' O ' ' OG ' ' A' ' 99' ' ' SER . 60.2 Cg_endo -76.68 -89.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.537 2.158 . . . . 0.0 111.837 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 98' ' ' PRO . 94.4 p 52.67 70.74 1.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.1 -171.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.782 2.321 . . . . 0.0 111.988 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.37 -9.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.12 -132.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.6 m -155.95 103.14 2.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.485 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 105' ' ' ASP . 33.8 t -148.24 -141.32 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.499 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.43 ' N ' ' OG ' ' A' ' 104' ' ' SER . 37.7 t70 45.34 87.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -149.09 -62.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.1 ttt -101.73 118.56 37.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.43 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.1 p -45.68 123.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.514 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -102.09 102.95 13.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.74 157.92 69.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.009 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -41.48 160.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.455 2.103 . . . . 0.0 111.877 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.64 0.01 28.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -108.13 18.54 21.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.734 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.607 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -120.97 83.33 37.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.4 Cg_exo -53.03 2.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.647 2.231 . . . . 0.0 112.102 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.0 mp -63.63 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.638 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -97.02 -44.05 7.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -70.34 -45.58 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.471 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 15.7 t-105 -73.13 -15.05 61.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.98 74.89 11.96 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.46 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -12.62 13.82 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.907 2.405 . . . . 0.0 112.092 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -53.93 -54.12 43.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.839 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.436 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 8.5 t -106.94 60.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.72 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.436 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 4.7 m-85 -164.68 -41.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.07 125.13 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.442 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.57 152.01 21.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 m -162.95 99.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.642 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.25 179.45 17.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.8 OUTLIER -80.37 143.49 33.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.551 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 30.2 m -93.52 131.85 38.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 85.89 0.56 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.208 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' OE1' ' OD1' ' A' ' 129' ' ' ASP . 39.9 tt0 -68.31 128.65 37.36 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.216 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.72 116.49 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.344 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -104.19 -29.6 10.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.662 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -173.8 147.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.21 161.6 37.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.362 0.601 . . . . 0.0 112.054 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.25 138.59 54.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.84 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.44 17.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.94 22.82 40.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 mt -124.72 136.0 53.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.42 148.81 50.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.743 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.413 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.5 mtt -48.74 -52.74 42.99 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.67 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 142' ' ' MET . 81.8 Cg_exo -43.51 -35.96 6.48 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.286 1.99 . . . . 0.0 112.033 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.65 -46.55 58.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.321 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.0 m95 -64.52 -57.7 8.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.2 tp -43.53 -39.26 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.104 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.9 -33.75 74.79 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.63 -40.6 94.91 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.9 mp -72.68 -31.76 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 110.632 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.05 -39.62 86.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.502 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 152' ' ' ALA . 1.2 tp -70.94 -37.05 66.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.139 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.406 ' N ' HG22 ' A' ' 151' ' ' ILE . . . -65.16 -53.33 46.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -60.43 -38.52 84.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.224 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.443 ' C ' ' CD2' ' A' ' 154' ' ' LEU . 7.2 tt -54.53 -37.84 65.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.4 mt -75.55 -40.64 41.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 73.8 t -48.96 -39.34 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.535 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.01 -43.63 43.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.963 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.58 -36.02 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.113 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.14 -32.72 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.45 ' O ' ' OG ' ' A' ' 163' ' ' SER . 54.2 t -77.76 -25.01 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.259 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.33 -50.75 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.32 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.536 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.4 mp -66.84 -22.54 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.716 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.1 p -52.81 -7.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.517 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.536 ' H ' ' C ' ' A' ' 162' ' ' ILE . 26.2 mt-30 -47.92 152.76 1.29 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.408 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -37.5 -30.26 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.758 2.305 . . . . 0.0 112.294 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 164' ' ' GLN . 0.5 OUTLIER -85.52 111.15 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.37 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 19.3 pttm -167.86 -36.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.65 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 167' ' ' LYS . . . 59.6 146.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.605 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -163.8 40.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -158.32 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' LEU . 43.3 ttt85 49.4 -100.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 172' ' ' ASP . 54.0 t0 45.94 17.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 110.587 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 171' ' ' ARG . 9.3 tp -80.62 75.78 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -97.57 -27.71 14.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.476 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -155.71 127.75 2.1 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -79.01 82.84 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -105.48 52.77 0.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -157.49 -21.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -155.5 79.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.685 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 180' ' ' HIS . 0.9 OUTLIER -87.62 11.48 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 t60 63.15 108.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -149.34 104.27 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.542 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp -62.79 -51.11 68.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.149 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -47.92 -34.66 9.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.41 -38.21 74.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.991 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.9 tp -50.97 -40.17 57.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -66.62 -29.39 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.019 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.95 -49.82 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.39 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.799 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 11' ' ' GLY . 54.1 p -75.52 -33.94 60.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.643 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.493 ' N ' ' HG ' ' A' ' 9' ' ' SER . 15.4 mt-30 -75.17 14.98 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.57 150.26 17.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.6 ttm105 -67.9 -20.7 65.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.392 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.75 86.88 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.36 -51.56 59.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.355 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.465 ' NE1' ' O ' ' A' ' 9' ' ' SER . 19.4 m0 -54.08 -42.55 69.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.375 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.5 -30.89 64.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tp -68.55 -32.59 72.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.04 -33.87 61.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -51.99 48.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.723 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -53.87 -52.05 61.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.1 m -46.03 -61.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.8 -30.39 14.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.569 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.97 -40.8 53.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.04 -40.84 46.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 8.5 mp -69.21 -36.75 77.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.581 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.36 -49.37 69.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.65 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.72 -50.95 70.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -53.65 -42.34 67.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.33 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.035 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -20.86 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.95 -41.63 15.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.135 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -50.97 -43.67 60.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.0 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -77.43 -40.52 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -71.07 -16.59 62.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.772 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 31' ' ' TRP . 66.1 t -109.34 -50.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.18 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mtt -90.75 14.71 12.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp 41.16 37.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 tp -63.43 155.58 28.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -120.25 90.93 45.62 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.967 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.11 147.52 19.95 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.567 2.178 . . . . 0.0 112.083 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 6.4 t -99.0 -173.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.779 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -67.19 -46.75 83.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.628 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.99 -47.02 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.216 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 m -49.19 -47.19 46.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.17 -39.95 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.235 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -54.67 -49.69 70.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.738 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -58.8 -39.71 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.435 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -58.68 -38.93 79.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.119 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.21 -39.52 94.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.506 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.91 82.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.9 tp -76.57 -50.4 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -44.11 -42.85 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.33 -41.41 96.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.47 -17.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.352 0.596 . . . . 0.0 109.901 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tp -81.79 -41.42 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.052 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -30.89 76.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.28 -35.15 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.151 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.78 97.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.1 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.61 -38.86 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.538 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.04 -21.0 78.29 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.68 3.64 32.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.279 . . . . 0.0 110.669 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -82.13 -49.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 179.15 77.09 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.25 21.35 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.892 2.395 . . . . 0.0 112.323 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -96.7 -8.37 31.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.116 0.484 . . . . 0.0 109.939 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -109.82 177.91 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.532 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 56.1 Cg_exo -50.49 -0.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.258 1.972 . . . . 0.0 112.278 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.616 ' H ' ' C ' ' A' ' 67' ' ' THR . 17.2 mt -62.33 -28.33 69.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' NH1' ' CD ' ' A' ' 164' ' ' GLN . 1.8 mtp180 -41.76 -64.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.573 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -55.5 -38.69 69.51 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.714 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -57.85 -54.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.546 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.03 -33.62 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.208 0.527 . . . . 0.0 110.314 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.1 ttt -64.56 -25.48 68.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.1 t -52.56 -32.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.457 0.646 . . . . 0.0 110.718 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -88.88 -31.56 5.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.097 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -65.98 -49.08 69.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.33 -43.51 77.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -46.87 -46.28 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.298 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -79.61 -21.48 44.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.742 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.61 -60.47 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.032 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -76.14 -48.47 20.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -67.77 -43.83 78.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.6 -47.64 90.14 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.87 -32.39 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.217 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.58 -28.6 65.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.39 -41.35 13.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 p -51.93 -51.88 53.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.727 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' O ' ' OG1' ' A' ' 92' ' ' THR . 8.2 m-85 -51.84 -48.36 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.137 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.09 -44.28 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.908 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' A' ' 91' ' ' HIS . 2.0 m-70 -62.82 -44.8 95.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.327 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 32.3 p -61.29 -47.75 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 15.3 tpt -45.5 -45.51 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.264 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.9 tp -64.94 -43.65 92.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.162 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.407 ' OE1' ' OE1' ' A' ' 141' ' ' GLU . 6.7 tt0 -58.67 -48.56 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.351 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 9.5 mp -80.62 -17.37 51.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.192 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 11.1 t80 -133.96 67.05 73.63 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 97' ' ' TYR . 78.4 Cg_exo -46.53 -177.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.95 2.433 . . . . 0.0 112.471 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.4 p -171.85 66.88 0.42 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.337 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -44.97 -38.48 13.49 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.82 2.346 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.14 101.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 140.05 57.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.443 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 p -142.45 -58.8 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -166.58 134.68 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.673 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -144.39 141.22 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.505 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -88.55 138.42 31.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.57 ' C ' ' H ' ' A' ' 109' ' ' ARG . 16.9 mtt -154.6 116.16 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.422 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 t 59.36 -1.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.678 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 107' ' ' MET . 13.5 mmt180 -89.7 99.57 12.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.47 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.5 154.93 81.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.907 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.48 119.96 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.405 2.07 . . . . 0.0 111.956 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.3 -2.69 26.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -99.7 2.26 44.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.251 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.664 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.0 tp -119.88 85.09 33.49 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.2 Cg_exo -56.14 16.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.668 2.245 . . . . 0.0 112.638 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.664 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.1 tp -77.14 -30.85 55.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.029 0.442 . . . . 0.0 110.312 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -97.75 -40.28 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.098 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -70.61 -45.32 65.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.6 t90 -76.19 -11.64 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.334 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.46 71.19 17.75 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.831 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.77 -14.91 15.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.763 2.308 . . . . 0.0 111.766 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -57.33 -53.27 59.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.827 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 53.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -158.14 -39.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.287 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.2 t -54.97 123.92 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.18 158.17 15.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.648 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.56 104.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.501 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.04 -177.06 20.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 t70 -89.33 139.69 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 110.284 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.615 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 54.6 m -91.47 134.65 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 86.52 -1.09 0.64 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.095 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -68.0 153.2 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 119.01 37.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -122.68 -12.61 8.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.719 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -173.3 127.92 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.796 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.32 160.97 38.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.266 0.555 . . . . 0.0 112.179 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.66 137.31 53.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.862 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt 50.64 17.19 0.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.44 21.5 37.52 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -122.46 134.5 54.58 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.407 ' OE1' ' OE1' ' A' ' 95' ' ' GLN . 8.1 mt-10 -69.16 148.6 49.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.669 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.434 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -49.18 -51.93 52.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 142' ' ' MET . 89.4 Cg_exo -44.01 -38.74 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.426 2.084 . . . . 0.0 112.119 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.32 -49.6 47.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.3 m95 -60.85 -57.11 14.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.291 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.4 tp -43.03 -39.9 2.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.178 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -60.84 -34.82 75.15 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.91 -45.12 95.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.9 -34.45 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.955 0.407 . . . . 0.0 110.131 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -54.71 -47.58 73.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.75 -42.88 96.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.491 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.33 -45.95 24.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.403 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -64.02 -42.97 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.936 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.4 mp -51.97 -32.89 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.94 -27.78 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.639 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 55.2 t -63.45 -33.35 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.0 110.235 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.54 -49.98 10.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.308 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 65.3 t -53.79 -37.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.547 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.449 ' O ' ' OG ' ' A' ' 163' ' ' SER . 4.0 mm? -84.87 -33.68 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.128 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 17.4 t -70.07 -29.3 39.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.422 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.7 m -83.09 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.578 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 162' ' ' ILE . 10.0 mt -71.73 -8.87 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.53 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 4.4 m -76.01 0.11 19.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.627 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.484 ' C ' ' H ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -63.45 -64.86 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 164' ' ' GLN . 18.9 Cg_endo -58.22 -0.71 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.547 2.164 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.484 ' H ' ' C ' ' A' ' 164' ' ' GLN . 76.6 t80 -40.9 132.33 2.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.427 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.626 ' HZ1' HH12 ' A' ' 176' ' ' ARG . 18.0 ttpt -152.52 116.5 4.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.28 -52.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.46 167.98 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -143.63 129.38 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.612 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -80.96 -30.05 35.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.37 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -155.97 -126.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.214 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.5 ' H ' ' CD2' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -72.35 -62.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.104 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.7 t80 42.16 89.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.522 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -80.59 -101.62 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.626 HH12 ' HZ1' ' A' ' 167' ' ' LYS . 7.3 tpt180 -149.88 -149.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.337 . . . . 0.0 110.357 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.414 ' H ' ' CG ' ' A' ' 176' ' ' ARG . . . 176.57 108.3 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -127.3 -32.16 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 110.401 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -84.58 116.53 23.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.508 ' O ' ' ND1' ' A' ' 180' ' ' HIS . 0.7 OUTLIER -155.58 22.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.385 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.636 ' ND1' ' H ' ' A' ' 182' ' ' HIS . 2.0 t60 -76.58 -176.07 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.636 ' H ' ' ND1' ' A' ' 181' ' ' HIS . 0.0 OUTLIER -162.96 28.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.634 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 19.7 t-160 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -42.79 79.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.089 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -53.58 -34.52 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -72.31 -41.62 66.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.01 -43.81 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.385 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -64.83 -29.2 70.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.003 0.43 . . . . 0.0 110.277 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -78.5 -47.76 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.63 88.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.806 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.8 p -76.63 -35.39 58.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.673 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 6.4 tt0 -68.83 4.9 1.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.05 0.452 . . . . 0.0 110.405 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.79 146.99 17.31 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 63' ' ' ILE . 65.1 mtt180 -69.47 -48.84 59.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.667 0.27 . . . . 0.0 110.81 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.05 -46.32 6.26 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.93 -46.99 86.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.13 -42.17 89.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.82 -28.08 69.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -70.0 -27.71 64.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . 23.0 mmt -76.47 -33.91 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.161 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.12 -54.48 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.604 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -52.13 -51.83 55.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.654 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 18' ' ' MET . 11.0 p -45.41 -61.7 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.49 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.65 -40.04 80.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.91 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.6 mp -75.5 -38.53 59.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.16 -46.47 83.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.82 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.63 -55.15 14.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.4 p -45.45 -40.81 8.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.71 -42.25 51.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.821 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.04 -18.57 3.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.7 t-105 -88.92 -35.32 16.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.554 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -32.22 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.171 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.604 HE21 ' CB ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.44 -47.65 39.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 34' ' ' HIS . 20.8 t60 -70.89 -7.38 45.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.941 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.14 -42.18 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.029 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.7 mtp -99.85 12.46 36.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 9.3 mp 42.9 38.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.604 ' CB ' HE21 ' A' ' 33' ' ' GLN . 23.8 mt -74.59 156.29 36.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.894 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 126.51 27.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.05 137.43 17.32 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.234 1.956 . . . . 0.0 111.836 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.7 t -92.25 -178.05 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.565 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.07 -46.43 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.05 -48.32 82.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -48.65 -45.76 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.518 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.2 mt -61.38 -43.41 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.051 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -48.16 73.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -63.22 -36.4 83.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.721 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -68.24 -38.27 81.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.74 79.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.19 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.69 -50.45 13.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.199 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -46.47 -39.92 11.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.96 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -44.29 89.4 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.59 -47.35 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.986 0.422 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tt -45.41 -49.73 12.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.537 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.34 -49.71 75.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.83 -34.92 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.366 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.63 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.278 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -36.91 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.718 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -73.55 -35.88 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.447 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -15.32 79.3 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 3.59 32.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.605 0.24 . . . . 0.0 111.199 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.439 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 2.8 pt -91.19 -23.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.813 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.08 67.5 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.79 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.87 15.67 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.82 2.347 . . . . 0.0 112.027 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -102.38 -8.96 20.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.668 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.98 163.37 17.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.066 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.04 3.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.574 2.182 . . . . 0.0 112.607 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.668 ' H ' ' C ' ' A' ' 67' ' ' THR . 6.7 mp -67.06 -30.19 70.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.291 . . . . 0.0 110.918 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HD3' ' H ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -38.66 -42.82 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.608 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.477 ' CZ ' ' CG1' ' A' ' 75' ' ' VAL . 75.7 t80 -59.69 -37.95 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.672 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 69' ' ' LEU . 4.2 m -59.62 -38.15 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.253 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -86.09 -30.51 22.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.716 -0.615 . . . . 0.0 110.114 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.8 ttp -67.75 -33.14 74.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.911 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 1.3 m -50.03 -28.57 4.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.562 0.696 . . . . 0.0 110.578 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.23 -31.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.976 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.439 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 13.8 t-105 -66.51 -47.6 72.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.81 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 tp -68.51 -47.85 65.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.439 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -43.98 -42.14 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.345 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -79.19 -24.28 43.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.583 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.37 -58.89 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.282 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CE2' ' NE2' ' A' ' 86' ' ' GLN . 73.5 t80 -74.2 -52.35 12.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.392 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -66.66 -40.86 88.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.15 -46.25 93.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.427 ' O ' ' OG1' ' A' ' 88' ' ' THR . 95.2 t -72.84 -36.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.467 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 82' ' ' PHE . 7.6 tt0 -67.48 -45.95 74.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 tp -65.15 -42.96 93.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.568 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 6.6 p -51.46 -47.63 63.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.401 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -48.07 -41.81 27.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -59.82 -38.51 82.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.578 ' C ' ' HD1' ' A' ' 91' ' ' HIS . 1.7 t-80 -69.41 -56.07 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.387 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.4 p -55.72 -52.14 64.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.706 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.4 tpp -48.76 -45.23 39.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.44 -44.77 90.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -62.53 -42.47 99.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.393 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.69 -22.45 34.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.57 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 93' ' ' MET . 27.0 t80 -136.31 68.56 61.81 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.682 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.26 160.28 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.771 2.314 . . . . 0.0 112.131 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.94 151.68 3.35 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.418 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -38.97 159.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.53 2.153 . . . . 0.0 112.197 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 22.5 p90 -113.42 115.95 28.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.53 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.19 -53.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.537 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.0 m -69.12 126.89 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.566 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m 49.69 89.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 106' ' ' PHE . 27.6 t70 -160.13 169.68 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CG ' ' C ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 174.47 -177.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.602 ' C ' ' H ' ' A' ' 109' ' ' ARG . 5.9 ptt? -160.13 132.01 6.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.1 t 59.37 -4.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.602 ' H ' ' C ' ' A' ' 107' ' ' MET . 10.9 ttm180 -87.95 99.91 12.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -115.0 149.95 43.37 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.346 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -37.99 138.14 0.41 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.487 2.125 . . . . 0.0 112.044 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -99.75 18.32 18.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.779 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.15 -5.96 7.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.432 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.654 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 mp -119.8 84.42 31.53 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.3 Cg_exo -55.15 11.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.568 2.179 . . . . 0.0 112.264 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.8 mm? -71.04 -32.74 69.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.086 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.0 p30 -97.63 -39.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 21.3 tttm -72.08 -45.26 61.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.8 t90 -76.34 -11.65 59.94 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.17 68.86 48.57 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -17.03 11.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.64 -33.99 35.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.28 45.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.586 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -149.55 -36.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.46 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.8 124.32 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.438 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.95 23.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t -164.98 101.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.584 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.66 -175.24 21.15 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -92.33 150.88 20.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.683 0.278 . . . . 0.0 110.323 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 11.9 m -100.74 132.07 46.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 95.56 -4.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.01 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.97 150.58 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.057 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -96.11 133.2 40.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.647 ' NE2' ' N ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -128.52 -22.5 3.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.732 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.647 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 21.6 t-105 -173.17 136.42 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.004 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 5.3 p30 -140.77 157.25 45.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 111.964 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.08 138.43 50.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.33 17.07 0.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.77 21.71 35.81 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.808 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.0 mt -124.86 137.27 54.3 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.33 148.86 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.402 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.9 mtt -47.89 -53.15 34.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -43.49 -37.35 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.419 2.079 . . . . 0.0 112.352 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -71.29 -50.33 33.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.993 0.425 . . . . 0.0 110.113 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 74.0 m95 -60.28 -57.84 11.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.09 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.7 tp -43.49 -37.8 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.062 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.7 tp -61.13 -34.94 75.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.72 -45.34 94.95 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.61 -31.88 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.12 -49.17 76.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.143 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.42 -46.68 94.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.537 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.42 -46.5 56.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.369 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -55.25 -43.24 74.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.2 mt -61.08 -30.58 70.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.869 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.62 -32.03 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.479 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 70.3 t -64.55 -37.6 80.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.439 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.29 -46.32 16.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.147 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.88 -44.01 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.37 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.42 -33.0 48.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 42.0 t -74.79 -22.97 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.882 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.431 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 46.2 t -82.17 -50.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.098 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.44 ' HA ' HE22 ' A' ' 164' ' ' GLN . 69.3 mt -67.67 -17.34 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.796 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 164' ' ' GLN . 17.7 p -70.88 -39.27 72.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 166' ' ' PHE . 1.2 mp0 57.69 156.27 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -70.96 28.73 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 111.826 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 164' ' ' GLN . 5.8 t80 -51.51 151.82 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -143.0 113.51 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.525 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.08 164.01 22.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -70.06 -109.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -124.01 -42.19 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.387 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 52.11 102.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.544 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -163.36 -28.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.683 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.9 mt 48.63 -121.1 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.449 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.33 88.63 3.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.49 -116.05 3.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 62.63 138.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -177.96 2.71 0.03 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -52.56 -34.26 49.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -83.22 146.03 28.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 181' ' ' HIS . 18.2 m-70 -88.28 149.26 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.509 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.543 ' C ' ' H ' ' A' ' 183' ' ' HIS . 0.8 OUTLIER 53.79 168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.49 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 70.39 -38.58 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.543 ' H ' ' C ' ' A' ' 181' ' ' HIS . 1.5 m-70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.49 -42.93 51.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.058 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -54.41 -31.59 55.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 12.6 t80 -74.89 -42.77 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.193 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.409 ' O ' ' OG ' ' A' ' 9' ' ' SER . 6.1 tp -47.97 -38.49 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.354 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -70.75 -27.05 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.448 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 7.1 tm0? -75.55 -49.94 17.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.23 -27.52 69.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 0.0 110.308 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' GLY . 23.0 m -76.51 -42.66 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.254 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -70.15 5.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.99 0.424 . . . . 0.0 110.684 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.69 142.66 16.2 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -69.0 -49.84 54.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.586 0.231 . . . . 0.0 110.713 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.86 -45.72 5.91 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -47.09 87.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -61.03 -37.07 81.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.26 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -32.34 70.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.95 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.82 -36.61 75.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.469 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.478 ' C ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -66.44 -34.79 78.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 -49.94 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.76 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.65 -41.87 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.9 m -64.39 -46.62 82.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.656 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.59 72.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -81.82 -42.08 20.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.91 -26.92 49.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -77.35 -39.82 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.542 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.2 -54.54 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -56.23 -50.48 71.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 p -49.91 -43.69 49.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.999 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.75 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.144 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -17.29 19.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -93.4 -37.63 11.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.702 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.78 -46.22 78.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.404 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -73.3 -36.21 66.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.63 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -61.25 -22.44 64.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.652 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.1 t -107.88 -28.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.805 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.6 mmt -92.03 3.27 55.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.999 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt 47.4 48.54 16.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.13 155.04 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.829 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -117.19 127.17 26.88 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.075 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.84 148.82 28.78 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.296 1.997 . . . . 0.0 112.368 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.654 ' H ' ' HG ' ' A' ' 44' ' ' SER . 10.2 t -94.58 173.57 7.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.32 -35.87 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 110.076 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -45.55 86.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.654 ' HG ' ' H ' ' A' ' 41' ' ' CYS . 19.0 m -48.94 -47.53 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.733 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.43 HG12 ' N ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -61.4 -38.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.43 ' N ' HG12 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -61.35 -46.19 91.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.838 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -65.1 -51.77 59.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.526 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -35.51 72.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.35 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.38 85.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.564 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.56 70.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.148 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' CD2' ' C ' ' A' ' 51' ' ' LEU . 7.0 tt -71.26 -53.71 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.026 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -44.84 -40.2 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.27 93.44 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 57' ' ' ALA . 60.2 t -59.91 -47.53 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 109.872 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.6 -45.39 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.329 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.79 -27.59 71.37 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -70.53 -37.68 74.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.059 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.42 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.952 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.385 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.51 -36.59 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.651 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -72.87 -34.3 59.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.49 2.93 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.716 0.293 . . . . 0.0 110.755 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.43 ' H ' ' C ' ' A' ' 61' ' ' GLY . 88.7 mt -77.97 -47.42 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.512 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.06 78.37 0.28 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.493 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.06 25.82 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.548 ' HZ3' ' CB ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -102.82 -10.93 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.175 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.624 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.48 176.46 1.48 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.485 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.96 -2.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.258 1.972 . . . . 0.0 111.874 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.2 tt -47.79 -37.17 13.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mmp_? -38.8 -67.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.827 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -52.49 -28.46 20.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.82 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.6 t -71.77 -47.04 58.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.715 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.51 53.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 110.484 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.55 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -63.2 -11.54 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.678 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.536 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 3.0 t -58.39 -38.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.372 0.606 . . . . 0.0 110.027 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -87.65 -32.54 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.309 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 12.4 t-105 -64.63 -53.69 43.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.169 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.0 tp -64.85 -47.22 78.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.832 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -44.16 -42.2 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.4 p -78.95 -22.36 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.75 -59.99 4.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.927 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -73.76 -55.02 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.218 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -66.35 -45.73 79.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -57.58 -46.57 91.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.483 ' O ' ' OG1' ' A' ' 88' ' ' THR . 86.7 t -70.77 -52.51 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -52.06 -29.41 21.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 tp -80.16 -43.6 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.359 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 61.5 p -52.44 -22.21 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.196 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -73.48 -51.7 16.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.36 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -50.13 -36.27 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -72.72 -36.51 67.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -74.99 -43.8 51.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.719 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 97' ' ' TYR . 39.4 ttm -52.57 -52.05 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.711 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.66 -40.91 92.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.557 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -60.84 -48.34 82.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tt -85.89 -17.68 34.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.706 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.9 t80 -137.39 72.6 51.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.044 0.449 . . . . 0.0 110.641 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.94 170.69 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.872 2.381 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 t -160.82 64.24 1.99 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.767 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 102' ' ' ALA . 88.8 Cg_endo -81.17 33.31 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.943 2.429 . . . . 0.0 112.189 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -67.0 1.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 100' ' ' PRO . . . -161.34 -24.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.555 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m 48.22 50.41 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.67 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.9 p -104.88 73.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.345 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.6 OUTLIER -99.91 -90.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.671 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 55.63 80.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.302 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.566 ' C ' ' H ' ' A' ' 109' ' ' ARG . 12.8 mtt -74.86 -121.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.8 t 60.99 -4.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.955 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.566 ' H ' ' C ' ' A' ' 107' ' ' MET . 50.1 ttm-85 -106.82 100.48 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.49 154.13 43.19 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.247 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -36.79 138.77 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.772 2.315 . . . . 0.0 112.326 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.47 18.02 20.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.224 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.498 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 1.4 p-90 -124.29 -2.47 8.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.644 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.2 tp -115.19 88.83 18.83 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.77 10.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.832 2.355 . . . . 0.0 113.198 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.644 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -80.02 -22.59 42.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.128 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -95.28 -46.83 6.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.819 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -24.92 64.78 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.209 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -93.23 -19.92 20.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.088 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.82 70.94 19.55 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.93 -15.85 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.949 2.432 . . . . 0.0 112.247 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -52.76 -35.9 57.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.368 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.41 22.2 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.71 0.291 . . . . 0.0 110.913 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.48 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 2.4 t80 -131.4 -6.08 3.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.66 129.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.85 135.9 33.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.3 m -164.7 116.16 1.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.523 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.25 -168.44 16.39 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -96.12 158.08 15.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.694 0.283 . . . . 0.0 110.241 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.573 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -109.19 130.05 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.776 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 95.98 -3.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.791 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.78 150.54 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.027 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.7 145.39 24.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.941 0.4 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -135.17 -31.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.1 t-105 -174.95 144.77 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -141.5 167.05 23.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 111.402 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -141.39 120.35 12.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.379 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.28 16.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.18 15.0 75.6 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.48 133.69 55.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.811 0.339 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.77 152.87 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.425 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -51.17 -51.64 66.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 142' ' ' MET . 70.9 Cg_exo -45.39 -37.87 14.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.3 2.0 . . . . 0.0 112.034 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.99 -42.54 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.205 0.526 . . . . 0.0 109.982 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.606 ' O ' ' N ' ' A' ' 148' ' ' GLY . 59.9 m95 -65.64 -57.14 8.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.0 tp -43.33 -39.01 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.066 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.23 -34.59 76.8 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.92 -42.91 96.98 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.6 mt -67.68 -39.53 82.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 0.0 110.146 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -55.25 -45.31 76.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.5 mt -57.2 -43.93 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.61 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.44 62.27 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.518 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.7 m-85 -53.76 -43.48 69.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.087 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.455 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 1.1 pp -75.01 -29.7 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.309 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.9 mt -69.97 -36.74 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.201 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.3 m -73.36 -38.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.989 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.29 -51.16 62.55 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.844 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.3 t -55.19 -50.96 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.01 -33.9 73.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.4 t -67.07 -28.99 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.794 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.94 -45.92 62.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.146 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.64 -27.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m -53.47 -16.06 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.523 ' C ' ' H ' ' A' ' 166' ' ' PHE . 19.9 pt20 -45.95 148.49 1.42 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.276 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 35.96 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.442 2.095 . . . . 0.0 111.912 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.523 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.4 OUTLIER -137.85 105.59 5.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.27 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 168' ' ' ALA . 12.6 tptp -153.7 51.18 0.69 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 167' ' ' LYS . . . 60.01 147.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.614 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -159.43 160.12 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -74.95 95.21 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.641 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -114.49 119.01 35.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.617 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -133.25 38.17 3.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.266 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.0 mp -66.15 91.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.538 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -146.61 -66.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.455 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 158.03 -76.07 0.2 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -78.49 126.46 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 0.0 110.618 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.39 -128.13 1.36 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -102.7 156.97 17.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -138.22 31.3 2.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.436 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -137.93 112.2 8.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.456 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 182' ' ' HIS . 24.5 t-80 -98.01 22.14 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.571 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 181' ' ' HIS . 37.4 m-70 -152.96 147.48 25.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.619 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.5 t60 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.582 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.84 -37.54 87.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.134 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.4 ptt-85 -58.74 -40.62 84.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -59.37 -47.63 84.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -51.19 -38.68 53.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -68.41 -31.26 70.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.348 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -77.06 -50.95 11.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.681 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.89 77.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 11' ' ' GLY . 85.3 p -76.96 -37.9 54.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.733 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.747 HE22 HH21 ' A' ' 70' ' ' ARG . 16.6 mm-40 -67.51 2.02 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.42 147.49 18.56 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -71.78 -49.68 36.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.685 0.278 . . . . 0.0 110.65 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.91 -45.05 5.85 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.19 84.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -58.41 -41.41 84.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.154 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -28.89 69.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.022 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.5 -30.48 67.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.308 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.433 ' O ' ' OG1' ' A' ' 21' ' ' THR . 0.4 OUTLIER -73.19 -33.09 65.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.02 7.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -47.97 -40.85 23.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -63.72 -50.17 70.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.377 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.13 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -37.27 41.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.92 -36.96 63.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.53 -37.93 65.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.46 -43.48 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.98 -48.31 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.508 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -54.47 -40.95 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.73 67.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.776 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 -20.4 63.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.424 ' NE1' ' CG2' ' A' ' 35' ' ' VAL . 32.1 t90 -88.95 -39.36 13.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.65 -43.61 57.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.43 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 4.5 tm0? -73.61 -29.56 62.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.02 -26.35 66.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' NE1' ' A' ' 31' ' ' TRP . 56.0 t -109.29 -53.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.924 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.68 1.13 8.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.96 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mt 48.54 41.36 17.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.43 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 1.4 tp -76.24 147.71 38.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -111.66 127.04 27.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.596 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.06 154.66 33.19 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 111.775 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 6.5 t -118.0 -171.98 2.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.787 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.23 -48.05 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.075 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.83 -50.1 70.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.442 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.7 p -53.08 -48.97 67.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mm -61.34 -45.23 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.327 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -58.41 -46.12 87.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.307 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -60.78 -38.32 84.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -64.59 -36.38 84.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.38 84.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.96 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.346 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.78 -49.58 15.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.049 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -46.32 -38.03 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.76 -44.25 81.29 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.9 -47.65 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -43.9 -48.62 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.6 -48.24 86.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.19 -33.02 25.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.27 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.77 -35.54 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.404 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.88 -37.26 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.223 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' N ' ' CD1' ' A' ' 60' ' ' ILE . 1.6 mp -75.24 -40.32 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.0 -28.67 73.34 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.77 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.705 0.288 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.1 mt -82.63 -32.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.46 73.36 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.442 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.75 24.58 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.518 2.145 . . . . 0.0 111.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.3 mttm -111.86 -7.56 14.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.13 162.44 21.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.655 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -38.91 -15.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.592 2.195 . . . . 0.0 112.304 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.4 mp -41.58 -33.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.747 HH21 HE22 ' A' ' 10' ' ' GLN . 71.9 mtt85 -39.22 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -51.95 -31.48 29.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.62 -45.94 80.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.97 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.46 -34.26 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.6 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -64.7 -19.66 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.678 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.413 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 2.1 t -54.09 -34.46 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 0.0 109.958 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 84.0 mt -89.15 -33.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.2 t-105 -65.87 -49.86 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.003 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -66.06 -49.58 67.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.3 m-85 -42.92 -42.61 3.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.8 p -78.11 -22.18 49.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.768 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.8 -59.86 4.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.281 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.3 -51.13 13.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.646 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -40.5 78.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 88' ' ' THR . . . -63.08 -47.14 90.98 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 81' ' ' ALA . 11.1 m -77.53 -32.73 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.336 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.04 -42.87 59.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.663 0.268 . . . . 0.0 111.191 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tp -73.72 -38.47 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.047 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 84' ' ' GLY . 7.9 p -59.56 -44.45 93.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.208 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -52.32 -52.13 54.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.522 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -50.84 -46.35 60.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -64.55 -33.16 75.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.9 m -70.97 -37.14 72.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.413 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 tpt -62.21 -33.01 73.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.2 -47.47 70.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.115 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -51.65 -42.33 62.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 8.9 mp -92.29 -9.57 41.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 93' ' ' MET . 1.4 t80 -140.87 69.35 29.66 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 110.438 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.22 171.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.06 157.21 57.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.383 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.32 -90.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.1 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -130.96 -36.0 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . -71.22 -165.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 31.6 p 49.53 99.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 t -61.62 -152.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -173.81 64.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.665 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -91.0 -173.79 3.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -163.26 -165.85 1.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.542 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 t 64.31 6.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.537 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -106.67 103.62 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.09 155.03 76.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.291 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.22 132.29 51.02 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.48 2.12 . . . . 0.0 111.835 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -80.66 4.2 19.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -99.22 -5.38 30.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.426 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 116' ' ' LEU . 10.4 mp -113.09 82.81 5.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.31 12.11 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.041 1.827 . . . . 0.0 111.756 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.9 mt -80.13 -28.42 38.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.013 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 1.4 p30 -97.31 -40.83 8.55 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.975 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 3.3 ttmm -69.27 -45.16 70.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.658 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 16.0 t-105 -76.85 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.405 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.17 71.13 22.81 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.761 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.74 -16.11 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.748 2.299 . . . . 0.0 111.805 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -52.29 -32.63 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.785 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -133.37 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.536 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -152.3 -40.53 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.239 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.7 128.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.99 155.47 17.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.4 p -158.17 102.8 1.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.599 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.58 -177.27 19.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 33.9 t70 -86.06 150.02 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.58 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 9.7 m -101.74 127.23 48.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 98.87 -8.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.87 128.82 37.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.733 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.19 136.22 51.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -130.16 -29.35 2.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -174.56 145.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.722 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -144.73 159.64 42.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.256 0.551 . . . . 0.0 112.102 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.408 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -115.09 138.13 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.705 178.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp 50.24 16.85 0.28 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 90.73 22.64 33.01 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.36 136.23 53.93 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 135' ' ' TRP . 6.0 mm-40 -69.33 146.73 51.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.315 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.442 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 9.5 mtt -44.94 -62.7 1.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.144 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 85.8 Cg_exo -33.78 -37.63 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.848 2.366 . . . . 0.0 112.639 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 144' ' ' GLN . 4.8 mp0 -72.34 -52.0 18.08 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.0 m95 -59.47 -57.28 13.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.848 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.5 tp -44.57 -35.55 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.9 -33.96 76.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.51 -46.19 94.83 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.8 mp -75.14 -25.88 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -64.54 -44.37 91.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.743 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.9 tt -69.24 -37.39 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -53.79 -46.99 71.21 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.054 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.79 -44.47 96.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.686 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 52.3 mt -65.19 -30.95 71.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.9 -33.35 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.321 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 41.5 t -64.95 -31.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.52 -47.5 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.7 t -55.41 -42.21 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -28.58 56.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.903 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 31.1 t -78.26 -20.33 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.8 -50.03 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.83 -25.96 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.76 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.3 p -71.77 0.07 9.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.548 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.13 74.14 5.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.25 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.8 57.75 5.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.563 2.175 . . . . 0.0 111.957 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 62.22 -174.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -142.76 -25.74 0.62 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.29 98.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -151.16 -42.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 172' ' ' ASP . 52.4 mtmt -84.74 -89.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 48.32 18.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 170' ' ' LYS . 74.8 m-20 -75.51 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.739 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.8 tp -81.15 -70.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.583 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.17 96.93 10.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.438 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -106.58 178.02 22.26 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -69.33 80.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.56 155.29 9.84 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 178' ' ' HIS . 45.4 p-80 -164.45 106.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.612 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -89.47 120.25 30.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.448 ' CD2' ' H ' ' A' ' 181' ' ' HIS . 0.6 OUTLIER -171.45 -149.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.429 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.448 ' H ' ' CD2' ' A' ' 180' ' ' HIS . 4.3 m-70 63.66 136.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.623 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.676 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 42.5 t60 -80.69 -175.24 5.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.676 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 1.8 t60 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.591 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 4' ' ' PHE . 29.6 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mp -47.85 -34.66 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 109.951 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.6 -31.84 66.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 7' ' ' GLN . 23.3 t80 -73.48 -44.94 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 5' ' ' LEU . 3.9 mm? -47.17 -39.88 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.003 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -68.46 -28.15 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.421 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 4' ' ' PHE . 24.4 tt0 -80.33 -49.45 11.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.36 72.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 11' ' ' GLY . 37.4 m -76.66 -34.99 58.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.754 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -72.76 7.41 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.07 142.08 15.87 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -68.44 -21.4 64.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 110.648 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.83 -46.06 61.94 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.83 76.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.327 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -58.17 -43.12 87.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.42 -33.06 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.323 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.48 -30.37 70.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . 60.3 mtp -73.66 -33.0 64.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.417 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.89 71.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.46 -51.83 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 18' ' ' MET . 12.7 p -41.65 -50.42 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.92 85.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.62 -39.67 80.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.306 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.71 -41.67 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.354 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.3 -33.78 63.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.543 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.76 -45.91 77.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.03 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -71.89 -46.55 57.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.92 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 87.5 m -46.8 -43.01 18.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.81 -21.45 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -68.49 -22.39 64.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.23 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.442 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 2.4 t-105 -97.68 -29.39 13.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.4 -39.86 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.51 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -78.8 -51.6 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.992 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -54.74 -53.41 55.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 31' ' ' TRP . 4.3 p -61.01 -18.19 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.0 ttt -106.3 10.56 31.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.589 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 8.2 mp 52.24 54.44 10.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.99 157.18 17.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.283 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -125.37 141.48 38.95 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.432 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.76 175.93 10.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 112.318 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.486 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 12.8 t -131.88 -179.34 5.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 39.6 t -56.06 -49.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.599 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.94 -38.24 87.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -54.23 -40.93 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.584 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.98 -37.59 78.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.428 . . . . 0.0 110.053 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -60.73 -48.2 82.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.038 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.94 -39.95 95.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -65.82 -36.16 82.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.366 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.11 86.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.05 -49.03 78.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 tp -76.04 -52.2 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.223 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -45.89 -42.59 12.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.53 89.47 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' ALA . 26.0 t -59.15 -46.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.298 0.571 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.09 -46.59 11.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.535 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.81 -27.42 71.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.04 -42.13 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.91 -21.51 62.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -43.93 19.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.34 -33.23 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -73.16 -31.38 61.63 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.44 6.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.798 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 61' ' ' GLY . 95.0 mt -82.81 -29.79 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.76 69.03 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.25 23.78 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.754 2.302 . . . . 0.0 111.654 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -102.29 -10.25 19.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.087 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.84 175.21 1.96 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.513 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.39 -9.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.281 1.987 . . . . 0.0 112.052 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -47.89 -31.43 5.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.126 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -40.33 -67.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.62 -26.08 63.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.43 -45.48 74.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.248 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.66 -36.48 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.47 0.653 . . . . 0.0 109.574 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -12.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.062 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.5 t -55.27 -44.21 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.306 0.574 . . . . 0.0 110.443 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.89 -31.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.627 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.493 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 10.0 t-105 -62.67 -55.79 23.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.129 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.1 tp -65.3 -48.17 74.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -43.58 -45.66 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.084 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 p -78.99 -21.14 47.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.43 -60.38 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.053 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.52 -51.27 17.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.09 -48.1 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -55.38 -48.42 69.76 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.469 ' O ' ' OG1' ' A' ' 88' ' ' THR . 66.1 t -69.29 -47.23 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.531 HE21 ' C ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -55.48 -23.48 25.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.292 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.39 -42.67 14.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.214 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 39.7 p -51.29 -26.38 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' O ' ' OG1' ' A' ' 92' ' ' THR . 5.5 m-85 -69.18 -46.53 67.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.246 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -55.38 -31.23 61.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.274 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 10.7 t-80 -70.09 -49.64 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.349 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 31.1 p -54.87 -56.36 20.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 110.199 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' TYR . 40.8 mtt -48.01 -50.68 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.028 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.72 -36.8 7.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.412 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -67.69 -31.19 70.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 93' ' ' MET . 10.6 mp -102.99 -4.17 25.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.228 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 93' ' ' MET . 18.6 t80 -130.49 89.99 42.4 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.437 ' O ' ' OG ' ' A' ' 99' ' ' SER . 72.3 Cg_endo -80.82 112.79 2.7 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.632 2.222 . . . . 0.0 112.372 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 98' ' ' PRO . 49.4 m -168.12 59.43 0.43 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.398 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.7 26.54 0.32 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.841 2.361 . . . . 0.0 112.256 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.435 ' H ' ' C ' ' A' ' 99' ' ' SER . 10.1 t80 -104.06 134.66 46.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.506 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.02 17.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.633 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.5 p -60.65 -7.85 2.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.632 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 t -167.86 123.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -73.26 88.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.458 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -47.09 117.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.589 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -160.89 129.43 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.64 2.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.589 ' H ' ' C ' ' A' ' 107' ' ' MET . 72.4 mtt180 -105.38 99.84 9.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.371 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -123.72 159.54 55.34 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.468 -179.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.63 144.72 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.63 2.22 . . . . 0.0 112.048 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -103.79 -14.41 16.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.459 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.85 -5.21 59.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.2 mp -119.68 81.85 25.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -52.67 -2.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.566 2.178 . . . . 0.0 112.016 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.569 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tt -59.53 -32.31 70.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -41.03 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.604 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -71.9 -45.28 61.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.721 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -73.71 -17.29 61.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.456 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.0 t -141.34 72.32 26.31 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -79.75 -16.48 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.895 2.396 . . . . 0.0 111.804 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -50.2 -49.11 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.816 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.97 53.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -154.57 -39.76 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -55.57 130.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.47 150.24 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.535 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.9 m -159.69 102.97 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.695 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.59 -176.7 20.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.3 m-20 -87.55 157.19 19.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 3.7 m -106.79 128.97 54.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.711 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 93.94 -7.87 0.13 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.429 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 8.1 mp0 -68.21 129.1 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.857 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.51 116.21 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.096 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -109.11 -31.04 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.84 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -174.06 143.26 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.794 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.96 156.45 44.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.295 0.569 . . . . 0.0 112.167 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -112.41 138.76 48.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.786 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.44 17.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 91.29 22.8 31.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.03 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.53 137.86 53.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.38 149.42 50.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.422 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 2.6 mtt -48.62 -52.74 42.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 142' ' ' MET . 86.5 Cg_exo -43.34 -34.21 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.396 2.064 . . . . 0.0 112.17 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.74 -52.66 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 148' ' ' GLY . 95.0 m95 -58.81 -58.3 9.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -43.83 -36.98 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.15 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.17 -34.6 75.29 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.67 -47.63 89.24 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.65 -25.57 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.049 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -64.85 -43.08 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.694 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 5.5 tp -68.27 -36.81 76.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.359 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.015 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -58.71 -33.74 70.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.1 mp -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.9 mt -82.43 -34.26 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.484 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 91.6 t -60.48 -40.3 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.625 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.47 -50.58 13.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 52.9 t -53.13 -50.61 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.442 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.8 OUTLIER -66.54 -31.17 71.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.013 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 11.1 t -70.87 -28.77 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.18 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.29 -49.42 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.222 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 39.7 mm -68.92 -11.14 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.569 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 6.9 m -66.66 -13.96 61.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.59 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 166' ' ' PHE . 21.1 mm-40 -141.38 74.71 23.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.13 -7.03 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 111.99 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 164' ' ' GLN . 47.1 p90 -163.22 179.35 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.494 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 122.34 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.46 102.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -64.98 100.15 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.598 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -46.79 131.82 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -86.5 31.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.453 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 173' ' ' LEU . 62.3 t0 -69.74 -73.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.587 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 172' ' ' ASP . 10.8 mp 54.05 165.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -60.27 112.12 1.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.33 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 165.94 119.77 0.49 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.535 ' N ' ' CD ' ' A' ' 176' ' ' ARG . 0.9 OUTLIER 46.8 56.29 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.639 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -98.42 -1.27 57.93 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -149.77 157.72 43.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -65.72 -81.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.529 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -177.68 141.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -78.03 -98.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.589 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.409 ' CD2' ' H ' ' A' ' 182' ' ' HIS . 19.9 m-70 -49.88 120.88 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.549 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.51 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.544 ' O2 ' H3M3 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tpt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -46.92 29.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.347 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.47 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -50.09 -45.69 52.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' GLN . 26.2 m-85 -63.03 -43.6 98.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.277 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.01 -42.36 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.262 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.8 -24.05 64.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 4' ' ' PHE . 52.1 tt0 -77.98 -48.19 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.55 87.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.472 ' C ' ' H ' ' A' ' 11' ' ' GLY . 8.2 m -76.72 -37.32 56.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 6.2 tt0 -66.24 1.87 1.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.12 149.5 19.05 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -70.92 -49.03 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.681 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.83 -45.63 5.87 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.41 83.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.096 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -59.46 -47.17 86.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.058 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.27 -28.22 66.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.9 -27.73 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.439 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.5 mmt -74.24 -34.44 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 -53.61 22.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.712 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -53.13 -52.71 57.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.485 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 p -44.74 -54.12 6.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.727 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.29 -22.2 62.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 20' ' ' PHE . 5.7 tp -85.73 -41.26 15.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.634 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.28 -39.92 64.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.0 mm? -73.11 -27.78 61.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.835 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.44 -38.74 90.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.589 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 mt -79.18 -41.4 28.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 2.5 m -48.06 -43.33 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.49 -32.28 32.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.104 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tp -57.06 -21.33 30.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -90.22 -38.94 13.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.08 -45.54 43.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.25 -25.26 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 -21.24 51.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.393 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.19 -38.67 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.483 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.4 mtp -98.68 5.73 47.47 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.107 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 3.4 mm? 47.22 45.0 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.9 mt -80.01 153.28 28.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.503 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -121.2 126.86 26.41 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.415 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 153.4 32.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.218 1.945 . . . . 0.0 111.934 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.8 t -100.15 -174.77 2.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.6 t -65.98 -41.74 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 110.822 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.65 -36.47 65.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t -57.69 -47.73 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 124' ' ' PHE . 25.5 pt -66.72 -36.36 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.089 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -55.06 -48.29 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.27 -36.15 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.87 84.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.504 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.92 -47.9 83.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -77.72 -49.71 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -46.6 -43.32 17.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 109.851 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.44 93.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' ALA . 55.1 t -58.31 -46.7 88.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.006 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.0 -42.95 29.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.543 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -24.15 72.45 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.87 -32.05 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.584 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -23.09 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 tp -79.63 -42.3 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.388 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.72 -36.9 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.679 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.52 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -69.71 -33.7 71.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.19 6.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.655 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.52 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.9 mt -79.64 -25.56 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 176.76 68.38 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.85 14.42 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.674 2.249 . . . . 0.0 111.995 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -8.81 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.197 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.27 162.47 20.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.813 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -42.04 -12.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.418 2.079 . . . . 0.0 112.246 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mp -50.35 -29.3 9.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 164' ' ' GLN . 26.7 ptt180 -37.9 -57.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.715 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.481 ' H ' ' CG ' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -52.72 -35.01 55.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.108 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' LEU . 18.2 t -64.02 -44.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.58 -33.89 47.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.203 0.525 . . . . 0.0 110.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 8.3 mmt -62.59 -20.06 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -51.78 -39.03 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.457 0.646 . . . . 0.0 110.342 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 76' ' ' ILE . 97.0 mt -88.74 -30.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.766 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.499 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 15.0 t-105 -66.95 -51.16 58.63 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.123 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.2 tp -67.29 -50.31 60.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.617 ' CE2' ' NE ' ' A' ' 83' ' ' ARG . 63.6 t80 -42.36 -42.49 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 110.267 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 p -79.12 -23.23 44.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.803 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.05 -58.95 6.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.256 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -74.71 -51.87 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.617 ' NE ' ' CE2' ' A' ' 79' ' ' TYR . 47.5 ttp85 -65.56 -42.33 91.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.77 -46.53 93.46 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.7 t -66.8 -36.68 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.647 0.261 . . . . 0.0 111.057 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -72.09 -29.18 63.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.774 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.53 -48.2 9.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.391 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.7 p -50.85 -54.6 22.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.395 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' O ' ' OG1' ' A' ' 92' ' ' THR . 50.0 t80 -51.69 -34.74 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.385 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -57.98 -39.8 79.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -68.09 -38.51 82.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.408 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 52.0 p -65.08 -50.57 65.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.44 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' TYR . 31.8 ttm -50.09 -39.58 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -45.44 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.492 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 19.0 tt0 -59.72 -44.92 93.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 mt -80.15 -19.21 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.111 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.9 OUTLIER -133.13 92.62 24.73 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.59 169.05 20.39 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.425 2.083 . . . . 0.0 112.422 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 162.04 57.65 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 102' ' ' ALA . 25.7 Cg_endo -63.37 99.84 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.491 2.127 . . . . 0.0 111.985 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -48.01 -17.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.692 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 100' ' ' PRO . . . 54.89 -106.66 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -80.34 -104.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.575 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.534 ' N ' ' OG1' ' A' ' 103' ' ' THR . 7.2 t -116.6 -94.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.14 -154.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.569 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.572 ' CB ' HH12 ' A' ' 109' ' ' ARG . 66.5 m-85 -134.18 159.61 40.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -95.91 154.37 17.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.43 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.6 m -45.74 112.53 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.572 HH12 ' CB ' ' A' ' 106' ' ' PHE . 10.8 ptt-85 -114.63 103.5 11.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.507 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' PRO . 53.0 m-85 -137.2 149.47 66.1 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' PHE . 87.1 Cg_exo -37.54 160.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.561 2.174 . . . . 0.0 112.263 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -100.28 -4.95 28.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.709 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -100.6 12.24 37.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.589 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.9 mt -121.69 79.39 39.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.062 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 119' ' ' TRP . 53.4 Cg_exo -48.66 -5.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.534 2.156 . . . . 0.0 111.968 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.589 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 tp -54.19 -31.8 53.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.32 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 32.3 p-10 -97.0 -42.79 7.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.268 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 26.0 ttpp -72.29 -45.78 58.58 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.895 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' PRO . 57.9 t-105 -71.1 -18.82 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.182 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -133.26 75.14 71.25 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.4 -26.65 3.93 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.779 2.319 . . . . 0.0 111.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -61.62 -54.35 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.013 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 t -98.09 59.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.748 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -169.37 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.96 127.47 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.418 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.4 160.58 14.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -166.14 99.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.79 -174.99 22.82 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.421 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -88.55 154.06 20.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.421 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 5.4 m -101.4 133.16 46.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 88.12 -4.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.928 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 12.4 tm-20 -67.93 150.95 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 19.6 ttm180 -85.82 126.84 34.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 110.538 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.25 -26.09 5.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -175.55 135.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 4.1 p30 -135.43 159.55 41.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.366 0.603 . . . . 0.0 112.135 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -123.54 137.79 54.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.062 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mp 54.38 17.1 1.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.521 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.35 13.78 61.16 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.72 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.409 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 13.8 mt -119.12 145.0 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 4.0 mp0 -75.9 148.09 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.4 mtt -50.18 -57.28 13.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.1 Cg_exo -37.34 -38.67 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.351 2.034 . . . . 0.0 111.923 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -73.07 -46.81 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.204 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.5 m95 -60.77 -57.52 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 tt -43.55 -41.01 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tt -57.38 -34.95 69.39 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.35 -43.66 95.56 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.612 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.9 mp -72.85 -38.35 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -46.98 64.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 0.0 109.707 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.48 -49.49 83.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.72 -48.82 78.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.43 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.0 m-85 -59.15 -44.65 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.444 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.525 ' C ' ' CD1' ' A' ' 154' ' ' LEU . 0.3 OUTLIER -69.64 -30.71 68.48 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.298 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.24 -36.69 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.722 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 50.2 t -62.12 -43.31 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.499 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -61.71 -48.42 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 83.3 t -52.17 -39.24 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.038 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.18 -41.42 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 45.7 t -59.26 -27.52 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 0.0 110.91 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.86 -44.66 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.17 -8.92 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.509 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 m -66.72 -11.13 53.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.616 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.491 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 4.1 pt20 -165.15 78.97 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' PHE . 73.0 Cg_endo -81.47 24.57 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.71 2.273 . . . . 0.0 111.944 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 165' ' ' PRO . 2.8 m-85 51.67 103.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.505 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -81.62 171.75 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -168.51 102.2 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.407 ' HD3' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -68.56 119.02 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.564 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -94.91 -165.84 1.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 60.7 mmt-85 -82.27 108.22 15.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.796 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -99.49 57.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.282 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 16.4 mt -120.3 145.4 47.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.619 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -82.2 -2.69 53.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.393 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -44.7 -72.47 0.35 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -104.7 173.8 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 179' ' ' HIS . . . -95.51 123.23 7.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -47.49 -18.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 110.651 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.409 ' N ' ' C ' ' A' ' 177' ' ' GLY . 6.1 m80 -105.84 147.25 28.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 181' ' ' HIS . 17.2 m80 -83.73 -159.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.073 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 180' ' ' HIS . 26.0 m80 -34.42 103.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.791 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -53.84 141.26 27.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.586 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.409 ' C8 ' ' C13' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 mt -58.94 -38.94 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.115 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -38.86 70.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.401 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.38 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.281 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.22 -42.0 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.663 HD22 ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -65.37 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.238 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -74.29 -50.08 20.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.89 71.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 11' ' ' GLY . 31.8 m -76.8 -37.36 55.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.663 ' NE2' HD22 ' A' ' 6' ' ' ASN . 0.7 OUTLIER -73.22 6.94 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.45 144.65 16.0 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -69.71 -49.15 56.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.732 0.301 . . . . 0.0 110.727 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.16 -46.12 6.42 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.26 85.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -59.19 -42.31 90.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.84 -28.95 69.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.051 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.54 -33.99 71.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.623 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.3 mtt -69.96 -33.35 71.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -51.8 35.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.669 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -50.05 -44.05 51.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.851 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -60.25 -62.0 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' O ' ' OE1' ' A' ' 26' ' ' GLU . . . -50.56 -29.45 10.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -37.5 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.418 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.38 -36.2 61.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.68 -37.37 84.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.716 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 3.1 mp0 -66.45 -46.02 77.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.497 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.45 -56.73 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 34.3 p -46.97 -44.81 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.722 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.71 -42.79 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.961 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.38 -19.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.953 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -92.36 -36.25 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.748 0.309 . . . . 0.0 110.48 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -44.07 58.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.133 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.93 -29.98 70.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -76.69 -13.02 60.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.587 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.03 -51.82 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.3 mmt -89.36 8.91 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.95 49.06 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.254 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 mt -82.45 155.25 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -124.34 95.58 43.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.36 140.02 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.389 2.059 . . . . 0.0 112.08 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.9 t -95.78 -168.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.67 -44.86 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.98 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -70.84 -50.13 38.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.745 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 41' ' ' CYS . 31.6 p -50.05 -51.17 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.46 -39.27 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.308 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -57.2 -45.36 83.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.85 -36.86 75.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.168 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -64.01 -33.81 76.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.022 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.66 80.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.89 77.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.383 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -76.51 -49.21 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.056 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -46.31 -40.1 11.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.496 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.61 -45.36 85.43 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.17 -45.45 98.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.187 0.518 . . . . 0.0 109.729 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.7 -46.73 10.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.586 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.15 -36.72 93.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.13 -44.91 96.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.629 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tp -78.17 -29.9 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.5 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -83.3 -40.18 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.77 -34.19 66.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.72 4.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.9 mt -87.46 -25.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -175.51 67.45 0.26 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.39 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.2 15.92 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.679 2.253 . . . . 0.0 112.116 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 64' ' ' ALA . 21.7 pttt -115.65 -4.05 12.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.111 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.12 163.17 19.71 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -39.97 -15.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.505 2.136 . . . . 0.0 112.255 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 mm? -41.81 -34.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.79 -70.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.536 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -48.35 -36.21 14.03 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.792 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -65.65 -45.7 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.63 -33.36 41.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.265 0.555 . . . . 0.0 110.295 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.4 mmt -65.62 -20.51 66.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.36 -34.67 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.0 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.415 HD11 HG21 ' A' ' 76' ' ' ILE . 69.3 mt -89.31 -32.25 5.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.205 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.517 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.3 t-105 -63.64 -51.41 65.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.997 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tp -69.11 -44.54 72.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.402 ' HH ' ' NH2' ' A' ' 83' ' ' ARG . 68.5 t80 -45.79 -46.51 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.174 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.8 p -78.5 -19.72 52.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.669 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' O ' ' CG2' ' A' ' 85' ' ' VAL . . . -60.75 -59.45 5.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -74.72 -49.76 19.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.618 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.402 ' NH2' ' HH ' ' A' ' 79' ' ' TYR . 27.3 mmm-85 -71.83 -40.23 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.814 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.47 -49.16 81.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.463 ' O ' ' OG1' ' A' ' 88' ' ' THR . 33.5 m -72.74 -47.4 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.746 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -50.72 -24.9 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 0.0 109.945 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 tt -81.44 -40.56 23.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.434 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 66.7 p -53.95 -25.64 21.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 110.085 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -52.07 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -56.95 -32.82 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.462 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 7.2 t-80 -71.73 -44.58 63.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -65.99 -52.22 51.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.616 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -57.45 -50.9 71.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -53.59 -33.4 54.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.823 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.6 -42.02 92.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 109.911 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.51 -5.51 39.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.203 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 93' ' ' MET . 34.5 t80 -133.76 69.57 75.77 Favored Pre-proline 0 C--N 1.334 -0.105 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.552 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -46.85 100.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.446 ' OG ' ' CD2' ' A' ' 97' ' ' TYR . 23.6 m -140.6 78.52 21.25 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -46.41 -27.3 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.624 2.216 . . . . 0.0 112.082 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 t80 41.24 90.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.594 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . 52.96 68.12 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.504 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 70.6 p 50.54 -101.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.531 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 p 57.97 9.29 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.636 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 103' ' ' THR . 18.1 t70 -77.75 -26.81 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.588 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.65 83.74 2.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.579 ' O ' ' N ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -60.18 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.545 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 108' ' ' VAL . 11.0 p 38.94 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.188 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 107' ' ' MET . 9.1 mmm180 -111.45 113.7 26.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.038 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -94.6 147.9 33.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.56 160.31 50.25 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.814 2.343 . . . . 0.0 111.932 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.8 pm0 -105.57 -10.89 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.642 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -101.21 -6.27 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.645 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.608 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.2 mt -123.61 78.91 55.56 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.986 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 45.5 Cg_exo -52.22 1.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.612 2.208 . . . . 0.0 112.194 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.608 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.0 tp -62.4 -29.31 70.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.551 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.4 OUTLIER -97.43 -41.18 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.443 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -75.29 -45.73 37.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.473 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.7 t90 -68.62 -17.67 64.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.203 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.3 p -161.13 79.42 2.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.996 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.02 -2.05 11.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.043 2.495 . . . . 0.0 111.785 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -49.05 -47.96 44.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.776 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.96 54.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -157.15 -41.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.408 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.3 p -54.43 128.9 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.66 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.78 150.41 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.776 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.4 t -167.82 110.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.476 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.02 -172.81 21.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.2 m-20 -87.08 139.1 30.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.211 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.523 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 28.6 m -93.16 131.09 38.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 87.38 -1.9 0.56 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.326 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.01 128.48 36.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.035 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -80.17 129.23 34.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -122.49 -15.49 7.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.62 144.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.02 159.26 42.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.553 . . . . 0.0 112.0 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.418 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.9 t80 -112.23 136.85 51.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.82 16.84 0.12 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.38 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 92.71 22.52 28.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.89 133.83 54.4 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 109.977 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.85 146.37 54.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.406 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.5 mtt -46.96 -52.65 31.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.722 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 142' ' ' MET . 77.0 Cg_exo -44.45 -35.63 8.83 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.329 2.019 . . . . 0.0 112.232 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.411 ' N ' HE21 ' A' ' 144' ' ' GLN . 0.0 OUTLIER -70.51 -52.51 21.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.457 . . . . 0.0 109.995 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.632 ' O ' ' N ' ' A' ' 148' ' ' GLY . 83.0 m95 -59.35 -56.97 15.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.125 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tt -43.26 -38.21 2.48 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -34.06 73.49 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.96 -41.9 98.07 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.437 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.07 -27.93 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.086 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -61.49 -48.47 80.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 tp -69.15 -37.2 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.26 67.34 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.025 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.1 -41.17 99.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.864 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 mp -51.93 -32.41 32.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.1 mm -82.08 -38.7 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.464 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 79.0 t -52.11 -36.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.319 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.517 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.27 -47.16 15.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.67 -37.67 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.097 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.01 -40.23 28.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 156' ' ' VAL . 45.3 t -68.48 -26.26 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.855 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.3 t -79.32 -49.0 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' A' ' 164' ' ' GLN . 74.7 mt -65.8 -13.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 83.2 p -52.9 -10.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.453 ' H ' ' C ' ' A' ' 162' ' ' ILE . 1.0 OUTLIER -47.54 152.28 1.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.302 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 166' ' ' PHE . 27.4 Cg_endo -63.67 -12.5 31.64 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.489 2.126 . . . . 0.0 111.804 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 165' ' ' PRO . 80.5 t80 37.58 91.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -58.75 108.43 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.549 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.56 113.26 24.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 49.47 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.574 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -170.99 -57.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.522 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 172' ' ' ASP . 50.6 ttt-85 -86.74 -5.1 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.543 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 171' ' ' ARG . 11.0 m-20 56.35 114.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.631 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.505 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.6 mp -80.43 131.28 35.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.12 12.69 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -169.92 -112.34 0.27 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -141.31 -14.02 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 171.09 178.05 41.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.645 ' HD1' ' N ' ' A' ' 178' ' ' HIS . 1.2 p-80 -168.68 77.5 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 0.0 110.711 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -58.62 2.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.375 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.578 ' CG ' ' H ' ' A' ' 181' ' ' HIS . 0.0 OUTLIER -62.66 -116.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.498 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.578 ' H ' ' CG ' ' A' ' 180' ' ' HIS . 1.7 t60 44.22 72.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.528 ' CG ' ' N ' ' A' ' 183' ' ' HIS . 1.7 t60 -73.52 -109.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.623 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.528 ' N ' ' CG ' ' A' ' 182' ' ' HIS . 11.9 p80 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.591 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.452 H102 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp -53.75 -38.39 64.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 19.1 ttp180 -57.49 -27.93 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.202 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.4 -42.64 58.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.074 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -50.76 -41.19 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.498 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.509 ' ND2' ' C ' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -71.98 -26.41 62.23 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.512 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.77 -49.46 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.623 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.03 77.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -76.74 -32.63 57.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -70.1 2.25 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.88 149.75 19.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -71.98 -49.72 34.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.448 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.15 -45.49 6.27 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -58.82 -45.32 90.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.026 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.7 -28.28 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.99 -30.75 68.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.433 ' O ' ' OG1' ' A' ' 21' ' ' THR . 27.2 tpp -72.13 -33.56 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.906 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -51.81 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -51.41 -52.03 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -49.66 -47.76 49.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -43.31 86.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.34 -41.3 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.89 -35.32 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.378 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' OG1' ' A' ' 28' ' ' THR . 35.4 mt -75.71 -39.6 57.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.487 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -64.82 -52.73 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -57.33 -42.04 81.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.644 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 25' ' ' LEU . 11.7 p -60.67 -42.25 96.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.124 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.95 -19.82 65.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.294 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -94.46 -37.7 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 110.843 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -55.41 -46.7 76.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.404 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -71.62 -40.45 69.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.693 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.539 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 45.7 t-80 -61.38 -15.02 32.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.1 t -108.84 -44.77 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.42 5.34 27.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.98 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt 48.34 48.98 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.715 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.4 mt -85.06 154.83 21.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.574 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -116.15 119.15 37.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.245 1.964 . . . . 0.0 112.022 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.447 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 3.9 t -127.19 -177.21 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.527 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 p -66.57 -34.93 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 0.0 110.401 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.52 -48.5 55.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.306 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 p -48.46 -50.77 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.1 mt -61.56 -38.43 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -60.52 -44.3 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.838 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.75 -47.88 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 -50.6 -42.79 56.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.917 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.92 74.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.26 -44.62 79.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.928 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.41 -50.83 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.043 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -39.49 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.25 -45.4 80.85 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.32 -43.74 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.559 . . . . 0.0 109.533 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.03 -49.42 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.362 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.12 92.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -29.3 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.5 -37.29 71.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.479 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -74.06 -23.76 59.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.357 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -84.19 -46.81 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.39 73.82 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.05 5.42 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.726 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.8 mt -80.44 -32.86 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.69 72.95 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.63 27.6 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.547 2.165 . . . . 0.0 111.68 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 64' ' ' ALA . 16.5 tttm -113.34 -10.71 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.933 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.42 162.6 19.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.654 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -39.05 -14.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.705 2.27 . . . . 0.0 112.665 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' THR . 44.4 mt -45.07 -28.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.699 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.2 OUTLIER -40.87 -70.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.547 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -51.03 -33.26 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.909 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.22 -45.45 89.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -36.13 26.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.625 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -62.73 -23.68 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.402 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.01 -31.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.407 0.622 . . . . 0.0 109.873 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.2 mt -88.86 -34.32 6.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.9 t-105 -65.34 -53.15 47.87 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 81' ' ' ALA . 4.8 mt -63.2 -47.96 80.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.666 0.27 . . . . 0.0 110.607 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -42.73 -43.31 3.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.256 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.0 p -77.66 -21.27 52.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.831 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.7 -60.61 3.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.45 -53.66 15.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.01 -48.41 53.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' O ' ' OG1' ' A' ' 88' ' ' THR . . . -55.89 -47.26 80.51 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.97 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.88 -32.43 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.542 0.211 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -72.06 -47.07 54.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.062 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.48 -49.91 43.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.674 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 84' ' ' GLY . 13.2 p -46.39 -48.42 18.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.441 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' THR . 50.4 t80 -57.29 -44.94 84.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.296 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -43.71 -42.06 5.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 109.987 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.02 -34.68 73.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.97 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 89' ' ' TYR . 10.1 m -62.24 -50.1 73.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.302 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' TYR . 18.9 ttt -56.48 -36.78 69.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.933 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -70.13 -36.9 75.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.52 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 48.5 tt0 -63.93 -37.52 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.509 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.19 -15.73 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 -139.93 75.56 29.8 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.04 -170.26 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.625 2.217 . . . . 0.0 111.949 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -179.18 -55.34 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.733 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 99' ' ' SER . 60.7 Cg_endo -74.4 172.3 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.229 1.952 . . . . 0.0 111.972 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -153.37 -13.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 104' ' ' SER . . . -157.49 -76.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.2 p 43.41 21.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.525 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 102' ' ' ALA . 14.8 m 55.32 49.58 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.45 122.89 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.535 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.73 108.04 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.463 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -113.15 173.42 6.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.599 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 39.6 t 55.27 20.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -83.92 106.43 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.586 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -118.64 151.11 49.44 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.35 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.13 140.75 91.0 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.504 2.136 . . . . 0.0 112.003 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.6 11.5 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.59 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -124.62 -1.01 8.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.624 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.642 ' C ' ' H ' ' A' ' 116' ' ' LEU . 53.3 mt -126.59 85.58 60.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.46 5.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.872 2.381 . . . . 0.0 112.745 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.642 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.0 mt -58.04 -31.41 66.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.78 -40.08 8.72 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.997 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.5 -45.54 90.24 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.39 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -79.6 -13.01 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.856 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.81 68.93 24.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.907 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -69.98 -20.04 34.29 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.813 2.342 . . . . 0.0 111.508 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.64 -53.49 57.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.344 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.54 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 4.0 t -101.94 54.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 6.3 m-85 -161.22 -46.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.32 129.44 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.74 152.18 19.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.662 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 101.78 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.733 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.79 176.41 14.92 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -83.13 160.47 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 131' ' ' ALA . 1.8 m -107.84 128.96 55.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 97.4 -8.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.726 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE2' ' N ' ' A' ' 129' ' ' ASP . 8.0 pt-20 -67.87 148.91 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.933 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -85.54 136.51 33.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -125.59 -31.17 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.407 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 39.8 t-105 -174.82 141.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 135' ' ' TRP . 3.6 m-20 -134.62 161.28 35.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.325 0.583 . . . . 0.0 112.161 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.415 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -118.98 136.67 53.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.517 178.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 49.13 16.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.479 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.415 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 93.85 19.75 33.25 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.227 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.1 144.05 51.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.06 0.43 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.52 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 50.8 mt-10 -70.38 145.95 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.558 ' SD ' ' C15' ' A' ' 201' ' ' UQ2 . 2.1 mmt -44.03 -61.93 1.76 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -34.97 -36.45 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.618 2.212 . . . . 0.0 112.238 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -69.57 -58.32 4.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.045 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.9 m95 -55.31 -57.38 12.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.6 tt -43.45 -35.52 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.126 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.37 -35.13 78.19 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.57 -48.27 85.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.484 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.9 mp -71.87 -33.28 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.02 -44.08 87.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.46 -43.33 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.47 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.65 -49.99 75.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.11 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -57.37 -48.24 79.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 0.0 111.058 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.461 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 4.5 mm? -66.98 -34.93 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.607 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 -36.73 37.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.199 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.9 t -54.66 -48.74 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.177 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -61.19 -48.69 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 76.7 t -48.9 -39.43 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 33.5 mt -78.38 -24.6 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.04 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 56.1 t -77.92 -22.7 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 110.718 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.24 -49.59 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.47 ' C ' ' H ' ' A' ' 164' ' ' GLN . 77.7 mt -64.48 -25.69 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.72 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.6 m -52.54 -11.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 0.0 110.403 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.626 ' NE2' ' CZ ' ' A' ' 166' ' ' PHE . 13.7 mt-30 -56.2 152.01 24.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.316 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.73 20.98 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.547 2.165 . . . . 0.0 111.918 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.626 ' CZ ' ' NE2' ' A' ' 164' ' ' GLN . 42.1 p90 -161.16 155.51 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -159.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.5 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 53.67 -166.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.349 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -78.39 -27.91 46.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.281 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -156.67 -57.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.605 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -174.23 -50.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.808 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.76 139.1 23.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.21 0.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -64.56 101.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.566 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 163.84 17.54 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -136.9 93.65 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.23 18.95 0.05 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.679 ' CD2' ' H ' ' A' ' 179' ' ' HIS . 42.2 t60 -76.4 -139.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 0.0 110.472 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . 0.679 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 49.1 t-80 38.98 -120.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.812 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . 0.659 ' H ' ' ND1' ' A' ' 179' ' ' HIS . 17.7 m-70 54.25 166.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.47 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -45.01 -30.94 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.67 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -46.34 129.91 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.529 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 17.9 m170 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.589 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.558 ' C15' ' SD ' ' A' ' 142' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.01 -44.75 94.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.375 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -51.3 -39.34 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.391 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -66.1 -44.92 82.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.2 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -39.65 12.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -69.45 -24.96 63.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.315 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tm0? -80.39 -48.22 13.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.56 69.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.522 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 11' ' ' GLY . 66.9 p -76.79 -34.48 57.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.418 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 1.9 tp-100 -70.96 6.37 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.99 141.08 15.15 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.75 -20.64 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.738 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.43 -44.2 74.59 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -51.33 66.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -53.76 -43.9 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mt -70.26 -30.28 67.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.05 -36.64 77.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.604 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.58 -34.49 75.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.27 37.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.394 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -50.63 -36.87 37.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.728 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.11 -56.72 14.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.778 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.71 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.658 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -84.21 -42.39 15.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.27 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.55 -34.61 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.35 -52.84 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.83 -52.28 60.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 p -51.23 -38.9 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.15 -34.14 68.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.46 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.28 -22.75 67.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.756 0.312 . . . . 0.0 110.426 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -85.03 -28.81 25.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -45.56 94.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.99 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -66.95 -27.46 67.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -83.17 -13.34 55.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.981 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.32 -33.13 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.132 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' MET . 14.3 ttm -109.21 6.63 24.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.153 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 mt 48.92 51.35 16.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.046 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mt -81.81 154.54 25.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.509 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 127' ' ' SER . 42.3 mttp -120.24 93.76 48.28 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.5 131.11 27.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.509 2.139 . . . . 0.0 112.022 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -89.8 -171.14 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 43' ' ' LEU . 8.6 p -62.22 -41.65 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 2.8 mp -58.89 -45.44 90.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.507 ' HG ' ' H ' ' A' ' 41' ' ' CYS . 11.5 m -48.45 -42.54 32.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -62.48 -42.22 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 110.12 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -65.83 -46.45 78.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.503 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -50.36 67.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.366 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -58.76 -30.77 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.72 68.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.81 80.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.62 -52.78 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.246 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -44.66 -40.19 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.74 87.93 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.44 -46.36 93.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mt -44.05 -46.09 8.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.427 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.19 -41.64 98.26 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.31 -44.38 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.512 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.3 -32.61 73.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 8.6 mt -73.33 -26.45 61.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mm -82.08 -35.33 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.351 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.16 80.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.81 5.71 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.695 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.5 mp -82.85 -35.12 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.426 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -179.83 73.23 0.18 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.206 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 53.0 Cg_endo -72.56 23.3 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.533 2.155 . . . . 0.0 112.055 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 64' ' ' ALA . 12.1 ttpt -113.8 -6.49 13.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -114.12 159.44 36.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.894 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -38.15 -18.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.628 2.219 . . . . 0.0 112.442 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.5 mp -41.34 -32.6 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.572 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.579 ' NH2' ' HG ' ' A' ' 163' ' ' SER . 34.8 mtp180 -39.76 -65.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.663 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.02 -32.49 46.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -66.0 -45.23 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.819 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 75' ' ' VAL . . . -74.51 -34.29 63.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.657 0.742 . . . . 0.0 109.129 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.533 ' O ' ' SD ' ' A' ' 74' ' ' MET . 11.0 tmm? -56.96 -11.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 73' ' ' ALA . 47.0 t -63.14 -44.17 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.29 0.567 . . . . 0.0 111.394 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.05 -32.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.442 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.477 ' CE3' ' N ' ' A' ' 78' ' ' LEU . 9.9 t90 -61.22 -53.17 60.31 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.588 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' CE3' ' A' ' 77' ' ' TRP . 20.9 tp -58.31 -53.67 55.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -43.82 -46.07 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.667 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -80.71 -27.31 36.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.01 -60.84 3.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.004 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -73.47 -55.69 6.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -66.93 -45.48 77.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.04 93.51 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 88' ' ' THR . 80.8 t -69.91 -53.18 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.531 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -47.6 -25.71 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 109.948 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 tp -78.09 -39.67 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.32 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 73.4 p -54.58 -29.52 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.355 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.44 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.5 OUTLIER -70.77 -52.46 20.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.856 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.09 -32.61 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -75.22 -34.97 61.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.772 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 17.6 p -72.05 -47.75 49.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -53.62 -53.87 45.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.554 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.72 -43.97 97.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.617 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.47 -38.72 69.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.203 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.55 -9.46 27.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.353 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 32.5 t80 -130.97 79.23 71.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.83 111.93 3.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.53 2.154 . . . . 0.0 111.9 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t -160.84 75.71 2.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.574 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.8 114.48 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.636 2.224 . . . . 0.0 112.043 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.14 -44.42 97.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.63 35.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.6 m 52.0 84.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.593 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 p -101.58 53.49 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.49 87.19 2.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.07 92.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.58 ' C ' ' H ' ' A' ' 109' ' ' ARG . 22.9 ptt? -101.98 164.52 11.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 49.0 t 58.31 -1.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.58 ' H ' ' C ' ' A' ' 107' ' ' MET . 45.4 ttt-85 -100.2 102.47 13.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.591 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.421 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -109.73 158.88 33.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.268 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.76 130.06 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.709 2.272 . . . . 0.0 111.802 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.73 -17.27 32.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.653 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -85.09 -6.21 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 110.36 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.65 ' C ' ' H ' ' A' ' 116' ' ' LEU . 12.0 mt -120.35 83.41 33.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.41 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 39.1 Cg_exo -54.0 11.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.79 2.326 . . . . 0.0 112.802 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.65 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.1 mt -75.16 -29.15 60.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.542 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 1.1 t70 -96.24 -40.22 9.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.805 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -67.87 -40.61 83.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.41 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.4 t90 -81.67 -16.02 52.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.45 74.15 20.2 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.68 -17.27 11.22 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.856 2.371 . . . . 0.0 111.841 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -51.71 -52.44 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 m -112.66 60.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.641 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.542 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 2.0 t80 -164.92 -40.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.329 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.4 125.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.81 146.56 23.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' LYS . 16.2 p -155.1 144.79 21.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.88 -175.71 38.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.477 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.1 m-20 -84.64 144.76 28.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.744 0.307 . . . . 0.0 110.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.59 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 32.8 m -92.72 132.65 36.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.963 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 130' ' ' CYS . . . 89.88 -3.27 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.452 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.92 128.3 36.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.826 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -76.93 134.95 38.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -128.06 -19.63 3.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.586 ' NE1' ' SD ' ' A' ' 142' ' ' MET . 6.7 p90 -172.95 149.6 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.228 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.11 166.89 24.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.28 0.562 . . . . 0.0 111.87 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -122.8 138.41 54.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.38 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.57 17.04 0.51 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.411 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.2 21.65 44.51 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.0 mt -126.34 137.67 53.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 143.7 55.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.25 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.586 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -48.1 -53.36 33.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.3 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.3 Cg_exo -40.95 -35.81 1.85 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.33 2.02 . . . . 0.0 111.863 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 -71.71 -49.64 37.6 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.619 ' O ' ' N ' ' A' ' 148' ' ' GLY . 79.5 m95 -59.17 -56.73 18.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.908 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -43.91 -38.54 3.45 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -35.19 72.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.08 -47.04 93.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 149' ' ' ILE . 1.7 mp -65.96 -43.67 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.04 -40.27 30.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.3 mt -65.38 -38.51 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.715 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.99 -49.71 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.991 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.08 -45.71 93.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.563 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 13.2 tp -47.97 -32.64 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.391 0.615 . . . . 0.0 109.844 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.0 mt -83.0 -37.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.292 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' A' ' 160' ' ' VAL . 53.0 t -52.61 -46.35 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' CB ' ' CE2' ' A' ' 77' ' ' TRP . . . -79.88 -44.17 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.548 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 43.0 t -50.16 -40.66 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.11 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.24 -42.15 14.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.477 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.423 ' O ' ' OG ' ' A' ' 163' ' ' SER . 55.6 t -64.68 -38.26 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.208 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.539 ' O ' ' NH2' ' A' ' 70' ' ' ARG . 63.8 t -71.75 -53.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 109.945 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.502 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -66.46 -5.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.579 ' HG ' ' NH2' ' A' ' 70' ' ' ARG . 66.7 p -52.46 -13.71 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.185 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 162' ' ' ILE . 13.1 mt-30 -40.46 154.29 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.218 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 167' ' ' LYS . 13.0 Cg_endo -57.24 -14.97 16.9 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.39 2.06 . . . . 0.0 111.934 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 166' ' ' PHE . 31.8 t80 40.39 27.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.654 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . 10.2 mtpt 55.21 89.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.408 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -147.59 -149.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 168' ' ' ALA . 17.9 mttm 60.48 129.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.528 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -101.78 -6.07 24.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.542 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.97 138.3 6.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.27 155.43 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.566 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.6 mp -100.44 -130.7 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.523 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 55.03 107.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.55 3.03 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -74.03 94.58 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.28 92.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -160.27 -10.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.48 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -64.24 -5.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -167.49 68.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.543 ' CG ' ' N ' ' A' ' 182' ' ' HIS . 2.0 p80 -62.96 -136.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.557 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.543 ' N ' ' CG ' ' A' ' 181' ' ' HIS . 13.6 t60 -158.58 -62.94 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.012 -0.995 . . . . 0.0 110.61 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' UQ2 . . . . . 0.407 ' O2 ' H3M3 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.8 mm? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -54.25 -36.42 63.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLN . 43.2 m-85 -72.25 -44.31 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.57 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -45.69 -42.9 12.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 110.095 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -68.33 -25.4 65.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.19 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.4 tp-100 -78.79 -48.77 14.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.42 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 11' ' ' GLY . 39.1 p -76.7 -41.02 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -69.03 6.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.139 0.495 . . . . 0.0 110.304 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.21 140.8 15.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -68.9 -49.2 60.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.846 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.95 -46.07 6.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.12 85.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.114 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -56.88 -47.1 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.55 -27.94 68.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.14 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.24 -36.41 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 mmt -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.202 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.11 73.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.909 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.08 -34.14 73.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.978 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 m -59.68 -58.98 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.626 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.17 -25.67 65.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -77.33 -42.11 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.279 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 28' ' ' THR . . . -61.39 -24.34 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.19 -45.4 10.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.454 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.0 -37.74 88.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.756 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.69 -51.42 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.925 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 24' ' ' ALA . 5.6 p -47.25 -37.15 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.91 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.815 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.1 -15.83 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.438 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.3 t-105 -94.46 -33.4 13.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.545 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -38.45 79.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.482 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -72.13 -39.2 68.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.579 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -8.42 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' TRP . 78.9 t -108.99 -46.48 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 mmt -96.2 14.43 24.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.744 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt 43.01 42.63 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.7 mt -70.01 154.98 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.115 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -111.56 103.28 54.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.108 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -52.1 167.84 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.154 1.903 . . . . 0.0 111.545 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.8 175.4 9.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.5 t -61.7 -48.31 89.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 9.8 mp -61.34 -45.51 94.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.14 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -49.09 -44.73 42.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.429 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 124' ' ' PHE . 69.6 mt -61.45 -43.82 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.094 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -47.11 73.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.597 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.397 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' NH2' ' CD1' ' A' ' 52' ' ' PHE . 3.8 tmt_? -62.63 -37.66 87.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.548 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.34 78.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -59.13 -48.36 81.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.817 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.8 tp -79.56 -50.3 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CD1' ' NH2' ' A' ' 48' ' ' ARG . 66.2 t80 -46.23 -41.48 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.759 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.93 -44.2 89.47 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 50' ' ' ALA . 47.5 t -62.61 -47.3 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.3 tp -44.62 -48.09 10.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.523 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.08 92.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.86 63.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.446 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.72 76.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.352 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.0 -27.09 54.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.45 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.9 mt -81.8 -43.48 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.397 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.79 -32.94 78.85 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.85 4.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.715 0.293 . . . . 0.0 110.944 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.7 mt -83.33 -26.49 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.67 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB1' ' OG1' ' A' ' 67' ' ' THR . . . -173.23 65.48 0.33 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.433 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.16 11.14 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.648 2.232 . . . . 0.0 112.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -111.04 -6.47 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.25 161.89 24.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.639 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -38.16 -16.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.554 2.169 . . . . 0.0 112.287 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.4 tp -43.22 -31.47 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -40.79 -65.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.583 ' O ' HG13 ' A' ' 75' ' ' VAL . 6.7 m-85 -55.69 -29.89 60.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 75' ' ' VAL . 12.2 t -67.6 -43.11 87.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.639 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -29.06 30.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.275 0.559 . . . . 0.0 109.955 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.7 ttt -65.25 -12.97 57.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 72' ' ' VAL . 30.3 m -59.71 -37.15 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.524 0.678 . . . . 0.0 110.537 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.411 ' N ' HG23 ' A' ' 75' ' ' VAL . 8.3 mt -89.27 -30.05 5.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.215 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.472 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 2.5 t-105 -68.6 -49.72 57.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.995 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 78' ' ' LEU . 3.9 tt -66.53 -50.61 62.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.0 m-85 -43.69 -39.98 3.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -79.71 -23.81 42.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.75 -61.77 2.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.804 0.335 . . . . 0.0 111.159 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -51.95 12.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.085 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HE ' HD23 ' A' ' 87' ' ' LEU . 5.3 tpm_? -68.51 -47.87 65.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.656 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.92 -46.11 92.87 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.965 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.41 -37.69 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.796 -0.238 . . . . 0.0 111.472 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -67.98 -25.41 65.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.549 HD23 ' HE ' ' A' ' 83' ' ' ARG . 3.6 mm? -90.21 -35.36 15.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.892 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.6 p -57.33 -52.53 64.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -48.93 -49.85 38.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.376 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -51.91 -42.73 62.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -67.04 -34.49 77.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -74.48 -29.92 61.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.571 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.4 mmt -64.24 -41.18 97.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.356 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.72 -51.15 61.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.431 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.572 0.225 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -125.22 -5.7 7.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -123.02 81.58 50.88 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 36.1 Cg_exo -56.55 15.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.351 . . . . 0.0 112.671 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.616 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -76.28 -32.35 58.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.013 0.435 . . . . 0.0 110.253 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 1.1 m-20 -98.4 -40.28 8.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.347 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.24 -45.35 63.44 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.018 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 9.9 t-105 -76.76 -10.37 59.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.39 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.02 68.99 35.47 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.75 -15.44 12.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.867 2.378 . . . . 0.0 111.668 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -53.08 -32.15 45.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.627 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 44.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.622 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -148.57 -36.87 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.436 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.2 p -58.73 127.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.694 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.27 152.91 18.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.31 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -155.08 102.39 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.14 -168.07 19.38 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.3 154.1 19.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.631 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 36.3 m -99.01 138.78 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 111.204 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 101.04 -5.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.634 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.84 149.22 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -98.86 122.58 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.735 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.55 -29.76 9.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -173.68 146.54 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.46 158.08 44.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.293 0.568 . . . . 0.0 112.106 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 13.4 m-85 -112.89 137.71 50.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.175 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.7 mm? 48.61 17.44 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.425 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.62 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 92.61 22.3 29.18 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.223 -0.513 . . . . 0.0 111.995 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 139' ' ' GLY . 2.1 mm? -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 5.2 mp0 -72.41 146.56 46.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.3 mtt -47.24 -56.42 12.43 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -40.95 -38.58 2.94 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.565 2.176 . . . . 0.0 112.672 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -70.14 -51.8 28.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.9 m95 -58.79 -56.64 19.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.9 tp -43.69 -38.29 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.1 tt -59.54 -36.82 76.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.98 -46.48 94.5 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.7 mt -75.09 -25.63 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.015 0.436 . . . . 0.0 110.061 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -63.36 -44.03 95.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.765 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 151' ' ' ILE . 4.8 tt -70.23 -36.83 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.578 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -56.0 -48.75 75.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.55 -40.42 94.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.686 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 81' ' ' ALA . 86.7 mt -64.36 -32.42 74.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.41 -29.65 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 160' ' ' VAL . 43.1 t -63.38 -40.14 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.34 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -70.08 -50.03 45.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 154' ' ' LEU . 92.4 t -51.62 -39.25 23.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.1 tp -81.18 -37.35 28.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.14 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.5 t -71.0 -22.48 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.795 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 157' ' ' ALA . 61.6 t -83.12 -48.29 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.0 110.24 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 162' ' ' ILE . 81.5 mt -69.16 -14.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.385 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 tp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.821 0.343 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -49.64 -48.91 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.404 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -52.83 -45.6 67.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.277 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tp -48.78 -43.76 38.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.126 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -69.56 -26.36 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.076 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -75.96 -50.49 14.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.28 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.81 70.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' GLY . 50.4 p -76.85 -41.57 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -68.28 5.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.419 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.75 140.98 15.12 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -70.19 -49.9 45.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.615 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.73 -46.42 5.91 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.45 89.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -61.58 -37.17 82.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.05 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.1 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.138 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' THR . 6.8 tp -70.31 -30.0 66.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.752 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.423 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.2 mtp -73.41 -33.69 65.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.89 -55.3 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.53 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -47.03 -47.92 22.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 17' ' ' LEU . 31.5 p -53.48 -58.02 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.379 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.14 -34.65 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.8 tp -76.32 -41.97 46.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.21 -32.14 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.293 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.57 -37.32 42.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.13 -52.84 62.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.821 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.26 -50.24 74.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.747 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 24' ' ' ALA . 17.1 p -48.59 -44.06 36.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.861 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.34 -46.21 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.034 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -53.15 -19.57 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.534 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -92.27 -39.41 11.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.61 -30.85 14.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -83.77 -42.1 16.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.011 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.414 ' CE1' HD12 ' A' ' 30' ' ' LEU . 36.0 m170 -69.09 -14.49 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 36' ' ' MET . 9.2 p -109.11 -39.22 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.899 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.445 ' N ' HG13 ' A' ' 35' ' ' VAL . 1.1 tpt -97.23 11.55 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.867 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.2 mp 43.85 44.97 6.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.199 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 134' ' ' GLN . 5.3 tp -77.6 153.0 33.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -108.78 129.85 23.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.691 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.27 169.17 21.8 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.468 2.112 . . . . 0.0 112.184 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.95 159.57 38.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.561 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -50.82 -42.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.155 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.88 -45.13 87.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -51.08 -42.83 60.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 124' ' ' PHE . 33.3 mt -66.21 -43.1 92.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.241 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -58.85 -44.91 91.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.757 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.07 -49.7 76.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -59.11 -30.09 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.131 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.98 82.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.347 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -57.43 -49.73 75.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.649 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.07 -49.27 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -46.1 -41.34 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.98 -42.39 92.68 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.5 t -64.97 -47.61 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 109.975 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 tt -45.21 -44.87 11.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.654 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -37.01 94.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -63.97 -37.88 89.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.2 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.73 -34.17 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.31 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -75.72 -27.14 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.186 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.39 -40.43 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.64 -26.81 73.46 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.96 9.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.662 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.2 mt -82.08 -39.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.63 74.38 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 0.0 110.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.31 26.8 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.701 2.267 . . . . 0.0 112.086 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -108.13 -9.02 15.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.309 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.564 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.8 175.85 1.71 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.686 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.65 -4.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.239 1.96 . . . . 0.0 112.047 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.8 mt -47.98 -35.45 10.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 58.8 mtt180 -40.83 -70.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.429 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.9 t80 -49.61 -20.22 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.171 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 69' ' ' LEU . 9.8 t -83.38 -46.56 18.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.806 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.85 -38.85 64.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 110.928 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -61.16 -9.51 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.86 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 8.0 t -57.87 -41.4 79.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.323 0.582 . . . . 0.0 109.989 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.7 -32.62 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.549 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.2 t-105 -65.15 -51.68 59.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.7 tp -65.73 -47.52 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -44.07 -43.58 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.231 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 p -78.74 -21.0 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.718 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.57 ' HA ' HD22 ' A' ' 154' ' ' LEU . . . -60.46 -60.51 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.853 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -73.75 -55.12 6.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.178 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -65.57 -44.71 85.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 88' ' ' THR . . . -61.48 -45.49 96.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.426 -0.892 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 81' ' ' ALA . 66.1 t -73.18 -44.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.692 0.282 . . . . 0.0 111.622 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -61.03 -41.62 96.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.305 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.2 -45.37 48.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 84' ' ' GLY . 8.7 p -48.68 -49.36 38.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.659 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -52.0 -38.5 57.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -56.88 -42.23 79.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -68.01 -37.55 81.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.434 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -67.27 -41.44 85.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ttt -53.48 -48.45 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.12 -46.85 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.142 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.132 179.724 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -110.26 -0.21 17.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.603 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 tp -126.46 77.49 72.91 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.139 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 42.2 Cg_exo -53.03 4.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.787 2.325 . . . . 0.0 112.436 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 114' ' ' LEU . 7.8 tp -61.38 -33.61 73.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.174 0.511 . . . . 0.0 109.978 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.53 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.3 OUTLIER -97.33 -43.88 7.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.528 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -66.95 -45.43 77.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.773 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -75.52 -11.75 60.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 70.51 46.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.7 -17.83 10.87 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.85 2.367 . . . . 0.0 111.884 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -57.44 -35.79 70.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.054 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.28 50.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.647 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.657 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -159.54 -35.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 125' ' ' VAL . 14.7 p -54.58 127.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.501 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.8 149.12 21.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -164.19 117.67 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.703 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.93 -169.28 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 11.9 t70 -93.94 163.29 13.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 61.5 m -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.53 -4.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.56 128.52 36.76 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.759 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.472 ' H ' ' CD ' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -62.24 111.8 2.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.196 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.611 ' HB3' HD11 ' A' ' 38' ' ' LEU . 61.3 mt-30 -111.53 -31.31 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.823 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -172.73 141.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.055 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -146.9 160.99 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.225 0.535 . . . . 0.0 111.897 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -122.84 139.51 53.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.942 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.08 17.52 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.823 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 22.61 51.01 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.26 135.41 52.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.837 0.351 . . . . 0.0 110.108 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.22 148.42 49.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.423 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 6.5 mtt -45.64 -60.33 3.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.35 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.5 Cg_exo -35.98 -37.62 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.68 2.253 . . . . 0.0 112.5 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -70.94 -50.46 34.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.014 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.596 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.8 m95 -60.81 -56.85 16.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.842 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.35 -35.6 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.248 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 tp -65.4 -33.87 76.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.46 -46.78 93.71 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.18 -38.8 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.686 ' CE2' HD11 ' A' ' 154' ' ' LEU . 26.2 t80 -50.88 -44.06 59.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.733 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.21 -40.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -55.72 -47.77 76.33 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.693 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.24 -46.2 88.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.04 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 150' ' ' PHE . 83.1 mt -61.7 -40.25 94.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.51 -40.38 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.464 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 152' ' ' ALA . 29.6 t -52.46 -43.29 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.397 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.81 -45.35 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 74.7 t -48.82 -36.78 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.937 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.09 -33.11 33.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.983 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 156' ' ' VAL . 91.7 t -76.32 -26.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.917 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.64 -50.54 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.68 -22.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.786 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.789 0.328 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -58.32 -38.74 77.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' GLN . 32.9 t80 -69.42 -47.58 63.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -46.12 -40.03 10.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.338 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.14 -22.11 63.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.211 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' PHE . 17.4 tp60 -80.03 -47.4 14.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.58 88.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' GLY . 92.5 p -76.82 -38.89 53.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.509 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 25.6 tt0 -64.94 2.5 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.93 146.63 18.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 12' ' ' ARG . 4.7 ptm180 -67.89 -48.33 66.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.559 0.219 . . . . 0.0 110.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -45.73 6.07 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.09 -47.53 84.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -59.79 -39.26 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.091 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.029 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -70.05 -33.22 71.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.714 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.2 mtt -70.68 -33.93 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.6 -51.6 40.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.581 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.94 -34.21 62.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.7 m -63.34 -57.0 11.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.703 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -22.95 63.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.75 -42.06 16.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.417 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -41.71 60.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.838 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.9 mp -72.06 -33.69 68.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -62.05 -42.83 99.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.428 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.21 -40.9 51.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.4 m -54.68 -45.88 74.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.585 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.86 64.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.547 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 tp -65.49 -20.69 66.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.729 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.62 -41.41 11.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -51.35 -38.41 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -71.16 -38.85 72.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.324 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.98 -6.79 52.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.848 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.34 -47.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.0 mtt -97.52 11.62 36.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 tp 46.48 48.25 13.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.616 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.1 mt -84.56 152.9 23.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -117.32 133.08 23.24 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.82 176.88 9.48 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 111.953 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.457 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 8.3 t -131.9 177.79 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.68 -46.07 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.95 -48.82 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.373 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -48.78 -48.33 41.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.657 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.64 -41.46 90.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -55.17 -47.73 74.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -63.08 -38.24 90.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -63.69 -36.77 84.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -40.59 77.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.35 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 tp -73.31 -53.08 11.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.05 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -45.06 -38.69 5.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.813 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.84 -42.55 94.98 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 43.5 t -60.61 -46.97 94.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.98 -46.68 11.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.62 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.2 -28.76 72.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.63 -38.8 70.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.299 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.73 76.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.019 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.418 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 4.3 mt -73.76 -28.11 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.14 -39.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.12 -21.44 78.41 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.48 7.79 5.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.715 0.293 . . . . 0.0 110.892 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.3 mp -84.03 -35.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.57 71.61 0.27 Allowed Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.07 13.53 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.514 2.143 . . . . 0.0 111.827 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -106.68 -8.86 16.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.05 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.99 161.94 25.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.607 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -39.9 -14.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.479 2.12 . . . . 0.0 112.207 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -42.39 -34.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.639 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtt180 -37.94 -63.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 75' ' ' VAL . 67.4 t80 -51.63 -31.12 24.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.842 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 69' ' ' LEU . 11.3 t -69.32 -45.44 79.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.947 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.89 -33.2 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.196 0.522 . . . . 0.0 110.317 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.467 ' O ' ' SD ' ' A' ' 74' ' ' MET . 2.8 tmm? -63.21 -14.52 50.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.026 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 71' ' ' TYR . 94.3 t -57.52 -39.11 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.52 0.676 . . . . 0.0 110.524 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.36 -31.49 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.4 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 9.0 t-105 -65.94 -54.33 27.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.174 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' ALA . 14.9 tp -63.67 -47.68 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -42.79 -42.94 3.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.381 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.8 p -78.11 -23.21 47.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.12 -60.03 4.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.361 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -49.97 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.681 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -39.0 69.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.703 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.13 -48.29 86.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 86' ' ' GLN . 14.2 m -72.85 -48.33 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.595 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.58 ' N ' HG23 ' A' ' 85' ' ' VAL . 14.6 tm0? -48.46 -29.06 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.09 -42.1 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.254 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 62.9 p -50.94 -31.03 16.44 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.38 -51.5 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.873 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.07 -36.76 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -71.63 -39.27 70.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -73.44 -52.17 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ttp -51.96 -52.94 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.12 -48.74 75.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.217 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.52 0.2 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' A' ' 113' ' ' TRP . 2.1 p-90 -122.09 9.87 9.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 116' ' ' LEU . 50.1 mt -122.01 81.04 42.95 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.271 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.1 Cg_exo -51.94 0.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.233 . . . . 0.0 112.267 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 mt -60.69 -32.23 71.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.429 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 27.9 p-10 -96.82 -41.3 8.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.625 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 35.4 tttm -71.69 -45.19 62.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.732 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -74.27 -16.79 60.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.532 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.8 71.96 29.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.983 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.51 ' O ' HG22 ' A' ' 125' ' ' VAL . 67.5 Cg_endo -78.1 -18.37 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.683 2.255 . . . . 0.0 111.861 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -50.14 -52.52 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.83 54.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.565 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -154.97 -40.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.322 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 121' ' ' PRO . 34.1 m -57.2 130.5 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.642 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.87 149.53 21.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -161.27 99.86 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.401 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.75 -177.32 20.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.457 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 44.4 t0 -91.4 157.05 17.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.54 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.7 m -103.51 131.25 50.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.123 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.02 -5.36 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.197 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.03 151.7 45.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.045 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -89.69 147.59 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -133.88 -31.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.459 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -174.89 143.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -132.97 164.15 27.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.769 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.21 118.01 9.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.283 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.81 16.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.4 10.63 79.56 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.1 mt -119.5 138.03 53.42 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.867 0.365 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.83 154.0 42.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.6 mtp -55.72 -50.25 88.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.584 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 55.4 Cg_exo -48.32 -38.8 34.71 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.446 2.098 . . . . 0.0 112.088 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -70.03 -42.51 72.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.524 0.678 . . . . 0.0 109.87 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.552 ' O ' ' N ' ' A' ' 148' ' ' GLY . 47.6 m95 -60.03 -56.15 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.222 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.9 tp -43.39 -42.76 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 143' ' ' PRO . 1.1 mt -56.91 -35.54 69.12 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.6 -44.28 96.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.835 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.81 -29.67 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.337 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 -44.78 88.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.987 0.422 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.4 -39.83 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.07 64.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.482 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.3 m-85 -52.91 -42.84 65.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 154' ' ' LEU . 0.8 OUTLIER -75.06 -29.43 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.247 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mt -70.83 -31.21 44.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.322 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 160' ' ' VAL . 16.0 m -78.25 -38.71 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.551 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.27 -54.23 40.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 159' ' ' LEU . 7.8 p -55.68 -45.22 79.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.545 ' N ' HG13 ' A' ' 158' ' ' VAL . 5.1 tp -63.23 -37.8 88.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 156' ' ' VAL . 47.7 t -71.49 -30.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.2 t -69.9 -50.16 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.999 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.18 -31.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.408 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -56.68 -38.58 72.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.298 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLN . 8.6 t80 -66.13 -47.36 74.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.176 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.44 -38.03 8.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -67.86 -21.28 65.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.068 0.461 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' PHE . 30.9 tt0 -81.71 -46.45 14.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.26 84.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.2 m -76.95 -34.43 57.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 20.6 tt0 -67.95 3.16 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.54 146.87 18.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -69.97 -48.82 56.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.739 0.304 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.23 -45.84 6.47 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.83 -48.07 80.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -56.26 -47.86 77.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -27.32 68.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -69.8 -29.24 66.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.625 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.73 -34.09 60.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.232 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.9 26.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.887 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -54.45 -49.02 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -46.58 -58.65 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.553 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.31 -29.39 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.31 -39.44 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.711 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.81 62.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.638 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.1 mt -74.11 -37.92 64.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.63 -50.54 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -57.93 -43.84 86.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -59.47 -43.64 93.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.39 -29.26 62.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -67.95 -21.62 65.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.688 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -88.0 -42.38 12.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -51.59 -39.94 58.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.124 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -71.51 -37.23 71.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 39.3 m80 -75.85 -10.55 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.18 -47.96 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -94.08 11.9 28.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.896 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tp 44.65 44.26 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.14 148.18 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.472 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -109.67 130.33 22.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.8 Cg_endo -76.35 174.36 12.95 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.288 1.992 . . . . 0.0 111.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -131.85 -178.5 4.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.93 -45.22 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.917 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 43' ' ' LEU . 8.6 mp -76.07 -42.8 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.844 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 m -58.84 -51.9 68.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 124' ' ' PHE . 13.3 tt -64.81 -36.07 76.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.996 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.07 -46.68 85.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.788 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.67 -37.14 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.294 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.3 -33.83 74.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.319 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.55 76.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.493 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.81 73.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.92 -45.45 58.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.38 -40.27 11.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.688 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.39 79.91 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 47.3 t -62.25 -47.99 90.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.078 0.466 . . . . 0.0 109.937 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -45.11 -44.63 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.83 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -29.62 75.81 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -65.17 -37.42 87.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.11 -27.18 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.736 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -70.12 -39.94 75.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.596 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 60' ' ' ILE . 15.7 pt -82.49 -31.94 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.14 -31.44 69.23 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.86 7.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 mp -83.8 -26.98 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.76 71.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -68.35 17.44 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.338 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 64' ' ' ALA . 59.6 mttt -112.2 -4.14 14.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.41 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -112.06 160.46 29.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.611 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -37.72 -16.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.556 2.171 . . . . 0.0 112.048 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.6 tp -43.13 -33.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -40.12 -67.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.522 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.64 -33.05 53.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.604 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.5 t -65.89 -55.85 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.617 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.93 74.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.236 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.9 mmt -61.79 -12.19 15.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.26 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.0 p -63.15 -31.51 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.469 0.652 . . . . 0.0 110.069 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.08 -30.64 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.606 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.487 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.3 t-105 -65.68 -49.68 67.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.806 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.72 -44.36 77.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.418 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -46.92 -45.28 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.4 p -78.17 -21.96 49.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.02 -59.5 5.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.016 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.5 -53.07 10.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.6 ttt85 -66.89 -45.68 77.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.64 -47.1 91.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 81' ' ' ALA . 59.8 t -69.81 -47.26 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 90' ' ' GLU . 25.1 mm-40 -52.98 -21.46 4.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.151 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -40.53 12.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.454 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 92' ' ' THR . 24.5 p -53.07 -26.01 14.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.532 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.72 -44.79 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.469 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 5.2 mp0 -56.22 -46.64 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.395 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -61.51 -50.06 74.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.363 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 88' ' ' THR . 60.7 p -59.3 -50.56 73.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.5 ttt -53.95 -49.36 68.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.54 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.57 -48.0 82.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.264 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.738 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.556 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.73 0.01 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.238 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.578 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 mt -117.63 83.54 17.73 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.256 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -50.38 -0.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.688 2.258 . . . . 0.0 112.403 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.2 mp -62.66 -30.41 71.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 -39.82 9.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.672 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.67 -45.46 52.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.424 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 10.3 t-105 -73.64 -17.95 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.449 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.63 72.57 24.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.783 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.569 ' O ' HG22 ' A' ' 125' ' ' VAL . 70.8 Cg_endo -78.84 -17.54 12.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.662 2.241 . . . . 0.0 111.688 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -54.32 -52.59 61.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.863 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.07 55.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.745 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.424 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -157.93 -41.1 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.363 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 121' ' ' PRO . 35.4 m -60.61 131.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.17 157.91 16.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' PRO . 47.9 p -164.87 99.82 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.564 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.12 -176.93 21.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 23.8 m-20 -84.55 156.57 21.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.798 0.332 . . . . 0.0 110.381 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -105.09 130.25 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.792 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.55 -6.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.889 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.71 151.97 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.896 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.718 ' HE ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -91.6 135.73 33.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 0.0 110.997 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -126.73 -24.4 3.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.25 141.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.7 163.35 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 112.23 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -130.83 139.61 50.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.8 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.3 17.13 3.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.5 19.95 61.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mt -122.7 134.48 54.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.922 0.391 . . . . 0.0 110.364 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.58 150.98 45.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.514 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.402 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.9 mtt -48.81 -55.18 21.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.765 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.6 Cg_exo -40.94 -37.98 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.379 2.052 . . . . 0.0 112.028 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -70.53 -50.91 32.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.253 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.0 m95 -59.66 -57.25 13.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.487 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.733 HD13 ' C ' ' A' ' 146' ' ' LEU . 3.0 tm? -43.53 -41.76 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.4 tt -55.53 -36.86 67.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.96 -40.83 93.85 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.728 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.2 mp -79.61 -26.55 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.192 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.14 -50.2 71.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.273 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 152' ' ' ALA . 7.7 tt -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.593 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.437 ' N ' HG23 ' A' ' 151' ' ' ILE . . . -50.28 -47.29 55.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.237 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.65 -45.91 73.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.5 mt -58.2 -30.54 66.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.832 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.54 -27.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.706 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 160' ' ' VAL . 95.8 t -71.45 -36.19 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.976 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.487 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.25 -52.74 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.544 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 154' ' ' LEU . 86.2 t -52.75 -38.76 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.627 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 3.7 mm? -81.71 -32.35 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.118 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.3 t -76.5 -22.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.8 t -80.63 -50.56 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 109.945 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -68.81 -17.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.55 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 90.8 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.521 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.5 tt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -46.8 -36.42 7.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.561 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -39.72 75.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -50.34 -44.16 54.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.305 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.84 -25.78 66.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.191 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -78.69 -46.78 18.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.8 76.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -76.62 -31.62 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.956 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 66' ' ' LYS . 17.5 tp60 -75.15 7.68 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.015 0.436 . . . . 0.0 110.462 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.17 145.58 17.02 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.06 -20.35 65.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.312 . . . . 0.0 110.601 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.59 58.48 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.43 67.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -55.98 -46.15 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.225 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.17 -31.66 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.523 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -32.45 71.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.3 mtt -69.85 -34.57 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.459 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.87 59.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.733 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -50.23 -51.05 47.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -52.32 -56.66 13.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.04 -31.24 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.88 -40.85 24.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.803 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.44 -44.56 17.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.706 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.4 mp -68.14 -25.4 65.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.02 -39.48 75.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.801 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -77.95 -47.34 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -50.23 -45.94 54.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.96 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.65 -20.99 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.829 0.347 . . . . 0.0 110.697 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -90.12 -22.14 21.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.5 -38.22 71.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.244 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 0.36 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.224 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -120.84 -49.35 2.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.46 -37.59 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.894 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.528 ' SD ' ' CZ3' ' A' ' 135' ' ' TRP . 15.8 ttt -109.81 13.54 23.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.6 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 37' ' ' LEU . 6.5 mp 42.36 37.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.51 149.69 43.88 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.657 ' HZ2' ' HB3' ' A' ' 39' ' ' LYS . 4.1 mtpm? -110.34 125.76 30.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.15 145.99 19.69 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.429 2.086 . . . . 0.0 111.891 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -101.06 -174.99 2.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.708 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.77 -46.73 91.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.08 -47.03 88.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -51.49 -44.49 62.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 124' ' ' PHE . 71.3 mt -61.42 -48.13 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.487 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 11.1 t80 -54.65 -44.99 73.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.728 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.52 -48.19 73.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.663 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -60.04 -38.21 82.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.73 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.2 90.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.507 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.03 76.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.405 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -73.41 -48.39 34.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.13 -42.24 19.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.8 -45.65 81.96 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 56.1 t -62.24 -45.81 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.135 0.493 . . . . 0.0 109.749 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 tp -44.2 -48.59 9.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.352 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.95 97.52 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -56.54 -37.87 71.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.46 . . . . 0.0 110.295 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.54 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.327 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -70.23 -44.73 67.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -73.52 -35.32 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -31.08 68.27 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.75 5.5 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.694 0.283 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 90.2 mt -79.18 -42.57 23.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.07 77.23 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.343 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.88 30.87 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.718 2.279 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HB2' HE21 ' A' ' 10' ' ' GLN . 4.3 tmmm? -110.54 -9.82 14.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.127 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -108.83 176.21 1.66 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.889 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -6.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.126 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 67' ' ' THR . 37.7 mt -53.47 -28.1 28.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -40.76 -70.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -54.95 -30.52 59.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.413 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 75' ' ' VAL . 9.3 t -67.02 -54.48 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.785 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.66 63.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.264 0.554 . . . . 0.0 110.222 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 74' ' ' MET . 6.6 tmm? -59.13 -12.23 4.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.961 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.2 p -62.7 -32.46 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.379 0.609 . . . . 0.0 110.355 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.29 -32.95 5.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.039 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.56 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -66.06 -48.81 69.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.864 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.1 tp -65.9 -48.63 70.83 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -42.42 -42.52 3.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.125 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 84' ' ' GLY . 18.2 p -79.4 -21.38 45.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.89 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.729 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.27 -61.51 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.069 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -71.48 -45.59 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.555 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.487 ' CZ ' ' OH ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -77.54 -41.96 37.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 80' ' ' SER . . . -57.6 -49.63 72.05 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.385 -0.912 . . . . 0.0 110.825 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 81' ' ' ALA . 28.2 m -68.3 -43.25 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.002 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.491 ' N ' HG23 ' A' ' 85' ' ' VAL . 45.9 tt0 -56.64 -31.36 64.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.506 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -77.12 -43.42 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 110.32 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 33.5 p -52.32 -26.69 12.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.288 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.49 -50.02 64.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.641 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -52.19 -41.26 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -62.43 -48.97 77.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.2 p -66.77 -48.95 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.5 ttt -49.96 -49.96 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.02 -47.5 77.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.681 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 2.4 pm0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.63 0.252 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.584 ' O ' HD22 ' A' ' 114' ' ' LEU . 20.9 p-90 -124.71 27.16 6.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.594 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 113' ' ' TRP . 3.1 mm? -122.58 78.15 46.92 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.852 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.24 -3.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.732 2.288 . . . . 0.0 112.266 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.5 mp -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 110.368 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -96.73 -42.98 7.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -70.24 -45.5 66.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.642 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -73.88 -17.14 61.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.17 71.78 33.57 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.26 -17.41 10.38 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.9 2.4 . . . . 0.0 111.785 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -51.89 -52.57 48.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.627 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.8 53.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.558 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.629 ' O ' HD13 ' A' ' 45' ' ' ILE . 1.2 m-85 -155.4 -40.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 125' ' ' VAL . 6.2 p -55.75 128.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.441 ' HA ' HD11 ' A' ' 45' ' ' ILE . . . -95.13 151.0 19.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -169.94 100.59 0.3 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.43 177.88 18.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 11.8 t70 -86.53 138.22 31.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.094 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 37.3 m -92.96 130.66 38.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.45 -7.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.85 147.83 52.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -80.99 132.18 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.422 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.38 -26.33 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.627 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.528 ' CZ3' ' SD ' ' A' ' 36' ' ' MET . 0.6 OUTLIER -175.69 135.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -139.01 167.17 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.158 0.504 . . . . 0.0 111.606 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.26 120.09 10.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.474 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.1 16.91 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.499 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 81.71 16.8 72.12 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.499 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.7 mp -120.85 136.29 54.96 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.76 154.6 41.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.594 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -55.42 -51.57 78.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 142' ' ' MET . 75.5 Cg_exo -45.84 -37.78 17.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.384 2.056 . . . . 0.0 111.785 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -72.88 -48.48 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.819 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 50.2 m95 -57.24 -57.19 13.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.0 tp -44.26 -38.88 4.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.1 tt -55.11 -37.54 67.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.21 -45.56 95.84 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.597 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.7 mp -75.63 -25.67 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 109.908 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.97 -46.32 85.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.5 pt -67.88 -35.77 73.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.385 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.98 -49.48 77.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.343 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.39 -48.37 71.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.717 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.547 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 31.1 mt -62.56 -34.32 76.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.073 0.463 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.9 mt -71.03 -35.56 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.611 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 160' ' ' VAL . 56.1 t -66.57 -42.1 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.321 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.693 ' O ' HG22 ' A' ' 161' ' ' VAL . . . -62.37 -34.21 76.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.3 t -73.35 -25.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.216 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 163' ' ' SER . 13.4 mt -84.83 -40.01 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.335 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 156' ' ' VAL . 34.7 m -73.97 -25.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 157' ' ' ALA . 31.6 m -82.89 -49.37 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.778 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.528 ' N ' HG23 ' A' ' 161' ' ' VAL . 35.1 mm -72.02 -8.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 2.7 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -52.26 -31.91 34.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 7' ' ' GLN . 10.6 t80 -76.26 -42.07 46.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.374 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -46.42 -39.67 10.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 10' ' ' GLN . 8.3 t-20 -66.57 -24.05 66.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.259 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' PHE . 41.9 tt0 -81.02 -45.89 15.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.54 89.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 11' ' ' GLY . 57.4 p -76.29 -37.37 57.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.638 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 6' ' ' ASN . 64.8 mt-30 -67.03 5.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.7 145.59 17.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.45 -48.48 60.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.34 6.05 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.94 81.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.144 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -58.25 -47.36 83.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.29 -28.33 68.01 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -69.55 -29.46 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -32.97 61.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.41 17.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 -52.83 39.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.678 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.0 p -48.26 -57.91 5.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.755 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.31 27.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 tt -81.45 -38.85 25.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.68 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.933 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.0 mp -69.0 -33.14 73.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.715 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -63.38 -41.37 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.1 -50.04 21.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.931 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -47.76 -47.2 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.665 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.95 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.34 -20.44 66.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.4 ' CE2' HG21 ' A' ' 35' ' ' VAL . 60.5 t90 -88.27 -42.77 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -51.61 -46.63 63.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.165 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' C ' ' OE1' ' A' ' 33' ' ' GLN . 0.5 OUTLIER -70.11 -29.01 65.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -68.04 -26.89 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG21 ' CE2' ' A' ' 31' ' ' TRP . 56.7 t -104.8 -53.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.162 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.0 mtt -75.4 3.51 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.17 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt 44.53 47.22 8.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.563 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 38' ' ' LEU . 96.6 mt -77.54 154.67 32.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.569 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -116.1 126.33 27.74 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 174.72 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.246 1.964 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.7 t -131.85 -175.82 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.765 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 40.5 t -64.44 -44.44 97.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.722 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.21 -49.96 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.54 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 9.2 t -49.14 -50.19 38.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.526 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.59 -41.36 89.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.918 0.39 . . . . 0.0 110.186 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -45.26 76.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.742 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -63.93 -35.96 82.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.044 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -65.27 -41.51 94.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.233 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.59 78.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.42 74.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.055 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.3 tp -77.41 -45.91 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.993 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -38.66 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.46 80.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 38.0 t -62.81 -47.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.241 0.543 . . . . 0.0 109.71 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.8 tp -42.87 -47.2 5.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.562 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.4 92.38 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -55.87 -43.57 77.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.17 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.75 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.227 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.68 -43.23 94.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mm -74.38 -43.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.623 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.13 68.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.34 4.36 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.43 -44.74 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.537 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -174.04 74.73 0.36 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.97 18.34 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.666 2.244 . . . . 0.0 112.407 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -104.9 -7.66 19.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.98 176.85 1.33 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.446 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.5 1.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 0.0 111.878 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.3 tp -54.71 -34.89 63.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.639 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' SD ' ' A' ' 74' ' ' MET . 30.9 mtm105 -38.24 -66.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -53.64 -22.1 8.12 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.176 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 75' ' ' VAL . 5.0 t -78.99 -48.26 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.336 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.16 -35.04 56.35 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 110.167 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.611 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.1 OUTLIER -64.83 -9.73 22.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.167 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 72' ' ' VAL . 6.3 p -62.67 -35.38 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.1 mm -87.93 -33.74 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.831 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.574 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 16.7 t-105 -61.1 -50.42 73.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.046 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.93 -45.03 79.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -45.19 -44.87 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -79.89 -23.36 41.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.3 -60.45 3.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.631 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -71.76 -56.32 6.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.169 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -66.39 -51.05 61.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.85 -47.73 52.77 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 81' ' ' ALA . 70.0 t -65.28 -32.05 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.266 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.54 -33.28 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.43 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.96 -40.65 38.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.542 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 46.6 p -52.77 -35.25 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.737 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.42 -52.14 24.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -46.1 -31.05 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.35 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -75.91 -45.56 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.652 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.1 p -67.5 -49.73 62.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.691 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -53.11 28.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.056 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.75 -49.62 72.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.464 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.323 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.758 0.313 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -4.18 58.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.395 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 116' ' ' LEU . 19.9 mt -128.44 80.77 71.88 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.1 Cg_exo -50.71 3.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.815 2.344 . . . . 0.0 112.269 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.2 mm? -57.72 -33.24 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 0.0 109.975 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.556 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -96.73 -45.35 6.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.531 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -65.73 -45.46 82.56 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.331 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 32.6 t-105 -73.75 -14.35 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.83 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 t -142.04 74.87 21.23 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.453 ' O ' HG12 ' A' ' 125' ' ' VAL . 72.8 Cg_endo -80.79 -17.12 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.849 2.366 . . . . 0.0 111.696 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -54.84 -53.76 51.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 123' ' ' VAL . 3.5 p -105.63 60.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.585 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.556 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -164.77 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.385 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 121' ' ' PRO . 13.6 p -62.4 130.22 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.1 157.98 15.98 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.8 p -162.73 99.66 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.499 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 142.84 -173.45 24.03 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 20.8 t70 -93.24 152.99 18.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.892 0.377 . . . . 0.0 110.172 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -104.68 128.59 52.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.54 -10.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.852 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -67.92 147.9 51.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 40.8 ttp180 -89.57 132.81 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.347 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -129.94 -21.47 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.503 ' CE3' ' SD ' ' A' ' 142' ' ' MET . 24.6 t90 -174.05 134.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.976 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -140.94 160.68 39.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.22 0.533 . . . . 0.0 111.914 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.77 140.46 50.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.085 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.68 17.44 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.607 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 87.49 21.82 46.44 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.607 HD22 ' O ' ' A' ' 139' ' ' GLY . 3.0 mm? -123.86 137.93 54.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -71.9 146.95 47.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.561 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.503 ' SD ' ' CE3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -47.39 -57.57 9.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.539 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.1 Cg_exo -38.28 -38.41 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.586 2.191 . . . . 0.0 112.568 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -73.28 -52.23 14.72 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.149 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.572 ' O ' ' N ' ' A' ' 148' ' ' GLY . 66.9 m95 -55.53 -58.0 9.58 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.823 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.1 tp -44.01 -39.36 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.673 HD23 ' O ' ' A' ' 147' ' ' LEU . 2.5 tt -54.96 -36.86 65.77 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.86 -43.37 99.3 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.643 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.94 -25.48 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -65.4 -43.56 90.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.6 pt -67.55 -37.8 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.286 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.88 -50.34 73.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.325 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.468 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 m-85 -54.33 -45.16 72.6 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.859 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.68 ' C ' HD12 ' A' ' 154' ' ' LEU . 0.5 OUTLIER -75.86 -29.72 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.881 -179.163 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.12 -35.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 160' ' ' VAL . 35.7 m -75.24 -35.86 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.75 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.574 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.81 -50.34 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.637 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.87 -48.03 78.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.67 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 156' ' ' VAL . 16.6 t -69.23 -27.12 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.72 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.1 t -80.98 -46.13 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.427 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.6 mm -75.7 -13.99 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.6 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.604 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.721 HD23 ' N ' ' A' ' 2' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.845 0.355 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -55.62 -40.47 72.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.305 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.37 -44.28 91.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.64 -42.16 44.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.309 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 10' ' ' GLN . 49.6 t30 -67.61 -28.14 67.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.915 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -73.04 -50.37 23.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.34 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.3 p -75.99 -35.36 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.588 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.519 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 38.3 mt-30 -74.32 12.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.966 0.413 . . . . 0.0 110.388 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.63 147.94 16.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -70.74 -49.89 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.32 -46.11 6.67 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.44 90.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.23 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.415 ' O ' ' HG3' ' A' ' 18' ' ' MET . 8.7 m95 -59.0 -32.03 69.33 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.942 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -74.29 -27.94 60.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -70.69 -36.37 73.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 18' ' ' MET . 1.4 ppp? -72.58 -31.22 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.2 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.2 -47.45 46.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.724 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.8 p -54.6 -62.16 1.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' HD13 ' A' ' 55' ' ' LEU . . . -49.23 -39.75 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.55 -41.47 75.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.07 -36.66 30.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.3 mp -71.71 -36.41 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.77 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.97 -46.29 89.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.116 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.16 -48.85 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.09 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.8 m -46.2 -43.06 14.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.18 53.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.494 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.43 -18.61 64.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.605 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.15 -44.67 52.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.52 -28.02 62.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -70.9 -24.78 62.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 36' ' ' MET . 7.5 p -106.52 -45.07 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.158 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.514 ' N ' HG13 ' A' ' 35' ' ' VAL . 1.2 mtt -83.96 5.07 26.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.86 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 mt 44.82 42.24 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.706 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.9 mt -80.42 153.73 28.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -117.84 130.32 24.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.79 179.39 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.249 1.966 . . . . 0.0 111.759 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.4 t -131.73 -175.49 3.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.402 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 126' ' ' ALA . 54.6 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.918 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -68.05 -50.12 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -49.41 -50.94 38.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.691 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.96 -41.08 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -54.61 -45.73 73.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.96 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.51 -40.21 86.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.161 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.4 HH21 HG12 ' A' ' 123' ' ' VAL . 41.6 ttp85 -57.89 -35.94 71.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.3 -38.31 78.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.472 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.438 HD21 ' HB1' ' A' ' 22' ' ' ALA . 5.2 tp -76.41 -51.07 12.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -46.99 -39.4 12.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -43.83 91.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' CG2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t -65.32 -41.58 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 110.037 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 22' ' ' ALA . 8.5 tp -50.8 -50.44 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.842 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.99 92.7 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.23 -37.29 34.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.975 -0.612 . . . . 0.0 110.218 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.53 -25.45 60.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -72.23 -43.42 64.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.579 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mm -73.64 -30.61 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.04 -26.46 48.78 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.58 -2.96 21.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.66 -20.8 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.502 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 178.86 68.87 0.12 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.75 25.79 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.875 2.384 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -110.27 -6.33 15.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.55 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.13 174.41 2.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.83 -9.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.226 1.95 . . . . 0.0 112.175 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.7 mt -51.32 -30.04 17.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -41.67 -69.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -51.53 -38.61 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.004 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.45 -54.04 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.45 70.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.399 0.619 . . . . 0.0 110.046 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.644 ' SD ' HG21 ' A' ' 161' ' ' VAL . 34.6 ttp -61.21 -25.24 66.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.612 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 71' ' ' TYR . 47.8 t -51.56 -37.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.242 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -85.38 -37.37 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.404 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.723 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 10.7 t90 -57.68 -49.47 76.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.68 -46.89 77.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -46.97 -47.57 21.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.426 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 59.6 p -79.28 -25.61 42.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.35 4.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -52.89 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -65.57 -42.46 91.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.781 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.72 -46.0 93.05 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.3 t -69.89 -54.24 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 111.12 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -47.7 -29.13 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.328 . . . . 0.0 110.743 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tp -85.16 -39.48 17.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.713 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 84' ' ' GLY . 40.7 p -53.18 -23.15 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.3 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -76.15 -40.48 52.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.506 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.35 -39.91 73.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.387 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.1 m170 -69.18 -49.53 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -61.96 -49.92 74.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 17.3 ttt -47.53 -46.71 27.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.635 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.52 -44.29 74.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.671 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.58 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.648 0.261 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.459 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 8.5 p-90 -124.99 -2.95 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.709 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.607 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.82 86.3 19.03 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.873 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.3 Cg_exo -53.76 8.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.646 2.231 . . . . 0.0 112.483 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.5 mm? -73.63 -27.61 61.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.05 0.452 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -96.36 -41.02 8.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -70.59 -45.15 65.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.314 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 3.2 t90 -73.29 -18.1 61.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.54 73.71 20.12 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' O ' HG12 ' A' ' 125' ' ' VAL . 64.2 Cg_endo -78.06 -18.09 13.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.669 2.246 . . . . 0.0 111.802 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -70.69 -11.22 60.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.867 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.4 HG12 HH21 ' A' ' 48' ' ' ARG . 2.9 t -136.41 45.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -38.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 121' ' ' PRO . 7.3 p -58.29 129.74 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -95.48 152.93 17.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.525 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 t -166.01 100.32 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.656 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.67 -176.15 21.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.454 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 31.3 t70 -87.12 147.88 25.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.336 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 11.9 m -99.61 130.09 45.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.814 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.0 -4.56 0.34 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.16 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.98 129.65 40.58 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -66.39 128.72 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -126.03 -25.27 3.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.708 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -174.86 136.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -139.94 161.15 38.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.085 0.469 . . . . 0.0 111.412 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -137.05 119.83 16.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.29 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 2.1 tp 78.63 16.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 83.24 14.84 73.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 139' ' ' GLY . 7.3 mp -119.83 133.19 55.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.746 0.308 . . . . 0.0 110.262 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.559 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.1 mp0 -74.82 156.55 36.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.407 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 6.4 mtm -48.38 -61.39 3.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.6 Cg_exo -35.55 -41.05 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.57 2.18 . . . . 0.0 112.49 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.17 -44.22 60.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.608 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.4 m95 -66.13 -57.89 6.67 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.927 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.65 -38.56 3.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.434 HD13 ' OG1' ' A' ' 88' ' ' THR . 34.1 tp -62.36 -34.3 76.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.04 -49.11 69.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.562 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -66.35 -27.11 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -39.12 90.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.49 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 151' ' ' ILE . 2.4 tt -66.62 -36.58 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.38 -48.89 71.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.75 -41.45 81.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.709 HD12 ' CZ2' ' A' ' 77' ' ' TRP . 10.2 tp -53.96 -30.9 48.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 0.0 109.927 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 40.1 mm -79.63 -32.3 14.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.013 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 160' ' ' VAL . 92.3 t -65.63 -45.86 91.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.924 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.723 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.18 -46.76 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.138 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 159' ' ' LEU . 3.3 p -51.79 -40.61 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.544 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 158' ' ' VAL . 15.7 mt -80.11 -33.13 38.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.171 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.2 t -73.29 -24.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.957 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.644 HG21 ' SD ' ' A' ' 74' ' ' MET . 77.2 t -80.66 -50.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.103 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 162' ' ' ILE . 39.5 mm -71.25 -10.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.483 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.236 179.634 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.861 0.362 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -52.02 -41.41 62.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.193 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' GLN . 22.3 m-85 -63.86 -44.43 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.074 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -45.93 -41.75 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -67.9 -28.68 67.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.003 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' PHE . 5.9 tp-100 -76.03 -50.82 13.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.428 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.86 73.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.2 m -76.64 -42.27 42.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.427 ' O ' ' CD ' ' A' ' 10' ' ' GLN . 1.8 tm0? -66.52 3.3 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.387 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.94 145.07 17.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -68.8 -49.56 57.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.577 0.227 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.54 -46.3 5.69 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.56 85.44 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -58.36 -47.97 82.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.46 -29.36 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -30.93 68.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.47 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 tpt -72.08 -33.56 67.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.154 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.48 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -52.73 -51.35 60.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.667 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 p -51.56 -49.71 61.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.23 72.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.649 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.41 -38.02 77.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.482 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.69 -35.27 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.565 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.9 mt -74.42 -41.21 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.57 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -67.18 -55.48 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.761 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.4 tt -54.86 -53.38 56.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 24' ' ' ALA . 16.9 p -49.31 -45.16 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.07 -43.24 65.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.735 0.302 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -53.76 -20.25 5.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.646 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -91.88 -39.49 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.542 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -48.86 -38.1 21.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.971 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -68.82 -38.58 79.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.77 -5.26 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.3 -46.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.891 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 30.6 mtt -100.81 10.01 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.926 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.95 42.61 28.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -87.69 154.06 20.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -121.09 141.43 32.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.864 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 127' ' ' SER . 88.0 Cg_endo -78.25 171.52 16.88 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 112.283 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.6 t -131.95 -173.67 3.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.405 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.9 t -64.3 -48.77 84.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 4.1 mm? -60.35 -46.88 88.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 41' ' ' CYS . 75.5 p -48.43 -43.97 34.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.333 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.54 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.919 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.53 -48.45 74.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.153 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 43' ' ' LEU . 2.5 mp0 -61.01 -42.73 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 52' ' ' PHE . 33.7 ttt-85 -64.3 -38.31 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.313 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.46 77.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.52 74.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.2 tt -78.35 -51.61 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.406 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 59.8 t80 -43.97 -40.08 4.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.667 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.46 74.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.5 -47.64 90.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.915 0.388 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 19.9 tp -44.53 -50.53 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.84 -49.37 75.1 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -32.7 18.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -67.37 -36.01 80.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.51 -32.03 69.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.595 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.7 mp -77.03 -38.49 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.585 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.76 -19.06 66.49 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.5 27.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.288 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 5.0 pt -83.77 -25.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.712 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.37 73.52 0.1 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.575 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.23 26.31 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.591 2.194 . . . . 0.0 111.96 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -104.66 -8.34 18.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.19 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.666 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.02 -2.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.264 1.976 . . . . 0.0 112.106 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.553 ' H ' ' C ' ' A' ' 67' ' ' THR . 42.9 mt -53.45 -33.85 55.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.549 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.8 ptp180 -40.89 -63.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.642 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.572 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 1.7 t80 -56.59 -29.85 62.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.458 0.572 . . . . 0.0 110.182 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' LEU . 12.5 t -68.22 -45.08 83.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.849 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.79 -32.59 46.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.51 . . . . 0.0 110.174 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 161' ' ' VAL . 29.9 ttp -65.43 -19.4 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.751 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.3 t -54.2 -37.25 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.373 0.606 . . . . 0.0 110.419 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.4 mt -88.72 -31.55 5.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.713 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.548 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -66.76 -46.88 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.482 HD23 ' CG ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -66.5 -48.54 69.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.47 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -44.78 -43.91 8.96 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 p -75.91 -24.15 55.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.555 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.99 -60.25 4.13 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.269 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -73.9 -53.4 10.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -67.91 -43.66 78.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.76 -46.05 95.24 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.91 -41.11 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.97 -45.18 93.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.528 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.98 -42.84 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.038 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 84' ' ' GLY . 4.2 p -48.8 -47.75 41.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.616 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -51.41 -32.37 26.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.404 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -71.01 -36.29 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.66 -36.99 73.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -74.2 -31.87 62.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.492 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 tpt -62.26 -43.14 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.421 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tp -64.2 -49.15 73.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.516 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' CD ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.601 0.238 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.511 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 3.8 p-90 -125.01 30.08 5.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 110.745 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 116' ' ' LEU . 6.5 tp -125.63 68.96 62.23 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.409 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -46.51 -8.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 112.285 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 114' ' ' LEU . 6.7 tp -53.31 -33.7 54.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 110.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.46 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 4.5 m-20 -96.45 -43.76 7.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.209 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.14 -45.28 67.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -73.2 -18.87 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.568 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.56 72.31 25.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.179 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.77 -15.25 9.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.837 2.358 . . . . 0.0 111.538 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -49.22 -48.14 45.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.77 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.91 53.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.46 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 5.7 t80 -156.11 -39.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 125' ' ' VAL . 8.4 p -60.86 130.0 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.66 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.97 150.54 20.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' PRO . 6.4 t -161.52 99.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.53 -172.45 23.02 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.529 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -88.41 151.52 22.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.671 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 12.9 m -103.19 130.3 50.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.21 -9.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.05 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 150.72 47.87 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.976 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -85.9 136.1 33.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.461 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -127.39 -17.62 4.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -172.92 120.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 7.7 t0 -115.04 148.96 38.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.344 0.593 . . . . 0.0 112.28 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.533 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 7.3 t80 -128.57 136.73 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.737 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp 54.27 17.44 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.439 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 88.14 13.02 64.73 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.665 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 139' ' ' GLY . 9.1 mp -121.11 146.82 46.35 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -76.72 151.26 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.44 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 4.0 mmt -48.04 -63.36 1.55 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.3 Cg_exo -32.18 -38.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.938 2.425 . . . . 0.0 112.449 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -69.45 -53.75 17.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.277 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 76.8 m95 -60.17 -57.02 14.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.0 tp -43.73 -37.67 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.88 -34.97 76.98 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.3 -44.57 96.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -76.28 -25.89 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 154' ' ' LEU . 39.7 t80 -62.45 -45.64 92.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.482 ' O ' HD13 ' A' ' 155' ' ' ILE . 15.5 pt -68.82 -38.7 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.479 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -53.73 -48.19 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.362 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.34 -41.67 94.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 150' ' ' PHE . 37.6 mt -69.29 -30.62 68.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.4 mp -77.83 -27.34 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 152' ' ' ALA . 54.7 t -73.85 -35.45 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.645 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -69.99 -52.36 24.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.107 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.86 -33.93 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.932 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.27 -43.55 23.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 156' ' ' VAL . 52.4 t -69.14 -26.86 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.888 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 157' ' ' ALA . 48.6 t -75.01 -45.44 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.328 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.64 -21.23 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.7 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.897 0.38 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -54.13 -42.89 70.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -45.38 87.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -50.34 -42.18 52.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.3 -29.48 69.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -78.53 -49.42 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.514 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -62.38 -33.34 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.69 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 41.3 p -76.33 -34.22 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -74.28 10.03 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -107.29 142.06 15.7 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -62.55 -18.38 61.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 0.0 110.294 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.51 -48.29 51.78 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -62.61 -51.43 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -52.76 -40.17 62.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.029 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.26 -30.11 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.17 -34.28 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.403 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 mtt -74.85 -33.16 62.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.84 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.82 32.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.775 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.35 -30.92 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -61.53 -61.99 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.43 -23.84 41.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -78.09 -39.92 40.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' THR . . . -58.63 -31.03 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.829 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -78.8 -29.71 45.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.736 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.77 -47.09 64.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.01 -46.4 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 24' ' ' ALA . 11.5 p -50.13 -46.33 53.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -73.19 -38.41 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.941 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -17.93 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.219 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -97.28 -25.87 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -46.62 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.773 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 19.4 mp0 -83.68 -30.1 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.008 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -60.38 -26.21 66.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.251 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 36' ' ' MET . 8.5 m -105.66 -38.11 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.805 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.406 ' N ' HG23 ' A' ' 35' ' ' VAL . 16.5 mmt -74.96 1.96 11.59 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.27 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 tp 55.83 50.48 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.722 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.1 mm? -103.84 156.17 18.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -117.01 142.27 29.65 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.659 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 127' ' ' SER . 65.7 Cg_endo -74.39 173.68 13.83 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.51 2.14 . . . . 0.0 111.918 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -131.94 178.43 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.46 -43.93 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.421 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.22 -48.93 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.468 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.3 t -51.8 -50.73 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.891 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.62 -38.62 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -54.46 -47.29 73.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.559 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -61.38 -43.85 98.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.265 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.32 60.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.091 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.23 80.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.88 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 mt -76.78 -53.33 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.997 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -45.81 -40.61 9.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.44 -45.35 86.29 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 8.1 t -61.84 -45.16 99.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -46.87 -44.0 19.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.566 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.28 -28.22 73.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.575 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.76 -26.84 57.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.56 -42.91 77.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.15 -29.93 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -12.74 83.08 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.81 1.78 51.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.529 0.204 . . . . 0.0 111.25 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 3.3 pt -87.22 -27.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.963 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.8 72.46 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.83 0.347 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.78 24.75 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.951 2.434 . . . . 0.0 112.177 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -104.9 -8.7 18.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.82 176.74 1.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.481 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -47.81 -4.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.321 2.014 . . . . 0.0 112.26 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.567 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 mm? -52.8 -31.22 37.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.139 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.496 ' NH1' ' OG ' ' A' ' 163' ' ' SER . 67.0 mtt180 -40.85 -69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.622 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.27 -35.73 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.437 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.4 t -62.27 -44.07 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.673 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.81 -33.13 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 109.483 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.62 -11.85 5.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.33 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.34 -42.85 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.288 0.566 . . . . 0.0 110.839 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.1 mt -87.06 -29.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.083 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.7 t-105 -60.74 -50.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.288 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 tp -70.07 -45.95 65.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.434 ' O ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -45.37 -50.41 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.015 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -71.12 -29.41 65.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.64 -58.92 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.425 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -70.85 -49.8 42.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -78.09 -33.8 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 83' ' ' ARG . . . -65.3 -46.93 84.85 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 81' ' ' ALA . 19.8 m -68.67 -44.72 82.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.766 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.516 ' N ' HG23 ' A' ' 85' ' ' VAL . 29.2 tp60 -50.13 -24.46 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.69 -41.1 16.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.8 p -49.0 -34.1 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.396 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.53 -52.0 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -49.1 -31.88 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -75.45 -50.18 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.013 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 p -68.97 -54.17 16.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.985 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 30.6 ttm -50.08 -49.14 52.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.3 tp -67.49 -39.25 85.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.677 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.723 0.297 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.499 ' CD1' ' C ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -88.53 9.06 25.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.211 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.1 tp -116.39 86.51 18.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.92 8.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.823 2.349 . . . . 0.0 113.003 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.5 tp -74.79 -28.12 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 124' ' ' PHE . 66.6 m-20 -95.76 -40.42 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.69 -33.99 76.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -86.93 -19.23 29.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.837 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.98 79.3 10.07 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 125' ' ' VAL . 74.2 Cg_endo -79.51 -16.08 12.08 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.605 2.203 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -79.86 -4.85 54.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.743 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.3 t -128.77 45.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.194 0.521 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.507 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 10.4 t80 -172.23 -39.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.336 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 121' ' ' PRO . 61.6 t -54.75 125.18 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.483 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.07 157.69 15.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 40' ' ' PRO . 42.1 t -173.39 103.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.533 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.45 -172.62 24.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.4 m-20 -92.18 143.94 25.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.685 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 27.3 m -93.95 134.49 36.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 86.79 -0.05 0.57 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.06 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -67.73 155.66 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.245 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.59 145.69 25.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -133.66 -29.23 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.75 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -174.41 145.54 0.99 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.194 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -138.91 167.72 21.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.082 0.467 . . . . 0.0 111.482 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 63.9 t80 -143.51 119.0 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.717 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.9 OUTLIER 78.27 17.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -177.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 81.05 15.93 75.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.1 mp -119.51 131.27 55.53 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.3 152.18 44.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.373 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -50.75 -52.34 57.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 142' ' ' MET . 82.9 Cg_exo -44.28 -38.92 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.159 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.87 -49.14 31.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 148' ' ' GLY . 48.7 m95 -56.71 -57.32 12.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.6 tp -42.83 -42.14 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.548 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -54.66 -35.75 63.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.56 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.94 -39.98 97.74 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.615 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.41 -30.71 11.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -47.72 84.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 152' ' ' ALA . 2.1 pp -68.3 -41.08 83.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.564 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' HD12 ' A' ' 151' ' ' ILE . . . -56.93 -49.57 75.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.106 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -51.46 -46.76 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 37.7 tp -52.8 -36.98 59.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.568 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 27.3 mm -68.78 -41.72 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.5 -37.66 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -75.47 -31.21 60.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.44 -27.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.351 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.15 -42.11 16.36 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.156 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.1 -31.87 36.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.195 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.0 t -73.25 -50.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.96 -22.96 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.496 ' OG ' ' NH1' ' A' ' 70' ' ' ARG . 24.1 p . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.49 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -60.46 -43.69 96.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 7' ' ' GLN . 42.4 t80 -62.21 -50.16 72.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -46.96 -37.24 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.245 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 38.2 t-20 -69.82 -25.91 63.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.311 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PHE . 85.9 mm-40 -82.4 -50.07 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.63 73.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.653 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 11' ' ' GLY . 88.7 p -76.24 -34.57 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.732 HE22 ' HA ' ' A' ' 66' ' ' LYS . 23.4 mm-40 -71.24 8.54 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.552 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.72 141.62 15.56 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -69.9 -50.1 45.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.769 0.319 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.12 5.7 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.06 86.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -60.63 -46.9 88.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.4 -30.27 68.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.37 -30.27 68.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.398 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.1 mmt -73.45 -31.16 63.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.73 -53.47 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.17 -32.69 64.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.928 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -65.99 -61.81 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.09 -23.86 62.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -81.82 -42.1 20.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.429 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -49.53 -50.97 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.648 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.2 mp -61.48 -33.88 74.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.599 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.88 -41.89 88.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.713 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.2 mm? -79.81 -52.13 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -42.11 -40.53 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.04 -41.72 34.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -55.36 -17.6 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.932 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -94.33 -35.34 12.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.607 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.82 -38.63 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.54 -35.29 60.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.555 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 1.5 t-80 -74.73 -10.12 59.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.294 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -109.18 -51.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.787 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.9 mtt -91.18 14.18 14.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.803 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.18 40.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.775 0.321 . . . . 0.0 110.721 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.31 152.11 46.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -108.66 115.93 56.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.87 147.73 21.7 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.272 1.981 . . . . 0.0 112.188 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 5.7 t -98.08 172.2 7.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.301 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 43' ' ' LEU . 8.3 p -59.46 -41.26 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.944 0.402 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HG13 ' A' ' 42' ' ' VAL . 76.4 mt -63.2 -45.27 92.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.056 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -48.84 -38.49 22.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.394 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.532 HG21 ' HA ' ' A' ' 124' ' ' PHE . 51.5 mt -69.49 -44.5 79.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.168 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -45.59 92.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.818 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -57.79 -44.34 86.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.386 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -61.33 -29.01 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -39.76 77.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.22 74.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 tp -76.59 -51.85 10.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -45.05 -39.96 6.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.25 -40.7 94.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 41.5 t -64.02 -17.71 21.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.699 0.762 . . . . 0.0 109.273 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -74.49 -45.17 47.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.426 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.81 83.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.38 -40.06 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.351 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.87 -31.45 69.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.94 -29.52 50.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.145 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -79.08 -39.91 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.557 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.74 -33.19 79.71 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.18 9.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.697 0.284 . . . . 0.0 110.652 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' A' ' 61' ' ' GLY . 66.0 mt -78.41 -54.92 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.288 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -168.1 75.36 0.89 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.566 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 21.5 Cg_exo -61.67 14.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.974 2.449 . . . . 0.0 112.485 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.732 ' HA ' HE22 ' A' ' 10' ' ' GLN . 13.8 ptpt -109.78 -3.58 16.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.84 161.03 31.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.685 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -39.4 -15.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.484 2.123 . . . . 0.0 112.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.2 mp -43.25 -35.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.721 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.4 mtm-85 -40.24 -65.57 0.39 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.13 -15.87 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.619 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 75' ' ' VAL . 19.3 t -82.1 -46.37 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.722 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.23 -34.05 59.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.045 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.82 -8.55 2.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.329 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 72' ' ' VAL . 32.7 m -59.25 -42.7 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 75' ' ' VAL . 6.1 mt -87.76 -29.77 5.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.23 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.611 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 4.9 t-105 -63.77 -53.58 48.8 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.777 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.04 -43.89 90.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.508 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -47.32 -46.88 25.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.5 p -80.44 -21.63 41.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.67 -61.98 2.22 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.909 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -73.99 -44.08 55.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.541 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -75.17 -42.11 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.076 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.29 -48.61 85.12 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 81' ' ' ALA . 17.3 m -71.04 -38.31 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.128 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.41 ' N ' HG23 ' A' ' 85' ' ' VAL . 14.3 tm0? -72.84 -36.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.32 -49.32 19.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.3 p -51.17 -49.1 61.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.573 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.53 -39.48 34.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 110.085 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -58.96 -41.69 88.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.379 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -66.78 -39.07 87.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.589 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -68.68 -35.02 76.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ttt -59.05 -44.13 91.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -49.34 78.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.114 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.179 179.729 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -103.83 -1.56 27.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -119.68 81.64 25.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 43.9 Cg_exo -53.24 4.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.547 2.165 . . . . 0.0 112.246 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.9 mm? -66.87 -30.18 70.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.06 0.457 . . . . 0.0 110.248 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -96.78 -41.53 8.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.179 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -71.12 -45.0 64.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.749 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 20.4 t-105 -75.26 -15.15 60.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.8 69.17 65.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.86 -20.23 9.16 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.734 2.289 . . . . 0.0 111.256 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -52.22 -53.89 37.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.504 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.92 55.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.732 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.532 ' HA ' HG21 ' A' ' 45' ' ' ILE . 2.1 t80 -157.89 -41.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.53 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.43 128.36 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.53 155.36 17.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.1 m -165.24 99.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.38 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.46 -173.37 23.1 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 9.1 m-20 -97.26 165.15 12.17 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -116.19 127.68 54.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.78 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.03 -8.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.94 143.15 55.77 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.01 128.05 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -132.82 -23.36 2.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -173.17 127.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.23 163.65 29.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.297 0.57 . . . . 0.0 112.164 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.02 137.92 54.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.156 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.84 16.69 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.92 13.43 53.09 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.365 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.3 mt -123.83 145.09 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.176 0.488 . . . . 0.0 109.955 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.35 150.82 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.699 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.446 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.4 mtp -47.53 -54.44 22.5 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.679 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 142' ' ' MET . 79.8 Cg_exo -40.21 -37.78 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.98 -47.18 60.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.947 0.403 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.9 m95 -65.79 -57.98 6.72 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -42.49 -36.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.947 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 146' ' ' LEU . 33.2 tp -66.49 -34.74 78.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.35 -35.86 73.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mm -69.76 -44.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.21 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -44.15 69.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.77 -46.37 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.779 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.39 -50.22 74.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -61.95 -47.17 86.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.912 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 154' ' ' LEU . 7.9 tt -53.57 -30.98 44.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.66 -27.68 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.147 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.66 ' O ' HG22 ' A' ' 160' ' ' VAL . 70.2 t -75.0 -28.58 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.913 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.611 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -80.65 -39.63 26.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.785 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.21 -31.5 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.557 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.7 -42.77 27.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.31 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 156' ' ' VAL . 28.4 m -71.26 -22.94 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.812 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 157' ' ' ALA . 21.1 t -77.68 -50.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 162' ' ' ILE . 77.3 mt -64.62 -15.73 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.821 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.528 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 25.2 mtt85 -53.55 -28.86 34.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.06 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 7' ' ' GLN . 35.2 m-85 -76.94 -42.91 37.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.405 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -46.8 -42.73 17.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 7' ' ' GLN . 24.5 p30 -72.61 -23.0 60.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.5 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 48.4 tp60 -79.93 -48.51 13.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.554 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.42 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 11' ' ' GLY . 19.7 m -76.53 -36.05 57.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -67.55 4.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.4 141.46 15.24 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.46 -46.2 87.34 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.99 -44.92 5.9 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.1 77.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -58.44 -43.28 88.72 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.196 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.3 mm? -67.04 -28.46 68.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.1 tp -69.34 -31.96 70.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.377 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 21' ' ' THR . 39.9 mtt -73.45 -32.87 64.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.02 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.4 -52.99 26.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.536 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.05 -49.63 50.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.2 p -53.42 -42.49 67.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.499 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.11 67.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.642 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.5 mt -87.79 -42.11 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.11 -25.02 60.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.536 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.14 -38.45 36.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.78 -47.07 64.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.54 -48.99 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.672 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.0 m -49.7 -47.64 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -73.47 -28.25 61.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.538 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.56 -20.53 66.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.978 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -91.45 -32.26 15.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.6 m-85 -58.23 -46.92 85.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.285 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 7.0 mp0 -62.68 -49.41 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.78 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -24.04 18.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.23 -18.94 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' PHE . 33.0 mmm -98.43 -3.17 37.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.85 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 37' ' ' LEU . 6.0 mp 53.88 39.81 30.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.93 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.66 HD12 ' OE1' ' A' ' 134' ' ' GLN . 1.0 OUTLIER -100.92 158.06 16.27 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -121.43 144.03 39.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.03 152.71 51.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.575 2.183 . . . . 0.0 112.2 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.7 t -115.81 -172.21 2.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.541 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.423 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 12.6 t -63.81 -47.86 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.034 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 43' ' ' LEU . 9.7 mp -62.26 -49.1 77.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.436 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 t -48.53 -46.42 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 124' ' ' PHE . 49.2 mt -61.63 -43.11 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.366 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -47.48 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.05 -39.29 93.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.83 -37.3 86.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.356 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.49 76.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.36 74.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tt -76.67 -51.92 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.214 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -45.68 -38.69 7.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.33 -43.91 91.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 25.5 t -61.47 -46.47 96.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 55' ' ' LEU . 1.5 tt -43.24 -47.67 6.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.312 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 60' ' ' ILE . . . -62.08 -32.79 83.57 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.35 -31.45 70.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.53 68.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.391 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.469 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 15.8 mt -76.63 -31.08 57.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 56' ' ' GLY . 1.4 mp -80.16 -36.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.848 0.356 . . . . 0.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.36 -23.0 78.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.22 6.93 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.611 0.243 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -77.78 -51.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.131 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -172.84 74.82 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 23.03 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.739 2.293 . . . . 0.0 112.14 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.59 -10.37 19.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.233 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 2.6 p -113.9 155.83 44.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.13 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -37.31 -17.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.808 2.338 . . . . 0.0 112.834 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.003 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.2 mm? -44.98 -31.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.588 ' NH1' HG22 ' A' ' 161' ' ' VAL . 3.5 mmp_? -34.32 -55.16 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -53.13 -36.31 60.65 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.951 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 69' ' ' LEU . 3.4 m -65.16 -39.86 86.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.816 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.24 -37.39 57.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.433 ' SD ' HG21 ' A' ' 161' ' ' VAL . 7.0 ttt -58.56 -14.36 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.468 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.8 t -55.08 -42.93 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.28 -31.14 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.644 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.474 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 6.2 t-105 -63.49 -55.4 24.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.113 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.0 tt -65.57 -48.41 72.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -42.84 -43.27 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.089 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 p -79.84 -22.43 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.791 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.45 -60.27 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.733 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.15 -55.08 6.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -65.95 -50.25 65.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.44 61.18 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.49 ' O ' ' OG1' ' A' ' 88' ' ' THR . 77.0 t -66.42 -45.42 89.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.895 0.379 . . . . 0.0 110.654 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.33 -31.86 67.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.58 -44.98 61.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -53.5 -27.0 23.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -70.97 -51.51 25.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -48.47 -34.24 10.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.25 -55.21 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -55.32 -46.69 76.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.1 ttt -56.73 -43.03 80.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tp -66.57 -22.99 66.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.059 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.993 0.425 . . . . 0.0 109.857 179.635 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.647 0.261 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -108.13 18.54 21.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.734 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.594 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -120.97 83.33 37.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.4 Cg_exo -53.03 2.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.647 2.231 . . . . 0.0 112.102 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.594 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.0 mp -63.63 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.638 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -97.02 -44.05 7.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -70.34 -45.58 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.471 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 15.7 t-105 -73.13 -15.05 61.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.98 74.89 11.96 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.46 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -12.62 13.82 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.907 2.405 . . . . 0.0 112.092 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -53.93 -54.12 43.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.839 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.436 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 8.5 t -106.94 60.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.72 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.621 ' O ' HD13 ' A' ' 45' ' ' ILE . 4.7 m-85 -164.68 -41.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.07 125.13 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.442 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.57 152.01 21.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 m -162.95 99.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.642 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.25 179.45 17.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.442 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.8 OUTLIER -80.37 143.49 33.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 30.2 m -93.52 131.85 38.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 85.89 0.56 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.208 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' OE1' ' OD1' ' A' ' 129' ' ' ASP . 39.9 tt0 -68.31 128.65 37.36 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.216 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.72 116.49 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.344 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.66 ' OE1' HD12 ' A' ' 38' ' ' LEU . 19.5 mt-30 -104.19 -29.6 10.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -173.8 147.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.21 161.6 37.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.362 0.601 . . . . 0.0 112.054 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.25 138.59 54.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.84 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.44 17.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.94 22.82 40.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 mt -124.72 136.0 53.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.42 148.81 50.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.743 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.432 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.5 mtt -48.74 -52.74 42.99 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.67 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 142' ' ' MET . 81.8 Cg_exo -43.51 -35.96 6.48 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.286 1.99 . . . . 0.0 112.033 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.65 -46.55 58.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.321 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.603 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.0 m95 -64.52 -57.7 8.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.2 tp -43.53 -39.26 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.104 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.9 -33.75 74.79 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.63 -40.6 94.91 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -72.68 -31.76 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 110.632 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.05 -39.62 86.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.502 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.2 tp -70.94 -37.05 66.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.139 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.16 -53.33 46.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -60.43 -38.52 84.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.224 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 154' ' ' LEU . 7.2 tt -54.53 -37.84 65.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.4 mt -75.55 -40.64 41.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 160' ' ' VAL . 73.8 t -48.96 -39.34 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.535 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -76.01 -43.63 43.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.963 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.58 -36.02 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.113 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.14 -32.72 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 156' ' ' VAL . 54.2 t -77.76 -25.01 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.259 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.588 HG22 ' NH1' ' A' ' 70' ' ' ARG . 92.6 t -83.33 -50.75 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.32 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -66.84 -22.54 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.716 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.1 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.517 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.888 0.375 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -47.92 -34.66 9.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.41 -38.21 74.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.991 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.9 tp -50.97 -40.17 57.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.62 -29.39 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.019 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.95 -49.82 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -66.16 -34.39 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.799 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 54.1 p -75.52 -33.94 60.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.643 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.17 14.98 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.57 150.26 17.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.6 ttm105 -67.9 -20.7 65.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.392 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.75 86.88 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -65.36 -51.56 59.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.465 ' NE1' ' O ' ' A' ' 9' ' ' SER . 19.4 m0 -54.08 -42.55 69.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.375 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.5 -30.89 64.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tp -68.55 -32.59 72.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.04 -33.87 61.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -51.99 48.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.723 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -53.87 -52.05 61.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.1 m -46.03 -61.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.8 -30.39 14.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.569 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.97 -40.8 53.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.04 -40.84 46.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.5 mp -69.21 -36.75 77.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.581 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.36 -49.37 69.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.65 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.72 -50.95 70.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -53.65 -42.34 67.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.33 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.035 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -20.86 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.95 -41.63 15.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.135 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -50.97 -43.67 60.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.0 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -77.43 -40.52 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.528 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -71.07 -16.59 62.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.772 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 31' ' ' TRP . 66.1 t -109.34 -50.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.18 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mtt -90.75 14.71 12.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp 41.16 37.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 38' ' ' LEU . 3.9 tp -63.43 155.58 28.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -120.25 90.93 45.62 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.967 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.11 147.52 19.95 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.567 2.178 . . . . 0.0 112.083 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 6.4 t -99.0 -173.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.779 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -67.19 -46.75 83.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.628 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.496 HD12 ' CG ' ' A' ' 91' ' ' HIS . 4.1 mm? -65.99 -47.02 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.216 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 m -49.19 -47.19 46.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.17 -39.95 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.235 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -54.67 -49.69 70.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.738 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -58.8 -39.71 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.435 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -58.68 -38.93 79.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.119 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.21 -39.52 94.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.506 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.91 82.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.9 tp -76.57 -50.4 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -44.11 -42.85 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.33 -41.41 96.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.47 -17.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.352 0.596 . . . . 0.0 109.901 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tp -81.79 -41.42 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.052 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -30.89 76.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.28 -35.15 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.151 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.78 97.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.1 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.61 -38.86 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.538 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.04 -21.0 78.29 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.68 3.64 32.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.279 . . . . 0.0 110.669 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -82.13 -49.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 179.15 77.09 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.25 21.35 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.892 2.395 . . . . 0.0 112.323 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -96.7 -8.37 31.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.116 0.484 . . . . 0.0 109.939 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.578 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -109.82 177.91 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.532 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 56.1 Cg_exo -50.49 -0.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.258 1.972 . . . . 0.0 112.278 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 67' ' ' THR . 17.2 mt -62.33 -28.33 69.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -41.76 -64.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.573 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 75' ' ' VAL . 37.9 m-85 -55.5 -38.69 69.51 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.714 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -57.85 -54.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.546 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.03 -33.62 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.208 0.527 . . . . 0.0 110.314 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.4 ' SD ' HG11 ' A' ' 161' ' ' VAL . 8.1 ttt -64.56 -25.48 68.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 71' ' ' TYR . 42.1 t -52.56 -32.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.457 0.646 . . . . 0.0 110.718 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.9 mp -88.88 -31.56 5.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.097 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -65.98 -49.08 69.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.33 -43.51 77.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -46.87 -46.28 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.298 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -79.61 -21.48 44.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.742 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.477 ' HA ' HD21 ' A' ' 154' ' ' LEU . . . -59.61 -60.47 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.032 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -76.14 -48.47 20.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -67.77 -43.83 78.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.6 -47.64 90.14 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.87 -32.39 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.217 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.58 -28.6 65.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.39 -41.35 13.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 84' ' ' GLY . 12.7 p -51.93 -51.88 53.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.727 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -51.84 -48.36 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.137 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.09 -44.28 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.908 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.496 ' CG ' HD12 ' A' ' 43' ' ' LEU . 2.0 m-70 -62.82 -44.8 95.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.327 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.3 p -61.29 -47.75 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.3 tpt -45.5 -45.51 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.264 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.9 tp -64.94 -43.65 92.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.162 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.558 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 50.5 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -99.7 2.26 44.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.251 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.0 tp -119.88 85.09 33.49 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.2 Cg_exo -56.14 16.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.668 2.245 . . . . 0.0 112.638 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.1 tp -77.14 -30.85 55.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.029 0.442 . . . . 0.0 110.312 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -97.75 -40.28 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.098 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -70.61 -45.32 65.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.6 t90 -76.19 -11.64 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.334 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.46 71.19 17.75 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.831 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 125' ' ' VAL . 72.4 Cg_endo -77.77 -14.91 15.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.763 2.308 . . . . 0.0 111.766 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -57.33 -53.27 59.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.827 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 53.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -158.14 -39.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.287 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 121' ' ' PRO . 42.2 t -54.97 123.92 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.18 158.17 15.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.648 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.56 104.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.501 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.04 -177.06 20.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 t70 -89.33 139.69 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 110.284 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 54.6 m -91.47 134.65 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 86.52 -1.09 0.64 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.095 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -68.0 153.2 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 119.01 37.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -122.68 -12.61 8.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.719 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -173.3 127.92 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.796 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.32 160.97 38.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.266 0.555 . . . . 0.0 112.179 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.66 137.31 53.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.862 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt 50.64 17.19 0.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.593 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 90.44 21.5 37.52 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 139' ' ' GLY . 3.2 mm? -122.46 134.5 54.58 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.558 ' OE1' ' NE2' ' A' ' 95' ' ' GLN . 8.1 mt-10 -69.16 148.6 49.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.669 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.434 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -49.18 -51.93 52.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 142' ' ' MET . 89.4 Cg_exo -44.01 -38.74 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.426 2.084 . . . . 0.0 112.119 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.32 -49.6 47.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.3 m95 -60.85 -57.11 14.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.291 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.4 tp -43.03 -39.9 2.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.178 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 143' ' ' PRO . 1.5 mm? -60.84 -34.82 75.15 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.91 -45.12 95.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.9 -34.45 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.955 0.407 . . . . 0.0 110.131 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -54.71 -47.58 73.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.75 -42.88 96.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.491 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.33 -45.95 24.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.403 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -64.02 -42.97 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.936 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 158' ' ' VAL . 6.4 mp -51.97 -32.89 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 155' ' ' ILE . 1.7 mp -81.94 -27.78 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.639 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.2 t -63.45 -33.35 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.0 110.235 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.54 -49.98 10.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.308 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 154' ' ' LEU . 65.3 t -53.79 -37.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.547 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 4.0 mm? -84.87 -33.68 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.128 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 156' ' ' VAL . 17.4 t -70.07 -29.3 39.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.422 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 162' ' ' ILE . 30.7 m -83.09 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.578 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.54 ' N ' HG23 ' A' ' 161' ' ' VAL . 10.0 mt -71.73 -8.87 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.53 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.627 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.089 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -53.58 -34.52 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -72.31 -41.62 66.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.01 -43.81 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.385 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -64.83 -29.2 70.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.003 0.43 . . . . 0.0 110.277 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -78.5 -47.76 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.63 88.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.806 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.8 p -76.63 -35.39 58.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.673 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 6.4 tt0 -68.83 4.9 1.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.05 0.452 . . . . 0.0 110.405 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.79 146.99 17.31 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 63' ' ' ILE . 65.1 mtt180 -69.47 -48.84 59.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.667 0.27 . . . . 0.0 110.81 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.05 -46.32 6.26 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.93 -46.99 86.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.13 -42.17 89.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.2 mm? -63.82 -28.08 69.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -70.0 -27.71 64.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . 23.0 mmt -76.47 -33.91 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.161 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.12 -54.48 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.604 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -52.13 -51.83 55.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.654 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 18' ' ' MET . 11.0 p -45.41 -61.7 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.49 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.65 -40.04 80.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.52 -37.91 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.6 mp -75.5 -38.53 59.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.16 -46.47 83.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.82 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.63 -55.15 14.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 24' ' ' ALA . 14.4 p -45.45 -40.81 8.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.71 -42.25 51.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.821 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -54.04 -18.57 3.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.434 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.7 t-105 -88.92 -35.32 16.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.554 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -32.22 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.171 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.43 ' OE1' ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -73.44 -47.65 39.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -70.89 -7.38 45.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.941 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 31' ' ' TRP . 71.7 t -109.14 -42.18 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.029 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.7 mtp -99.85 12.46 36.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 37' ' ' LEU . 9.3 mp 42.9 38.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.43 ' C ' ' OE1' ' A' ' 33' ' ' GLN . 23.8 mt -74.59 156.29 36.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.894 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -115.4 126.51 27.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.195 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.05 137.43 17.32 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.234 1.956 . . . . 0.0 111.836 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.7 t -92.25 -178.05 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.565 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.07 -46.43 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.05 -48.32 82.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -48.65 -45.76 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.518 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 124' ' ' PHE . 59.2 mt -61.38 -43.41 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -48.16 73.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -63.22 -36.4 83.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.721 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -68.24 -38.27 81.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.74 79.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.19 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.69 -50.45 13.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.199 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -46.47 -39.92 11.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.96 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -44.29 89.4 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.59 -47.35 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.986 0.422 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 55' ' ' LEU . 2.0 tt -45.41 -49.73 12.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.537 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.34 -49.71 75.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.83 -34.92 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.366 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.63 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.278 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -36.91 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.718 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -73.55 -35.88 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.447 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -15.32 79.3 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 3.59 32.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.605 0.24 . . . . 0.0 111.199 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.439 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 2.8 pt -91.19 -23.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.813 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.08 67.5 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.79 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.87 15.67 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.82 2.347 . . . . 0.0 112.027 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -102.38 -8.96 20.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.624 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.98 163.37 17.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.066 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.04 3.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.574 2.182 . . . . 0.0 112.607 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.019 ' O ' HG22 ' A' ' 72' ' ' VAL . 6.7 mp -67.06 -30.19 70.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.291 . . . . 0.0 110.918 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD3' ' H ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -38.66 -42.82 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.608 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.501 ' H ' ' HD3' ' A' ' 70' ' ' ARG . 75.7 t80 -59.69 -37.95 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.672 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.019 HG22 ' O ' ' A' ' 69' ' ' LEU . 4.2 m -59.62 -38.15 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.253 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.09 -30.51 22.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.716 -0.615 . . . . 0.0 110.114 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 161' ' ' VAL . 11.8 ttp -67.75 -33.14 74.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.911 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 1.3 m -50.03 -28.57 4.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.562 0.696 . . . . 0.0 110.578 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.23 -31.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.976 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.439 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 13.8 t-105 -66.51 -47.6 72.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.81 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 tp -68.51 -47.85 65.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.439 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -43.98 -42.14 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.345 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -79.19 -24.28 43.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.583 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.37 -58.89 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.282 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CE2' ' NE2' ' A' ' 86' ' ' GLN . 73.5 t80 -74.2 -52.35 12.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.392 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -66.66 -40.86 88.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.15 -46.25 93.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.427 ' O ' ' OG1' ' A' ' 88' ' ' THR . 95.2 t -72.84 -36.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.467 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 82' ' ' PHE . 7.6 tt0 -67.48 -45.95 74.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 tp -65.15 -42.96 93.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.568 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 84' ' ' GLY . 6.6 p -51.46 -47.63 63.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.401 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -48.07 -41.81 27.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -59.82 -38.51 82.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.605 ' C ' ' HD1' ' A' ' 91' ' ' HIS . 1.7 t-80 -69.41 -56.07 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.387 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.4 p -55.72 -52.14 64.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.706 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 35.4 tpp -48.76 -45.23 39.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.44 -44.77 90.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.393 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.553 0.216 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.411 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.15 -5.96 7.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.432 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 mp -119.8 84.42 31.53 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.3 Cg_exo -55.15 11.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.568 2.179 . . . . 0.0 112.264 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.623 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.8 mm? -71.04 -32.74 69.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.086 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.0 p30 -97.63 -39.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 21.3 tttm -72.08 -45.26 61.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.8 t90 -76.34 -11.65 59.94 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.17 68.86 48.57 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -17.03 11.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -51.64 -33.99 35.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.28 45.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.586 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.59 ' O ' HD13 ' A' ' 45' ' ' ILE . 1.3 m-85 -149.55 -36.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.9 p -54.8 124.32 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.438 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.95 23.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t -164.98 101.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.584 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.66 -175.24 21.15 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -92.33 150.88 20.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.683 0.278 . . . . 0.0 110.323 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 11.9 m -100.74 132.07 46.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.56 -4.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.01 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.97 150.58 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.057 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -96.11 133.2 40.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.563 ' H ' ' CD ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -128.52 -22.5 3.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.732 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.485 ' N ' ' OE1' ' A' ' 134' ' ' GLN . 21.6 t-105 -173.17 136.42 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.004 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 5.3 p30 -140.77 157.25 45.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 111.964 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.08 138.43 50.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.33 17.07 0.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.77 21.71 35.81 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.808 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.42 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 5.0 mt -124.86 137.27 54.3 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.33 148.86 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.413 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.9 mtt -47.89 -53.15 34.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -43.49 -37.35 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.419 2.079 . . . . 0.0 112.352 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -71.29 -50.33 33.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.993 0.425 . . . . 0.0 110.113 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 74.0 m95 -60.28 -57.84 11.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.09 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.7 tp -43.49 -37.8 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.062 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.512 ' CD1' HG21 ' A' ' 88' ' ' THR . 11.7 tp -61.13 -34.94 75.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.72 -45.34 94.95 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 149' ' ' ILE . 3.4 mp -75.61 -31.88 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.12 -49.17 76.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.143 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.42 -46.68 94.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.537 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.42 -46.5 56.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.369 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -55.25 -43.24 74.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.2 mt -61.08 -30.58 70.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.869 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.62 -32.03 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 160' ' ' VAL . 70.3 t -64.55 -37.6 80.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -80.29 -46.32 16.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.147 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 154' ' ' LEU . 54.7 t -53.88 -44.01 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.42 -33.0 48.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.0 t -74.79 -22.97 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.882 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.542 HG21 ' SD ' ' A' ' 74' ' ' MET . 46.2 t -82.17 -50.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.098 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.67 -17.34 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.796 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.7 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 -179.48 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -54.41 -31.59 55.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 12.6 t80 -74.89 -42.77 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.193 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -47.97 -38.49 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.354 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -70.75 -27.05 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.448 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 7.1 tm0? -75.55 -49.94 17.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.23 -27.52 69.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 0.0 110.308 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 m -76.51 -42.66 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.254 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -70.15 5.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.99 0.424 . . . . 0.0 110.684 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.69 142.66 16.2 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -69.0 -49.84 54.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.586 0.231 . . . . 0.0 110.713 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.86 -45.72 5.91 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -47.09 87.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -61.03 -37.07 81.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.26 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -32.34 70.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.95 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.82 -36.61 75.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.469 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.478 ' C ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -66.44 -34.79 78.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 -49.94 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.76 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.65 -41.87 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.9 m -64.39 -46.62 82.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.656 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.59 72.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -81.82 -42.08 20.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 28' ' ' THR . . . -55.91 -26.92 49.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -77.35 -39.82 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.542 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.2 -54.54 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -56.23 -50.48 71.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 24' ' ' ALA . 8.9 p -49.91 -43.69 49.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.999 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.75 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.144 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -17.29 19.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -93.4 -37.63 11.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.702 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.78 -46.22 78.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.404 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 38' ' ' LEU . 7.3 tm0? -73.3 -36.21 66.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.63 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -61.25 -22.44 64.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.652 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.1 t -107.88 -28.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.805 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.6 mmt -92.03 3.27 55.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.999 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt 47.4 48.54 16.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' H ' ' HG2' ' A' ' 33' ' ' GLN . 93.6 mt -93.13 155.04 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.829 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -117.19 127.17 26.88 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.075 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.84 148.82 28.78 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.296 1.997 . . . . 0.0 112.368 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.2 t -94.58 173.57 7.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.32 -35.87 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 110.076 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -64.71 -45.55 86.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 m -48.94 -47.53 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.733 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.448 HG12 ' N ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -61.4 -38.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.448 ' N ' HG12 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -61.35 -46.19 91.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.838 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -65.1 -51.77 59.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.526 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.536 ' NH1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -58.55 -35.51 72.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.35 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.38 85.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.564 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.56 70.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.148 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 51' ' ' LEU . 7.0 tt -71.26 -53.71 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.026 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -44.84 -40.2 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.27 93.44 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 57' ' ' ALA . 60.2 t -59.91 -47.53 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 109.872 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.533 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.6 -45.39 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.329 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.79 -27.59 71.37 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -70.53 -37.68 74.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.059 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.42 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.952 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.385 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.51 -36.59 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.651 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.87 -34.3 59.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.49 2.93 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.716 0.293 . . . . 0.0 110.755 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 88.7 mt -77.97 -47.42 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.06 78.37 0.28 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.493 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.06 25.82 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.82 -10.93 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.175 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.48 176.46 1.48 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.485 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.96 -2.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.258 1.972 . . . . 0.0 111.874 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.2 tt -47.79 -37.17 13.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mmp_? -38.8 -67.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.827 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 75' ' ' VAL . 81.8 t80 -52.49 -28.46 20.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.82 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.6 t -71.77 -47.04 58.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.715 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.51 53.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 110.484 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.55 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -63.2 -11.54 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.678 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.536 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 3.0 t -58.39 -38.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.372 0.606 . . . . 0.0 110.027 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -87.65 -32.54 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.309 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 12.4 t-105 -64.63 -53.69 43.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.169 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.0 tp -64.85 -47.22 78.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.832 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -44.16 -42.2 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.4 p -78.95 -22.36 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.75 -59.99 4.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.927 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -73.76 -55.02 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.218 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -66.35 -45.73 79.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.58 -46.57 91.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' O ' ' OG1' ' A' ' 88' ' ' THR . 86.7 t -70.77 -52.51 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -52.06 -29.41 21.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 tp -80.16 -43.6 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.359 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' GLY . 61.5 p -52.44 -22.21 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.196 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -73.48 -51.7 16.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.36 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -50.13 -36.27 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -72.72 -36.51 67.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 88' ' ' THR . 40.4 p -74.99 -43.8 51.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.719 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 39.4 ttm -52.57 -52.05 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.711 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.66 -40.91 92.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.557 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.498 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 1.4 p-90 -124.29 -2.47 8.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.2 tp -115.19 88.83 18.83 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.77 10.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.832 2.355 . . . . 0.0 113.198 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.633 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -80.02 -22.59 42.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.128 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -95.28 -46.83 6.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.819 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -24.92 64.78 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.209 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -93.23 -19.92 20.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.088 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.82 70.94 19.55 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.3 Cg_endo -80.93 -15.85 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.949 2.432 . . . . 0.0 112.247 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -52.76 -35.9 57.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.368 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.536 HG21 ' NH1' ' A' ' 48' ' ' ARG . 33.6 m -127.41 22.2 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.71 0.291 . . . . 0.0 110.913 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.48 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 2.4 t80 -131.4 -6.08 3.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 125' ' ' VAL . 13.4 p -84.66 129.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.85 135.9 33.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.3 m -164.7 116.16 1.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.523 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.25 -168.44 16.39 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -96.12 158.08 15.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.694 0.283 . . . . 0.0 110.241 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.675 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -109.19 130.05 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.776 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.98 -3.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.791 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.78 150.54 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.027 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.7 145.39 24.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.941 0.4 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -135.17 -31.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.1 t-105 -174.95 144.77 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -141.5 167.05 23.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 111.402 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -141.39 120.35 12.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.379 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.28 16.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.18 15.0 75.6 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.48 133.69 55.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.811 0.339 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.77 152.87 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.425 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -51.17 -51.64 66.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 142' ' ' MET . 70.9 Cg_exo -45.39 -37.87 14.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.3 2.0 . . . . 0.0 112.034 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.99 -42.54 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.205 0.526 . . . . 0.0 109.982 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 148' ' ' GLY . 59.9 m95 -65.64 -57.14 8.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.0 tp -43.33 -39.01 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.066 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 88' ' ' THR . 38.7 tp -62.23 -34.59 76.8 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.92 -42.91 96.98 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.6 mt -67.68 -39.53 82.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 0.0 110.146 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -55.25 -45.31 76.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.5 mt -57.2 -43.93 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.61 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.44 62.27 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.518 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.7 m-85 -53.76 -43.48 69.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.087 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.501 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 1.1 pp -75.01 -29.7 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.309 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.9 mt -69.97 -36.74 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.201 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 160' ' ' VAL . 23.3 m -73.36 -38.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.989 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.29 -51.16 62.55 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.844 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 154' ' ' LEU . 79.3 t -55.19 -50.96 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.01 -33.9 73.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 156' ' ' VAL . 16.4 t -67.07 -28.99 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.94 -45.92 62.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.146 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.64 -27.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 179.83 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.3 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.865 0.364 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 3' ' ' ARG . 8.4 ptt-85 -58.74 -40.62 84.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -59.37 -47.63 84.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -51.19 -38.68 53.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -68.41 -31.26 70.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.348 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -77.06 -50.95 11.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.681 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.89 77.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -76.96 -37.9 54.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.733 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.48 HE21 ' CA ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -67.51 2.02 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.42 147.49 18.56 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -71.78 -49.68 36.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.685 0.278 . . . . 0.0 110.65 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.91 -45.05 5.85 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.19 84.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -58.41 -41.41 84.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.154 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -28.89 69.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.022 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -70.5 -30.48 67.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.308 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.433 ' O ' ' OG1' ' A' ' 21' ' ' THR . 0.4 OUTLIER -73.19 -33.09 65.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.02 7.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -47.97 -40.85 23.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -63.72 -50.17 70.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.377 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.13 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -37.27 41.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.92 -36.96 63.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.53 -37.93 65.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.46 -43.48 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.98 -48.31 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.508 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 24' ' ' ALA . 19.4 p -54.47 -40.95 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.73 67.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.776 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 -20.4 63.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' NE1' ' CG2' ' A' ' 35' ' ' VAL . 32.1 t90 -88.95 -39.36 13.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.65 -43.61 57.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 4.5 tm0? -73.61 -29.56 62.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.02 -26.35 66.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' NE1' ' A' ' 31' ' ' TRP . 56.0 t -109.29 -53.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.924 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.68 1.13 8.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.96 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mt 48.54 41.36 17.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 134' ' ' GLN . 1.4 tp -76.24 147.71 38.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -111.66 127.04 27.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.596 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.06 154.66 33.19 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 111.775 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 6.5 t -118.0 -171.98 2.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.787 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.23 -48.05 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.075 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.83 -50.1 70.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.442 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.7 p -53.08 -48.97 67.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mm -61.34 -45.23 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.327 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -58.41 -46.12 87.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.307 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -60.78 -38.32 84.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -64.59 -36.38 84.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.38 84.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.96 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.346 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.2 tt -76.78 -49.58 15.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.049 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -46.32 -38.03 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.76 -44.25 81.29 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.9 -47.65 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -43.9 -48.62 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.6 -48.24 86.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.19 -33.02 25.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.27 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.77 -35.54 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.404 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.88 -37.26 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.223 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -75.24 -40.32 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.0 -28.67 73.34 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.77 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.705 0.288 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 94.1 mt -82.63 -32.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.46 73.36 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.442 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.75 24.58 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.518 2.145 . . . . 0.0 111.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.3 mttm -111.86 -7.56 14.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.13 162.44 21.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.655 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -38.91 -15.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.592 2.195 . . . . 0.0 112.304 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.4 mp -41.58 -33.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.493 ' O ' ' SD ' ' A' ' 74' ' ' MET . 71.9 mtt85 -39.22 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 75' ' ' VAL . 67.2 t80 -51.95 -31.48 29.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.62 -45.94 80.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.97 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.46 -34.26 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.6 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -64.7 -19.66 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.678 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.1 t -54.09 -34.46 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 0.0 109.958 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 84.0 mt -89.15 -33.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.2 t-105 -65.87 -49.86 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.003 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -66.06 -49.58 67.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.3 m-85 -42.92 -42.61 3.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.8 p -78.11 -22.18 49.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.768 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.8 -59.86 4.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.281 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.3 -51.13 13.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.646 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -40.5 78.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.08 -47.14 90.98 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 81' ' ' ALA . 11.1 m -77.53 -32.73 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.336 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.04 -42.87 59.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.663 0.268 . . . . 0.0 111.191 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tp -73.72 -38.47 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.047 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 84' ' ' GLY . 7.9 p -59.56 -44.45 93.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.208 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -52.32 -52.13 54.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.522 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -50.84 -46.35 60.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -64.55 -33.16 75.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.9 m -70.97 -37.14 72.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.413 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.4 tpt -62.21 -33.01 73.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.115 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.2 -47.47 70.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.115 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 179.842 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.708 0.289 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.502 ' C ' HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -99.22 -5.38 30.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.426 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 116' ' ' LEU . 10.4 mp -113.09 82.81 5.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.31 12.11 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.041 1.827 . . . . 0.0 111.756 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.527 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.9 mt -80.13 -28.42 38.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.013 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 1.4 p30 -97.31 -40.83 8.55 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.975 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 3.3 ttmm -69.27 -45.16 70.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.658 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 16.0 t-105 -76.85 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.405 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.17 71.13 22.81 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.761 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.74 -16.11 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.748 2.299 . . . . 0.0 111.805 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -52.29 -32.63 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.785 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -133.37 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.536 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -152.3 -40.53 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.239 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.7 128.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.99 155.47 17.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.4 p -158.17 102.8 1.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.599 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.58 -177.27 19.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 33.9 t70 -86.06 150.02 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 9.7 m -101.74 127.23 48.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 98.87 -8.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.87 128.82 37.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.733 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.19 136.22 51.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.514 ' HB3' HD21 ' A' ' 38' ' ' LEU . 77.9 mt-30 -130.16 -29.35 2.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -174.56 145.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.722 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -144.73 159.64 42.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.256 0.551 . . . . 0.0 112.102 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.408 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -115.09 138.13 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.705 178.577 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp 50.24 16.85 0.28 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.597 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 90.73 22.64 33.01 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 139' ' ' GLY . 2.6 mm? -124.36 136.23 53.93 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 135' ' ' TRP . 6.0 mm-40 -69.33 146.73 51.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.315 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.442 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 9.5 mtt -44.94 -62.7 1.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.144 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 85.8 Cg_exo -33.78 -37.63 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.848 2.366 . . . . 0.0 112.639 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 144' ' ' GLN . 4.8 mp0 -72.34 -52.0 18.08 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.0 m95 -59.47 -57.28 13.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.848 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.5 tp -44.57 -35.55 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.423 HD11 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -62.9 -33.96 76.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.51 -46.19 94.83 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.708 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -75.14 -25.88 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -64.54 -44.37 91.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.743 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.9 tt -69.24 -37.39 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -53.79 -46.99 71.21 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.054 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.79 -44.47 96.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.686 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 81' ' ' ALA . 52.3 mt -65.19 -30.95 71.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.9 -33.35 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.321 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.5 t -64.95 -31.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.52 -47.5 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 154' ' ' LEU . 73.7 t -55.41 -42.21 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -28.58 56.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.903 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 156' ' ' VAL . 31.1 t -78.26 -20.33 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.8 -50.03 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.83 -25.96 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.76 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.548 -179.873 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.987 0.422 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.6 -31.84 66.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 7' ' ' GLN . 23.3 t80 -73.48 -44.94 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.527 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.9 mm? -47.17 -39.88 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.003 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -68.46 -28.15 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.421 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 4' ' ' PHE . 24.4 tt0 -80.33 -49.45 11.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.36 72.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -76.66 -34.99 58.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.76 7.41 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.07 142.08 15.87 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -68.44 -21.4 64.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 110.648 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.83 -46.06 61.94 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.83 76.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.327 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -58.17 -43.12 87.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.42 -33.06 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.323 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -67.48 -30.37 70.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . 60.3 mtp -73.66 -33.0 64.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.417 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.89 71.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.46 -51.83 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 17' ' ' LEU . 12.7 p -41.65 -50.42 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.92 85.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.62 -39.67 80.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.306 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.71 -41.67 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.354 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.3 -33.78 63.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.543 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.76 -45.91 77.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.03 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -71.89 -46.55 57.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.92 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 87.5 m -46.8 -43.01 18.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.81 -21.45 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -68.49 -22.39 64.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.23 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.4 t-105 -97.68 -29.39 13.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.4 -39.86 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.51 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -78.8 -51.6 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.992 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -54.74 -53.41 55.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 31' ' ' TRP . 4.3 p -61.01 -18.19 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.0 ttt -106.3 10.56 31.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.589 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.66 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.2 mp 52.24 54.44 10.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.99 157.18 17.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.283 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -125.37 141.48 38.95 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.432 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.76 175.93 10.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 112.318 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.486 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 12.8 t -131.88 -179.34 5.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 39.6 t -56.06 -49.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.599 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.94 -38.24 87.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -54.23 -40.93 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.584 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.699 HD12 HH21 ' A' ' 48' ' ' ARG . 1.4 tp -67.98 -37.59 78.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.428 . . . . 0.0 110.053 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -60.73 -48.2 82.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.038 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.94 -39.95 95.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.699 HH21 HD12 ' A' ' 45' ' ' ILE . 11.6 ttp180 -65.82 -36.16 82.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.11 86.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.05 -49.03 78.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 tp -76.04 -52.2 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.223 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -45.89 -42.59 12.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.53 89.47 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' ALA . 26.0 t -59.15 -46.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.298 0.571 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.09 -46.59 11.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.535 179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.81 -27.42 71.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.04 -42.13 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.91 -21.51 62.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -43.93 19.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.34 -33.23 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -73.16 -31.38 61.63 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.44 6.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.798 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 95.0 mt -82.81 -29.79 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.76 69.03 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.25 23.78 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.754 2.302 . . . . 0.0 111.654 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.29 -10.25 19.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.087 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.84 175.21 1.96 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.513 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.39 -9.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.281 1.987 . . . . 0.0 112.052 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -47.89 -31.43 5.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.126 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -40.33 -67.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.62 -26.08 63.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.43 -45.48 74.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.248 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.66 -36.48 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.47 0.653 . . . . 0.0 109.574 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 161' ' ' VAL . 0.8 OUTLIER -57.15 -12.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.062 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.5 t -55.27 -44.21 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.306 0.574 . . . . 0.0 110.443 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.89 -31.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.627 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.493 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 10.0 t-105 -62.67 -55.79 23.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.129 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.1 tp -65.3 -48.17 74.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -43.58 -45.66 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.084 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 p -78.99 -21.14 47.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.43 -60.38 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.053 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.52 -51.27 17.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.09 -48.1 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 88' ' ' THR . . . -55.38 -48.42 69.76 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' ' OG1' ' A' ' 88' ' ' THR . 66.1 t -69.29 -47.23 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -55.48 -23.48 25.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.292 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.39 -42.67 14.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.214 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 84' ' ' GLY . 39.7 p -51.29 -26.38 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -69.18 -46.53 67.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.246 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -55.38 -31.23 61.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.274 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 10.7 t-80 -70.09 -49.64 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.349 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.1 p -54.87 -56.36 20.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 110.199 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 40.8 mtt -48.01 -50.68 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.028 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.72 -36.8 7.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.412 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.525 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.793 0.33 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.85 -5.21 59.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.2 mp -119.68 81.85 25.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -52.67 -2.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.566 2.178 . . . . 0.0 112.016 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tt -59.53 -32.31 70.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -41.03 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.604 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -71.9 -45.28 61.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.721 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -73.71 -17.29 61.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.456 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.0 t -141.34 72.32 26.31 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.514 ' O ' HG22 ' A' ' 125' ' ' VAL . 74.4 Cg_endo -79.75 -16.48 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.895 2.396 . . . . 0.0 111.804 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -50.2 -49.11 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.816 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.97 53.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.431 ' HA ' HD11 ' A' ' 45' ' ' ILE . 6.0 t80 -154.57 -39.76 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 121' ' ' PRO . 27.5 m -55.57 130.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.47 150.24 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.535 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.9 m -159.69 102.97 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.695 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.59 -176.7 20.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.3 m-20 -87.55 157.19 19.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 3.7 m -106.79 128.97 54.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.711 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 93.94 -7.87 0.13 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.429 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 8.1 mp0 -68.21 129.1 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.857 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.51 116.21 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.096 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -109.11 -31.04 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.84 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -174.06 143.26 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.794 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.96 156.45 44.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.295 0.569 . . . . 0.0 112.167 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -112.41 138.76 48.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.786 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.44 17.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 91.29 22.8 31.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.03 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.53 137.86 53.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.38 149.42 50.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.6 mtt -48.62 -52.74 42.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 86.5 Cg_exo -43.34 -34.21 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.396 2.064 . . . . 0.0 112.17 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.74 -52.66 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 148' ' ' GLY . 95.0 m95 -58.81 -58.3 9.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -43.83 -36.98 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.15 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.3 tt -61.17 -34.6 75.29 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.67 -47.63 89.24 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.65 -25.57 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.049 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.468 ' O ' HD13 ' A' ' 154' ' ' LEU . 6.6 t80 -64.85 -43.08 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.694 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 148' ' ' GLY . 5.5 tp -68.27 -36.81 76.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.359 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.015 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -58.71 -33.74 70.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 150' ' ' PHE . 4.1 mp -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.9 mt -82.43 -34.26 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.484 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 160' ' ' VAL . 91.6 t -60.48 -40.3 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.625 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.47 -50.58 13.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 154' ' ' LEU . 52.9 t -53.13 -50.61 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.54 -31.17 71.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.013 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 156' ' ' VAL . 11.1 t -70.87 -28.77 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.18 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 74' ' ' MET . 61.0 t -79.29 -49.42 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.222 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 162' ' ' ILE . 39.7 mm -68.92 -11.14 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.569 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.59 -179.987 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.807 0.337 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.501 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -50.09 -45.69 52.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' GLN . 26.2 m-85 -63.03 -43.6 98.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.277 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -48.01 -42.36 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.262 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -68.8 -24.05 64.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 4' ' ' PHE . 52.1 tt0 -77.98 -48.19 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.55 87.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' GLY . 8.2 m -76.72 -37.32 56.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 34.4 tt0 -66.24 1.87 1.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.12 149.5 19.05 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -70.92 -49.03 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.681 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.83 -45.63 5.87 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.41 83.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.096 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -59.46 -47.17 86.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.058 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 16' ' ' LEU . 4.2 mm? -59.27 -28.22 66.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 21' ' ' THR . 0.9 OUTLIER -70.9 -27.73 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.439 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.5 mmt -74.24 -34.44 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 -53.61 22.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.712 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -52.71 57.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.485 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 17' ' ' LEU . 16.2 p -44.74 -54.12 6.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.727 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.29 -22.2 62.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.73 -41.26 15.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.634 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.28 -39.92 64.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.0 mm? -73.11 -27.78 61.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.835 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.44 -38.74 90.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.589 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 mt -79.18 -41.4 28.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 2.5 m -48.06 -43.33 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.49 -32.28 32.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.104 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tp -57.06 -21.33 30.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -90.22 -38.94 13.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.08 -45.54 43.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -71.25 -25.26 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 -21.24 51.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.393 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 36' ' ' MET . 7.6 p -107.19 -38.67 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.483 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.431 ' N ' HG13 ' A' ' 35' ' ' VAL . 12.4 mtp -98.68 5.73 47.47 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.4 mm? 47.22 45.0 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 46.9 mt -80.01 153.28 28.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.503 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -121.2 126.86 26.41 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.415 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 153.4 32.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.218 1.945 . . . . 0.0 111.934 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.8 t -100.15 -174.77 2.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.6 t -65.98 -41.74 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 110.822 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.65 -36.47 65.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t -57.69 -47.73 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 124' ' ' PHE . 25.5 pt -66.72 -36.36 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.089 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -55.06 -48.29 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.27 -36.15 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.87 84.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.504 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -58.92 -47.9 83.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -77.72 -49.71 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -46.6 -43.32 17.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 109.851 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.44 93.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' ALA . 55.1 t -58.31 -46.7 88.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.006 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.0 -42.95 29.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.543 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -24.15 72.45 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.87 -32.05 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.584 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -23.09 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 tp -79.63 -42.3 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.388 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.72 -36.9 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.679 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -69.71 -33.7 71.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.19 6.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.655 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.9 mt -79.64 -25.56 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.76 68.38 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.85 14.42 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.674 2.249 . . . . 0.0 111.995 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -8.81 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.197 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.27 162.47 20.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.813 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -42.04 -12.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.418 2.079 . . . . 0.0 112.246 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mp -50.35 -29.3 9.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' CG ' ' N ' ' A' ' 71' ' ' TYR . 26.7 ptt180 -37.9 -57.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.715 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -52.72 -35.01 55.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.108 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' LEU . 18.2 t -64.02 -44.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.58 -33.89 47.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.203 0.525 . . . . 0.0 110.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.51 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 8.3 mmt -62.59 -20.06 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 71' ' ' TYR . 3.4 t -51.78 -39.03 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.457 0.646 . . . . 0.0 110.342 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.74 -30.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.766 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.499 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 15.0 t-105 -66.95 -51.16 58.63 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.123 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.2 tp -67.29 -50.31 60.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.617 ' CE2' ' NE ' ' A' ' 83' ' ' ARG . 63.6 t80 -42.36 -42.49 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 110.267 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 p -79.12 -23.23 44.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.803 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.05 -58.95 6.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.256 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -74.71 -51.87 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.617 ' NE ' ' CE2' ' A' ' 79' ' ' TYR . 47.5 ttp85 -65.56 -42.33 91.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 88' ' ' THR . . . -62.77 -46.53 93.46 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 81' ' ' ALA . 70.7 t -66.8 -36.68 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.647 0.261 . . . . 0.0 111.057 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -72.09 -29.18 63.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.774 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -84.53 -48.2 9.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.391 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 84' ' ' GLY . 18.7 p -50.85 -54.6 22.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.395 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -51.69 -34.74 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.385 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -57.98 -39.8 79.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -68.09 -38.51 82.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.408 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.0 p -65.08 -50.57 65.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 ttm -50.09 -39.58 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -45.44 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.712 0.291 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -100.6 12.24 37.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.9 mt -121.69 79.39 39.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.062 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 119' ' ' TRP . 53.4 Cg_exo -48.66 -5.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.534 2.156 . . . . 0.0 111.968 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 tp -54.19 -31.8 53.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.32 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 32.3 p-10 -97.0 -42.79 7.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.268 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 26.0 ttpp -72.29 -45.78 58.58 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.895 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' PRO . 57.9 t-105 -71.1 -18.82 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.182 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -133.26 75.14 71.25 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.4 -26.65 3.93 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.779 2.319 . . . . 0.0 111.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -61.62 -54.35 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.013 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 t -98.09 59.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.748 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -169.37 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 125' ' ' VAL . 10.6 p -60.96 127.47 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.418 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.4 160.58 14.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -166.14 99.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.79 -174.99 22.82 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.421 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -88.55 154.06 20.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.421 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -101.4 133.16 46.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.12 -4.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.928 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 12.4 tm-20 -67.93 150.95 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 19.6 ttm180 -85.82 126.84 34.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 110.538 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.25 -26.09 5.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -175.55 135.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 4.1 p30 -135.43 159.55 41.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.366 0.603 . . . . 0.0 112.135 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 138' ' ' LEU . 12.8 t80 -123.54 137.79 54.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.062 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.553 HD13 ' CE2' ' A' ' 137' ' ' PHE . 3.1 mp 54.38 17.1 1.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.521 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.35 13.78 61.16 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.72 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.434 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 13.8 mt -119.12 145.0 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.599 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 4.0 mp0 -75.9 148.09 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.4 mtt -50.18 -57.28 13.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.1 Cg_exo -37.34 -38.67 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.351 2.034 . . . . 0.0 111.923 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -73.07 -46.81 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.204 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.5 m95 -60.77 -57.52 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 tt -43.55 -41.01 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.5 tt -57.38 -34.95 69.39 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.35 -43.66 95.56 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.612 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -72.85 -38.35 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -46.98 64.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 0.0 109.707 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.48 -49.49 83.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -57.72 -48.82 78.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.43 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.0 m-85 -59.15 -44.65 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.444 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.3 OUTLIER -69.64 -30.71 68.48 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.298 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.24 -36.69 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.722 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.2 t -62.12 -43.31 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' SD ' ' A' ' 74' ' ' MET . . . -61.71 -48.42 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 154' ' ' LEU . 83.3 t -52.17 -39.24 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.038 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.18 -41.42 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.7 t -59.26 -27.52 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 0.0 110.91 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.86 -44.66 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 162' ' ' ILE . 88.2 mt -69.17 -8.92 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.509 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.616 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.874 0.369 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -38.86 70.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.401 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.38 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.281 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.22 -42.0 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -65.37 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.238 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -74.29 -50.08 20.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.89 71.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.8 m -76.8 -37.36 55.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.532 ' OE1' ' N ' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -73.22 6.94 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.45 144.65 16.0 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -69.71 -49.15 56.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.732 0.301 . . . . 0.0 110.727 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.16 -46.12 6.42 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.26 85.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -59.19 -42.31 90.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.84 -28.95 69.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.051 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.54 -33.99 71.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.623 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.3 mtt -69.96 -33.35 71.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -51.8 35.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.669 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -50.05 -44.05 51.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.851 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -60.25 -62.0 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' O ' ' OE1' ' A' ' 26' ' ' GLU . . . -50.56 -29.45 10.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -37.5 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.418 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.38 -36.2 61.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.0 mp -66.68 -37.37 84.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.716 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 3.1 mp0 -66.45 -46.02 77.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.497 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.45 -56.73 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 24' ' ' ALA . 34.3 p -46.97 -44.81 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.722 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.71 -42.79 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.961 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.38 -19.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.953 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -92.36 -36.25 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.748 0.309 . . . . 0.0 110.48 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -44.07 58.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.133 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.93 -29.98 70.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -76.69 -13.02 60.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.587 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.03 -51.82 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.3 mmt -89.36 8.91 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER 46.95 49.06 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.254 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 mt -82.45 155.25 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -124.34 95.58 43.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.36 140.02 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.389 2.059 . . . . 0.0 112.08 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.9 t -95.78 -168.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' CB ' ' A' ' 126' ' ' ALA . 59.2 t -65.67 -44.86 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.98 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -70.84 -50.13 38.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.745 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 p -50.05 -51.17 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.46 -39.27 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.308 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -57.2 -45.36 83.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.85 -36.86 75.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.168 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -64.01 -33.81 76.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.022 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.66 80.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.89 77.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.383 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.416 HD12 ' HB1' ' A' ' 22' ' ' ALA . 1.5 mm? -76.51 -49.21 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.056 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -46.31 -40.1 11.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.496 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.61 -45.36 85.43 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 72.3 t -62.17 -45.45 98.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.187 0.518 . . . . 0.0 109.729 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.516 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.7 -46.73 10.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.586 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.15 -36.72 93.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -61.13 -44.91 96.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.629 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tp -78.17 -29.9 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.5 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -83.3 -40.18 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.77 -34.19 66.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.72 4.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.9 mt -87.46 -25.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB1' ' OG1' ' A' ' 67' ' ' THR . . . -175.51 67.45 0.26 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.39 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.2 15.92 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.679 2.253 . . . . 0.0 112.116 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -115.65 -4.05 12.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.111 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.12 163.17 19.71 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -39.97 -15.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.505 2.136 . . . . 0.0 112.255 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 mm? -41.81 -34.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.79 -70.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.536 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.497 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.2 m-85 -48.35 -36.21 14.03 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.792 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -65.65 -45.7 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.63 -33.36 41.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.265 0.555 . . . . 0.0 110.295 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.488 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 10.4 mmt -65.62 -20.51 66.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.1 t -53.36 -34.67 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.0 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.3 mt -89.31 -32.25 5.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.205 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.517 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.3 t-105 -63.64 -51.41 65.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.997 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tp -69.11 -44.54 72.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -45.79 -46.51 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.174 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.8 p -78.5 -19.72 52.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.669 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.787 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.75 -59.45 5.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -74.72 -49.76 19.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.618 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -71.83 -40.23 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.814 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.47 -49.16 81.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 81' ' ' ALA . 33.5 m -72.74 -47.4 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.746 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.55 ' N ' HG23 ' A' ' 85' ' ' VAL . 21.1 tt0 -50.72 -24.9 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 0.0 109.945 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 tt -81.44 -40.56 23.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.434 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.614 ' CG2' HD21 ' A' ' 147' ' ' LEU . 66.7 p -53.95 -25.64 21.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 110.085 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -52.07 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -56.95 -32.82 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.462 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 7.2 t-80 -71.73 -44.58 63.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -65.99 -52.22 51.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.408 ' N ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -57.45 -50.9 71.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -53.59 -33.4 54.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.823 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 109.911 179.624 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.8 pm0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.637 0.256 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -101.21 -6.27 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.645 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.2 mt -123.61 78.91 55.56 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.986 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 45.5 Cg_exo -52.22 1.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.612 2.208 . . . . 0.0 112.194 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.593 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.0 tp -62.4 -29.31 70.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.551 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.4 OUTLIER -97.43 -41.18 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.443 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -75.29 -45.73 37.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.473 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.7 t90 -68.62 -17.67 64.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.203 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 116' ' ' LEU . 4.3 p -161.13 79.42 2.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.996 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.02 -2.05 11.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.043 2.495 . . . . 0.0 111.785 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -49.05 -47.96 44.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.776 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.96 54.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -157.15 -41.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.408 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 125' ' ' VAL . 14.3 p -54.43 128.9 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.66 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -97.78 150.41 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.776 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.4 t -167.82 110.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.476 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.02 -172.81 21.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.2 m-20 -87.08 139.1 30.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.211 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 28.6 m -93.16 131.09 38.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 87.38 -1.9 0.56 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.326 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.01 128.48 36.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.035 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -80.17 129.23 34.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -122.49 -15.49 7.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.62 144.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.02 159.26 42.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.553 . . . . 0.0 112.0 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.418 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.9 t80 -112.23 136.85 51.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.82 16.84 0.12 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.38 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.429 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 92.71 22.52 28.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 139' ' ' GLY . 4.7 mp -122.89 133.83 54.4 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 109.977 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.85 146.37 54.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.416 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.5 mtt -46.96 -52.65 31.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.722 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 142' ' ' MET . 77.0 Cg_exo -44.45 -35.63 8.83 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.329 2.019 . . . . 0.0 112.232 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -52.51 21.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.457 . . . . 0.0 109.995 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.632 ' O ' ' N ' ' A' ' 148' ' ' GLY . 83.0 m95 -59.35 -56.97 15.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.125 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tt -43.26 -38.21 2.48 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.614 HD21 ' CG2' ' A' ' 88' ' ' THR . 0.5 OUTLIER -60.47 -34.06 73.49 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.96 -41.9 98.07 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.437 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.07 -27.93 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.086 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.513 ' O ' HD13 ' A' ' 154' ' ' LEU . 10.4 t80 -61.49 -48.47 80.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 tp -69.15 -37.2 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.26 67.34 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.025 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.1 -41.17 99.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.864 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 150' ' ' PHE . 6.5 mp -51.93 -32.41 32.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.1 mm -82.08 -38.7 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 160' ' ' VAL . 79.0 t -52.11 -36.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.319 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.517 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.27 -47.16 15.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 154' ' ' LEU . 72.0 t -58.67 -37.67 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.097 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.556 ' O ' HD13 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -80.01 -40.23 28.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.3 t -68.48 -26.26 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.855 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 157' ' ' ALA . 43.3 t -79.32 -49.0 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 162' ' ' ILE . 74.7 mt -65.8 -13.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 -179.845 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.624 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 19.1 ttp180 -57.49 -27.93 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.202 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.4 -42.64 58.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.074 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.3 mm? -50.76 -41.19 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.498 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 3' ' ' ARG . 8.4 p30 -71.98 -26.41 62.23 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.512 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.77 -49.46 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.623 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.03 77.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -76.74 -32.63 57.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -70.1 2.25 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.88 149.75 19.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -71.98 -49.72 34.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.448 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.15 -45.49 6.27 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -58.82 -45.32 90.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.026 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.7 -28.28 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.99 -30.75 68.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.439 ' O ' ' OG1' ' A' ' 21' ' ' THR . 27.2 tpp -72.13 -33.56 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.906 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -51.81 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -51.41 -52.03 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -49.66 -47.76 49.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -43.31 86.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.34 -41.3 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.89 -35.32 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.378 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' OG1' ' A' ' 28' ' ' THR . 35.4 mt -75.71 -39.6 57.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.487 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -64.82 -52.73 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -57.33 -42.04 81.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.644 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 24' ' ' ALA . 11.7 p -60.67 -42.25 96.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.124 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.95 -19.82 65.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.294 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -94.46 -37.7 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 110.843 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -55.41 -46.7 76.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.404 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -71.62 -40.45 69.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.693 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.539 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 45.7 t-80 -61.38 -15.02 32.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.1 t -108.84 -44.77 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.42 5.34 27.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.98 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt 48.34 48.98 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.715 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.4 mt -85.06 154.83 21.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.574 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -116.15 119.15 37.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.245 1.964 . . . . 0.0 112.022 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.447 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 3.9 t -127.19 -177.21 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.527 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.8 p -66.57 -34.93 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 0.0 110.401 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.52 -48.5 55.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.306 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 p -48.46 -50.77 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.1 mt -61.56 -38.43 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -60.52 -44.3 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.838 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.4 tp10 -61.75 -47.88 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 -50.6 -42.79 56.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.917 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.92 74.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 47' ' ' GLU . . . -56.26 -44.62 79.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.928 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.41 -50.83 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.043 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -39.49 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.25 -45.4 80.85 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.32 -43.74 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.559 . . . . 0.0 109.533 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.523 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.03 -49.42 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.362 179.078 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.12 92.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -29.3 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.5 -37.29 71.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.479 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -74.06 -23.76 59.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.357 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -84.19 -46.81 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.39 73.82 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.05 5.42 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.726 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 97.8 mt -80.44 -32.86 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.69 72.95 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.63 27.6 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.547 2.165 . . . . 0.0 111.68 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 64' ' ' ALA . 16.5 tttm -113.34 -10.71 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.933 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.42 162.6 19.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.654 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -39.05 -14.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.705 2.27 . . . . 0.0 112.665 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' THR . 44.4 mt -45.07 -28.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.699 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.2 OUTLIER -40.87 -70.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.547 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.566 ' O ' HG23 ' A' ' 75' ' ' VAL . 43.3 m-85 -51.03 -33.26 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.909 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.22 -45.45 89.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -36.13 26.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.625 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -62.73 -23.68 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.402 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.7 t -53.01 -31.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.407 0.622 . . . . 0.0 109.873 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.2 mt -88.86 -34.32 6.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.587 ' CD1' HD13 ' A' ' 154' ' ' LEU . 2.9 t-105 -65.34 -53.15 47.87 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 81' ' ' ALA . 4.8 mt -63.2 -47.96 80.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.666 0.27 . . . . 0.0 110.607 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -42.73 -43.31 3.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.256 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.659 ' OG ' HD11 ' A' ' 154' ' ' LEU . 19.0 p -77.66 -21.27 52.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.831 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 154' ' ' LEU . . . -59.7 -60.61 3.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.45 -53.66 15.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.01 -48.41 53.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.581 ' O ' HG23 ' A' ' 88' ' ' THR . . . -55.89 -47.26 80.51 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.97 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.88 -32.43 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.542 0.211 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -72.06 -47.07 54.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.062 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.48 -49.91 43.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.674 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 84' ' ' GLY . 13.2 p -46.39 -48.42 18.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.441 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' THR . 50.4 t80 -57.29 -44.94 84.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.296 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -43.71 -42.06 5.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 109.987 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.02 -34.68 73.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.97 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 89' ' ' TYR . 10.1 m -62.24 -50.1 73.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.302 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ttt -56.48 -36.78 69.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.933 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -70.13 -36.9 75.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.52 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 48.5 tt0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.509 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.651 0.262 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.59 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -124.62 -1.01 8.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.624 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 116' ' ' LEU . 53.3 mt -126.59 85.58 60.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.46 5.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.872 2.381 . . . . 0.0 112.745 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.619 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.0 mt -58.04 -31.41 66.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.78 -40.08 8.72 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.997 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.5 -45.54 90.24 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.39 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -79.6 -13.01 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.856 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.81 68.93 24.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.907 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.451 ' O ' HG23 ' A' ' 125' ' ' VAL . 7.5 Cg_exo -69.98 -20.04 34.29 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.813 2.342 . . . . 0.0 111.508 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.64 -53.49 57.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.344 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.54 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 4.0 t -101.94 54.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 6.3 m-85 -161.22 -46.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 121' ' ' PRO . 77.2 t -55.32 129.44 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.74 152.18 19.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.662 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 101.78 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.733 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.79 176.41 14.92 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -83.13 160.47 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.8 m -107.84 128.96 55.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.4 -8.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.726 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE2' ' N ' ' A' ' 129' ' ' ASP . 8.0 pt-20 -67.87 148.91 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.933 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -85.54 136.51 33.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -125.59 -31.17 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.407 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 39.8 t-105 -174.82 141.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 135' ' ' TRP . 3.6 m-20 -134.62 161.28 35.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.325 0.583 . . . . 0.0 112.161 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.415 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -118.98 136.67 53.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.517 178.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 49.13 16.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.479 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.415 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 93.85 19.75 33.25 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.227 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.1 144.05 51.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.06 0.43 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.52 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 50.8 mt-10 -70.38 145.95 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.424 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mmt -44.03 -61.93 1.76 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -34.97 -36.45 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.618 2.212 . . . . 0.0 112.238 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -69.57 -58.32 4.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.045 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.9 m95 -55.31 -57.38 12.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.6 tt -43.45 -35.52 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.126 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.37 -35.13 78.19 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.57 -48.27 85.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.677 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -71.87 -33.28 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.02 -44.08 87.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.46 -43.33 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.47 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -60.65 -49.99 75.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.11 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -57.37 -48.24 79.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 0.0 111.058 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.659 HD11 ' OG ' ' A' ' 80' ' ' SER . 4.5 mm? -66.98 -34.93 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.607 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 -36.73 37.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.199 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 152' ' ' ALA . 14.9 t -54.66 -48.74 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -61.19 -48.69 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 154' ' ' LEU . 76.7 t -48.9 -39.43 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 33.5 mt -78.38 -24.6 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.04 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 156' ' ' VAL . 56.1 t -77.92 -22.7 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 110.718 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.24 -49.59 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.48 -25.69 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.72 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 0.0 110.403 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.845 0.355 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -51.3 -39.34 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.391 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -66.1 -44.92 82.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.2 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -39.65 12.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -69.45 -24.96 63.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.315 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tm0? -80.39 -48.22 13.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.56 69.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.522 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 p -76.79 -34.48 57.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.684 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.418 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 1.9 tp-100 -70.96 6.37 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 141.08 15.15 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.75 -20.64 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.738 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.43 -44.2 74.59 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -51.33 66.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -53.76 -43.9 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mt -70.26 -30.28 67.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.05 -36.64 77.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.604 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.58 -34.49 75.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.27 37.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.394 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -50.63 -36.87 37.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.728 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.11 -56.72 14.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.778 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.71 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.658 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -84.21 -42.39 15.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.27 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.55 -34.61 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.35 -52.84 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.83 -52.28 60.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 p -51.23 -38.9 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.15 -34.14 68.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.46 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.28 -22.75 67.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.756 0.312 . . . . 0.0 110.426 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -85.03 -28.81 25.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -45.56 94.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.99 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.413 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 11.1 pt20 -66.95 -27.46 67.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -83.17 -13.34 55.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.981 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.32 -33.13 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.132 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' MET . 14.3 ttm -109.21 6.63 24.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.153 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 mt 48.92 51.35 16.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.046 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 8.6 mt -81.81 154.54 25.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 127' ' ' SER . 42.3 mttp -120.24 93.76 48.28 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.5 131.11 27.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.509 2.139 . . . . 0.0 112.022 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -89.8 -171.14 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 43' ' ' LEU . 8.6 p -62.22 -41.65 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.8 mp -58.89 -45.44 90.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -48.45 -42.54 32.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -62.48 -42.22 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 110.12 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -65.83 -46.45 78.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.503 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -50.36 67.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.366 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -58.76 -30.77 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.72 68.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' ' CZ ' ' A' ' 150' ' ' PHE . . . -59.22 -48.81 80.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.62 -52.78 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.246 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -44.66 -40.19 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.74 87.93 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.44 -46.36 93.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mt -44.05 -46.09 8.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.427 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.19 -41.64 98.26 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.31 -44.38 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.512 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.3 -32.61 73.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 8.6 mt -73.33 -26.45 61.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mm -82.08 -35.33 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.351 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.16 80.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.81 5.71 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.695 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.5 mp -82.85 -35.12 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.426 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -179.83 73.23 0.18 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.206 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 53.0 Cg_endo -72.56 23.3 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.533 2.155 . . . . 0.0 112.055 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 12.1 ttpt -113.8 -6.49 13.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -114.12 159.44 36.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.894 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -38.15 -18.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.628 2.219 . . . . 0.0 112.442 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.5 mp -41.34 -32.6 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.572 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 161' ' ' VAL . 34.8 mtp180 -39.76 -65.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.663 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.02 -32.49 46.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -66.0 -45.23 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.819 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.29 63.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.657 0.742 . . . . 0.0 109.129 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.533 ' O ' ' SD ' ' A' ' 74' ' ' MET . 11.0 tmm? -56.96 -11.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.14 -44.17 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.29 0.567 . . . . 0.0 111.394 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.05 -32.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.442 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.776 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 9.9 t90 -61.22 -53.17 60.31 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.588 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' CE3' ' A' ' 77' ' ' TRP . 20.9 tp -58.31 -53.67 55.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -43.82 -46.07 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.667 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -80.71 -27.31 36.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.01 -60.84 3.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.004 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -73.47 -55.69 6.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -66.93 -45.48 77.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.04 93.51 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -69.91 -53.18 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.531 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -47.6 -25.71 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 109.948 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 tp -78.09 -39.67 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.32 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.4 p -54.58 -29.52 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.355 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.44 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.5 OUTLIER -70.77 -52.46 20.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.856 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.09 -32.61 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -75.22 -34.97 61.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.772 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 17.6 p -72.05 -47.75 49.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.542 ' N ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -53.62 -53.87 45.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.554 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.72 -43.97 97.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.617 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.203 179.84 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.597 0.237 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.653 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -85.09 -6.21 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 110.36 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.613 ' C ' ' H ' ' A' ' 116' ' ' LEU . 12.0 mt -120.35 83.41 33.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.41 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 39.1 Cg_exo -54.0 11.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.79 2.326 . . . . 0.0 112.802 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.1 mt -75.16 -29.15 60.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.542 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 1.1 t70 -96.24 -40.22 9.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.805 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -67.87 -40.61 83.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.41 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.4 t90 -81.67 -16.02 52.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.45 74.15 20.2 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.68 -17.27 11.22 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.856 2.371 . . . . 0.0 111.841 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -51.71 -52.44 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 m -112.66 60.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.641 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.542 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 2.0 t80 -164.92 -40.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.329 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.4 125.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.81 146.56 23.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' LYS . 16.2 p -155.1 144.79 21.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.88 -175.71 38.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.477 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.1 m-20 -84.64 144.76 28.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.744 0.307 . . . . 0.0 110.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 32.8 m -92.72 132.65 36.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.963 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.88 -3.27 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.452 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.92 128.3 36.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.826 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -76.93 134.95 38.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -128.06 -19.63 3.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TRP . . . . . 0.586 ' NE1' ' SD ' ' A' ' 142' ' ' MET . 6.7 p90 -172.95 149.6 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.228 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.11 166.89 24.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.28 0.562 . . . . 0.0 111.87 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -122.8 138.41 54.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.38 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.57 17.04 0.51 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.411 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.2 21.65 44.51 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.0 mt -126.34 137.67 53.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 143.7 55.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.25 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.586 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -48.1 -53.36 33.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.3 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.3 Cg_exo -40.95 -35.81 1.85 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.33 2.02 . . . . 0.0 111.863 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -71.71 -49.64 37.6 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.619 ' O ' ' N ' ' A' ' 148' ' ' GLY . 79.5 m95 -59.17 -56.73 18.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.908 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -43.91 -38.54 3.45 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -58.74 -35.19 72.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.525 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.08 -47.04 93.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.583 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.7 mp -65.96 -43.67 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.52 ' CZ ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -49.04 -40.27 30.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.3 mt -65.38 -38.51 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.715 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 149' ' ' ILE . . . -52.99 -49.71 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.991 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.08 -45.71 93.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.563 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 158' ' ' VAL . 13.2 tp -47.97 -32.64 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.391 0.615 . . . . 0.0 109.844 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.0 mt -83.0 -37.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.292 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.0 t -52.61 -46.35 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.776 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.88 -44.17 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.548 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 154' ' ' LEU . 43.0 t -50.16 -40.66 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.11 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.24 -42.15 14.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.477 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 156' ' ' VAL . 55.6 t -64.68 -38.26 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.208 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.539 ' O ' ' NH2' ' A' ' 70' ' ' ARG . 63.8 t -71.75 -53.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 109.945 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.502 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -66.46 -5.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.185 179.657 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 2' ' ' LEU . 3.8 mm? -63.95 -39.27 93.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.205 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -54.25 -36.42 63.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLN . 43.2 m-85 -72.25 -44.31 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.57 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -45.69 -42.9 12.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 110.095 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -68.33 -25.4 65.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.19 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.4 tp-100 -78.79 -48.77 14.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.42 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 11' ' ' GLY . 39.1 p -76.7 -41.02 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -69.03 6.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.139 0.495 . . . . 0.0 110.304 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.21 140.8 15.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -68.9 -49.2 60.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.846 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.95 -46.07 6.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.12 85.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.114 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -56.88 -47.1 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.55 -27.94 68.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.14 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.24 -36.41 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 mmt -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.202 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.11 73.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.909 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.08 -34.14 73.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.978 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 m -59.68 -58.98 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.626 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.17 -25.67 65.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -77.33 -42.11 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.279 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 28' ' ' THR . . . -61.39 -24.34 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.19 -45.4 10.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.454 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.0 -37.74 88.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.756 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.69 -51.42 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.925 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 24' ' ' ALA . 5.6 p -47.25 -37.15 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.91 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.815 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.1 -15.83 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.438 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.3 t-105 -94.46 -33.4 13.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.545 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -38.45 79.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.482 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -72.13 -39.2 68.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.579 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -8.42 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' TRP . 78.9 t -108.99 -46.48 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 mmt -96.2 14.43 24.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.744 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt 43.01 42.63 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.7 mt -70.01 154.98 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.115 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -111.56 103.28 54.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.108 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -52.1 167.84 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.154 1.903 . . . . 0.0 111.545 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.8 175.4 9.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.5 t -61.7 -48.31 89.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 9.8 mp -61.34 -45.51 94.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.14 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -49.09 -44.73 42.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.429 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 124' ' ' PHE . 69.6 mt -61.45 -43.82 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.094 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -47.11 73.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.597 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.397 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' NH2' ' CD1' ' A' ' 52' ' ' PHE . 3.8 tmt_? -62.63 -37.66 87.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.548 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.34 78.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -59.13 -48.36 81.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.817 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.8 tp -79.56 -50.3 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CD1' ' NH2' ' A' ' 48' ' ' ARG . 66.2 t80 -46.23 -41.48 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.759 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.93 -44.2 89.47 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 50' ' ' ALA . 47.5 t -62.61 -47.3 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.3 tp -44.62 -48.09 10.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.523 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.08 92.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.86 63.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.446 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.72 76.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.352 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.0 -27.09 54.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.45 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.9 mt -81.8 -43.48 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.397 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.79 -32.94 78.85 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.85 4.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.715 0.293 . . . . 0.0 110.944 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.7 mt -83.33 -26.49 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.67 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB1' ' OG1' ' A' ' 67' ' ' THR . . . -173.23 65.48 0.33 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.433 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.16 11.14 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.648 2.232 . . . . 0.0 112.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -111.04 -6.47 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.25 161.89 24.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.639 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -38.16 -16.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.554 2.169 . . . . 0.0 112.287 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.4 tp -43.22 -31.47 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -40.79 -65.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.583 ' O ' HG13 ' A' ' 75' ' ' VAL . 6.7 m-85 -55.69 -29.89 60.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 75' ' ' VAL . 12.2 t -67.6 -43.11 87.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.639 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -29.06 30.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.275 0.559 . . . . 0.0 109.955 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.7 ttt -65.25 -12.97 57.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 72' ' ' VAL . 30.3 m -59.71 -37.15 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.524 0.678 . . . . 0.0 110.537 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' N ' HG23 ' A' ' 75' ' ' VAL . 8.3 mt -89.27 -30.05 5.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.215 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.472 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 2.5 t-105 -68.6 -49.72 57.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.995 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 78' ' ' LEU . 3.9 tt -66.53 -50.61 62.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.0 m-85 -43.69 -39.98 3.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -79.71 -23.81 42.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.75 -61.77 2.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.804 0.335 . . . . 0.0 111.159 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -51.95 12.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.085 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HE ' HD23 ' A' ' 87' ' ' LEU . 5.3 tpm_? -68.51 -47.87 65.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.656 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.92 -46.11 92.87 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.965 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.41 -37.69 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.796 -0.238 . . . . 0.0 111.472 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -67.98 -25.41 65.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.549 HD23 ' HE ' ' A' ' 83' ' ' ARG . 3.6 mm? -90.21 -35.36 15.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.892 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.6 p -57.33 -52.53 64.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -48.93 -49.85 38.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.376 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -51.91 -42.73 62.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -67.04 -34.49 77.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -74.48 -29.92 61.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.571 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.4 mmt -64.24 -41.18 97.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.356 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.72 -51.15 61.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.431 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 0.4 OUTLIER -57.2 -48.02 79.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.171 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -74.26 -22.67 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.416 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 98' ' ' PRO . 17.2 t80 -138.56 70.02 45.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 97' ' ' TYR . 42.8 Cg_exo -53.6 -159.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.826 2.351 . . . . 0.0 112.228 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p 175.09 152.5 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.16 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -37.77 154.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.694 2.263 . . . . 0.0 112.372 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.58 37.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.3 -45.34 26.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.537 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 104' ' ' SER . 20.4 m -47.98 -21.49 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 103' ' ' THR . 49.4 p 58.81 129.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.11 142.78 18.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CD2' ' N ' ' A' ' 107' ' ' MET . 5.6 p90 -159.33 -142.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.573 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 33.0 mtt -56.08 134.62 52.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 108' ' ' VAL . 12.6 p -70.18 131.99 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.624 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -86.03 99.85 11.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.249 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.64 150.31 94.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.64 160.18 50.72 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.732 2.288 . . . . 0.0 111.907 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -108.07 8.45 28.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -125.22 -5.7 7.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -123.02 81.58 50.88 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 36.1 Cg_exo -56.55 15.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.351 . . . . 0.0 112.671 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.616 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -76.28 -32.35 58.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.013 0.435 . . . . 0.0 110.253 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 1.1 m-20 -98.4 -40.28 8.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.347 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.24 -45.35 63.44 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.018 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 9.9 t-105 -76.76 -10.37 59.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.39 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.02 68.99 35.47 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.75 -15.44 12.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.867 2.378 . . . . 0.0 111.668 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -53.08 -32.15 45.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.627 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 44.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.622 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -148.57 -36.87 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.436 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.2 p -58.73 127.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.694 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.27 152.91 18.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.31 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -155.08 102.39 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.14 -168.07 19.38 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.3 154.1 19.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.631 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 36.3 m -99.01 138.78 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 111.204 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 101.04 -5.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.634 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.84 149.22 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -98.86 122.58 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.735 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.55 -29.76 9.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -173.68 146.54 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.46 158.08 44.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.293 0.568 . . . . 0.0 112.106 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 13.4 m-85 -112.89 137.71 50.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.175 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.7 mm? 48.61 17.44 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.425 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.62 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 92.61 22.3 29.18 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.223 -0.513 . . . . 0.0 111.995 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 139' ' ' GLY . 2.1 mm? -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 5.2 mp0 -72.41 146.56 46.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.3 mtt -47.24 -56.42 12.43 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -40.95 -38.58 2.94 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.565 2.176 . . . . 0.0 112.672 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -70.14 -51.8 28.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.9 m95 -58.79 -56.64 19.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.9 tp -43.69 -38.29 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.577 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.1 tt -59.54 -36.82 76.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.98 -46.48 94.5 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.7 mt -75.09 -25.63 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.015 0.436 . . . . 0.0 110.061 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -63.36 -44.03 95.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.765 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 151' ' ' ILE . 4.8 tt -70.23 -36.83 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.578 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -56.0 -48.75 75.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.55 -40.42 94.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.686 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 81' ' ' ALA . 86.7 mt -64.36 -32.42 74.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.41 -29.65 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 160' ' ' VAL . 43.1 t -63.38 -40.14 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.34 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -70.08 -50.03 45.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 154' ' ' LEU . 92.4 t -51.62 -39.25 23.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.1 tp -81.18 -37.35 28.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.14 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.5 t -71.0 -22.48 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.795 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 157' ' ' ALA . 61.6 t -83.12 -48.29 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.0 110.24 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 162' ' ' ILE . 81.5 mt -69.16 -14.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.9 m -52.91 -14.27 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.62 ' C ' ' H ' ' A' ' 166' ' ' PHE . 61.7 tt0 -40.07 104.04 0.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.59 2.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.234 1.956 . . . . 0.0 112.276 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.62 ' H ' ' C ' ' A' ' 164' ' ' GLN . 62.5 m-85 56.73 -95.2 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.434 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -163.61 -11.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.643 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.69 66.29 9.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -76.06 -143.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.746 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 172' ' ' ASP . 16.3 pttm -158.51 -1.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.536 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.408 ' H ' ' H ' ' A' ' 170' ' ' LYS . 10.4 tpp85 65.08 -68.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.51 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 170' ' ' LYS . 5.5 m-20 -158.06 168.72 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.691 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.5 mm? -75.41 158.36 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -83.39 138.6 33.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.32 79.51 0.29 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -91.95 -76.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.365 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -99.18 -51.33 1.35 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.595 ' CG ' ' H ' ' A' ' 179' ' ' HIS . 16.0 t-80 59.45 -136.69 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 110.574 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.595 ' H ' ' CG ' ' A' ' 178' ' ' HIS . 34.4 t-80 -81.45 99.03 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.638 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -161.47 91.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -58.7 -176.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 32.4 m170 54.24 82.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.518 ' O ' ' ND1' ' A' ' 183' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.491 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.7 -47.81 81.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -49.64 -48.91 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.404 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -52.83 -45.6 67.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.277 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tp -48.78 -43.76 38.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.126 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -69.56 -26.36 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.076 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -75.96 -50.49 14.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.28 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.81 70.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' GLY . 50.4 p -76.85 -41.57 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -68.28 5.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.419 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.75 140.98 15.12 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -70.19 -49.9 45.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.615 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.73 -46.42 5.91 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.45 89.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -61.58 -37.17 82.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.05 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.1 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.138 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' THR . 6.8 tp -70.31 -30.0 66.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.752 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.423 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.2 mtp -73.41 -33.69 65.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.89 -55.3 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.53 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -47.03 -47.92 22.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 17' ' ' LEU . 31.5 p -53.48 -58.02 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.379 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.14 -34.65 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.8 tp -76.32 -41.97 46.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.21 -32.14 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.293 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.57 -37.32 42.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.13 -52.84 62.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.821 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.26 -50.24 74.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.747 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 24' ' ' ALA . 17.1 p -48.59 -44.06 36.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.861 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.34 -46.21 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.034 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -53.15 -19.57 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.534 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -92.27 -39.41 11.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.61 -30.85 14.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -83.77 -42.1 16.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.011 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.414 ' CE1' HD12 ' A' ' 30' ' ' LEU . 36.0 m170 -69.09 -14.49 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 36' ' ' MET . 9.2 p -109.11 -39.22 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.899 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.445 ' N ' HG13 ' A' ' 35' ' ' VAL . 1.1 tpt -97.23 11.55 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.867 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.632 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.2 mp 43.85 44.97 6.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.199 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 134' ' ' GLN . 5.3 tp -77.6 153.0 33.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -108.78 129.85 23.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.691 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.27 169.17 21.8 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.468 2.112 . . . . 0.0 112.184 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.95 159.57 38.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.561 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -50.82 -42.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.155 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.88 -45.13 87.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -51.08 -42.83 60.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 124' ' ' PHE . 33.3 mt -66.21 -43.1 92.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.241 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -58.85 -44.91 91.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.757 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.07 -49.7 76.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -59.11 -30.09 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.131 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.98 82.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.347 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -57.43 -49.73 75.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.649 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.07 -49.27 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -46.1 -41.34 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.98 -42.39 92.68 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.5 t -64.97 -47.61 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 109.975 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 tt -45.21 -44.87 11.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.654 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -37.01 94.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -63.97 -37.88 89.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.2 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.73 -34.17 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.31 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -75.72 -27.14 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.186 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.39 -40.43 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.64 -26.81 73.46 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.96 9.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.662 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.2 mt -82.08 -39.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.63 74.38 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 0.0 110.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.31 26.8 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.701 2.267 . . . . 0.0 112.086 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -108.13 -9.02 15.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.309 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.564 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.8 175.85 1.71 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.686 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.65 -4.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.239 1.96 . . . . 0.0 112.047 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.8 mt -47.98 -35.45 10.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 58.8 mtt180 -40.83 -70.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.429 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.9 t80 -49.61 -20.22 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.171 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 69' ' ' LEU . 9.8 t -83.38 -46.56 18.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.806 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.85 -38.85 64.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 110.928 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.501 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -61.16 -9.51 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.86 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 8.0 t -57.87 -41.4 79.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.323 0.582 . . . . 0.0 109.989 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.7 -32.62 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.549 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.2 t-105 -65.15 -51.68 59.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.7 tp -65.73 -47.52 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -44.07 -43.58 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.231 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 p -78.74 -21.0 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.718 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.57 ' HA ' HD22 ' A' ' 154' ' ' LEU . . . -60.46 -60.51 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.853 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -73.75 -55.12 6.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.178 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -65.57 -44.71 85.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 88' ' ' THR . . . -61.48 -45.49 96.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.426 -0.892 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 81' ' ' ALA . 66.1 t -73.18 -44.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.692 0.282 . . . . 0.0 111.622 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -61.03 -41.62 96.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.305 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.2 -45.37 48.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 84' ' ' GLY . 8.7 p -48.68 -49.36 38.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.659 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -52.0 -38.5 57.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -56.88 -42.23 79.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -68.01 -37.55 81.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.434 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -67.27 -41.44 85.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' TYR . 13.0 ttt -53.48 -48.45 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.12 -46.85 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.142 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -50.71 -41.32 56.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.132 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.0 mm? -91.17 -13.95 31.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' PRO . 80.1 t80 -121.48 85.48 43.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.407 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 97' ' ' TYR . 50.8 Cg_exo -52.94 -140.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.746 2.297 . . . . 0.0 112.247 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 99' ' ' SER . 14.2 p 60.88 58.28 3.64 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.66 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.804 2.336 . . . . 0.0 112.041 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 73.21 99.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.361 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.5 114.89 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.7 m -96.58 -60.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.697 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.1 t -120.0 -65.45 1.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 24.2 t0 60.87 -172.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.448 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.501 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 27.7 m-85 -147.5 76.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.571 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.561 ' C ' ' H ' ' A' ' 109' ' ' ARG . 7.9 mmt -85.9 128.8 34.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.7 t 61.39 -5.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 107' ' ' MET . 76.0 mtt85 -97.52 99.73 11.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.575 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 164.06 15.71 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -40.96 151.95 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.687 2.258 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.12 -9.71 14.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.555 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -110.26 -0.21 17.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.603 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 tp -126.46 77.49 72.91 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.139 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 42.2 Cg_exo -53.03 4.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.787 2.325 . . . . 0.0 112.436 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 114' ' ' LEU . 7.8 tp -61.38 -33.61 73.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.174 0.511 . . . . 0.0 109.978 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.53 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.3 OUTLIER -97.33 -43.88 7.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.528 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -66.95 -45.43 77.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.773 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -75.52 -11.75 60.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 70.51 46.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.7 -17.83 10.87 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.85 2.367 . . . . 0.0 111.884 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -57.44 -35.79 70.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.054 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.28 50.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.647 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.657 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -159.54 -35.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 125' ' ' VAL . 14.7 p -54.58 127.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.501 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.8 149.12 21.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -164.19 117.67 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.703 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.93 -169.28 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 11.9 t70 -93.94 163.29 13.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 61.5 m -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.53 -4.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.56 128.52 36.76 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.759 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' H ' ' CD ' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -62.24 111.8 2.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.196 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.611 ' HB3' HD11 ' A' ' 38' ' ' LEU . 61.3 mt-30 -111.53 -31.31 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.823 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -172.73 141.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.055 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -146.9 160.99 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.225 0.535 . . . . 0.0 111.897 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -122.84 139.51 53.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.942 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.08 17.52 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.823 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 22.61 51.01 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.26 135.41 52.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.837 0.351 . . . . 0.0 110.108 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.22 148.42 49.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.423 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 6.5 mtt -45.64 -60.33 3.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.35 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.5 Cg_exo -35.98 -37.62 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.68 2.253 . . . . 0.0 112.5 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -70.94 -50.46 34.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.014 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.596 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.8 m95 -60.81 -56.85 16.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.842 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.413 ' CD1' H101 ' A' ' 201' ' ' UQ2 . 4.2 tt -43.35 -35.6 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.248 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 tp -65.4 -33.87 76.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.46 -46.78 93.71 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.18 -38.8 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.686 ' CE2' HD11 ' A' ' 154' ' ' LEU . 26.2 t80 -50.88 -44.06 59.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.733 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.21 -40.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -55.72 -47.77 76.33 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.693 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.24 -46.2 88.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.04 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 150' ' ' PHE . 83.1 mt -61.7 -40.25 94.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.51 -40.38 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.464 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 152' ' ' ALA . 29.6 t -52.46 -43.29 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.397 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.81 -45.35 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 74.7 t -48.82 -36.78 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.937 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.09 -33.11 33.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.983 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 156' ' ' VAL . 91.7 t -76.32 -26.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.917 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.64 -50.54 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 164' ' ' GLN . 2.1 pp -65.68 -22.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.8 p -54.19 -4.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.596 ' NE2' ' O ' ' A' ' 166' ' ' PHE . 1.0 OUTLIER -117.56 148.19 42.4 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.477 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.64 52.52 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.413 2.076 . . . . 0.0 111.96 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.596 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 57.8 t80 41.26 -109.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.722 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 66.6 tttt -169.76 98.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.674 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.44 -56.65 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -179.2 23.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -82.14 87.49 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.587 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -93.96 128.31 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -65.68 157.53 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.636 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.14 -168.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.546 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.55 143.8 49.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.511 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -85.27 -122.35 1.15 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 54.26 170.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.767 0.318 . . . . 0.0 110.538 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.19 7.8 77.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.7 m170 58.9 42.41 19.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.43 132.38 53.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.38 -56.03 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.532 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 62.33 150.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 51.32 66.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.587 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.439 ' H71' H5M1 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.3 -38.64 88.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.383 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -58.32 -38.74 77.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' GLN . 32.9 t80 -69.42 -47.58 63.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -46.12 -40.03 10.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.338 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -69.14 -22.11 63.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.211 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' PHE . 17.4 tp60 -80.03 -47.4 14.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.58 88.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' GLY . 92.5 p -76.82 -38.89 53.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.509 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 25.6 tt0 -64.94 2.5 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.93 146.63 18.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 12' ' ' ARG . 4.7 ptm180 -67.89 -48.33 66.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.559 0.219 . . . . 0.0 110.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -45.73 6.07 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.09 -47.53 84.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -59.79 -39.26 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.091 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.029 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -70.05 -33.22 71.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.714 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.2 mtt -70.68 -33.93 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.6 -51.6 40.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.581 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.94 -34.21 62.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.7 m -63.34 -57.0 11.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.703 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -22.95 63.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.75 -42.06 16.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.417 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -41.71 60.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.838 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.9 mp -72.06 -33.69 68.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -62.05 -42.83 99.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.428 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.21 -40.9 51.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.4 m -54.68 -45.88 74.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.585 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.86 64.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.547 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 tp -65.49 -20.69 66.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.729 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.62 -41.41 11.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -51.35 -38.41 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -71.16 -38.85 72.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.324 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.98 -6.79 52.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.848 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.34 -47.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.0 mtt -97.52 11.62 36.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 tp 46.48 48.25 13.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.616 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.1 mt -84.56 152.9 23.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -117.32 133.08 23.24 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.82 176.88 9.48 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 111.953 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.457 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 8.3 t -131.9 177.79 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.68 -46.07 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.95 -48.82 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.373 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -48.78 -48.33 41.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.657 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.64 -41.46 90.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -55.17 -47.73 74.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -63.08 -38.24 90.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -63.69 -36.77 84.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -40.59 77.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.35 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 tp -73.31 -53.08 11.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.05 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -45.06 -38.69 5.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.813 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.84 -42.55 94.98 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 43.5 t -60.61 -46.97 94.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.98 -46.68 11.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.62 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.2 -28.76 72.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.63 -38.8 70.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.299 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.73 76.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.019 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 4.3 mt -73.76 -28.11 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.14 -39.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.12 -21.44 78.41 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.48 7.79 5.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.715 0.293 . . . . 0.0 110.892 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.3 mp -84.03 -35.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.57 71.61 0.27 Allowed Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.07 13.53 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.514 2.143 . . . . 0.0 111.827 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -106.68 -8.86 16.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.05 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.99 161.94 25.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.607 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -39.9 -14.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.479 2.12 . . . . 0.0 112.207 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -42.39 -34.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.639 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtt180 -37.94 -63.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 75' ' ' VAL . 67.4 t80 -51.63 -31.12 24.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.842 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 69' ' ' LEU . 11.3 t -69.32 -45.44 79.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.947 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.89 -33.2 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.196 0.522 . . . . 0.0 110.317 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.467 ' O ' ' SD ' ' A' ' 74' ' ' MET . 2.8 tmm? -63.21 -14.52 50.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.026 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 71' ' ' TYR . 94.3 t -57.52 -39.11 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.52 0.676 . . . . 0.0 110.524 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.36 -31.49 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.4 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 9.0 t-105 -65.94 -54.33 27.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.174 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' ALA . 14.9 tp -63.67 -47.68 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -42.79 -42.94 3.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.381 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.8 p -78.11 -23.21 47.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.12 -60.03 4.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.361 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -49.97 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.681 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -39.0 69.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.703 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.13 -48.29 86.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 86' ' ' GLN . 14.2 m -72.85 -48.33 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.595 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.58 ' N ' HG23 ' A' ' 85' ' ' VAL . 14.6 tm0? -48.46 -29.06 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.09 -42.1 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.254 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 62.9 p -50.94 -31.03 16.44 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.38 -51.5 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.873 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.07 -36.76 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -71.63 -39.27 70.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -73.44 -52.17 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.5 ttp -51.96 -52.94 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.12 -48.74 75.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -54.76 -36.06 64.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.217 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -92.33 -15.96 26.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.55 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 93' ' ' MET . 51.9 m-85 -139.36 68.43 39.48 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -48.85 163.87 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.718 2.279 . . . . 0.0 111.874 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.0 m -171.56 67.77 0.44 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.727 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.88 114.03 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.693 2.262 . . . . 0.0 111.963 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 102' ' ' ALA . 2.1 t80 -150.44 64.22 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.434 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . 44.84 -171.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 m 52.78 19.49 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -64.63 -16.82 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 54.98 47.03 23.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.46 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -43.43 -31.32 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.623 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmm -79.55 178.35 8.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 108' ' ' VAL . 2.4 p -124.3 99.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.44 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -106.07 99.64 9.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -101.04 159.79 28.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.175 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.39 160.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.441 2.094 . . . . 0.0 111.931 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.52 20.03 16.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.003 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' A' ' 113' ' ' TRP . 2.1 p-90 -122.09 9.87 9.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 116' ' ' LEU . 50.1 mt -122.01 81.04 42.95 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.271 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.1 Cg_exo -51.94 0.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.233 . . . . 0.0 112.267 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 mt -60.69 -32.23 71.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.429 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 27.9 p-10 -96.82 -41.3 8.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.625 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 35.4 tttm -71.69 -45.19 62.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.732 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -74.27 -16.79 60.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.532 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.8 71.96 29.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.983 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.51 ' O ' HG22 ' A' ' 125' ' ' VAL . 67.5 Cg_endo -78.1 -18.37 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.683 2.255 . . . . 0.0 111.861 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -50.14 -52.52 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.83 54.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.565 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -154.97 -40.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.322 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 121' ' ' PRO . 34.1 m -57.2 130.5 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.642 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.87 149.53 21.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -161.27 99.86 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.401 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.75 -177.32 20.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 44.4 t0 -91.4 157.05 17.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.54 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.7 m -103.51 131.25 50.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.123 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.02 -5.36 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.197 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.03 151.7 45.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.045 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -89.69 147.59 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.431 HE22 ' CM3' ' A' ' 201' ' ' UQ2 . 28.9 mt-30 -133.88 -31.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.459 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -174.89 143.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -132.97 164.15 27.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.769 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.21 118.01 9.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.283 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.81 16.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.4 10.63 79.56 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.1 mt -119.5 138.03 53.42 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.867 0.365 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.83 154.0 42.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.6 mtp -55.72 -50.25 88.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.584 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 55.4 Cg_exo -48.32 -38.8 34.71 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.446 2.098 . . . . 0.0 112.088 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -70.03 -42.51 72.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.524 0.678 . . . . 0.0 109.87 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.552 ' O ' ' N ' ' A' ' 148' ' ' GLY . 47.6 m95 -60.03 -56.15 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.222 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.9 tp -43.39 -42.76 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 143' ' ' PRO . 1.1 mt -56.91 -35.54 69.12 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.6 -44.28 96.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.835 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.81 -29.67 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.337 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 -44.78 88.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.987 0.422 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.4 -39.83 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.07 64.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.482 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.3 m-85 -52.91 -42.84 65.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 154' ' ' LEU . 0.8 OUTLIER -75.06 -29.43 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.247 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mt -70.83 -31.21 44.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.322 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 160' ' ' VAL . 16.0 m -78.25 -38.71 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.551 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.27 -54.23 40.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 159' ' ' LEU . 7.8 p -55.68 -45.22 79.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.545 ' N ' HG13 ' A' ' 158' ' ' VAL . 5.1 tp -63.23 -37.8 88.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 156' ' ' VAL . 47.7 t -71.49 -30.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.2 t -69.9 -50.16 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.999 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.18 -31.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.0 m -53.13 -18.82 2.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.408 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -104.12 110.65 64.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.363 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -43.92 85.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.175 1.917 . . . . 0.0 111.968 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' GLN . 18.4 p90 -44.21 162.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -42.98 125.0 3.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.492 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -122.36 -47.73 2.11 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 169' ' ' LYS . 27.6 pttt -86.29 101.94 13.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 172' ' ' ASP . 2.2 ptpp? -96.98 165.87 11.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.526 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 55.09 -81.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.56 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 170' ' ' LYS . 22.7 t0 64.01 124.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.638 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.6 mt -83.0 -162.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -145.79 165.6 28.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -79.97 -75.17 1.06 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -154.08 -33.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.52 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -160.4 17.45 0.21 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.418 ' C ' ' N ' ' A' ' 180' ' ' HIS . 5.0 m80 -68.64 -62.15 1.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.426 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 179' ' ' HIS . 46.0 t-80 45.92 21.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.418 ' N ' ' C ' ' A' ' 178' ' ' HIS . 47.5 t-80 -41.36 123.06 2.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.733 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.426 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 3.2 t-80 -110.19 -15.02 14.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.667 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 1.5 t-80 64.84 -144.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.528 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.667 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.561 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.431 ' CM3' HE22 ' A' ' 134' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -76.84 -47.2 22.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.389 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -56.68 -38.58 72.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.298 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLN . 8.6 t80 -66.13 -47.36 74.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.176 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.44 -38.03 8.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -67.86 -21.28 65.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.068 0.461 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' PHE . 30.9 tt0 -81.71 -46.45 14.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.26 84.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.2 m -76.95 -34.43 57.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 20.6 tt0 -67.95 3.16 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.54 146.87 18.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -69.97 -48.82 56.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.739 0.304 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.23 -45.84 6.47 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.83 -48.07 80.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -56.26 -47.86 77.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -27.32 68.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -69.8 -29.24 66.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.625 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.73 -34.09 60.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.232 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.9 26.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.887 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -54.45 -49.02 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -46.58 -58.65 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.553 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.31 -29.39 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.31 -39.44 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.711 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.81 62.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.638 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.1 mt -74.11 -37.92 64.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.63 -50.54 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -57.93 -43.84 86.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -59.47 -43.64 93.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.39 -29.26 62.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -67.95 -21.62 65.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.688 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -88.0 -42.38 12.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -51.59 -39.94 58.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.124 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -71.51 -37.23 71.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 39.3 m80 -75.85 -10.55 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.18 -47.96 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -94.08 11.9 28.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.896 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tp 44.65 44.26 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.14 148.18 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.472 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -109.67 130.33 22.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.8 Cg_endo -76.35 174.36 12.95 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.288 1.992 . . . . 0.0 111.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -131.85 -178.5 4.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.93 -45.22 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.917 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 43' ' ' LEU . 8.6 mp -76.07 -42.8 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.844 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 m -58.84 -51.9 68.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 124' ' ' PHE . 13.3 tt -64.81 -36.07 76.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.996 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.07 -46.68 85.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.788 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.67 -37.14 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.294 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.3 -33.83 74.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.319 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.55 76.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.493 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.81 73.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.92 -45.45 58.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.38 -40.27 11.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.688 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.39 79.91 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 47.3 t -62.25 -47.99 90.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.078 0.466 . . . . 0.0 109.937 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -45.11 -44.63 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.83 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -29.62 75.81 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -65.17 -37.42 87.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.11 -27.18 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.736 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -70.12 -39.94 75.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.596 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 60' ' ' ILE . 15.7 pt -82.49 -31.94 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.14 -31.44 69.23 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.86 7.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 mp -83.8 -26.98 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.76 71.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -68.35 17.44 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.338 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 64' ' ' ALA . 59.6 mttt -112.2 -4.14 14.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.41 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -112.06 160.46 29.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.611 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -37.72 -16.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.556 2.171 . . . . 0.0 112.048 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.6 tp -43.13 -33.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -40.12 -67.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.522 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.64 -33.05 53.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.604 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.5 t -65.89 -55.85 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.617 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.93 74.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.236 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.9 mmt -61.79 -12.19 15.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.26 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.0 p -63.15 -31.51 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.469 0.652 . . . . 0.0 110.069 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.08 -30.64 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.606 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.487 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.3 t-105 -65.68 -49.68 67.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.806 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.72 -44.36 77.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.418 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -46.92 -45.28 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.4 p -78.17 -21.96 49.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.02 -59.5 5.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.016 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.5 -53.07 10.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.6 ttt85 -66.89 -45.68 77.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.64 -47.1 91.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 81' ' ' ALA . 59.8 t -69.81 -47.26 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 90' ' ' GLU . 25.1 mm-40 -52.98 -21.46 4.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.151 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -40.53 12.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.454 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 92' ' ' THR . 24.5 p -53.07 -26.01 14.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.532 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.72 -44.79 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.469 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 5.2 mp0 -56.22 -46.64 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.395 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -61.51 -50.06 74.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.363 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 88' ' ' THR . 60.7 p -59.3 -50.56 73.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.55 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.5 ttt -53.95 -49.36 68.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.54 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.57 -48.0 82.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.264 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -49.98 -41.8 47.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.4 mt -96.71 -6.62 35.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.422 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.55 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.4 t80 -126.08 80.85 67.44 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.633 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 99' ' ' SER . 65.9 Cg_endo -77.43 -158.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.512 2.141 . . . . 0.0 112.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER 82.17 66.78 0.12 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.466 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.19 157.94 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 112.207 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 101' ' ' PHE . 34.7 t80 -165.27 -25.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -125.56 -19.87 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.377 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.1 m -80.85 64.29 5.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.483 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.3 p -77.84 122.89 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.622 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 51.84 93.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -48.84 107.71 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.187 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.4 ttt -160.22 125.23 3.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.598 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -70.29 142.71 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.427 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -150.04 100.0 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.04 149.56 42.75 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.188 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.82 130.58 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.53 2.153 . . . . 0.0 112.224 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -71.96 -0.05 10.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.226 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.556 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.73 0.01 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.238 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.578 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 mt -117.63 83.54 17.73 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.256 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -50.38 -0.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.688 2.258 . . . . 0.0 112.403 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.2 mp -62.66 -30.41 71.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 -39.82 9.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.672 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.67 -45.46 52.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.424 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 10.3 t-105 -73.64 -17.95 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.449 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.63 72.57 24.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.783 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.569 ' O ' HG22 ' A' ' 125' ' ' VAL . 70.8 Cg_endo -78.84 -17.54 12.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.662 2.241 . . . . 0.0 111.688 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -54.32 -52.59 61.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.863 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.07 55.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.745 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.424 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -157.93 -41.1 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.363 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 121' ' ' PRO . 35.4 m -60.61 131.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.17 157.91 16.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' PRO . 47.9 p -164.87 99.82 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.564 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.12 -176.93 21.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 23.8 m-20 -84.55 156.57 21.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.798 0.332 . . . . 0.0 110.381 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -105.09 130.25 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.792 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.55 -6.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.889 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.71 151.97 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.896 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.718 ' HE ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -91.6 135.73 33.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 0.0 110.997 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -126.73 -24.4 3.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.25 141.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.7 163.35 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 112.23 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -130.83 139.61 50.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.8 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.3 17.13 3.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.5 19.95 61.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mt -122.7 134.48 54.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.922 0.391 . . . . 0.0 110.364 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.58 150.98 45.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.514 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.41 ' SD ' H163 ' A' ' 201' ' ' UQ2 . 3.9 mtt -48.81 -55.18 21.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.765 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.6 Cg_exo -40.94 -37.98 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.379 2.052 . . . . 0.0 112.028 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -70.53 -50.91 32.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.253 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.0 m95 -59.66 -57.25 13.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.487 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.733 HD13 ' C ' ' A' ' 146' ' ' LEU . 3.0 tm? -43.53 -41.76 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.628 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.4 tt -55.53 -36.86 67.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.96 -40.83 93.85 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.728 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.2 mp -79.61 -26.55 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.192 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.14 -50.2 71.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.273 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 152' ' ' ALA . 7.7 tt -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.593 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.437 ' N ' HG23 ' A' ' 151' ' ' ILE . . . -50.28 -47.29 55.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.237 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.65 -45.91 73.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.5 mt -58.2 -30.54 66.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.832 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.54 -27.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.706 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 160' ' ' VAL . 95.8 t -71.45 -36.19 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.976 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.487 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.25 -52.74 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.544 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 154' ' ' LEU . 86.2 t -52.75 -38.76 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.627 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 3.7 mm? -81.71 -32.35 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.118 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.3 t -76.5 -22.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.8 t -80.63 -50.56 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 109.945 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.474 ' C ' ' H ' ' A' ' 164' ' ' GLN . 68.2 mt -68.81 -17.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.55 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 90.8 p -52.72 -8.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.55 ' C ' ' H ' ' A' ' 166' ' ' PHE . 44.2 mm-40 -76.02 147.05 79.84 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.516 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 166' ' ' PHE . 54.0 Cg_exo -47.92 -4.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.434 2.09 . . . . 0.0 112.49 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.55 ' H ' ' C ' ' A' ' 164' ' ' GLN . 51.7 t80 -31.41 -82.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.234 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -45.14 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -141.48 -149.03 0.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 168' ' ' ALA . 26.5 mttm 57.1 117.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.529 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -151.54 35.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.434 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 63.09 91.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.589 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -173.68 171.56 3.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.628 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.92 158.93 33.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -85.43 -108.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 170.48 128.91 1.06 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -161.57 23.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.623 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.07 160.1 9.9 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -114.1 103.13 10.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.875 0.369 . . . . 0.0 110.393 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -85.31 -49.87 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 9.8 p-80 -72.5 170.93 13.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.605 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 12.7 m-70 -145.46 171.06 15.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -79.04 47.6 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.529 ' CG ' ' OXT' ' A' ' 183' ' ' HIS . 54.5 t-80 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.484 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mmt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.521 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.5 tt -61.13 -55.66 29.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -46.8 -36.42 7.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.561 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -39.72 75.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -50.34 -44.16 54.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.305 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.84 -25.78 66.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.191 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -78.69 -46.78 18.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.8 76.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -76.62 -31.62 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.956 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 66' ' ' LYS . 17.5 tp60 -75.15 7.68 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.015 0.436 . . . . 0.0 110.462 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.17 145.58 17.02 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.06 -20.35 65.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.312 . . . . 0.0 110.601 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.59 58.48 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.43 67.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -55.98 -46.15 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.225 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.17 -31.66 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.523 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -32.45 71.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.3 mtt -69.85 -34.57 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.459 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.87 59.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.733 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -50.23 -51.05 47.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -52.32 -56.66 13.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.04 -31.24 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.88 -40.85 24.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.803 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.44 -44.56 17.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.706 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.4 mp -68.14 -25.4 65.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.02 -39.48 75.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.801 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -77.95 -47.34 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -50.23 -45.94 54.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.96 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.65 -20.99 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.829 0.347 . . . . 0.0 110.697 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -90.12 -22.14 21.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.5 -38.22 71.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.244 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 0.36 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.224 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -120.84 -49.35 2.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.46 -37.59 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.894 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.528 ' SD ' ' CZ3' ' A' ' 135' ' ' TRP . 15.8 ttt -109.81 13.54 23.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.6 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 37' ' ' LEU . 6.5 mp 42.36 37.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.51 149.69 43.88 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.657 ' HZ2' ' HB3' ' A' ' 39' ' ' LYS . 4.1 mtpm? -110.34 125.76 30.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.15 145.99 19.69 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.429 2.086 . . . . 0.0 111.891 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -101.06 -174.99 2.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.708 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.77 -46.73 91.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.08 -47.03 88.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -51.49 -44.49 62.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 124' ' ' PHE . 71.3 mt -61.42 -48.13 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.487 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 11.1 t80 -54.65 -44.99 73.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.728 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.52 -48.19 73.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.663 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -60.04 -38.21 82.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.73 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.2 90.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.507 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.03 76.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.405 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -73.41 -48.39 34.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.13 -42.24 19.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.8 -45.65 81.96 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 56.1 t -62.24 -45.81 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.135 0.493 . . . . 0.0 109.749 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 tp -44.2 -48.59 9.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.352 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.95 97.52 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -56.54 -37.87 71.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.46 . . . . 0.0 110.295 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.54 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.327 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -70.23 -44.73 67.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -73.52 -35.32 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -31.08 68.27 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.75 5.5 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.694 0.283 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 90.2 mt -79.18 -42.57 23.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.07 77.23 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.343 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.88 30.87 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.718 2.279 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HB2' HE21 ' A' ' 10' ' ' GLN . 4.3 tmmm? -110.54 -9.82 14.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.127 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -108.83 176.21 1.66 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.889 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -6.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.126 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 67' ' ' THR . 37.7 mt -53.47 -28.1 28.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -40.76 -70.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -54.95 -30.52 59.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.413 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 75' ' ' VAL . 9.3 t -67.02 -54.48 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.785 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.66 63.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.264 0.554 . . . . 0.0 110.222 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 74' ' ' MET . 6.6 tmm? -59.13 -12.23 4.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.961 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.2 p -62.7 -32.46 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.379 0.609 . . . . 0.0 110.355 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.29 -32.95 5.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.039 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.56 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -66.06 -48.81 69.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.864 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.1 tp -65.9 -48.63 70.83 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -42.42 -42.52 3.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.125 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 84' ' ' GLY . 18.2 p -79.4 -21.38 45.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.89 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.729 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.27 -61.51 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.069 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -71.48 -45.59 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.555 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.487 ' CZ ' ' OH ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -77.54 -41.96 37.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 80' ' ' SER . . . -57.6 -49.63 72.05 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.385 -0.912 . . . . 0.0 110.825 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 81' ' ' ALA . 28.2 m -68.3 -43.25 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.002 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.491 ' N ' HG23 ' A' ' 85' ' ' VAL . 45.9 tt0 -56.64 -31.36 64.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.506 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -77.12 -43.42 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 110.32 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 33.5 p -52.32 -26.69 12.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.288 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.49 -50.02 64.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.641 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -52.19 -41.26 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -62.43 -48.97 77.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.2 p -66.77 -48.95 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 97' ' ' TYR . 15.5 ttt -49.96 -49.96 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.67 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.02 -47.5 77.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.681 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -53.92 -37.86 64.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -11.14 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.584 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' MET . 29.2 t80 -145.41 81.19 10.42 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.686 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.4 136.09 9.73 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.733 2.289 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -124.76 151.3 67.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.292 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.22 -59.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.408 2.072 . . . . 0.0 112.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -57.75 104.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.36 150.46 22.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.53 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 104' ' ' SER . 63.8 p -48.9 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 103' ' ' THR . 3.2 m 179.58 12.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.4 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.42 58.58 3.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.42 -22.06 60.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.343 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' ARG . 75.6 mtm -149.0 162.63 39.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.652 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 108' ' ' VAL . 2.7 m -52.87 84.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 107' ' ' MET . 2.9 tpp180 -84.77 101.67 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 111' ' ' PRO . 44.9 m-85 -122.01 153.22 60.78 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 110' ' ' PHE . 90.9 Cg_exo -36.46 160.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.584 2.189 . . . . 0.0 112.117 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 2.4 pm0 -95.05 6.58 48.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.813 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.584 ' O ' HD22 ' A' ' 114' ' ' LEU . 20.9 p-90 -124.71 27.16 6.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.594 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 113' ' ' TRP . 3.1 mm? -122.58 78.15 46.92 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.852 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.24 -3.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.732 2.288 . . . . 0.0 112.266 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.5 mp -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 110.368 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -96.73 -42.98 7.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -70.24 -45.5 66.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.642 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -73.88 -17.14 61.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.17 71.78 33.57 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.26 -17.41 10.38 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.9 2.4 . . . . 0.0 111.785 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -51.89 -52.57 48.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.627 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.8 53.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.558 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.629 ' O ' HD13 ' A' ' 45' ' ' ILE . 1.2 m-85 -155.4 -40.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 125' ' ' VAL . 6.2 p -55.75 128.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.441 ' HA ' HD11 ' A' ' 45' ' ' ILE . . . -95.13 151.0 19.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -169.94 100.59 0.3 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.43 177.88 18.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 11.8 t70 -86.53 138.22 31.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.094 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 37.3 m -92.96 130.66 38.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.45 -7.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.85 147.83 52.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -80.99 132.18 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.422 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.38 -26.33 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.627 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.528 ' CZ3' ' SD ' ' A' ' 36' ' ' MET . 0.6 OUTLIER -175.69 135.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -139.01 167.17 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.158 0.504 . . . . 0.0 111.606 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.26 120.09 10.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.474 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.1 16.91 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.499 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 81.71 16.8 72.12 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.499 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.7 mp -120.85 136.29 54.96 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.76 154.6 41.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.594 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -55.42 -51.57 78.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 142' ' ' MET . 75.5 Cg_exo -45.84 -37.78 17.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.384 2.056 . . . . 0.0 111.785 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -72.88 -48.48 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.819 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 50.2 m95 -57.24 -57.19 13.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.435 HD13 ' H13' ' A' ' 201' ' ' UQ2 . 17.0 tp -44.26 -38.88 4.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.1 tt -55.11 -37.54 67.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.21 -45.56 95.84 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.597 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.7 mp -75.63 -25.67 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 109.908 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.97 -46.32 85.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.5 pt -67.88 -35.77 73.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.385 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.98 -49.48 77.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.343 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.39 -48.37 71.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.717 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.547 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 31.1 mt -62.56 -34.32 76.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.073 0.463 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.9 mt -71.03 -35.56 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.611 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 160' ' ' VAL . 56.1 t -66.57 -42.1 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.321 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.693 ' O ' HG22 ' A' ' 161' ' ' VAL . . . -62.37 -34.21 76.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.3 t -73.35 -25.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.216 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 163' ' ' SER . 13.4 mt -84.83 -40.01 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.335 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 156' ' ' VAL . 34.7 m -73.97 -25.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 157' ' ' ALA . 31.6 m -82.89 -49.37 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.778 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.528 ' N ' HG23 ' A' ' 161' ' ' VAL . 35.1 mm -72.02 -8.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 2.7 m -56.29 -25.32 48.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -173.68 78.97 0.38 Allowed Pre-proline 0 CA--C 1.528 0.129 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 166' ' ' PHE . 86.2 Cg_endo -85.2 19.65 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.973 2.449 . . . . 0.0 112.09 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 165' ' ' PRO . 6.0 m-85 55.23 165.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -64.38 -92.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.645 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 169' ' ' LYS . . . -176.6 -45.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 168' ' ' ALA . 37.9 pttt 31.59 55.62 0.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -70.1 135.44 49.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.174 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -50.66 -178.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.786 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 60.32 122.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.91 25.08 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 t80 54.17 90.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.687 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 47.49 -139.48 9.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -140.49 98.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.37 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -158.17 43.08 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.644 ' CD2' ' H ' ' A' ' 179' ' ' HIS . 3.3 p-80 -53.11 -79.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.318 . . . . 0.0 110.456 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.644 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 97.4 m-70 45.67 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.24 162.35 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 59.4 83.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.681 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -49.62 164.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.502 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.8 m80 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.488 -179.945 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.459 H3M2 ' O2 ' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.8 mtp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER -77.44 -46.17 23.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.48 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -52.26 -31.91 34.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 7' ' ' GLN . 10.6 t80 -76.26 -42.07 46.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.374 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -46.42 -39.67 10.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.569 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 31.7 t30 -66.57 -24.05 66.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.259 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' PHE . 41.9 tt0 -81.02 -45.89 15.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.54 89.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 11' ' ' GLY . 57.4 p -76.29 -37.37 57.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.638 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 6' ' ' ASN . 10.4 mt-30 -67.03 5.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.7 145.59 17.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.45 -48.48 60.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.34 6.05 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.94 81.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.144 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -58.25 -47.36 83.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.29 -28.33 68.01 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -69.55 -29.46 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -32.97 61.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.41 17.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 -52.83 39.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.678 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.0 p -48.26 -57.91 5.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.755 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.31 27.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 tt -81.45 -38.85 25.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.68 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.933 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.0 mp -69.0 -33.14 73.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.715 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -63.38 -41.37 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.1 -50.04 21.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.931 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -47.76 -47.2 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.665 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.95 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.34 -20.44 66.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.4 ' CE2' HG21 ' A' ' 35' ' ' VAL . 60.5 t90 -88.27 -42.77 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -51.61 -46.63 63.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.165 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' C ' ' OE1' ' A' ' 33' ' ' GLN . 0.5 OUTLIER -70.11 -29.01 65.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -68.04 -26.89 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG21 ' CE2' ' A' ' 31' ' ' TRP . 56.7 t -104.8 -53.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.162 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.0 mtt -75.4 3.51 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.17 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt 44.53 47.22 8.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.563 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 38' ' ' LEU . 96.6 mt -77.54 154.67 32.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.569 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -116.1 126.33 27.74 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 174.72 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.246 1.964 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.7 t -131.85 -175.82 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.765 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 40.5 t -64.44 -44.44 97.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.722 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.21 -49.96 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.54 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 9.2 t -49.14 -50.19 38.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.526 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.59 -41.36 89.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.918 0.39 . . . . 0.0 110.186 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -45.26 76.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.742 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -63.93 -35.96 82.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.044 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -65.27 -41.51 94.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.233 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.59 78.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.42 74.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.055 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.3 tp -77.41 -45.91 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.993 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -38.66 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.46 80.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 38.0 t -62.81 -47.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.241 0.543 . . . . 0.0 109.71 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.8 tp -42.87 -47.2 5.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.562 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.4 92.38 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -55.87 -43.57 77.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.17 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.75 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.227 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.68 -43.23 94.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mm -74.38 -43.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.623 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.13 68.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.34 4.36 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.43 -44.74 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.537 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -174.04 74.73 0.36 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.97 18.34 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.666 2.244 . . . . 0.0 112.407 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -104.9 -7.66 19.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.98 176.85 1.33 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.446 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.5 1.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 0.0 111.878 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.3 tp -54.71 -34.89 63.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.639 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' SD ' ' A' ' 74' ' ' MET . 30.9 mtm105 -38.24 -66.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -53.64 -22.1 8.12 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.176 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 75' ' ' VAL . 5.0 t -78.99 -48.26 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.336 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.16 -35.04 56.35 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 110.167 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.611 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.1 OUTLIER -64.83 -9.73 22.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.167 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 72' ' ' VAL . 6.3 p -62.67 -35.38 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.1 mm -87.93 -33.74 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.831 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.574 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 16.7 t-105 -61.1 -50.42 73.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.046 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.93 -45.03 79.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -45.19 -44.87 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -79.89 -23.36 41.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.3 -60.45 3.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.631 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -71.76 -56.32 6.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.169 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -66.39 -51.05 61.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.85 -47.73 52.77 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 81' ' ' ALA . 70.0 t -65.28 -32.05 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.266 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.54 -33.28 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.43 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.96 -40.65 38.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.542 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 46.6 p -52.77 -35.25 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.737 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.42 -52.14 24.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -46.1 -31.05 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.35 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -75.91 -45.56 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.652 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.1 p -67.5 -49.73 62.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.691 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -49.9 -53.11 28.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.056 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.75 -49.62 72.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.464 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -49.84 -35.78 24.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.323 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 tp -100.16 -8.83 23.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' MET . 34.8 t80 -128.32 75.6 78.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.609 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.63 118.67 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.719 2.279 . . . . 0.0 112.016 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.09 154.39 74.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.25 88.53 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.493 2.129 . . . . 0.0 112.003 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.92 163.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.14 161.73 25.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.619 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.6 p -79.11 38.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.5 p -119.13 -12.36 9.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' PHE . 4.1 p30 -53.37 -53.8 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.605 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 67.6 m-85 -41.33 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.735 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 30.6 mtm -95.23 112.75 24.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.549 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 108' ' ' VAL . 33.3 m -72.97 121.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -78.14 99.79 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.255 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -90.27 150.35 42.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.539 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.03 150.24 88.27 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.581 2.188 . . . . 0.0 111.879 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -99.39 -15.19 18.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -4.18 58.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.395 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 116' ' ' LEU . 19.9 mt -128.44 80.77 71.88 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.1 Cg_exo -50.71 3.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.815 2.344 . . . . 0.0 112.269 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.2 mm? -57.72 -33.24 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 0.0 109.975 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.556 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -96.73 -45.35 6.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.531 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -65.73 -45.46 82.56 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.331 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 32.6 t-105 -73.75 -14.35 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.83 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 t -142.04 74.87 21.23 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.453 ' O ' HG12 ' A' ' 125' ' ' VAL . 72.8 Cg_endo -80.79 -17.12 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.849 2.366 . . . . 0.0 111.696 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -54.84 -53.76 51.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 123' ' ' VAL . 3.5 p -105.63 60.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.585 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.556 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -164.77 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.385 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 121' ' ' PRO . 13.6 p -62.4 130.22 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.1 157.98 15.98 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.8 p -162.73 99.66 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.499 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 142.84 -173.45 24.03 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.484 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 20.8 t70 -93.24 152.99 18.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.892 0.377 . . . . 0.0 110.172 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -104.68 128.59 52.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.54 -10.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.852 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -67.92 147.9 51.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 40.8 ttp180 -89.57 132.81 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.347 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -129.94 -21.47 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.503 ' CE3' ' SD ' ' A' ' 142' ' ' MET . 24.6 t90 -174.05 134.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.976 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -140.94 160.68 39.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.22 0.533 . . . . 0.0 111.914 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.77 140.46 50.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.085 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.68 17.44 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.607 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 87.49 21.82 46.44 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.607 HD22 ' O ' ' A' ' 139' ' ' GLY . 3.0 mm? -123.86 137.93 54.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -71.9 146.95 47.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.561 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.503 ' SD ' ' CE3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -47.39 -57.57 9.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.539 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.1 Cg_exo -38.28 -38.41 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.586 2.191 . . . . 0.0 112.568 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -73.28 -52.23 14.72 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.149 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.572 ' O ' ' N ' ' A' ' 148' ' ' GLY . 66.9 m95 -55.53 -58.0 9.58 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.823 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.1 tp -44.01 -39.36 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.673 HD23 ' O ' ' A' ' 147' ' ' LEU . 2.5 tt -54.96 -36.86 65.77 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.86 -43.37 99.3 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.643 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.94 -25.48 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -65.4 -43.56 90.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.6 pt -67.55 -37.8 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.286 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.88 -50.34 73.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.325 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.468 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 m-85 -54.33 -45.16 72.6 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.859 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.68 ' C ' HD12 ' A' ' 154' ' ' LEU . 0.5 OUTLIER -75.86 -29.72 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.881 -179.163 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.12 -35.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 160' ' ' VAL . 35.7 m -75.24 -35.86 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.75 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.574 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.81 -50.34 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.637 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.87 -48.03 78.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.463 HD11 ' NZ ' ' A' ' 169' ' ' LYS . 3.2 mm? -64.67 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 156' ' ' VAL . 16.6 t -69.23 -27.12 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.72 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.1 t -80.98 -46.13 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.427 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.6 mm -75.7 -13.99 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.6 p -67.61 -14.54 63.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.604 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.473 ' CB ' ' CD ' ' A' ' 165' ' ' PRO . 2.6 mp0 -67.06 -64.77 1.92 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.569 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 25.0 Cg_endo -61.79 -35.42 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.466 2.11 . . . . 0.0 111.838 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER 55.67 150.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.729 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 168' ' ' ALA . 44.6 pttt -175.86 -2.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.588 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 167' ' ' LYS . . . 60.57 119.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.463 ' NZ ' HD11 ' A' ' 159' ' ' LEU . 38.3 mttp -52.84 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -156.45 164.47 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 70.72 124.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 0.5 OUTLIER -80.26 -140.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 174' ' ' PHE . 3.5 mp -102.75 -57.48 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 173' ' ' LEU . 73.4 m-85 54.23 107.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -141.97 140.81 10.37 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.529 ' O ' ' NE ' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -82.59 -54.82 4.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.519 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 61.33 75.48 0.29 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -82.44 133.54 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.0 110.78 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -84.33 -173.96 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -120.43 171.77 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.512 ' H ' ' CD2' ' A' ' 181' ' ' HIS . 6.1 p80 -60.35 178.1 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.563 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -75.12 -74.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.4 m80 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.536 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.448 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mmt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.721 HD23 ' N ' ' A' ' 2' ' ' LEU . 1.9 pt? -59.35 -35.54 74.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.452 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -55.62 -40.47 72.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.305 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.37 -44.28 91.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.64 -42.16 44.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.309 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 10' ' ' GLN . 49.6 t30 -67.61 -28.14 67.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.915 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -73.04 -50.37 23.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.34 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.3 p -75.99 -35.36 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.588 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 38.3 mt-30 -74.32 12.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.966 0.413 . . . . 0.0 110.388 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.63 147.94 16.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -70.74 -49.89 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.32 -46.11 6.67 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.44 90.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.23 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.415 ' O ' ' HG3' ' A' ' 18' ' ' MET . 8.7 m95 -59.0 -32.03 69.33 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.942 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -74.29 -27.94 60.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -70.69 -36.37 73.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 18' ' ' MET . 1.4 ppp? -72.58 -31.22 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.2 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.2 -47.45 46.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.724 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.8 p -54.6 -62.16 1.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' HD13 ' A' ' 55' ' ' LEU . . . -49.23 -39.75 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.55 -41.47 75.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.07 -36.66 30.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.3 mp -71.71 -36.41 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.77 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.97 -46.29 89.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.116 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.16 -48.85 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.09 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.8 m -46.2 -43.06 14.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.18 53.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.494 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.43 -18.61 64.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.605 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.15 -44.67 52.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.52 -28.02 62.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -70.9 -24.78 62.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 36' ' ' MET . 7.5 p -106.52 -45.07 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.158 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.514 ' N ' HG13 ' A' ' 35' ' ' VAL . 1.2 mtt -83.96 5.07 26.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.86 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 mt 44.82 42.24 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.706 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.9 mt -80.42 153.73 28.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -117.84 130.32 24.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.79 179.39 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.249 1.966 . . . . 0.0 111.759 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.4 t -131.73 -175.49 3.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.402 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 126' ' ' ALA . 54.6 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.918 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -68.05 -50.12 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -49.41 -50.94 38.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.691 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.96 -41.08 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -54.61 -45.73 73.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.96 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.51 -40.21 86.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.161 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.4 HH21 HG12 ' A' ' 123' ' ' VAL . 41.6 ttp85 -57.89 -35.94 71.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.3 -38.31 78.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.472 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.438 HD21 ' HB1' ' A' ' 22' ' ' ALA . 5.2 tp -76.41 -51.07 12.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -46.99 -39.4 12.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -43.83 91.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' CG2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t -65.32 -41.58 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 110.037 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 22' ' ' ALA . 8.5 tp -50.8 -50.44 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.842 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.99 92.7 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.23 -37.29 34.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.975 -0.612 . . . . 0.0 110.218 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.53 -25.45 60.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -72.23 -43.42 64.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.579 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mm -73.64 -30.61 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.04 -26.46 48.78 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.58 -2.96 21.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.66 -20.8 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.502 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 178.86 68.87 0.12 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.75 25.79 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.875 2.384 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -110.27 -6.33 15.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.55 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.13 174.41 2.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.83 -9.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.226 1.95 . . . . 0.0 112.175 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.7 mt -51.32 -30.04 17.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -41.67 -69.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -51.53 -38.61 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.004 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.45 -54.04 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.45 70.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.399 0.619 . . . . 0.0 110.046 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.644 ' SD ' HG21 ' A' ' 161' ' ' VAL . 34.6 ttp -61.21 -25.24 66.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.612 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 71' ' ' TYR . 47.8 t -51.56 -37.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.242 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -85.38 -37.37 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.404 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.723 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 10.7 t90 -57.68 -49.47 76.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.68 -46.89 77.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -46.97 -47.57 21.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.426 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 59.6 p -79.28 -25.61 42.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.35 4.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -52.89 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -65.57 -42.46 91.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.781 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.72 -46.0 93.05 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.3 t -69.89 -54.24 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 111.12 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -47.7 -29.13 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.328 . . . . 0.0 110.743 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tp -85.16 -39.48 17.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.713 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 84' ' ' GLY . 40.7 p -53.18 -23.15 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.3 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -76.15 -40.48 52.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.506 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.35 -39.91 73.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.387 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.1 m170 -69.18 -49.53 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -61.96 -49.92 74.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.3 ttt -47.53 -46.71 27.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.635 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 98' ' ' PRO . 19.7 mt -68.52 -44.29 74.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.671 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -59.17 -47.14 86.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.58 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.87 -25.81 37.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.46 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 t80 -143.81 68.62 16.47 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . 51.6 Cg_exo -50.95 154.22 7.53 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.711 2.274 . . . . 0.0 112.003 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.516 ' O ' ' CZ ' ' A' ' 101' ' ' PHE . 15.1 m -153.27 59.21 2.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.43 159.12 47.11 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.757 2.305 . . . . 0.0 111.921 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.516 ' CZ ' ' O ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -131.75 -172.27 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.429 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.78 19.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 101' ' ' PHE . 3.8 p -132.92 -170.2 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -169.75 65.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.674 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -80.12 -167.23 1.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 51.83 69.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 107' ' ' MET . 5.4 ppp? -154.32 127.88 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.298 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 t 45.56 64.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -143.92 113.6 7.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.76 156.12 59.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.33 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 150.3 87.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.619 2.213 . . . . 0.0 112.042 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -101.37 12.85 36.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.459 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 8.5 p-90 -124.99 -2.95 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.709 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.607 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.82 86.3 19.03 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.873 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.3 Cg_exo -53.76 8.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.646 2.231 . . . . 0.0 112.483 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.5 mm? -73.63 -27.61 61.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.05 0.452 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -96.36 -41.02 8.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -70.59 -45.15 65.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.314 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 3.2 t90 -73.29 -18.1 61.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.54 73.71 20.12 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' O ' HG12 ' A' ' 125' ' ' VAL . 64.2 Cg_endo -78.06 -18.09 13.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.669 2.246 . . . . 0.0 111.802 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -70.69 -11.22 60.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.867 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.4 HG12 HH21 ' A' ' 48' ' ' ARG . 2.9 t -136.41 45.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -38.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 121' ' ' PRO . 7.3 p -58.29 129.74 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -95.48 152.93 17.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.525 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 t -166.01 100.32 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.656 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.67 -176.15 21.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.454 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 31.3 t70 -87.12 147.88 25.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.336 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 11.9 m -99.61 130.09 45.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.814 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.0 -4.56 0.34 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.16 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.98 129.65 40.58 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -66.39 128.72 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -126.03 -25.27 3.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.708 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -174.86 136.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -139.94 161.15 38.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.085 0.469 . . . . 0.0 111.412 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -137.05 119.83 16.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.29 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 2.1 tp 78.63 16.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 83.24 14.84 73.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 139' ' ' GLY . 7.3 mp -119.83 133.19 55.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.746 0.308 . . . . 0.0 110.262 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.559 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 2.1 mp0 -74.82 156.55 36.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.407 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 6.4 mtm -48.38 -61.39 3.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.6 Cg_exo -35.55 -41.05 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.57 2.18 . . . . 0.0 112.49 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.17 -44.22 60.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.608 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.4 m95 -66.13 -57.89 6.67 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.927 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.65 -38.56 3.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.434 HD13 ' OG1' ' A' ' 88' ' ' THR . 34.1 tp -62.36 -34.3 76.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.04 -49.11 69.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.562 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -66.35 -27.11 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -39.12 90.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.49 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 151' ' ' ILE . 2.4 tt -66.62 -36.58 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.38 -48.89 71.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.75 -41.45 81.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.709 HD12 ' CZ2' ' A' ' 77' ' ' TRP . 10.2 tp -53.96 -30.9 48.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 0.0 109.927 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 40.1 mm -79.63 -32.3 14.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.013 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 160' ' ' VAL . 92.3 t -65.63 -45.86 91.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.924 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.723 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.18 -46.76 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.138 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 159' ' ' LEU . 3.3 p -51.79 -40.61 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.544 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 158' ' ' VAL . 15.7 mt -80.11 -33.13 38.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.171 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.2 t -73.29 -24.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.957 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.644 HG21 ' SD ' ' A' ' 74' ' ' MET . 77.2 t -80.66 -50.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.103 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 162' ' ' ILE . 39.5 mm -71.25 -10.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.483 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.2 m -52.6 -19.45 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.236 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 166' ' ' PHE . 35.8 mt-30 45.8 56.43 15.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 164' ' ' GLN . 39.9 Cg_endo -68.74 14.52 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.639 2.226 . . . . 0.0 111.71 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.4 OUTLIER -145.95 133.31 20.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -73.1 -48.18 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.799 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.69 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.549 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 tttp 68.36 -1.44 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -93.26 -32.8 14.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.542 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -156.95 -165.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 29.5 t70 -152.8 175.79 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.451 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 2.4 pp -51.75 144.03 11.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -82.16 -69.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.91 -134.23 31.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -171.31 59.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.594 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -45.17 -49.11 10.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 32.0 m170 52.82 -115.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.752 0.31 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 180' ' ' HIS . 0.7 OUTLIER -83.07 -129.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.508 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.59 ' H ' ' CG ' ' A' ' 179' ' ' HIS . 65.6 m80 -144.35 74.48 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.488 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 52.15 -129.92 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -170.3 -20.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.535 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.539 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.46 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 2' ' ' LEU . 4.6 mp -68.34 -41.84 80.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.289 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -52.02 -41.41 62.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.193 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' GLN . 22.3 m-85 -63.86 -44.43 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.074 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -45.93 -41.75 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -67.9 -28.68 67.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.003 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' PHE . 5.9 tp-100 -76.03 -50.82 13.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.428 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.86 73.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.2 m -76.64 -42.27 42.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.427 ' O ' ' CD ' ' A' ' 10' ' ' GLN . 1.8 tm0? -66.52 3.3 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.387 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.94 145.07 17.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -68.8 -49.56 57.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.577 0.227 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.54 -46.3 5.69 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.56 85.44 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -58.36 -47.97 82.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.46 -29.36 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -30.93 68.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.47 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 tpt -72.08 -33.56 67.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.154 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.48 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -52.73 -51.35 60.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.667 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 p -51.56 -49.71 61.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.23 72.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.649 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.41 -38.02 77.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.482 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.69 -35.27 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.565 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.9 mt -74.42 -41.21 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.57 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -67.18 -55.48 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.761 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 27' ' ' LEU . 1.4 tt -54.86 -53.38 56.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 24' ' ' ALA . 16.9 p -49.31 -45.16 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.487 ' HB2' H121 ' A' ' 201' ' ' UQ2 . . . -72.07 -43.24 65.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.735 0.302 . . . . 0.0 111.047 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -53.76 -20.25 5.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.646 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -91.88 -39.49 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.542 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -48.86 -38.1 21.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.971 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -68.82 -38.58 79.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.77 -5.26 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.3 -46.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.891 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 30.6 mtt -100.81 10.01 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.926 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.95 42.61 28.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -87.69 154.06 20.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -121.09 141.43 32.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.864 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 127' ' ' SER . 88.0 Cg_endo -78.25 171.52 16.88 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 112.283 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.6 t -131.95 -173.67 3.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.405 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.9 t -64.3 -48.77 84.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 4.1 mm? -60.35 -46.88 88.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 41' ' ' CYS . 75.5 p -48.43 -43.97 34.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.333 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.54 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.919 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.53 -48.45 74.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.153 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 43' ' ' LEU . 2.5 mp0 -61.01 -42.73 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 52' ' ' PHE . 33.7 ttt-85 -64.3 -38.31 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.313 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.46 77.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.52 74.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.2 tt -78.35 -51.61 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.406 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 59.8 t80 -43.97 -40.08 4.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.667 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.46 74.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.5 -47.64 90.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.915 0.388 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 19.9 tp -44.53 -50.53 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.84 -49.37 75.1 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -32.7 18.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -67.37 -36.01 80.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.51 -32.03 69.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.595 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.7 mp -77.03 -38.49 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.585 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.76 -19.06 66.49 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.5 27.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.288 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 5.0 pt -83.77 -25.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.712 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.37 73.52 0.1 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.575 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.23 26.31 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.591 2.194 . . . . 0.0 111.96 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -104.66 -8.34 18.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.19 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.666 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.02 -2.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.264 1.976 . . . . 0.0 112.106 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.553 ' H ' ' C ' ' A' ' 67' ' ' THR . 42.9 mt -53.45 -33.85 55.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.549 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.8 ptp180 -40.89 -63.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.642 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.572 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 1.7 t80 -56.59 -29.85 62.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.458 0.572 . . . . 0.0 110.182 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' LEU . 12.5 t -68.22 -45.08 83.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.849 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.79 -32.59 46.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.51 . . . . 0.0 110.174 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 161' ' ' VAL . 29.9 ttp -65.43 -19.4 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.751 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.3 t -54.2 -37.25 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.373 0.606 . . . . 0.0 110.419 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.4 mt -88.72 -31.55 5.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.713 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.548 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -66.76 -46.88 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.482 HD23 ' CG ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -66.5 -48.54 69.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.47 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -44.78 -43.91 8.96 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 p -75.91 -24.15 55.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.555 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.99 -60.25 4.13 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.269 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -73.9 -53.4 10.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -67.91 -43.66 78.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.76 -46.05 95.24 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.91 -41.11 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.97 -45.18 93.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.528 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.98 -42.84 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.038 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 84' ' ' GLY . 4.2 p -48.8 -47.75 41.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.616 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -51.41 -32.37 26.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.404 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -71.01 -36.29 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.66 -36.99 73.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -74.2 -31.87 62.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.492 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.535 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.7 tpt -62.26 -43.14 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.421 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tp -64.2 -49.15 73.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.516 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -56.46 -46.92 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.82 -14.79 43.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.763 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' MET . 21.1 t80 -152.12 76.84 7.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.51 121.3 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.661 2.24 . . . . 0.0 112.004 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 101' ' ' PHE . 1.8 t -55.86 150.16 29.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 101' ' ' PHE . 77.1 Cg_exo -43.06 78.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.659 2.24 . . . . 0.0 112.589 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 99' ' ' SER . 0.3 OUTLIER 36.37 94.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.879 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . -158.9 176.65 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 20.5 p 50.07 77.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.691 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m -85.5 152.93 22.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.398 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.17 158.78 38.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.714 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -155.99 -72.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.374 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.5 mtp -85.07 130.31 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 108' ' ' VAL . 14.0 p -78.68 128.86 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.484 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 mtt85 -112.9 102.15 10.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.621 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -107.89 161.88 21.76 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.313 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' PHE . 90.7 Cg_exo -36.91 160.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.843 2.362 . . . . 0.0 112.307 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' CD ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -96.52 2.73 52.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.925 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.511 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 3.8 p-90 -125.01 30.08 5.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 110.745 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 116' ' ' LEU . 6.5 tp -125.63 68.96 62.23 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.409 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -46.51 -8.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 112.285 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 114' ' ' LEU . 6.7 tp -53.31 -33.7 54.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 110.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.46 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 4.5 m-20 -96.45 -43.76 7.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.209 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.14 -45.28 67.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -73.2 -18.87 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.568 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.56 72.31 25.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.179 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.77 -15.25 9.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.837 2.358 . . . . 0.0 111.538 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -49.22 -48.14 45.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.77 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.91 53.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.46 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 5.7 t80 -156.11 -39.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 125' ' ' VAL . 8.4 p -60.86 130.0 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.66 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.97 150.54 20.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' PRO . 6.4 t -161.52 99.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.53 -172.45 23.02 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.529 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -88.41 151.52 22.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.671 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 12.9 m -103.19 130.3 50.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.21 -9.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.05 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 150.72 47.87 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.976 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -85.9 136.1 33.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.461 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -127.39 -17.62 4.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -172.92 120.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 7.7 t0 -115.04 148.96 38.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.344 0.593 . . . . 0.0 112.28 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.533 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 7.3 t80 -128.57 136.73 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.737 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp 54.27 17.44 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.439 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 88.14 13.02 64.73 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.665 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 139' ' ' GLY . 9.1 mp -121.11 146.82 46.35 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -76.72 151.26 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.464 ' SD ' H151 ' A' ' 201' ' ' UQ2 . 4.0 mmt -48.04 -63.36 1.55 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.3 Cg_exo -32.18 -38.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.938 2.425 . . . . 0.0 112.449 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -69.45 -53.75 17.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.277 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 76.8 m95 -60.17 -57.02 14.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.0 tp -43.73 -37.67 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.88 -34.97 76.98 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.3 -44.57 96.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -76.28 -25.89 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 154' ' ' LEU . 39.7 t80 -62.45 -45.64 92.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.482 ' O ' HD13 ' A' ' 155' ' ' ILE . 15.5 pt -68.82 -38.7 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.479 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -53.73 -48.19 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.362 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.34 -41.67 94.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 150' ' ' PHE . 37.6 mt -69.29 -30.62 68.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.4 mp -77.83 -27.34 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 152' ' ' ALA . 54.7 t -73.85 -35.45 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.645 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -69.99 -52.36 24.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.107 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.86 -33.93 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.932 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.27 -43.55 23.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 156' ' ' VAL . 52.4 t -69.14 -26.86 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.888 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 157' ' ' ALA . 48.6 t -75.01 -45.44 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.328 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 164' ' ' GLN . 72.5 mt -66.64 -21.23 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.7 p -58.4 -4.25 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 166' ' ' PHE . 4.2 pt20 -45.74 152.46 0.72 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.409 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -37.85 -22.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.614 2.21 . . . . 0.0 112.29 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' GLN . 9.6 t80 71.78 31.79 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 43.42 25.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.09 134.64 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.448 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' LYS . 9.9 tptp -100.12 -78.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 169' ' ' LYS . 13.5 mmmt 48.63 179.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.612 ' CA ' ' HE ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 41.11 77.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -170.88 34.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.473 ' CG ' ' H ' ' A' ' 174' ' ' PHE . 4.2 tp 63.56 -137.76 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.473 ' H ' ' CG ' ' A' ' 173' ' ' LEU . 3.5 m-85 47.08 61.37 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -55.4 -76.41 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -86.78 -51.24 6.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.7 -167.56 24.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -176.62 -178.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' A' ' 181' ' ' HIS . 2.8 m-70 -45.28 -56.24 5.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.672 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 8.2 t60 69.83 -38.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 179' ' ' HIS . 23.3 t60 -52.27 -61.86 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.558 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -62.22 -139.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.452 ' ND1' ' OXT' ' A' ' 183' ' ' HIS . 65.3 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.538 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.648 ' O1 ' H2M3 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 mt -61.82 -42.68 99.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.311 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -54.13 -42.89 70.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -45.38 87.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -50.34 -42.18 52.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.3 -29.48 69.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -78.53 -49.42 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.514 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -62.38 -33.34 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.69 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 41.3 p -76.33 -34.22 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -74.28 10.03 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -107.29 142.06 15.7 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -62.55 -18.38 61.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 0.0 110.294 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.51 -48.29 51.78 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -62.61 -51.43 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -52.76 -40.17 62.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.029 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.26 -30.11 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.17 -34.28 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.403 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 mtt -74.85 -33.16 62.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.84 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.82 32.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.775 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.35 -30.92 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -61.53 -61.99 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.43 -23.84 41.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -78.09 -39.92 40.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' THR . . . -58.63 -31.03 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.829 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -78.8 -29.71 45.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.736 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.77 -47.09 64.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.01 -46.4 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 24' ' ' ALA . 11.5 p -50.13 -46.33 53.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -73.19 -38.41 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.941 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -17.93 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.219 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -97.28 -25.87 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -46.62 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.773 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.492 ' NE2' ' O4 ' ' A' ' 201' ' ' UQ2 . 19.4 mp0 -83.68 -30.1 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.008 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -60.38 -26.21 66.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.251 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 36' ' ' MET . 8.5 m -105.66 -38.11 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.805 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.406 ' N ' HG23 ' A' ' 35' ' ' VAL . 16.5 mmt -74.96 1.96 11.59 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.27 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 tp 55.83 50.48 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.722 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.1 mm? -103.84 156.17 18.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -117.01 142.27 29.65 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.659 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 127' ' ' SER . 65.7 Cg_endo -74.39 173.68 13.83 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.51 2.14 . . . . 0.0 111.918 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -131.94 178.43 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.46 -43.93 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.421 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.22 -48.93 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.468 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.3 t -51.8 -50.73 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.891 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.62 -38.62 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -54.46 -47.29 73.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.559 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -61.38 -43.85 98.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.265 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.32 60.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.091 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.23 80.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.88 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 mt -76.78 -53.33 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.997 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -45.81 -40.61 9.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.44 -45.35 86.29 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 8.1 t -61.84 -45.16 99.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -46.87 -44.0 19.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.566 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.28 -28.22 73.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.575 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.76 -26.84 57.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.56 -42.91 77.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.15 -29.93 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -12.74 83.08 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.81 1.78 51.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.529 0.204 . . . . 0.0 111.25 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 3.3 pt -87.22 -27.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.963 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.8 72.46 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.83 0.347 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.78 24.75 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.951 2.434 . . . . 0.0 112.177 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -104.9 -8.7 18.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.82 176.74 1.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.481 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -47.81 -4.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.321 2.014 . . . . 0.0 112.26 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.567 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 mm? -52.8 -31.22 37.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.139 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.496 ' NH1' ' OG ' ' A' ' 163' ' ' SER . 67.0 mtt180 -40.85 -69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.622 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.27 -35.73 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.437 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.4 t -62.27 -44.07 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.673 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.81 -33.13 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 109.483 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.62 -11.85 5.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.33 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.34 -42.85 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.288 0.566 . . . . 0.0 110.839 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.1 mt -87.06 -29.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.083 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.7 t-105 -60.74 -50.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.288 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 tp -70.07 -45.95 65.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.434 ' O ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -45.37 -50.41 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.015 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -71.12 -29.41 65.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.64 -58.92 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.425 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -70.85 -49.8 42.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -78.09 -33.8 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 83' ' ' ARG . . . -65.3 -46.93 84.85 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 81' ' ' ALA . 19.8 m -68.67 -44.72 82.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.766 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.516 ' N ' HG23 ' A' ' 85' ' ' VAL . 29.2 tp60 -50.13 -24.46 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.69 -41.1 16.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.8 p -49.0 -34.1 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.396 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.53 -52.0 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -49.1 -31.88 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -75.45 -50.18 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.013 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 p -68.97 -54.17 16.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.985 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.537 ' O ' ' N ' ' A' ' 97' ' ' TYR . 30.6 ttm -50.08 -49.14 52.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.3 tp -67.49 -39.25 85.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -63.08 -37.69 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.6 tp -97.44 -20.16 17.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' A' ' 93' ' ' MET . 8.8 t80 -127.93 79.58 73.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.797 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.91 155.17 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.619 2.213 . . . . 0.0 112.123 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 m -147.36 153.13 43.87 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.36 -1.59 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.555 2.17 . . . . 0.0 112.205 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -162.11 142.75 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.811 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -172.69 -0.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.556 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.3 m 46.26 92.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.587 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.1 m -72.22 -78.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.671 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.437 ' H ' ' H ' ' A' ' 106' ' ' PHE . 22.2 t0 -173.57 -1.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.683 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' H ' ' H ' ' A' ' 105' ' ' ASP . 17.0 m-85 44.05 80.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.522 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.425 ' O ' ' O ' ' A' ' 106' ' ' PHE . 44.7 mtm 58.46 151.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 108' ' ' VAL . 14.9 p -60.56 123.62 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.624 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -150.14 100.6 2.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.509 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -137.03 153.93 75.63 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.254 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 113' ' ' TRP . 88.8 Cg_exo -37.4 122.7 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.645 2.23 . . . . 0.0 112.195 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -75.97 20.05 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.499 ' CD1' ' C ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -88.53 9.06 25.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.211 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.1 tp -116.39 86.51 18.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.92 8.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.823 2.349 . . . . 0.0 113.003 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.5 tp -74.79 -28.12 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 124' ' ' PHE . 66.6 m-20 -95.76 -40.42 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.69 -33.99 76.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -86.93 -19.23 29.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.837 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.98 79.3 10.07 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 125' ' ' VAL . 74.2 Cg_endo -79.51 -16.08 12.08 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.605 2.203 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -79.86 -4.85 54.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.743 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 123' ' ' VAL . 21.3 t -128.77 45.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.194 0.521 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.507 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 10.4 t80 -172.23 -39.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.336 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 121' ' ' PRO . 61.6 t -54.75 125.18 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.483 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.07 157.69 15.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 40' ' ' PRO . 42.1 t -173.39 103.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.533 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.45 -172.62 24.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.4 m-20 -92.18 143.94 25.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.685 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 27.3 m -93.95 134.49 36.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 86.79 -0.05 0.57 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.06 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -67.73 155.66 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.245 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.59 145.69 25.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.411 ' OE1' ' O4 ' ' A' ' 201' ' ' UQ2 . 64.9 mt-30 -133.66 -29.23 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.75 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -174.41 145.54 0.99 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.194 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -138.91 167.72 21.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.082 0.467 . . . . 0.0 111.482 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 63.9 t80 -143.51 119.0 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.717 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.9 OUTLIER 78.27 17.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -177.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 81.05 15.93 75.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.1 mp -119.51 131.27 55.53 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.3 152.18 44.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.373 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -50.75 -52.34 57.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 142' ' ' MET . 82.9 Cg_exo -44.28 -38.92 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.159 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.87 -49.14 31.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 148' ' ' GLY . 48.7 m95 -56.71 -57.32 12.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.6 tp -42.83 -42.14 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.548 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.565 HD23 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -54.66 -35.75 63.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.94 -39.98 97.74 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.615 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.41 -30.71 11.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -47.72 84.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 152' ' ' ALA . 2.1 pp -68.3 -41.08 83.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.564 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' HD12 ' A' ' 151' ' ' ILE . . . -56.93 -49.57 75.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.106 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -51.46 -46.76 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 37.7 tp -52.8 -36.98 59.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.568 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 27.3 mm -68.78 -41.72 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.5 -37.66 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -75.47 -31.21 60.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.44 -27.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.351 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.15 -42.11 16.36 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.156 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.1 -31.87 36.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.195 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.0 t -73.25 -50.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.578 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.3 mp -62.96 -22.96 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.998 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.496 ' OG ' ' NH1' ' A' ' 70' ' ' ARG . 24.1 p -57.2 -0.09 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.49 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.592 ' O ' ' N ' ' A' ' 166' ' ' PHE . 8.3 mt-30 -38.34 160.42 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -40.77 -13.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.751 2.301 . . . . 0.0 112.553 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.592 ' N ' ' O ' ' A' ' 164' ' ' GLN . 16.7 t80 58.27 109.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -101.14 -35.42 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -176.74 145.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -168.81 -44.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.409 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -97.31 -43.91 7.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.56 92.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.618 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -53.81 -178.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.65 -127.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.5 t80 45.43 93.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.452 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -78.38 140.96 24.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -79.46 63.73 4.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 52.49 40.78 55.04 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 77.9 m80 50.76 -106.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.485 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.505 ' O ' ' CD2' ' A' ' 180' ' ' HIS . 0.4 OUTLIER 172.77 168.11 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 179' ' ' HIS . 18.4 m-70 -148.58 155.08 40.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.311 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.615 ' CG ' ' H ' ' A' ' 182' ' ' HIS . 12.2 p80 -175.57 -61.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.615 ' H ' ' CG ' ' A' ' 181' ' ' HIS . 8.7 t60 -96.0 -88.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.414 ' CD2' ' N ' ' A' ' 183' ' ' HIS . 26.9 m170 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.596 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.492 ' O4 ' ' NE2' ' A' ' 33' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -78.34 -36.53 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.078 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -60.46 -43.69 96.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 7' ' ' GLN . 42.4 t80 -62.21 -50.16 72.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -46.96 -37.24 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.245 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 38.2 t-20 -69.82 -25.91 63.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.311 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PHE . 85.9 mm-40 -82.4 -50.07 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.63 73.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.653 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 11' ' ' GLY . 88.7 p -76.24 -34.57 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.732 HE22 ' HA ' ' A' ' 66' ' ' LYS . 23.4 mm-40 -71.24 8.54 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.552 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.72 141.62 15.56 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -69.9 -50.1 45.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.769 0.319 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.12 5.7 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.06 86.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -60.63 -46.9 88.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.4 -30.27 68.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.37 -30.27 68.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.398 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.1 mmt -73.45 -31.16 63.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.73 -53.47 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.17 -32.69 64.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.928 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -65.99 -61.81 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.09 -23.86 62.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -81.82 -42.1 20.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.429 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -49.53 -50.97 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.648 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.2 mp -61.48 -33.88 74.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.599 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.88 -41.89 88.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.713 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.2 mm? -79.81 -52.13 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -42.11 -40.53 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.04 -41.72 34.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -55.36 -17.6 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.932 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -94.33 -35.34 12.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.607 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.82 -38.63 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.54 -35.29 60.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.555 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 1.5 t-80 -74.73 -10.12 59.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.294 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -109.18 -51.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.787 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.9 mtt -91.18 14.18 14.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.803 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.18 40.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.775 0.321 . . . . 0.0 110.721 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.31 152.11 46.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -108.66 115.93 56.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.87 147.73 21.7 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.272 1.981 . . . . 0.0 112.188 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 5.7 t -98.08 172.2 7.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.301 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 43' ' ' LEU . 8.3 p -59.46 -41.26 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.944 0.402 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HG13 ' A' ' 42' ' ' VAL . 76.4 mt -63.2 -45.27 92.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.056 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -48.84 -38.49 22.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.394 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.532 HG21 ' HA ' ' A' ' 124' ' ' PHE . 51.5 mt -69.49 -44.5 79.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.168 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -45.59 92.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.818 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -57.79 -44.34 86.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.386 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -61.33 -29.01 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -39.76 77.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.22 74.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 tp -76.59 -51.85 10.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -45.05 -39.96 6.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.25 -40.7 94.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 41.5 t -64.02 -17.71 21.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.699 0.762 . . . . 0.0 109.273 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -74.49 -45.17 47.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.426 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.81 83.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.38 -40.06 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.351 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.87 -31.45 69.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.94 -29.52 50.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.145 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -79.08 -39.91 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.557 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.74 -33.19 79.71 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.18 9.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.697 0.284 . . . . 0.0 110.652 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' A' ' 61' ' ' GLY . 66.0 mt -78.41 -54.92 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.288 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -168.1 75.36 0.89 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.566 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 21.5 Cg_exo -61.67 14.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.974 2.449 . . . . 0.0 112.485 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.732 ' HA ' HE22 ' A' ' 10' ' ' GLN . 13.8 ptpt -109.78 -3.58 16.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.84 161.03 31.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.685 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -39.4 -15.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.484 2.123 . . . . 0.0 112.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.2 mp -43.25 -35.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.721 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.4 mtm-85 -40.24 -65.57 0.39 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.13 -15.87 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.619 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 75' ' ' VAL . 19.3 t -82.1 -46.37 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.722 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.23 -34.05 59.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.045 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.82 -8.55 2.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.329 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 72' ' ' VAL . 32.7 m -59.25 -42.7 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 75' ' ' VAL . 6.1 mt -87.76 -29.77 5.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.23 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.611 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 4.9 t-105 -63.77 -53.58 48.8 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.777 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.04 -43.89 90.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.508 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -47.32 -46.88 25.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.5 p -80.44 -21.63 41.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.67 -61.98 2.22 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.909 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -73.99 -44.08 55.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.541 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -75.17 -42.11 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.076 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.29 -48.61 85.12 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 81' ' ' ALA . 17.3 m -71.04 -38.31 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.128 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.41 ' N ' HG23 ' A' ' 85' ' ' VAL . 14.3 tm0? -72.84 -36.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.32 -49.32 19.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.3 p -51.17 -49.1 61.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.573 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.53 -39.48 34.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 110.085 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -58.96 -41.69 88.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.379 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -66.78 -39.07 87.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.589 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -68.68 -35.02 76.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 97' ' ' TYR . 12.9 ttt -59.05 -44.13 91.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -59.59 -49.34 78.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.114 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -50.81 -49.24 58.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.179 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.1 mm? -82.91 -14.3 54.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.062 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 93' ' ' MET . 30.9 t80 -141.89 70.75 24.26 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.37 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.44 ' N ' ' O ' ' A' ' 94' ' ' LEU . 76.5 Cg_exo -44.73 -71.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.785 2.324 . . . . 0.0 112.467 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.407 ' OG ' ' CE2' ' A' ' 97' ' ' TYR . 29.0 m 42.99 77.52 0.44 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.478 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.66 -158.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.582 2.188 . . . . 0.0 112.062 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.0 t80 72.89 159.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.66 14.42 8.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.67 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -157.62 -69.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.412 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 103' ' ' THR . 46.9 t 54.25 108.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.88 132.11 22.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.669 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -161.41 79.68 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 6.7 ttm 60.72 -147.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.346 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -152.04 135.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.723 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -99.52 99.55 10.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.888 0.375 . . . . 0.0 110.383 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.07 155.7 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.158 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.56 158.31 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.479 2.119 . . . . 0.0 111.671 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.66 -1.33 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.667 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.586 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -103.83 -1.56 27.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -119.68 81.64 25.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 43.9 Cg_exo -53.24 4.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.547 2.165 . . . . 0.0 112.246 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.9 mm? -66.87 -30.18 70.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.06 0.457 . . . . 0.0 110.248 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -96.78 -41.53 8.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.179 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -71.12 -45.0 64.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.749 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 20.4 t-105 -75.26 -15.15 60.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.8 69.17 65.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.86 -20.23 9.16 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.734 2.289 . . . . 0.0 111.256 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -52.22 -53.89 37.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.504 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.92 55.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.732 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' HA ' HG21 ' A' ' 45' ' ' ILE . 2.1 t80 -157.89 -41.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.53 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.43 128.36 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.53 155.36 17.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.1 m -165.24 99.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.38 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.46 -173.37 23.1 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 9.1 m-20 -97.26 165.15 12.17 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -116.19 127.68 54.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.78 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.03 -8.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.94 143.15 55.77 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.01 128.05 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -132.82 -23.36 2.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -173.17 127.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.23 163.65 29.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.297 0.57 . . . . 0.0 112.164 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.02 137.92 54.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.156 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.84 16.69 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.92 13.43 53.09 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.365 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.3 mt -123.83 145.09 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.176 0.488 . . . . 0.0 109.955 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.35 150.82 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.699 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.446 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.4 mtp -47.53 -54.44 22.5 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.679 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 142' ' ' MET . 79.8 Cg_exo -40.21 -37.78 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.98 -47.18 60.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.947 0.403 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.9 m95 -65.79 -57.98 6.72 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -42.49 -36.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.947 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 146' ' ' LEU . 33.2 tp -66.49 -34.74 78.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.35 -35.86 73.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mm -69.76 -44.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.21 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -44.15 69.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.77 -46.37 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.779 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.39 -50.22 74.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -61.95 -47.17 86.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.912 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 154' ' ' LEU . 7.9 tt -53.57 -30.98 44.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.66 -27.68 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.147 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.66 ' O ' HG22 ' A' ' 160' ' ' VAL . 70.2 t -75.0 -28.58 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.913 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.611 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -80.65 -39.63 26.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.785 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.21 -31.5 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.557 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.7 -42.77 27.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.31 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 156' ' ' VAL . 28.4 m -71.26 -22.94 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.812 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 157' ' ' ALA . 21.1 t -77.68 -50.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.527 ' C ' ' H ' ' A' ' 164' ' ' GLN . 77.3 mt -64.62 -15.73 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.821 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p -52.87 -6.21 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.528 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 162' ' ' ILE . 61.2 tt0 -144.05 83.1 10.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.382 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 167' ' ' LYS . 60.7 Cg_endo -77.52 25.02 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.37 2.046 . . . . 0.0 112.085 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 43.71 16.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . 81.5 tttt -90.48 134.46 34.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.545 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -44.7 153.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.535 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -139.18 22.24 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -74.87 -122.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 56.14 -155.44 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.591 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' CE1' ' A' ' 174' ' ' PHE . 14.2 t70 -154.89 81.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 174' ' ' PHE . 12.9 mt -76.42 2.67 12.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.583 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.445 ' CE1' ' OD2' ' A' ' 172' ' ' ASP . 53.1 m-85 58.14 119.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -76.73 -153.34 5.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -146.25 -138.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 178' ' ' HIS . . . 173.56 -120.79 0.82 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.436 ' CG ' ' O ' ' A' ' 177' ' ' GLY . 57.1 m80 -157.01 140.83 16.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.318 . . . . 0.0 110.521 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -103.49 64.67 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.527 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.478 ' O ' ' CG ' ' A' ' 180' ' ' HIS . 0.5 OUTLIER -88.38 117.6 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.629 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 182' ' ' HIS . 0.1 OUTLIER -101.8 -102.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 181' ' ' HIS . 4.2 m-70 -103.73 133.99 47.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.524 ' ND1' ' OXT' ' A' ' 183' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.494 H153 HD23 ' A' ' 25' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mmt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.88 -44.43 49.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.37 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 25.2 mtt85 -53.55 -28.86 34.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.06 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 7' ' ' GLN . 35.2 m-85 -76.94 -42.91 37.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.405 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -46.8 -42.73 17.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 7' ' ' GLN . 24.5 p30 -72.61 -23.0 60.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.5 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 48.4 tp60 -79.93 -48.51 13.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.554 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.42 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 11' ' ' GLY . 19.7 m -76.53 -36.05 57.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -67.55 4.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.4 141.46 15.24 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.46 -46.2 87.34 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.99 -44.92 5.9 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.1 77.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -58.44 -43.28 88.72 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.196 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.3 mm? -67.04 -28.46 68.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.1 tp -69.34 -31.96 70.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.377 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 21' ' ' THR . 39.9 mtt -73.45 -32.87 64.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.02 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.4 -52.99 26.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.536 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.05 -49.63 50.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.2 p -53.42 -42.49 67.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.499 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.11 67.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.642 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.5 mt -87.79 -42.11 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.11 -25.02 60.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.536 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.14 -38.45 36.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.78 -47.07 64.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.54 -48.99 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.672 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.0 m -49.7 -47.64 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -73.47 -28.25 61.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.538 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.56 -20.53 66.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.978 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -91.45 -32.26 15.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.6 m-85 -58.23 -46.92 85.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.285 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 7.0 mp0 -62.68 -49.41 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.78 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -24.04 18.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.23 -18.94 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' PHE . 33.0 mmm -98.43 -3.17 37.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.85 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.486 ' N ' HD12 ' A' ' 37' ' ' LEU . 6.0 mp 53.88 39.81 30.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.93 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.81 HD12 ' NE2' ' A' ' 134' ' ' GLN . 1.0 OUTLIER -100.92 158.06 16.27 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -121.43 144.03 39.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.03 152.71 51.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.575 2.183 . . . . 0.0 112.2 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.7 t -115.81 -172.21 2.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.541 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.423 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 12.6 t -63.81 -47.86 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.034 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 43' ' ' LEU . 9.7 mp -62.26 -49.1 77.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.436 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 t -48.53 -46.42 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 124' ' ' PHE . 49.2 mt -61.63 -43.11 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.366 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -47.48 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.05 -39.29 93.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.83 -37.3 86.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.356 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.49 76.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.36 74.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tt -76.67 -51.92 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.214 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -45.68 -38.69 7.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.33 -43.91 91.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 25.5 t -61.47 -46.47 96.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 55' ' ' LEU . 1.5 tt -43.24 -47.67 6.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.312 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 60' ' ' ILE . . . -62.08 -32.79 83.57 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.35 -31.45 70.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.53 68.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.391 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.469 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 15.8 mt -76.63 -31.08 57.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 56' ' ' GLY . 1.4 mp -80.16 -36.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.848 0.356 . . . . 0.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.36 -23.0 78.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.22 6.93 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.611 0.243 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -77.78 -51.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.131 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -172.84 74.82 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 23.03 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.739 2.293 . . . . 0.0 112.14 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.59 -10.37 19.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.233 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 2.6 p -113.9 155.83 44.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.13 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -37.31 -17.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.808 2.338 . . . . 0.0 112.834 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.003 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.2 mm? -44.98 -31.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.588 ' NH1' HG22 ' A' ' 161' ' ' VAL . 3.5 mmp_? -34.32 -55.16 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -53.13 -36.31 60.65 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.951 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 69' ' ' LEU . 3.4 m -65.16 -39.86 86.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.816 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.24 -37.39 57.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.433 ' SD ' HG21 ' A' ' 161' ' ' VAL . 7.0 ttt -58.56 -14.36 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.468 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.8 t -55.08 -42.93 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.28 -31.14 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.644 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.474 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 6.2 t-105 -63.49 -55.4 24.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.113 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.0 tt -65.57 -48.41 72.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -42.84 -43.27 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.089 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 p -79.84 -22.43 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.791 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.45 -60.27 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.733 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.15 -55.08 6.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -65.95 -50.25 65.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.44 61.18 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.49 ' O ' ' OG1' ' A' ' 88' ' ' THR . 77.0 t -66.42 -45.42 89.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.895 0.379 . . . . 0.0 110.654 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.33 -31.86 67.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.58 -44.98 61.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -53.5 -27.0 23.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -70.97 -51.51 25.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -48.47 -34.24 10.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.25 -55.21 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -55.32 -46.69 76.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 97' ' ' TYR . 18.1 ttt -56.73 -43.03 80.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tp -66.57 -22.99 66.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.059 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.405 ' C ' HD22 ' A' ' 96' ' ' LEU . 33.9 mt-30 -80.6 -32.97 36.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.993 0.425 . . . . 0.0 109.857 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.1 mm? -98.67 -15.54 19.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.097 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.6 t80 -137.6 71.78 50.95 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.717 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.453 ' O ' ' OG ' ' A' ' 99' ' ' SER . 60.2 Cg_endo -76.68 -89.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.537 2.158 . . . . 0.0 111.837 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 98' ' ' PRO . 94.4 p 52.67 70.74 1.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.1 -171.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.782 2.321 . . . . 0.0 111.988 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.37 -9.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.12 -132.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.6 m -155.95 103.14 2.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.485 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 105' ' ' ASP . 33.8 t -148.24 -141.32 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.499 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.43 ' N ' ' OG ' ' A' ' 104' ' ' SER . 37.7 t70 45.34 87.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -149.09 -62.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.1 ttt -101.73 118.56 37.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.43 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 108' ' ' VAL . 11.1 p -45.68 123.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.514 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -102.09 102.95 13.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.74 157.92 69.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.009 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -41.48 160.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.455 2.103 . . . . 0.0 111.877 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.64 0.01 28.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -108.13 18.54 21.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.734 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.594 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -120.97 83.33 37.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.4 Cg_exo -53.03 2.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.647 2.231 . . . . 0.0 112.102 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.594 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.0 mp -63.63 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.638 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -97.02 -44.05 7.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -70.34 -45.58 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.471 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 15.7 t-105 -73.13 -15.05 61.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.98 74.89 11.96 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.46 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -12.62 13.82 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.907 2.405 . . . . 0.0 112.092 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -53.93 -54.12 43.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.839 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.436 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 8.5 t -106.94 60.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.72 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.621 ' O ' HD13 ' A' ' 45' ' ' ILE . 4.7 m-85 -164.68 -41.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.07 125.13 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.442 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.57 152.01 21.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 m -162.95 99.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.642 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.25 179.45 17.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.8 OUTLIER -80.37 143.49 33.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 30.2 m -93.52 131.85 38.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 85.89 0.56 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.208 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' OE1' ' OD1' ' A' ' 129' ' ' ASP . 39.9 tt0 -68.31 128.65 37.36 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.216 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.72 116.49 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.344 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.81 ' NE2' HD12 ' A' ' 38' ' ' LEU . 62.8 mt-30 -104.19 -29.6 10.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -173.8 147.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.21 161.6 37.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.362 0.601 . . . . 0.0 112.054 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.25 138.59 54.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.84 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.44 17.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.94 22.82 40.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 mt -124.72 136.0 53.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.42 148.81 50.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.743 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.432 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.5 mtt -48.74 -52.74 42.99 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.67 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 142' ' ' MET . 81.8 Cg_exo -43.51 -35.96 6.48 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.286 1.99 . . . . 0.0 112.033 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.65 -46.55 58.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.321 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.603 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.0 m95 -64.52 -57.7 8.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.2 tp -43.53 -39.26 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.104 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.9 -33.75 74.79 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.63 -40.6 94.91 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -72.68 -31.76 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 110.632 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.05 -39.62 86.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.502 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.2 tp -70.94 -37.05 66.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.139 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.16 -53.33 46.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -60.43 -38.52 84.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.224 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 154' ' ' LEU . 7.2 tt -54.53 -37.84 65.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.4 mt -75.55 -40.64 41.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 160' ' ' VAL . 73.8 t -48.96 -39.34 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.535 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -76.01 -43.63 43.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.963 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.58 -36.02 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.113 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.14 -32.72 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 156' ' ' VAL . 54.2 t -77.76 -25.01 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.259 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.588 HG22 ' NH1' ' A' ' 70' ' ' ARG . 92.6 t -83.33 -50.75 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.32 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.498 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.4 mp -66.84 -22.54 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.716 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.1 p -52.81 -7.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.517 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 162' ' ' ILE . 26.2 mt-30 -47.92 152.76 1.29 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.408 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -37.5 -30.26 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.758 2.305 . . . . 0.0 112.294 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 164' ' ' GLN . 0.5 OUTLIER -85.52 111.15 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.37 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 19.3 pttm -167.86 -36.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.65 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 167' ' ' LYS . . . 59.6 146.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.605 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -163.8 40.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -158.32 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' LEU . 43.3 ttt85 49.4 -100.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 172' ' ' ASP . 54.0 t0 45.94 17.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 110.587 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 171' ' ' ARG . 9.3 tp -80.62 75.78 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -97.57 -27.71 14.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.476 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -155.71 127.75 2.1 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -79.01 82.84 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -105.48 52.77 0.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -157.49 -21.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -155.5 79.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.685 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 180' ' ' HIS . 0.9 OUTLIER -87.62 11.48 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 t60 63.15 108.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -149.34 104.27 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.542 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.423 ' H71' H5M1 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp -62.79 -51.11 68.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.149 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -47.92 -34.66 9.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.41 -38.21 74.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.991 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.9 tp -50.97 -40.17 57.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.62 -29.39 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.019 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.95 -49.82 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -66.16 -34.39 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.799 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 54.1 p -75.52 -33.94 60.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.643 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -75.17 14.98 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.57 150.26 17.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.6 ttm105 -67.9 -20.7 65.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.392 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.75 86.88 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -65.36 -51.56 59.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.465 ' NE1' ' O ' ' A' ' 9' ' ' SER . 19.4 m0 -54.08 -42.55 69.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.375 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.5 -30.89 64.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tp -68.55 -32.59 72.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.04 -33.87 61.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -51.99 48.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.723 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -53.87 -52.05 61.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.1 m -46.03 -61.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.8 -30.39 14.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.569 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.97 -40.8 53.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.04 -40.84 46.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.5 mp -69.21 -36.75 77.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.581 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.36 -49.37 69.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.65 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.72 -50.95 70.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -53.65 -42.34 67.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.33 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.035 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -20.86 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.95 -41.63 15.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.135 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -50.97 -43.67 60.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.0 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -77.43 -40.52 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -71.07 -16.59 62.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.772 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 31' ' ' TRP . 66.1 t -109.34 -50.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.18 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mtt -90.75 14.71 12.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp 41.16 37.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.508 HD23 ' CM3' ' A' ' 201' ' ' UQ2 . 3.9 tp -63.43 155.58 28.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -120.25 90.93 45.62 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.967 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.11 147.52 19.95 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.567 2.178 . . . . 0.0 112.083 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 6.4 t -99.0 -173.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.779 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -67.19 -46.75 83.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.628 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.496 HD12 ' CG ' ' A' ' 91' ' ' HIS . 4.1 mm? -65.99 -47.02 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.216 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 m -49.19 -47.19 46.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.17 -39.95 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.235 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -54.67 -49.69 70.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.738 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -58.8 -39.71 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.435 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -58.68 -38.93 79.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.119 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.21 -39.52 94.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.506 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.91 82.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.9 tp -76.57 -50.4 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -44.11 -42.85 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.33 -41.41 96.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.47 -17.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.352 0.596 . . . . 0.0 109.901 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tp -81.79 -41.42 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.052 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -30.89 76.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.28 -35.15 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.151 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.78 97.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.1 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.61 -38.86 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.538 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.04 -21.0 78.29 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.68 3.64 32.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.279 . . . . 0.0 110.669 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -82.13 -49.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 179.15 77.09 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.25 21.35 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.892 2.395 . . . . 0.0 112.323 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -96.7 -8.37 31.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.116 0.484 . . . . 0.0 109.939 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.578 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -109.82 177.91 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.532 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 56.1 Cg_exo -50.49 -0.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.258 1.972 . . . . 0.0 112.278 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 67' ' ' THR . 17.2 mt -62.33 -28.33 69.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' NH1' ' CD ' ' A' ' 164' ' ' GLN . 1.8 mtp180 -41.76 -64.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.573 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 75' ' ' VAL . 37.9 m-85 -55.5 -38.69 69.51 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.714 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -57.85 -54.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.546 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.03 -33.62 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.208 0.527 . . . . 0.0 110.314 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.4 ' SD ' HG11 ' A' ' 161' ' ' VAL . 8.1 ttt -64.56 -25.48 68.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 71' ' ' TYR . 42.1 t -52.56 -32.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.457 0.646 . . . . 0.0 110.718 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.9 mp -88.88 -31.56 5.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.097 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -65.98 -49.08 69.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.33 -43.51 77.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -46.87 -46.28 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.298 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -79.61 -21.48 44.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.742 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.477 ' HA ' HD21 ' A' ' 154' ' ' LEU . . . -59.61 -60.47 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.032 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -76.14 -48.47 20.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -67.77 -43.83 78.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.6 -47.64 90.14 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.87 -32.39 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.217 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.58 -28.6 65.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.39 -41.35 13.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 84' ' ' GLY . 12.7 p -51.93 -51.88 53.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.727 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -51.84 -48.36 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.137 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.09 -44.28 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.908 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.496 ' CG ' HD12 ' A' ' 43' ' ' LEU . 2.0 m-70 -62.82 -44.8 95.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.327 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.3 p -61.29 -47.75 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 15.3 tpt -45.5 -45.51 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.264 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.9 tp -64.94 -43.65 92.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.162 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.558 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 50.5 tt0 -58.67 -48.56 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.351 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 96' ' ' LEU . 9.5 mp -80.62 -17.37 51.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.192 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 11.1 t80 -133.96 67.05 73.63 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 97' ' ' TYR . 78.4 Cg_exo -46.53 -177.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.95 2.433 . . . . 0.0 112.471 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.4 p -171.85 66.88 0.42 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.337 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -44.97 -38.48 13.49 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.82 2.346 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.14 101.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 140.05 57.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.443 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 p -142.45 -58.8 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -166.58 134.68 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.673 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -144.39 141.22 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.505 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -88.55 138.42 31.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.521 ' C ' ' H ' ' A' ' 109' ' ' ARG . 16.9 mtt -154.6 116.16 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.422 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.8 t 59.36 -1.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.678 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 107' ' ' MET . 13.5 mmt180 -89.7 99.57 12.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.47 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.5 154.93 81.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.907 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.48 119.96 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.405 2.07 . . . . 0.0 111.956 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.3 -2.69 26.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -99.7 2.26 44.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.251 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.0 tp -119.88 85.09 33.49 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.2 Cg_exo -56.14 16.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.668 2.245 . . . . 0.0 112.638 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.1 tp -77.14 -30.85 55.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.029 0.442 . . . . 0.0 110.312 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -97.75 -40.28 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.098 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -70.61 -45.32 65.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.6 t90 -76.19 -11.64 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.334 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.46 71.19 17.75 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.831 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 125' ' ' VAL . 72.4 Cg_endo -77.77 -14.91 15.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.763 2.308 . . . . 0.0 111.766 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -57.33 -53.27 59.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.827 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 53.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -158.14 -39.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.287 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 121' ' ' PRO . 42.2 t -54.97 123.92 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.18 158.17 15.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.648 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.56 104.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.501 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.04 -177.06 20.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 t70 -89.33 139.69 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 110.284 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 54.6 m -91.47 134.65 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 86.52 -1.09 0.64 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.095 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -68.0 153.2 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 119.01 37.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -122.68 -12.61 8.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.719 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -173.3 127.92 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.796 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.32 160.97 38.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.266 0.555 . . . . 0.0 112.179 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.66 137.31 53.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.862 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt 50.64 17.19 0.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.593 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 90.44 21.5 37.52 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 139' ' ' GLY . 3.2 mm? -122.46 134.5 54.58 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.558 ' OE1' ' NE2' ' A' ' 95' ' ' GLN . 8.1 mt-10 -69.16 148.6 49.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.669 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.434 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -49.18 -51.93 52.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 142' ' ' MET . 89.4 Cg_exo -44.01 -38.74 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.426 2.084 . . . . 0.0 112.119 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.32 -49.6 47.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.3 m95 -60.85 -57.11 14.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.291 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.4 tp -43.03 -39.9 2.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.178 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 143' ' ' PRO . 1.5 mm? -60.84 -34.82 75.15 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.91 -45.12 95.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.9 -34.45 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.955 0.407 . . . . 0.0 110.131 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -54.71 -47.58 73.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.75 -42.88 96.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.491 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.33 -45.95 24.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.403 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -64.02 -42.97 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.936 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 158' ' ' VAL . 6.4 mp -51.97 -32.89 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 155' ' ' ILE . 1.7 mp -81.94 -27.78 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.639 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.2 t -63.45 -33.35 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.0 110.235 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.54 -49.98 10.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.308 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 154' ' ' LEU . 65.3 t -53.79 -37.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.547 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 4.0 mm? -84.87 -33.68 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.128 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 156' ' ' VAL . 17.4 t -70.07 -29.3 39.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.422 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 162' ' ' ILE . 30.7 m -83.09 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.578 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.54 ' N ' HG23 ' A' ' 161' ' ' VAL . 10.0 mt -71.73 -8.87 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.53 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 m -76.01 0.11 19.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.627 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.476 ' CB ' ' CD ' ' A' ' 165' ' ' PRO . 0.0 OUTLIER -63.45 -64.86 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 164' ' ' GLN . 18.9 Cg_endo -58.22 -0.71 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.547 2.164 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 164' ' ' GLN . 76.6 t80 -40.9 132.33 2.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.427 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.531 ' NZ ' ' NH2' ' A' ' 176' ' ' ARG . 18.0 ttpt -152.52 116.5 4.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.28 -52.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.46 167.98 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -143.63 129.38 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.612 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -80.96 -30.05 35.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.37 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -155.97 -126.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.214 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.574 ' CD2' ' H ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -72.35 -62.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.104 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.7 t80 42.16 89.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.522 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -80.59 -101.62 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.531 ' NH2' ' NZ ' ' A' ' 167' ' ' LYS . 7.3 tpt180 -149.88 -149.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.337 . . . . 0.0 110.357 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 176.57 108.3 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -127.3 -32.16 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 110.401 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -84.58 116.53 23.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.508 ' O ' ' ND1' ' A' ' 180' ' ' HIS . 0.7 OUTLIER -155.58 22.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.385 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.601 ' CG ' ' H ' ' A' ' 182' ' ' HIS . 2.0 t60 -76.58 -176.07 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 181' ' ' HIS . 0.0 OUTLIER -162.96 28.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.634 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 3.4 t60 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.508 ' CM3' HD23 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -68.25 -42.79 79.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.089 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -53.58 -34.52 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -72.31 -41.62 66.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.01 -43.81 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.385 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -64.83 -29.2 70.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.003 0.43 . . . . 0.0 110.277 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -78.5 -47.76 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.63 88.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.806 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.8 p -76.63 -35.39 58.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.673 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 6.4 tt0 -68.83 4.9 1.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.05 0.452 . . . . 0.0 110.405 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.79 146.99 17.31 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 63' ' ' ILE . 65.1 mtt180 -69.47 -48.84 59.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.667 0.27 . . . . 0.0 110.81 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.05 -46.32 6.26 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.93 -46.99 86.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.13 -42.17 89.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.2 mm? -63.82 -28.08 69.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -70.0 -27.71 64.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . 23.0 mmt -76.47 -33.91 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.161 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.12 -54.48 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.604 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -52.13 -51.83 55.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.654 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 18' ' ' MET . 11.0 p -45.41 -61.7 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.49 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.65 -40.04 80.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.52 -37.91 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.6 mp -75.5 -38.53 59.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.16 -46.47 83.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.82 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.63 -55.15 14.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 24' ' ' ALA . 14.4 p -45.45 -40.81 8.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.71 -42.25 51.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.821 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -54.04 -18.57 3.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.434 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.7 t-105 -88.92 -35.32 16.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.554 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -32.22 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.171 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.43 ' OE1' ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -73.44 -47.65 39.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -70.89 -7.38 45.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.941 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 31' ' ' TRP . 71.7 t -109.14 -42.18 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.029 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.7 mtp -99.85 12.46 36.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 37' ' ' LEU . 9.3 mp 42.9 38.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.43 ' C ' ' OE1' ' A' ' 33' ' ' GLN . 23.8 mt -74.59 156.29 36.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.894 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HD3' ' H ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -115.4 126.51 27.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.195 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.05 137.43 17.32 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.234 1.956 . . . . 0.0 111.836 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.7 t -92.25 -178.05 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.565 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.07 -46.43 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.05 -48.32 82.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -48.65 -45.76 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.518 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 124' ' ' PHE . 59.2 mt -61.38 -43.41 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -48.16 73.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -63.22 -36.4 83.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.721 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -68.24 -38.27 81.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.74 79.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.19 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.69 -50.45 13.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.199 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -46.47 -39.92 11.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.96 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -44.29 89.4 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.59 -47.35 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.986 0.422 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 55' ' ' LEU . 2.0 tt -45.41 -49.73 12.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.537 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.34 -49.71 75.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.83 -34.92 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.366 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.63 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.278 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -36.91 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.718 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -73.55 -35.88 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.447 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -15.32 79.3 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 3.59 32.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.605 0.24 . . . . 0.0 111.199 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.439 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 2.8 pt -91.19 -23.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.813 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.08 67.5 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.79 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.87 15.67 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.82 2.347 . . . . 0.0 112.027 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -102.38 -8.96 20.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.624 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.98 163.37 17.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.066 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.04 3.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.574 2.182 . . . . 0.0 112.607 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.019 ' O ' HG22 ' A' ' 72' ' ' VAL . 6.7 mp -67.06 -30.19 70.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.291 . . . . 0.0 110.918 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD3' ' H ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -38.66 -42.82 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.608 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.501 ' H ' ' HD3' ' A' ' 70' ' ' ARG . 75.7 t80 -59.69 -37.95 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.672 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.019 HG22 ' O ' ' A' ' 69' ' ' LEU . 4.2 m -59.62 -38.15 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.253 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.09 -30.51 22.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.716 -0.615 . . . . 0.0 110.114 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 161' ' ' VAL . 11.8 ttp -67.75 -33.14 74.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.911 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 1.3 m -50.03 -28.57 4.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.562 0.696 . . . . 0.0 110.578 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.23 -31.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.976 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.439 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 13.8 t-105 -66.51 -47.6 72.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.81 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 tp -68.51 -47.85 65.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.439 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -43.98 -42.14 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.345 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -79.19 -24.28 43.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.583 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.37 -58.89 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.282 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CE2' ' NE2' ' A' ' 86' ' ' GLN . 73.5 t80 -74.2 -52.35 12.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.392 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -66.66 -40.86 88.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.15 -46.25 93.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.427 ' O ' ' OG1' ' A' ' 88' ' ' THR . 95.2 t -72.84 -36.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.467 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 82' ' ' PHE . 7.6 tt0 -67.48 -45.95 74.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 tp -65.15 -42.96 93.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.568 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 84' ' ' GLY . 6.6 p -51.46 -47.63 63.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.401 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -48.07 -41.81 27.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -59.82 -38.51 82.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.605 ' C ' ' HD1' ' A' ' 91' ' ' HIS . 1.7 t-80 -69.41 -56.07 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.387 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.4 p -55.72 -52.14 64.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.706 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.4 tpp -48.76 -45.23 39.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.44 -44.77 90.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -62.53 -42.47 99.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.393 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.69 -22.45 34.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.57 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 93' ' ' MET . 27.0 t80 -136.31 68.56 61.81 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.682 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.26 160.28 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.771 2.314 . . . . 0.0 112.131 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.94 151.68 3.35 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.418 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -38.97 159.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.53 2.153 . . . . 0.0 112.197 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 101' ' ' PHE . 22.5 p90 -113.42 115.95 28.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.53 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.19 -53.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.537 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.0 m -69.12 126.89 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.566 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m 49.69 89.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 106' ' ' PHE . 27.6 t70 -160.13 169.68 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CG ' ' C ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 174.47 -177.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.563 ' C ' ' H ' ' A' ' 109' ' ' ARG . 5.9 ptt? -160.13 132.01 6.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 108' ' ' VAL . 25.1 t 59.37 -4.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' A' ' 107' ' ' MET . 10.9 ttm180 -87.95 99.91 12.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -115.0 149.95 43.37 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.346 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -37.99 138.14 0.41 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.487 2.125 . . . . 0.0 112.044 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -99.75 18.32 18.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.779 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.411 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.15 -5.96 7.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.432 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 mp -119.8 84.42 31.53 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.3 Cg_exo -55.15 11.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.568 2.179 . . . . 0.0 112.264 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.623 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.8 mm? -71.04 -32.74 69.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.086 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.0 p30 -97.63 -39.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 21.3 tttm -72.08 -45.26 61.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.8 t90 -76.34 -11.65 59.94 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.17 68.86 48.57 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -17.03 11.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -51.64 -33.99 35.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.28 45.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.586 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.59 ' O ' HD13 ' A' ' 45' ' ' ILE . 1.3 m-85 -149.55 -36.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.9 p -54.8 124.32 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.438 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.95 23.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t -164.98 101.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.584 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.66 -175.24 21.15 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -92.33 150.88 20.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.683 0.278 . . . . 0.0 110.323 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 11.9 m -100.74 132.07 46.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.56 -4.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.01 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.97 150.58 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.057 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -96.11 133.2 40.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.563 ' H ' ' CD ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -128.52 -22.5 3.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.732 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.485 ' N ' ' OE1' ' A' ' 134' ' ' GLN . 21.6 t-105 -173.17 136.42 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.004 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 5.3 p30 -140.77 157.25 45.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 111.964 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.08 138.43 50.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.33 17.07 0.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.77 21.71 35.81 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.808 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.42 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 5.0 mt -124.86 137.27 54.3 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.33 148.86 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.462 ' SD ' H163 ' A' ' 201' ' ' UQ2 . 3.9 mtt -47.89 -53.15 34.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -43.49 -37.35 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.419 2.079 . . . . 0.0 112.352 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -71.29 -50.33 33.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.993 0.425 . . . . 0.0 110.113 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 74.0 m95 -60.28 -57.84 11.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.09 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.7 tp -43.49 -37.8 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.062 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.512 ' CD1' HG21 ' A' ' 88' ' ' THR . 11.7 tp -61.13 -34.94 75.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.72 -45.34 94.95 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 149' ' ' ILE . 3.4 mp -75.61 -31.88 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.12 -49.17 76.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.143 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.42 -46.68 94.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.537 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.42 -46.5 56.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.369 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -55.25 -43.24 74.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.2 mt -61.08 -30.58 70.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.869 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.62 -32.03 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 160' ' ' VAL . 70.3 t -64.55 -37.6 80.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -80.29 -46.32 16.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.147 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 154' ' ' LEU . 54.7 t -53.88 -44.01 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.42 -33.0 48.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.0 t -74.79 -22.97 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.882 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.573 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 46.2 t -82.17 -50.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.098 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.67 -17.34 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.796 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 164' ' ' GLN . 17.7 p -70.88 -39.27 72.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' A' ' 161' ' ' VAL . 7.7 mp0 57.69 156.27 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -70.96 28.73 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 111.826 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 164' ' ' GLN . 5.8 t80 -51.51 151.82 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -143.0 113.51 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.525 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.08 164.01 22.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -70.06 -109.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -124.01 -42.19 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.387 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 52.11 102.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.544 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -163.36 -28.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.683 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.9 mt 48.63 -121.1 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.449 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.33 88.63 3.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.49 -116.05 3.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 62.63 138.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -177.96 2.71 0.03 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -52.56 -34.26 49.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -83.22 146.03 28.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 181' ' ' HIS . 18.2 m-70 -88.28 149.26 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.509 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.503 ' C ' ' H ' ' A' ' 183' ' ' HIS . 0.8 OUTLIER 53.79 168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.49 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 70.39 -38.58 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 181' ' ' HIS . 1.5 m-70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.472 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.49 -42.93 51.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.058 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -54.41 -31.59 55.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 12.6 t80 -74.89 -42.77 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.193 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -47.97 -38.49 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.354 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -70.75 -27.05 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.448 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 7.1 tm0? -75.55 -49.94 17.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.23 -27.52 69.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 0.0 110.308 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 m -76.51 -42.66 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.254 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -70.15 5.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.99 0.424 . . . . 0.0 110.684 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.69 142.66 16.2 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -69.0 -49.84 54.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.586 0.231 . . . . 0.0 110.713 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.86 -45.72 5.91 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -47.09 87.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -61.03 -37.07 81.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.26 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -32.34 70.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.95 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.82 -36.61 75.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.469 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.478 ' C ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -66.44 -34.79 78.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 -49.94 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.76 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.65 -41.87 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.9 m -64.39 -46.62 82.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.656 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.59 72.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -81.82 -42.08 20.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 28' ' ' THR . . . -55.91 -26.92 49.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -77.35 -39.82 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.542 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.2 -54.54 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -56.23 -50.48 71.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 24' ' ' ALA . 8.9 p -49.91 -43.69 49.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.999 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.75 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.144 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -17.29 19.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -93.4 -37.63 11.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.702 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.78 -46.22 78.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.404 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 38' ' ' LEU . 7.3 tm0? -73.3 -36.21 66.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.63 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -61.25 -22.44 64.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.652 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.1 t -107.88 -28.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.805 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.6 mmt -92.03 3.27 55.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.999 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt 47.4 48.54 16.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' H ' ' HG2' ' A' ' 33' ' ' GLN . 93.6 mt -93.13 155.04 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.829 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -117.19 127.17 26.88 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.075 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.84 148.82 28.78 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.296 1.997 . . . . 0.0 112.368 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.2 t -94.58 173.57 7.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.32 -35.87 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 110.076 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -64.71 -45.55 86.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 m -48.94 -47.53 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.733 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.448 HG12 ' N ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -61.4 -38.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.448 ' N ' HG12 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -61.35 -46.19 91.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.838 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -65.1 -51.77 59.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.526 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.536 ' NH1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -58.55 -35.51 72.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.35 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.38 85.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.564 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.56 70.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.148 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 51' ' ' LEU . 7.0 tt -71.26 -53.71 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.026 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -44.84 -40.2 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.27 93.44 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 57' ' ' ALA . 60.2 t -59.91 -47.53 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 109.872 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.533 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.6 -45.39 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.329 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.79 -27.59 71.37 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -70.53 -37.68 74.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.059 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.42 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.952 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.385 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.51 -36.59 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.651 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.87 -34.3 59.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.49 2.93 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.716 0.293 . . . . 0.0 110.755 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 88.7 mt -77.97 -47.42 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.06 78.37 0.28 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.493 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.06 25.82 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.82 -10.93 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.175 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.48 176.46 1.48 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.485 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.96 -2.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.258 1.972 . . . . 0.0 111.874 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.2 tt -47.79 -37.17 13.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mmp_? -38.8 -67.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.827 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 75' ' ' VAL . 81.8 t80 -52.49 -28.46 20.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.82 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.6 t -71.77 -47.04 58.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.715 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.51 53.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 110.484 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.55 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -63.2 -11.54 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.678 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.536 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 3.0 t -58.39 -38.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.372 0.606 . . . . 0.0 110.027 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -87.65 -32.54 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.309 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 12.4 t-105 -64.63 -53.69 43.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.169 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.0 tp -64.85 -47.22 78.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.832 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -44.16 -42.2 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.4 p -78.95 -22.36 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.75 -59.99 4.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.927 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -73.76 -55.02 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.218 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -66.35 -45.73 79.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.58 -46.57 91.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' O ' ' OG1' ' A' ' 88' ' ' THR . 86.7 t -70.77 -52.51 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -52.06 -29.41 21.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 tp -80.16 -43.6 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.359 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' GLY . 61.5 p -52.44 -22.21 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.196 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -73.48 -51.7 16.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.36 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -50.13 -36.27 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -72.72 -36.51 67.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 88' ' ' THR . 40.4 p -74.99 -43.8 51.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.719 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 97' ' ' TYR . 39.4 ttm -52.57 -52.05 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.711 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.66 -40.91 92.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.557 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -60.84 -48.34 82.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tt -85.89 -17.68 34.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.706 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.9 t80 -137.39 72.6 51.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.044 0.449 . . . . 0.0 110.641 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.94 170.69 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.872 2.381 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 t -160.82 64.24 1.99 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.767 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.17 33.31 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.943 2.429 . . . . 0.0 112.189 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -67.0 1.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -161.34 -24.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.555 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m 48.22 50.41 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.67 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.9 p -104.88 73.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.345 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.6 OUTLIER -99.91 -90.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.671 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 55.63 80.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.302 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.537 ' C ' ' H ' ' A' ' 109' ' ' ARG . 12.8 mtt -74.86 -121.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' VAL . 16.8 t 60.99 -4.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.955 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 107' ' ' MET . 50.1 ttm-85 -106.82 100.48 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.49 154.13 43.19 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.247 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -36.79 138.77 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.772 2.315 . . . . 0.0 112.326 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.47 18.02 20.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.224 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.498 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 1.4 p-90 -124.29 -2.47 8.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.2 tp -115.19 88.83 18.83 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.77 10.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.832 2.355 . . . . 0.0 113.198 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.633 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -80.02 -22.59 42.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.128 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -95.28 -46.83 6.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.819 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -24.92 64.78 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.209 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -93.23 -19.92 20.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.088 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.82 70.94 19.55 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.3 Cg_endo -80.93 -15.85 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.949 2.432 . . . . 0.0 112.247 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -52.76 -35.9 57.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.368 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.536 HG21 ' NH1' ' A' ' 48' ' ' ARG . 33.6 m -127.41 22.2 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.71 0.291 . . . . 0.0 110.913 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.48 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 2.4 t80 -131.4 -6.08 3.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 125' ' ' VAL . 13.4 p -84.66 129.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.85 135.9 33.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.3 m -164.7 116.16 1.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.523 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.25 -168.44 16.39 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -96.12 158.08 15.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.694 0.283 . . . . 0.0 110.241 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.675 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -109.19 130.05 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.776 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.98 -3.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.791 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.78 150.54 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.027 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.7 145.39 24.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.941 0.4 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -135.17 -31.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.1 t-105 -174.95 144.77 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -141.5 167.05 23.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 111.402 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -141.39 120.35 12.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.379 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.28 16.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.18 15.0 75.6 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.48 133.69 55.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.811 0.339 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.77 152.87 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.463 ' SD ' H163 ' A' ' 201' ' ' UQ2 . 3.1 mtt -51.17 -51.64 66.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 142' ' ' MET . 70.9 Cg_exo -45.39 -37.87 14.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.3 2.0 . . . . 0.0 112.034 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.99 -42.54 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.205 0.526 . . . . 0.0 109.982 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 148' ' ' GLY . 59.9 m95 -65.64 -57.14 8.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.0 tp -43.33 -39.01 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.066 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 88' ' ' THR . 38.7 tp -62.23 -34.59 76.8 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.92 -42.91 96.98 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.6 mt -67.68 -39.53 82.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 0.0 110.146 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -55.25 -45.31 76.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.5 mt -57.2 -43.93 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.61 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.44 62.27 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.518 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.7 m-85 -53.76 -43.48 69.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.087 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.501 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 1.1 pp -75.01 -29.7 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.309 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.9 mt -69.97 -36.74 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.201 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 160' ' ' VAL . 23.3 m -73.36 -38.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.989 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.29 -51.16 62.55 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.844 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 154' ' ' LEU . 79.3 t -55.19 -50.96 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.01 -33.9 73.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 156' ' ' VAL . 16.4 t -67.07 -28.99 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.94 -45.92 62.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.146 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.64 -27.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m -53.47 -16.06 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 166' ' ' PHE . 19.9 pt20 -45.95 148.49 1.42 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.276 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 35.96 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.442 2.095 . . . . 0.0 111.912 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.4 OUTLIER -137.85 105.59 5.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.27 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 168' ' ' ALA . 12.6 tptp -153.7 51.18 0.69 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 167' ' ' LYS . . . 60.01 147.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.614 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -159.43 160.12 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -74.95 95.21 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.641 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -114.49 119.01 35.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.617 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -133.25 38.17 3.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.266 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.0 mp -66.15 91.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.538 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -146.61 -66.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.455 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 158.03 -76.07 0.2 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -78.49 126.46 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 0.0 110.618 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.39 -128.13 1.36 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -102.7 156.97 17.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -138.22 31.3 2.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.436 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -137.93 112.2 8.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.456 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 182' ' ' HIS . 24.5 t-80 -98.01 22.14 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.571 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 181' ' ' HIS . 37.4 m-70 -152.96 147.48 25.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.619 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.5 t60 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.582 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.463 H163 ' SD ' ' A' ' 142' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.84 -37.54 87.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.134 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 3' ' ' ARG . 8.4 ptt-85 -58.74 -40.62 84.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -59.37 -47.63 84.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -51.19 -38.68 53.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -68.41 -31.26 70.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.348 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -77.06 -50.95 11.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.681 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.89 77.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -76.96 -37.9 54.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.733 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.48 HE21 ' CA ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -67.51 2.02 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.42 147.49 18.56 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -71.78 -49.68 36.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.685 0.278 . . . . 0.0 110.65 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.91 -45.05 5.85 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.19 84.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -58.41 -41.41 84.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.154 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -28.89 69.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.022 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -70.5 -30.48 67.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.308 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.433 ' O ' ' OG1' ' A' ' 21' ' ' THR . 0.4 OUTLIER -73.19 -33.09 65.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.02 7.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -47.97 -40.85 23.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -63.72 -50.17 70.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.377 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.13 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -37.27 41.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.92 -36.96 63.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.53 -37.93 65.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.46 -43.48 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.98 -48.31 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.508 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 24' ' ' ALA . 19.4 p -54.47 -40.95 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.73 67.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.776 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 -20.4 63.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.424 ' NE1' ' CG2' ' A' ' 35' ' ' VAL . 32.1 t90 -88.95 -39.36 13.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.65 -43.61 57.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 4.5 tm0? -73.61 -29.56 62.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.02 -26.35 66.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' NE1' ' A' ' 31' ' ' TRP . 56.0 t -109.29 -53.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.924 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.68 1.13 8.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.96 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mt 48.54 41.36 17.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.684 HD23 ' O3 ' ' A' ' 201' ' ' UQ2 . 1.4 tp -76.24 147.71 38.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -111.66 127.04 27.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.596 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.06 154.66 33.19 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 111.775 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 6.5 t -118.0 -171.98 2.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.787 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.23 -48.05 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.075 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.83 -50.1 70.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.442 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.7 p -53.08 -48.97 67.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mm -61.34 -45.23 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.327 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -58.41 -46.12 87.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.307 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -60.78 -38.32 84.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -64.59 -36.38 84.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.38 84.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.96 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.346 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 51' ' ' LEU . 1.2 tt -76.78 -49.58 15.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.049 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -46.32 -38.03 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.76 -44.25 81.29 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.9 -47.65 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -43.9 -48.62 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.6 -48.24 86.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.19 -33.02 25.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.27 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.77 -35.54 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.404 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.88 -37.26 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.223 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -75.24 -40.32 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.0 -28.67 73.34 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.77 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.705 0.288 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 94.1 mt -82.63 -32.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.46 73.36 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.442 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.75 24.58 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.518 2.145 . . . . 0.0 111.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.3 mttm -111.86 -7.56 14.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.13 162.44 21.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.655 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -38.91 -15.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.592 2.195 . . . . 0.0 112.304 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.4 mp -41.58 -33.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.493 ' O ' ' SD ' ' A' ' 74' ' ' MET . 71.9 mtt85 -39.22 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 75' ' ' VAL . 67.2 t80 -51.95 -31.48 29.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.62 -45.94 80.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.97 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.46 -34.26 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.6 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -64.7 -19.66 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.678 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.1 t -54.09 -34.46 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 0.0 109.958 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 84.0 mt -89.15 -33.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.2 t-105 -65.87 -49.86 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.003 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -66.06 -49.58 67.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.3 m-85 -42.92 -42.61 3.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.8 p -78.11 -22.18 49.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.768 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.8 -59.86 4.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.281 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.3 -51.13 13.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.646 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -40.5 78.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.08 -47.14 90.98 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 81' ' ' ALA . 11.1 m -77.53 -32.73 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.336 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.04 -42.87 59.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.663 0.268 . . . . 0.0 111.191 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tp -73.72 -38.47 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.047 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 84' ' ' GLY . 7.9 p -59.56 -44.45 93.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.208 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -52.32 -52.13 54.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.522 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -50.84 -46.35 60.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -64.55 -33.16 75.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.9 m -70.97 -37.14 72.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.413 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 tpt -62.21 -33.01 73.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.2 -47.47 70.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.115 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -51.65 -42.33 62.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.617 ' N ' HD12 ' A' ' 96' ' ' LEU . 8.9 mp -92.29 -9.57 41.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 93' ' ' MET . 1.4 t80 -140.87 69.35 29.66 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 110.438 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.22 171.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.06 157.21 57.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.383 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.32 -90.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.1 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -130.96 -36.0 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . -71.22 -165.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 31.6 p 49.53 99.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 t -61.62 -152.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -173.81 64.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.665 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -91.0 -173.79 3.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -163.26 -165.85 1.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.542 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 108' ' ' VAL . 12.2 t 64.31 6.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.537 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -106.67 103.62 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.09 155.03 76.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.291 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.22 132.29 51.02 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.48 2.12 . . . . 0.0 111.835 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -80.66 4.2 19.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.502 ' C ' HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -99.22 -5.38 30.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.426 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 116' ' ' LEU . 10.4 mp -113.09 82.81 5.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.31 12.11 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.041 1.827 . . . . 0.0 111.756 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.527 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.9 mt -80.13 -28.42 38.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.013 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 1.4 p30 -97.31 -40.83 8.55 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.975 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 3.3 ttmm -69.27 -45.16 70.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.658 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 16.0 t-105 -76.85 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.405 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.17 71.13 22.81 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.761 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.74 -16.11 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.748 2.299 . . . . 0.0 111.805 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -52.29 -32.63 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.785 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -133.37 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.536 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -152.3 -40.53 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.239 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.7 128.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.99 155.47 17.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.4 p -158.17 102.8 1.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.599 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.58 -177.27 19.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 33.9 t70 -86.06 150.02 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 9.7 m -101.74 127.23 48.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 98.87 -8.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.87 128.82 37.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.733 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.19 136.22 51.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.514 ' HB3' HD21 ' A' ' 38' ' ' LEU . 77.9 mt-30 -130.16 -29.35 2.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -174.56 145.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.722 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -144.73 159.64 42.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.256 0.551 . . . . 0.0 112.102 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.408 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -115.09 138.13 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.705 178.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp 50.24 16.85 0.28 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.597 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 90.73 22.64 33.01 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 139' ' ' GLY . 2.6 mm? -124.36 136.23 53.93 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 135' ' ' TRP . 6.0 mm-40 -69.33 146.73 51.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.315 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.442 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 9.5 mtt -44.94 -62.7 1.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.144 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 85.8 Cg_exo -33.78 -37.63 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.848 2.366 . . . . 0.0 112.639 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 144' ' ' GLN . 4.8 mp0 -72.34 -52.0 18.08 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.0 m95 -59.47 -57.28 13.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.848 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.5 tp -44.57 -35.55 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.423 HD11 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -62.9 -33.96 76.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.51 -46.19 94.83 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.708 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -75.14 -25.88 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -64.54 -44.37 91.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.743 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.9 tt -69.24 -37.39 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -53.79 -46.99 71.21 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.054 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.79 -44.47 96.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.686 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 81' ' ' ALA . 52.3 mt -65.19 -30.95 71.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.9 -33.35 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.321 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.5 t -64.95 -31.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.52 -47.5 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 154' ' ' LEU . 73.7 t -55.41 -42.21 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -28.58 56.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.903 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 156' ' ' VAL . 31.1 t -78.26 -20.33 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.8 -50.03 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.83 -25.96 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.76 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.3 p -71.77 0.07 9.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.548 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.455 HE22 ' HA ' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -155.13 74.14 5.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.25 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.8 57.75 5.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.563 2.175 . . . . 0.0 111.957 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.455 ' HA ' HE22 ' A' ' 164' ' ' GLN . 18.1 m-85 62.22 -174.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -142.76 -25.74 0.62 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.29 98.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -151.16 -42.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 172' ' ' ASP . 52.4 mtmt -84.74 -89.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 48.32 18.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 170' ' ' LYS . 74.8 m-20 -75.51 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.739 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.8 tp -81.15 -70.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.583 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.17 96.93 10.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.438 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -106.58 178.02 22.26 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -69.33 80.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.56 155.29 9.84 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 178' ' ' HIS . 45.4 p-80 -164.45 106.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.612 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -89.47 120.25 30.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -171.45 -149.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.429 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 63.66 136.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.623 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.642 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 42.5 t60 -80.69 -175.24 5.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.642 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 1.8 t60 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.591 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.684 ' O3 ' HD23 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mp -47.85 -34.66 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 109.951 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.6 -31.84 66.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 7' ' ' GLN . 23.3 t80 -73.48 -44.94 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.527 ' N ' HD22 ' A' ' 5' ' ' LEU . 3.9 mm? -47.17 -39.88 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.003 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -68.46 -28.15 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.421 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 4' ' ' PHE . 24.4 tt0 -80.33 -49.45 11.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.36 72.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -76.66 -34.99 58.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.76 7.41 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.07 142.08 15.87 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -68.44 -21.4 64.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 110.648 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.83 -46.06 61.94 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.83 76.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.327 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -58.17 -43.12 87.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.42 -33.06 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.323 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -67.48 -30.37 70.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . 60.3 mtp -73.66 -33.0 64.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.417 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.89 71.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.46 -51.83 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 17' ' ' LEU . 12.7 p -41.65 -50.42 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.92 85.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.62 -39.67 80.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.306 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.71 -41.67 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.354 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.3 -33.78 63.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.543 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.76 -45.91 77.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.03 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -71.89 -46.55 57.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.92 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 87.5 m -46.8 -43.01 18.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.81 -21.45 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -68.49 -22.39 64.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.23 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.4 t-105 -97.68 -29.39 13.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.4 -39.86 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.51 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -78.8 -51.6 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.992 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -54.74 -53.41 55.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 31' ' ' TRP . 4.3 p -61.01 -18.19 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.0 ttt -106.3 10.56 31.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.589 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.66 ' N ' HD12 ' A' ' 37' ' ' LEU . 8.2 mp 52.24 54.44 10.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.99 157.18 17.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.283 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -125.37 141.48 38.95 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.432 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.76 175.93 10.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 112.318 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.486 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 12.8 t -131.88 -179.34 5.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 39.6 t -56.06 -49.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.599 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.94 -38.24 87.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -54.23 -40.93 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.584 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.699 HD12 HH21 ' A' ' 48' ' ' ARG . 1.4 tp -67.98 -37.59 78.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.428 . . . . 0.0 110.053 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -60.73 -48.2 82.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.038 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.94 -39.95 95.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.699 HH21 HD12 ' A' ' 45' ' ' ILE . 11.6 ttp180 -65.82 -36.16 82.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.11 86.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.05 -49.03 78.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 tp -76.04 -52.2 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.223 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -45.89 -42.59 12.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.53 89.47 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' ALA . 26.0 t -59.15 -46.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.298 0.571 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.09 -46.59 11.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.535 179.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.81 -27.42 71.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.04 -42.13 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.91 -21.51 62.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -43.93 19.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.34 -33.23 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -73.16 -31.38 61.63 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.44 6.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.798 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 95.0 mt -82.81 -29.79 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.76 69.03 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.25 23.78 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.754 2.302 . . . . 0.0 111.654 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.29 -10.25 19.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.087 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.84 175.21 1.96 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.513 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.39 -9.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.281 1.987 . . . . 0.0 112.052 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -47.89 -31.43 5.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.126 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -40.33 -67.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.62 -26.08 63.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.43 -45.48 74.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.248 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.66 -36.48 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.47 0.653 . . . . 0.0 109.574 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 161' ' ' VAL . 0.8 OUTLIER -57.15 -12.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.062 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.5 t -55.27 -44.21 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.306 0.574 . . . . 0.0 110.443 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.89 -31.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.627 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.493 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 10.0 t-105 -62.67 -55.79 23.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.129 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.1 tp -65.3 -48.17 74.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -43.58 -45.66 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.084 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 p -78.99 -21.14 47.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.43 -60.38 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.053 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.52 -51.27 17.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.09 -48.1 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 88' ' ' THR . . . -55.38 -48.42 69.76 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' ' OG1' ' A' ' 88' ' ' THR . 66.1 t -69.29 -47.23 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -55.48 -23.48 25.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.292 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.39 -42.67 14.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.214 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 84' ' ' GLY . 39.7 p -51.29 -26.38 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -69.18 -46.53 67.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.246 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -55.38 -31.23 61.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.274 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 10.7 t-80 -70.09 -49.64 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.349 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.1 p -54.87 -56.36 20.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 110.199 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' TYR . 40.8 mtt -48.01 -50.68 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.028 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.72 -36.8 7.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.412 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.444 ' C ' HD12 ' A' ' 96' ' ' LEU . 26.9 tp60 -67.69 -31.19 70.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.6 mp -102.99 -4.17 25.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.228 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 93' ' ' MET . 18.6 t80 -130.49 89.99 42.4 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.437 ' O ' ' OG ' ' A' ' 99' ' ' SER . 72.3 Cg_endo -80.82 112.79 2.7 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.632 2.222 . . . . 0.0 112.372 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 98' ' ' PRO . 49.4 m -168.12 59.43 0.43 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.398 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.7 26.54 0.32 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.841 2.361 . . . . 0.0 112.256 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' H ' ' C ' ' A' ' 99' ' ' SER . 10.1 t80 -104.06 134.66 46.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.506 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.02 17.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.633 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.5 p -60.65 -7.85 2.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.632 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 t -167.86 123.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -73.26 88.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.458 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -47.09 117.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.549 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -160.89 129.43 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.64 2.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.549 ' H ' ' C ' ' A' ' 107' ' ' MET . 72.4 mtt180 -105.38 99.84 9.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.371 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -123.72 159.54 55.34 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.468 -179.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.63 144.72 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.63 2.22 . . . . 0.0 112.048 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -103.79 -14.41 16.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.459 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.634 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.85 -5.21 59.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.2 mp -119.68 81.85 25.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -52.67 -2.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.566 2.178 . . . . 0.0 112.016 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tt -59.53 -32.31 70.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -41.03 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.604 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -71.9 -45.28 61.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.721 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -73.71 -17.29 61.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.456 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.0 t -141.34 72.32 26.31 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.514 ' O ' HG22 ' A' ' 125' ' ' VAL . 74.4 Cg_endo -79.75 -16.48 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.895 2.396 . . . . 0.0 111.804 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -50.2 -49.11 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.816 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.97 53.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.431 ' HA ' HD11 ' A' ' 45' ' ' ILE . 6.0 t80 -154.57 -39.76 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 121' ' ' PRO . 27.5 m -55.57 130.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.47 150.24 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.535 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.9 m -159.69 102.97 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.695 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.59 -176.7 20.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.3 m-20 -87.55 157.19 19.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 3.7 m -106.79 128.97 54.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.711 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 93.94 -7.87 0.13 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.429 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 8.1 mp0 -68.21 129.1 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.857 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.51 116.21 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.096 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -109.11 -31.04 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.84 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -174.06 143.26 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.794 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.96 156.45 44.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.295 0.569 . . . . 0.0 112.167 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -112.41 138.76 48.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.786 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.44 17.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 91.29 22.8 31.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.03 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.53 137.86 53.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.38 149.42 50.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.6 mtt -48.62 -52.74 42.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 86.5 Cg_exo -43.34 -34.21 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.396 2.064 . . . . 0.0 112.17 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.74 -52.66 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 148' ' ' GLY . 95.0 m95 -58.81 -58.3 9.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -43.83 -36.98 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.15 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.3 tt -61.17 -34.6 75.29 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.67 -47.63 89.24 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.65 -25.57 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.049 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.468 ' O ' HD13 ' A' ' 154' ' ' LEU . 6.6 t80 -64.85 -43.08 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.694 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 148' ' ' GLY . 5.5 tp -68.27 -36.81 76.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.359 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.015 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -58.71 -33.74 70.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 150' ' ' PHE . 4.1 mp -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.9 mt -82.43 -34.26 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.484 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 160' ' ' VAL . 91.6 t -60.48 -40.3 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.625 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.47 -50.58 13.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 154' ' ' LEU . 52.9 t -53.13 -50.61 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.54 -31.17 71.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.013 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 156' ' ' VAL . 11.1 t -70.87 -28.77 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.18 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 74' ' ' MET . 61.0 t -79.29 -49.42 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.222 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 162' ' ' ILE . 39.7 mm -68.92 -11.14 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.569 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.9 m -66.66 -13.96 61.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.59 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.409 ' C ' ' H ' ' A' ' 166' ' ' PHE . 21.1 mm-40 -141.38 74.71 23.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.13 -7.03 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 111.99 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 164' ' ' GLN . 47.1 p90 -163.22 179.35 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.494 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 122.34 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.46 102.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -64.98 100.15 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.598 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -46.79 131.82 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.462 ' H ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -86.5 31.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.453 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 173' ' ' LEU . 62.3 t0 -69.74 -73.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.587 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 172' ' ' ASP . 10.8 mp 54.05 165.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -60.27 112.12 1.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.33 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 165.94 119.77 0.49 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.535 ' N ' ' CD ' ' A' ' 176' ' ' ARG . 0.9 OUTLIER 46.8 56.29 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.639 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -98.42 -1.27 57.93 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -149.77 157.72 43.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -65.72 -81.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.529 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -177.68 141.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -78.03 -98.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.589 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -49.88 120.88 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.549 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.51 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.589 H3M2 ' O2 ' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tpt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -46.92 29.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.347 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.501 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -50.09 -45.69 52.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' GLN . 26.2 m-85 -63.03 -43.6 98.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.277 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.0 OUTLIER -48.01 -42.36 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.262 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -68.8 -24.05 64.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 4' ' ' PHE . 52.1 tt0 -77.98 -48.19 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.55 87.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' GLY . 8.2 m -76.72 -37.32 56.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' O ' ' CG ' ' A' ' 10' ' ' GLN . 34.4 tt0 -66.24 1.87 1.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.12 149.5 19.05 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -70.92 -49.03 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.681 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.83 -45.63 5.87 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.41 83.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.096 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -59.46 -47.17 86.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.058 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.413 ' HA ' HD13 ' A' ' 16' ' ' LEU . 4.2 mm? -59.27 -28.22 66.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 21' ' ' THR . 0.9 OUTLIER -70.9 -27.73 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.439 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.5 mmt -74.24 -34.44 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 -53.61 22.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.712 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -52.71 57.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.485 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 17' ' ' LEU . 16.2 p -44.74 -54.12 6.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.727 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.29 -22.2 62.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.73 -41.26 15.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.634 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.28 -39.92 64.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 25' ' ' LEU . 4.0 mm? -73.11 -27.78 61.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.835 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.44 -38.74 90.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.589 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 mt -79.18 -41.4 28.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 2.5 m -48.06 -43.33 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.49 -32.28 32.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.104 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tp -57.06 -21.33 30.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -90.22 -38.94 13.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.08 -45.54 43.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -71.25 -25.26 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 -21.24 51.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.393 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 36' ' ' MET . 7.6 p -107.19 -38.67 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.483 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.431 ' N ' HG13 ' A' ' 35' ' ' VAL . 12.4 mtp -98.68 5.73 47.47 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.4 mm? 47.22 45.0 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 46.9 mt -80.01 153.28 28.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.503 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -121.2 126.86 26.41 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.415 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 153.4 32.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.218 1.945 . . . . 0.0 111.934 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.8 t -100.15 -174.77 2.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.6 t -65.98 -41.74 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 110.822 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.65 -36.47 65.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t -57.69 -47.73 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 124' ' ' PHE . 25.5 pt -66.72 -36.36 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.089 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -55.06 -48.29 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.27 -36.15 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.87 84.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.504 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -58.92 -47.9 83.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -77.72 -49.71 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -46.6 -43.32 17.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 109.851 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.44 93.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' ALA . 55.1 t -58.31 -46.7 88.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.006 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.0 -42.95 29.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.543 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -24.15 72.45 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.87 -32.05 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.584 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -23.09 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 tp -79.63 -42.3 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.388 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.72 -36.9 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.679 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -69.71 -33.7 71.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.19 6.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.655 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.9 mt -79.64 -25.56 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.76 68.38 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.85 14.42 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.674 2.249 . . . . 0.0 111.995 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -8.81 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.197 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.27 162.47 20.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.813 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -42.04 -12.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.418 2.079 . . . . 0.0 112.246 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mp -50.35 -29.3 9.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 164' ' ' GLN . 26.7 ptt180 -37.9 -57.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.715 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -52.72 -35.01 55.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.108 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' LEU . 18.2 t -64.02 -44.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.58 -33.89 47.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.203 0.525 . . . . 0.0 110.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.51 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 8.3 mmt -62.59 -20.06 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 71' ' ' TYR . 3.4 t -51.78 -39.03 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.457 0.646 . . . . 0.0 110.342 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.74 -30.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.766 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.499 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 15.0 t-105 -66.95 -51.16 58.63 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.123 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.2 tp -67.29 -50.31 60.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.617 ' CE2' ' NE ' ' A' ' 83' ' ' ARG . 63.6 t80 -42.36 -42.49 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 110.267 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 p -79.12 -23.23 44.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.803 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.05 -58.95 6.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.256 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -74.71 -51.87 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.617 ' NE ' ' CE2' ' A' ' 79' ' ' TYR . 47.5 ttp85 -65.56 -42.33 91.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 88' ' ' THR . . . -62.77 -46.53 93.46 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 81' ' ' ALA . 70.7 t -66.8 -36.68 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.647 0.261 . . . . 0.0 111.057 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -72.09 -29.18 63.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.774 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -84.53 -48.2 9.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.391 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 84' ' ' GLY . 18.7 p -50.85 -54.6 22.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.395 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -51.69 -34.74 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.385 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -57.98 -39.8 79.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -68.09 -38.51 82.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.408 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.0 p -65.08 -50.57 65.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' TYR . 31.8 ttm -50.09 -39.58 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -45.44 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -59.72 -44.92 93.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 mt -80.15 -19.21 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.111 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.9 OUTLIER -133.13 92.62 24.73 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.59 169.05 20.39 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.425 2.083 . . . . 0.0 112.422 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 162.04 57.65 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 102' ' ' ALA . 25.7 Cg_endo -63.37 99.84 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.491 2.127 . . . . 0.0 111.985 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -48.01 -17.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.692 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 100' ' ' PRO . . . 54.89 -106.66 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -80.34 -104.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.575 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.534 ' N ' ' OG1' ' A' ' 103' ' ' THR . 7.2 t -116.6 -94.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.14 -154.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.569 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CB ' HH12 ' A' ' 109' ' ' ARG . 66.5 m-85 -134.18 159.61 40.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -95.91 154.37 17.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.43 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 108' ' ' VAL . 28.6 m -45.74 112.53 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.588 HH12 ' CB ' ' A' ' 106' ' ' PHE . 10.8 ptt-85 -114.63 103.5 11.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.507 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' PRO . 53.0 m-85 -137.2 149.47 66.1 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' PHE . 87.1 Cg_exo -37.54 160.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.561 2.174 . . . . 0.0 112.263 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -100.28 -4.95 28.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.709 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -100.6 12.24 37.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.9 mt -121.69 79.39 39.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.062 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 119' ' ' TRP . 53.4 Cg_exo -48.66 -5.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.534 2.156 . . . . 0.0 111.968 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 tp -54.19 -31.8 53.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.32 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 32.3 p-10 -97.0 -42.79 7.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.268 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 26.0 ttpp -72.29 -45.78 58.58 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.895 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' PRO . 57.9 t-105 -71.1 -18.82 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.182 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -133.26 75.14 71.25 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.4 -26.65 3.93 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.779 2.319 . . . . 0.0 111.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -61.62 -54.35 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.013 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 t -98.09 59.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.748 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -169.37 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 125' ' ' VAL . 10.6 p -60.96 127.47 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.418 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.4 160.58 14.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -166.14 99.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.79 -174.99 22.82 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.421 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -88.55 154.06 20.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.421 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -101.4 133.16 46.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.12 -4.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.928 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 12.4 tm-20 -67.93 150.95 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 19.6 ttm180 -85.82 126.84 34.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 110.538 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.25 -26.09 5.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -175.55 135.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 4.1 p30 -135.43 159.55 41.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.366 0.603 . . . . 0.0 112.135 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 138' ' ' LEU . 12.8 t80 -123.54 137.79 54.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.062 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.553 HD13 ' CE2' ' A' ' 137' ' ' PHE . 3.1 mp 54.38 17.1 1.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.521 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.35 13.78 61.16 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.72 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.434 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 13.8 mt -119.12 145.0 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.599 ' H ' ' CD ' ' A' ' 141' ' ' GLU . 4.0 mp0 -75.9 148.09 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.4 mtt -50.18 -57.28 13.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.1 Cg_exo -37.34 -38.67 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.351 2.034 . . . . 0.0 111.923 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -73.07 -46.81 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.204 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.5 m95 -60.77 -57.52 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 tt -43.55 -41.01 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.5 tt -57.38 -34.95 69.39 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.35 -43.66 95.56 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.612 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -72.85 -38.35 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -46.98 64.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 0.0 109.707 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.48 -49.49 83.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -57.72 -48.82 78.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.43 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.0 m-85 -59.15 -44.65 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.444 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.3 OUTLIER -69.64 -30.71 68.48 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.298 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.24 -36.69 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.722 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.2 t -62.12 -43.31 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' SD ' ' A' ' 74' ' ' MET . . . -61.71 -48.42 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 154' ' ' LEU . 83.3 t -52.17 -39.24 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.038 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.18 -41.42 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.7 t -59.26 -27.52 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 0.0 110.91 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.86 -44.66 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 162' ' ' ILE . 88.2 mt -69.17 -8.92 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.509 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 m -66.72 -11.13 53.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.616 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.491 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 8.1 pt20 -165.15 78.97 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' PHE . 73.0 Cg_endo -81.47 24.57 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.71 2.273 . . . . 0.0 111.944 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 165' ' ' PRO . 2.8 m-85 51.67 103.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.505 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -81.62 171.75 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -168.51 102.2 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.464 ' CD ' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -68.56 119.02 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.564 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -94.91 -165.84 1.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 60.7 mmt-85 -82.27 108.22 15.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.796 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -99.49 57.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.282 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 16.4 mt -120.3 145.4 47.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.619 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -82.2 -2.69 53.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.393 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -44.7 -72.47 0.35 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -104.7 173.8 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 179' ' ' HIS . . . -95.51 123.23 7.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -47.49 -18.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 110.651 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.409 ' N ' ' C ' ' A' ' 177' ' ' GLY . 6.1 m80 -105.84 147.25 28.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 181' ' ' HIS . 17.2 m80 -83.73 -159.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.073 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 180' ' ' HIS . 26.0 m80 -34.42 103.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.791 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -53.84 141.26 27.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.586 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.494 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 mt -58.94 -38.94 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.115 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -38.86 70.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.401 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.38 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.281 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.22 -42.0 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -65.37 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.238 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -74.29 -50.08 20.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.89 71.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.8 m -76.8 -37.36 55.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.532 ' OE1' ' N ' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -73.22 6.94 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.45 144.65 16.0 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -69.71 -49.15 56.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.732 0.301 . . . . 0.0 110.727 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.16 -46.12 6.42 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.26 85.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -59.19 -42.31 90.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.84 -28.95 69.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.051 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.54 -33.99 71.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.623 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.3 mtt -69.96 -33.35 71.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -51.8 35.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.669 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -50.05 -44.05 51.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.851 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -60.25 -62.0 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' O ' ' OE1' ' A' ' 26' ' ' GLU . . . -50.56 -29.45 10.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -37.5 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.418 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.38 -36.2 61.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.0 mp -66.68 -37.37 84.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.716 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 3.1 mp0 -66.45 -46.02 77.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.497 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.45 -56.73 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 24' ' ' ALA . 34.3 p -46.97 -44.81 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.722 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.71 -42.79 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.961 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.38 -19.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.953 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -92.36 -36.25 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.748 0.309 . . . . 0.0 110.48 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -44.07 58.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.133 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.93 -29.98 70.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -76.69 -13.02 60.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.587 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.03 -51.82 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.3 mmt -89.36 8.91 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER 46.95 49.06 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.254 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 mt -82.45 155.25 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -124.34 95.58 43.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.36 140.02 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.389 2.059 . . . . 0.0 112.08 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.9 t -95.78 -168.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' CB ' ' A' ' 126' ' ' ALA . 59.2 t -65.67 -44.86 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.98 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -70.84 -50.13 38.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.745 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 p -50.05 -51.17 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.46 -39.27 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.308 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -57.2 -45.36 83.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.85 -36.86 75.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.168 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -64.01 -33.81 76.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.022 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.66 80.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.89 77.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.383 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.416 HD12 ' HB1' ' A' ' 22' ' ' ALA . 1.5 mm? -76.51 -49.21 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.056 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -46.31 -40.1 11.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.496 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.61 -45.36 85.43 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 72.3 t -62.17 -45.45 98.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.187 0.518 . . . . 0.0 109.729 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.7 -46.73 10.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.586 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.15 -36.72 93.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -61.13 -44.91 96.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.629 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tp -78.17 -29.9 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.5 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -83.3 -40.18 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.77 -34.19 66.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.72 4.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.9 mt -87.46 -25.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB1' ' OG1' ' A' ' 67' ' ' THR . . . -175.51 67.45 0.26 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.39 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.2 15.92 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.679 2.253 . . . . 0.0 112.116 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -115.65 -4.05 12.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.111 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.12 163.17 19.71 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -39.97 -15.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.505 2.136 . . . . 0.0 112.255 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 mm? -41.81 -34.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.79 -70.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.536 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.497 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.2 m-85 -48.35 -36.21 14.03 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.792 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -65.65 -45.7 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.63 -33.36 41.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.265 0.555 . . . . 0.0 110.295 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.488 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 10.4 mmt -65.62 -20.51 66.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.1 t -53.36 -34.67 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.0 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.3 mt -89.31 -32.25 5.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.205 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.517 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.3 t-105 -63.64 -51.41 65.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.997 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tp -69.11 -44.54 72.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -45.79 -46.51 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.174 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.8 p -78.5 -19.72 52.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.669 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.787 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.75 -59.45 5.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -74.72 -49.76 19.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.618 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -71.83 -40.23 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.814 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.47 -49.16 81.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 81' ' ' ALA . 33.5 m -72.74 -47.4 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.746 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.55 ' N ' HG23 ' A' ' 85' ' ' VAL . 21.1 tt0 -50.72 -24.9 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 0.0 109.945 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 tt -81.44 -40.56 23.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.434 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.614 ' CG2' HD21 ' A' ' 147' ' ' LEU . 66.7 p -53.95 -25.64 21.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 110.085 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -52.07 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -56.95 -32.82 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.462 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 7.2 t-80 -71.73 -44.58 63.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -65.99 -52.22 51.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.616 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -57.45 -50.9 71.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -53.59 -33.4 54.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.823 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.6 -42.02 92.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 109.911 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 96' ' ' LEU . 11.2 mp -96.51 -5.51 39.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.203 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 93' ' ' MET . 34.5 t80 -133.76 69.57 75.77 Favored Pre-proline 0 C--N 1.334 -0.105 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.552 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -46.85 100.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.446 ' OG ' ' CD2' ' A' ' 97' ' ' TYR . 23.6 m -140.6 78.52 21.25 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -46.41 -27.3 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.624 2.216 . . . . 0.0 112.082 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 t80 41.24 90.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.594 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 52.96 68.12 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.504 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.439 ' HG1' ' N ' ' A' ' 104' ' ' SER . 70.6 p 50.54 -101.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.531 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.439 ' N ' ' HG1' ' A' ' 103' ' ' THR . 14.4 p 57.97 9.29 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.75 -26.81 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.588 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.65 83.74 2.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.579 ' O ' ' N ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -60.18 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.545 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.726 ' O ' HG22 ' A' ' 108' ' ' VAL . 11.0 p 38.94 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.188 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 107' ' ' MET . 9.1 mmm180 -111.45 113.7 26.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.038 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -94.6 147.9 33.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.56 160.31 50.25 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.814 2.343 . . . . 0.0 111.932 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.8 pm0 -105.57 -10.89 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.642 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -101.21 -6.27 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.645 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.2 mt -123.61 78.91 55.56 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.986 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 45.5 Cg_exo -52.22 1.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.612 2.208 . . . . 0.0 112.194 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.593 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.0 tp -62.4 -29.31 70.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.551 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.4 OUTLIER -97.43 -41.18 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.443 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -75.29 -45.73 37.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.473 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.7 t90 -68.62 -17.67 64.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.203 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 116' ' ' LEU . 4.3 p -161.13 79.42 2.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.996 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.02 -2.05 11.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.043 2.495 . . . . 0.0 111.785 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -49.05 -47.96 44.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.776 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.96 54.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -157.15 -41.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.408 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 125' ' ' VAL . 14.3 p -54.43 128.9 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.66 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -97.78 150.41 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.776 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.4 t -167.82 110.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.476 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.02 -172.81 21.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.2 m-20 -87.08 139.1 30.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.211 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 28.6 m -93.16 131.09 38.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 87.38 -1.9 0.56 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.326 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.01 128.48 36.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.035 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -80.17 129.23 34.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -122.49 -15.49 7.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.62 144.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.02 159.26 42.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.553 . . . . 0.0 112.0 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.418 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.9 t80 -112.23 136.85 51.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.82 16.84 0.12 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.38 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.429 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 92.71 22.52 28.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 139' ' ' GLY . 4.7 mp -122.89 133.83 54.4 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 109.977 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.85 146.37 54.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.416 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.5 mtt -46.96 -52.65 31.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.722 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 142' ' ' MET . 77.0 Cg_exo -44.45 -35.63 8.83 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.329 2.019 . . . . 0.0 112.232 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -52.51 21.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.457 . . . . 0.0 109.995 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.632 ' O ' ' N ' ' A' ' 148' ' ' GLY . 83.0 m95 -59.35 -56.97 15.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.125 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tt -43.26 -38.21 2.48 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.614 HD21 ' CG2' ' A' ' 88' ' ' THR . 0.5 OUTLIER -60.47 -34.06 73.49 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.96 -41.9 98.07 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.437 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.07 -27.93 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.086 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.513 ' O ' HD13 ' A' ' 154' ' ' LEU . 10.4 t80 -61.49 -48.47 80.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 tp -69.15 -37.2 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.26 67.34 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.025 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.1 -41.17 99.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.864 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 150' ' ' PHE . 6.5 mp -51.93 -32.41 32.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.1 mm -82.08 -38.7 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 160' ' ' VAL . 79.0 t -52.11 -36.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.319 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.517 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.27 -47.16 15.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 154' ' ' LEU . 72.0 t -58.67 -37.67 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.097 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.556 ' O ' HD13 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -80.01 -40.23 28.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.3 t -68.48 -26.26 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.855 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 157' ' ' ALA . 43.3 t -79.32 -49.0 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 162' ' ' ILE . 74.7 mt -65.8 -13.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 83.2 p -52.9 -10.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 162' ' ' ILE . 2.4 pt20 -47.54 152.28 1.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.302 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 166' ' ' PHE . 27.4 Cg_endo -63.67 -12.5 31.64 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.489 2.126 . . . . 0.0 111.804 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 165' ' ' PRO . 80.5 t80 37.58 91.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -58.75 108.43 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.549 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.56 113.26 24.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 49.47 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.574 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -170.99 -57.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.522 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 172' ' ' ASP . 50.6 ttt-85 -86.74 -5.1 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.543 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 171' ' ' ARG . 11.0 m-20 56.35 114.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.631 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.6 mp -80.43 131.28 35.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.12 12.69 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -169.92 -112.34 0.27 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -141.31 -14.02 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 171.09 178.05 41.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.543 ' N ' ' ND1' ' A' ' 178' ' ' HIS . 1.2 p-80 -168.68 77.5 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 0.0 110.711 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -58.62 2.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.375 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.525 ' CG ' ' H ' ' A' ' 181' ' ' HIS . 0.0 OUTLIER -62.66 -116.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.498 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.525 ' H ' ' CG ' ' A' ' 180' ' ' HIS . 1.7 t60 44.22 72.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.528 ' CG ' ' N ' ' A' ' 183' ' ' HIS . 1.7 t60 -73.52 -109.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.623 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.528 ' N ' ' CG ' ' A' ' 182' ' ' HIS . 23.1 p-80 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.591 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.528 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp -53.75 -38.39 64.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.624 ' O ' ' ND2' ' A' ' 6' ' ' ASN . 19.1 ttp180 -57.49 -27.93 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.202 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.4 -42.64 58.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.074 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.3 mm? -50.76 -41.19 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.498 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.624 ' ND2' ' O ' ' A' ' 3' ' ' ARG . 8.4 p30 -71.98 -26.41 62.23 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.512 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.77 -49.46 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.623 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.03 77.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -76.74 -32.63 57.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -70.1 2.25 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.88 149.75 19.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -71.98 -49.72 34.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.448 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.15 -45.49 6.27 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -58.82 -45.32 90.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.026 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.7 -28.28 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.99 -30.75 68.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.439 ' O ' ' OG1' ' A' ' 21' ' ' THR . 27.2 tpp -72.13 -33.56 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.906 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -51.81 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -51.41 -52.03 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -49.66 -47.76 49.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -43.31 86.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.34 -41.3 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.89 -35.32 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.378 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' OG1' ' A' ' 28' ' ' THR . 35.4 mt -75.71 -39.6 57.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.487 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -64.82 -52.73 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -57.33 -42.04 81.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.644 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 24' ' ' ALA . 11.7 p -60.67 -42.25 96.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.124 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.95 -19.82 65.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.294 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -94.46 -37.7 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 110.843 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -55.41 -46.7 76.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.404 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -71.62 -40.45 69.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.693 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.539 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 45.7 t-80 -61.38 -15.02 32.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.1 t -108.84 -44.77 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.42 5.34 27.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.98 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt 48.34 48.98 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.715 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.4 mt -85.06 154.83 21.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.574 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -116.15 119.15 37.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.245 1.964 . . . . 0.0 112.022 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.447 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 3.9 t -127.19 -177.21 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.527 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.8 p -66.57 -34.93 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 0.0 110.401 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.52 -48.5 55.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.306 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 p -48.46 -50.77 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.1 mt -61.56 -38.43 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -60.52 -44.3 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.838 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.4 tp10 -61.75 -47.88 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 -50.6 -42.79 56.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.917 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.92 74.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 47' ' ' GLU . . . -56.26 -44.62 79.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.928 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.41 -50.83 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.043 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -39.49 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.25 -45.4 80.85 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.32 -43.74 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.559 . . . . 0.0 109.533 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.523 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.03 -49.42 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.362 179.078 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.12 92.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -29.3 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.5 -37.29 71.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.479 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -74.06 -23.76 59.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.357 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -84.19 -46.81 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.39 73.82 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.05 5.42 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.726 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 97.8 mt -80.44 -32.86 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.69 72.95 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.63 27.6 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.547 2.165 . . . . 0.0 111.68 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 64' ' ' ALA . 16.5 tttm -113.34 -10.71 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.933 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.42 162.6 19.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.654 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -39.05 -14.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.705 2.27 . . . . 0.0 112.665 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' THR . 44.4 mt -45.07 -28.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.699 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.2 OUTLIER -40.87 -70.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.547 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.566 ' O ' HG23 ' A' ' 75' ' ' VAL . 43.3 m-85 -51.03 -33.26 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.909 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.22 -45.45 89.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -36.13 26.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.625 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -62.73 -23.68 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.402 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.7 t -53.01 -31.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.407 0.622 . . . . 0.0 109.873 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.2 mt -88.86 -34.32 6.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.587 ' CD1' HD13 ' A' ' 154' ' ' LEU . 2.9 t-105 -65.34 -53.15 47.87 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 81' ' ' ALA . 4.8 mt -63.2 -47.96 80.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.666 0.27 . . . . 0.0 110.607 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -42.73 -43.31 3.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.256 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.659 ' OG ' HD11 ' A' ' 154' ' ' LEU . 19.0 p -77.66 -21.27 52.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.831 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 154' ' ' LEU . . . -59.7 -60.61 3.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.45 -53.66 15.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.01 -48.41 53.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.581 ' O ' HG23 ' A' ' 88' ' ' THR . . . -55.89 -47.26 80.51 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.97 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.88 -32.43 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.542 0.211 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -72.06 -47.07 54.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.062 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.48 -49.91 43.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.674 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 84' ' ' GLY . 13.2 p -46.39 -48.42 18.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.441 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' THR . 50.4 t80 -57.29 -44.94 84.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.296 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -43.71 -42.06 5.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 109.987 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.02 -34.68 73.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.97 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 89' ' ' TYR . 10.1 m -62.24 -50.1 73.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.302 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' TYR . 18.9 ttt -56.48 -36.78 69.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.933 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -70.13 -36.9 75.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.52 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 48.5 tt0 -63.93 -37.52 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.509 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.19 -15.73 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 -139.93 75.56 29.8 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.04 -170.26 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.625 2.217 . . . . 0.0 111.949 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.443 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -179.18 -55.34 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.733 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 99' ' ' SER . 60.7 Cg_endo -74.4 172.3 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.229 1.952 . . . . 0.0 111.972 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -153.37 -13.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 104' ' ' SER . . . -157.49 -76.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.2 p 43.41 21.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.525 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 102' ' ' ALA . 14.8 m 55.32 49.58 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.45 122.89 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.535 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.73 108.04 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.463 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -113.15 173.42 6.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.599 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 108' ' ' VAL . 39.6 t 55.27 20.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -83.92 106.43 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.586 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -118.64 151.11 49.44 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.35 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.13 140.75 91.0 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.504 2.136 . . . . 0.0 112.003 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.6 11.5 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.59 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -124.62 -1.01 8.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.624 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 116' ' ' LEU . 53.3 mt -126.59 85.58 60.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.46 5.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.872 2.381 . . . . 0.0 112.745 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.619 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.0 mt -58.04 -31.41 66.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.78 -40.08 8.72 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.997 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.5 -45.54 90.24 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.39 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -79.6 -13.01 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.856 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.81 68.93 24.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.907 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.451 ' O ' HG23 ' A' ' 125' ' ' VAL . 7.5 Cg_exo -69.98 -20.04 34.29 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.813 2.342 . . . . 0.0 111.508 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.64 -53.49 57.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.344 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.54 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 4.0 t -101.94 54.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 6.3 m-85 -161.22 -46.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 121' ' ' PRO . 77.2 t -55.32 129.44 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.74 152.18 19.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.662 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 101.78 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.733 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.79 176.41 14.92 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -83.13 160.47 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.8 m -107.84 128.96 55.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.4 -8.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.726 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE2' ' N ' ' A' ' 129' ' ' ASP . 8.0 pt-20 -67.87 148.91 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.933 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -85.54 136.51 33.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -125.59 -31.17 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.407 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 39.8 t-105 -174.82 141.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 135' ' ' TRP . 3.6 m-20 -134.62 161.28 35.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.325 0.583 . . . . 0.0 112.161 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.415 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -118.98 136.67 53.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.517 178.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 49.13 16.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.479 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.415 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 93.85 19.75 33.25 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.227 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.1 144.05 51.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.06 0.43 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.52 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 50.8 mt-10 -70.38 145.95 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.558 ' SD ' ' C15' ' A' ' 201' ' ' UQ2 . 2.1 mmt -44.03 -61.93 1.76 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -34.97 -36.45 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.618 2.212 . . . . 0.0 112.238 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -69.57 -58.32 4.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.045 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.9 m95 -55.31 -57.38 12.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.6 tt -43.45 -35.52 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.126 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.37 -35.13 78.19 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.57 -48.27 85.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.677 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -71.87 -33.28 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.02 -44.08 87.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.46 -43.33 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.47 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -60.65 -49.99 75.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.11 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -57.37 -48.24 79.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 0.0 111.058 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.659 HD11 ' OG ' ' A' ' 80' ' ' SER . 4.5 mm? -66.98 -34.93 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.607 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 -36.73 37.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.199 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 152' ' ' ALA . 14.9 t -54.66 -48.74 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -61.19 -48.69 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 154' ' ' LEU . 76.7 t -48.9 -39.43 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 33.5 mt -78.38 -24.6 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.04 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 156' ' ' VAL . 56.1 t -77.92 -22.7 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 110.718 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.24 -49.59 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.439 ' C ' ' N ' ' A' ' 164' ' ' GLN . 77.7 mt -64.48 -25.69 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.72 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.6 m -52.54 -11.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 0.0 110.403 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.626 ' NE2' ' CZ ' ' A' ' 166' ' ' PHE . 13.7 mt-30 -56.2 152.01 24.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.316 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.73 20.98 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.547 2.165 . . . . 0.0 111.918 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.626 ' CZ ' ' NE2' ' A' ' 164' ' ' GLN . 42.1 p90 -161.16 155.51 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -159.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.5 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 53.67 -166.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.349 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -78.39 -27.91 46.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.281 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -156.67 -57.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.605 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -174.23 -50.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.808 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.76 139.1 23.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 173' ' ' LEU . 0.6 OUTLIER -162.21 0.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.405 ' H ' ' H ' ' A' ' 173' ' ' LEU . 11.9 m-85 -64.56 101.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.566 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 176' ' ' ARG . . . 163.84 17.54 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 175' ' ' GLY . 15.0 mmt180 -136.9 93.65 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.23 18.95 0.05 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' A' ' 179' ' ' HIS . 14.1 t-80 -76.4 -139.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 0.0 110.472 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' HIS . . . . . 0.6 ' H ' ' CG ' ' A' ' 178' ' ' HIS . 49.1 t-80 38.98 -120.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.812 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' HIS . . . . . 0.52 ' N ' ' ND1' ' A' ' 179' ' ' HIS . 17.7 m-70 54.25 166.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.47 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -45.01 -30.94 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.67 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -46.34 129.91 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.529 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 17.9 m170 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.589 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.558 ' C15' ' SD ' ' A' ' 142' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.01 -44.75 94.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.375 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -51.3 -39.34 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.391 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -66.1 -44.92 82.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.2 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -39.65 12.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -69.45 -24.96 63.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.315 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tm0? -80.39 -48.22 13.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.56 69.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.522 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 p -76.79 -34.48 57.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.684 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.418 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 1.9 tp-100 -70.96 6.37 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 141.08 15.15 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.75 -20.64 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.738 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.43 -44.2 74.59 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -51.33 66.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -53.76 -43.9 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mt -70.26 -30.28 67.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.05 -36.64 77.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.604 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.58 -34.49 75.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.27 37.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.394 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -50.63 -36.87 37.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.728 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.11 -56.72 14.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.778 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.71 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.658 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 23' ' ' LEU . 1.1 tt -84.21 -42.39 15.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.27 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.55 -34.61 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.35 -52.84 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.83 -52.28 60.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 p -51.23 -38.9 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.15 -34.14 68.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.46 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.28 -22.75 67.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.756 0.312 . . . . 0.0 110.426 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -85.03 -28.81 25.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -45.56 94.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.99 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.413 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 11.1 pt20 -66.95 -27.46 67.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -83.17 -13.34 55.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.981 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.32 -33.13 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.132 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 36' ' ' MET . 14.3 ttm -109.21 6.63 24.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.153 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 mt 48.92 51.35 16.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.046 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 8.6 mt -81.81 154.54 25.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 127' ' ' SER . 42.3 mttp -120.24 93.76 48.28 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.5 131.11 27.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.509 2.139 . . . . 0.0 112.022 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -89.8 -171.14 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 43' ' ' LEU . 8.6 p -62.22 -41.65 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.8 mp -58.89 -45.44 90.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -48.45 -42.54 32.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -62.48 -42.22 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 110.12 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -65.83 -46.45 78.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.503 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -50.36 67.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.366 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -58.76 -30.77 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.72 68.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' ' CZ ' ' A' ' 150' ' ' PHE . . . -59.22 -48.81 80.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.62 -52.78 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.246 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -44.66 -40.19 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.74 87.93 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.44 -46.36 93.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mt -44.05 -46.09 8.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.427 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.19 -41.64 98.26 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.31 -44.38 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.512 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.3 -32.61 73.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 8.6 mt -73.33 -26.45 61.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mm -82.08 -35.33 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.351 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.16 80.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.81 5.71 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.695 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.5 mp -82.85 -35.12 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.426 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -179.83 73.23 0.18 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.206 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 53.0 Cg_endo -72.56 23.3 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.533 2.155 . . . . 0.0 112.055 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 12.1 ttpt -113.8 -6.49 13.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -114.12 159.44 36.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.894 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -38.15 -18.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.628 2.219 . . . . 0.0 112.442 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.5 mp -41.34 -32.6 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.572 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 161' ' ' VAL . 34.8 mtp180 -39.76 -65.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.663 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.02 -32.49 46.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -66.0 -45.23 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.819 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.29 63.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.657 0.742 . . . . 0.0 109.129 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.533 ' O ' ' SD ' ' A' ' 74' ' ' MET . 11.0 tmm? -56.96 -11.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.14 -44.17 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.29 0.567 . . . . 0.0 111.394 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.05 -32.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.442 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.776 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 9.9 t90 -61.22 -53.17 60.31 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.588 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' CE3' ' A' ' 77' ' ' TRP . 20.9 tp -58.31 -53.67 55.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -43.82 -46.07 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.667 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -80.71 -27.31 36.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.01 -60.84 3.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.004 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -73.47 -55.69 6.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -66.93 -45.48 77.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.04 93.51 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -69.91 -53.18 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.531 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -47.6 -25.71 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 109.948 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 tp -78.09 -39.67 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.32 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.4 p -54.58 -29.52 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.355 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.44 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.5 OUTLIER -70.77 -52.46 20.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.856 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.09 -32.61 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -75.22 -34.97 61.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.772 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 89' ' ' TYR . 17.6 p -72.05 -47.75 49.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -53.62 -53.87 45.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.554 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.72 -43.97 97.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.617 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.47 -38.72 69.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.203 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.55 -9.46 27.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.353 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 32.5 t80 -130.97 79.23 71.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.83 111.93 3.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.53 2.154 . . . . 0.0 111.9 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t -160.84 75.71 2.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.574 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.8 114.48 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.636 2.224 . . . . 0.0 112.043 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.14 -44.42 97.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.63 35.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.6 m 52.0 84.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.593 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 p -101.58 53.49 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.49 87.19 2.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.07 92.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.55 ' C ' ' H ' ' A' ' 109' ' ' ARG . 22.9 ptt? -101.98 164.52 11.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 108' ' ' VAL . 49.0 t 58.31 -1.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 107' ' ' MET . 45.4 ttt-85 -100.2 102.47 13.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.591 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.421 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -109.73 158.88 33.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.268 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.76 130.06 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.709 2.272 . . . . 0.0 111.802 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.73 -17.27 32.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.653 ' N ' ' CD1' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -85.09 -6.21 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 110.36 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.613 ' C ' ' H ' ' A' ' 116' ' ' LEU . 12.0 mt -120.35 83.41 33.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.41 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 39.1 Cg_exo -54.0 11.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.79 2.326 . . . . 0.0 112.802 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.1 mt -75.16 -29.15 60.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.542 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 1.1 t70 -96.24 -40.22 9.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.805 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -67.87 -40.61 83.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.41 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.4 t90 -81.67 -16.02 52.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.45 74.15 20.2 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.68 -17.27 11.22 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.856 2.371 . . . . 0.0 111.841 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -51.71 -52.44 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 m -112.66 60.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.641 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.542 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 2.0 t80 -164.92 -40.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.329 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.4 125.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.81 146.56 23.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' LYS . 16.2 p -155.1 144.79 21.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.88 -175.71 38.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.477 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.1 m-20 -84.64 144.76 28.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.744 0.307 . . . . 0.0 110.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 32.8 m -92.72 132.65 36.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.963 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.88 -3.27 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.452 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.92 128.3 36.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.826 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -76.93 134.95 38.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -128.06 -19.63 3.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.586 ' NE1' ' SD ' ' A' ' 142' ' ' MET . 6.7 p90 -172.95 149.6 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.228 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.11 166.89 24.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.28 0.562 . . . . 0.0 111.87 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -122.8 138.41 54.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.38 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.57 17.04 0.51 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.411 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.2 21.65 44.51 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.0 mt -126.34 137.67 53.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 143.7 55.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.25 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.586 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -48.1 -53.36 33.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.3 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.3 Cg_exo -40.95 -35.81 1.85 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.33 2.02 . . . . 0.0 111.863 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -71.71 -49.64 37.6 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.619 ' O ' ' N ' ' A' ' 148' ' ' GLY . 79.5 m95 -59.17 -56.73 18.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.908 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -43.91 -38.54 3.45 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -58.74 -35.19 72.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.08 -47.04 93.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.583 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.7 mp -65.96 -43.67 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.52 ' CZ ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -49.04 -40.27 30.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.3 mt -65.38 -38.51 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.715 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 149' ' ' ILE . . . -52.99 -49.71 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.991 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.08 -45.71 93.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.563 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 158' ' ' VAL . 13.2 tp -47.97 -32.64 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.391 0.615 . . . . 0.0 109.844 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.0 mt -83.0 -37.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.292 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.0 t -52.61 -46.35 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.776 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.88 -44.17 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.548 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 154' ' ' LEU . 43.0 t -50.16 -40.66 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.11 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.24 -42.15 14.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.477 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 156' ' ' VAL . 55.6 t -64.68 -38.26 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.208 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.539 ' O ' ' NH2' ' A' ' 70' ' ' ARG . 63.8 t -71.75 -53.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 109.945 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.502 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 1.3 mp -66.46 -5.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 p -52.46 -13.71 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.185 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.403 ' N ' ' C ' ' A' ' 162' ' ' ILE . 50.9 mt-30 -40.46 154.29 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.218 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 167' ' ' LYS . 13.0 Cg_endo -57.24 -14.97 16.9 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.39 2.06 . . . . 0.0 111.934 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 166' ' ' PHE . 31.8 t80 40.39 27.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.654 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . 10.2 mtpt 55.21 89.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.408 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -147.59 -149.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 168' ' ' ALA . 17.9 mttm 60.48 129.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.528 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -101.78 -6.07 24.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.542 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.97 138.3 6.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.27 155.43 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.566 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.6 mp -100.44 -130.7 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.523 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 55.03 107.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.55 3.03 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -74.03 94.58 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.28 92.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -160.27 -10.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.48 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -64.24 -5.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -167.49 68.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.543 ' CG ' ' N ' ' A' ' 182' ' ' HIS . 2.0 p80 -62.96 -136.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.557 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.543 ' N ' ' CG ' ' A' ' 181' ' ' HIS . 13.6 t60 -158.58 -62.94 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.012 -0.995 . . . . 0.0 110.61 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' UQ2 . . . . . 0.543 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.8 mm? . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -54.25 -36.42 63.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLN . 43.2 m-85 -72.25 -44.31 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.57 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -45.69 -42.9 12.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 110.095 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -68.33 -25.4 65.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.19 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.4 tp-100 -78.79 -48.77 14.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.42 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 11' ' ' GLY . 39.1 p -76.7 -41.02 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -69.03 6.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.139 0.495 . . . . 0.0 110.304 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.21 140.8 15.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -68.9 -49.2 60.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.846 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.95 -46.07 6.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.12 85.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.114 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -56.88 -47.1 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.55 -27.94 68.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.14 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.24 -36.41 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 mmt -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.202 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.11 73.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.909 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.08 -34.14 73.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.978 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 m -59.68 -58.98 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.626 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.17 -25.67 65.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -77.33 -42.11 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.279 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 28' ' ' THR . . . -61.39 -24.34 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.19 -45.4 10.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.454 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.0 -37.74 88.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.756 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.69 -51.42 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.925 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 24' ' ' ALA . 5.6 p -47.25 -37.15 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.91 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.815 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.1 -15.83 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.438 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.3 t-105 -94.46 -33.4 13.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.545 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -38.45 79.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.482 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -72.13 -39.2 68.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.579 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -8.42 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' TRP . 78.9 t -108.99 -46.48 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 mmt -96.2 14.43 24.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.744 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt 43.01 42.63 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.7 mt -70.01 154.98 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.115 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -111.56 103.28 54.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.108 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -52.1 167.84 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.154 1.903 . . . . 0.0 111.545 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.8 175.4 9.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.5 t -61.7 -48.31 89.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 9.8 mp -61.34 -45.51 94.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.14 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -49.09 -44.73 42.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.429 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 124' ' ' PHE . 69.6 mt -61.45 -43.82 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.094 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -47.11 73.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.597 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.397 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' NH2' ' CD1' ' A' ' 52' ' ' PHE . 3.8 tmt_? -62.63 -37.66 87.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.548 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.34 78.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -59.13 -48.36 81.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.817 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.8 tp -79.56 -50.3 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CD1' ' NH2' ' A' ' 48' ' ' ARG . 66.2 t80 -46.23 -41.48 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.759 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.93 -44.2 89.47 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 50' ' ' ALA . 47.5 t -62.61 -47.3 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.3 tp -44.62 -48.09 10.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.523 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.08 92.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.86 63.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.446 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.72 76.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.352 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.0 -27.09 54.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.45 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.9 mt -81.8 -43.48 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.397 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.79 -32.94 78.85 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.85 4.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.715 0.293 . . . . 0.0 110.944 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.7 mt -83.33 -26.49 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.67 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB1' ' OG1' ' A' ' 67' ' ' THR . . . -173.23 65.48 0.33 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.433 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.16 11.14 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.648 2.232 . . . . 0.0 112.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -111.04 -6.47 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.25 161.89 24.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.639 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -38.16 -16.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.554 2.169 . . . . 0.0 112.287 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.4 tp -43.22 -31.47 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -40.79 -65.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.583 ' O ' HG13 ' A' ' 75' ' ' VAL . 6.7 m-85 -55.69 -29.89 60.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 75' ' ' VAL . 12.2 t -67.6 -43.11 87.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.639 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -29.06 30.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.275 0.559 . . . . 0.0 109.955 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.7 ttt -65.25 -12.97 57.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 72' ' ' VAL . 30.3 m -59.71 -37.15 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.524 0.678 . . . . 0.0 110.537 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.411 ' N ' HG23 ' A' ' 75' ' ' VAL . 8.3 mt -89.27 -30.05 5.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.215 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.472 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 2.5 t-105 -68.6 -49.72 57.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.995 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.554 ' O ' HD23 ' A' ' 78' ' ' LEU . 3.9 tt -66.53 -50.61 62.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.0 m-85 -43.69 -39.98 3.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -79.71 -23.81 42.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.75 -61.77 2.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.804 0.335 . . . . 0.0 111.159 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -51.95 12.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.085 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HE ' HD23 ' A' ' 87' ' ' LEU . 5.3 tpm_? -68.51 -47.87 65.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.656 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.92 -46.11 92.87 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.965 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.41 -37.69 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.796 -0.238 . . . . 0.0 111.472 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -67.98 -25.41 65.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.549 HD23 ' HE ' ' A' ' 83' ' ' ARG . 3.6 mm? -90.21 -35.36 15.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.892 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.6 p -57.33 -52.53 64.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -48.93 -49.85 38.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.376 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -51.91 -42.73 62.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -67.04 -34.49 77.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -74.48 -29.92 61.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.571 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 20.4 mmt -64.24 -41.18 97.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.356 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.72 -51.15 61.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.431 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.171 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.572 0.225 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -125.22 -5.7 7.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -123.02 81.58 50.88 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 36.1 Cg_exo -56.55 15.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.351 . . . . 0.0 112.671 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.616 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -76.28 -32.35 58.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.013 0.435 . . . . 0.0 110.253 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 1.1 m-20 -98.4 -40.28 8.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.347 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.24 -45.35 63.44 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.018 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 9.9 t-105 -76.76 -10.37 59.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.39 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.02 68.99 35.47 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.75 -15.44 12.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.867 2.378 . . . . 0.0 111.668 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -53.08 -32.15 45.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.627 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 44.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.622 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -148.57 -36.87 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.436 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.2 p -58.73 127.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.694 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.27 152.91 18.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.31 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -155.08 102.39 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.14 -168.07 19.38 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.3 154.1 19.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.631 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 36.3 m -99.01 138.78 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 111.204 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 101.04 -5.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.634 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.84 149.22 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -98.86 122.58 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.735 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.55 -29.76 9.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -173.68 146.54 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.46 158.08 44.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.293 0.568 . . . . 0.0 112.106 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 13.4 m-85 -112.89 137.71 50.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.175 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.7 mm? 48.61 17.44 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.425 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.62 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 92.61 22.3 29.18 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.223 -0.513 . . . . 0.0 111.995 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 139' ' ' GLY . 2.1 mm? -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.614 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 5.2 mp0 -72.41 146.56 46.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.3 mtt -47.24 -56.42 12.43 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -40.95 -38.58 2.94 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.565 2.176 . . . . 0.0 112.672 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -70.14 -51.8 28.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.9 m95 -58.79 -56.64 19.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.9 tp -43.69 -38.29 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.1 tt -59.54 -36.82 76.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.98 -46.48 94.5 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.7 mt -75.09 -25.63 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.015 0.436 . . . . 0.0 110.061 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -63.36 -44.03 95.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.765 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 151' ' ' ILE . 4.8 tt -70.23 -36.83 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.578 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -56.0 -48.75 75.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.55 -40.42 94.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.686 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 81' ' ' ALA . 86.7 mt -64.36 -32.42 74.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.41 -29.65 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 160' ' ' VAL . 43.1 t -63.38 -40.14 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.34 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -70.08 -50.03 45.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 154' ' ' LEU . 92.4 t -51.62 -39.25 23.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.1 tp -81.18 -37.35 28.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.14 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.5 t -71.0 -22.48 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.795 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 157' ' ' ALA . 61.6 t -83.12 -48.29 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.0 110.24 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.421 ' O ' HG22 ' A' ' 162' ' ' ILE . 81.5 mt -69.16 -14.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.385 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 tp . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.821 0.343 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -49.64 -48.91 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.404 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -52.83 -45.6 67.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.277 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tp -48.78 -43.76 38.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.126 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -69.56 -26.36 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.076 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -75.96 -50.49 14.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.28 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.81 70.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' GLY . 50.4 p -76.85 -41.57 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -68.28 5.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.419 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.75 140.98 15.12 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -70.19 -49.9 45.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.615 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.73 -46.42 5.91 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.45 89.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -61.58 -37.17 82.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.05 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.1 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.138 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' THR . 6.8 tp -70.31 -30.0 66.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.752 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.423 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.2 mtp -73.41 -33.69 65.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.89 -55.3 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.53 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -47.03 -47.92 22.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 17' ' ' LEU . 31.5 p -53.48 -58.02 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.379 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.14 -34.65 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.8 tp -76.32 -41.97 46.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.21 -32.14 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.293 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.57 -37.32 42.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.13 -52.84 62.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.821 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.26 -50.24 74.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.747 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 24' ' ' ALA . 17.1 p -48.59 -44.06 36.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.861 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.34 -46.21 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.034 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -53.15 -19.57 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.534 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -92.27 -39.41 11.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.61 -30.85 14.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -83.77 -42.1 16.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.011 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.414 ' CE1' HD12 ' A' ' 30' ' ' LEU . 36.0 m170 -69.09 -14.49 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 36' ' ' MET . 9.2 p -109.11 -39.22 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.899 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.445 ' N ' HG13 ' A' ' 35' ' ' VAL . 1.1 tpt -97.23 11.55 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.867 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.2 mp 43.85 44.97 6.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.199 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 134' ' ' GLN . 5.3 tp -77.6 153.0 33.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -108.78 129.85 23.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.691 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.27 169.17 21.8 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.468 2.112 . . . . 0.0 112.184 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.95 159.57 38.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.561 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -50.82 -42.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.155 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.88 -45.13 87.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -51.08 -42.83 60.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 124' ' ' PHE . 33.3 mt -66.21 -43.1 92.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.241 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -58.85 -44.91 91.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.757 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.07 -49.7 76.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -59.11 -30.09 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.131 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.98 82.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.347 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -57.43 -49.73 75.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.649 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.07 -49.27 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -46.1 -41.34 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.98 -42.39 92.68 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.5 t -64.97 -47.61 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 109.975 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 tt -45.21 -44.87 11.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.654 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -37.01 94.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -63.97 -37.88 89.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.2 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.73 -34.17 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.31 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -75.72 -27.14 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.186 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.39 -40.43 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.64 -26.81 73.46 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.96 9.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.662 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.2 mt -82.08 -39.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.63 74.38 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 0.0 110.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.31 26.8 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.701 2.267 . . . . 0.0 112.086 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -108.13 -9.02 15.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.309 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.564 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.8 175.85 1.71 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.686 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.65 -4.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.239 1.96 . . . . 0.0 112.047 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.8 mt -47.98 -35.45 10.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 58.8 mtt180 -40.83 -70.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.429 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.9 t80 -49.61 -20.22 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.171 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 69' ' ' LEU . 9.8 t -83.38 -46.56 18.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.806 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.85 -38.85 64.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 110.928 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -61.16 -9.51 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.86 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 8.0 t -57.87 -41.4 79.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.323 0.582 . . . . 0.0 109.989 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.7 -32.62 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.549 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.2 t-105 -65.15 -51.68 59.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.7 tp -65.73 -47.52 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -44.07 -43.58 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.231 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 p -78.74 -21.0 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.718 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.57 ' HA ' HD22 ' A' ' 154' ' ' LEU . . . -60.46 -60.51 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.853 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -73.75 -55.12 6.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.178 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -65.57 -44.71 85.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 88' ' ' THR . . . -61.48 -45.49 96.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.426 -0.892 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 81' ' ' ALA . 66.1 t -73.18 -44.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.692 0.282 . . . . 0.0 111.622 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -41.62 96.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.305 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.2 -45.37 48.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 84' ' ' GLY . 8.7 p -48.68 -49.36 38.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.659 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -52.0 -38.5 57.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -56.88 -42.23 79.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -68.01 -37.55 81.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.434 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -67.27 -41.44 85.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.0 ttt -53.48 -48.45 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.12 -46.85 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.142 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.132 179.724 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.619 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -110.26 -0.21 17.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.603 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 tp -126.46 77.49 72.91 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.139 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 42.2 Cg_exo -53.03 4.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.787 2.325 . . . . 0.0 112.436 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 114' ' ' LEU . 7.8 tp -61.38 -33.61 73.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.174 0.511 . . . . 0.0 109.978 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.53 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.3 OUTLIER -97.33 -43.88 7.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.528 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -66.95 -45.43 77.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.773 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -75.52 -11.75 60.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 70.51 46.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.7 -17.83 10.87 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.85 2.367 . . . . 0.0 111.884 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -57.44 -35.79 70.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.054 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.28 50.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.647 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.657 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -159.54 -35.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 125' ' ' VAL . 14.7 p -54.58 127.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.501 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.8 149.12 21.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -164.19 117.67 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.703 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.93 -169.28 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 11.9 t70 -93.94 163.29 13.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 61.5 m -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.53 -4.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.56 128.52 36.76 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.759 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.472 ' CD ' ' H ' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -62.24 111.8 2.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.196 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.611 ' HB3' HD11 ' A' ' 38' ' ' LEU . 61.3 mt-30 -111.53 -31.31 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.823 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -172.73 141.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.055 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -146.9 160.99 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.225 0.535 . . . . 0.0 111.897 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -122.84 139.51 53.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.942 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.08 17.52 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.823 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 22.61 51.01 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.26 135.41 52.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.837 0.351 . . . . 0.0 110.108 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.22 148.42 49.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.423 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 6.5 mtt -45.64 -60.33 3.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.35 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.5 Cg_exo -35.98 -37.62 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.68 2.253 . . . . 0.0 112.5 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -70.94 -50.46 34.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.014 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.596 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.8 m95 -60.81 -56.85 16.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.842 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.2 tt -43.35 -35.6 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.248 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 tp -65.4 -33.87 76.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.46 -46.78 93.71 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.18 -38.8 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.686 ' CE2' HD11 ' A' ' 154' ' ' LEU . 26.2 t80 -50.88 -44.06 59.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.733 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.21 -40.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -55.72 -47.77 76.33 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.693 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.24 -46.2 88.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.04 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 150' ' ' PHE . 83.1 mt -61.7 -40.25 94.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.51 -40.38 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.464 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 152' ' ' ALA . 29.6 t -52.46 -43.29 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.397 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.81 -45.35 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 74.7 t -48.82 -36.78 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.937 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.09 -33.11 33.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.983 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 156' ' ' VAL . 91.7 t -76.32 -26.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.917 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.64 -50.54 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.68 -22.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.786 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 -179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.789 0.328 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -58.32 -38.74 77.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' GLN . 32.9 t80 -69.42 -47.58 63.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.6 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -46.12 -40.03 10.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.338 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.14 -22.11 63.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.211 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.6 tp-100 -80.03 -47.4 14.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.58 88.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' GLY . 92.5 p -76.82 -38.89 53.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.509 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 6.5 tt0 -64.94 2.5 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.93 146.63 18.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 12' ' ' ARG . 4.7 ptm180 -67.89 -48.33 66.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.559 0.219 . . . . 0.0 110.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -45.73 6.07 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.09 -47.53 84.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -59.79 -39.26 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.091 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.029 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -70.05 -33.22 71.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.714 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.2 mtt -70.68 -33.93 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.6 -51.6 40.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.581 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.94 -34.21 62.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.7 m -63.34 -57.0 11.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.703 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -22.95 63.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.75 -42.06 16.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.417 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -41.71 60.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.838 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.9 mp -72.06 -33.69 68.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -62.05 -42.83 99.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.428 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.21 -40.9 51.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.4 m -54.68 -45.88 74.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.585 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.86 64.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.547 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 tp -65.49 -20.69 66.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.729 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.62 -41.41 11.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -51.35 -38.41 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -71.16 -38.85 72.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.324 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.98 -6.79 52.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.848 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.34 -47.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.0 mtt -97.52 11.62 36.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 tp 46.48 48.25 13.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.616 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.1 mt -84.56 152.9 23.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -117.32 133.08 23.24 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.82 176.88 9.48 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 111.953 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.457 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 8.3 t -131.9 177.79 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.68 -46.07 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.95 -48.82 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.373 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -48.78 -48.33 41.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.657 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.64 -41.46 90.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -55.17 -47.73 74.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -63.08 -38.24 90.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -63.69 -36.77 84.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -40.59 77.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.35 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 tp -73.31 -53.08 11.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.05 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -45.06 -38.69 5.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.813 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.84 -42.55 94.98 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 43.5 t -60.61 -46.97 94.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.98 -46.68 11.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.62 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.2 -28.76 72.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.63 -38.8 70.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.299 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.73 76.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.019 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.418 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 4.3 mt -73.76 -28.11 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.14 -39.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.12 -21.44 78.41 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.48 7.79 5.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.715 0.293 . . . . 0.0 110.892 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.3 mp -84.03 -35.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.57 71.61 0.27 Allowed Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.07 13.53 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.514 2.143 . . . . 0.0 111.827 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -106.68 -8.86 16.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.05 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.99 161.94 25.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.607 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -39.9 -14.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.479 2.12 . . . . 0.0 112.207 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -42.39 -34.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.639 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtt180 -37.94 -63.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 75' ' ' VAL . 67.4 t80 -51.63 -31.12 24.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.842 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 69' ' ' LEU . 11.3 t -69.32 -45.44 79.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.947 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.89 -33.2 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.196 0.522 . . . . 0.0 110.317 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 74' ' ' MET . 2.8 tmm? -63.21 -14.52 50.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.026 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 71' ' ' TYR . 94.3 t -57.52 -39.11 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.52 0.676 . . . . 0.0 110.524 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.36 -31.49 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.4 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 9.0 t-105 -65.94 -54.33 27.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.174 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' ALA . 14.9 tp -63.67 -47.68 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -42.79 -42.94 3.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.381 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.8 p -78.11 -23.21 47.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.12 -60.03 4.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.361 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -49.97 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.681 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -39.0 69.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.703 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.13 -48.29 86.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 86' ' ' GLN . 14.2 m -72.85 -48.33 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.595 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.58 ' N ' HG23 ' A' ' 85' ' ' VAL . 14.6 tm0? -48.46 -29.06 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.09 -42.1 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.254 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 62.9 p -50.94 -31.03 16.44 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.38 -51.5 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.873 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.07 -36.76 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.466 ' ND1' ' O ' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -71.63 -39.27 70.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -73.44 -52.17 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 19.5 ttp -51.96 -52.94 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.12 -48.74 75.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.217 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.52 0.2 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.543 ' O ' ' CE3' ' A' ' 113' ' ' TRP . 2.1 p-90 -122.09 9.87 9.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 116' ' ' LEU . 50.1 mt -122.01 81.04 42.95 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.271 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.1 Cg_exo -51.94 0.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.233 . . . . 0.0 112.267 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 mt -60.69 -32.23 71.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.429 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 27.9 p-10 -96.82 -41.3 8.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.625 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 35.4 tttm -71.69 -45.19 62.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.732 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -74.27 -16.79 60.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.532 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.8 71.96 29.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.983 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.51 ' O ' HG22 ' A' ' 125' ' ' VAL . 67.5 Cg_endo -78.1 -18.37 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.683 2.255 . . . . 0.0 111.861 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -50.14 -52.52 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.83 54.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.565 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -154.97 -40.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.322 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 121' ' ' PRO . 34.1 m -57.2 130.5 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.642 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.87 149.53 21.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -161.27 99.86 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.401 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.75 -177.32 20.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.457 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 44.4 t0 -91.4 157.05 17.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.54 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.7 m -103.51 131.25 50.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.123 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.02 -5.36 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.197 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.03 151.7 45.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.045 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -89.69 147.59 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -133.88 -31.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.459 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -174.89 143.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -132.97 164.15 27.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.769 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.21 118.01 9.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.283 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.81 16.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.4 10.63 79.56 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.1 mt -119.5 138.03 53.42 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.867 0.365 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.83 154.0 42.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.6 mtp -55.72 -50.25 88.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.584 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 55.4 Cg_exo -48.32 -38.8 34.71 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.446 2.098 . . . . 0.0 112.088 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.709 HE21 ' N ' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -70.03 -42.51 72.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.524 0.678 . . . . 0.0 109.87 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.709 ' N ' HE21 ' A' ' 144' ' ' GLN . 47.6 m95 -60.03 -56.15 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.222 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.9 tp -43.39 -42.76 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 143' ' ' PRO . 1.1 mt -56.91 -35.54 69.12 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.6 -44.28 96.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.835 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.81 -29.67 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.337 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 -44.78 88.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.987 0.422 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.4 -39.83 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.07 64.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.482 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.3 m-85 -52.91 -42.84 65.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 154' ' ' LEU . 0.8 OUTLIER -75.06 -29.43 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.247 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mt -70.83 -31.21 44.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.322 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 160' ' ' VAL . 16.0 m -78.25 -38.71 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.551 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.27 -54.23 40.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 159' ' ' LEU . 7.8 p -55.68 -45.22 79.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.545 ' N ' HG13 ' A' ' 158' ' ' VAL . 5.1 tp -63.23 -37.8 88.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 156' ' ' VAL . 47.7 t -71.49 -30.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.2 t -69.9 -50.16 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.999 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.18 -31.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.408 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.889 0.376 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -56.68 -38.58 72.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.298 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLN . 8.6 t80 -66.13 -47.36 74.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.176 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.44 -38.03 8.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.86 -21.28 65.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.068 0.461 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' PHE . 30.9 tt0 -81.71 -46.45 14.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.26 84.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.2 m -76.95 -34.43 57.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 20.6 tt0 -67.95 3.16 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.54 146.87 18.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -69.97 -48.82 56.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.739 0.304 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.23 -45.84 6.47 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.83 -48.07 80.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -56.26 -47.86 77.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -27.32 68.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -69.8 -29.24 66.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.625 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.73 -34.09 60.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.232 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.9 26.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.887 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -54.45 -49.02 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -46.58 -58.65 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.553 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.31 -29.39 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.31 -39.44 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.711 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.81 62.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.638 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.1 mt -74.11 -37.92 64.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.63 -50.54 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -57.93 -43.84 86.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -59.47 -43.64 93.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.39 -29.26 62.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -67.95 -21.62 65.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.688 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -88.0 -42.38 12.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -51.59 -39.94 58.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.124 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -71.51 -37.23 71.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 39.3 m80 -75.85 -10.55 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.18 -47.96 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -94.08 11.9 28.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.896 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tp 44.65 44.26 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.14 148.18 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.472 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -109.67 130.33 22.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.8 Cg_endo -76.35 174.36 12.95 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.288 1.992 . . . . 0.0 111.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -131.85 -178.5 4.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.93 -45.22 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.917 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.6 mp -76.07 -42.8 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.844 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 m -58.84 -51.9 68.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 124' ' ' PHE . 13.3 tt -64.81 -36.07 76.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.996 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.07 -46.68 85.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.788 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.67 -37.14 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.294 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.3 -33.83 74.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.319 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.55 76.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.493 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.81 73.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.92 -45.45 58.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.38 -40.27 11.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.688 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.39 79.91 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.3 t -62.25 -47.99 90.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.078 0.466 . . . . 0.0 109.937 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -45.11 -44.63 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.83 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -29.62 75.81 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.17 -37.42 87.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.11 -27.18 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.736 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -70.12 -39.94 75.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.596 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 60' ' ' ILE . 15.7 pt -82.49 -31.94 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.14 -31.44 69.23 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.86 7.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 mp -83.8 -26.98 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.76 71.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -68.35 17.44 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.338 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 64' ' ' ALA . 59.6 mttt -112.2 -4.14 14.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.41 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -112.06 160.46 29.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.611 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -37.72 -16.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.556 2.171 . . . . 0.0 112.048 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.6 tp -43.13 -33.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -40.12 -67.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.522 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.64 -33.05 53.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.604 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.5 t -65.89 -55.85 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.617 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.93 74.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.236 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.9 mmt -61.79 -12.19 15.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.26 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.0 p -63.15 -31.51 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.469 0.652 . . . . 0.0 110.069 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.08 -30.64 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.606 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.487 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.3 t-105 -65.68 -49.68 67.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.806 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.72 -44.36 77.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.418 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -46.92 -45.28 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.4 p -78.17 -21.96 49.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.02 -59.5 5.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.016 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.5 -53.07 10.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.6 ttt85 -66.89 -45.68 77.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.64 -47.1 91.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 81' ' ' ALA . 59.8 t -69.81 -47.26 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -52.98 -21.46 4.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.151 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -40.53 12.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.454 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 92' ' ' THR . 24.5 p -53.07 -26.01 14.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.532 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.72 -44.79 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.469 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 5.2 mp0 -56.22 -46.64 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.395 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -61.51 -50.06 74.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.363 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 88' ' ' THR . 60.7 p -59.3 -50.56 73.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.5 ttt -53.95 -49.36 68.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.54 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.57 -48.0 82.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.264 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.738 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.556 ' CG ' ' O ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.73 0.01 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.238 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.578 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 mt -117.63 83.54 17.73 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.256 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -50.38 -0.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.688 2.258 . . . . 0.0 112.403 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.2 mp -62.66 -30.41 71.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 -39.82 9.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.672 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.67 -45.46 52.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.424 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 10.3 t-105 -73.64 -17.95 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.449 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.63 72.57 24.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.783 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.569 ' O ' HG22 ' A' ' 125' ' ' VAL . 70.8 Cg_endo -78.84 -17.54 12.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.662 2.241 . . . . 0.0 111.688 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -54.32 -52.59 61.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.863 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.07 55.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.745 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.424 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -157.93 -41.1 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.363 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 121' ' ' PRO . 35.4 m -60.61 131.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.17 157.91 16.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' PRO . 47.9 p -164.87 99.82 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.564 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.12 -176.93 21.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 23.8 m-20 -84.55 156.57 21.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.798 0.332 . . . . 0.0 110.381 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -105.09 130.25 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.792 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.55 -6.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.889 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.71 151.97 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.896 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.718 ' HE ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -91.6 135.73 33.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 0.0 110.997 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -126.73 -24.4 3.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.25 141.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.7 163.35 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 112.23 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -130.83 139.61 50.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.8 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.3 17.13 3.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.5 19.95 61.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mt -122.7 134.48 54.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.922 0.391 . . . . 0.0 110.364 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.58 150.98 45.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.514 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.402 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.9 mtt -48.81 -55.18 21.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.765 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.6 Cg_exo -40.94 -37.98 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.379 2.052 . . . . 0.0 112.028 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.53 -50.91 32.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.253 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.0 m95 -59.66 -57.25 13.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.487 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.733 HD13 ' C ' ' A' ' 146' ' ' LEU . 3.0 tm? -43.53 -41.76 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.628 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.4 tt -55.53 -36.86 67.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.96 -40.83 93.85 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.728 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.2 mp -79.61 -26.55 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.192 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.14 -50.2 71.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.273 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 152' ' ' ALA . 7.7 tt -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.593 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.437 ' N ' HG23 ' A' ' 151' ' ' ILE . . . -50.28 -47.29 55.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.237 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.65 -45.91 73.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.5 mt -58.2 -30.54 66.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.832 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.54 -27.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.706 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 160' ' ' VAL . 95.8 t -71.45 -36.19 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.976 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.487 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.25 -52.74 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.544 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 154' ' ' LEU . 86.2 t -52.75 -38.76 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.627 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 3.7 mm? -81.71 -32.35 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.118 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.3 t -76.5 -22.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.8 t -80.63 -50.56 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 109.945 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.2 mt -68.81 -17.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.55 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 90.8 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.521 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.5 tt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 121.0 0.429 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -46.8 -36.42 7.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.561 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -39.72 75.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.531 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -50.34 -44.16 54.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.305 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.84 -25.78 66.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.191 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -78.69 -46.78 18.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.8 76.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -76.62 -31.62 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.956 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 66' ' ' LYS . 17.5 tp60 -75.15 7.68 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.015 0.436 . . . . 0.0 110.462 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.17 145.58 17.02 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.06 -20.35 65.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.312 . . . . 0.0 110.601 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.59 58.48 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.43 67.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -55.98 -46.15 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.225 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.17 -31.66 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.523 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -32.45 71.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.3 mtt -69.85 -34.57 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.459 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.87 59.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.733 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -50.23 -51.05 47.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -52.32 -56.66 13.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.04 -31.24 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.88 -40.85 24.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.803 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.44 -44.56 17.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.706 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.4 mp -68.14 -25.4 65.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.02 -39.48 75.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.801 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -77.95 -47.34 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -50.23 -45.94 54.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.96 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.65 -20.99 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.829 0.347 . . . . 0.0 110.697 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -90.12 -22.14 21.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.5 -38.22 71.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.244 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 0.36 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.224 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -120.84 -49.35 2.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.46 -37.59 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.894 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.528 ' SD ' ' CZ3' ' A' ' 135' ' ' TRP . 15.8 ttt -109.81 13.54 23.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.6 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 37' ' ' LEU . 6.5 mp 42.36 37.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.51 149.69 43.88 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.657 ' HZ2' ' HB3' ' A' ' 39' ' ' LYS . 4.1 mtpm? -110.34 125.76 30.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.15 145.99 19.69 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.429 2.086 . . . . 0.0 111.891 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -101.06 -174.99 2.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.708 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.77 -46.73 91.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.08 -47.03 88.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -51.49 -44.49 62.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 124' ' ' PHE . 71.3 mt -61.42 -48.13 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.487 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 11.1 t80 -54.65 -44.99 73.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.728 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.52 -48.19 73.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.663 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -60.04 -38.21 82.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.73 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.2 90.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.507 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.03 76.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.405 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -73.41 -48.39 34.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.13 -42.24 19.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.8 -45.65 81.96 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 56.1 t -62.24 -45.81 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.135 0.493 . . . . 0.0 109.749 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 tp -44.2 -48.59 9.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.352 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.95 97.52 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -56.54 -37.87 71.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.46 . . . . 0.0 110.295 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.54 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.327 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -70.23 -44.73 67.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -73.52 -35.32 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -31.08 68.27 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.75 5.5 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.694 0.283 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 90.2 mt -79.18 -42.57 23.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.07 77.23 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.343 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.88 30.87 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.718 2.279 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HB2' HE21 ' A' ' 10' ' ' GLN . 4.3 tmmm? -110.54 -9.82 14.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.127 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -108.83 176.21 1.66 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.889 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -6.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.126 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 67' ' ' THR . 37.7 mt -53.47 -28.1 28.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -40.76 -70.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -54.95 -30.52 59.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.413 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 75' ' ' VAL . 9.3 t -67.02 -54.48 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.785 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.66 63.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.264 0.554 . . . . 0.0 110.222 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 74' ' ' MET . 6.6 tmm? -59.13 -12.23 4.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.961 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.2 p -62.7 -32.46 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.379 0.609 . . . . 0.0 110.355 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.29 -32.95 5.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.039 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.56 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -66.06 -48.81 69.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.864 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.1 tp -65.9 -48.63 70.83 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -42.42 -42.52 3.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.125 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 84' ' ' GLY . 18.2 p -79.4 -21.38 45.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.89 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.729 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.27 -61.51 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.069 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -71.48 -45.59 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.555 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.487 ' CZ ' ' OH ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -77.54 -41.96 37.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 80' ' ' SER . . . -57.6 -49.63 72.05 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.385 -0.912 . . . . 0.0 110.825 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 81' ' ' ALA . 28.2 m -68.3 -43.25 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.002 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.491 ' N ' HG23 ' A' ' 85' ' ' VAL . 5.9 tt0 -56.64 -31.36 64.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.506 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -77.12 -43.42 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 110.32 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 33.5 p -52.32 -26.69 12.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.288 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.49 -50.02 64.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.641 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -52.19 -41.26 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -62.43 -48.97 77.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.2 p -66.77 -48.95 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.5 ttt -49.96 -49.96 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.67 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.02 -47.5 77.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.681 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.419 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 2.4 pm0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.63 0.252 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.584 ' O ' HD22 ' A' ' 114' ' ' LEU . 20.9 p-90 -124.71 27.16 6.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.594 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 113' ' ' TRP . 3.1 mm? -122.58 78.15 46.92 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.852 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.24 -3.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.732 2.288 . . . . 0.0 112.266 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.5 mp -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 110.368 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -96.73 -42.98 7.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -70.24 -45.5 66.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.642 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -73.88 -17.14 61.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.17 71.78 33.57 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.26 -17.41 10.38 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.9 2.4 . . . . 0.0 111.785 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -51.89 -52.57 48.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.627 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.8 53.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.558 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.629 ' O ' HD13 ' A' ' 45' ' ' ILE . 1.2 m-85 -155.4 -40.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 125' ' ' VAL . 6.2 p -55.75 128.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.441 ' HA ' HD11 ' A' ' 45' ' ' ILE . . . -95.13 151.0 19.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -169.94 100.59 0.3 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.43 177.88 18.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.455 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 11.8 t70 -86.53 138.22 31.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.094 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 37.3 m -92.96 130.66 38.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.45 -7.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.85 147.83 52.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -80.99 132.18 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.422 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.38 -26.33 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.627 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.528 ' CZ3' ' SD ' ' A' ' 36' ' ' MET . 0.6 OUTLIER -175.69 135.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -139.01 167.17 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.158 0.504 . . . . 0.0 111.606 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.26 120.09 10.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.474 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.1 16.91 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.499 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 81.71 16.8 72.12 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.533 HD23 HE21 ' A' ' 144' ' ' GLN . 8.7 mp -120.85 136.29 54.96 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.76 154.6 41.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.594 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -55.42 -51.57 78.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 142' ' ' MET . 75.5 Cg_exo -45.84 -37.78 17.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.384 2.056 . . . . 0.0 111.785 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.533 HE21 HD23 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -72.88 -48.48 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.819 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 50.2 m95 -57.24 -57.19 13.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 17.0 tp -44.26 -38.88 4.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.1 tt -55.11 -37.54 67.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.21 -45.56 95.84 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.597 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.7 mp -75.63 -25.67 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 109.908 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.97 -46.32 85.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.5 pt -67.88 -35.77 73.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.385 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.98 -49.48 77.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.343 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.39 -48.37 71.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.717 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.547 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 31.1 mt -62.56 -34.32 76.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.073 0.463 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.9 mt -71.03 -35.56 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.611 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 160' ' ' VAL . 56.1 t -66.57 -42.1 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.321 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.693 ' O ' HG22 ' A' ' 161' ' ' VAL . . . -62.37 -34.21 76.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.3 t -73.35 -25.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.216 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 163' ' ' SER . 13.4 mt -84.83 -40.01 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.335 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 156' ' ' VAL . 34.7 m -73.97 -25.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 157' ' ' ALA . 31.6 m -82.89 -49.37 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.778 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.528 ' N ' HG23 ' A' ' 161' ' ' VAL . 35.1 mm -72.02 -8.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 2.7 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.414 ' N ' HD23 ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.781 0.324 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -52.26 -31.91 34.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 7' ' ' GLN . 10.6 t80 -76.26 -42.07 46.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.374 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -46.42 -39.67 10.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 10' ' ' GLN . 8.3 t-20 -66.57 -24.05 66.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.259 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' PHE . 41.9 tt0 -81.02 -45.89 15.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.54 89.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 11' ' ' GLY . 57.4 p -76.29 -37.37 57.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.638 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 6' ' ' ASN . 64.8 mt-30 -67.03 5.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.7 145.59 17.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.45 -48.48 60.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.34 6.05 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.94 81.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.144 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -58.25 -47.36 83.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.29 -28.33 68.01 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -69.55 -29.46 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -32.97 61.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.41 17.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 -52.83 39.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.678 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.0 p -48.26 -57.91 5.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.755 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.31 27.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 tt -81.45 -38.85 25.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.68 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.933 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.0 mp -69.0 -33.14 73.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.715 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -63.38 -41.37 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.1 -50.04 21.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.931 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -47.76 -47.2 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.665 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.95 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.34 -20.44 66.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.4 ' CE2' HG21 ' A' ' 35' ' ' VAL . 60.5 t90 -88.27 -42.77 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -51.61 -46.63 63.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.165 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.4 ' C ' ' OE1' ' A' ' 33' ' ' GLN . 0.5 OUTLIER -70.11 -29.01 65.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -68.04 -26.89 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG21 ' CE2' ' A' ' 31' ' ' TRP . 56.7 t -104.8 -53.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.162 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.0 mtt -75.4 3.51 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.17 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt 44.53 47.22 8.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.563 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 38' ' ' LEU . 96.6 mt -77.54 154.67 32.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.569 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -116.1 126.33 27.74 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 174.72 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.246 1.964 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.484 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.7 t -131.85 -175.82 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.765 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 40.5 t -64.44 -44.44 97.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.722 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.21 -49.96 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.54 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 9.2 t -49.14 -50.19 38.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.526 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.59 -41.36 89.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.918 0.39 . . . . 0.0 110.186 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -45.26 76.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.742 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -63.93 -35.96 82.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.044 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -65.27 -41.51 94.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.233 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.59 78.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.42 74.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.055 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.3 tp -77.41 -45.91 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.993 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -38.66 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.46 80.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 38.0 t -62.81 -47.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.241 0.543 . . . . 0.0 109.71 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.8 tp -42.87 -47.2 5.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.562 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.4 92.38 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -55.87 -43.57 77.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.17 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.75 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.227 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.68 -43.23 94.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mm -74.38 -43.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.623 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.13 68.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.34 4.36 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.43 -44.74 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.537 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -174.04 74.73 0.36 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.97 18.34 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.666 2.244 . . . . 0.0 112.407 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -104.9 -7.66 19.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.98 176.85 1.33 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.446 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.5 1.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 0.0 111.878 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.3 tp -54.71 -34.89 63.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.639 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' SD ' ' A' ' 74' ' ' MET . 30.9 mtm105 -38.24 -66.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -53.64 -22.1 8.12 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.176 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 75' ' ' VAL . 5.0 t -78.99 -48.26 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.336 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.16 -35.04 56.35 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 110.167 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.1 OUTLIER -64.83 -9.73 22.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.167 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 72' ' ' VAL . 6.3 p -62.67 -35.38 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.1 mm -87.93 -33.74 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.831 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.574 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 16.7 t-105 -61.1 -50.42 73.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.046 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.93 -45.03 79.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -45.19 -44.87 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -79.89 -23.36 41.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.3 -60.45 3.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.631 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -71.76 -56.32 6.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.169 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -66.39 -51.05 61.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.85 -47.73 52.77 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 81' ' ' ALA . 70.0 t -65.28 -32.05 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.266 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.54 -33.28 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.43 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.96 -40.65 38.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.542 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 46.6 p -52.77 -35.25 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.737 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.42 -52.14 24.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -46.1 -31.05 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.35 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -75.91 -45.56 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.652 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.1 p -67.5 -49.73 62.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.691 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -53.11 28.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.056 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.75 -49.62 72.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.464 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.323 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.758 0.313 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -4.18 58.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.395 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 116' ' ' LEU . 19.9 mt -128.44 80.77 71.88 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.1 Cg_exo -50.71 3.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.815 2.344 . . . . 0.0 112.269 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.2 mm? -57.72 -33.24 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 0.0 109.975 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.556 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -96.73 -45.35 6.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.531 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -65.73 -45.46 82.56 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.331 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 32.6 t-105 -73.75 -14.35 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.83 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 t -142.04 74.87 21.23 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.453 ' O ' HG12 ' A' ' 125' ' ' VAL . 72.8 Cg_endo -80.79 -17.12 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.849 2.366 . . . . 0.0 111.696 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -54.84 -53.76 51.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 123' ' ' VAL . 3.5 p -105.63 60.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.585 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.556 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -164.77 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.385 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 121' ' ' PRO . 13.6 p -62.4 130.22 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.1 157.98 15.98 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.8 p -162.73 99.66 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.499 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 142.84 -173.45 24.03 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 20.8 t70 -93.24 152.99 18.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.892 0.377 . . . . 0.0 110.172 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -104.68 128.59 52.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.54 -10.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.852 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -67.92 147.9 51.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 40.8 ttp180 -89.57 132.81 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.347 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -129.94 -21.47 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.503 ' CE3' ' SD ' ' A' ' 142' ' ' MET . 24.6 t90 -174.05 134.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.976 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -140.94 160.68 39.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.22 0.533 . . . . 0.0 111.914 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.77 140.46 50.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.085 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.68 17.44 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.607 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 87.49 21.82 46.44 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.607 HD22 ' O ' ' A' ' 139' ' ' GLY . 3.0 mm? -123.86 137.93 54.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -71.9 146.95 47.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.561 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.503 ' SD ' ' CE3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -47.39 -57.57 9.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.539 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.1 Cg_exo -38.28 -38.41 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.586 2.191 . . . . 0.0 112.568 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -73.28 -52.23 14.72 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.149 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.572 ' O ' ' N ' ' A' ' 148' ' ' GLY . 66.9 m95 -55.53 -58.0 9.58 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.823 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.1 tp -44.01 -39.36 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.673 ' O ' HD23 ' A' ' 147' ' ' LEU . 2.5 tt -54.96 -36.86 65.77 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.86 -43.37 99.3 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.643 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.94 -25.48 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -65.4 -43.56 90.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.6 pt -67.55 -37.8 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.286 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.88 -50.34 73.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.325 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.468 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 m-85 -54.33 -45.16 72.6 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.859 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 154' ' ' LEU . 0.5 OUTLIER -75.86 -29.72 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.881 -179.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.12 -35.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 160' ' ' VAL . 35.7 m -75.24 -35.86 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.75 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.574 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.81 -50.34 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.637 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.87 -48.03 78.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.67 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 156' ' ' VAL . 16.6 t -69.23 -27.12 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.72 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.1 t -80.98 -46.13 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.427 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.6 mm -75.7 -13.99 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.6 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.604 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.721 ' N ' HD23 ' A' ' 2' ' ' LEU . 1.9 pt? . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.845 0.355 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -55.62 -40.47 72.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.305 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.37 -44.28 91.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.64 -42.16 44.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.309 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 10' ' ' GLN . 49.6 t30 -67.61 -28.14 67.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.915 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -73.04 -50.37 23.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.34 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.3 p -75.99 -35.36 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.588 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.519 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 38.3 mt-30 -74.32 12.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.966 0.413 . . . . 0.0 110.388 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.63 147.94 16.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -70.74 -49.89 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.32 -46.11 6.67 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.44 90.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.23 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.415 ' O ' ' HG3' ' A' ' 18' ' ' MET . 8.7 m95 -59.0 -32.03 69.33 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.942 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -74.29 -27.94 60.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -70.69 -36.37 73.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 18' ' ' MET . 1.4 ppp? -72.58 -31.22 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.2 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.2 -47.45 46.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.724 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.8 p -54.6 -62.16 1.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' HD13 ' A' ' 55' ' ' LEU . . . -49.23 -39.75 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.55 -41.47 75.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.07 -36.66 30.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.3 mp -71.71 -36.41 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.77 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.97 -46.29 89.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.116 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.16 -48.85 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.09 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.8 m -46.2 -43.06 14.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.18 53.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.494 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.43 -18.61 64.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.605 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.15 -44.67 52.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.52 -28.02 62.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -70.9 -24.78 62.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 36' ' ' MET . 7.5 p -106.52 -45.07 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.158 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.514 ' N ' HG13 ' A' ' 35' ' ' VAL . 1.2 mtt -83.96 5.07 26.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.86 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 mt 44.82 42.24 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.706 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.9 mt -80.42 153.73 28.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -117.84 130.32 24.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.79 179.39 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.249 1.966 . . . . 0.0 111.759 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.4 t -131.73 -175.49 3.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.402 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 126' ' ' ALA . 54.6 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.918 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -68.05 -50.12 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -49.41 -50.94 38.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.691 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.96 -41.08 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -54.61 -45.73 73.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.96 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.51 -40.21 86.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.161 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.4 HH21 HG12 ' A' ' 123' ' ' VAL . 41.6 ttp85 -57.89 -35.94 71.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.3 -38.31 78.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.472 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.438 HD21 ' HB1' ' A' ' 22' ' ' ALA . 5.2 tp -76.41 -51.07 12.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -46.99 -39.4 12.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -43.83 91.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' CG2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t -65.32 -41.58 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 110.037 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 22' ' ' ALA . 8.5 tp -50.8 -50.44 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.842 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.99 92.7 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.23 -37.29 34.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.975 -0.612 . . . . 0.0 110.218 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.53 -25.45 60.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -72.23 -43.42 64.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.579 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mm -73.64 -30.61 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.04 -26.46 48.78 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.58 -2.96 21.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.66 -20.8 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.502 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 178.86 68.87 0.12 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.75 25.79 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.875 2.384 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -110.27 -6.33 15.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.55 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.13 174.41 2.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.83 -9.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.226 1.95 . . . . 0.0 112.175 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.7 mt -51.32 -30.04 17.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -41.67 -69.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -51.53 -38.61 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.004 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.45 -54.04 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.45 70.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.399 0.619 . . . . 0.0 110.046 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.644 ' SD ' HG21 ' A' ' 161' ' ' VAL . 34.6 ttp -61.21 -25.24 66.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.612 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 71' ' ' TYR . 47.8 t -51.56 -37.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.242 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -85.38 -37.37 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.404 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.723 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 10.7 t90 -57.68 -49.47 76.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.68 -46.89 77.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -46.97 -47.57 21.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.426 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 59.6 p -79.28 -25.61 42.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.35 4.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -52.89 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -65.57 -42.46 91.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.781 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.72 -46.0 93.05 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.3 t -69.89 -54.24 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 111.12 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -47.7 -29.13 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.328 . . . . 0.0 110.743 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tp -85.16 -39.48 17.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.713 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 84' ' ' GLY . 40.7 p -53.18 -23.15 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.3 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -76.15 -40.48 52.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.506 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.35 -39.91 73.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.387 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.1 m170 -69.18 -49.53 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -61.96 -49.92 74.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 17.3 ttt -47.53 -46.71 27.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.635 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.52 -44.29 74.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.671 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.58 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.648 0.261 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.459 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 8.5 p-90 -124.99 -2.95 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.709 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.607 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.82 86.3 19.03 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.873 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.3 Cg_exo -53.76 8.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.646 2.231 . . . . 0.0 112.483 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.5 mm? -73.63 -27.61 61.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.05 0.452 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -96.36 -41.02 8.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -70.59 -45.15 65.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.314 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 3.2 t90 -73.29 -18.1 61.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.54 73.71 20.12 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' O ' HG12 ' A' ' 125' ' ' VAL . 64.2 Cg_endo -78.06 -18.09 13.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.669 2.246 . . . . 0.0 111.802 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.69 -11.22 60.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.867 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.4 HG12 HH21 ' A' ' 48' ' ' ARG . 2.9 t -136.41 45.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -38.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 121' ' ' PRO . 7.3 p -58.29 129.74 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -95.48 152.93 17.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.525 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 t -166.01 100.32 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.656 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.67 -176.15 21.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.454 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 31.3 t70 -87.12 147.88 25.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.336 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 11.9 m -99.61 130.09 45.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.814 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.0 -4.56 0.34 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.16 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.98 129.65 40.58 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -66.39 128.72 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -126.03 -25.27 3.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.708 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -174.86 136.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -139.94 161.15 38.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.085 0.469 . . . . 0.0 111.412 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -137.05 119.83 16.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.29 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 2.1 tp 78.63 16.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 83.24 14.84 73.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 139' ' ' GLY . 7.3 mp -119.83 133.19 55.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.746 0.308 . . . . 0.0 110.262 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.1 mp0 -74.82 156.55 36.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.407 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 6.4 mtm -48.38 -61.39 3.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.6 Cg_exo -35.55 -41.05 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.57 2.18 . . . . 0.0 112.49 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.17 -44.22 60.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.608 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.4 m95 -66.13 -57.89 6.67 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.927 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.65 -38.56 3.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.434 HD13 ' OG1' ' A' ' 88' ' ' THR . 34.1 tp -62.36 -34.3 76.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.04 -49.11 69.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.562 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -66.35 -27.11 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -39.12 90.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.49 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 151' ' ' ILE . 2.4 tt -66.62 -36.58 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.38 -48.89 71.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.75 -41.45 81.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.709 HD12 ' CZ2' ' A' ' 77' ' ' TRP . 10.2 tp -53.96 -30.9 48.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 0.0 109.927 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 40.1 mm -79.63 -32.3 14.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.013 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 160' ' ' VAL . 92.3 t -65.63 -45.86 91.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.924 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.723 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.18 -46.76 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.138 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 159' ' ' LEU . 3.3 p -51.79 -40.61 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.544 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 158' ' ' VAL . 15.7 mt -80.11 -33.13 38.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.171 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.2 t -73.29 -24.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.957 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.644 HG21 ' SD ' ' A' ' 74' ' ' MET . 77.2 t -80.66 -50.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.103 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 162' ' ' ILE . 39.5 mm -71.25 -10.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.483 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.236 179.634 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.861 0.362 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -52.02 -41.41 62.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.193 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' GLN . 22.3 m-85 -63.86 -44.43 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.074 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -45.93 -41.75 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -67.9 -28.68 67.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.003 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' PHE . 5.9 tp-100 -76.03 -50.82 13.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.428 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.86 73.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.2 m -76.64 -42.27 42.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -66.52 3.3 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.387 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.94 145.07 17.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -68.8 -49.56 57.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.577 0.227 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.54 -46.3 5.69 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.56 85.44 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -58.36 -47.97 82.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.46 -29.36 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -30.93 68.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.47 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 tpt -72.08 -33.56 67.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.154 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.48 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -52.73 -51.35 60.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.667 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 p -51.56 -49.71 61.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.23 72.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.649 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.41 -38.02 77.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.482 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.69 -35.27 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.565 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.9 mt -74.42 -41.21 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.57 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -67.18 -55.48 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.761 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.4 tt -54.86 -53.38 56.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 24' ' ' ALA . 16.9 p -49.31 -45.16 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.07 -43.24 65.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.735 0.302 . . . . 0.0 111.047 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.566 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -53.76 -20.25 5.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.646 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -91.88 -39.49 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.542 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -48.86 -38.1 21.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.971 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -68.82 -38.58 79.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.77 -5.26 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.3 -46.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.891 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 30.6 mtt -100.81 10.01 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.926 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.95 42.61 28.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -87.69 154.06 20.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -121.09 141.43 32.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.864 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 127' ' ' SER . 88.0 Cg_endo -78.25 171.52 16.88 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 112.283 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.6 t -131.95 -173.67 3.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.405 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.9 t -64.3 -48.77 84.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 4.1 mm? -60.35 -46.88 88.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 41' ' ' CYS . 75.5 p -48.43 -43.97 34.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.333 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.54 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.919 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.53 -48.45 74.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.153 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 43' ' ' LEU . 2.5 mp0 -61.01 -42.73 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 52' ' ' PHE . 33.7 ttt-85 -64.3 -38.31 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.313 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.46 77.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.52 74.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.2 tt -78.35 -51.61 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.406 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 59.8 t80 -43.97 -40.08 4.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.667 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.46 74.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.5 -47.64 90.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.915 0.388 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 19.9 tp -44.53 -50.53 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.84 -49.37 75.1 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -32.7 18.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -67.37 -36.01 80.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.51 -32.03 69.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.595 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.7 mp -77.03 -38.49 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.585 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.76 -19.06 66.49 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.5 27.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.288 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 5.0 pt -83.77 -25.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.712 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.37 73.52 0.1 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.575 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.23 26.31 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.591 2.194 . . . . 0.0 111.96 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -104.66 -8.34 18.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.19 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.666 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.02 -2.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.264 1.976 . . . . 0.0 112.106 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.553 ' H ' ' C ' ' A' ' 67' ' ' THR . 42.9 mt -53.45 -33.85 55.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.549 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.8 ptp180 -40.89 -63.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.642 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.572 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 1.7 t80 -56.59 -29.85 62.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.458 0.572 . . . . 0.0 110.182 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' LEU . 12.5 t -68.22 -45.08 83.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.849 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.79 -32.59 46.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.51 . . . . 0.0 110.174 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 161' ' ' VAL . 29.9 ttp -65.43 -19.4 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.751 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.3 t -54.2 -37.25 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.373 0.606 . . . . 0.0 110.419 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.4 mt -88.72 -31.55 5.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.713 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.548 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -66.76 -46.88 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.482 HD23 ' CG ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -66.5 -48.54 69.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.47 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -44.78 -43.91 8.96 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 p -75.91 -24.15 55.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.555 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.99 -60.25 4.13 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.269 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -73.9 -53.4 10.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -67.91 -43.66 78.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.76 -46.05 95.24 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.91 -41.11 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.97 -45.18 93.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.528 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.98 -42.84 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.038 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 84' ' ' GLY . 4.2 p -48.8 -47.75 41.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.616 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -51.41 -32.37 26.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.404 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -71.01 -36.29 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.66 -36.99 73.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -74.2 -31.87 62.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.492 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.7 tpt -62.26 -43.14 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.421 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tp -64.2 -49.15 73.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.516 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' CD ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.601 0.238 . . . . 0.0 110.925 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.511 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 3.8 p-90 -125.01 30.08 5.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 110.745 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 116' ' ' LEU . 6.5 tp -125.63 68.96 62.23 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.409 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -46.51 -8.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 112.285 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 114' ' ' LEU . 6.7 tp -53.31 -33.7 54.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 110.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.46 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 4.5 m-20 -96.45 -43.76 7.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.209 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.14 -45.28 67.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -73.2 -18.87 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.568 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.56 72.31 25.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.179 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.77 -15.25 9.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.837 2.358 . . . . 0.0 111.538 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -49.22 -48.14 45.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.77 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.91 53.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.46 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 5.7 t80 -156.11 -39.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 125' ' ' VAL . 8.4 p -60.86 130.0 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.66 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.97 150.54 20.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' PRO . 6.4 t -161.52 99.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.53 -172.45 23.02 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.529 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -88.41 151.52 22.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.671 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 12.9 m -103.19 130.3 50.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.21 -9.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.05 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 150.72 47.87 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.976 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -85.9 136.1 33.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.461 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -127.39 -17.62 4.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -172.92 120.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 7.7 t0 -115.04 148.96 38.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.344 0.593 . . . . 0.0 112.28 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.533 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 7.3 t80 -128.57 136.73 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.737 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp 54.27 17.44 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.439 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 88.14 13.02 64.73 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.665 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 139' ' ' GLY . 9.1 mp -121.11 146.82 46.35 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -76.72 151.26 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.44 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 4.0 mmt -48.04 -63.36 1.55 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.3 Cg_exo -32.18 -38.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.938 2.425 . . . . 0.0 112.449 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -69.45 -53.75 17.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.277 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 76.8 m95 -60.17 -57.02 14.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.0 tp -43.73 -37.67 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.88 -34.97 76.98 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.3 -44.57 96.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -76.28 -25.89 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 154' ' ' LEU . 39.7 t80 -62.45 -45.64 92.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.482 ' O ' HD13 ' A' ' 155' ' ' ILE . 15.5 pt -68.82 -38.7 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.479 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -53.73 -48.19 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.362 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.34 -41.67 94.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 150' ' ' PHE . 37.6 mt -69.29 -30.62 68.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.4 mp -77.83 -27.34 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 152' ' ' ALA . 54.7 t -73.85 -35.45 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.645 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -69.99 -52.36 24.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.107 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.86 -33.93 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.932 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.27 -43.55 23.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 156' ' ' VAL . 52.4 t -69.14 -26.86 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.888 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 157' ' ' ALA . 48.6 t -75.01 -45.44 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.328 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 72.5 mt -66.64 -21.23 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.7 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.897 0.38 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -54.13 -42.89 70.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -45.38 87.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -50.34 -42.18 52.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.3 -29.48 69.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -78.53 -49.42 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.514 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -62.38 -33.34 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.69 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 41.3 p -76.33 -34.22 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -74.28 10.03 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -107.29 142.06 15.7 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -62.55 -18.38 61.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 0.0 110.294 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.51 -48.29 51.78 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -62.61 -51.43 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -52.76 -40.17 62.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.029 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.26 -30.11 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.17 -34.28 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.403 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 mtt -74.85 -33.16 62.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.84 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.82 32.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.775 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.35 -30.92 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -61.53 -61.99 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.43 -23.84 41.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 tt -78.09 -39.92 40.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' THR . . . -58.63 -31.03 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.829 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -78.8 -29.71 45.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.736 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.77 -47.09 64.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.01 -46.4 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 24' ' ' ALA . 11.5 p -50.13 -46.33 53.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -73.19 -38.41 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.941 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -17.93 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.219 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -97.28 -25.87 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -46.62 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.773 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 29' ' ' ALA . 19.4 mp0 -83.68 -30.1 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.008 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -60.38 -26.21 66.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.251 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 36' ' ' MET . 8.5 m -105.66 -38.11 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.805 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.406 ' N ' HG23 ' A' ' 35' ' ' VAL . 16.5 mmt -74.96 1.96 11.59 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.27 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 tp 55.83 50.48 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.722 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.1 mm? -103.84 156.17 18.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -117.01 142.27 29.65 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.659 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 127' ' ' SER . 65.7 Cg_endo -74.39 173.68 13.83 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.51 2.14 . . . . 0.0 111.918 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -131.94 178.43 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.46 -43.93 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.421 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.22 -48.93 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.468 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.3 t -51.8 -50.73 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.891 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.62 -38.62 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -54.46 -47.29 73.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.559 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -61.38 -43.85 98.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.265 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.32 60.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.091 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.23 80.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.88 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 mt -76.78 -53.33 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.997 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -45.81 -40.61 9.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.44 -45.35 86.29 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 8.1 t -61.84 -45.16 99.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -46.87 -44.0 19.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.566 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.28 -28.22 73.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.575 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.76 -26.84 57.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.56 -42.91 77.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.15 -29.93 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -12.74 83.08 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.81 1.78 51.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.529 0.204 . . . . 0.0 111.25 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 3.3 pt -87.22 -27.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.963 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.8 72.46 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.83 0.347 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.78 24.75 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.951 2.434 . . . . 0.0 112.177 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -104.9 -8.7 18.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.82 176.74 1.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.481 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -47.81 -4.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.321 2.014 . . . . 0.0 112.26 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.567 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 mm? -52.8 -31.22 37.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.139 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.496 ' NH1' ' OG ' ' A' ' 163' ' ' SER . 67.0 mtt180 -40.85 -69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.622 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.27 -35.73 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.437 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.4 t -62.27 -44.07 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.673 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.81 -33.13 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 109.483 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.62 -11.85 5.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.33 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.34 -42.85 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.288 0.566 . . . . 0.0 110.839 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.1 mt -87.06 -29.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.083 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.7 t-105 -60.74 -50.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.288 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 tp -70.07 -45.95 65.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.434 ' O ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -45.37 -50.41 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.015 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -71.12 -29.41 65.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.64 -58.92 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.425 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -70.85 -49.8 42.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -78.09 -33.8 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 83' ' ' ARG . . . -65.3 -46.93 84.85 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 81' ' ' ALA . 19.8 m -68.67 -44.72 82.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.766 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.516 ' N ' HG23 ' A' ' 85' ' ' VAL . 2.9 tp-100 -50.13 -24.46 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.69 -41.1 16.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.8 p -49.0 -34.1 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.396 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.53 -52.0 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -49.1 -31.88 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -75.45 -50.18 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.013 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 p -68.97 -54.17 16.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.985 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 30.6 ttm -50.08 -49.14 52.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.3 tp -67.49 -39.25 85.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 131' ' ' ALA . 6.5 tp-100 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.723 0.297 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.499 ' CD1' ' C ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -88.53 9.06 25.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.211 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.1 tp -116.39 86.51 18.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.92 8.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.823 2.349 . . . . 0.0 113.003 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.5 tp -74.79 -28.12 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 124' ' ' PHE . 66.6 m-20 -95.76 -40.42 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.69 -33.99 76.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -86.93 -19.23 29.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.837 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.98 79.3 10.07 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 125' ' ' VAL . 74.2 Cg_endo -79.51 -16.08 12.08 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.605 2.203 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -79.86 -4.85 54.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.743 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 123' ' ' VAL . 21.3 t -128.77 45.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.194 0.521 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.507 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 10.4 t80 -172.23 -39.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.336 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 121' ' ' PRO . 61.6 t -54.75 125.18 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.483 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.07 157.69 15.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 40' ' ' PRO . 42.1 t -173.39 103.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.533 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.45 -172.62 24.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.4 m-20 -92.18 143.94 25.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.685 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 27.3 m -93.95 134.49 36.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 86.79 -0.05 0.57 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.06 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -67.73 155.66 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.245 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.59 145.69 25.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -133.66 -29.23 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.75 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -174.41 145.54 0.99 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.194 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -138.91 167.72 21.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.082 0.467 . . . . 0.0 111.482 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 63.9 t80 -143.51 119.0 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.717 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.9 OUTLIER 78.27 17.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -177.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 81.05 15.93 75.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.1 mp -119.51 131.27 55.53 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.3 152.18 44.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.373 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -50.75 -52.34 57.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 142' ' ' MET . 82.9 Cg_exo -44.28 -38.92 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.159 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.87 -49.14 31.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 148' ' ' GLY . 48.7 m95 -56.71 -57.32 12.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.6 tp -42.83 -42.14 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.548 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.565 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -54.66 -35.75 63.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.94 -39.98 97.74 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.615 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.41 -30.71 11.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -47.72 84.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 152' ' ' ALA . 2.1 pp -68.3 -41.08 83.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.564 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' HD12 ' A' ' 151' ' ' ILE . . . -56.93 -49.57 75.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.106 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -51.46 -46.76 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 37.7 tp -52.8 -36.98 59.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.568 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 27.3 mm -68.78 -41.72 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.5 -37.66 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -75.47 -31.21 60.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.44 -27.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.351 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.15 -42.11 16.36 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.156 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.1 -31.87 36.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.195 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.0 t -73.25 -50.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp -62.96 -22.96 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.496 ' OG ' ' NH1' ' A' ' 70' ' ' ARG . 24.1 p . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.49 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -60.46 -43.69 96.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 7' ' ' GLN . 42.4 t80 -62.21 -50.16 72.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -46.96 -37.24 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.245 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 38.2 t-20 -69.82 -25.91 63.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.311 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PHE . 85.9 mm-40 -82.4 -50.07 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.63 73.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.653 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 11' ' ' GLY . 88.7 p -76.24 -34.57 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -71.24 8.54 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.552 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.72 141.62 15.56 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -69.9 -50.1 45.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.769 0.319 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.12 5.7 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.06 86.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -60.63 -46.9 88.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.4 -30.27 68.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.37 -30.27 68.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.398 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.1 mmt -73.45 -31.16 63.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.73 -53.47 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.17 -32.69 64.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.928 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -65.99 -61.81 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.09 -23.86 62.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -81.82 -42.1 20.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.429 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -49.53 -50.97 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.648 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.2 mp -61.48 -33.88 74.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.599 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.88 -41.89 88.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.713 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.2 mm? -79.81 -52.13 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -42.11 -40.53 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.04 -41.72 34.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -55.36 -17.6 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.932 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -94.33 -35.34 12.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.607 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.82 -38.63 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.54 -35.29 60.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.555 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 1.5 t-80 -74.73 -10.12 59.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.294 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -109.18 -51.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.787 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.9 mtt -91.18 14.18 14.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.803 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.18 40.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.775 0.321 . . . . 0.0 110.721 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.31 152.11 46.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -108.66 115.93 56.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.87 147.73 21.7 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.272 1.981 . . . . 0.0 112.188 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 5.7 t -98.08 172.2 7.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.301 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 43' ' ' LEU . 8.3 p -59.46 -41.26 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.944 0.402 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HG13 ' A' ' 42' ' ' VAL . 76.4 mt -63.2 -45.27 92.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.056 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -48.84 -38.49 22.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.394 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.532 HG21 ' HA ' ' A' ' 124' ' ' PHE . 51.5 mt -69.49 -44.5 79.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.168 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -45.59 92.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.818 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -57.79 -44.34 86.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.386 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -61.33 -29.01 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -39.76 77.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.22 74.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 tp -76.59 -51.85 10.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -45.05 -39.96 6.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.25 -40.7 94.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 41.5 t -64.02 -17.71 21.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.699 0.762 . . . . 0.0 109.273 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -74.49 -45.17 47.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.426 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.81 83.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.38 -40.06 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.351 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.87 -31.45 69.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.94 -29.52 50.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.145 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -79.08 -39.91 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.557 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.74 -33.19 79.71 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.18 9.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.697 0.284 . . . . 0.0 110.652 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' A' ' 61' ' ' GLY . 66.0 mt -78.41 -54.92 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.288 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -168.1 75.36 0.89 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 21.5 Cg_exo -61.67 14.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.974 2.449 . . . . 0.0 112.485 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 64' ' ' ALA . 13.8 ptpt -109.78 -3.58 16.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.84 161.03 31.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.685 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -39.4 -15.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.484 2.123 . . . . 0.0 112.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.2 mp -43.25 -35.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.721 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.4 mtm-85 -40.24 -65.57 0.39 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.13 -15.87 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.619 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 75' ' ' VAL . 19.3 t -82.1 -46.37 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.722 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.23 -34.05 59.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.045 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.82 -8.55 2.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.329 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 72' ' ' VAL . 32.7 m -59.25 -42.7 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 75' ' ' VAL . 6.1 mt -87.76 -29.77 5.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.23 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.611 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 4.9 t-105 -63.77 -53.58 48.8 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.777 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.04 -43.89 90.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.508 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -47.32 -46.88 25.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.5 p -80.44 -21.63 41.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.67 -61.98 2.22 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.909 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -73.99 -44.08 55.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.541 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -75.17 -42.11 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.076 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.29 -48.61 85.12 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 81' ' ' ALA . 17.3 m -71.04 -38.31 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.128 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.41 ' N ' HG23 ' A' ' 85' ' ' VAL . 14.3 tm0? -72.84 -36.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.32 -49.32 19.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.3 p -51.17 -49.1 61.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.573 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.53 -39.48 34.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 110.085 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -58.96 -41.69 88.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.379 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -66.78 -39.07 87.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.589 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -68.68 -35.02 76.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ttt -59.05 -44.13 91.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.59 -49.34 78.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.114 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.179 179.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.845 0.355 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.586 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -103.83 -1.56 27.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -119.68 81.64 25.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 43.9 Cg_exo -53.24 4.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.547 2.165 . . . . 0.0 112.246 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.9 mm? -66.87 -30.18 70.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.06 0.457 . . . . 0.0 110.248 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -96.78 -41.53 8.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.179 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -71.12 -45.0 64.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.749 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 20.4 t-105 -75.26 -15.15 60.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.8 69.17 65.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.86 -20.23 9.16 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.734 2.289 . . . . 0.0 111.256 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -52.22 -53.89 37.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.504 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.92 55.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.732 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.532 ' HA ' HG21 ' A' ' 45' ' ' ILE . 2.1 t80 -157.89 -41.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.53 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.43 128.36 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.53 155.36 17.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.1 m -165.24 99.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.38 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.46 -173.37 23.1 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 9.1 m-20 -97.26 165.15 12.17 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -116.19 127.68 54.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.78 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.03 -8.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.94 143.15 55.77 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.01 128.05 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -132.82 -23.36 2.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -173.17 127.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.23 163.65 29.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.297 0.57 . . . . 0.0 112.164 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.02 137.92 54.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.156 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.84 16.69 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.92 13.43 53.09 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.365 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.3 mt -123.83 145.09 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.176 0.488 . . . . 0.0 109.955 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.35 150.82 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.699 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.446 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.4 mtp -47.53 -54.44 22.5 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.679 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 142' ' ' MET . 79.8 Cg_exo -40.21 -37.78 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.98 -47.18 60.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.947 0.403 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.9 m95 -65.79 -57.98 6.72 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -42.49 -36.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.947 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 146' ' ' LEU . 33.2 tp -66.49 -34.74 78.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.35 -35.86 73.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mm -69.76 -44.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.21 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -44.15 69.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.77 -46.37 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.779 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.39 -50.22 74.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -61.95 -47.17 86.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.912 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.673 ' C ' HD23 ' A' ' 154' ' ' LEU . 7.9 tt -53.57 -30.98 44.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.66 -27.68 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.147 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.66 ' O ' HG22 ' A' ' 160' ' ' VAL . 70.2 t -75.0 -28.58 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.913 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.611 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -80.65 -39.63 26.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.785 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.21 -31.5 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.557 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.7 -42.77 27.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.31 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 156' ' ' VAL . 28.4 m -71.26 -22.94 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.812 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 157' ' ' ALA . 21.1 t -77.68 -50.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 162' ' ' ILE . 77.3 mt -64.62 -15.73 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.821 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.528 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.911 0.386 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 25.2 mtt85 -53.55 -28.86 34.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.06 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 7' ' ' GLN . 35.2 m-85 -76.94 -42.91 37.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.405 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -46.8 -42.73 17.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 7' ' ' GLN . 24.5 p30 -72.61 -23.0 60.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.5 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 48.4 tp60 -79.93 -48.51 13.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.554 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.42 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 11' ' ' GLY . 19.7 m -76.53 -36.05 57.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -67.55 4.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.4 141.46 15.24 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.46 -46.2 87.34 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.99 -44.92 5.9 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.1 77.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -58.44 -43.28 88.72 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.196 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.3 mm? -67.04 -28.46 68.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.1 tp -69.34 -31.96 70.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.377 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 21' ' ' THR . 39.9 mtt -73.45 -32.87 64.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.02 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.4 -52.99 26.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.536 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.05 -49.63 50.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.2 p -53.42 -42.49 67.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.499 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.11 67.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.642 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.5 mt -87.79 -42.11 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.11 -25.02 60.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.536 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.14 -38.45 36.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.78 -47.07 64.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.54 -48.99 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.672 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.0 m -49.7 -47.64 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.566 ' O ' ' NE2' ' A' ' 33' ' ' GLN . . . -73.47 -28.25 61.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.538 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.56 -20.53 66.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.978 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -91.45 -32.26 15.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.6 m-85 -58.23 -46.92 85.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.285 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 29' ' ' ALA . 1.0 OUTLIER -62.68 -49.41 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.78 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -24.04 18.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.23 -18.94 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' PHE . 33.0 mmm -98.43 -3.17 37.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.85 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 37' ' ' LEU . 6.0 mp 53.88 39.81 30.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.93 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.81 HD12 ' NE2' ' A' ' 134' ' ' GLN . 1.0 OUTLIER -100.92 158.06 16.27 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -121.43 144.03 39.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.03 152.71 51.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.575 2.183 . . . . 0.0 112.2 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.7 t -115.81 -172.21 2.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.541 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.423 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 12.6 t -63.81 -47.86 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.034 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 43' ' ' LEU . 9.7 mp -62.26 -49.1 77.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.436 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 t -48.53 -46.42 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 124' ' ' PHE . 49.2 mt -61.63 -43.11 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.366 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -47.48 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.05 -39.29 93.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.83 -37.3 86.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.356 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.49 76.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.36 74.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tt -76.67 -51.92 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.214 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -45.68 -38.69 7.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.33 -43.91 91.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 25.5 t -61.47 -46.47 96.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.5 tt -43.24 -47.67 6.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.312 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 60' ' ' ILE . . . -62.08 -32.79 83.57 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.35 -31.45 70.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.53 68.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.391 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.469 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 15.8 mt -76.63 -31.08 57.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 56' ' ' GLY . 1.4 mp -80.16 -36.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.848 0.356 . . . . 0.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.36 -23.0 78.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.22 6.93 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.611 0.243 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -77.78 -51.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.131 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -172.84 74.82 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 23.03 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.739 2.293 . . . . 0.0 112.14 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.59 -10.37 19.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.233 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 2.6 p -113.9 155.83 44.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.13 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -37.31 -17.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.808 2.338 . . . . 0.0 112.834 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.003 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.2 mm? -44.98 -31.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.588 ' NH1' HG22 ' A' ' 161' ' ' VAL . 3.5 mmp_? -34.32 -55.16 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -53.13 -36.31 60.65 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.951 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 69' ' ' LEU . 3.4 m -65.16 -39.86 86.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.816 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.24 -37.39 57.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.433 ' SD ' HG21 ' A' ' 161' ' ' VAL . 7.0 ttt -58.56 -14.36 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.468 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.8 t -55.08 -42.93 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.28 -31.14 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.644 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.474 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 6.2 t-105 -63.49 -55.4 24.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.113 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.0 tt -65.57 -48.41 72.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -42.84 -43.27 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.089 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 p -79.84 -22.43 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.791 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.45 -60.27 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.733 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.15 -55.08 6.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -65.95 -50.25 65.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.44 61.18 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.49 ' O ' ' OG1' ' A' ' 88' ' ' THR . 77.0 t -66.42 -45.42 89.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.895 0.379 . . . . 0.0 110.654 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.33 -31.86 67.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.58 -44.98 61.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -53.5 -27.0 23.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -70.97 -51.51 25.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -48.47 -34.24 10.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.25 -55.21 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -55.32 -46.69 76.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.1 ttt -56.73 -43.03 80.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tp -66.57 -22.99 66.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.059 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 120.993 0.425 . . . . 0.0 109.857 179.635 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.647 0.261 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -108.13 18.54 21.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.734 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.594 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -120.97 83.33 37.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.4 Cg_exo -53.03 2.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.647 2.231 . . . . 0.0 112.102 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.594 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.0 mp -63.63 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.638 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -97.02 -44.05 7.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -70.34 -45.58 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.471 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 15.7 t-105 -73.13 -15.05 61.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.98 74.89 11.96 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.46 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -12.62 13.82 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.907 2.405 . . . . 0.0 112.092 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -53.93 -54.12 43.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.839 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.436 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 8.5 t -106.94 60.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.72 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.621 ' O ' HD13 ' A' ' 45' ' ' ILE . 4.7 m-85 -164.68 -41.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.07 125.13 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.442 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.57 152.01 21.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 m -162.95 99.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.642 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.25 179.45 17.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.442 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.8 OUTLIER -80.37 143.49 33.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 30.2 m -93.52 131.85 38.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 85.89 0.56 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.208 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' OE1' ' OD1' ' A' ' 129' ' ' ASP . 39.9 tt0 -68.31 128.65 37.36 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.216 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.72 116.49 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.344 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.81 ' NE2' HD12 ' A' ' 38' ' ' LEU . 62.8 mt-30 -104.19 -29.6 10.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -173.8 147.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.21 161.6 37.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.362 0.601 . . . . 0.0 112.054 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.25 138.59 54.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.84 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.44 17.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.94 22.82 40.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 mt -124.72 136.0 53.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.42 148.81 50.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.743 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.432 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.5 mtt -48.74 -52.74 42.99 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.67 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 142' ' ' MET . 81.8 Cg_exo -43.51 -35.96 6.48 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.286 1.99 . . . . 0.0 112.033 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.65 -46.55 58.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.321 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.603 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.0 m95 -64.52 -57.7 8.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.2 tp -43.53 -39.26 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.104 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.9 -33.75 74.79 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.63 -40.6 94.91 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -72.68 -31.76 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 110.632 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.05 -39.62 86.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.502 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.2 tp -70.94 -37.05 66.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.139 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.16 -53.33 46.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -60.43 -38.52 84.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.224 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.705 ' C ' HD23 ' A' ' 154' ' ' LEU . 7.2 tt -54.53 -37.84 65.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.4 mt -75.55 -40.64 41.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 160' ' ' VAL . 73.8 t -48.96 -39.34 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.535 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -76.01 -43.63 43.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.963 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.58 -36.02 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.113 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.14 -32.72 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 156' ' ' VAL . 54.2 t -77.76 -25.01 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.259 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.588 HG22 ' NH1' ' A' ' 70' ' ' ARG . 92.6 t -83.33 -50.75 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.32 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 162' ' ' ILE . 1.4 mp -66.84 -22.54 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.716 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.1 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.517 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.888 0.375 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -47.92 -34.66 9.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.41 -38.21 74.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.991 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.9 tp -50.97 -40.17 57.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -66.62 -29.39 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.019 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.95 -49.82 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -66.16 -34.39 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.799 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 54.1 p -75.52 -33.94 60.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.643 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -75.17 14.98 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.57 150.26 17.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.6 ttm105 -67.9 -20.7 65.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.392 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.75 86.88 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -65.36 -51.56 59.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.465 ' NE1' ' O ' ' A' ' 9' ' ' SER . 19.4 m0 -54.08 -42.55 69.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.375 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.5 -30.89 64.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tp -68.55 -32.59 72.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.04 -33.87 61.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -51.99 48.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.723 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -53.87 -52.05 61.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.1 m -46.03 -61.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.8 -30.39 14.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.569 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.97 -40.8 53.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.04 -40.84 46.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.5 mp -69.21 -36.75 77.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.581 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.36 -49.37 69.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.65 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.72 -50.95 70.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -53.65 -42.34 67.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.33 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.035 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -20.86 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.95 -41.63 15.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.135 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -50.97 -43.67 60.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.0 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -77.43 -40.52 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -71.07 -16.59 62.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.772 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 31' ' ' TRP . 66.1 t -109.34 -50.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.18 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mtt -90.75 14.71 12.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp 41.16 37.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 38' ' ' LEU . 3.9 tp -63.43 155.58 28.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -120.25 90.93 45.62 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.967 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.11 147.52 19.95 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.567 2.178 . . . . 0.0 112.083 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 6.4 t -99.0 -173.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.779 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -67.19 -46.75 83.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.628 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.496 HD12 ' CG ' ' A' ' 91' ' ' HIS . 4.1 mm? -65.99 -47.02 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.216 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 m -49.19 -47.19 46.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.17 -39.95 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.235 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -54.67 -49.69 70.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.738 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -58.8 -39.71 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.435 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -58.68 -38.93 79.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.119 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.21 -39.52 94.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.506 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.91 82.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.9 tp -76.57 -50.4 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -44.11 -42.85 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.33 -41.41 96.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.47 -17.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.352 0.596 . . . . 0.0 109.901 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tp -81.79 -41.42 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.052 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -30.89 76.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.28 -35.15 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.151 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.78 97.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.1 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.61 -38.86 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.538 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.04 -21.0 78.29 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.68 3.64 32.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.279 . . . . 0.0 110.669 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -82.13 -49.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 179.15 77.09 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.25 21.35 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.892 2.395 . . . . 0.0 112.323 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -96.7 -8.37 31.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.116 0.484 . . . . 0.0 109.939 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.578 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -109.82 177.91 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.532 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 56.1 Cg_exo -50.49 -0.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.258 1.972 . . . . 0.0 112.278 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 67' ' ' THR . 17.2 mt -62.33 -28.33 69.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -41.76 -64.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.573 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 75' ' ' VAL . 37.9 m-85 -55.5 -38.69 69.51 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.714 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -57.85 -54.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.546 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.03 -33.62 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.208 0.527 . . . . 0.0 110.314 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.4 ' SD ' HG11 ' A' ' 161' ' ' VAL . 8.1 ttt -64.56 -25.48 68.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 71' ' ' TYR . 42.1 t -52.56 -32.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.457 0.646 . . . . 0.0 110.718 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.9 mp -88.88 -31.56 5.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.097 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -65.98 -49.08 69.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.33 -43.51 77.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -46.87 -46.28 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.298 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -79.61 -21.48 44.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.742 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.477 ' HA ' HD21 ' A' ' 154' ' ' LEU . . . -59.61 -60.47 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.032 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -76.14 -48.47 20.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -67.77 -43.83 78.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.6 -47.64 90.14 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.87 -32.39 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.217 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.58 -28.6 65.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.39 -41.35 13.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 84' ' ' GLY . 12.7 p -51.93 -51.88 53.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.727 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -51.84 -48.36 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.137 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.09 -44.28 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.908 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.496 ' CG ' HD12 ' A' ' 43' ' ' LEU . 2.0 m-70 -62.82 -44.8 95.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.327 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.3 p -61.29 -47.75 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.3 tpt -45.5 -45.51 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.264 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.9 tp -64.94 -43.65 92.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.162 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.407 ' OE1' ' OE1' ' A' ' 141' ' ' GLU . 6.7 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.351 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -99.7 2.26 44.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.251 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.0 tp -119.88 85.09 33.49 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.2 Cg_exo -56.14 16.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.668 2.245 . . . . 0.0 112.638 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.1 tp -77.14 -30.85 55.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.029 0.442 . . . . 0.0 110.312 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -97.75 -40.28 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.098 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -70.61 -45.32 65.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.6 t90 -76.19 -11.64 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.334 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.46 71.19 17.75 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.831 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 125' ' ' VAL . 72.4 Cg_endo -77.77 -14.91 15.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.763 2.308 . . . . 0.0 111.766 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -57.33 -53.27 59.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.827 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 53.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -158.14 -39.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.287 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 121' ' ' PRO . 42.2 t -54.97 123.92 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.18 158.17 15.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.648 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.56 104.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.501 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.04 -177.06 20.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 t70 -89.33 139.69 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 110.284 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 54.6 m -91.47 134.65 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 86.52 -1.09 0.64 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.095 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -68.0 153.2 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 119.01 37.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -122.68 -12.61 8.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.719 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -173.3 127.92 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.796 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.32 160.97 38.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.266 0.555 . . . . 0.0 112.179 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.66 137.31 53.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.862 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt 50.64 17.19 0.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.593 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 90.44 21.5 37.52 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 139' ' ' GLY . 3.2 mm? -122.46 134.5 54.58 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.407 ' OE1' ' OE1' ' A' ' 95' ' ' GLN . 8.1 mt-10 -69.16 148.6 49.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.669 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.434 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -49.18 -51.93 52.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 142' ' ' MET . 89.4 Cg_exo -44.01 -38.74 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.426 2.084 . . . . 0.0 112.119 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.32 -49.6 47.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.3 m95 -60.85 -57.11 14.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.291 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.4 tp -43.03 -39.9 2.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.178 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 143' ' ' PRO . 1.5 mm? -60.84 -34.82 75.15 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.91 -45.12 95.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.9 -34.45 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.955 0.407 . . . . 0.0 110.131 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -54.71 -47.58 73.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.75 -42.88 96.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.491 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.33 -45.95 24.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.403 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -64.02 -42.97 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.936 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 158' ' ' VAL . 6.4 mp -51.97 -32.89 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 155' ' ' ILE . 1.7 mp -81.94 -27.78 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.639 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.2 t -63.45 -33.35 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.0 110.235 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.54 -49.98 10.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.308 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 154' ' ' LEU . 65.3 t -53.79 -37.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.547 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 4.0 mm? -84.87 -33.68 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.128 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 156' ' ' VAL . 17.4 t -70.07 -29.3 39.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.422 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 162' ' ' ILE . 30.7 m -83.09 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.578 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.54 ' N ' HG23 ' A' ' 161' ' ' VAL . 10.0 mt -71.73 -8.87 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.53 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.627 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.036 0.446 . . . . 0.0 110.089 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -53.58 -34.52 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -72.31 -41.62 66.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.01 -43.81 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.385 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -64.83 -29.2 70.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.003 0.43 . . . . 0.0 110.277 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -78.5 -47.76 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.63 88.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.806 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.8 p -76.63 -35.39 58.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.673 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 6.4 tt0 -68.83 4.9 1.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.05 0.452 . . . . 0.0 110.405 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.79 146.99 17.31 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 63' ' ' ILE . 65.1 mtt180 -69.47 -48.84 59.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.667 0.27 . . . . 0.0 110.81 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.05 -46.32 6.26 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.93 -46.99 86.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.13 -42.17 89.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.2 mm? -63.82 -28.08 69.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -70.0 -27.71 64.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . 23.0 mmt -76.47 -33.91 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.161 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.12 -54.48 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.604 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -52.13 -51.83 55.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.654 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 18' ' ' MET . 11.0 p -45.41 -61.7 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.49 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.65 -40.04 80.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.52 -37.91 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.6 mp -75.5 -38.53 59.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.16 -46.47 83.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.82 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.63 -55.15 14.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 24' ' ' ALA . 14.4 p -45.45 -40.81 8.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.71 -42.25 51.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.821 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -54.04 -18.57 3.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.434 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.7 t-105 -88.92 -35.32 16.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.554 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -32.22 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.171 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.641 HE21 ' CB ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.44 -47.65 39.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.445 ' O ' ' CD2' ' A' ' 34' ' ' HIS . 20.8 t60 -70.89 -7.38 45.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.941 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 31' ' ' TRP . 71.7 t -109.14 -42.18 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.029 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.7 mtp -99.85 12.46 36.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.3 mp 42.9 38.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.641 ' CB ' HE21 ' A' ' 33' ' ' GLN . 23.8 mt -74.59 156.29 36.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.894 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' H ' ' HD3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -115.4 126.51 27.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.195 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.05 137.43 17.32 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.234 1.956 . . . . 0.0 111.836 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.7 t -92.25 -178.05 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.565 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.07 -46.43 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.05 -48.32 82.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -48.65 -45.76 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.518 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 124' ' ' PHE . 59.2 mt -61.38 -43.41 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -48.16 73.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -63.22 -36.4 83.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.721 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -68.24 -38.27 81.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.74 79.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.19 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.69 -50.45 13.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.199 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -46.47 -39.92 11.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.96 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -44.29 89.4 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.59 -47.35 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.986 0.422 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.0 tt -45.41 -49.73 12.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.537 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.34 -49.71 75.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.83 -34.92 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.366 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.63 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.278 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -36.91 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.718 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -73.55 -35.88 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.447 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -15.32 79.3 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 3.59 32.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.605 0.24 . . . . 0.0 111.199 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.439 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 2.8 pt -91.19 -23.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.813 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.08 67.5 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.79 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.87 15.67 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.82 2.347 . . . . 0.0 112.027 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -102.38 -8.96 20.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.624 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.98 163.37 17.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.066 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.04 3.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.574 2.182 . . . . 0.0 112.607 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.019 ' O ' HG22 ' A' ' 72' ' ' VAL . 6.7 mp -67.06 -30.19 70.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.291 . . . . 0.0 110.918 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD3' ' H ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -38.66 -42.82 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.608 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.501 ' H ' ' HD3' ' A' ' 70' ' ' ARG . 75.7 t80 -59.69 -37.95 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.672 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.019 HG22 ' O ' ' A' ' 69' ' ' LEU . 4.2 m -59.62 -38.15 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.253 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.09 -30.51 22.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.716 -0.615 . . . . 0.0 110.114 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 161' ' ' VAL . 11.8 ttp -67.75 -33.14 74.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.911 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 1.3 m -50.03 -28.57 4.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.562 0.696 . . . . 0.0 110.578 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.23 -31.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.976 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.439 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 13.8 t-105 -66.51 -47.6 72.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.81 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 tp -68.51 -47.85 65.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.439 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -43.98 -42.14 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.345 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -79.19 -24.28 43.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.583 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.37 -58.89 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.282 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CE2' ' NE2' ' A' ' 86' ' ' GLN . 73.5 t80 -74.2 -52.35 12.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.392 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -66.66 -40.86 88.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.15 -46.25 93.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.427 ' O ' ' OG1' ' A' ' 88' ' ' THR . 95.2 t -72.84 -36.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.467 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 82' ' ' PHE . 7.6 tt0 -67.48 -45.95 74.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 tp -65.15 -42.96 93.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.568 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 84' ' ' GLY . 6.6 p -51.46 -47.63 63.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.401 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -48.07 -41.81 27.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -59.82 -38.51 82.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.605 ' HD1' ' C ' ' A' ' 91' ' ' HIS . 1.7 t-80 -69.41 -56.07 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.387 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.4 p -55.72 -52.14 64.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.706 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 35.4 tpp -48.76 -45.23 39.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.44 -44.77 90.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.393 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.553 0.216 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.411 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.15 -5.96 7.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.432 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 mp -119.8 84.42 31.53 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.3 Cg_exo -55.15 11.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.568 2.179 . . . . 0.0 112.264 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.623 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.8 mm? -71.04 -32.74 69.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.086 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.0 p30 -97.63 -39.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 21.3 tttm -72.08 -45.26 61.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.8 t90 -76.34 -11.65 59.94 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.17 68.86 48.57 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -17.03 11.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.64 -33.99 35.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.28 45.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.586 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.59 ' O ' HD13 ' A' ' 45' ' ' ILE . 1.3 m-85 -149.55 -36.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.9 p -54.8 124.32 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.438 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.95 23.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t -164.98 101.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.584 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.66 -175.24 21.15 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.478 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -92.33 150.88 20.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.683 0.278 . . . . 0.0 110.323 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 11.9 m -100.74 132.07 46.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.56 -4.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.01 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.97 150.58 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.057 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -96.11 133.2 40.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.647 ' NE2' ' N ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -128.52 -22.5 3.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.732 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.647 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 21.6 t-105 -173.17 136.42 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.004 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 5.3 p30 -140.77 157.25 45.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 111.964 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.08 138.43 50.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.33 17.07 0.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.77 21.71 35.81 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.808 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.42 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 5.0 mt -124.86 137.27 54.3 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.33 148.86 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.413 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.9 mtt -47.89 -53.15 34.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -43.49 -37.35 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.419 2.079 . . . . 0.0 112.352 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -71.29 -50.33 33.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.993 0.425 . . . . 0.0 110.113 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 74.0 m95 -60.28 -57.84 11.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.09 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.7 tp -43.49 -37.8 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.062 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.512 ' CD1' HG21 ' A' ' 88' ' ' THR . 11.7 tp -61.13 -34.94 75.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.72 -45.34 94.95 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 149' ' ' ILE . 3.4 mp -75.61 -31.88 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.12 -49.17 76.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.143 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.42 -46.68 94.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.537 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.42 -46.5 56.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.369 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -55.25 -43.24 74.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.2 mt -61.08 -30.58 70.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.869 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.62 -32.03 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 160' ' ' VAL . 70.3 t -64.55 -37.6 80.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -80.29 -46.32 16.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.147 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 154' ' ' LEU . 54.7 t -53.88 -44.01 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.42 -33.0 48.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.0 t -74.79 -22.97 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.882 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.542 HG21 ' SD ' ' A' ' 74' ' ' MET . 46.2 t -82.17 -50.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.098 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.3 mt -67.67 -17.34 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.796 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.7 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 -179.48 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -54.41 -31.59 55.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 12.6 t80 -74.89 -42.77 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.193 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -47.97 -38.49 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.354 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -70.75 -27.05 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.448 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 7.1 tm0? -75.55 -49.94 17.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.23 -27.52 69.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 0.0 110.308 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 m -76.51 -42.66 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.254 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -70.15 5.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.99 0.424 . . . . 0.0 110.684 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.69 142.66 16.2 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -69.0 -49.84 54.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.586 0.231 . . . . 0.0 110.713 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.86 -45.72 5.91 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -47.09 87.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -61.03 -37.07 81.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.26 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -32.34 70.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.95 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.82 -36.61 75.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.469 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.478 ' C ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -66.44 -34.79 78.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 -49.94 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.76 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.65 -41.87 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.9 m -64.39 -46.62 82.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.656 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.59 72.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 tt -81.82 -42.08 20.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 28' ' ' THR . . . -55.91 -26.92 49.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -77.35 -39.82 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.542 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.2 -54.54 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -56.23 -50.48 71.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 24' ' ' ALA . 8.9 p -49.91 -43.69 49.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.999 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.75 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.144 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -17.29 19.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -93.4 -37.63 11.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.702 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.78 -46.22 78.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.404 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 38' ' ' LEU . 7.3 tm0? -73.3 -36.21 66.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.63 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -61.25 -22.44 64.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.652 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.1 t -107.88 -28.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.805 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.6 mmt -92.03 3.27 55.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.999 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt 47.4 48.54 16.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' H ' ' HG2' ' A' ' 33' ' ' GLN . 93.6 mt -93.13 155.04 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.829 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -117.19 127.17 26.88 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.075 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.84 148.82 28.78 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.296 1.997 . . . . 0.0 112.368 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.2 t -94.58 173.57 7.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.32 -35.87 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 110.076 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -64.71 -45.55 86.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 m -48.94 -47.53 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.733 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.448 HG12 ' N ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -61.4 -38.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.448 ' N ' HG12 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -61.35 -46.19 91.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.838 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -65.1 -51.77 59.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.526 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.536 ' NH1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -58.55 -35.51 72.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.35 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.38 85.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.564 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.56 70.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.148 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.706 HD23 ' C ' ' A' ' 51' ' ' LEU . 7.0 tt -71.26 -53.71 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.026 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -44.84 -40.2 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.27 93.44 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 57' ' ' ALA . 60.2 t -59.91 -47.53 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 109.872 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.6 -45.39 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.329 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.79 -27.59 71.37 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -70.53 -37.68 74.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.059 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.42 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.952 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.385 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.51 -36.59 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.651 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.87 -34.3 59.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.49 2.93 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.716 0.293 . . . . 0.0 110.755 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 88.7 mt -77.97 -47.42 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.06 78.37 0.28 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.493 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.06 25.82 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.82 -10.93 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.175 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.48 176.46 1.48 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.485 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.96 -2.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.258 1.972 . . . . 0.0 111.874 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.2 tt -47.79 -37.17 13.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mmp_? -38.8 -67.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.827 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 75' ' ' VAL . 81.8 t80 -52.49 -28.46 20.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.82 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.6 t -71.77 -47.04 58.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.715 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.51 53.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 110.484 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -63.2 -11.54 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.678 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.536 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 3.0 t -58.39 -38.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.372 0.606 . . . . 0.0 110.027 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -87.65 -32.54 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.309 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 12.4 t-105 -64.63 -53.69 43.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.169 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.0 tp -64.85 -47.22 78.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.832 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -44.16 -42.2 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.4 p -78.95 -22.36 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.75 -59.99 4.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.927 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -73.76 -55.02 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.218 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -66.35 -45.73 79.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.58 -46.57 91.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.436 ' O ' ' OG1' ' A' ' 88' ' ' THR . 86.7 t -70.77 -52.51 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -52.06 -29.41 21.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 tp -80.16 -43.6 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.359 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' GLY . 61.5 p -52.44 -22.21 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.196 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -73.48 -51.7 16.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.36 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -50.13 -36.27 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -72.72 -36.51 67.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 88' ' ' THR . 40.4 p -74.99 -43.8 51.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.719 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 39.4 ttm -52.57 -52.05 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.711 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.66 -40.91 92.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.557 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 -179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.15 0 CA-C-O 120.816 0.341 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 1.4 p-90 -124.29 -2.47 8.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.2 tp -115.19 88.83 18.83 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.77 10.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.832 2.355 . . . . 0.0 113.198 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.633 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -80.02 -22.59 42.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.128 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -95.28 -46.83 6.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.819 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -24.92 64.78 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.209 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -93.23 -19.92 20.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.088 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.82 70.94 19.55 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.3 Cg_endo -80.93 -15.85 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.949 2.432 . . . . 0.0 112.247 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -52.76 -35.9 57.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.368 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.536 HG21 ' NH1' ' A' ' 48' ' ' ARG . 33.6 m -127.41 22.2 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.71 0.291 . . . . 0.0 110.913 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.48 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 2.4 t80 -131.4 -6.08 3.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 125' ' ' VAL . 13.4 p -84.66 129.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.85 135.9 33.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.3 m -164.7 116.16 1.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.523 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.25 -168.44 16.39 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -96.12 158.08 15.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.694 0.283 . . . . 0.0 110.241 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.675 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -109.19 130.05 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.776 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.98 -3.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.791 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.78 150.54 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.027 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.7 145.39 24.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.941 0.4 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -135.17 -31.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.1 t-105 -174.95 144.77 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -141.5 167.05 23.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 111.402 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -141.39 120.35 12.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.379 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.28 16.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.18 15.0 75.6 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.48 133.69 55.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.811 0.339 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.77 152.87 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.425 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -51.17 -51.64 66.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 142' ' ' MET . 70.9 Cg_exo -45.39 -37.87 14.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.3 2.0 . . . . 0.0 112.034 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.99 -42.54 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.205 0.526 . . . . 0.0 109.982 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 148' ' ' GLY . 59.9 m95 -65.64 -57.14 8.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.0 tp -43.33 -39.01 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.066 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 88' ' ' THR . 38.7 tp -62.23 -34.59 76.8 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.92 -42.91 96.98 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.6 mt -67.68 -39.53 82.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 0.0 110.146 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -55.25 -45.31 76.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.5 mt -57.2 -43.93 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.61 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.44 62.27 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.518 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.7 m-85 -53.76 -43.48 69.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.087 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.501 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 1.1 pp -75.01 -29.7 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.309 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.9 mt -69.97 -36.74 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.201 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 160' ' ' VAL . 23.3 m -73.36 -38.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.989 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.29 -51.16 62.55 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.844 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 154' ' ' LEU . 79.3 t -55.19 -50.96 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.01 -33.9 73.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 156' ' ' VAL . 16.4 t -67.07 -28.99 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.94 -45.92 62.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.146 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.64 -27.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 179.83 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.3 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.865 0.364 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 3' ' ' ARG . 8.4 ptt-85 -58.74 -40.62 84.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -59.37 -47.63 84.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -51.19 -38.68 53.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -68.41 -31.26 70.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.348 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -77.06 -50.95 11.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.681 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.89 77.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -76.96 -37.9 54.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.733 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.77 HE22 HH21 ' A' ' 70' ' ' ARG . 16.6 mm-40 -67.51 2.02 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.42 147.49 18.56 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -71.78 -49.68 36.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.685 0.278 . . . . 0.0 110.65 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.91 -45.05 5.85 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.19 84.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -58.41 -41.41 84.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.154 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -28.89 69.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.022 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -70.5 -30.48 67.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.308 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.433 ' O ' ' OG1' ' A' ' 21' ' ' THR . 0.4 OUTLIER -73.19 -33.09 65.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.02 7.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -47.97 -40.85 23.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -63.72 -50.17 70.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.377 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.13 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -37.27 41.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.92 -36.96 63.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.53 -37.93 65.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.46 -43.48 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.98 -48.31 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.508 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 24' ' ' ALA . 19.4 p -54.47 -40.95 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.73 67.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.776 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 -20.4 63.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.424 ' NE1' ' CG2' ' A' ' 35' ' ' VAL . 32.1 t90 -88.95 -39.36 13.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.65 -43.61 57.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 4.5 tm0? -73.61 -29.56 62.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.02 -26.35 66.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' NE1' ' A' ' 31' ' ' TRP . 56.0 t -109.29 -53.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.924 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.68 1.13 8.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.96 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mt 48.54 41.36 17.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 134' ' ' GLN . 1.4 tp -76.24 147.71 38.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -111.66 127.04 27.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.596 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.06 154.66 33.19 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 111.775 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 6.5 t -118.0 -171.98 2.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.787 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.23 -48.05 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.075 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.83 -50.1 70.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.442 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.7 p -53.08 -48.97 67.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mm -61.34 -45.23 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.327 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -58.41 -46.12 87.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.307 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -60.78 -38.32 84.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -64.59 -36.38 84.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.38 84.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.96 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.346 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.492 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.2 tt -76.78 -49.58 15.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.049 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -46.32 -38.03 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.76 -44.25 81.29 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.9 -47.65 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -43.9 -48.62 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.6 -48.24 86.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.19 -33.02 25.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.27 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.77 -35.54 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.404 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.88 -37.26 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.223 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -75.24 -40.32 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.0 -28.67 73.34 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.77 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.705 0.288 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 94.1 mt -82.63 -32.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.46 73.36 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.442 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.75 24.58 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.518 2.145 . . . . 0.0 111.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.3 mttm -111.86 -7.56 14.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.13 162.44 21.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.655 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -38.91 -15.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.592 2.195 . . . . 0.0 112.304 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.4 mp -41.58 -33.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.77 HH21 HE22 ' A' ' 10' ' ' GLN . 71.9 mtt85 -39.22 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 75' ' ' VAL . 67.2 t80 -51.95 -31.48 29.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.62 -45.94 80.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.97 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.46 -34.26 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -64.7 -19.66 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.678 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.1 t -54.09 -34.46 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 0.0 109.958 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 84.0 mt -89.15 -33.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.2 t-105 -65.87 -49.86 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.003 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -66.06 -49.58 67.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.3 m-85 -42.92 -42.61 3.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.8 p -78.11 -22.18 49.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.768 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.8 -59.86 4.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.281 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.3 -51.13 13.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.646 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -40.5 78.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.08 -47.14 90.98 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 81' ' ' ALA . 11.1 m -77.53 -32.73 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.336 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.04 -42.87 59.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.663 0.268 . . . . 0.0 111.191 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tp -73.72 -38.47 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.047 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 84' ' ' GLY . 7.9 p -59.56 -44.45 93.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.208 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -52.32 -52.13 54.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.522 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -50.84 -46.35 60.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -64.55 -33.16 75.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.9 m -70.97 -37.14 72.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.413 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 7.4 tpt -62.21 -33.01 73.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.115 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.2 -47.47 70.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.115 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 179.842 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.708 0.289 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.502 ' C ' HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -99.22 -5.38 30.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.426 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 116' ' ' LEU . 10.4 mp -113.09 82.81 5.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.31 12.11 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.041 1.827 . . . . 0.0 111.756 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.527 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.9 mt -80.13 -28.42 38.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.013 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 1.4 p30 -97.31 -40.83 8.55 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.975 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 3.3 ttmm -69.27 -45.16 70.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.658 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 16.0 t-105 -76.85 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.405 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.17 71.13 22.81 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.761 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.74 -16.11 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.748 2.299 . . . . 0.0 111.805 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -52.29 -32.63 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.785 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -133.37 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.536 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -152.3 -40.53 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.239 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.7 128.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.99 155.47 17.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.4 p -158.17 102.8 1.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.599 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.58 -177.27 19.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 33.9 t70 -86.06 150.02 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 9.7 m -101.74 127.23 48.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 98.87 -8.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.87 128.82 37.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.733 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.19 136.22 51.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.514 ' HB3' HD21 ' A' ' 38' ' ' LEU . 77.9 mt-30 -130.16 -29.35 2.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -174.56 145.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.722 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -144.73 159.64 42.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.256 0.551 . . . . 0.0 112.102 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.408 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -115.09 138.13 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.705 178.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp 50.24 16.85 0.28 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.597 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 90.73 22.64 33.01 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 139' ' ' GLY . 2.6 mm? -124.36 136.23 53.93 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 135' ' ' TRP . 6.0 mm-40 -69.33 146.73 51.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.315 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.442 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 9.5 mtt -44.94 -62.7 1.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.144 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 85.8 Cg_exo -33.78 -37.63 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.848 2.366 . . . . 0.0 112.639 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 144' ' ' GLN . 4.8 mp0 -72.34 -52.0 18.08 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.0 m95 -59.47 -57.28 13.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.848 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.5 tp -44.57 -35.55 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.423 HD11 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -62.9 -33.96 76.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.51 -46.19 94.83 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.708 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -75.14 -25.88 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -64.54 -44.37 91.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.743 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.9 tt -69.24 -37.39 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -53.79 -46.99 71.21 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.054 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.79 -44.47 96.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.686 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 81' ' ' ALA . 52.3 mt -65.19 -30.95 71.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.9 -33.35 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.321 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.5 t -64.95 -31.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.52 -47.5 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 154' ' ' LEU . 73.7 t -55.41 -42.21 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -28.58 56.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.903 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 156' ' ' VAL . 31.1 t -78.26 -20.33 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.8 -50.03 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.83 -25.96 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.76 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.548 -179.873 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.987 0.422 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.6 -31.84 66.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 7' ' ' GLN . 23.3 t80 -73.48 -44.94 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -47.17 -39.88 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.003 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -68.46 -28.15 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.421 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 4' ' ' PHE . 24.4 tt0 -80.33 -49.45 11.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.36 72.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -76.66 -34.99 58.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -72.76 7.41 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.07 142.08 15.87 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -68.44 -21.4 64.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 110.648 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.83 -46.06 61.94 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.83 76.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.327 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -58.17 -43.12 87.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.42 -33.06 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.323 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -67.48 -30.37 70.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . 60.3 mtp -73.66 -33.0 64.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.417 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.89 71.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.46 -51.83 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 17' ' ' LEU . 12.7 p -41.65 -50.42 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.92 85.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.62 -39.67 80.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.306 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.71 -41.67 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.354 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.3 -33.78 63.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.543 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.76 -45.91 77.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.03 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -71.89 -46.55 57.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.92 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 87.5 m -46.8 -43.01 18.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.81 -21.45 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -68.49 -22.39 64.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.23 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.4 t-105 -97.68 -29.39 13.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.4 -39.86 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.51 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -78.8 -51.6 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.992 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -54.74 -53.41 55.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 31' ' ' TRP . 4.3 p -61.01 -18.19 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.0 ttt -106.3 10.56 31.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.589 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.2 mp 52.24 54.44 10.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.99 157.18 17.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.283 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -125.37 141.48 38.95 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.432 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.76 175.93 10.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 112.318 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.486 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 12.8 t -131.88 -179.34 5.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 39.6 t -56.06 -49.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.599 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.94 -38.24 87.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -54.23 -40.93 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.584 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.699 HD12 HH21 ' A' ' 48' ' ' ARG . 1.4 tp -67.98 -37.59 78.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.428 . . . . 0.0 110.053 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -60.73 -48.2 82.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.038 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.94 -39.95 95.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.699 HH21 HD12 ' A' ' 45' ' ' ILE . 11.6 ttp180 -65.82 -36.16 82.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.11 86.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.05 -49.03 78.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 tp -76.04 -52.2 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.223 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -45.89 -42.59 12.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.53 89.47 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' ALA . 26.0 t -59.15 -46.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.298 0.571 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.09 -46.59 11.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.535 179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.81 -27.42 71.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.04 -42.13 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.91 -21.51 62.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -43.93 19.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.34 -33.23 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -73.16 -31.38 61.63 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.44 6.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.798 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 95.0 mt -82.81 -29.79 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.76 69.03 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.25 23.78 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.754 2.302 . . . . 0.0 111.654 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.29 -10.25 19.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.087 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.84 175.21 1.96 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.513 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.39 -9.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.281 1.987 . . . . 0.0 112.052 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -47.89 -31.43 5.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.126 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -40.33 -67.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.62 -26.08 63.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.43 -45.48 74.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.248 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.66 -36.48 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.47 0.653 . . . . 0.0 109.574 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 161' ' ' VAL . 0.8 OUTLIER -57.15 -12.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.062 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.5 t -55.27 -44.21 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.306 0.574 . . . . 0.0 110.443 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.89 -31.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.627 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.493 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 10.0 t-105 -62.67 -55.79 23.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.129 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.1 tp -65.3 -48.17 74.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -43.58 -45.66 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.084 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 p -78.99 -21.14 47.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.43 -60.38 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.053 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.52 -51.27 17.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.09 -48.1 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 88' ' ' THR . . . -55.38 -48.42 69.76 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' ' OG1' ' A' ' 88' ' ' THR . 66.1 t -69.29 -47.23 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.553 HE21 ' C ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -55.48 -23.48 25.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.292 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.39 -42.67 14.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.214 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 84' ' ' GLY . 39.7 p -51.29 -26.38 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -69.18 -46.53 67.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.246 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -55.38 -31.23 61.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.274 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 10.7 t-80 -70.09 -49.64 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.349 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.1 p -54.87 -56.36 20.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 110.199 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 40.8 mtt -48.01 -50.68 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.028 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.72 -36.8 7.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.412 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.525 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.793 0.33 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.85 -5.21 59.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.2 mp -119.68 81.85 25.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -52.67 -2.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.566 2.178 . . . . 0.0 112.016 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tt -59.53 -32.31 70.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -41.03 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.604 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -71.9 -45.28 61.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.721 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -73.71 -17.29 61.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.456 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.0 t -141.34 72.32 26.31 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.514 ' O ' HG22 ' A' ' 125' ' ' VAL . 74.4 Cg_endo -79.75 -16.48 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.895 2.396 . . . . 0.0 111.804 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -50.2 -49.11 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.816 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.97 53.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.431 ' HA ' HD11 ' A' ' 45' ' ' ILE . 6.0 t80 -154.57 -39.76 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 121' ' ' PRO . 27.5 m -55.57 130.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.47 150.24 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.535 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.9 m -159.69 102.97 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.695 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.59 -176.7 20.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.3 m-20 -87.55 157.19 19.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 3.7 m -106.79 128.97 54.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.711 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 93.94 -7.87 0.13 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.429 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 8.1 mp0 -68.21 129.1 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.857 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.51 116.21 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.096 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -109.11 -31.04 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.84 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -174.06 143.26 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.794 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.96 156.45 44.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.295 0.569 . . . . 0.0 112.167 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -112.41 138.76 48.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.786 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.44 17.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 91.29 22.8 31.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.03 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.53 137.86 53.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.38 149.42 50.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.6 mtt -48.62 -52.74 42.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 86.5 Cg_exo -43.34 -34.21 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.396 2.064 . . . . 0.0 112.17 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.74 -52.66 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 148' ' ' GLY . 95.0 m95 -58.81 -58.3 9.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -43.83 -36.98 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.15 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.59 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.3 tt -61.17 -34.6 75.29 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.67 -47.63 89.24 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.65 -25.57 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.049 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.468 ' O ' HD13 ' A' ' 154' ' ' LEU . 6.6 t80 -64.85 -43.08 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.694 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 148' ' ' GLY . 5.5 tp -68.27 -36.81 76.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.359 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.015 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -58.71 -33.74 70.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 150' ' ' PHE . 4.1 mp -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.9 mt -82.43 -34.26 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.484 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 160' ' ' VAL . 91.6 t -60.48 -40.3 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.625 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.47 -50.58 13.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 154' ' ' LEU . 52.9 t -53.13 -50.61 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.54 -31.17 71.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.013 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 156' ' ' VAL . 11.1 t -70.87 -28.77 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.18 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 74' ' ' MET . 61.0 t -79.29 -49.42 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.222 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 162' ' ' ILE . 39.7 mm -68.92 -11.14 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.569 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.59 -179.987 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.807 0.337 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.501 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -50.09 -45.69 52.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' GLN . 26.2 m-85 -63.03 -43.6 98.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.277 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -48.01 -42.36 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.262 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.8 -24.05 64.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 4' ' ' PHE . 52.1 tt0 -77.98 -48.19 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.55 87.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' GLY . 8.2 m -76.72 -37.32 56.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 6.2 tt0 -66.24 1.87 1.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.12 149.5 19.05 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -70.92 -49.03 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.681 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.83 -45.63 5.87 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.41 83.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.096 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -59.46 -47.17 86.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.058 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.2 mm? -59.27 -28.22 66.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 21' ' ' THR . 0.9 OUTLIER -70.9 -27.73 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.439 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.5 mmt -74.24 -34.44 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 -53.61 22.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.712 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -52.71 57.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.485 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 17' ' ' LEU . 16.2 p -44.74 -54.12 6.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.727 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.29 -22.2 62.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.73 -41.26 15.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.634 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.28 -39.92 64.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.0 mm? -73.11 -27.78 61.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.835 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.44 -38.74 90.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.589 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 mt -79.18 -41.4 28.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 2.5 m -48.06 -43.33 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.49 -32.28 32.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.104 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tp -57.06 -21.33 30.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -90.22 -38.94 13.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.08 -45.54 43.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -71.25 -25.26 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 -21.24 51.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.393 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 36' ' ' MET . 7.6 p -107.19 -38.67 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.483 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.431 ' N ' HG13 ' A' ' 35' ' ' VAL . 12.4 mtp -98.68 5.73 47.47 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.4 mm? 47.22 45.0 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 46.9 mt -80.01 153.28 28.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.503 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -121.2 126.86 26.41 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.415 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 153.4 32.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.218 1.945 . . . . 0.0 111.934 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.8 t -100.15 -174.77 2.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.6 t -65.98 -41.74 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 110.822 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.65 -36.47 65.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t -57.69 -47.73 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 124' ' ' PHE . 25.5 pt -66.72 -36.36 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.089 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -55.06 -48.29 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.27 -36.15 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.87 84.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.504 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -58.92 -47.9 83.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -77.72 -49.71 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -46.6 -43.32 17.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 109.851 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.44 93.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' ALA . 55.1 t -58.31 -46.7 88.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.006 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.0 -42.95 29.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.543 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -24.15 72.45 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.87 -32.05 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.584 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -23.09 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 tp -79.63 -42.3 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.388 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.72 -36.9 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.679 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -69.71 -33.7 71.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.19 6.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.655 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.9 mt -79.64 -25.56 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.76 68.38 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.85 14.42 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.674 2.249 . . . . 0.0 111.995 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -8.81 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.197 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.27 162.47 20.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.813 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -42.04 -12.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.418 2.079 . . . . 0.0 112.246 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mp -50.35 -29.3 9.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' CG ' ' N ' ' A' ' 71' ' ' TYR . 26.7 ptt180 -37.9 -57.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.715 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -52.72 -35.01 55.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.108 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' LEU . 18.2 t -64.02 -44.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.58 -33.89 47.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.203 0.525 . . . . 0.0 110.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.51 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 8.3 mmt -62.59 -20.06 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 71' ' ' TYR . 3.4 t -51.78 -39.03 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.457 0.646 . . . . 0.0 110.342 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.74 -30.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.766 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.499 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 15.0 t-105 -66.95 -51.16 58.63 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.123 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.2 tp -67.29 -50.31 60.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.617 ' CE2' ' NE ' ' A' ' 83' ' ' ARG . 63.6 t80 -42.36 -42.49 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 110.267 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 p -79.12 -23.23 44.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.803 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.05 -58.95 6.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.256 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -74.71 -51.87 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.617 ' NE ' ' CE2' ' A' ' 79' ' ' TYR . 47.5 ttp85 -65.56 -42.33 91.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 88' ' ' THR . . . -62.77 -46.53 93.46 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 81' ' ' ALA . 70.7 t -66.8 -36.68 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.647 0.261 . . . . 0.0 111.057 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -72.09 -29.18 63.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.774 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -84.53 -48.2 9.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.391 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 84' ' ' GLY . 18.7 p -50.85 -54.6 22.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.395 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -51.69 -34.74 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.385 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -57.98 -39.8 79.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -68.09 -38.51 82.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.408 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.0 p -65.08 -50.57 65.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 31.8 ttm -50.09 -39.58 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -45.44 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.492 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 19.0 tt0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.712 0.291 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -100.6 12.24 37.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.9 mt -121.69 79.39 39.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.062 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 119' ' ' TRP . 53.4 Cg_exo -48.66 -5.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.534 2.156 . . . . 0.0 111.968 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 tp -54.19 -31.8 53.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.32 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 32.3 p-10 -97.0 -42.79 7.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.268 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 26.0 ttpp -72.29 -45.78 58.58 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.895 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' PRO . 57.9 t-105 -71.1 -18.82 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.182 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -133.26 75.14 71.25 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.4 -26.65 3.93 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.779 2.319 . . . . 0.0 111.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -61.62 -54.35 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.013 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 t -98.09 59.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.748 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -169.37 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 125' ' ' VAL . 10.6 p -60.96 127.47 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.418 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.4 160.58 14.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -166.14 99.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.79 -174.99 22.82 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.421 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -88.55 154.06 20.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.421 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -101.4 133.16 46.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.12 -4.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.928 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 12.4 tm-20 -67.93 150.95 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 19.6 ttm180 -85.82 126.84 34.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 110.538 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.25 -26.09 5.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -175.55 135.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 4.1 p30 -135.43 159.55 41.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.366 0.603 . . . . 0.0 112.135 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 138' ' ' LEU . 12.8 t80 -123.54 137.79 54.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.062 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.553 HD13 ' CE2' ' A' ' 137' ' ' PHE . 3.1 mp 54.38 17.1 1.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.521 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.35 13.78 61.16 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.72 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.434 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 13.8 mt -119.12 145.0 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 4.0 mp0 -75.9 148.09 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.4 mtt -50.18 -57.28 13.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.1 Cg_exo -37.34 -38.67 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.351 2.034 . . . . 0.0 111.923 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -73.07 -46.81 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.204 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.5 m95 -60.77 -57.52 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 tt -43.55 -41.01 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.668 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.5 tt -57.38 -34.95 69.39 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.35 -43.66 95.56 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.612 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -72.85 -38.35 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -46.98 64.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 0.0 109.707 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.48 -49.49 83.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -57.72 -48.82 78.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.43 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.0 m-85 -59.15 -44.65 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.444 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.3 OUTLIER -69.64 -30.71 68.48 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.298 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.24 -36.69 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.722 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.2 t -62.12 -43.31 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' SD ' ' A' ' 74' ' ' MET . . . -61.71 -48.42 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 154' ' ' LEU . 83.3 t -52.17 -39.24 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.038 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.18 -41.42 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.7 t -59.26 -27.52 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 0.0 110.91 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.86 -44.66 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 162' ' ' ILE . 88.2 mt -69.17 -8.92 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.509 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 m . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.616 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.874 0.369 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -38.86 70.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.401 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.38 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.281 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.22 -42.0 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.695 HD21 ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -65.37 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.238 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -74.29 -50.08 20.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.89 71.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.8 m -76.8 -37.36 55.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.695 ' NE2' HD21 ' A' ' 6' ' ' ASN . 0.7 OUTLIER -73.22 6.94 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.45 144.65 16.0 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -69.71 -49.15 56.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.732 0.301 . . . . 0.0 110.727 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.16 -46.12 6.42 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.26 85.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -59.19 -42.31 90.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.84 -28.95 69.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.051 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.54 -33.99 71.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.623 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.3 mtt -69.96 -33.35 71.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -51.8 35.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.669 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -50.05 -44.05 51.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.851 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -60.25 -62.0 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' O ' ' OE1' ' A' ' 26' ' ' GLU . . . -50.56 -29.45 10.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -37.5 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.418 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.38 -36.2 61.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.0 mp -66.68 -37.37 84.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.716 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 3.1 mp0 -66.45 -46.02 77.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.497 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.45 -56.73 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 24' ' ' ALA . 34.3 p -46.97 -44.81 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.722 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.71 -42.79 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.961 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.38 -19.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.953 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -92.36 -36.25 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.748 0.309 . . . . 0.0 110.48 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -44.07 58.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.133 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.93 -29.98 70.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -76.69 -13.02 60.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.587 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.03 -51.82 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.3 mmt -89.36 8.91 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER 46.95 49.06 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.254 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 mt -82.45 155.25 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -124.34 95.58 43.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.36 140.02 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.389 2.059 . . . . 0.0 112.08 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.9 t -95.78 -168.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' CB ' ' A' ' 126' ' ' ALA . 59.2 t -65.67 -44.86 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.98 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -70.84 -50.13 38.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.745 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 p -50.05 -51.17 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.46 -39.27 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.308 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -57.2 -45.36 83.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.85 -36.86 75.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.168 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -64.01 -33.81 76.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.022 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.66 80.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.89 77.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.383 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.416 HD12 ' HB1' ' A' ' 22' ' ' ALA . 1.5 mm? -76.51 -49.21 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.056 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -46.31 -40.1 11.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.496 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.61 -45.36 85.43 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 72.3 t -62.17 -45.45 98.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.187 0.518 . . . . 0.0 109.729 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.7 -46.73 10.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.586 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.15 -36.72 93.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -61.13 -44.91 96.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.629 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tp -78.17 -29.9 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.5 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -83.3 -40.18 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.77 -34.19 66.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.72 4.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.9 mt -87.46 -25.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB1' ' OG1' ' A' ' 67' ' ' THR . . . -175.51 67.45 0.26 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.39 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.2 15.92 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.679 2.253 . . . . 0.0 112.116 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -115.65 -4.05 12.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.111 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.12 163.17 19.71 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -39.97 -15.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.505 2.136 . . . . 0.0 112.255 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 mm? -41.81 -34.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.79 -70.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.536 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.497 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.2 m-85 -48.35 -36.21 14.03 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.792 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -65.65 -45.7 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.63 -33.36 41.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.265 0.555 . . . . 0.0 110.295 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.488 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 10.4 mmt -65.62 -20.51 66.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.1 t -53.36 -34.67 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.0 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.3 mt -89.31 -32.25 5.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.205 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.517 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.3 t-105 -63.64 -51.41 65.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.997 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tp -69.11 -44.54 72.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -45.79 -46.51 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.174 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.8 p -78.5 -19.72 52.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.669 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.787 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.75 -59.45 5.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -74.72 -49.76 19.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.618 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -71.83 -40.23 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.814 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.47 -49.16 81.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 81' ' ' ALA . 33.5 m -72.74 -47.4 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.746 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.55 ' N ' HG23 ' A' ' 85' ' ' VAL . 21.1 tt0 -50.72 -24.9 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 0.0 109.945 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 tt -81.44 -40.56 23.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.434 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.614 ' CG2' HD21 ' A' ' 147' ' ' LEU . 66.7 p -53.95 -25.64 21.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 110.085 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -52.07 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -56.95 -32.82 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.462 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 7.2 t-80 -71.73 -44.58 63.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -65.99 -52.22 51.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.408 ' N ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -57.45 -50.9 71.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -53.59 -33.4 54.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.823 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 109.911 179.624 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 1.8 pm0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.637 0.256 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -101.21 -6.27 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.645 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.2 mt -123.61 78.91 55.56 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.986 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 45.5 Cg_exo -52.22 1.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.612 2.208 . . . . 0.0 112.194 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.593 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.0 tp -62.4 -29.31 70.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.551 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.4 OUTLIER -97.43 -41.18 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.443 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -75.29 -45.73 37.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.473 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.7 t90 -68.62 -17.67 64.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.203 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 116' ' ' LEU . 4.3 p -161.13 79.42 2.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.996 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.02 -2.05 11.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.043 2.495 . . . . 0.0 111.785 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.409 ' O ' ' NE2' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -49.05 -47.96 44.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.776 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.96 54.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -157.15 -41.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.408 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 125' ' ' VAL . 14.3 p -54.43 128.9 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.66 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -97.78 150.41 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.776 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.4 t -167.82 110.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.476 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.02 -172.81 21.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.2 m-20 -87.08 139.1 30.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.211 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 28.6 m -93.16 131.09 38.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 87.38 -1.9 0.56 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.326 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.01 128.48 36.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.035 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -80.17 129.23 34.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -122.49 -15.49 7.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.62 144.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.02 159.26 42.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.553 . . . . 0.0 112.0 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.418 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.9 t80 -112.23 136.85 51.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.82 16.84 0.12 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.38 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.429 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 92.71 22.52 28.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 139' ' ' GLY . 4.7 mp -122.89 133.83 54.4 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 109.977 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.85 146.37 54.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.416 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.5 mtt -46.96 -52.65 31.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.722 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 142' ' ' MET . 77.0 Cg_exo -44.45 -35.63 8.83 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.329 2.019 . . . . 0.0 112.232 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.446 HE21 ' N ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -70.51 -52.51 21.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.457 . . . . 0.0 109.995 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.632 ' O ' ' N ' ' A' ' 148' ' ' GLY . 83.0 m95 -59.35 -56.97 15.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.125 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tt -43.26 -38.21 2.48 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.614 HD21 ' CG2' ' A' ' 88' ' ' THR . 0.5 OUTLIER -60.47 -34.06 73.49 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.96 -41.9 98.07 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.437 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.07 -27.93 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.086 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.513 ' O ' HD13 ' A' ' 154' ' ' LEU . 10.4 t80 -61.49 -48.47 80.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 tp -69.15 -37.2 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.26 67.34 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.025 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.1 -41.17 99.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.864 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 150' ' ' PHE . 6.5 mp -51.93 -32.41 32.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.1 mm -82.08 -38.7 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 160' ' ' VAL . 79.0 t -52.11 -36.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.319 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.517 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.27 -47.16 15.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 154' ' ' LEU . 72.0 t -58.67 -37.67 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.097 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -80.01 -40.23 28.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.3 t -68.48 -26.26 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.855 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 157' ' ' ALA . 43.3 t -79.32 -49.0 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 162' ' ' ILE . 74.7 mt -65.8 -13.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 83.2 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 -179.845 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 19.1 ttp180 -57.49 -27.93 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.202 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.4 -42.64 58.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.074 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.3 mm? -50.76 -41.19 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.498 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.509 ' C ' ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -71.98 -26.41 62.23 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.512 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.77 -49.46 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.623 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.03 77.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -76.74 -32.63 57.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -70.1 2.25 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.88 149.75 19.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -71.98 -49.72 34.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.448 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.15 -45.49 6.27 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -58.82 -45.32 90.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.026 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.7 -28.28 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.99 -30.75 68.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.439 ' O ' ' OG1' ' A' ' 21' ' ' THR . 27.2 tpp -72.13 -33.56 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.906 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -51.81 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -51.41 -52.03 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -49.66 -47.76 49.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -43.31 86.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.34 -41.3 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.89 -35.32 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.378 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' OG1' ' A' ' 28' ' ' THR . 35.4 mt -75.71 -39.6 57.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.487 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -64.82 -52.73 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -57.33 -42.04 81.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.644 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 24' ' ' ALA . 11.7 p -60.67 -42.25 96.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.124 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.95 -19.82 65.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.294 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -94.46 -37.7 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 110.843 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -55.41 -46.7 76.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.404 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -71.62 -40.45 69.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.693 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 45.7 t-80 -61.38 -15.02 32.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.1 t -108.84 -44.77 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.42 5.34 27.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.98 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt 48.34 48.98 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.715 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.4 mt -85.06 154.83 21.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.574 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -116.15 119.15 37.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.245 1.964 . . . . 0.0 112.022 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.447 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 3.9 t -127.19 -177.21 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.527 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.8 p -66.57 -34.93 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 0.0 110.401 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.52 -48.5 55.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.306 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 p -48.46 -50.77 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.1 mt -61.56 -38.43 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -60.52 -44.3 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.838 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.4 tp10 -61.75 -47.88 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 -50.6 -42.79 56.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.917 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.92 74.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 47' ' ' GLU . . . -56.26 -44.62 79.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.928 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.41 -50.83 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.043 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -39.49 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.25 -45.4 80.85 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.32 -43.74 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.559 . . . . 0.0 109.533 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.03 -49.42 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.362 179.078 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.12 92.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -29.3 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.5 -37.29 71.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.479 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -74.06 -23.76 59.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.357 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -84.19 -46.81 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.39 73.82 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.05 5.42 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.726 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 97.8 mt -80.44 -32.86 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.69 72.95 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.63 27.6 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.547 2.165 . . . . 0.0 111.68 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 64' ' ' ALA . 16.5 tttm -113.34 -10.71 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.933 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.42 162.6 19.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.654 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -39.05 -14.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.705 2.27 . . . . 0.0 112.665 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' THR . 44.4 mt -45.07 -28.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.699 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.2 OUTLIER -40.87 -70.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.547 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.566 ' O ' HG23 ' A' ' 75' ' ' VAL . 43.3 m-85 -51.03 -33.26 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.909 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.22 -45.45 89.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -36.13 26.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.625 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -62.73 -23.68 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.402 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.7 t -53.01 -31.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.407 0.622 . . . . 0.0 109.873 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.2 mt -88.86 -34.32 6.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.587 ' CD1' HD13 ' A' ' 154' ' ' LEU . 2.9 t-105 -65.34 -53.15 47.87 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 81' ' ' ALA . 4.8 mt -63.2 -47.96 80.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.666 0.27 . . . . 0.0 110.607 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -42.73 -43.31 3.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.256 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.659 ' OG ' HD11 ' A' ' 154' ' ' LEU . 19.0 p -77.66 -21.27 52.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.831 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 154' ' ' LEU . . . -59.7 -60.61 3.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.45 -53.66 15.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.01 -48.41 53.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.581 ' O ' HG23 ' A' ' 88' ' ' THR . . . -55.89 -47.26 80.51 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.97 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.88 -32.43 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.542 0.211 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -72.06 -47.07 54.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.062 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.48 -49.91 43.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.674 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 84' ' ' GLY . 13.2 p -46.39 -48.42 18.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.441 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' THR . 50.4 t80 -57.29 -44.94 84.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.296 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -43.71 -42.06 5.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 109.987 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.02 -34.68 73.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.97 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 89' ' ' TYR . 10.1 m -62.24 -50.1 73.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.302 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ttt -56.48 -36.78 69.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.933 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -70.13 -36.9 75.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.52 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 48.5 tt0 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.509 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.651 0.262 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -124.62 -1.01 8.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.624 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 116' ' ' LEU . 53.3 mt -126.59 85.58 60.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.46 5.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.872 2.381 . . . . 0.0 112.745 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.619 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.0 mt -58.04 -31.41 66.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.78 -40.08 8.72 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.997 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.5 -45.54 90.24 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.39 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -79.6 -13.01 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.856 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.81 68.93 24.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.907 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.451 ' O ' HG23 ' A' ' 125' ' ' VAL . 7.5 Cg_exo -69.98 -20.04 34.29 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.813 2.342 . . . . 0.0 111.508 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.64 -53.49 57.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.344 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.54 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 4.0 t -101.94 54.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 6.3 m-85 -161.22 -46.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 121' ' ' PRO . 77.2 t -55.32 129.44 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.74 152.18 19.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.662 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 101.78 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.733 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.79 176.41 14.92 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -83.13 160.47 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.8 m -107.84 128.96 55.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.4 -8.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.726 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE2' ' N ' ' A' ' 129' ' ' ASP . 8.0 pt-20 -67.87 148.91 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.933 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -85.54 136.51 33.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -125.59 -31.17 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.407 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 39.8 t-105 -174.82 141.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 135' ' ' TRP . 3.6 m-20 -134.62 161.28 35.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.325 0.583 . . . . 0.0 112.161 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.415 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -118.98 136.67 53.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.517 178.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 49.13 16.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.479 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.415 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 93.85 19.75 33.25 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.227 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.1 144.05 51.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.06 0.43 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.52 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 50.8 mt-10 -70.38 145.95 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.424 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 2.1 mmt -44.03 -61.93 1.76 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -34.97 -36.45 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.618 2.212 . . . . 0.0 112.238 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -69.57 -58.32 4.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.045 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.9 m95 -55.31 -57.38 12.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.6 tt -43.45 -35.52 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.126 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.37 -35.13 78.19 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.57 -48.27 85.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.677 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -71.87 -33.28 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.02 -44.08 87.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.46 -43.33 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.47 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -60.65 -49.99 75.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.11 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -57.37 -48.24 79.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 0.0 111.058 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.659 HD11 ' OG ' ' A' ' 80' ' ' SER . 4.5 mm? -66.98 -34.93 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.607 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 -36.73 37.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.199 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 152' ' ' ALA . 14.9 t -54.66 -48.74 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -61.19 -48.69 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 154' ' ' LEU . 76.7 t -48.9 -39.43 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 33.5 mt -78.38 -24.6 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.04 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 156' ' ' VAL . 56.1 t -77.92 -22.7 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 110.718 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.24 -49.59 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.7 mt -64.48 -25.69 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.72 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.6 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 0.0 110.403 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.845 0.355 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -51.3 -39.34 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.391 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -66.1 -44.92 82.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.2 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -39.65 12.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -69.45 -24.96 63.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.315 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tm0? -80.39 -48.22 13.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.56 69.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.522 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 p -76.79 -34.48 57.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.684 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.418 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 1.9 tp-100 -70.96 6.37 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 141.08 15.15 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.75 -20.64 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.738 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.43 -44.2 74.59 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -51.33 66.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -53.76 -43.9 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mt -70.26 -30.28 67.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.05 -36.64 77.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.604 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.58 -34.49 75.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.27 37.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.394 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -50.63 -36.87 37.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.728 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.11 -56.72 14.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.778 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.71 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.658 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 tt -84.21 -42.39 15.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.27 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.55 -34.61 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.35 -52.84 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.83 -52.28 60.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 p -51.23 -38.9 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.15 -34.14 68.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.46 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.28 -22.75 67.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.756 0.312 . . . . 0.0 110.426 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -85.03 -28.81 25.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -45.56 94.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.99 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.413 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 11.1 pt20 -66.95 -27.46 67.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -83.17 -13.34 55.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.981 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.32 -33.13 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.132 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' MET . 14.3 ttm -109.21 6.63 24.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.153 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 mt 48.92 51.35 16.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.046 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 8.6 mt -81.81 154.54 25.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 127' ' ' SER . 42.3 mttp -120.24 93.76 48.28 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.5 131.11 27.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.509 2.139 . . . . 0.0 112.022 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -89.8 -171.14 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 43' ' ' LEU . 8.6 p -62.22 -41.65 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.8 mp -58.89 -45.44 90.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -48.45 -42.54 32.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -62.48 -42.22 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 110.12 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -65.83 -46.45 78.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.503 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -50.36 67.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.366 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -58.76 -30.77 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.72 68.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' ' CZ ' ' A' ' 150' ' ' PHE . . . -59.22 -48.81 80.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.62 -52.78 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.246 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -44.66 -40.19 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.74 87.93 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.44 -46.36 93.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mt -44.05 -46.09 8.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.427 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.19 -41.64 98.26 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.31 -44.38 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.512 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.3 -32.61 73.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 8.6 mt -73.33 -26.45 61.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mm -82.08 -35.33 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.351 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.16 80.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.81 5.71 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.695 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.5 mp -82.85 -35.12 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.426 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -179.83 73.23 0.18 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.206 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 53.0 Cg_endo -72.56 23.3 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.533 2.155 . . . . 0.0 112.055 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 12.1 ttpt -113.8 -6.49 13.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -114.12 159.44 36.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.894 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -38.15 -18.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.628 2.219 . . . . 0.0 112.442 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.5 mp -41.34 -32.6 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.572 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 161' ' ' VAL . 34.8 mtp180 -39.76 -65.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.663 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.02 -32.49 46.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -66.0 -45.23 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.819 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.29 63.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.657 0.742 . . . . 0.0 109.129 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.533 ' SD ' ' O ' ' A' ' 74' ' ' MET . 11.0 tmm? -56.96 -11.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.14 -44.17 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.29 0.567 . . . . 0.0 111.394 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.05 -32.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.442 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.776 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 9.9 t90 -61.22 -53.17 60.31 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.588 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' CE3' ' A' ' 77' ' ' TRP . 20.9 tp -58.31 -53.67 55.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -43.82 -46.07 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.667 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -80.71 -27.31 36.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.01 -60.84 3.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.004 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -73.47 -55.69 6.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -66.93 -45.48 77.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.04 93.51 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -69.91 -53.18 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.531 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -47.6 -25.71 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 109.948 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 tp -78.09 -39.67 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.32 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.4 p -54.58 -29.52 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.355 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.44 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.5 OUTLIER -70.77 -52.46 20.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.856 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.09 -32.61 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -75.22 -34.97 61.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.772 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.462 HG22 HE22 ' A' ' 144' ' ' GLN . 17.6 p -72.05 -47.75 49.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.542 ' N ' ' SD ' ' A' ' 93' ' ' MET . 0.0 OUTLIER -53.62 -53.87 45.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.554 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.72 -43.97 97.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.617 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.203 179.84 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.597 0.237 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.653 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -85.09 -6.21 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 110.36 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.613 ' C ' ' H ' ' A' ' 116' ' ' LEU . 12.0 mt -120.35 83.41 33.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.41 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 39.1 Cg_exo -54.0 11.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.79 2.326 . . . . 0.0 112.802 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.1 mt -75.16 -29.15 60.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.542 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 1.1 t70 -96.24 -40.22 9.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.805 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -67.87 -40.61 83.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.41 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.4 t90 -81.67 -16.02 52.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.45 74.15 20.2 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.68 -17.27 11.22 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.856 2.371 . . . . 0.0 111.841 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -51.71 -52.44 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 m -112.66 60.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.641 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.542 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 2.0 t80 -164.92 -40.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.329 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.4 125.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.81 146.56 23.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' LYS . 16.2 p -155.1 144.79 21.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.88 -175.71 38.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.477 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.1 m-20 -84.64 144.76 28.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.744 0.307 . . . . 0.0 110.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 32.8 m -92.72 132.65 36.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.963 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.88 -3.27 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.452 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.92 128.3 36.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.826 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -76.93 134.95 38.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -128.06 -19.63 3.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TRP . . . . . 0.586 ' NE1' ' SD ' ' A' ' 142' ' ' MET . 6.7 p90 -172.95 149.6 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.228 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.11 166.89 24.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.28 0.562 . . . . 0.0 111.87 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -122.8 138.41 54.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.38 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.57 17.04 0.51 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.411 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.2 21.65 44.51 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.0 mt -126.34 137.67 53.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 143.7 55.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.25 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.586 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -48.1 -53.36 33.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.3 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.3 Cg_exo -40.95 -35.81 1.85 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.33 2.02 . . . . 0.0 111.863 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.462 HE22 HG22 ' A' ' 92' ' ' THR . 73.6 mm-40 -71.71 -49.64 37.6 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.619 ' O ' ' N ' ' A' ' 148' ' ' GLY . 79.5 m95 -59.17 -56.73 18.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.908 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -43.91 -38.54 3.45 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -58.74 -35.19 72.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.08 -47.04 93.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.583 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.7 mp -65.96 -43.67 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.52 ' CZ ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -49.04 -40.27 30.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.3 mt -65.38 -38.51 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.715 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 149' ' ' ILE . . . -52.99 -49.71 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.991 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.08 -45.71 93.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.563 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 158' ' ' VAL . 13.2 tp -47.97 -32.64 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.391 0.615 . . . . 0.0 109.844 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.0 mt -83.0 -37.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.292 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.0 t -52.61 -46.35 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.776 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.88 -44.17 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.548 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 154' ' ' LEU . 43.0 t -50.16 -40.66 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.11 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.24 -42.15 14.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.477 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 156' ' ' VAL . 55.6 t -64.68 -38.26 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.208 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.539 ' O ' ' NH2' ' A' ' 70' ' ' ARG . 63.8 t -71.75 -53.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 109.945 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.502 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.3 mp -66.46 -5.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.185 179.657 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mmt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 2' ' ' LEU . 3.8 mm? -63.95 -39.27 93.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.205 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -54.25 -36.42 63.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.623 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' GLN . 43.2 m-85 -72.25 -44.31 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.57 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -45.69 -42.9 12.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.85 0.357 . . . . 0.0 110.095 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -68.33 -25.4 65.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.19 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 4' ' ' PHE . 3.4 tp-100 -78.79 -48.77 14.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.447 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.42 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 11' ' ' GLY . 39.1 p -76.7 -41.02 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.4 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -69.03 6.55 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.139 0.495 . . . . 0.0 110.304 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -100.21 140.8 15.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -68.9 -49.2 60.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.673 0.273 . . . . 0.0 110.846 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.95 -46.07 6.08 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.62 -47.12 85.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.794 0.33 . . . . 0.0 110.114 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -56.88 -47.1 81.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.55 -27.94 68.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.14 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.24 -36.41 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 mmt -68.4 -34.03 75.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.202 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.11 73.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.909 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -60.08 -34.14 73.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.978 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 42.9 m -59.68 -58.98 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.626 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.17 -25.67 65.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.306 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -77.33 -42.11 37.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.279 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' O ' HG23 ' A' ' 28' ' ' THR . . . -61.39 -24.34 66.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.454 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.19 -45.4 10.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.454 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.0 -37.74 88.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.756 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tp -75.69 -51.42 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.925 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 24' ' ' ALA . 5.6 p -47.25 -37.15 10.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.935 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.91 27.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.884 -0.327 . . . . 0.0 110.815 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.1 -15.83 2.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.438 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.3 t-105 -94.46 -33.4 13.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.821 0.343 . . . . 0.0 110.545 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.99 -38.45 79.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.482 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -72.13 -39.2 68.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.579 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.78 -8.42 55.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.511 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 31' ' ' TRP . 78.9 t -108.99 -46.48 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.802 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 2.8 mmt -96.2 14.43 24.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.744 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt 43.01 42.63 3.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.7 mt -70.01 154.98 41.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.115 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -111.56 103.28 54.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.108 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -52.1 167.84 0.45 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.154 1.903 . . . . 0.0 111.545 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.616 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.8 175.4 9.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.422 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.616 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 21.5 t -61.7 -48.31 89.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.056 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 9.8 mp -61.34 -45.51 94.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.14 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -49.09 -44.73 42.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.429 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.622 HD13 ' O ' ' A' ' 124' ' ' PHE . 69.6 mt -61.45 -43.82 97.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 110.094 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -47.11 73.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.597 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.397 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' NH2' ' CD1' ' A' ' 52' ' ' PHE . 3.8 tmt_? -62.63 -37.66 87.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.548 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.34 78.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.692 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -59.13 -48.36 81.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.817 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.8 tp -79.56 -50.3 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CD1' ' NH2' ' A' ' 48' ' ' ARG . 66.2 t80 -46.23 -41.48 12.95 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.759 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.93 -44.2 89.47 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 50' ' ' ALA . 47.5 t -62.61 -47.3 93.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.3 tp -44.62 -48.09 10.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.523 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.43 -47.08 92.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.97 -36.86 63.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.446 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.72 76.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.352 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.7 mt -77.0 -27.09 54.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.45 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.9 mt -81.8 -43.48 19.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.397 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.79 -32.94 78.85 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.85 4.67 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.715 0.293 . . . . 0.0 110.944 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.7 mt -83.33 -26.49 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.67 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB1' ' OG1' ' A' ' 67' ' ' THR . . . -173.23 65.48 0.33 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.433 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.16 11.14 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.648 2.232 . . . . 0.0 112.095 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -111.04 -6.47 14.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.25 161.89 24.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.639 179.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -38.16 -16.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.554 2.169 . . . . 0.0 112.287 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 2.4 tp -43.22 -31.47 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -40.79 -65.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.642 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.583 ' O ' HG13 ' A' ' 75' ' ' VAL . 6.7 m-85 -55.69 -29.89 60.16 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.557 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.67 ' O ' HG22 ' A' ' 75' ' ' VAL . 12.2 t -67.6 -43.11 87.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.639 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.69 -29.06 30.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.275 0.559 . . . . 0.0 109.955 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.7 ttt -65.25 -12.97 57.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 72' ' ' VAL . 30.3 m -59.71 -37.15 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 121.524 0.678 . . . . 0.0 110.537 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' N ' HG23 ' A' ' 75' ' ' VAL . 8.3 mt -89.27 -30.05 5.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.215 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.472 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 2.5 t-105 -68.6 -49.72 57.17 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.995 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.554 ' O ' HD23 ' A' ' 78' ' ' LEU . 3.9 tt -66.53 -50.61 62.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 110.285 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 3.0 m-85 -43.69 -39.98 3.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 p -79.71 -23.81 42.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.75 -61.77 2.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.804 0.335 . . . . 0.0 111.159 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.73 -51.95 12.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.085 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.549 ' HE ' HD23 ' A' ' 87' ' ' LEU . 5.3 tpm_? -68.51 -47.87 65.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.656 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.92 -46.11 92.87 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.481 -0.866 . . . . 0.0 110.965 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.41 -37.69 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 122.796 -0.238 . . . . 0.0 111.472 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -67.98 -25.41 65.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.189 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.549 HD23 ' HE ' ' A' ' 83' ' ' ARG . 3.6 mm? -90.21 -35.36 15.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.892 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.6 p -57.33 -52.53 64.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.911 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -48.93 -49.85 38.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.383 . . . . 0.0 110.376 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -51.91 -42.73 62.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -67.04 -34.49 77.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.8 p -74.48 -29.92 61.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.571 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 97' ' ' TYR . 20.4 mmt -64.24 -41.18 97.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.356 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.72 -51.15 61.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.431 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.437 ' O ' ' OE1' ' A' ' 95' ' ' GLN . 0.4 OUTLIER -57.2 -48.02 79.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.171 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.2 mt -74.26 -22.67 59.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.416 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 98' ' ' PRO . 17.2 t80 -138.56 70.02 45.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.433 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 97' ' ' TYR . 42.8 Cg_exo -53.6 -159.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.826 2.351 . . . . 0.0 112.228 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p 175.09 152.5 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.16 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -37.77 154.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.694 2.263 . . . . 0.0 112.372 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -78.58 37.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.579 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.3 -45.34 26.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.537 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 104' ' ' SER . 20.4 m -47.98 -21.49 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 103' ' ' THR . 49.4 p 58.81 129.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -156.11 142.78 18.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' CD2' ' N ' ' A' ' 107' ' ' MET . 5.6 p90 -159.33 -142.31 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.463 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.573 ' N ' ' CD2' ' A' ' 106' ' ' PHE . 33.0 mtt -56.08 134.62 52.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.499 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 108' ' ' VAL . 12.6 p -70.18 131.99 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.624 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -86.03 99.85 11.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.249 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -64.64 150.31 94.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.54 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.64 160.18 50.72 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.732 2.288 . . . . 0.0 111.907 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -108.07 8.45 28.2 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.646 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -125.22 -5.7 7.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -123.02 81.58 50.88 Favored Pre-proline 0 C--N 1.331 -0.198 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.462 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 36.1 Cg_exo -56.55 15.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.826 2.351 . . . . 0.0 112.671 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.616 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.5 OUTLIER -76.28 -32.35 58.76 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.013 0.435 . . . . 0.0 110.253 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 1.1 m-20 -98.4 -40.28 8.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.347 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -71.24 -45.35 63.44 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.018 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 9.9 t-105 -76.76 -10.37 59.33 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.39 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.02 68.99 35.47 Favored Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.925 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.75 -15.44 12.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.867 2.378 . . . . 0.0 111.668 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -53.08 -32.15 45.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.627 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 44.71 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.622 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -148.57 -36.87 0.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.436 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.2 p -58.73 127.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.694 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.27 152.91 18.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.31 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.1 m -155.08 102.39 2.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.857 0.36 . . . . 0.0 110.506 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 127.14 -168.07 19.38 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -101.3 154.1 19.07 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.631 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 36.3 m -99.01 138.78 35.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 111.204 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 101.04 -5.41 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.634 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.84 149.22 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -98.86 122.58 42.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.942 0.401 . . . . 0.0 110.735 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -105.55 -29.76 9.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.38 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -173.68 146.54 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.781 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.46 158.08 44.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.293 0.568 . . . . 0.0 112.106 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.406 ' C ' ' N ' ' A' ' 139' ' ' GLY . 13.4 m-85 -112.89 137.71 50.84 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.175 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 138' ' ' LEU . 2.7 mm? 48.61 17.44 0.14 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.425 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.62 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 92.61 22.3 29.18 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.223 -0.513 . . . . 0.0 111.995 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 139' ' ' GLY . 2.1 mm? -125.43 140.51 52.72 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.614 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 5.2 mp0 -72.41 146.56 46.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.726 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.3 mtt -47.24 -56.42 12.43 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.811 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -40.95 -38.58 2.94 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.565 2.176 . . . . 0.0 112.672 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -70.14 -51.8 28.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.339 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.566 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.9 m95 -58.79 -56.64 19.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 12.9 tp -43.69 -38.29 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.1 tt -59.54 -36.82 76.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.98 -46.48 94.5 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.7 mt -75.09 -25.63 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.015 0.436 . . . . 0.0 110.061 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -63.36 -44.03 95.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.765 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 151' ' ' ILE . 4.8 tt -70.23 -36.83 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.578 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -56.0 -48.75 75.3 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.187 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -61.55 -40.42 94.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.686 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 81' ' ' ALA . 86.7 mt -64.36 -32.42 74.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.924 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.41 -29.65 15.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.879 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 160' ' ' VAL . 43.1 t -63.38 -40.14 87.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.34 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -70.08 -50.03 45.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 154' ' ' LEU . 92.4 t -51.62 -39.25 23.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.091 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.1 tp -81.18 -37.35 28.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.14 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.5 t -71.0 -22.48 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.795 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 157' ' ' ALA . 61.6 t -83.12 -48.29 17.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.0 110.24 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.421 ' O ' HG22 ' A' ' 162' ' ' ILE . 81.5 mt -69.16 -14.06 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.72 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.9 m -52.91 -14.27 0.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.62 ' C ' ' H ' ' A' ' 166' ' ' PHE . 61.7 tt0 -40.07 104.04 0.31 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.59 2.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.234 1.956 . . . . 0.0 112.276 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.62 ' H ' ' C ' ' A' ' 164' ' ' GLN . 62.5 m-85 56.73 -95.2 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.434 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.5 pttp -163.61 -11.13 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.643 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.69 66.29 9.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.459 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -76.06 -143.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.746 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 172' ' ' ASP . 16.3 pttm -158.51 -1.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.536 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.408 ' H ' ' H ' ' A' ' 170' ' ' LYS . 10.4 tpp85 65.08 -68.49 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.51 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 170' ' ' LYS . 5.5 m-20 -158.06 168.72 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.691 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 173' ' ' LEU . 3.5 mm? -75.41 158.36 32.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.404 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -83.39 138.6 33.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.511 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 69.32 79.51 0.29 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -91.95 -76.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 0.0 110.365 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -99.18 -51.33 1.35 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.694 ' CD2' ' H ' ' A' ' 179' ' ' HIS . 45.1 t60 59.45 -136.69 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 0.0 110.574 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.694 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 34.4 t-80 -81.45 99.03 8.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.638 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -161.47 91.69 0.85 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.555 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 -58.7 -176.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 32.4 m170 54.24 82.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.518 ' ND1' ' O ' ' A' ' 183' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.491 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.7 -47.81 81.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.344 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -49.64 -48.91 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.404 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -52.83 -45.6 67.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.277 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.5 tp -48.78 -43.76 38.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.126 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -69.56 -26.36 64.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.076 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -75.96 -50.49 14.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.28 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.81 70.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 11' ' ' GLY . 50.4 p -76.85 -41.57 43.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -68.28 5.66 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.419 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.75 140.98 15.12 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -70.19 -49.9 45.61 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.615 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.73 -46.42 5.91 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -46.45 89.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.101 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -61.58 -37.17 82.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.05 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -66.1 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.138 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 21' ' ' THR . 6.8 tp -70.31 -30.0 66.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.752 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.423 ' O ' ' OG1' ' A' ' 21' ' ' THR . 31.2 mtp -73.41 -33.69 65.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.12 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.89 -55.3 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.53 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -47.03 -47.92 22.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 17' ' ' LEU . 31.5 p -53.48 -58.02 8.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.379 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -48.14 -34.65 10.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.8 tp -76.32 -41.97 46.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.21 -32.14 35.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.293 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -78.57 -37.32 42.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.138 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.13 -52.84 62.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.821 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.26 -50.24 74.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.747 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 24' ' ' ALA . 17.1 p -48.59 -44.06 36.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.861 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.34 -46.21 34.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.034 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -53.15 -19.57 3.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.534 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -92.27 -39.41 11.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.328 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.61 -30.85 14.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.167 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -83.77 -42.1 16.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.011 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.414 ' CE1' HD12 ' A' ' 30' ' ' LEU . 36.0 m170 -69.09 -14.49 63.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 36' ' ' MET . 9.2 p -109.11 -39.22 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.899 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.445 ' N ' HG13 ' A' ' 35' ' ' VAL . 1.1 tpt -97.23 11.55 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.867 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.632 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.2 mp 43.85 44.97 6.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.199 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 134' ' ' GLN . 5.3 tp -77.6 153.0 33.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -108.78 129.85 23.45 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.691 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.27 169.17 21.8 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.468 2.112 . . . . 0.0 112.184 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -131.95 159.57 38.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.561 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.554 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -50.82 -42.38 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.155 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 mp -64.88 -45.13 87.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.239 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 74.5 m -51.08 -42.83 60.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.495 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 124' ' ' PHE . 33.3 mt -66.21 -43.1 92.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.241 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -58.85 -44.91 91.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.757 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -59.07 -49.7 76.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -59.11 -30.09 67.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.131 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.11 -38.98 82.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.347 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -57.43 -49.73 75.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.649 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.07 -49.27 15.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.41 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -46.1 -41.34 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.98 -42.39 92.68 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 57' ' ' ALA . 54.5 t -64.97 -47.61 87.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.935 0.398 . . . . 0.0 109.975 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.8 tt -45.21 -44.87 11.38 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.654 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.02 -37.01 94.0 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -63.97 -37.88 89.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.959 -0.621 . . . . 0.0 110.2 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.73 -34.17 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.31 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -75.72 -27.14 58.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.186 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.39 -40.43 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.471 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.64 -26.81 73.46 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.96 9.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.662 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 96.2 mt -82.08 -39.53 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.666 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.63 74.38 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.718 0.294 . . . . 0.0 110.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -77.31 26.8 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.701 2.267 . . . . 0.0 112.086 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -108.13 -9.02 15.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.309 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.564 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.8 175.85 1.71 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.686 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -48.65 -4.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.239 1.96 . . . . 0.0 112.047 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.8 mt -47.98 -35.45 10.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.513 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 58.8 mtt180 -40.83 -70.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.429 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.9 t80 -49.61 -20.22 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.171 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 69' ' ' LEU . 9.8 t -83.38 -46.56 18.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.806 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.85 -38.85 64.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 0.0 110.928 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -61.16 -9.51 4.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.86 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.529 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 8.0 t -57.87 -41.4 79.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.323 0.582 . . . . 0.0 109.989 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.0 mp -87.7 -32.62 6.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.468 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.549 ' HE1' ' HA ' ' A' ' 154' ' ' LEU . 2.2 t-105 -65.15 -51.68 59.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.168 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.7 tp -65.73 -47.52 75.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -44.07 -43.58 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.37 . . . . 0.0 110.231 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 p -78.74 -21.0 48.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.718 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.57 ' HA ' HD22 ' A' ' 154' ' ' LEU . . . -60.46 -60.51 3.69 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.853 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -73.75 -55.12 6.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.178 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttm-85 -65.57 -44.71 85.86 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 88' ' ' THR . . . -61.48 -45.49 96.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.426 -0.892 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 81' ' ' ALA . 66.1 t -73.18 -44.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.692 0.282 . . . . 0.0 111.622 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -41.62 96.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.305 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.4 tp -74.2 -45.37 48.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 84' ' ' GLY . 8.7 p -48.68 -49.36 38.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.892 0.377 . . . . 0.0 110.659 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -52.0 -38.5 57.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -56.88 -42.23 79.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.124 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.0 m170 -68.01 -37.55 81.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.434 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -67.27 -41.44 85.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.347 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.502 ' O ' ' N ' ' A' ' 97' ' ' TYR . 13.0 ttt -53.48 -48.45 68.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.224 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.12 -46.85 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.142 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -50.71 -41.32 56.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.132 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.0 mm? -91.17 -13.95 31.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.166 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' O ' ' O ' ' A' ' 98' ' ' PRO . 80.1 t80 -121.48 85.48 43.14 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.407 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 97' ' ' TYR . 50.8 Cg_exo -52.94 -140.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.746 2.297 . . . . 0.0 112.247 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 99' ' ' SER . 14.2 p 60.88 58.28 3.64 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.516 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.66 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.804 2.336 . . . . 0.0 112.041 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 73.21 99.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.361 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.5 114.89 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.7 m -96.58 -60.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.697 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.1 t -120.0 -65.45 1.16 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.611 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 106' ' ' PHE . 24.2 t0 60.87 -172.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.448 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.501 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 27.7 m-85 -147.5 76.21 1.39 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.571 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.561 ' C ' ' H ' ' A' ' 109' ' ' ARG . 7.9 mmt -85.9 128.8 34.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.589 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.7 t 61.39 -5.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.705 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 107' ' ' MET . 76.0 mtt85 -97.52 99.73 11.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.575 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 164.06 15.71 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.145 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -40.96 151.95 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.687 2.258 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.12 -9.71 14.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.555 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.619 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -110.26 -0.21 17.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.603 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.8 tp -126.46 77.49 72.91 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.139 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 42.2 Cg_exo -53.03 4.85 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.787 2.325 . . . . 0.0 112.436 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 114' ' ' LEU . 7.8 tp -61.38 -33.61 73.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.174 0.511 . . . . 0.0 109.978 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.53 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.3 OUTLIER -97.33 -43.88 7.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.528 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -66.95 -45.43 77.82 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.773 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.415 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -75.52 -11.75 60.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -138.36 70.51 46.69 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.701 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.7 -17.83 10.87 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.85 2.367 . . . . 0.0 111.884 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -57.44 -35.79 70.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.054 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.28 50.83 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.647 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.657 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -159.54 -35.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.595 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 125' ' ' VAL . 14.7 p -54.58 127.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.501 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.8 149.12 21.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.4 t -164.19 117.67 1.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.703 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.93 -169.28 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 130' ' ' CYS . 11.9 t70 -93.94 163.29 13.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 61.5 m -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.747 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.53 -4.37 0.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.209 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -67.56 128.52 36.76 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.759 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.472 ' CD ' ' H ' ' A' ' 133' ' ' ARG . 0.6 OUTLIER -62.24 111.8 2.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.196 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.611 ' HB3' HD11 ' A' ' 38' ' ' LEU . 61.3 mt-30 -111.53 -31.31 7.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.823 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -172.73 141.68 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.055 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -146.9 160.99 41.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.225 0.535 . . . . 0.0 111.897 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -122.84 139.51 53.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.293 -0.867 . . . . 0.0 108.942 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.08 17.52 1.44 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.574 -0.45 . . . . 0.0 109.823 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.31 22.61 51.01 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.26 135.41 52.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.837 0.351 . . . . 0.0 110.108 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.22 148.42 49.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.5 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.423 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 6.5 mtt -45.64 -60.33 3.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.35 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.5 Cg_exo -35.98 -37.62 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.68 2.253 . . . . 0.0 112.5 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -70.94 -50.46 34.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.997 0.427 . . . . 0.0 110.014 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.596 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.8 m95 -60.81 -56.85 16.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.842 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.413 ' CD1' H101 ' A' ' 201' ' ' UQ2 . 4.2 tt -43.35 -35.6 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.248 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.1 tp -65.4 -33.87 76.97 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.46 -46.78 93.71 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.2 mt -73.18 -38.8 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.686 ' CE2' HD11 ' A' ' 154' ' ' LEU . 26.2 t80 -50.88 -44.06 59.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.733 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.21 -40.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.023 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -55.72 -47.77 76.33 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.693 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -63.24 -46.2 88.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.04 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 150' ' ' PHE . 83.1 mt -61.7 -40.25 94.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.51 -40.38 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.464 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 152' ' ' ALA . 29.6 t -52.46 -43.29 41.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.397 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.505 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.81 -45.35 82.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.894 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 74.7 t -48.82 -36.78 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.937 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.09 -33.11 33.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.983 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 156' ' ' VAL . 91.7 t -76.32 -26.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.917 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.64 -50.54 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 164' ' ' GLN . 2.1 pp -65.68 -22.62 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.786 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.8 p -54.19 -4.82 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.654 HE21 ' N ' ' A' ' 165' ' ' PRO . 0.0 OUTLIER -117.56 148.19 42.4 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.477 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.654 ' N ' HE21 ' A' ' 164' ' ' GLN . 56.2 Cg_endo -70.64 52.52 1.29 Allowed 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.413 2.076 . . . . 0.0 111.96 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.65 ' N ' ' NE2' ' A' ' 164' ' ' GLN . 57.8 t80 41.26 -109.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.722 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 166' ' ' PHE . 66.6 tttt -169.76 98.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.674 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.44 -56.65 6.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -179.2 23.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.598 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -82.14 87.49 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.587 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -93.96 128.31 40.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.484 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -65.68 157.53 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.636 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.14 -168.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.546 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -123.55 143.8 49.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.511 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -85.27 -122.35 1.15 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 54.26 170.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.767 0.318 . . . . 0.0 110.538 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 74.19 7.8 77.97 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 8.7 m170 58.9 42.41 19.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 110.45 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -59.43 132.38 53.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.603 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.38 -56.03 4.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.532 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 62.33 150.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.56 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 51.32 66.02 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.587 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.439 ' H71' H5M1 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 tpt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.4 mt -66.3 -38.64 88.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.383 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -58.32 -38.74 77.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.49 ' O ' ' N ' ' A' ' 7' ' ' GLN . 32.9 t80 -69.42 -47.58 63.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.443 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.6 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -46.12 -40.03 10.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.338 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -69.14 -22.11 63.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.211 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.6 tp-100 -80.03 -47.4 14.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.599 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.58 88.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.603 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 11' ' ' GLY . 92.5 p -76.82 -38.89 53.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.509 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.465 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 6.5 tt0 -64.94 2.5 0.71 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.496 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.93 146.63 18.21 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' A' ' 12' ' ' ARG . 4.7 ptm180 -67.89 -48.33 66.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.559 0.219 . . . . 0.0 110.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.0 -45.73 6.07 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.09 -47.53 84.23 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -59.79 -39.26 84.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.091 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -31.07 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.029 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -70.05 -33.22 71.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.714 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.2 mtt -70.68 -33.93 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.6 -51.6 40.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.581 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.94 -34.21 62.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.7 m -63.34 -57.0 11.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.82 0.343 . . . . 0.0 110.703 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.92 -22.95 63.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.625 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.75 -42.06 16.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.417 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.27 -41.71 60.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.838 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 25' ' ' LEU . 7.9 mp -72.06 -33.69 68.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -62.05 -42.83 99.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.428 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 tt -76.21 -40.9 51.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.4 m -54.68 -45.88 74.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.585 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.86 64.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.547 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 tp -65.49 -20.69 66.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.729 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 t90 -90.62 -41.41 11.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 110.599 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -51.35 -38.41 53.05 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.467 ' NE2' ' O2 ' ' A' ' 201' ' ' UQ2 . 1.7 tt0 -71.16 -38.85 72.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.324 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.98 -6.79 52.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.848 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.34 -47.18 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.0 mtt -97.52 11.62 36.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.954 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 tp 46.48 48.25 13.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.871 0.367 . . . . 0.0 110.616 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 19.1 mt -84.56 152.9 23.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -117.32 133.08 23.24 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.82 176.88 9.48 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 111.953 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.457 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 8.3 t -131.9 177.79 7.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.543 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.68 -46.07 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.459 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.95 -48.82 72.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.373 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -48.78 -48.33 41.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.657 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.3 mt -61.64 -41.46 90.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.031 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -55.17 -47.73 74.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -63.08 -38.24 90.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.478 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -63.69 -36.77 84.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.44 -40.59 77.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.758 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.12 -50.35 73.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.541 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 tp -73.31 -53.08 11.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.05 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -45.06 -38.69 5.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.813 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.84 -42.55 94.98 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 57' ' ' ALA . 43.5 t -60.61 -46.97 94.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.98 -46.68 11.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.62 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.2 -28.76 72.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -71.63 -38.8 70.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.299 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.77 -33.73 76.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.019 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 4.3 mt -73.76 -28.11 61.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.163 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.9 mt -82.14 -39.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.12 -21.44 78.41 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.48 7.79 5.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.715 0.293 . . . . 0.0 110.892 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.3 mp -84.03 -35.86 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.663 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -175.57 71.61 0.27 Allowed Pre-proline 0 C--N 1.332 -0.164 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.601 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.07 13.53 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.514 2.143 . . . . 0.0 111.827 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -106.68 -8.86 16.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.05 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.99 161.94 25.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.607 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -39.9 -14.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.479 2.12 . . . . 0.0 112.207 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -42.39 -34.0 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.639 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 69' ' ' LEU . 67.8 mtt180 -37.94 -63.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.702 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.639 ' O ' HG23 ' A' ' 75' ' ' VAL . 67.4 t80 -51.63 -31.12 24.09 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.842 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 69' ' ' LEU . 11.3 t -69.32 -45.44 79.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.947 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.89 -33.2 45.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.196 0.522 . . . . 0.0 110.317 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 74' ' ' MET . 2.8 tmm? -63.21 -14.52 50.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.026 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 71' ' ' TYR . 94.3 t -57.52 -39.11 67.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.52 0.676 . . . . 0.0 110.524 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.36 -31.49 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.4 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.551 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 9.0 t-105 -65.94 -54.33 27.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.174 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 81' ' ' ALA . 14.9 tp -63.67 -47.68 80.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.456 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -42.79 -42.94 3.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.381 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.8 p -78.11 -23.21 47.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -61.12 -60.03 4.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.361 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.8 -49.97 22.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.681 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -39.0 69.44 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.703 -178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.13 -48.29 86.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.544 -1.023 . . . . 0.0 110.544 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 86' ' ' GLN . 14.2 m -72.85 -48.33 45.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.595 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.58 ' N ' HG23 ' A' ' 85' ' ' VAL . 14.6 tm0? -48.46 -29.06 3.72 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.09 -42.1 57.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.254 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 62.9 p -50.94 -31.03 16.44 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.467 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.38 -51.5 69.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.873 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -60.07 -36.76 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.751 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.466 ' ND1' ' O ' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -71.63 -39.27 70.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.815 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.2 p -73.44 -52.17 14.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.831 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 97' ' ' TYR . 19.5 ttp -51.96 -52.94 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.528 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 tt -56.12 -48.74 75.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.372 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -54.76 -36.06 64.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.217 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tp -92.33 -15.96 26.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.55 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.546 ' N ' ' O ' ' A' ' 93' ' ' MET . 51.9 m-85 -139.36 68.43 39.48 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.606 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -48.85 163.87 0.27 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.718 2.279 . . . . 0.0 111.874 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.0 m -171.56 67.77 0.44 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.727 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -77.88 114.03 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.693 2.262 . . . . 0.0 111.963 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.432 ' O ' ' O ' ' A' ' 102' ' ' ALA . 2.1 t80 -150.44 64.22 0.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.434 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 101' ' ' PHE . . . 44.84 -171.08 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.541 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 m 52.78 19.49 1.3 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.5 t -64.63 -16.82 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.587 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 54.98 47.03 23.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.46 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -43.43 -31.32 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.623 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 25.0 mmm -79.55 178.35 8.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.322 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 108' ' ' VAL . 2.4 p -124.3 99.65 6.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.44 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -106.07 99.64 9.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.526 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -101.04 159.79 28.5 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.175 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -40.39 160.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.441 2.094 . . . . 0.0 111.931 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.52 20.03 16.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.003 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.543 ' O ' ' CE3' ' A' ' 113' ' ' TRP . 2.1 p-90 -122.09 9.87 9.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.846 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 116' ' ' LEU . 50.1 mt -122.01 81.04 42.95 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.271 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.443 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 53.1 Cg_exo -51.94 0.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.233 . . . . 0.0 112.267 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 mt -60.69 -32.23 71.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.053 0.454 . . . . 0.0 110.429 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 27.9 p-10 -96.82 -41.3 8.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.625 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 35.4 tttm -71.69 -45.19 62.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.732 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.0 t90 -74.27 -16.79 60.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.532 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -140.8 71.96 29.41 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.983 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.51 ' O ' HG22 ' A' ' 125' ' ' VAL . 67.5 Cg_endo -78.1 -18.37 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.683 2.255 . . . . 0.0 111.861 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -50.14 -52.52 34.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.643 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.83 54.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.565 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -154.97 -40.99 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.322 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 121' ' ' PRO . 34.1 m -57.2 130.5 20.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.642 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.87 149.53 21.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.75 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 80.0 p -161.27 99.86 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.401 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.75 -177.32 20.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 44.4 t0 -91.4 157.05 17.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.709 0.29 . . . . 0.0 110.54 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.665 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.7 m -103.51 131.25 50.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.123 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.02 -5.36 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.197 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.03 151.7 45.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.045 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.7 mtm-85 -89.69 147.59 23.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.431 HE22 ' CM3' ' A' ' 201' ' ' UQ2 . 28.9 mt-30 -133.88 -31.07 1.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.459 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -174.89 143.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.816 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -132.97 164.15 27.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.164 0.507 . . . . 0.0 111.769 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.465 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.21 118.01 9.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.283 179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.465 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.81 16.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 84.4 10.63 79.56 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.1 mt -119.5 138.03 53.42 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.867 0.365 . . . . 0.0 110.364 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -68.83 154.0 42.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.572 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.466 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 1.6 mtp -55.72 -50.25 88.12 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.635 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.584 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 55.4 Cg_exo -48.32 -38.8 34.71 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.446 2.098 . . . . 0.0 112.088 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.709 HE21 ' N ' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -70.03 -42.51 72.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.524 0.678 . . . . 0.0 109.87 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.709 ' N ' HE21 ' A' ' 144' ' ' GLN . 47.6 m95 -60.03 -56.15 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.222 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 42.9 tp -43.39 -42.76 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.375 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 143' ' ' PRO . 1.1 mt -56.91 -35.54 69.12 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.6 -44.28 96.96 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.835 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.81 -29.67 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.337 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 -44.78 88.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.987 0.422 . . . . 0.0 110.007 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.4 -39.83 80.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.632 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.84 -47.07 64.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.482 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 3.3 m-85 -52.91 -42.84 65.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 154' ' ' LEU . 0.8 OUTLIER -75.06 -29.43 60.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.247 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 45.5 mt -70.83 -31.21 44.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.322 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 160' ' ' VAL . 16.0 m -78.25 -38.71 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.735 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.551 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.27 -54.23 40.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.761 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 159' ' ' LEU . 7.8 p -55.68 -45.22 79.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.545 ' N ' HG13 ' A' ' 158' ' ' VAL . 5.1 tp -63.23 -37.8 88.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 156' ' ' VAL . 47.7 t -71.49 -30.63 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.2 t -69.9 -50.16 50.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.999 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.0 mt -58.18 -31.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.583 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 35.0 m -53.13 -18.82 2.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.408 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -104.12 110.65 64.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.363 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -43.92 85.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.175 1.917 . . . . 0.0 111.968 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 164' ' ' GLN . 18.4 p90 -44.21 162.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.853 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -42.98 125.0 3.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.492 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -122.36 -47.73 2.11 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.636 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.406 ' HG2' ' H ' ' A' ' 169' ' ' LYS . 27.6 pttt -86.29 101.94 13.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.666 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 172' ' ' ASP . 2.2 ptpp? -96.98 165.87 11.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.526 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 55.09 -81.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.56 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.534 ' N ' ' O ' ' A' ' 170' ' ' LYS . 22.7 t0 64.01 124.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.638 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.6 mt -83.0 -162.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.577 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -145.79 165.6 28.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.559 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -79.97 -75.17 1.06 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 9.2 tpm_? -154.08 -33.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.52 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -160.4 17.45 0.21 Allowed Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.418 ' C ' ' N ' ' A' ' 180' ' ' HIS . 5.0 m80 -68.64 -62.15 1.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.426 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 179' ' ' HIS . 46.0 t-80 45.92 21.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.279 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.418 ' N ' ' C ' ' A' ' 178' ' ' HIS . 5.1 t60 -41.36 123.06 2.03 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.733 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.426 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 3.2 t-80 -110.19 -15.02 14.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.416 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.667 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 1.5 t-80 64.84 -144.41 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.528 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.667 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.544 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.561 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.467 ' O2 ' ' NE2' ' A' ' 33' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -76.84 -47.2 22.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.389 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.4 ttt-85 -56.68 -38.58 72.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.298 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' A' ' 7' ' ' GLN . 8.6 t80 -66.13 -47.36 74.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.176 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.44 -38.03 8.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.388 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.86 -21.28 65.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.068 0.461 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 4' ' ' PHE . 30.9 tt0 -81.71 -46.45 14.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.26 84.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.689 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.2 m -76.95 -34.43 57.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.595 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 20.6 tt0 -67.95 3.16 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.613 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.54 146.87 18.34 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -69.97 -48.82 56.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.739 0.304 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.23 -45.84 6.47 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.504 ' O ' ' SD ' ' A' ' 18' ' ' MET . . . -62.83 -48.07 80.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -56.26 -47.86 77.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.302 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.13 -27.32 68.3 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.577 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -69.8 -29.24 66.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.625 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -75.73 -34.09 60.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.232 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.9 26.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.887 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -54.45 -49.02 71.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.583 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.7 m -46.58 -58.65 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.553 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.31 -29.39 23.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.811 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 tp -78.31 -39.44 39.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.711 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.6 -34.81 62.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.638 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.1 mt -74.11 -37.92 64.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.793 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.63 -50.54 50.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.1 tp -57.93 -43.84 86.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.822 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -59.47 -43.64 93.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.39 -29.26 62.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.643 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -67.95 -21.62 65.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.688 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 15.2 t-105 -88.0 -42.38 12.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 110.276 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -51.59 -39.94 58.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.124 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -71.51 -37.23 71.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 39.3 m80 -75.85 -10.55 59.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.9 t -109.18 -47.96 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.652 0.263 . . . . 0.0 110.824 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -94.08 11.9 28.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.896 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tp 44.65 44.26 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.14 148.18 39.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.472 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -109.67 130.33 22.92 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.243 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 127' ' ' SER . 73.8 Cg_endo -76.35 174.36 12.95 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 122.288 1.992 . . . . 0.0 111.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.489 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.0 t -131.85 -178.5 4.91 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.93 -45.22 91.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.917 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 43' ' ' LEU . 8.6 mp -76.07 -42.8 46.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.844 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 m -58.84 -51.9 68.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 124' ' ' PHE . 13.3 tt -64.81 -36.07 76.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.371 -0.377 . . . . 0.0 109.996 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.07 -46.68 85.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.788 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -56.67 -37.14 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.294 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -61.3 -33.83 74.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.319 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.55 76.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.493 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.09 -48.81 73.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.498 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.92 -45.45 58.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.38 -40.27 11.73 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.688 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.39 79.91 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' O ' ' N ' ' A' ' 57' ' ' ALA . 47.3 t -62.25 -47.99 90.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.078 0.466 . . . . 0.0 109.937 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -45.11 -44.63 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.83 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.13 -29.62 75.81 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -65.17 -37.42 87.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.828 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.11 -27.18 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.736 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -70.12 -39.94 75.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.596 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 60' ' ' ILE . 15.7 pt -82.49 -31.94 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.676 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.14 -31.44 69.23 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.86 7.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.223 -0.191 . . . . 0.0 111.228 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.4 mp -83.8 -26.98 7.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.52 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.76 71.47 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -68.35 17.44 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.806 2.338 . . . . 0.0 111.912 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 64' ' ' ALA . 59.6 mttt -112.2 -4.14 14.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.41 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.66 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -112.06 160.46 29.9 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.611 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -37.72 -16.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.556 2.171 . . . . 0.0 112.048 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 67' ' ' THR . 1.6 tp -43.13 -33.42 0.88 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.687 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -40.12 -67.02 0.26 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.522 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.64 -33.05 53.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.604 ' O ' HG12 ' A' ' 75' ' ' VAL . 7.5 t -65.89 -55.85 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.617 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.26 -40.93 74.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.236 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.9 mmt -61.79 -12.19 15.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.26 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.0 p -63.15 -31.51 52.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.469 0.652 . . . . 0.0 110.069 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.5 mt -90.08 -30.64 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.606 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.487 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 7.3 t-105 -65.68 -49.68 67.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.806 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 tp -67.72 -44.36 77.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.418 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -46.92 -45.28 20.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.4 p -78.17 -21.96 49.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.02 -59.5 5.33 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.016 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -74.5 -53.07 10.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.112 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.6 ttt85 -66.89 -45.68 77.27 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.64 -47.1 91.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 81' ' ' ALA . 59.8 t -69.81 -47.26 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.32 . . . . 0.0 110.85 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.443 ' O ' ' OE1' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -52.98 -21.46 4.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.151 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -40.53 12.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.454 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 92' ' ' THR . 24.5 p -53.07 -26.01 14.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.532 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -68.72 -44.79 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.469 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 5.2 mp0 -56.22 -46.64 79.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.395 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -61.51 -50.06 74.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.363 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 88' ' ' THR . 60.7 p -59.3 -50.56 73.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.438 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.55 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.5 ttt -53.95 -49.36 68.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.54 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -58.57 -48.0 82.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.264 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -49.98 -41.8 47.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.329 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.4 mt -96.71 -6.62 35.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.422 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.55 ' N ' ' O ' ' A' ' 93' ' ' MET . 24.4 t80 -126.08 80.85 67.44 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.633 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 99' ' ' SER . 65.9 Cg_endo -77.43 -158.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.512 2.141 . . . . 0.0 112.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER 82.17 66.78 0.12 Allowed Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.466 -179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.19 157.94 0.22 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.88 2.387 . . . . 0.0 112.207 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 101' ' ' PHE . 34.7 t80 -165.27 -25.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.427 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -125.56 -19.87 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.377 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.1 m -80.85 64.29 5.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.483 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 48.3 p -77.84 122.89 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.622 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 51.84 93.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.664 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 0.1 OUTLIER -48.84 107.71 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.187 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 14.4 ttt -160.22 125.23 3.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.598 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -70.29 142.71 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.427 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -150.04 100.0 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.481 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.04 149.56 42.75 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.188 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -39.82 130.58 1.98 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.53 2.153 . . . . 0.0 112.224 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -71.96 -0.05 10.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.226 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.556 ' CG ' ' O ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.73 0.01 52.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.238 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.578 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.8 mt -117.63 83.54 17.73 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.256 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 51.8 Cg_exo -50.38 -0.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.688 2.258 . . . . 0.0 112.403 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.2 mp -62.66 -30.41 71.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.934 0.397 . . . . 0.0 110.371 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 -39.82 9.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.672 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.67 -45.46 52.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.593 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.424 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 10.3 t-105 -73.64 -17.95 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.449 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.63 72.57 24.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.783 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.569 ' O ' HG22 ' A' ' 125' ' ' VAL . 70.8 Cg_endo -78.84 -17.54 12.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.662 2.241 . . . . 0.0 111.688 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -54.32 -52.59 61.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.863 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.07 55.23 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.745 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.424 ' O ' HD13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -157.93 -41.1 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.363 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 121' ' ' PRO . 35.4 m -60.61 131.56 25.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.047 0.451 . . . . 0.0 110.775 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.17 157.91 16.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.711 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' PRO . 47.9 p -164.87 99.82 0.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.564 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.12 -176.93 21.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.489 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 23.8 m-20 -84.55 156.57 21.59 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.798 0.332 . . . . 0.0 110.381 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -105.09 130.25 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.792 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.55 -6.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.889 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.71 151.97 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.618 -0.433 . . . . 0.0 109.896 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.718 ' HE ' ' N ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -91.6 135.73 33.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.367 . . . . 0.0 110.997 -179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -126.73 -24.4 3.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.461 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.25 141.22 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.151 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -143.7 163.35 33.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.317 0.58 . . . . 0.0 112.23 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -130.83 139.61 50.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.992 -1.003 . . . . 0.0 108.8 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.3 17.13 3.49 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.5 19.95 61.11 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 mt -122.7 134.48 54.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.922 0.391 . . . . 0.0 110.364 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -70.58 150.98 45.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.514 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.41 ' SD ' H163 ' A' ' 201' ' ' UQ2 . 3.9 mtt -48.81 -55.18 21.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.765 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.6 Cg_exo -40.94 -37.98 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.379 2.052 . . . . 0.0 112.028 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -70.53 -50.91 32.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.253 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.0 m95 -59.66 -57.25 13.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.487 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.733 HD13 ' C ' ' A' ' 146' ' ' LEU . 3.0 tm? -43.53 -41.76 4.63 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.628 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.4 tt -55.53 -36.86 67.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.96 -40.83 93.85 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.728 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.2 mp -79.61 -26.55 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.0 110.192 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -63.14 -50.2 71.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.273 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 152' ' ' ALA . 7.7 tt -63.43 -44.65 98.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.593 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.437 ' N ' HG23 ' A' ' 151' ' ' ILE . . . -50.28 -47.29 55.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.237 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -54.65 -45.91 73.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.556 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.503 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.5 mt -58.2 -30.54 66.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.832 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.54 -27.28 18.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.706 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.551 ' O ' HG23 ' A' ' 160' ' ' VAL . 95.8 t -71.45 -36.19 59.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.976 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.487 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.25 -52.74 7.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.544 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 154' ' ' LEU . 86.2 t -52.75 -38.76 28.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.627 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 3.7 mm? -81.71 -32.35 31.69 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.118 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.3 t -76.5 -22.52 15.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.077 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.8 t -80.63 -50.56 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.099 0.476 . . . . 0.0 109.945 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.474 ' C ' ' H ' ' A' ' 164' ' ' GLN . 68.2 mt -68.81 -17.58 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.55 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 90.8 p -52.72 -8.76 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.55 ' C ' ' H ' ' A' ' 166' ' ' PHE . 2.7 mm100 -76.02 147.05 79.84 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.516 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.47 ' O ' ' C ' ' A' ' 166' ' ' PHE . 54.0 Cg_exo -47.92 -4.63 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.434 2.09 . . . . 0.0 112.49 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.55 ' H ' ' C ' ' A' ' 164' ' ' GLN . 51.7 t80 -31.41 -82.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.234 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -45.14 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -141.48 -149.03 0.26 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 168' ' ' ALA . 26.5 mttm 57.1 117.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.529 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -151.54 35.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.434 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 63.09 91.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.589 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 17.4 p30 -173.68 171.56 3.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.628 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 13.9 mt -73.92 158.93 33.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.555 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -85.43 -108.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 170.48 128.91 1.06 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -161.57 23.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.623 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 157.07 160.1 9.9 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -114.1 103.13 10.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.875 0.369 . . . . 0.0 110.393 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -85.31 -49.87 7.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.565 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 181' ' ' HIS . 9.8 p-80 -72.5 170.93 13.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.605 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 12.7 m-70 -145.46 171.06 15.19 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -79.04 47.6 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.498 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.539 ' OXT' ' CD2' ' A' ' 183' ' ' HIS . 79.0 t60 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.909 -1.043 . . . . 0.0 110.476 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.484 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mmt . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.521 ' O ' HD23 ' A' ' 2' ' ' LEU . 1.5 tt -61.13 -55.66 29.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.093 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.9 ttm-85 -46.8 -36.42 7.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.561 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -39.72 75.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.418 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.531 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -50.34 -44.16 54.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.305 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.84 -25.78 66.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.191 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -78.69 -46.78 18.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.939 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.67 -33.8 76.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.7 m -76.62 -31.62 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.956 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 66' ' ' LYS . 17.5 tp60 -75.15 7.68 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.015 0.436 . . . . 0.0 110.462 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.17 145.58 17.02 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -67.06 -20.35 65.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.756 0.312 . . . . 0.0 110.601 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.02 -46.59 58.48 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.094 -0.803 . . . . 0.0 111.094 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.43 67.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.444 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -55.98 -46.15 78.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.225 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.17 -31.66 72.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.523 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -32.45 71.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.3 mtt -69.85 -34.57 73.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.459 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.16 -50.87 59.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.733 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -50.23 -51.05 47.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -52.32 -56.66 13.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.709 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.04 -31.24 40.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.961 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 tp -80.88 -40.85 24.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.803 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -46.44 -44.56 17.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.706 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.4 mp -68.14 -25.4 65.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.765 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.02 -39.48 75.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.801 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.2 mt -77.95 -47.34 18.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.683 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 1.2 m -50.23 -45.94 54.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.764 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.57 -32.96 66.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.502 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.1 tp -62.65 -20.99 65.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.829 0.347 . . . . 0.0 110.697 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.4 t-105 -90.12 -22.14 21.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.431 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -71.5 -38.22 71.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.244 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.22 0.36 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.224 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -120.84 -49.35 2.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.845 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.46 -37.59 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.894 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.528 ' SD ' ' CZ3' ' A' ' 135' ' ' TRP . 15.8 ttt -109.81 13.54 23.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.6 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 37' ' ' LEU . 6.5 mp 42.36 37.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.593 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.51 149.69 43.88 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.096 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.657 ' HZ2' ' HB3' ' A' ' 39' ' ' LYS . 4.1 mtpm? -110.34 125.76 30.3 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.15 145.99 19.69 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.429 2.086 . . . . 0.0 111.891 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.571 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -101.06 -174.99 2.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.904 0.383 . . . . 0.0 110.708 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.77 -46.73 91.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.682 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.08 -47.03 88.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -51.49 -44.49 62.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.442 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.629 HD13 ' O ' ' A' ' 124' ' ' PHE . 71.3 mt -61.42 -48.13 90.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.953 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.487 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 11.1 t80 -54.65 -44.99 73.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.728 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -65.52 -48.19 73.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.663 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -60.04 -38.21 82.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.73 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.2 90.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.507 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.4 -47.03 76.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.405 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 51' ' ' LEU . 3.7 mm? -73.41 -48.39 34.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.123 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.13 -42.24 19.01 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.8 -45.65 81.96 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 56.1 t -62.24 -45.81 97.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.135 0.493 . . . . 0.0 109.749 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 tp -44.2 -48.59 9.3 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.352 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.81 -39.95 97.52 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -56.54 -37.87 71.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.46 . . . . 0.0 110.295 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.13 -30.54 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.327 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.1 tp -70.23 -44.73 67.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -73.52 -35.32 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.475 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.53 -31.08 68.27 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.75 5.5 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.694 0.283 . . . . 0.0 110.621 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 90.2 mt -79.18 -42.57 23.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.589 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.07 77.23 0.11 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.343 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.88 30.87 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.718 2.279 . . . . 0.0 112.125 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' HB2' HE21 ' A' ' 10' ' ' GLN . 4.3 tmmm? -110.54 -9.82 14.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.127 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -108.83 176.21 1.66 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.889 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -49.28 -6.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.126 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 67' ' ' THR . 37.7 mt -53.47 -28.1 28.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.497 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -40.76 -70.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -54.95 -30.52 59.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.413 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 75' ' ' VAL . 9.3 t -67.02 -54.48 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.785 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.66 63.24 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.264 0.554 . . . . 0.0 110.222 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 74' ' ' MET . 6.6 tmm? -59.13 -12.23 4.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.961 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 72' ' ' VAL . 2.2 p -62.7 -32.46 55.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.379 0.609 . . . . 0.0 110.355 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.29 -32.95 5.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.039 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.56 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 5.5 t-105 -66.06 -48.81 69.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.634 -0.426 . . . . 0.0 109.864 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 81' ' ' ALA . 9.1 tp -65.9 -48.63 70.83 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.416 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -42.42 -42.52 3.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 0.0 110.125 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 84' ' ' GLY . 18.2 p -79.4 -21.38 45.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.89 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.729 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.27 -61.51 2.55 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.069 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -71.48 -45.59 62.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.555 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.487 ' CZ ' ' OH ' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -77.54 -41.96 37.19 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 80' ' ' SER . . . -57.6 -49.63 72.05 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.385 -0.912 . . . . 0.0 110.825 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 81' ' ' ALA . 28.2 m -68.3 -43.25 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.002 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.491 ' N ' HG23 ' A' ' 85' ' ' VAL . 5.9 tt0 -56.64 -31.36 64.28 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.506 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -77.12 -43.42 34.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 110.32 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 33.5 p -52.32 -26.69 12.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.288 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.49 -50.02 64.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.641 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -52.19 -41.26 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.442 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -62.43 -48.97 77.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 51.2 p -66.77 -48.95 67.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.057 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 97' ' ' TYR . 15.5 ttt -49.96 -49.96 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.67 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.0 tp -65.02 -47.5 77.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.681 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -53.92 -37.86 64.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.635 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -11.14 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.584 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.489 ' N ' ' O ' ' A' ' 93' ' ' MET . 29.2 t80 -145.41 81.19 10.42 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.686 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.4 136.09 9.73 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.733 2.289 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.3 t -124.76 151.3 67.82 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.292 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.22 -59.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.408 2.072 . . . . 0.0 112.069 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -57.75 104.1 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -99.36 150.46 22.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.53 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 104' ' ' SER . 63.8 p -48.9 -94.37 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.475 ' N ' ' OG1' ' A' ' 103' ' ' THR . 3.2 m 179.58 12.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.4 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.42 58.58 3.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.587 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -59.42 -22.06 60.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.343 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 109' ' ' ARG . 75.6 mtm -149.0 162.63 39.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.652 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 108' ' ' VAL . 2.7 m -52.87 84.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.375 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 107' ' ' MET . 2.9 tpp180 -84.77 101.67 12.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.397 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.435 ' O ' ' O ' ' A' ' 111' ' ' PRO . 44.9 m-85 -122.01 153.22 60.78 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.193 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.435 ' O ' ' O ' ' A' ' 110' ' ' PHE . 90.9 Cg_exo -36.46 160.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.584 2.189 . . . . 0.0 112.117 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 2.4 pm0 -95.05 6.58 48.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.813 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.584 ' O ' HD22 ' A' ' 114' ' ' LEU . 20.9 p-90 -124.71 27.16 6.94 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.594 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 113' ' ' TRP . 3.1 mm? -122.58 78.15 46.92 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.852 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.24 -3.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.732 2.288 . . . . 0.0 112.266 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.5 mp -58.04 -32.2 67.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.043 0.449 . . . . 0.0 110.368 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -96.73 -42.98 7.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.762 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -70.24 -45.5 66.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.642 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.9 t-105 -73.88 -17.14 61.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -140.17 71.78 33.57 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.045 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -80.26 -17.41 10.38 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.9 2.4 . . . . 0.0 111.785 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -51.89 -52.57 48.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.627 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.3 m -109.8 53.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.558 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.629 ' O ' HD13 ' A' ' 45' ' ' ILE . 1.2 m-85 -155.4 -40.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 125' ' ' VAL . 6.2 p -55.75 128.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.441 ' HA ' HD11 ' A' ' 45' ' ' ILE . . . -95.13 151.0 19.58 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.3 t -169.94 100.59 0.3 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.431 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.43 177.88 18.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 11.8 t70 -86.53 138.22 31.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.921 0.391 . . . . 0.0 110.094 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 37.3 m -92.96 130.66 38.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.002 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 92.45 -7.65 0.19 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.005 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -67.85 147.83 52.0 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -80.99 132.18 35.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.824 0.345 . . . . 0.0 110.422 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -128.38 -26.33 2.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.627 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.528 ' CZ3' ' SD ' ' A' ' 36' ' ' MET . 0.6 OUTLIER -175.69 135.61 0.31 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -139.01 167.17 22.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.158 0.504 . . . . 0.0 111.606 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -144.26 120.09 10.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.322 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.474 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.8 OUTLIER 78.1 16.91 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.499 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 81.71 16.8 72.12 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.533 HD23 HE21 ' A' ' 144' ' ' GLN . 8.7 mp -120.85 136.29 54.96 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.744 0.307 . . . . 0.0 110.312 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.76 154.6 41.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.594 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtt -55.42 -51.57 78.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 142' ' ' MET . 75.5 Cg_exo -45.84 -37.78 17.07 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.384 2.056 . . . . 0.0 111.785 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.533 HE21 HD23 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -72.88 -48.48 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.819 179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.564 ' O ' ' N ' ' A' ' 148' ' ' GLY . 50.2 m95 -57.24 -57.19 13.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.435 HD13 ' H13' ' A' ' 201' ' ' UQ2 . 17.0 tp -44.26 -38.88 4.1 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.573 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.1 tt -55.11 -37.54 67.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.21 -45.56 95.84 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.597 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.702 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.7 mp -75.63 -25.67 17.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.005 0.431 . . . . 0.0 109.908 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -63.97 -46.32 85.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.513 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.5 pt -67.88 -35.77 73.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.385 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.98 -49.48 77.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.343 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.39 -48.37 71.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.717 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.547 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 31.1 mt -62.56 -34.32 76.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.073 0.463 . . . . 0.0 110.691 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 49.9 mt -71.03 -35.56 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.611 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.427 ' O ' HG22 ' A' ' 160' ' ' VAL . 56.1 t -66.57 -42.1 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.321 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.693 ' O ' HG22 ' A' ' 161' ' ' VAL . . . -62.37 -34.21 76.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 73.3 t -73.35 -25.93 21.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.216 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 163' ' ' SER . 13.4 mt -84.83 -40.01 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.335 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 156' ' ' VAL . 34.7 m -73.97 -25.38 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 157' ' ' ALA . 31.6 m -82.89 -49.37 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.778 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.528 ' N ' HG23 ' A' ' 161' ' ' VAL . 35.1 mm -72.02 -8.9 12.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.306 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 159' ' ' LEU . 2.7 m -56.29 -25.32 48.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.689 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -173.68 78.97 0.38 Allowed Pre-proline 0 CA--C 1.528 0.129 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 166' ' ' PHE . 86.2 Cg_endo -85.2 19.65 1.36 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.973 2.449 . . . . 0.0 112.09 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.421 ' O ' ' O ' ' A' ' 165' ' ' PRO . 6.0 m-85 55.23 165.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.369 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -64.38 -92.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.645 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 169' ' ' LYS . . . -176.6 -45.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.468 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 168' ' ' ALA . 37.9 pttt 31.59 55.62 0.28 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.181 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -70.1 135.44 49.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.174 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -50.66 -178.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.786 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 60.32 122.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.91 25.08 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 t80 54.17 90.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.687 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 47.49 -139.48 9.16 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -140.49 98.14 3.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.37 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -158.17 43.08 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.644 ' CD2' ' H ' ' A' ' 179' ' ' HIS . 3.3 p-80 -53.11 -79.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.318 . . . . 0.0 110.456 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.644 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 97.4 m-70 45.67 -172.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.24 162.35 2.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.459 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 8.7 m170 59.4 83.88 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.681 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -49.62 164.69 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.502 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 19.8 m80 . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.488 -179.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.459 ' O2 ' H3M2 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.8 mtp . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -77.44 -46.17 23.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.48 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -52.26 -31.91 34.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.281 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' O ' ' N ' ' A' ' 7' ' ' GLN . 10.6 t80 -76.26 -42.07 46.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.374 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.1 tp -46.42 -39.67 10.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.201 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 10' ' ' GLN . 8.3 t-20 -66.57 -24.05 66.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.259 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' PHE . 41.9 tt0 -81.02 -45.89 15.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.903 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.54 89.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.799 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 11' ' ' GLY . 57.4 p -76.29 -37.37 57.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.638 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 6' ' ' ASN . 64.8 mt-30 -67.03 5.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.559 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -98.7 145.59 17.79 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.45 -48.48 60.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.804 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.03 -45.34 6.05 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.94 81.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.522 -0.339 . . . . 0.0 110.144 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -58.25 -47.36 83.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.29 -28.33 68.01 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.486 ' O ' HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -69.55 -29.46 67.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -32.97 61.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.01 -53.41 17.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.06 -52.83 39.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 110.678 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.0 p -48.26 -57.91 5.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.755 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.3 -30.31 27.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.152 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 tt -81.45 -38.85 25.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 110.82 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.68 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.933 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.0 mp -69.0 -33.14 73.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.715 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -63.38 -41.37 98.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.809 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.1 -50.04 21.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.931 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -47.76 -47.2 30.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.665 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.14 -28.95 64.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.34 -20.44 66.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.989 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.4 ' CE2' HG21 ' A' ' 35' ' ' VAL . 60.5 t90 -88.27 -42.77 12.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -51.61 -46.63 63.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.165 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.4 ' C ' ' OE1' ' A' ' 33' ' ' GLN . 0.5 OUTLIER -70.11 -29.01 65.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.597 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -68.04 -26.89 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.448 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG21 ' CE2' ' A' ' 31' ' ' TRP . 56.7 t -104.8 -53.37 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.162 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.0 mtt -75.4 3.51 9.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.17 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 tt 44.53 47.22 8.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.86 0.362 . . . . 0.0 110.563 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 38' ' ' LEU . 96.6 mt -77.54 154.67 32.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.569 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -116.1 126.33 27.74 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.457 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.47 174.72 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.246 1.964 . . . . 0.0 111.758 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.484 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.7 t -131.85 -175.82 3.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.875 0.369 . . . . 0.0 110.765 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 40.5 t -64.44 -44.44 97.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.722 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.21 -49.96 57.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.54 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 9.2 t -49.14 -50.19 38.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.526 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 94.8 mt -61.59 -41.36 89.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.918 0.39 . . . . 0.0 110.186 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -45.26 76.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.742 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -63.93 -35.96 82.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.044 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 -65.27 -41.51 94.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.233 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -36.59 78.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.618 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.42 74.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.055 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.3 tp -77.41 -45.91 24.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.993 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -38.66 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -45.46 80.18 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 38.0 t -62.81 -47.39 93.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.241 0.543 . . . . 0.0 109.71 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.8 tp -42.87 -47.2 5.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.562 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.4 92.38 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -55.87 -43.57 77.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.865 0.364 . . . . 0.0 110.17 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.02 -36.75 82.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.227 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.68 -43.23 94.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mm -74.38 -43.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.623 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.13 68.32 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.34 4.36 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.669 0.271 . . . . 0.0 110.761 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.43 -44.74 23.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.537 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -174.04 74.73 0.36 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.26 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.97 18.34 0.65 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.666 2.244 . . . . 0.0 112.407 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -104.9 -7.66 19.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.111 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -113.98 176.85 1.33 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.446 179.402 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.5 1.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 0.0 111.878 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.3 tp -54.71 -34.89 63.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.639 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' SD ' ' A' ' 74' ' ' MET . 30.9 mtm105 -38.24 -66.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -53.64 -22.1 8.12 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.176 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.606 ' O ' HG12 ' A' ' 75' ' ' VAL . 5.0 t -78.99 -48.26 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.336 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.16 -35.04 56.35 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 110.167 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.1 OUTLIER -64.83 -9.73 22.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.167 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 72' ' ' VAL . 6.3 p -62.67 -35.38 70.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.363 0.602 . . . . 0.0 110.287 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.1 mm -87.93 -33.74 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.831 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.574 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 16.7 t-105 -61.1 -50.42 73.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.046 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mp -66.93 -45.03 79.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.426 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -45.19 -44.87 11.25 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.44 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -79.89 -23.36 41.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.757 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -60.3 -60.45 3.8 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.631 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -71.76 -56.32 6.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.169 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -66.39 -51.05 61.09 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.85 -47.73 52.77 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 81' ' ' ALA . 70.0 t -65.28 -32.05 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.266 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -62.54 -33.28 74.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.43 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.96 -40.65 38.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.542 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 46.6 p -52.77 -35.25 56.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.737 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -70.42 -52.14 24.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.641 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -46.1 -31.05 2.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.35 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -75.91 -45.56 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.652 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.1 p -67.5 -49.73 62.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.691 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.488 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -49.9 -53.11 28.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.056 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 tp -63.75 -49.62 72.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.464 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 50.2 tp60 -49.84 -35.78 24.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.323 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.9 tp -100.16 -8.83 23.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.34 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' MET . 34.8 t80 -128.32 75.6 78.93 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.609 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.63 118.67 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.719 2.279 . . . . 0.0 112.016 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.09 154.39 74.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.25 88.53 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.493 2.129 . . . . 0.0 112.003 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -45.92 163.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.405 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.14 161.73 25.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.619 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.6 p -79.11 38.35 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.562 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.5 p -119.13 -12.36 9.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.537 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 106' ' ' PHE . 4.1 p30 -53.37 -53.8 45.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.605 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 67.6 m-85 -41.33 -85.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.735 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 30.6 mtm -95.23 112.75 24.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.549 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 108' ' ' VAL . 33.3 m -72.97 121.56 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.643 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -78.14 99.79 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.255 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -90.27 150.35 42.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.539 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.03 150.24 88.27 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.581 2.188 . . . . 0.0 111.879 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -99.39 -15.19 18.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.726 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.81 -4.18 58.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.395 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 116' ' ' LEU . 19.9 mt -128.44 80.77 71.88 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.996 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.1 Cg_exo -50.71 3.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.815 2.344 . . . . 0.0 112.269 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 114' ' ' LEU . 4.2 mm? -57.72 -33.24 68.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 0.0 109.975 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.556 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -96.73 -45.35 6.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.531 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -65.73 -45.46 82.56 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.331 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.441 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 32.6 t-105 -73.75 -14.35 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.83 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 t -142.04 74.87 21.23 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.87 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.453 ' O ' HG12 ' A' ' 125' ' ' VAL . 72.8 Cg_endo -80.79 -17.12 9.87 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.849 2.366 . . . . 0.0 111.696 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -54.84 -53.76 51.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.741 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 123' ' ' VAL . 3.5 p -105.63 60.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.275 0.559 . . . . 0.0 110.585 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.556 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 0.4 OUTLIER -164.77 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.385 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 121' ' ' PRO . 13.6 p -62.4 130.22 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.791 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.1 157.98 15.98 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 63.8 p -162.73 99.66 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.499 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 142.84 -173.45 24.03 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.484 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 20.8 t70 -93.24 152.99 18.85 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.892 0.377 . . . . 0.0 110.172 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.64 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -104.68 128.59 52.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 99.54 -10.23 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.852 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -67.92 147.9 51.85 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 40.8 ttp180 -89.57 132.81 34.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.762 0.315 . . . . 0.0 110.347 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -129.94 -21.47 3.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.503 ' CE3' ' SD ' ' A' ' 142' ' ' MET . 24.6 t90 -174.05 134.09 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.976 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -140.94 160.68 39.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.22 0.533 . . . . 0.0 111.914 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -119.77 140.46 50.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.085 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.68 17.44 0.39 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.226 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.607 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 87.49 21.82 46.44 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.607 HD22 ' O ' ' A' ' 139' ' ' GLY . 3.0 mm? -123.86 137.93 54.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -71.9 146.95 47.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.561 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.503 ' SD ' ' CE3' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -47.39 -57.57 9.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.539 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 142' ' ' MET . 83.1 Cg_exo -38.28 -38.41 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.586 2.191 . . . . 0.0 112.568 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -73.28 -52.23 14.72 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.149 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.572 ' O ' ' N ' ' A' ' 148' ' ' GLY . 66.9 m95 -55.53 -58.0 9.58 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.823 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.1 tp -44.01 -39.36 4.07 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.673 ' O ' HD23 ' A' ' 147' ' ' LEU . 2.5 tt -54.96 -36.86 65.77 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.86 -43.37 99.3 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.643 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.0 mp -75.94 -25.48 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -65.4 -43.56 90.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.579 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.6 pt -67.55 -37.8 79.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.286 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.88 -50.34 73.8 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.325 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.468 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.5 m-85 -54.33 -45.16 72.6 Favored 'General case' 0 CA--C 1.533 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.859 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 154' ' ' LEU . 0.5 OUTLIER -75.86 -29.72 58.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.881 -179.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.0 mt -71.12 -35.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 160' ' ' VAL . 35.7 m -75.24 -35.86 35.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.75 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.574 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -63.81 -50.34 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.637 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.87 -48.03 78.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.463 HD11 ' NZ ' ' A' ' 169' ' ' LYS . 3.2 mm? -64.67 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.487 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 156' ' ' VAL . 16.6 t -69.23 -27.12 33.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.72 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.1 t -80.98 -46.13 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.427 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 32.6 mm -75.7 -13.99 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.6 p -67.61 -14.54 63.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.604 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.636 HE21 ' H ' ' A' ' 164' ' ' GLN . 0.0 OUTLIER -67.06 -64.77 1.92 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.615 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.569 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 25.0 Cg_endo -61.79 -35.42 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.466 2.11 . . . . 0.0 111.838 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 165' ' ' PRO . 0.1 OUTLIER 55.67 150.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.729 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.412 ' H ' ' H ' ' A' ' 168' ' ' ALA . 44.6 pttt -175.86 -2.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.588 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' H ' ' H ' ' A' ' 167' ' ' LYS . . . 60.57 119.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.463 ' NZ ' HD11 ' A' ' 159' ' ' LEU . 38.3 mttp -52.84 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.715 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.7 mttm -156.45 164.47 38.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.219 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 70.72 124.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.444 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 172' ' ' ASP . 0.5 OUTLIER -80.26 -140.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.631 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 174' ' ' PHE . 3.5 mp -102.75 -57.48 2.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.536 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 173' ' ' LEU . 73.4 m-85 54.23 107.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.436 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -141.97 140.81 10.37 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.529 ' O ' ' NE ' ' A' ' 176' ' ' ARG . 0.0 OUTLIER -82.59 -54.82 4.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.802 0.334 . . . . 0.0 110.519 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 61.33 75.48 0.29 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -82.44 133.54 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 0.0 110.78 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.625 ' H ' ' CD2' ' A' ' 179' ' ' HIS . 5.7 p80 -84.33 -173.96 5.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.428 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -120.43 171.77 8.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.557 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.512 ' H ' ' CD2' ' A' ' 181' ' ' HIS . 6.1 p80 -60.35 178.1 0.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.563 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -75.12 -74.41 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.647 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.4 m80 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.536 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.448 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 mmt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.721 ' N ' HD23 ' A' ' 2' ' ' LEU . 1.9 pt? -59.35 -35.54 74.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.452 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 64.9 mtm-85 -55.62 -40.47 72.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.305 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -64.37 -44.28 91.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -49.64 -42.16 44.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.309 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' ND2' ' OE1' ' A' ' 10' ' ' GLN . 49.6 t30 -67.61 -28.14 67.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.915 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -73.04 -50.37 23.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -32.34 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.3 p -75.99 -35.36 59.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.588 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' OE1' ' ND2' ' A' ' 6' ' ' ASN . 38.3 mt-30 -74.32 12.31 0.78 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.966 0.413 . . . . 0.0 110.388 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.63 147.94 16.74 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.2 mtp180 -70.74 -49.89 41.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.462 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.32 -46.11 6.67 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -46.44 90.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.23 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.415 ' O ' ' HG3' ' A' ' 18' ' ' MET . 8.7 m95 -59.0 -32.03 69.33 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 109.942 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -74.29 -27.94 60.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -70.69 -36.37 73.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.902 -179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.42 ' C ' ' SD ' ' A' ' 18' ' ' MET . 1.4 ppp? -72.58 -31.22 65.05 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.2 14.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.2 -47.45 46.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.724 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.8 p -54.6 -62.16 1.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.883 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' HD13 ' A' ' 55' ' ' LEU . . . -49.23 -39.75 31.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.946 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.55 -41.47 75.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.07 -36.66 30.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.866 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.3 mp -71.71 -36.41 70.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.77 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.97 -46.29 89.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.116 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.0 tp -75.16 -48.85 21.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.09 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.8 m -46.2 -43.06 14.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.694 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.27 -28.18 53.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.494 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -64.43 -18.61 64.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.747 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -91.08 -40.86 11.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.605 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -50.15 -44.67 52.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.234 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.52 -28.02 62.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -70.9 -24.78 62.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG13 ' N ' ' A' ' 36' ' ' MET . 7.5 p -106.52 -45.07 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.158 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.514 ' N ' HG13 ' A' ' 35' ' ' VAL . 1.2 mtt -83.96 5.07 26.95 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.86 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 mt 44.82 42.24 5.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.706 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.9 mt -80.42 153.73 28.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -117.84 130.32 24.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.435 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.79 179.39 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.249 1.966 . . . . 0.0 111.759 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.456 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.4 t -131.73 -175.49 3.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.943 0.402 . . . . 0.0 110.715 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 126' ' ' ALA . 54.6 t -65.69 -46.61 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.918 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.3 mt -68.05 -50.12 57.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.537 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.7 m -49.41 -50.94 38.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.691 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.96 -41.08 89.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.616 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -54.61 -45.73 73.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.96 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -59.51 -40.21 86.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.161 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.4 HH21 HG12 ' A' ' 123' ' ' VAL . 41.6 ttp85 -57.89 -35.94 71.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.3 -38.31 78.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.472 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.594 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.438 HD21 ' HB1' ' A' ' 22' ' ' ALA . 5.2 tp -76.41 -51.07 12.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.339 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -46.99 -39.4 12.42 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.58 -43.83 91.27 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' CG2' ' OG ' ' A' ' 80' ' ' SER . 45.3 t -65.32 -41.58 91.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 110.037 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 22' ' ' ALA . 8.5 tp -50.8 -50.44 56.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.842 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.99 92.7 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.23 -37.29 34.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.975 -0.612 . . . . 0.0 110.218 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.53 -25.45 60.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.28 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -72.23 -43.42 64.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.579 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 mm -73.64 -30.61 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.595 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.04 -26.46 48.78 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.58 -2.96 21.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 0.0 110.71 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.66 -20.8 8.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.502 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 178.86 68.87 0.12 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.75 25.79 0.61 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.875 2.384 . . . . 0.0 112.253 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -110.27 -6.33 15.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.55 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.13 174.41 2.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.731 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -45.83 -9.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.226 1.95 . . . . 0.0 112.175 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 67' ' ' THR . 11.7 mt -51.32 -30.04 17.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.327 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -41.67 -69.81 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.598 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.575 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -51.53 -38.61 55.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.004 179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -59.45 -54.04 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -32.45 70.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.399 0.619 . . . . 0.0 110.046 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.644 ' SD ' HG21 ' A' ' 161' ' ' VAL . 34.6 ttp -61.21 -25.24 66.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.612 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 71' ' ' TYR . 47.8 t -51.56 -37.31 19.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.317 0.58 . . . . 0.0 111.242 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.6 mt -85.38 -37.37 12.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.404 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.723 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 10.7 t90 -57.68 -49.47 76.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 tt -65.68 -46.89 77.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 110.494 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -46.97 -47.57 21.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.736 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.426 ' OG ' ' CG2' ' A' ' 54' ' ' VAL . 59.6 p -79.28 -25.61 42.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.438 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.41 -60.35 4.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.256 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -52.89 10.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.158 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -65.57 -42.46 91.74 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.781 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.72 -46.0 93.05 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.3 t -69.89 -54.24 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 111.12 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -47.7 -29.13 2.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.328 . . . . 0.0 110.743 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 tp -85.16 -39.48 17.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.713 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 84' ' ' GLY . 40.7 p -53.18 -23.15 7.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.3 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -76.15 -40.48 52.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.506 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -56.35 -39.91 73.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.387 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.52 ' N ' ' CD2' ' A' ' 91' ' ' HIS . 1.1 m170 -69.18 -49.53 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.856 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.3 p -61.96 -49.92 74.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.879 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.426 ' O ' ' N ' ' A' ' 97' ' ' TYR . 17.3 ttt -47.53 -46.71 27.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.635 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 98' ' ' PRO . 19.7 mt -68.52 -44.29 74.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.671 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.0 tm0? -59.17 -47.14 86.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.58 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.87 -25.81 37.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.46 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.426 ' N ' ' O ' ' A' ' 93' ' ' MET . 23.7 t80 -143.81 68.62 16.47 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' LEU . 51.6 Cg_exo -50.95 154.22 7.53 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.711 2.274 . . . . 0.0 112.003 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.516 ' O ' ' CZ ' ' A' ' 101' ' ' PHE . 15.1 m -153.27 59.21 2.64 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.578 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.43 159.12 47.11 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.757 2.305 . . . . 0.0 111.921 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.516 ' CZ ' ' O ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -131.75 -172.27 2.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.429 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.78 19.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.383 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.459 ' H ' ' C ' ' A' ' 101' ' ' PHE . 3.8 p -132.92 -170.2 2.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.51 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 86.3 p -169.75 65.35 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.674 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -80.12 -167.23 1.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.538 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 51.83 69.11 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.629 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 107' ' ' MET . 5.4 ppp? -154.32 127.88 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.298 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 t 45.56 64.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.401 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.2 ttm-85 -143.92 113.6 7.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.379 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.76 156.12 59.36 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.33 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.37 150.3 87.26 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.619 2.213 . . . . 0.0 112.042 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -101.37 12.85 36.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.717 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.459 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 8.5 p-90 -124.99 -2.95 7.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.709 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.607 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.82 86.3 19.03 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.873 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.438 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 41.3 Cg_exo -53.76 8.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.646 2.231 . . . . 0.0 112.483 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.5 mm? -73.63 -27.61 61.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.05 0.452 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -96.36 -41.02 8.83 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.469 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -70.59 -45.15 65.87 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.314 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 3.2 t90 -73.29 -18.1 61.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.087 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.54 73.71 20.12 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' O ' HG12 ' A' ' 125' ' ' VAL . 64.2 Cg_endo -78.06 -18.09 13.14 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.669 2.246 . . . . 0.0 111.802 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -70.69 -11.22 60.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.867 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.4 HG12 HH21 ' A' ' 48' ' ' ARG . 2.9 t -136.41 45.79 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.65 -38.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 121' ' ' PRO . 7.3 p -58.29 129.74 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -95.48 152.93 17.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.525 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 t -166.01 100.32 0.65 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.656 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.67 -176.15 21.32 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.454 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 31.3 t70 -87.12 147.88 25.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.336 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 11.9 m -99.61 130.09 45.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.814 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 90.0 -4.56 0.34 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.16 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.98 129.65 40.58 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.16 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -66.39 128.72 37.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.258 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -126.03 -25.27 3.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.708 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -174.86 136.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.112 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -139.94 161.15 38.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.085 0.469 . . . . 0.0 111.412 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -137.05 119.83 16.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.29 179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 2.1 tp 78.63 16.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.416 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 83.24 14.84 73.38 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 139' ' ' GLY . 7.3 mp -119.83 133.19 55.68 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.746 0.308 . . . . 0.0 110.262 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 2.1 mp0 -74.82 156.55 36.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.446 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.407 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 6.4 mtm -48.38 -61.39 3.21 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.6 Cg_exo -35.55 -41.05 0.37 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.57 2.18 . . . . 0.0 112.49 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.17 -44.22 60.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.511 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.608 ' O ' ' N ' ' A' ' 148' ' ' GLY . 49.4 m95 -66.13 -57.89 6.67 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.927 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 tt -43.65 -38.56 3.13 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.434 HD13 ' OG1' ' A' ' 88' ' ' THR . 34.1 tp -62.36 -34.3 76.4 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -64.04 -49.11 69.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.562 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.637 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -66.35 -27.11 39.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.128 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -39.12 90.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.49 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 151' ' ' ILE . 2.4 tt -66.62 -36.58 77.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -54.38 -48.89 71.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -57.75 -41.45 81.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.383 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.709 HD12 ' CZ2' ' A' ' 77' ' ' TRP . 10.2 tp -53.96 -30.9 48.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.242 0.544 . . . . 0.0 109.927 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 40.1 mm -79.63 -32.3 14.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.013 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 160' ' ' VAL . 92.3 t -65.63 -45.86 91.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.924 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.723 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.18 -46.76 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.138 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 159' ' ' LEU . 3.3 p -51.79 -40.61 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.544 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 158' ' ' VAL . 15.7 mt -80.11 -33.13 38.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.171 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.2 t -73.29 -24.04 20.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.957 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.644 HG21 ' SD ' ' A' ' 74' ' ' MET . 77.2 t -80.66 -50.2 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.103 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 162' ' ' ILE . 39.5 mm -71.25 -10.75 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.483 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.2 m -52.6 -19.45 2.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.236 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 166' ' ' PHE . 35.8 mt-30 45.8 56.43 15.71 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 164' ' ' GLN . 39.9 Cg_endo -68.74 14.52 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.639 2.226 . . . . 0.0 111.71 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.4 OUTLIER -145.95 133.31 20.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -73.1 -48.18 37.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.799 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.69 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.549 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 tttp 68.36 -1.44 1.87 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.644 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -93.26 -32.8 14.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.542 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -156.95 -165.43 1.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' A' ' 173' ' ' LEU . 29.5 t70 -152.8 175.79 12.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.594 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.451 ' H ' ' CG ' ' A' ' 172' ' ' ASP . 2.4 pp -51.75 144.03 11.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.63 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -82.16 -69.64 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.585 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 50.91 -134.23 31.55 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.926 -0.869 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -171.31 59.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.594 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -45.17 -49.11 10.16 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 32.0 m170 52.82 -115.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.752 0.31 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' A' ' 180' ' ' HIS . 0.7 OUTLIER -83.07 -129.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.508 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.59 ' H ' ' CG ' ' A' ' 179' ' ' HIS . 65.6 m80 -144.35 74.48 1.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.488 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 52.15 -129.92 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.569 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -170.3 -20.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.535 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.539 179.992 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.46 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 2' ' ' LEU . 4.6 mp -68.34 -41.84 80.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.289 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptt-85 -52.02 -41.41 62.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.193 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 7' ' ' GLN . 22.3 m-85 -63.86 -44.43 93.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.074 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -45.93 -41.75 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -67.9 -28.68 67.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.003 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' PHE . 5.9 tp-100 -76.03 -50.82 13.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.428 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.31 -31.86 73.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' GLY . 20.2 m -76.64 -42.27 42.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -66.52 3.3 1.0 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.387 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.94 145.07 17.23 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 30.8 mmm-85 -68.8 -49.56 57.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.577 0.227 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.54 -46.3 5.69 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -47.56 85.44 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -58.36 -47.97 82.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.353 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.46 -29.36 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.215 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.91 -30.93 68.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.47 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 tpt -72.08 -33.56 67.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.154 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.48 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.685 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -52.73 -51.35 60.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.667 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.1 p -51.56 -49.71 61.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -42.23 72.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.649 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.41 -38.02 77.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.482 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.69 -35.27 55.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.565 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 45.9 mt -74.42 -41.21 61.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.57 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -67.18 -55.48 13.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.761 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.4 tt -54.86 -53.38 56.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.898 0.38 . . . . 0.0 110.6 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 24' ' ' ALA . 16.9 p -49.31 -45.16 44.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.487 ' HB2' H121 ' A' ' 201' ' ' UQ2 . . . -72.07 -43.24 65.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.735 0.302 . . . . 0.0 111.047 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -53.76 -20.25 5.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.646 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 20.8 t-105 -91.88 -39.49 11.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.542 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -48.86 -38.1 21.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.971 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -68.82 -38.58 79.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.663 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -80.77 -5.26 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.964 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.3 -46.99 7.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.891 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 30.6 mtt -100.81 10.01 41.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.926 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.95 42.61 28.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.682 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -87.69 154.06 20.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -121.09 141.43 32.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.864 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 127' ' ' SER . 88.0 Cg_endo -78.25 171.52 16.88 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.648 2.232 . . . . 0.0 112.283 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.529 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 7.6 t -131.95 -173.67 3.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.052 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.405 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 16.9 t -64.3 -48.77 84.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' A' ' 47' ' ' GLU . 4.1 mm? -60.35 -46.88 88.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 41' ' ' CYS . 75.5 p -48.43 -43.97 34.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.333 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.54 -43.53 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.919 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -55.53 -48.45 74.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.153 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 43' ' ' LEU . 2.5 mp0 -61.01 -42.73 99.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.275 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.406 ' O ' ' CB ' ' A' ' 52' ' ' PHE . 33.7 ttt-85 -64.3 -38.31 90.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.313 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.46 77.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.52 74.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.2 tt -78.35 -51.61 9.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.305 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.406 ' CB ' ' O ' ' A' ' 48' ' ' ARG . 59.8 t80 -43.97 -40.08 4.46 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.667 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.83 -45.46 74.47 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.5 -47.64 90.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.915 0.388 . . . . 0.0 109.984 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 19.9 tp -44.53 -50.53 9.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.84 -49.37 75.1 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.44 -32.7 18.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 55' ' ' LEU . . . -67.37 -36.01 80.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.205 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.51 -32.03 69.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.595 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.7 mp -77.03 -38.49 28.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.585 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.76 -19.06 66.49 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.5 27.56 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.288 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 5.0 pt -83.77 -25.9 7.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.712 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 177.37 73.52 0.1 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.575 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.23 26.31 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.591 2.194 . . . . 0.0 111.96 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -104.66 -8.34 18.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.19 176.92 1.31 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.666 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.02 -2.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.264 1.976 . . . . 0.0 112.106 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.553 ' H ' ' C ' ' A' ' 67' ' ' THR . 42.9 mt -53.45 -33.85 55.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.549 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 71' ' ' TYR . 2.8 ptp180 -40.89 -63.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.642 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.572 ' H ' ' HG3' ' A' ' 70' ' ' ARG . 1.7 t80 -56.59 -29.85 62.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 118.458 0.572 . . . . 0.0 110.182 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' LEU . 12.5 t -68.22 -45.08 83.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.849 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.79 -32.59 46.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.172 0.51 . . . . 0.0 110.174 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 161' ' ' VAL . 29.9 ttp -65.43 -19.4 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.751 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.3 t -54.2 -37.25 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.373 0.606 . . . . 0.0 110.419 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 78.4 mt -88.72 -31.55 5.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.713 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.548 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -66.76 -46.88 73.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.482 HD23 ' CG ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -66.5 -48.54 69.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.47 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -44.78 -43.91 8.96 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 p -75.91 -24.15 55.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.555 ' HA ' HD13 ' A' ' 154' ' ' LEU . . . -59.99 -60.25 4.13 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.269 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -73.9 -53.4 10.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -67.91 -43.66 78.7 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.76 -46.05 95.24 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.91 -41.11 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -62.97 -45.18 93.67 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.528 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.98 -42.84 69.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.038 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 84' ' ' GLY . 4.2 p -48.8 -47.75 41.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.898 0.38 . . . . 0.0 110.616 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -51.41 -32.37 26.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.404 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -71.01 -36.29 72.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.414 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.66 -36.99 73.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.561 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.7 p -74.2 -31.87 62.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.492 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.535 ' O ' ' N ' ' A' ' 97' ' ' TYR . 11.7 tpt -62.26 -43.14 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.421 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tp -64.2 -49.15 73.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.516 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -56.46 -46.92 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.82 -14.79 43.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.763 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.535 ' N ' ' O ' ' A' ' 93' ' ' MET . 21.1 t80 -152.12 76.84 7.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.765 0.317 . . . . 0.0 110.829 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.51 121.3 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.661 2.24 . . . . 0.0 112.004 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 101' ' ' PHE . 1.8 t -55.86 150.16 29.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.543 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 101' ' ' PHE . 77.1 Cg_exo -43.06 78.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.659 2.24 . . . . 0.0 112.589 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 99' ' ' SER . 0.3 OUTLIER 36.37 94.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.879 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . -158.9 176.65 12.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 20.5 p 50.07 77.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.691 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.8 m -85.5 152.93 22.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.398 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -156.17 158.78 38.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.714 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -155.99 -72.58 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.374 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 43.5 mtp -85.07 130.31 34.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.546 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 108' ' ' VAL . 14.0 p -78.68 128.86 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.484 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 mtt85 -112.9 102.15 10.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.621 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' PRO . 0.6 OUTLIER -107.89 161.88 21.76 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.313 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' PHE . 90.7 Cg_exo -36.91 160.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.843 2.362 . . . . 0.0 112.307 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' O ' ' CD ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -96.52 2.73 52.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.925 -179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.511 ' O ' ' CG ' ' A' ' 113' ' ' TRP . 3.8 p-90 -125.01 30.08 5.97 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 110.745 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 116' ' ' LEU . 6.5 tp -125.63 68.96 62.23 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.409 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -46.51 -8.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.75 2.3 . . . . 0.0 112.285 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 114' ' ' LEU . 6.7 tp -53.31 -33.7 54.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.026 0.441 . . . . 0.0 110.679 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.46 ' OD1' ' CE2' ' A' ' 124' ' ' PHE . 4.5 m-20 -96.45 -43.76 7.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.209 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -70.14 -45.28 67.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.81 0.338 . . . . 0.0 110.867 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -73.2 -18.87 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.568 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -141.56 72.31 25.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.179 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.77 -15.25 9.65 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.837 2.358 . . . . 0.0 111.538 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -49.22 -48.14 45.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.77 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.91 53.36 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.46 ' CE2' ' OD1' ' A' ' 117' ' ' ASP . 5.7 t80 -156.11 -39.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.595 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 125' ' ' VAL . 8.4 p -60.86 130.0 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.66 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.97 150.54 20.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' PRO . 6.4 t -161.52 99.84 1.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 110.747 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.53 -172.45 23.02 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.529 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -88.41 151.52 22.52 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.671 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 12.9 m -103.19 130.3 50.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.832 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.21 -9.54 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.05 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 150.72 47.87 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.606 -0.438 . . . . 0.0 109.976 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -85.9 136.1 33.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.461 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -127.39 -17.62 4.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -172.92 120.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 137' ' ' PHE . 7.7 t0 -115.04 148.96 38.22 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.344 0.593 . . . . 0.0 112.28 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.533 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 7.3 t80 -128.57 136.73 51.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.737 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mp 54.27 17.44 1.51 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.439 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.525 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 88.14 13.02 64.73 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.665 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 139' ' ' GLY . 9.1 mp -121.11 146.82 46.35 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -76.72 151.26 36.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.626 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.464 ' SD ' H151 ' A' ' 201' ' ' UQ2 . 4.0 mmt -48.04 -63.36 1.55 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.462 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 84.3 Cg_exo -32.18 -38.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.938 2.425 . . . . 0.0 112.449 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -69.45 -53.75 17.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.98 0.419 . . . . 0.0 110.277 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 148' ' ' GLY . 76.8 m95 -60.17 -57.02 14.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.0 tp -43.73 -37.67 2.79 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.88 -34.97 76.98 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.3 -44.57 96.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -76.28 -25.89 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 154' ' ' LEU . 39.7 t80 -62.45 -45.64 92.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.514 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.482 ' O ' HD13 ' A' ' 155' ' ' ILE . 15.5 pt -68.82 -38.7 79.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.544 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.479 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -53.73 -48.19 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.362 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.34 -41.67 94.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 150' ' ' PHE . 37.6 mt -69.29 -30.62 68.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.482 HD13 ' O ' ' A' ' 151' ' ' ILE . 1.4 mp -77.83 -27.34 15.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.579 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 152' ' ' ALA . 54.7 t -73.85 -35.45 42.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.645 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -69.99 -52.36 24.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.107 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 34.1 m -57.86 -33.93 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.932 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.27 -43.55 23.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 0.0 110.943 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 156' ' ' VAL . 52.4 t -69.14 -26.86 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.888 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 157' ' ' ALA . 48.6 t -75.01 -45.44 42.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.328 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.462 ' C ' ' H ' ' A' ' 164' ' ' GLN . 72.5 mt -66.64 -21.23 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.7 p -58.4 -4.25 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.734 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 166' ' ' PHE . 1.7 pt20 -45.74 152.46 0.72 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.409 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -37.85 -22.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.614 2.21 . . . . 0.0 112.29 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 164' ' ' GLN . 9.6 t80 71.78 31.79 2.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 43.42 25.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.586 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -151.09 134.64 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.448 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 170' ' ' LYS . 9.9 tptp -100.12 -78.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.629 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 169' ' ' LYS . 13.5 mmmt 48.63 179.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.531 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.612 ' CA ' ' HE ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER 41.11 77.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.56 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -170.88 34.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.467 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.473 ' CG ' ' H ' ' A' ' 174' ' ' PHE . 4.2 tp 63.56 -137.76 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.569 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.473 ' H ' ' CG ' ' A' ' 173' ' ' LEU . 3.5 m-85 47.08 61.37 2.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.173 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -55.4 -76.41 0.2 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -86.78 -51.24 6.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 0.0 110.532 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 63.7 -167.56 24.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -176.62 -178.04 0.87 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.795 0.331 . . . . 0.0 110.457 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.498 ' C ' ' H ' ' A' ' 181' ' ' HIS . 2.8 m-70 -45.28 -56.24 5.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.672 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 8.2 t60 69.83 -38.45 0.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 179' ' ' HIS . 23.3 t60 -52.27 -61.86 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.558 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -62.22 -139.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.569 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.452 ' OXT' ' ND1' ' A' ' 183' ' ' HIS . 65.3 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.538 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.648 ' O1 ' H2M3 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 24.2 mt -61.82 -42.68 99.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.311 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -54.13 -42.89 70.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -45.38 87.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -50.34 -42.18 52.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -66.3 -29.48 69.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.124 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -78.53 -49.42 13.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.514 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -62.38 -33.34 74.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.69 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 11' ' ' GLY . 41.3 p -76.33 -34.22 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.554 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -74.28 10.03 1.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.35 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -107.29 142.06 15.7 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -62.55 -18.38 61.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.288 . . . . 0.0 110.294 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.51 -48.29 51.78 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -62.61 -51.43 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.738 0.304 . . . . 0.0 110.393 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -52.76 -40.17 62.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.029 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -76.26 -30.11 57.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 tp -69.17 -34.28 74.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.403 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 41.6 mtt -74.85 -33.16 62.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.84 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.82 32.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.775 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -61.35 -30.92 70.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -61.53 -61.99 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.511 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.43 -23.84 41.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.358 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 tt -78.09 -39.92 40.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.169 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' THR . . . -58.63 -31.03 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.829 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 mt -78.8 -29.71 45.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.736 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -69.77 -47.09 64.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tt -64.01 -46.4 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 24' ' ' ALA . 11.5 p -50.13 -46.33 53.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 33' ' ' GLN . . . -73.19 -38.41 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.941 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.72 -17.93 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.219 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -97.28 -25.87 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -46.62 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.773 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.492 ' NE2' ' O4 ' ' A' ' 201' ' ' UQ2 . 19.4 mp0 -83.68 -30.1 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.008 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -60.38 -26.21 66.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.251 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 36' ' ' MET . 8.5 m -105.66 -38.11 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.805 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.406 ' N ' HG23 ' A' ' 35' ' ' VAL . 16.5 mmt -74.96 1.96 11.59 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.27 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 tp 55.83 50.48 13.99 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.722 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 38' ' ' LEU . 4.1 mm? -103.84 156.17 18.04 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -117.01 142.27 29.65 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.659 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 127' ' ' SER . 65.7 Cg_endo -74.39 173.68 13.83 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.51 2.14 . . . . 0.0 111.918 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 5.2 t -131.94 178.43 6.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.374 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 t -62.46 -43.93 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.421 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tp -69.22 -48.93 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.468 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 41' ' ' CYS . 5.3 t -51.8 -50.73 60.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.891 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.62 -38.62 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -54.46 -47.29 73.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.559 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -61.38 -43.85 98.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.265 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.32 60.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.091 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.23 80.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.265 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.53 -45.88 92.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.432 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.4 mt -76.78 -53.33 8.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.997 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -45.81 -40.61 9.97 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.44 -45.35 86.29 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.518 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 8.1 t -61.84 -45.16 99.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -46.87 -44.0 19.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.566 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.28 -28.22 73.55 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -64.32 -38.46 91.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.454 -0.373 . . . . 0.0 110.575 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.76 -26.84 57.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.48 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.56 -42.91 77.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.1 pt -78.15 -29.93 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.668 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -12.74 83.08 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.81 1.78 51.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.529 0.204 . . . . 0.0 111.25 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 3.3 pt -87.22 -27.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.963 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.8 72.46 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.83 0.347 . . . . 0.0 110.628 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -81.78 24.75 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.951 2.434 . . . . 0.0 112.177 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -104.9 -8.7 18.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.82 176.74 1.39 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.481 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -47.81 -4.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.321 2.014 . . . . 0.0 112.26 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.567 ' H ' ' C ' ' A' ' 67' ' ' THR . 1.5 mm? -52.8 -31.22 37.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.139 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.496 ' NH1' ' OG ' ' A' ' 163' ' ' SER . 67.0 mtt180 -40.85 -69.81 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.622 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.27 -35.73 50.85 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.437 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.4 t -62.27 -44.07 98.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.673 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.81 -33.13 58.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.31 0.576 . . . . 0.0 109.483 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.62 -11.85 5.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.33 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.34 -42.85 95.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.288 0.566 . . . . 0.0 110.839 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.1 mt -87.06 -29.89 5.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.083 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 17.7 t-105 -60.74 -50.88 71.68 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.288 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 tp -70.07 -45.95 65.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.766 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.434 ' O ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -45.37 -50.41 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.015 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.3 p -71.12 -29.41 65.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.578 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.67 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.64 -58.92 6.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.425 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -70.85 -49.8 42.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -78.09 -33.8 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 83' ' ' ARG . . . -65.3 -46.93 84.85 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 81' ' ' ALA . 19.8 m -68.67 -44.72 82.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.766 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.516 ' N ' HG23 ' A' ' 85' ' ' VAL . 2.9 tp-100 -50.13 -24.46 2.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tp -84.69 -41.1 16.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.629 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.8 p -49.0 -34.1 12.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.353 . . . . 0.0 110.396 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -62.53 -52.0 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.166 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -49.1 -31.88 8.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -75.45 -50.18 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.013 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 p -68.97 -54.17 16.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.985 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.537 ' O ' ' N ' ' A' ' 97' ' ' TYR . 30.6 ttm -50.08 -49.14 52.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.698 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.3 tp -67.49 -39.25 85.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.73 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 131' ' ' ALA . 6.5 tp-100 -63.08 -37.69 88.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.6 tp -97.44 -20.16 17.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.875 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' A' ' 93' ' ' MET . 8.8 t80 -127.93 79.58 73.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.797 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.91 155.17 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.619 2.213 . . . . 0.0 112.123 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 m -147.36 153.13 43.87 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.288 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.36 -1.59 9.22 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.555 2.17 . . . . 0.0 112.205 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -162.11 142.75 10.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.811 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -172.69 -0.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.556 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.3 m 46.26 92.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.587 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.1 m -72.22 -78.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.671 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.437 ' H ' ' H ' ' A' ' 106' ' ' PHE . 22.2 t0 -173.57 -1.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.683 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' H ' ' H ' ' A' ' 105' ' ' ASP . 17.0 m-85 44.05 80.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.522 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.425 ' O ' ' O ' ' A' ' 106' ' ' PHE . 44.7 mtm 58.46 151.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.605 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 108' ' ' VAL . 14.9 p -60.56 123.62 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.624 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -150.14 100.6 2.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.509 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -137.03 153.93 75.63 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.254 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 113' ' ' TRP . 88.8 Cg_exo -37.4 122.7 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.645 2.23 . . . . 0.0 112.195 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -75.97 20.05 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.499 ' CD1' ' C ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -88.53 9.06 25.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.211 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.1 tp -116.39 86.51 18.05 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.107 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.92 8.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.823 2.349 . . . . 0.0 113.003 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.624 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.5 tp -74.79 -28.12 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.018 0.437 . . . . 0.0 110.39 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 124' ' ' PHE . 66.6 m-20 -95.76 -40.42 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.22 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -66.69 -33.99 76.86 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -86.93 -19.23 29.12 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.837 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.98 79.3 10.07 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.617 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' O ' HG23 ' A' ' 125' ' ' VAL . 74.2 Cg_endo -79.51 -16.08 12.08 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.605 2.203 . . . . 0.0 112.096 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -79.86 -4.85 54.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.743 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 123' ' ' VAL . 21.3 t -128.77 45.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.194 0.521 . . . . 0.0 110.448 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.507 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 10.4 t80 -172.23 -39.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.336 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 121' ' ' PRO . 61.6 t -54.75 125.18 8.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.483 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.07 157.69 15.98 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.994 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 40' ' ' PRO . 42.1 t -173.39 103.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.533 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.45 -172.62 24.75 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.4 m-20 -92.18 143.94 25.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.685 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 27.3 m -93.95 134.49 36.29 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 86.79 -0.05 0.57 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.06 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -67.73 155.66 38.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.245 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -95.59 145.69 25.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.822 0.344 . . . . 0.0 110.365 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.411 ' OE1' ' O4 ' ' A' ' 201' ' ' UQ2 . 64.9 mt-30 -133.66 -29.23 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.75 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 36.9 t90 -174.41 145.54 0.99 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.194 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -138.91 167.72 21.42 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.082 0.467 . . . . 0.0 111.482 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.45 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 63.9 t80 -143.51 119.0 10.32 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.717 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 0.9 OUTLIER 78.27 17.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -177.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 140' ' ' LEU . . . 81.05 15.93 75.96 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 139' ' ' GLY . 8.1 mp -119.51 131.27 55.53 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.3 152.18 44.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.373 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.408 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 3.1 mtm -50.75 -52.34 57.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 142' ' ' MET . 82.9 Cg_exo -44.28 -38.92 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.339 2.026 . . . . 0.0 112.159 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -72.87 -49.14 31.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.026 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.614 ' O ' ' N ' ' A' ' 148' ' ' GLY . 48.7 m95 -56.71 -57.32 12.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 38.6 tp -42.83 -42.14 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.548 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.565 ' O ' HD23 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -54.66 -35.75 63.85 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -60.94 -39.98 97.74 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.615 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.9 mt -81.41 -30.71 11.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.773 0.32 . . . . 0.0 110.555 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -47.72 84.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.529 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 152' ' ' ALA . 2.1 pp -68.3 -41.08 83.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.564 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.537 ' N ' HD12 ' A' ' 151' ' ' ILE . . . -56.93 -49.57 75.24 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.106 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -51.46 -46.76 63.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 37.7 tp -52.8 -36.98 59.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.568 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 27.3 mm -68.78 -41.72 82.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.903 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 70.6 t -56.5 -37.66 52.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.918 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -75.47 -31.21 60.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.21 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.44 -27.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.351 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.15 -42.11 16.36 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.156 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 9.3 p -73.1 -31.87 36.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.195 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 157' ' ' ALA . 54.0 t -73.25 -50.36 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.578 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.3 mp -62.96 -22.96 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.998 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.496 ' OG ' ' NH1' ' A' ' 70' ' ' ARG . 24.1 p -57.2 -0.09 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.49 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.592 ' O ' ' N ' ' A' ' 166' ' ' PHE . 8.3 mt-30 -38.34 160.42 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -40.77 -13.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.751 2.301 . . . . 0.0 112.553 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.592 ' N ' ' O ' ' A' ' 164' ' ' GLN . 16.7 t80 58.27 109.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.359 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 43.8 tttm -101.14 -35.42 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.591 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -176.74 145.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -168.81 -44.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.409 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -97.31 -43.91 7.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.56 92.16 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.618 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -53.81 -178.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.397 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.65 -127.0 0.15 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.402 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 74.5 t80 45.43 93.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.813 0.339 . . . . 0.0 110.452 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -78.38 140.96 24.28 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 25.1 mtp85 -79.46 63.73 4.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.723 0.297 . . . . 0.0 110.591 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 52.49 40.78 55.04 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 77.9 m80 50.76 -106.03 0.22 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 110.485 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.505 ' O ' ' CD2' ' A' ' 180' ' ' HIS . 0.4 OUTLIER 172.77 168.11 0.12 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.441 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.505 ' CD2' ' O ' ' A' ' 179' ' ' HIS . 18.4 m-70 -148.58 155.08 40.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.311 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.615 ' CG ' ' H ' ' A' ' 182' ' ' HIS . 12.2 p80 -175.57 -61.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.615 ' H ' ' CG ' ' A' ' 181' ' ' HIS . 8.7 t60 -96.0 -88.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.482 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.414 ' CD2' ' N ' ' A' ' 183' ' ' HIS . 26.9 m170 . . . . . 0 C--O 1.219 -0.525 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.596 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.492 ' O4 ' ' NE2' ' A' ' 33' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 2' ' ' LEU . 0.2 OUTLIER -78.34 -36.53 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.078 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 45.7 mtt85 -60.46 -43.69 96.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.283 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 7' ' ' GLN . 42.4 t80 -62.21 -50.16 72.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.4 tp -46.96 -37.24 8.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.245 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 38.2 t-20 -69.82 -25.91 63.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.311 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 4' ' ' PHE . 85.9 mm-40 -82.4 -50.07 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.544 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.26 -33.63 73.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.653 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 11' ' ' GLY . 88.7 p -76.24 -34.57 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.416 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 0.4 OUTLIER -71.24 8.54 0.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.552 179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.72 141.62 15.56 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtt85 -69.9 -50.1 45.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.769 0.319 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.77 -45.12 5.7 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -47.06 86.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -60.63 -46.9 88.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.378 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.4 -30.27 68.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.94 0.4 . . . . 0.0 110.035 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.37 -30.27 68.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.398 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.1 mmt -73.45 -31.16 63.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.122 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.73 -53.47 13.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.655 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.17 -32.69 64.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.928 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.8 m -65.99 -61.81 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.569 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.09 -23.86 62.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -81.82 -42.1 20.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.429 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -49.53 -50.97 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.648 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.2 mp -61.48 -33.88 74.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.599 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.88 -41.89 88.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.713 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.2 mm? -79.81 -52.13 8.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -42.11 -40.53 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -78.04 -41.72 34.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.1 tp -55.36 -17.6 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.932 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -94.33 -35.34 12.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.607 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -55.82 -38.63 70.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.54 -35.29 60.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.555 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 1.5 t-80 -74.73 -10.12 59.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.294 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.7 t -109.18 -51.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.787 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.9 mtt -91.18 14.18 14.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.803 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.18 40.59 1.77 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.775 0.321 . . . . 0.0 110.721 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.0 mt -67.31 152.11 46.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.372 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -108.66 115.93 56.84 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.432 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.87 147.73 21.7 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.272 1.981 . . . . 0.0 112.188 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 129' ' ' ASP . 5.7 t -98.08 172.2 7.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.301 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 43' ' ' LEU . 8.3 p -59.46 -41.26 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.944 0.402 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HG13 ' A' ' 42' ' ' VAL . 76.4 mt -63.2 -45.27 92.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.056 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -48.84 -38.49 22.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.394 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.532 HG21 ' HA ' ' A' ' 124' ' ' PHE . 51.5 mt -69.49 -44.5 79.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.168 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.11 -45.59 92.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.818 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -57.79 -44.34 86.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.386 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -61.33 -29.01 69.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -39.76 77.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.45 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.22 74.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.638 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' VAL . 5.3 tp -76.59 -51.85 10.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.255 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -45.05 -39.96 6.23 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.25 -40.7 94.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 51' ' ' LEU . 41.5 t -64.02 -17.71 21.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 121.699 0.762 . . . . 0.0 109.273 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -74.49 -45.17 47.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.426 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.81 83.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.38 -40.06 67.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.865 0.364 . . . . 0.0 110.351 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.87 -31.45 69.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.141 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.94 -29.52 50.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.145 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.0 mt -79.08 -39.91 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.557 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -67.74 -33.19 79.71 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.18 9.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.697 0.284 . . . . 0.0 110.652 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' A' ' 61' ' ' GLY . 66.0 mt -78.41 -54.92 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.288 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -168.1 75.36 0.89 Allowed Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.831 0.348 . . . . 0.0 110.274 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 21.5 Cg_exo -61.67 14.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.974 2.449 . . . . 0.0 112.485 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 64' ' ' ALA . 13.8 ptpt -109.78 -3.58 16.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.123 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -114.84 161.03 31.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.685 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -39.4 -15.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.484 2.123 . . . . 0.0 112.297 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 67' ' ' THR . 6.2 mp -43.25 -35.24 1.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.721 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' SD ' ' A' ' 74' ' ' MET . 1.4 mtm-85 -40.24 -65.57 0.39 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.487 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.13 -15.87 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.619 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 75' ' ' VAL . 19.3 t -82.1 -46.37 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.298 -0.561 . . . . 0.0 111.722 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.23 -34.05 59.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.045 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.82 -8.55 2.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.329 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 72' ' ' VAL . 32.7 m -59.25 -42.7 87.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.54 0.686 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.522 ' N ' HG23 ' A' ' 75' ' ' VAL . 6.1 mt -87.76 -29.77 5.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.23 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.611 ' NE1' ' HB2' ' A' ' 157' ' ' ALA . 4.9 t-105 -63.77 -53.58 48.8 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.777 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.04 -43.89 90.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.508 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -47.32 -46.88 25.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.458 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.5 p -80.44 -21.63 41.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.67 -61.98 2.22 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.909 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -73.99 -44.08 55.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.541 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -75.17 -42.11 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.076 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 88' ' ' THR . . . -59.29 -48.61 85.12 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 81' ' ' ALA . 17.3 m -71.04 -38.31 71.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.128 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.41 ' N ' HG23 ' A' ' 85' ' ' VAL . 14.3 tm0? -72.84 -36.45 67.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.523 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -75.32 -49.32 19.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 84' ' ' GLY . 11.3 p -51.17 -49.1 61.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.573 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.53 -39.48 34.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 110.085 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -58.96 -41.69 88.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.379 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -66.78 -39.07 87.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.589 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -68.68 -35.02 76.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.469 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 97' ' ' TYR . 12.9 ttt -59.05 -44.13 91.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -59.59 -49.34 78.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.114 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -50.81 -49.24 58.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.179 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.1 mm? -82.91 -14.3 54.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.062 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.529 ' N ' ' O ' ' A' ' 93' ' ' MET . 30.9 t80 -141.89 70.75 24.26 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.37 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.44 ' N ' ' O ' ' A' ' 94' ' ' LEU . 76.5 Cg_exo -44.73 -71.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.785 2.324 . . . . 0.0 112.467 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.407 ' OG ' ' CE2' ' A' ' 97' ' ' TYR . 29.0 m 42.99 77.52 0.44 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.478 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -77.66 -158.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.582 2.188 . . . . 0.0 112.062 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.0 t80 72.89 159.73 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 63.66 14.42 8.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.67 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -157.62 -69.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.412 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 103' ' ' THR . 46.9 t 54.25 108.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.557 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.88 132.11 22.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.669 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -161.41 79.68 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.481 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 6.7 ttm 60.72 -147.96 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.346 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.5 p -152.04 135.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.723 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -99.52 99.55 10.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.888 0.375 . . . . 0.0 110.383 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.07 155.7 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.158 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.56 158.31 46.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.479 2.119 . . . . 0.0 111.671 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -100.66 -1.33 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.667 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.586 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -103.83 -1.56 27.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.421 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.61 ' C ' ' H ' ' A' ' 116' ' ' LEU . 1.7 tp -119.68 81.64 25.36 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.007 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 43.9 Cg_exo -53.24 4.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.547 2.165 . . . . 0.0 112.246 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.9 mm? -66.87 -30.18 70.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.06 0.457 . . . . 0.0 110.248 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD1' ' CZ ' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -96.78 -41.53 8.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.179 179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -71.12 -45.0 64.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.749 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 20.4 t-105 -75.26 -15.15 60.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.188 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.8 69.17 65.53 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.86 -20.23 9.16 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.734 2.289 . . . . 0.0 111.256 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -52.22 -53.89 37.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.504 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.3 t -108.92 55.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.732 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' HA ' HG21 ' A' ' 45' ' ' ILE . 2.1 t80 -157.89 -41.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.53 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.43 128.36 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.472 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.53 155.36 17.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.785 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 52.1 m -165.24 99.79 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.38 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.46 -173.37 23.1 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' O ' ' SG ' ' A' ' 41' ' ' CYS . 9.1 m-20 -97.26 165.15 12.17 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.3 m -116.19 127.68 54.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.78 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 100.03 -8.44 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.584 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.94 143.15 55.77 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.01 128.05 34.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -132.82 -23.36 2.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.102 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -173.17 127.04 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.932 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.23 163.65 29.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.297 0.57 . . . . 0.0 112.164 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.02 137.92 54.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.156 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 50.84 16.69 0.35 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.756 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.92 13.43 53.09 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.365 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.3 mt -123.83 145.09 49.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.176 0.488 . . . . 0.0 109.955 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.35 150.82 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.699 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.446 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.4 mtp -47.53 -54.44 22.5 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.679 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 142' ' ' MET . 79.8 Cg_exo -40.21 -37.78 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.43 2.087 . . . . 0.0 112.425 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -70.98 -47.18 60.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.947 0.403 . . . . 0.0 110.146 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.601 ' O ' ' N ' ' A' ' 148' ' ' GLY . 69.9 m95 -65.79 -57.98 6.72 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.953 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.7 OUTLIER -42.49 -36.31 1.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.947 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.432 ' N ' HD23 ' A' ' 146' ' ' LEU . 33.2 tp -66.49 -34.74 78.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -57.35 -35.86 73.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.0 mm -69.76 -44.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.886 0.374 . . . . 0.0 110.21 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -44.15 69.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.975 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.6 mt -55.77 -46.37 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.779 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.39 -50.22 74.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.26 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -61.95 -47.17 86.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 0.0 110.912 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.673 ' C ' HD23 ' A' ' 154' ' ' LEU . 7.9 tt -53.57 -30.98 44.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.131 0.491 . . . . 0.0 110.496 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 56.4 mt -79.66 -27.68 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.147 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.66 ' O ' HG22 ' A' ' 160' ' ' VAL . 70.2 t -75.0 -28.58 21.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.913 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.611 ' HB2' ' NE1' ' A' ' 77' ' ' TRP . . . -80.65 -39.63 26.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.785 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.21 -31.5 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.557 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.2 mt -78.7 -42.77 27.53 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.31 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 156' ' ' VAL . 28.4 m -71.26 -22.94 22.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.812 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 157' ' ' ALA . 21.1 t -77.68 -50.8 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.527 ' C ' ' H ' ' A' ' 164' ' ' GLN . 77.3 mt -64.62 -15.73 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.821 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 91.7 p -52.87 -6.21 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.528 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 162' ' ' ILE . 8.1 tt0 -144.05 83.1 10.47 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.382 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 167' ' ' LYS . 60.7 Cg_endo -77.52 25.02 0.49 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.37 2.046 . . . . 0.0 112.085 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 43.71 16.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.938 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 165' ' ' PRO . 81.5 tttt -90.48 134.46 34.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.545 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -44.7 153.69 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.535 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -139.18 22.24 2.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.231 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -74.87 -122.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 56.14 -155.44 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.591 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' CE1' ' A' ' 174' ' ' PHE . 14.2 t70 -154.89 81.75 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 174' ' ' PHE . 12.9 mt -76.42 2.67 12.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.583 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.445 ' CE1' ' OD2' ' A' ' 172' ' ' ASP . 53.1 m-85 58.14 119.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.736 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -76.73 -153.34 5.11 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.1 mtt-85 -146.25 -138.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 178' ' ' HIS . . . 173.56 -120.79 0.82 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.436 ' CG ' ' O ' ' A' ' 177' ' ' GLY . 57.1 m80 -157.01 140.83 16.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.318 . . . . 0.0 110.521 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -103.49 64.67 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.527 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 180' ' ' HIS . 0.5 OUTLIER -88.38 117.6 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.629 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 182' ' ' HIS . 0.1 OUTLIER -101.8 -102.77 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' A' ' 181' ' ' HIS . 4.2 m-70 -103.73 133.99 47.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.551 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.524 ' OXT' ' ND1' ' A' ' 183' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.218 -0.559 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.513 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.494 H153 HD23 ' A' ' 25' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 mmt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.88 -44.43 49.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.37 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 25.2 mtt85 -53.55 -28.86 34.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.06 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 7' ' ' GLN . 35.2 m-85 -76.94 -42.91 37.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.405 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -46.8 -42.73 17.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.324 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 7' ' ' GLN . 24.5 p30 -72.61 -23.0 60.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.5 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 48.4 tp60 -79.93 -48.51 13.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.554 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.61 -34.42 77.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.662 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 11' ' ' GLY . 19.7 m -76.53 -36.05 57.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.501 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -67.55 4.93 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -103.4 141.46 15.24 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.46 -46.2 87.34 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.99 -44.92 5.9 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.1 77.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -58.44 -43.28 88.72 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.196 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.3 mm? -67.04 -28.46 68.23 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.1 tp -69.34 -31.96 70.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.377 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.4 ' O ' ' OG1' ' A' ' 21' ' ' THR . 39.9 mtt -73.45 -32.87 64.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.02 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.4 -52.99 26.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.536 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.05 -49.63 50.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 18' ' ' MET . 16.2 p -53.42 -42.49 67.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.499 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.35 -24.11 67.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.642 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 35.5 mt -87.79 -42.11 12.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.515 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.11 -25.02 60.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.536 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 48.7 mt -79.14 -38.45 36.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.794 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.78 -47.07 64.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.54 -48.99 78.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.672 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.0 m -49.7 -47.64 50.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.566 ' O ' ' NE2' ' A' ' 33' ' ' GLN . . . -73.47 -28.25 61.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.538 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.56 -20.53 66.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.978 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -91.45 -32.26 15.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.888 0.375 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.513 ' O ' ' N ' ' A' ' 36' ' ' MET . 3.6 m-85 -58.23 -46.92 85.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.285 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.566 ' NE2' ' O ' ' A' ' 29' ' ' ALA . 1.0 OUTLIER -62.68 -49.41 75.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.78 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -24.04 18.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.773 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.4 t -109.23 -18.94 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.234 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.513 ' N ' ' O ' ' A' ' 32' ' ' PHE . 33.0 mmm -98.43 -3.17 37.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.85 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 37' ' ' LEU . 6.0 mp 53.88 39.81 30.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.93 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.81 HD12 ' NE2' ' A' ' 134' ' ' GLN . 1.0 OUTLIER -100.92 158.06 16.27 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -121.43 144.03 39.12 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.462 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.03 152.71 51.67 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.575 2.183 . . . . 0.0 112.2 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.551 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.7 t -115.81 -172.21 2.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.541 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.423 ' N ' ' SG ' ' A' ' 130' ' ' CYS . 12.6 t -63.81 -47.86 88.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.034 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 43' ' ' LEU . 9.7 mp -62.26 -49.1 77.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.436 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 t -48.53 -46.42 38.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 124' ' ' PHE . 49.2 mt -61.63 -43.11 96.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.366 . . . . 0.0 110.036 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.85 -47.48 77.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.148 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.05 -39.29 93.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.583 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -63.83 -37.3 86.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.356 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.89 -39.49 76.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.579 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.5 -49.36 74.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.581 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tt -76.67 -51.92 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.214 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -45.68 -38.69 7.06 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.33 -43.91 91.74 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 57' ' ' ALA . 25.5 t -61.47 -46.47 96.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.5 tt -43.24 -47.67 6.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.312 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.458 ' O ' HD13 ' A' ' 60' ' ' ILE . . . -62.08 -32.79 83.57 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -68.35 -31.45 70.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 0.0 110.299 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.99 -31.53 68.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.391 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.469 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 15.8 mt -76.63 -31.08 57.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.579 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 56' ' ' GLY . 1.4 mp -80.16 -36.68 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.848 0.356 . . . . 0.0 110.053 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.36 -23.0 78.2 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.22 6.93 5.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.611 0.243 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.4 mp -77.78 -51.11 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.131 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -172.84 74.82 0.42 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.444 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 23.03 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.739 2.293 . . . . 0.0 112.14 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.59 -10.37 19.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.233 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 69' ' ' LEU . 2.6 p -113.9 155.83 44.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.13 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -37.31 -17.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.808 2.338 . . . . 0.0 112.834 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.003 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.2 mm? -44.98 -31.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.588 ' NH1' HG22 ' A' ' 161' ' ' VAL . 3.5 mmp_? -34.32 -55.16 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -53.13 -36.31 60.65 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.951 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 69' ' ' LEU . 3.4 m -65.16 -39.86 86.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 119.874 -0.731 . . . . 0.0 111.816 -178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.24 -37.39 57.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.433 ' SD ' HG21 ' A' ' 161' ' ' VAL . 7.0 ttt -58.56 -14.36 7.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.468 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.8 t -55.08 -42.93 67.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.368 0.604 . . . . 0.0 110.585 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.8 mt -87.28 -31.14 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.644 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.474 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 6.2 t-105 -63.49 -55.4 24.33 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.729 -0.389 . . . . 0.0 110.113 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' ALA . 6.0 tt -65.57 -48.41 72.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.524 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.8 m-85 -42.84 -43.27 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.089 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 p -79.84 -22.43 42.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.791 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.45 -60.27 4.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.733 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -73.15 -55.08 6.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.005 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -65.95 -50.25 65.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -53.19 -47.44 61.18 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.49 ' O ' ' OG1' ' A' ' 88' ' ' THR . 77.0 t -66.42 -45.42 89.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.895 0.379 . . . . 0.0 110.654 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.33 -31.86 67.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.286 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.58 -44.98 61.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.183 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 85' ' ' VAL . 32.2 p -53.5 -27.0 23.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.004 0.43 . . . . 0.0 110.036 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -70.97 -51.51 25.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.46 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -48.47 -34.24 10.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.55 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -75.25 -55.21 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.607 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -55.32 -46.69 76.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.722 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.551 ' O ' ' N ' ' A' ' 97' ' ' TYR . 18.1 ttt -56.73 -43.03 80.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 tp -66.57 -22.99 66.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.059 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.405 ' C ' HD22 ' A' ' 96' ' ' LEU . 33.9 mt-30 -80.6 -32.97 36.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.993 0.425 . . . . 0.0 109.857 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 96' ' ' LEU . 4.1 mm? -98.67 -15.54 19.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.097 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.551 ' N ' ' O ' ' A' ' 93' ' ' MET . 63.6 t80 -137.6 71.78 50.95 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.717 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.453 ' O ' ' OG ' ' A' ' 99' ' ' SER . 60.2 Cg_endo -76.68 -89.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.537 2.158 . . . . 0.0 111.837 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 98' ' ' PRO . 94.4 p 52.67 70.74 1.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.733 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.1 -171.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.782 2.321 . . . . 0.0 111.988 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -163.37 -9.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.644 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.12 -132.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.509 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 78.6 m -155.95 103.14 2.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.485 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 105' ' ' ASP . 33.8 t -148.24 -141.32 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.499 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.43 ' N ' ' OG ' ' A' ' 104' ' ' SER . 37.7 t70 45.34 87.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -149.09 -62.08 0.23 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 26.1 ttt -101.73 118.56 37.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.43 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 108' ' ' VAL . 11.1 p -45.68 123.18 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.514 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -102.09 102.95 13.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.74 157.92 69.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.009 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -41.48 160.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.455 2.103 . . . . 0.0 111.877 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -104.64 0.01 28.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 43.3 p-90 -108.13 18.54 21.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.734 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.594 ' C ' ' H ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -120.97 83.33 37.4 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 50.4 Cg_exo -53.03 2.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.647 2.231 . . . . 0.0 112.102 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.594 ' H ' ' C ' ' A' ' 114' ' ' LEU . 10.0 mp -63.63 -31.1 72.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.638 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -97.02 -44.05 7.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.739 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -70.34 -45.58 65.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.708 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.471 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 15.7 t-105 -73.13 -15.05 61.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.044 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.98 74.89 11.96 Favored Pre-proline 0 N--CA 1.462 0.164 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.46 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -12.62 13.82 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.907 2.405 . . . . 0.0 112.092 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -53.93 -54.12 43.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.839 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.436 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 8.5 t -106.94 60.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.058 0.456 . . . . 0.0 110.72 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.621 ' O ' HD13 ' A' ' 45' ' ' ILE . 4.7 m-85 -164.68 -41.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.147 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.07 125.13 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.442 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.57 152.01 21.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.494 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 24.1 m -162.95 99.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.642 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 138.25 179.45 17.15 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.442 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.8 OUTLIER -80.37 143.49 33.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.892 0.377 . . . . 0.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 30.2 m -93.52 131.85 38.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 85.89 0.56 0.67 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.208 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' OE1' ' OD1' ' A' ' 129' ' ' ASP . 39.9 tt0 -68.31 128.65 37.36 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.216 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.72 116.49 8.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.344 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.81 ' NE2' HD12 ' A' ' 38' ' ' LEU . 62.8 mt-30 -104.19 -29.6 10.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.662 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -173.8 147.83 1.39 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -141.21 161.6 37.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.362 0.601 . . . . 0.0 112.054 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.25 138.59 54.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.84 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.44 17.1 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.303 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 87.94 22.82 40.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 7.2 mt -124.72 136.0 53.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.42 148.81 50.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.743 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.432 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.5 mtt -48.74 -52.74 42.99 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.67 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 142' ' ' MET . 81.8 Cg_exo -43.51 -35.96 6.48 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.286 1.99 . . . . 0.0 112.033 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.65 -46.55 58.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.321 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.603 ' O ' ' N ' ' A' ' 148' ' ' GLY . 78.0 m95 -64.52 -57.7 8.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.233 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.2 tp -43.53 -39.26 3.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.104 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.9 -33.75 74.79 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.63 -40.6 94.91 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -72.68 -31.76 38.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.635 0.255 . . . . 0.0 110.632 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.05 -39.62 86.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.502 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.2 tp -70.94 -37.05 66.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.139 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.16 -53.33 46.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.16 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -60.43 -38.52 84.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 0.0 110.224 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.705 ' C ' HD23 ' A' ' 154' ' ' LEU . 7.2 tt -54.53 -37.84 65.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.26 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 54.4 mt -75.55 -40.64 41.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 160' ' ' VAL . 73.8 t -48.96 -39.34 11.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.535 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -76.01 -43.63 43.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.963 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.58 -36.02 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.113 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.14 -32.72 22.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.497 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 156' ' ' VAL . 54.2 t -77.76 -25.01 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.259 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.588 HG22 ' NH1' ' A' ' 70' ' ' ARG . 92.6 t -83.33 -50.75 15.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 110.32 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.498 ' C ' ' H ' ' A' ' 164' ' ' GLN . 1.4 mp -66.84 -22.54 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.716 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 160' ' ' VAL . 9.1 p -52.81 -7.84 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.517 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 162' ' ' ILE . 26.2 mt-30 -47.92 152.76 1.29 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.408 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -37.5 -30.26 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.758 2.305 . . . . 0.0 112.294 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 164' ' ' GLN . 0.5 OUTLIER -85.52 111.15 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.37 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 168' ' ' ALA . 19.3 pttm -167.86 -36.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.65 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 167' ' ' LYS . . . 59.6 146.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.605 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -163.8 40.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.51 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -158.32 -30.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.401 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 173' ' ' LEU . 43.3 ttt85 49.4 -100.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.551 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' A' ' 172' ' ' ASP . 54.0 t0 45.94 17.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.711 0.291 . . . . 0.0 110.587 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 171' ' ' ARG . 9.3 tp -80.62 75.78 7.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.491 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -97.57 -27.71 14.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.476 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -155.71 127.75 2.1 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 21.5 mtm-85 -79.01 82.84 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.653 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -105.48 52.77 0.69 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -157.49 -21.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.6 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -155.5 79.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.685 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 0.9 OUTLIER -87.62 11.48 14.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.374 179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 t60 63.15 108.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -149.34 104.27 3.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.389 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.542 -179.828 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.423 ' H71' H5M1 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.1 tp -62.79 -51.11 68.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.149 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -47.92 -34.66 9.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -70.41 -38.21 74.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.991 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.9 tp -50.97 -40.17 57.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.225 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -66.62 -29.39 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.019 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -74.95 -49.82 18.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.499 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' ALA . . . -66.16 -34.39 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.799 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 54.1 p -75.52 -33.94 60.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.643 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -75.17 14.98 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.419 . . . . 0.0 110.189 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -108.57 150.26 17.02 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.6 ttm105 -67.9 -20.7 65.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.556 -0.322 . . . . 0.0 110.392 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -40.75 86.88 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 8' ' ' ALA . . . -65.36 -51.56 59.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.355 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.465 ' NE1' ' O ' ' A' ' 9' ' ' SER . 19.4 m0 -54.08 -42.55 69.44 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.375 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.9 tp -72.5 -30.89 64.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 tp -68.55 -32.59 72.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -75.04 -33.87 61.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.86 -51.99 48.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.723 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -53.87 -52.05 61.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.682 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.1 m -46.03 -61.98 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.696 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.8 -30.39 14.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.569 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.97 -40.8 53.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.355 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.04 -40.84 46.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.704 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.5 mp -69.21 -36.75 77.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.581 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.36 -49.37 69.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.65 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 tt -61.72 -50.95 70.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.698 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 p -53.65 -42.34 67.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.053 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.33 65.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.035 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -20.86 65.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.66 -0.246 . . . . 0.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.424 ' O ' ' N ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -84.95 -41.63 15.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.135 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -50.97 -43.67 60.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.0 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -77.43 -40.52 43.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -71.07 -16.59 62.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.772 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' A' ' 31' ' ' TRP . 66.1 t -109.34 -50.05 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.18 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mtt -90.75 14.71 12.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.303 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp 41.16 37.54 0.6 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.508 HD23 ' CM3' ' A' ' 201' ' ' UQ2 . 3.9 tp -63.43 155.58 28.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.483 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.1 mtpt -120.25 90.93 45.62 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.967 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.11 147.52 19.95 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.567 2.178 . . . . 0.0 112.083 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.615 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 6.4 t -99.0 -173.23 2.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.779 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 t -67.19 -46.75 83.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.628 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.496 HD12 ' CG ' ' A' ' 91' ' ' HIS . 4.1 mm? -65.99 -47.02 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.216 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 m -49.19 -47.19 46.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.574 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.17 -39.95 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.235 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -54.67 -49.69 70.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.738 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -58.8 -39.71 81.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.435 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 tpt85 -58.68 -38.93 79.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.119 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.21 -39.52 94.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.506 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.91 82.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.9 tp -76.57 -50.4 13.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.337 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -44.11 -42.85 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.33 -41.41 96.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.47 -17.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.352 0.596 . . . . 0.0 109.901 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tp -81.79 -41.42 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.052 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.27 -30.89 76.0 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.28 -35.15 59.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.961 0.41 . . . . 0.0 110.151 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.78 97.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.375 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.1 -42.42 94.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.078 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.61 -38.86 82.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.538 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.04 -21.0 78.29 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.68 3.64 32.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.685 0.279 . . . . 0.0 110.669 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.2 mt -82.13 -49.06 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.936 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 179.15 77.09 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.769 0.319 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -82.25 21.35 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.892 2.395 . . . . 0.0 112.323 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -96.7 -8.37 31.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.116 0.484 . . . . 0.0 109.939 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.578 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -109.82 177.91 1.13 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.532 179.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 67' ' ' THR . 56.1 Cg_exo -50.49 -0.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.258 1.972 . . . . 0.0 112.278 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 67' ' ' THR . 17.2 mt -62.33 -28.33 69.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.582 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' NH1' ' CD ' ' A' ' 164' ' ' GLN . 1.8 mtp180 -41.76 -64.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.573 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 75' ' ' VAL . 37.9 m-85 -55.5 -38.69 69.51 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.714 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -57.85 -54.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.546 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.03 -33.62 73.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.208 0.527 . . . . 0.0 110.314 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.4 ' SD ' HG11 ' A' ' 161' ' ' VAL . 8.1 ttt -64.56 -25.48 68.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.774 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 71' ' ' TYR . 42.1 t -52.56 -32.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.457 0.646 . . . . 0.0 110.718 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.9 mp -88.88 -31.56 5.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.097 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.489 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 4.7 t-105 -65.98 -49.08 69.1 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.9 tp -68.33 -43.51 77.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.219 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -46.87 -46.28 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.298 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.2 p -79.61 -21.48 44.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.742 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.477 ' HA ' HD21 ' A' ' 154' ' ' LEU . . . -59.61 -60.47 3.8 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.032 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -76.14 -48.47 20.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.085 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -67.77 -43.83 78.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.602 ' O ' HG23 ' A' ' 88' ' ' THR . . . -60.6 -47.64 90.14 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.87 -32.39 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.217 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.58 -28.6 65.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.753 0.311 . . . . 0.0 110.926 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.39 -41.35 13.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.864 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 84' ' ' GLY . 12.7 p -51.93 -51.88 53.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.727 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -51.84 -48.36 63.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.137 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.09 -44.28 7.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.908 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.496 ' CG ' HD12 ' A' ' 43' ' ' LEU . 2.0 m-70 -62.82 -44.8 95.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.327 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.3 p -61.29 -47.75 84.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.336 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.464 ' O ' ' N ' ' A' ' 97' ' ' TYR . 15.3 tpt -45.5 -45.51 13.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.264 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.9 tp -64.94 -43.65 92.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.162 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.407 ' OE1' ' OE1' ' A' ' 141' ' ' GLU . 6.7 tt0 -58.67 -48.56 80.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.351 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 96' ' ' LEU . 9.5 mp -80.62 -17.37 51.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.192 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 93' ' ' MET . 11.1 t80 -133.96 67.05 73.63 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' A' ' 97' ' ' TYR . 78.4 Cg_exo -46.53 -177.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.95 2.433 . . . . 0.0 112.471 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.4 p -171.85 66.88 0.42 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.337 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -44.97 -38.48 13.49 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.82 2.346 . . . . 0.0 112.255 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.14 101.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.29 140.05 57.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.443 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 p -142.45 -58.8 0.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.55 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 70.1 m -166.58 134.68 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.673 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -144.39 141.22 29.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.505 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -88.55 138.42 31.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.633 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.521 ' C ' ' H ' ' A' ' 109' ' ' ARG . 16.9 mtt -154.6 116.16 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.422 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.8 t 59.36 -1.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.678 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 107' ' ' MET . 13.5 mmt180 -89.7 99.57 12.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.907 0.384 . . . . 0.0 110.47 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.5 154.93 81.74 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.907 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -39.48 119.96 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.405 2.07 . . . . 0.0 111.956 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.3 -2.69 26.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.362 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -99.7 2.26 44.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.251 179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.0 tp -119.88 85.09 33.49 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 35.2 Cg_exo -56.14 16.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.668 2.245 . . . . 0.0 112.638 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 114' ' ' LEU . 12.1 tp -77.14 -30.85 55.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.029 0.442 . . . . 0.0 110.312 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -97.75 -40.28 8.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.098 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -70.61 -45.32 65.49 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 2.6 t90 -76.19 -11.64 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.334 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.0 t -143.46 71.19 17.75 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.831 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 125' ' ' VAL . 72.4 Cg_endo -77.77 -14.91 15.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.763 2.308 . . . . 0.0 111.766 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -57.33 -53.27 59.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.827 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.6 53.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.054 0.455 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -158.14 -39.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.287 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 121' ' ' PRO . 42.2 t -54.97 123.92 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.605 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.18 158.17 15.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.648 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.56 104.24 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.501 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 140.04 -177.06 20.88 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 34.8 t70 -89.33 139.69 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.776 0.322 . . . . 0.0 110.284 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.686 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 54.6 m -91.47 134.65 34.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.118 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 86.52 -1.09 0.64 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.095 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -68.0 153.2 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.376 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.95 119.01 37.57 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -122.68 -12.61 8.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.719 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -173.3 127.92 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.796 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -140.32 160.97 38.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.266 0.555 . . . . 0.0 112.179 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -118.66 137.31 53.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.862 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mt 50.64 17.19 0.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.593 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 90.44 21.5 37.52 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.593 HD22 ' O ' ' A' ' 139' ' ' GLY . 3.2 mm? -122.46 134.5 54.58 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.407 ' OE1' ' OE1' ' A' ' 95' ' ' GLN . 8.1 mt-10 -69.16 148.6 49.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.669 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.434 ' N ' ' CD ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -49.18 -51.93 52.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.715 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 142' ' ' MET . 89.4 Cg_exo -44.01 -38.74 10.65 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.426 2.084 . . . . 0.0 112.119 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -70.32 -49.6 47.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.581 ' O ' ' N ' ' A' ' 148' ' ' GLY . 63.3 m95 -60.85 -57.11 14.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.291 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.4 tp -43.03 -39.9 2.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.178 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 143' ' ' PRO . 1.5 mm? -60.84 -34.82 75.15 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.91 -45.12 95.55 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.4 mt -75.9 -34.45 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.955 0.407 . . . . 0.0 110.131 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -54.71 -47.58 73.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.5 mt -64.75 -42.88 96.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.491 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -47.33 -45.95 24.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.403 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -64.02 -42.97 96.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.936 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 158' ' ' VAL . 6.4 mp -51.97 -32.89 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 155' ' ' ILE . 1.7 mp -81.94 -27.78 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.639 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.2 t -63.45 -33.35 60.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.792 0.329 . . . . 0.0 110.235 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.54 -49.98 10.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.308 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 154' ' ' LEU . 65.3 t -53.79 -37.0 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.547 -178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' A' ' 159' ' ' LEU . 4.0 mm? -84.87 -33.68 22.77 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.128 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 156' ' ' VAL . 17.4 t -70.07 -29.3 39.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.422 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 162' ' ' ILE . 30.7 m -83.09 -46.79 18.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.578 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.54 ' N ' HG23 ' A' ' 161' ' ' VAL . 10.0 mt -71.73 -8.87 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.53 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 m -76.01 0.11 19.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.627 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.476 ' CB ' ' CD ' ' A' ' 165' ' ' PRO . 0.0 OUTLIER -63.45 -64.86 2.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 164' ' ' GLN . 18.9 Cg_endo -58.22 -0.71 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.547 2.164 . . . . 0.0 112.129 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.453 ' H ' ' C ' ' A' ' 164' ' ' GLN . 76.6 t80 -40.9 132.33 2.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.427 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.531 ' NZ ' ' NH2' ' A' ' 176' ' ' ARG . 18.0 ttpt -152.52 116.5 4.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.64 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -162.28 -52.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.592 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.46 167.98 17.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -143.63 129.38 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.612 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -80.96 -30.05 35.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.37 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -155.97 -126.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.214 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.574 ' CD2' ' H ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -72.35 -62.3 1.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.104 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.7 t80 42.16 89.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.522 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -80.59 -101.62 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.531 ' NH2' ' NZ ' ' A' ' 167' ' ' LYS . 7.3 tpt180 -149.88 -149.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.337 . . . . 0.0 110.357 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 176.57 108.3 0.22 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -127.3 -32.16 2.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.762 0.315 . . . . 0.0 110.401 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -84.58 116.53 23.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.508 ' ND1' ' O ' ' A' ' 180' ' ' HIS . 0.7 OUTLIER -155.58 22.74 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.385 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.601 ' CG ' ' H ' ' A' ' 182' ' ' HIS . 2.0 t60 -76.58 -176.07 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.501 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.601 ' H ' ' CG ' ' A' ' 181' ' ' HIS . 0.0 OUTLIER -162.96 28.26 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.634 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 183' ' ' HIS . 19.7 t-160 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.621 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.508 ' CM3' HD23 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 mtt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -68.25 -42.79 79.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.089 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -53.58 -34.52 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.582 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -72.31 -41.62 66.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.825 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -50.01 -43.81 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.385 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -64.83 -29.2 70.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.003 0.43 . . . . 0.0 110.277 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -78.5 -47.76 16.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.934 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.25 -37.63 88.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.806 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 11' ' ' GLY . 21.8 p -76.63 -35.39 58.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.673 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.474 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 6.4 tt0 -68.83 4.9 1.27 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.05 0.452 . . . . 0.0 110.405 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -101.79 146.99 17.31 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 63' ' ' ILE . 65.1 mtt180 -69.47 -48.84 59.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.667 0.27 . . . . 0.0 110.81 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.05 -46.32 6.26 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.93 -46.99 86.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.258 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -59.13 -42.17 89.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.97 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.2 mm? -63.82 -28.08 69.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -70.0 -27.71 64.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.518 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.415 ' O ' ' OG1' ' A' ' 21' ' ' THR . 23.0 mmt -76.47 -33.91 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.161 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.12 -54.48 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.604 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -52.13 -51.83 55.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.654 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 18' ' ' MET . 11.0 p -45.41 -61.7 1.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.49 49.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.65 -40.04 80.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.588 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 28' ' ' THR . . . -52.52 -37.91 58.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.6 mp -75.5 -38.53 59.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.512 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -64.16 -46.47 83.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.82 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 tp -67.63 -55.15 14.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 24' ' ' ALA . 14.4 p -45.45 -40.81 8.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.71 -42.25 51.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.821 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.539 ' O ' HD23 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -54.04 -18.57 3.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.831 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.434 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.7 t-105 -88.92 -35.32 16.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.955 0.407 . . . . 0.0 110.554 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -32.22 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.171 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.641 HE21 ' CB ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -73.44 -47.65 39.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.445 ' O ' ' CD2' ' A' ' 34' ' ' HIS . 20.8 t60 -70.89 -7.38 45.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.941 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 31' ' ' TRP . 71.7 t -109.14 -42.18 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.029 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.7 mtp -99.85 12.46 36.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.075 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 37' ' ' LEU . 9.3 mp 42.9 38.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.061 0.458 . . . . 0.0 110.411 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.641 ' CB ' HE21 ' A' ' 33' ' ' GLN . 23.8 mt -74.59 156.29 36.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.894 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' H ' ' HD3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -115.4 126.51 27.7 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.195 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.05 137.43 17.32 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 122.234 1.956 . . . . 0.0 111.836 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.7 t -92.25 -178.05 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.565 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.07 -46.43 93.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.05 -48.32 82.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.094 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.5 m -48.65 -45.76 39.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.518 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.59 HD13 ' O ' ' A' ' 124' ' ' PHE . 59.2 mt -61.38 -43.41 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 0.0 110.051 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -48.16 73.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.905 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -63.22 -36.4 83.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.721 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -68.24 -38.27 81.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.74 79.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.732 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.06 -49.19 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -76.69 -50.45 13.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.199 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -46.47 -39.92 11.49 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.54 -0.464 . . . . 0.0 109.96 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.88 -44.29 89.4 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.59 -47.35 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.986 0.422 . . . . 0.0 109.866 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.0 tt -45.41 -49.73 12.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.537 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.34 -49.71 75.55 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.83 -34.92 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.366 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.63 76.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.278 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 tp -68.3 -36.91 80.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.718 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -73.55 -35.88 46.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.447 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.94 -15.32 79.3 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.82 3.59 32.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.605 0.24 . . . . 0.0 111.199 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.439 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 2.8 pt -91.19 -23.29 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.813 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.08 67.5 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.79 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -79.87 15.67 1.61 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.82 2.347 . . . . 0.0 112.027 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -102.38 -8.96 20.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.681 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.624 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.98 163.37 17.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.066 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.04 3.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.574 2.182 . . . . 0.0 112.607 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.019 ' O ' HG22 ' A' ' 72' ' ' VAL . 6.7 mp -67.06 -30.19 70.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.71 0.291 . . . . 0.0 110.918 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.501 ' HD3' ' H ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -38.66 -42.82 0.83 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.608 -179.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.501 ' H ' ' HD3' ' A' ' 70' ' ' ARG . 75.7 t80 -59.69 -37.95 80.22 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.672 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.019 HG22 ' O ' ' A' ' 69' ' ' LEU . 4.2 m -59.62 -38.15 74.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.253 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.09 -30.51 22.52 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.716 -0.615 . . . . 0.0 110.114 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.542 ' SD ' HG21 ' A' ' 161' ' ' VAL . 11.8 ttp -67.75 -33.14 74.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.911 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 1.3 m -50.03 -28.57 4.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.562 0.696 . . . . 0.0 110.578 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.23 -31.56 5.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.976 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.439 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 13.8 t-105 -66.51 -47.6 72.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.81 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.7 tp -68.51 -47.85 65.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.439 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -43.98 -42.14 5.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.345 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.7 p -79.19 -24.28 43.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.583 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.37 -58.89 6.59 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.282 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.605 ' CE2' ' NE2' ' A' ' 86' ' ' GLN . 73.5 t80 -74.2 -52.35 12.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.392 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 ttt-85 -66.66 -40.86 88.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.15 -46.25 93.62 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.427 ' O ' ' OG1' ' A' ' 88' ' ' THR . 95.2 t -72.84 -36.77 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.467 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 82' ' ' PHE . 7.6 tt0 -67.48 -45.95 74.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.824 0.345 . . . . 0.0 110.794 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 tp -65.15 -42.96 93.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.568 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 84' ' ' GLY . 6.6 p -51.46 -47.63 63.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.401 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -48.07 -41.81 27.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.102 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -59.82 -38.51 82.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.144 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.605 ' HD1' ' C ' ' A' ' 91' ' ' HIS . 1.7 t-80 -69.41 -56.07 8.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.387 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.4 p -55.72 -52.14 64.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.706 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' TYR . 35.4 tpp -48.76 -45.23 39.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.571 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.6 tp -64.44 -44.77 90.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.491 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -62.53 -42.47 99.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.393 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 44.4 tp -82.69 -22.45 34.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.57 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.509 ' N ' ' O ' ' A' ' 93' ' ' MET . 27.0 t80 -136.31 68.56 61.81 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.682 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.26 160.28 0.92 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.771 2.314 . . . . 0.0 112.131 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -170.94 151.68 3.35 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.418 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -38.97 159.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.53 2.153 . . . . 0.0 112.197 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' A' ' 101' ' ' PHE . 22.5 p90 -113.42 115.95 28.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.53 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -166.19 -53.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.537 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 88.0 m -69.12 126.89 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.566 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 37.5 m 49.69 89.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.562 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 106' ' ' PHE . 27.6 t70 -160.13 169.68 22.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.585 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CG ' ' C ' ' A' ' 105' ' ' ASP . 0.7 OUTLIER 174.47 -177.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.469 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.563 ' C ' ' H ' ' A' ' 109' ' ' ARG . 5.9 ptt? -160.13 132.01 6.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.649 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 108' ' ' VAL . 25.1 t 59.37 -4.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' A' ' 107' ' ' MET . 10.9 ttm180 -87.95 99.91 12.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.51 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -115.0 149.95 43.37 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.346 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -37.99 138.14 0.41 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.487 2.125 . . . . 0.0 112.044 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -99.75 18.32 18.47 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.779 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.411 ' O ' HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -125.15 -5.96 7.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.432 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.623 ' C ' ' H ' ' A' ' 116' ' ' LEU . 6.8 mp -119.8 84.42 31.53 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.112 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 32.3 Cg_exo -55.15 11.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.568 2.179 . . . . 0.0 112.264 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.623 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.8 mm? -71.04 -32.74 69.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.914 0.388 . . . . 0.0 110.086 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 2.0 p30 -97.63 -39.0 9.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.068 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 21.3 tttm -72.08 -45.26 61.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.074 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.48 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 1.8 t90 -76.34 -11.65 59.94 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.258 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.17 68.86 48.57 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.707 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.51 -17.03 11.58 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -51.64 -33.99 35.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.28 45.94 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.586 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.59 ' O ' HD13 ' A' ' 45' ' ' ILE . 1.3 m-85 -149.55 -36.48 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.46 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.9 p -54.8 124.32 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.438 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.97 148.95 23.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.533 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.0 t -164.98 101.81 0.77 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.584 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.66 -175.24 21.15 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.6 m-20 -92.33 150.88 20.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.683 0.278 . . . . 0.0 110.323 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 11.9 m -100.74 132.07 46.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.945 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.56 -4.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.01 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -67.97 150.58 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.057 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -96.11 133.2 40.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 0.0 110.48 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.647 ' NE2' ' N ' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -128.52 -22.5 3.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.732 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.647 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 21.6 t-105 -173.17 136.42 0.63 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.004 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 5.3 p30 -140.77 157.25 45.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 111.964 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.08 138.43 50.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.952 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.3 tp 50.33 17.07 0.31 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.48 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.77 21.71 35.81 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.171 -0.538 . . . . 0.0 111.808 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.42 ' HB2' ' HE1' ' A' ' 145' ' ' TRP . 5.0 mt -124.86 137.27 54.3 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.33 148.86 49.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.851 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.462 ' SD ' H163 ' A' ' 201' ' ' UQ2 . 3.9 mtt -47.89 -53.15 34.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.804 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -43.49 -37.35 7.7 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.419 2.079 . . . . 0.0 112.352 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -71.29 -50.33 33.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.993 0.425 . . . . 0.0 110.113 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.586 ' O ' ' N ' ' A' ' 148' ' ' GLY . 74.0 m95 -60.28 -57.84 11.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.09 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 36.7 tp -43.49 -37.8 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.062 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.512 ' CD1' HG21 ' A' ' 88' ' ' THR . 11.7 tp -61.13 -34.94 75.8 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.72 -45.34 94.95 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 149' ' ' ILE . 3.4 mp -75.61 -31.88 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -57.12 -49.17 76.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.143 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.0 mt -60.42 -46.68 94.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.537 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -50.42 -46.5 56.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.369 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -55.25 -43.24 74.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 158' ' ' VAL . 9.2 mt -61.08 -30.58 70.43 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.869 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.62 -32.03 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.056 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 160' ' ' VAL . 70.3 t -64.55 -37.6 80.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.78 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.459 ' O ' HG23 ' A' ' 161' ' ' VAL . . . -80.29 -46.32 16.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.147 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 154' ' ' LEU . 54.7 t -53.88 -44.01 59.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.37 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.2 tp -78.42 -33.0 48.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.319 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 156' ' ' VAL . 42.0 t -74.79 -22.97 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.882 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.542 HG21 ' SD ' ' A' ' 74' ' ' MET . 46.2 t -82.17 -50.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.098 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.497 ' HA ' HE22 ' A' ' 164' ' ' GLN . 69.3 mt -67.67 -17.34 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.796 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 164' ' ' GLN . 17.7 p -70.88 -39.27 72.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.497 HE22 ' HA ' ' A' ' 162' ' ' ILE . 1.2 mp0 57.69 156.27 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -70.96 28.73 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.508 2.139 . . . . 0.0 111.826 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' H ' ' C ' ' A' ' 164' ' ' GLN . 5.8 t80 -51.51 151.82 2.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.503 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -143.0 113.51 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.525 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.08 164.01 22.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -70.06 -109.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -124.01 -42.19 2.17 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.387 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 52.11 102.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.544 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -163.36 -28.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.683 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.9 mt 48.63 -121.1 1.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.449 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.33 88.63 3.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.594 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -99.49 -116.05 3.77 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 6.2 tpp85 62.63 138.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.741 0.305 . . . . 0.0 110.64 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -177.96 2.71 0.03 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -52.56 -34.26 49.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -83.22 146.03 28.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.538 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 181' ' ' HIS . 18.2 m-70 -88.28 149.26 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.509 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.503 ' C ' ' H ' ' A' ' 183' ' ' HIS . 0.8 OUTLIER 53.79 168.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.49 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 70.39 -38.58 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.608 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 181' ' ' HIS . 1.5 m-70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.295 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.472 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 mtt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.49 -42.93 51.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.058 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -54.41 -31.59 55.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.31 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 7' ' ' GLN . 12.6 t80 -74.89 -42.77 57.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.193 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -47.97 -38.49 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.354 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -70.75 -27.05 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.448 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 4' ' ' PHE . 7.1 tm0? -75.55 -49.94 17.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.23 -27.52 69.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 0.0 110.308 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 m -76.51 -42.66 42.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.254 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -70.15 5.81 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.99 0.424 . . . . 0.0 110.684 -179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.69 142.66 16.2 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -69.0 -49.84 54.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.586 0.231 . . . . 0.0 110.713 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.86 -45.72 5.91 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -47.09 87.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -61.03 -37.07 81.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.26 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -32.34 70.66 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.95 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.3 tp -69.82 -36.61 75.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.469 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.478 ' C ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -66.44 -34.79 78.73 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 -49.94 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.76 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -51.65 -41.87 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.9 m -64.39 -46.62 82.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.9 0.381 . . . . 0.0 110.656 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.59 72.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.755 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 tt -81.82 -42.08 20.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.478 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 28' ' ' THR . . . -55.91 -26.92 49.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.662 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -77.35 -39.82 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.542 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -63.2 -54.54 35.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.657 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -56.23 -50.48 71.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.608 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 24' ' ' ALA . 8.9 p -49.91 -43.69 49.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.999 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.75 59.83 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.144 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.44 -17.29 19.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.849 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 32.2 t90 -93.4 -37.63 11.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.702 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -55.78 -46.22 78.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.404 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 38' ' ' LEU . 7.3 tm0? -73.3 -36.21 66.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.63 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -61.25 -22.44 64.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.652 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.1 t -107.88 -28.64 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.805 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 22.6 mmt -92.03 3.27 55.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.999 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.3 mt 47.4 48.54 16.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.881 0.372 . . . . 0.0 110.55 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' H ' ' HG2' ' A' ' 33' ' ' GLN . 93.6 mt -93.13 155.04 17.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.829 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -117.19 127.17 26.88 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.075 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.84 148.82 28.78 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.296 1.997 . . . . 0.0 112.368 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.2 t -94.58 173.57 7.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.994 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -58.32 -35.87 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 110.076 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -64.71 -45.55 86.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.802 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 m -48.94 -47.53 43.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.733 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.448 HG12 ' N ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -61.4 -38.29 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.448 ' N ' HG12 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -61.35 -46.19 91.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.838 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -65.1 -51.77 59.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.526 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.536 ' NH1' HG21 ' A' ' 123' ' ' VAL . 0.0 OUTLIER -58.55 -35.51 72.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.35 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.98 -42.38 85.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.564 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.56 70.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.148 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.706 HD23 ' C ' ' A' ' 51' ' ' LEU . 7.0 tt -71.26 -53.71 13.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.026 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -44.84 -40.2 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.45 -44.27 93.44 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 57' ' ' ALA . 60.2 t -59.91 -47.53 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.186 0.517 . . . . 0.0 109.872 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.6 -45.39 13.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.329 179.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.79 -27.59 71.37 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -70.53 -37.68 74.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.059 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.42 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.952 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 tp -68.69 -37.54 79.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.385 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.6 mt -75.51 -36.59 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.651 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.87 -34.3 59.23 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.49 2.93 2.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.716 0.293 . . . . 0.0 110.755 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 88.7 mt -77.97 -47.42 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.512 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -176.06 78.37 0.28 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.493 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.06 25.82 0.56 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.749 2.299 . . . . 0.0 112.021 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.82 -10.93 18.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.175 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.592 ' C ' ' H ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.48 176.46 1.48 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.485 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.96 -2.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.258 1.972 . . . . 0.0 111.874 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.592 ' H ' ' C ' ' A' ' 67' ' ' THR . 5.2 tt -47.79 -37.17 13.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.499 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.486 ' O ' ' SD ' ' A' ' 74' ' ' MET . 3.8 mmp_? -38.8 -67.16 0.22 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.827 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 75' ' ' VAL . 81.8 t80 -52.49 -28.46 20.51 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.82 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 69' ' ' LEU . 5.6 t -71.77 -47.04 58.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.715 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.61 -34.51 53.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.266 0.555 . . . . 0.0 110.484 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -63.2 -11.54 21.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.678 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.536 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 3.0 t -58.39 -38.96 72.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.372 0.606 . . . . 0.0 110.027 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -87.65 -32.54 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.309 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.6 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 12.4 t-105 -64.63 -53.69 43.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.169 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ALA . 7.0 tp -64.85 -47.22 78.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.832 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.7 m-85 -44.16 -42.2 6.23 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.4 p -78.95 -22.36 45.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.834 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.75 -59.99 4.5 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.927 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -73.76 -55.02 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.218 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.3 ttm-85 -66.35 -45.73 79.2 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' THR . . . -57.58 -46.57 91.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' O ' ' OG1' ' A' ' 88' ' ' THR . 86.7 t -70.77 -52.51 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.959 0.409 . . . . 0.0 110.276 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -52.06 -29.41 21.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.295 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.8 tp -80.16 -43.6 21.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.359 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' GLY . 61.5 p -52.44 -22.21 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.196 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -73.48 -51.7 16.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.36 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -50.13 -36.27 29.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.718 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -72.72 -36.51 67.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 88' ' ' THR . 40.4 p -74.99 -43.8 51.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.719 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 97' ' ' TYR . 39.4 ttm -52.57 -52.05 56.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.711 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.66 -40.91 92.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.557 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -60.84 -48.34 82.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.5 tt -85.89 -17.68 34.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.706 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 93' ' ' MET . 3.9 t80 -137.39 72.6 51.21 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.044 0.449 . . . . 0.0 110.641 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -53.94 170.69 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.872 2.381 . . . . 0.0 112.179 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.4 t -160.82 64.24 1.99 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.767 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.17 33.31 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.943 2.429 . . . . 0.0 112.189 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -67.0 1.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.978 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -161.34 -24.6 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.555 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m 48.22 50.41 16.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.67 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.9 p -104.88 73.21 1.05 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.345 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.6 OUTLIER -99.91 -90.84 0.3 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.671 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 55.63 80.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.302 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.537 ' C ' ' H ' ' A' ' 109' ' ' ARG . 12.8 mtt -74.86 -121.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.474 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 108' ' ' VAL . 16.8 t 60.99 -4.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.955 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 107' ' ' MET . 50.1 ttm-85 -106.82 100.48 9.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.635 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.49 154.13 43.19 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.247 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -36.79 138.77 0.21 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.772 2.315 . . . . 0.0 112.326 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.47 18.02 20.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.224 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 1.4 p-90 -124.29 -2.47 8.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.536 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.2 tp -115.19 88.83 18.83 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.77 10.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.832 2.355 . . . . 0.0 113.198 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.633 ' H ' ' C ' ' A' ' 114' ' ' LEU . 0.8 OUTLIER -80.02 -22.59 42.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.123 0.487 . . . . 0.0 110.128 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -95.28 -46.83 6.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.819 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -24.92 64.78 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.209 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -93.23 -19.92 20.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.088 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 t -142.82 70.94 19.55 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.984 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' O ' HG12 ' A' ' 125' ' ' VAL . 84.3 Cg_endo -80.93 -15.85 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.949 2.432 . . . . 0.0 112.247 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -52.76 -35.9 57.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.368 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.536 HG21 ' NH1' ' A' ' 48' ' ' ARG . 33.6 m -127.41 22.2 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.71 0.291 . . . . 0.0 110.913 -179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.48 ' CE1' ' CG ' ' A' ' 117' ' ' ASP . 2.4 t80 -131.4 -6.08 3.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.788 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 125' ' ' VAL . 13.4 p -84.66 129.98 36.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.73 0.3 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.85 135.9 33.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.69 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.3 m -164.7 116.16 1.22 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.523 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.25 -168.44 16.39 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -96.12 158.08 15.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.694 0.283 . . . . 0.0 110.241 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.675 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -109.19 130.05 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.776 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 95.98 -3.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.791 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -67.78 150.54 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.027 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.7 145.39 24.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.941 0.4 . . . . 0.0 110.355 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -135.17 -31.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 53.1 t-105 -174.95 144.77 0.79 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.157 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -141.5 167.05 23.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.02 0.438 . . . . 0.0 111.402 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.46 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -141.39 120.35 12.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.379 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.46 ' CB ' ' O ' ' A' ' 137' ' ' PHE . 1.8 tp 78.28 16.91 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.18 15.0 75.6 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.3 mp -120.48 133.69 55.38 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.811 0.339 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -69.77 152.87 44.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.463 ' SD ' H163 ' A' ' 201' ' ' UQ2 . 3.1 mtt -51.17 -51.64 66.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 142' ' ' MET . 70.9 Cg_exo -45.39 -37.87 14.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.3 2.0 . . . . 0.0 112.034 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -71.99 -42.54 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.205 0.526 . . . . 0.0 109.982 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 148' ' ' GLY . 59.9 m95 -65.64 -57.14 8.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 39.0 tp -43.33 -39.01 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.066 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 88' ' ' THR . 38.7 tp -62.23 -34.59 76.8 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.92 -42.91 96.98 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.595 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.6 mt -67.68 -39.53 82.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.828 0.347 . . . . 0.0 110.146 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -55.25 -45.31 76.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.865 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 95.5 mt -57.2 -43.93 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.61 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.97 -47.44 62.27 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.518 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.7 m-85 -53.76 -43.48 69.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.087 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.501 ' HA ' ' HE1' ' A' ' 77' ' ' TRP . 1.1 pp -75.01 -29.7 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.309 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.9 mt -69.97 -36.74 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.201 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 160' ' ' VAL . 23.3 m -73.36 -38.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.989 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.6 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -65.29 -51.16 62.55 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.844 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 154' ' ' LEU . 79.3 t -55.19 -50.96 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.894 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.8 tp -61.01 -33.9 73.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 156' ' ' VAL . 16.4 t -67.07 -28.99 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.794 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.94 -45.92 62.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.146 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 28.8 mm -60.64 -27.66 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 31.2 m -53.47 -16.06 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.419 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 166' ' ' PHE . 19.9 pt20 -45.95 148.49 1.42 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.276 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.11 35.96 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.442 2.095 . . . . 0.0 111.912 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 164' ' ' GLN . 0.4 OUTLIER -137.85 105.59 5.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.27 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 168' ' ' ALA . 12.6 tptp -153.7 51.18 0.69 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.564 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 167' ' ' LYS . . . 60.01 147.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.614 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -159.43 160.12 34.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.394 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -74.95 95.21 2.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.641 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 50.1 mtm-85 -114.49 119.01 35.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.617 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -133.25 38.17 3.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.266 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.0 mp -66.15 91.15 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.538 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -146.61 -66.23 0.28 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.455 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 158.03 -76.07 0.2 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -78.49 126.46 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.762 0.315 . . . . 0.0 110.618 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.39 -128.13 1.36 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -102.7 156.97 17.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -138.22 31.3 2.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.436 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -137.93 112.2 8.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.456 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.527 ' O ' ' ND1' ' A' ' 182' ' ' HIS . 24.5 t-80 -98.01 22.14 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.571 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 181' ' ' HIS . 37.4 m-70 -152.96 147.48 25.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.619 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 40.5 t60 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.582 -179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.463 H163 ' SD ' ' A' ' 142' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 mtt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.84 -37.54 87.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.134 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 3' ' ' ARG . 8.4 ptt-85 -58.74 -40.62 84.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.25 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -59.37 -47.63 84.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.198 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -51.19 -38.68 53.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.245 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -68.41 -31.26 70.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.348 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -77.06 -50.95 11.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.681 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.07 -34.89 77.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.634 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.3 p -76.96 -37.9 54.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.733 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.77 HE22 HH21 ' A' ' 70' ' ' ARG . 16.6 mm-40 -67.51 2.02 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.701 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.42 147.49 18.56 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -71.78 -49.68 36.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.685 0.278 . . . . 0.0 110.65 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.91 -45.05 5.85 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.19 84.74 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -58.41 -41.41 84.86 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.154 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.98 -28.89 69.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.022 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -70.5 -30.48 67.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.308 -179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.433 ' O ' ' OG1' ' A' ' 21' ' ' THR . 0.4 OUTLIER -73.19 -33.09 65.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.02 7.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.271 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -47.97 -40.85 23.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.507 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -63.72 -50.17 70.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.377 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.21 -35.13 69.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -37.27 41.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.92 -36.96 63.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.53 -37.93 65.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.472 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -65.46 -43.48 90.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.572 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 tp -66.98 -48.31 68.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.508 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 24' ' ' ALA . 19.4 p -54.47 -40.95 68.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.706 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.76 -36.73 67.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.776 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.61 -20.4 63.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.592 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.424 ' NE1' ' CG2' ' A' ' 35' ' ' VAL . 32.1 t90 -88.95 -39.36 13.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.448 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.65 -43.61 57.28 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 4.5 tm0? -73.61 -29.56 62.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.398 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.02 -26.35 66.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.766 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' CG2' ' NE1' ' A' ' 31' ' ' TRP . 56.0 t -109.29 -53.34 6.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.924 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.6 mmt -72.68 1.13 8.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.96 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mt 48.54 41.36 17.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.91 0.386 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.684 HD23 ' O3 ' ' A' ' 201' ' ' UQ2 . 1.4 tp -76.24 147.71 38.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.256 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -111.66 127.04 27.46 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.596 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.06 154.66 33.19 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.286 1.991 . . . . 0.0 111.775 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.473 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 6.5 t -118.0 -171.98 2.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.874 0.369 . . . . 0.0 110.787 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.23 -48.05 87.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.075 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.4 mt -63.83 -50.1 70.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.442 -179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.7 p -53.08 -48.97 67.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mm -61.34 -45.23 99.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.327 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -58.41 -46.12 87.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.307 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -60.78 -38.32 84.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -64.59 -36.38 84.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.337 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.38 84.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.96 74.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.346 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.492 ' O ' HD23 ' A' ' 51' ' ' LEU . 1.2 tt -76.78 -49.58 15.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.049 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -46.32 -38.03 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.76 -44.25 81.29 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.9 -47.65 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 tt -43.9 -48.62 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.6 -48.24 86.98 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.19 -33.02 25.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.27 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.77 -35.54 77.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.404 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.88 -37.26 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.223 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -75.24 -40.32 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.324 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.0 -28.67 73.34 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.12 7.77 3.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.705 0.288 . . . . 0.0 110.686 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 94.1 mt -82.63 -32.41 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.52 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.46 73.36 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.442 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.75 24.58 0.33 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.518 2.145 . . . . 0.0 111.9 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' H ' ' C ' ' A' ' 64' ' ' ALA . 40.3 mttm -111.86 -7.56 14.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.155 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.634 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -113.13 162.44 21.95 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.655 179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -38.91 -15.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.592 2.195 . . . . 0.0 112.304 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.634 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.4 mp -41.58 -33.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.539 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.77 HH21 HE22 ' A' ' 10' ' ' GLN . 71.9 mtt85 -39.22 -68.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.56 ' O ' HG23 ' A' ' 75' ' ' VAL . 67.2 t80 -51.95 -31.48 29.12 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.763 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.0 t -68.62 -45.94 80.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.97 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.46 -34.26 36.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.243 0.544 . . . . 0.0 110.443 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.6 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -64.7 -19.66 65.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.678 -179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.1 t -54.09 -34.46 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 0.0 109.958 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 84.0 mt -89.15 -33.11 6.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.486 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.514 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.2 t-105 -65.87 -49.86 66.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.003 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.8 tp -66.06 -49.58 67.16 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.3 m-85 -42.92 -42.61 3.78 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.15 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.8 p -78.11 -22.18 49.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.768 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -59.8 -59.86 4.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.281 -179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -75.3 -51.13 13.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.646 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -40.5 78.86 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 88' ' ' THR . . . -63.08 -47.14 90.98 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 81' ' ' ALA . 11.1 m -77.53 -32.73 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.336 -178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -74.04 -42.87 59.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.663 0.268 . . . . 0.0 111.191 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 tp -73.72 -38.47 64.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.047 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 84' ' ' GLY . 7.9 p -59.56 -44.45 93.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.208 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -52.32 -52.13 54.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.522 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -50.84 -46.35 60.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -64.55 -33.16 75.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.518 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.9 m -70.97 -37.14 72.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.413 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 97' ' ' TYR . 7.4 tpt -62.21 -33.01 73.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.115 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.2 -47.47 70.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.115 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -51.65 -42.33 62.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.617 HD12 ' N ' ' A' ' 96' ' ' LEU . 8.9 mp -92.29 -9.57 41.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.394 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 93' ' ' MET . 1.4 t80 -140.87 69.35 29.66 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 121.097 0.475 . . . . 0.0 110.438 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.22 171.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.78 2.32 . . . . 0.0 112.201 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.06 157.21 57.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.383 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.32 -90.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.665 2.243 . . . . 0.0 112.1 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -130.96 -36.0 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.345 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 103' ' ' THR . . . -71.22 -165.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.681 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 102' ' ' ALA . 31.6 p 49.53 99.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.7 t -61.62 -152.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -173.81 64.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.665 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -91.0 -173.79 3.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.375 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -163.26 -165.85 1.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.542 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 108' ' ' VAL . 12.2 t 64.31 6.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.537 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -106.67 103.62 13.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.348 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.09 155.03 76.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.291 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.22 132.29 51.02 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.48 2.12 . . . . 0.0 111.835 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -80.66 4.2 19.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.855 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.502 ' C ' HD12 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -99.22 -5.38 30.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.426 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.527 ' C ' ' H ' ' A' ' 116' ' ' LEU . 10.4 mp -113.09 82.81 5.7 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.405 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 28.3 Cg_endo -65.31 12.11 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.041 1.827 . . . . 0.0 111.756 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.527 ' H ' ' C ' ' A' ' 114' ' ' LEU . 6.9 mt -80.13 -28.42 38.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.013 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 1.4 p30 -97.31 -40.83 8.55 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.975 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 3.3 ttmm -69.27 -45.16 70.36 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.658 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 16.0 t-105 -76.85 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.405 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.17 71.13 22.81 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.761 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -77.74 -16.11 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.748 2.299 . . . . 0.0 111.805 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -52.29 -32.63 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.785 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.9 m -133.37 48.59 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.536 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -152.3 -40.53 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.239 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.7 128.79 29.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.531 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.99 155.47 17.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.732 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 37.4 p -158.17 102.8 1.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.599 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.58 -177.27 19.58 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.473 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 33.9 t70 -86.06 150.02 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.087 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.654 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 9.7 m -101.74 127.23 48.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.72 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 98.87 -8.22 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.062 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.87 128.82 37.92 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.733 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 -69.19 136.22 51.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.408 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.514 ' HB3' HD21 ' A' ' 38' ' ' LEU . 77.9 mt-30 -130.16 -29.35 2.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.767 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' A' ' 141' ' ' GLU . 0.0 OUTLIER -174.56 145.4 0.93 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.722 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -144.73 159.64 42.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.256 0.551 . . . . 0.0 112.102 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.408 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -115.09 138.13 51.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.705 178.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp 50.24 16.85 0.28 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.221 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.597 ' O ' HD22 ' A' ' 140' ' ' LEU . . . 90.73 22.64 33.01 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.739 -0.544 . . . . 0.0 111.739 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.597 HD22 ' O ' ' A' ' 139' ' ' GLY . 2.6 mm? -124.36 136.23 53.93 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' A' ' 135' ' ' TRP . 6.0 mm-40 -69.33 146.73 51.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.315 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.442 ' CB ' ' CD ' ' A' ' 143' ' ' PRO . 9.5 mtt -44.94 -62.7 1.48 Allowed Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.144 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 85.8 Cg_exo -33.78 -37.63 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.848 2.366 . . . . 0.0 112.639 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 144' ' ' GLN . 4.8 mp0 -72.34 -52.0 18.08 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.591 ' O ' ' N ' ' A' ' 148' ' ' GLY . 71.0 m95 -59.47 -57.28 13.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.848 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 34.5 tp -44.57 -35.55 2.6 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.423 HD11 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -62.9 -33.96 76.41 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.51 -46.19 94.83 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.708 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.8 mp -75.14 -25.88 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -64.54 -44.37 91.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.743 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.9 tt -69.24 -37.39 76.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.707 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -53.79 -46.99 71.21 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.054 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.79 -44.47 96.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.686 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 81' ' ' ALA . 52.3 mt -65.19 -30.95 71.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 -179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.9 -33.35 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.321 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.5 t -64.95 -31.66 54.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.466 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -77.52 -47.5 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 154' ' ' LEU . 73.7 t -55.41 -42.21 66.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.181 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.36 -28.58 56.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.903 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 156' ' ' VAL . 31.1 t -78.26 -20.33 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.782 0.325 . . . . 0.0 110.896 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.8 -50.03 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.232 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.83 -25.96 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.76 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 78.3 p -71.77 0.07 9.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.548 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.455 HE22 ' HA ' ' A' ' 166' ' ' PHE . 0.5 OUTLIER -155.13 74.14 5.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.25 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.8 57.75 5.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.563 2.175 . . . . 0.0 111.957 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.455 ' HA ' HE22 ' A' ' 164' ' ' GLN . 18.1 m-85 62.22 -174.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.717 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -142.76 -25.74 0.62 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -159.29 98.52 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -151.16 -42.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.272 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 172' ' ' ASP . 52.4 mtmt -84.74 -89.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.602 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 48.32 18.84 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.408 ' N ' ' C ' ' A' ' 170' ' ' LYS . 74.8 m-20 -75.51 -91.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.739 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.8 tp -81.15 -70.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.583 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -88.17 96.93 10.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.438 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -106.58 178.02 22.26 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -69.33 80.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 0.0 110.555 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.56 155.29 9.84 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 178' ' ' HIS . 45.4 p-80 -164.45 106.16 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.763 0.316 . . . . 0.0 110.612 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -89.47 120.25 30.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.449 ' CD2' ' H ' ' A' ' 181' ' ' HIS . 0.6 OUTLIER -171.45 -149.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.429 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.449 ' H ' ' CD2' ' A' ' 180' ' ' HIS . 4.3 m-70 63.66 136.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.623 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.642 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 42.5 t60 -80.69 -175.24 5.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.5 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.642 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 1.8 t60 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.591 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.684 ' O3 ' HD23 ' A' ' 38' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 11.1 mp -47.85 -34.66 9.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.987 0.422 . . . . 0.0 109.951 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -57.6 -31.84 66.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 7' ' ' GLN . 23.3 t80 -73.48 -44.94 56.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 5' ' ' LEU . 3.9 mm? -47.17 -39.88 14.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.003 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -68.46 -28.15 66.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.421 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 4' ' ' PHE . 24.4 tt0 -80.33 -49.45 11.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.642 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.31 -32.36 72.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.715 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -76.66 -34.99 58.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.754 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -72.76 7.41 1.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.533 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.07 142.08 15.87 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -68.44 -21.4 64.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.598 0.237 . . . . 0.0 110.648 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.83 -46.06 61.94 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.83 76.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.801 0.334 . . . . 0.0 110.327 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -58.17 -43.12 87.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.302 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 tp -66.42 -33.06 74.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.323 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.8 OUTLIER -67.48 -30.37 70.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . 60.3 mtp -73.66 -33.0 64.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.417 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.89 71.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.716 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.46 -51.83 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 17' ' ' LEU . 12.7 p -41.65 -50.42 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.522 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.79 -40.92 85.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.655 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mt -68.62 -39.67 80.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.306 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -50.71 -41.67 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.354 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.3 -33.78 63.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.543 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -66.76 -45.91 77.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.03 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 tt -71.89 -46.55 57.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.92 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 87.5 m -46.8 -43.01 18.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.002 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.81 -21.45 37.67 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.602 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -68.49 -22.39 64.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.23 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.544 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.4 t-105 -97.68 -29.39 13.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.8 0.333 . . . . 0.0 111.191 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.4 -39.86 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.51 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -78.8 -51.6 9.53 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.992 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -54.74 -53.41 55.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.48 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 31' ' ' TRP . 4.3 p -61.01 -18.19 17.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.511 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.0 ttt -106.3 10.56 31.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.589 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 37' ' ' LEU . 8.2 mp 52.24 54.44 10.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.99 157.18 17.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.283 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -125.37 141.48 38.95 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.432 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.76 175.93 10.49 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 112.318 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.486 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 12.8 t -131.88 -179.34 5.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.091 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' N ' ' SG ' ' A' ' 41' ' ' CYS . 39.6 t -56.06 -49.53 75.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.599 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.94 -38.24 87.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -54.23 -40.93 68.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.584 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.699 HD12 HH21 ' A' ' 48' ' ' ARG . 1.4 tp -67.98 -37.59 78.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.0 0.428 . . . . 0.0 110.053 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -60.73 -48.2 82.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.038 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.94 -39.95 95.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.668 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.699 HH21 HD12 ' A' ' 45' ' ' ILE . 11.6 ttp180 -65.82 -36.16 82.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.366 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.11 86.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.565 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.05 -49.03 78.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.446 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 tp -76.04 -52.2 10.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.223 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -45.89 -42.59 12.81 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.51 -45.53 89.47 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' ALA . 26.0 t -59.15 -46.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.298 0.571 . . . . 0.0 109.615 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.09 -46.59 11.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.535 179.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.81 -27.42 71.13 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -73.04 -42.13 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.491 -0.354 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.91 -21.51 62.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.493 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -43.93 19.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.209 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.34 -33.23 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.546 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -73.16 -31.38 61.63 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.44 6.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 0.0 110.798 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 95.0 mt -82.81 -29.79 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.705 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.76 69.03 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.25 23.78 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.754 2.302 . . . . 0.0 111.654 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.29 -10.25 19.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.087 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.564 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -111.84 175.21 1.96 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.513 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -45.39 -9.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.281 1.987 . . . . 0.0 112.052 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' THR . 0.7 OUTLIER -47.89 -31.43 5.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.126 179.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -40.33 -67.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.788 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -58.62 -26.08 63.34 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.522 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.43 -45.48 74.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.248 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.66 -36.48 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.47 0.653 . . . . 0.0 109.574 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 161' ' ' VAL . 0.8 OUTLIER -57.15 -12.81 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.062 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 79' ' ' TYR . 55.5 t -55.27 -44.21 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.306 0.574 . . . . 0.0 110.443 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.89 -31.94 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.627 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.493 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 10.0 t-105 -62.67 -55.79 23.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.129 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.1 tp -65.3 -48.17 74.06 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.211 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 75' ' ' VAL . 2.9 m-85 -43.58 -45.66 6.8 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.084 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 p -78.99 -21.14 47.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -59.43 -60.38 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.053 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.52 -51.27 17.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -68.09 -48.1 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.493 ' O ' HG23 ' A' ' 88' ' ' THR . . . -55.38 -48.42 69.76 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' ' OG1' ' A' ' 88' ' ' THR . 66.1 t -69.29 -47.23 74.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 110.478 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.553 HE21 ' C ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -55.48 -23.48 25.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.292 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.4 mt -85.39 -42.67 14.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.214 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 84' ' ' GLY . 39.7 p -51.29 -26.38 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -69.18 -46.53 67.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.246 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -55.38 -31.23 61.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.274 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.453 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 10.7 t-80 -70.09 -49.64 48.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.349 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.1 p -54.87 -56.36 20.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 110.199 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.614 ' O ' ' N ' ' A' ' 97' ' ' TYR . 40.8 mtt -48.01 -50.68 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.028 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.72 -36.8 7.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.412 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.444 ' C ' HD12 ' A' ' 96' ' ' LEU . 4.4 tp-100 -67.69 -31.19 70.98 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 96' ' ' LEU . 10.6 mp -102.99 -4.17 25.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.228 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.614 ' N ' ' O ' ' A' ' 93' ' ' MET . 18.6 t80 -130.49 89.99 42.4 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.286 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.437 ' O ' ' OG ' ' A' ' 99' ' ' SER . 72.3 Cg_endo -80.82 112.79 2.7 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.632 2.222 . . . . 0.0 112.372 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 98' ' ' PRO . 49.4 m -168.12 59.43 0.43 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.398 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.7 26.54 0.32 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.841 2.361 . . . . 0.0 112.256 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' H ' ' C ' ' A' ' 99' ' ' SER . 10.1 t80 -104.06 134.66 46.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.506 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.5 172.02 17.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.633 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.5 p -60.65 -7.85 2.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.632 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.4 t -167.86 123.96 1.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.516 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -73.26 88.42 1.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.458 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -47.09 117.67 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.525 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.549 ' C ' ' H ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -160.89 129.43 4.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.778 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.64 2.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.717 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.549 ' H ' ' C ' ' A' ' 107' ' ' MET . 72.4 mtt180 -105.38 99.84 9.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.371 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -123.72 159.54 55.34 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.468 -179.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -40.63 144.72 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.63 2.22 . . . . 0.0 112.048 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -103.79 -14.41 16.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.459 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.634 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -84.85 -5.21 59.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.364 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 116' ' ' LEU . 4.2 mp -119.68 81.85 25.68 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.239 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -52.67 -2.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.566 2.178 . . . . 0.0 112.016 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 114' ' ' LEU . 5.3 tt -59.53 -32.31 70.2 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.012 0.434 . . . . 0.0 110.291 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.4 -41.03 8.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.604 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -71.9 -45.28 61.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.721 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 45.1 t-105 -73.71 -17.29 61.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.456 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.0 t -141.34 72.32 26.31 Favored Pre-proline 0 N--CA 1.463 0.218 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.514 ' O ' HG22 ' A' ' 125' ' ' VAL . 74.4 Cg_endo -79.75 -16.48 11.55 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.895 2.396 . . . . 0.0 111.804 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -50.2 -49.11 53.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.816 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.97 53.91 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.641 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.431 ' HA ' HD11 ' A' ' 45' ' ' ILE . 6.0 t80 -154.57 -39.76 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.464 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 121' ' ' PRO . 27.5 m -55.57 130.3 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.697 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -96.47 150.24 20.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.535 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.9 m -159.69 102.97 1.53 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.695 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.59 -176.7 20.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.3 m-20 -87.55 157.19 19.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.938 0.399 . . . . 0.0 110.02 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 3.7 m -106.79 128.97 54.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.711 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 93.94 -7.87 0.13 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.429 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 8.1 mp0 -68.21 129.1 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.857 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.51 116.21 4.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.096 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -109.11 -31.04 7.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.84 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -174.06 143.26 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.794 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.96 156.45 44.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.295 0.569 . . . . 0.0 112.167 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.407 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.8 OUTLIER -112.41 138.76 48.69 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.786 178.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 49.44 17.11 0.2 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.316 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 91.29 22.8 31.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.03 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.53 137.86 53.41 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.38 149.42 50.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.967 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.436 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 2.6 mtt -48.62 -52.74 42.22 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 142' ' ' MET . 86.5 Cg_exo -43.34 -34.21 4.55 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.396 2.064 . . . . 0.0 112.17 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.74 -52.66 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.171 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.611 ' O ' ' N ' ' A' ' 148' ' ' GLY . 95.0 m95 -58.81 -58.3 9.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.117 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -43.83 -36.98 2.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.15 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.59 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.3 tt -61.17 -34.6 75.29 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.67 -47.63 89.24 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.65 -25.57 22.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.049 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.468 ' O ' HD13 ' A' ' 154' ' ' LEU . 6.6 t80 -64.85 -43.08 94.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.694 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 148' ' ' GLY . 5.5 tp -68.27 -36.81 76.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.359 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -58.94 -50.11 75.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.015 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -58.71 -33.74 70.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 150' ' ' PHE . 4.1 mp -64.49 -30.5 71.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.782 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 74.9 mt -82.43 -34.26 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.484 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.648 ' O ' HG23 ' A' ' 160' ' ' VAL . 91.6 t -60.48 -40.3 83.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.625 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.493 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -76.47 -50.58 13.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 154' ' ' LEU . 52.9 t -53.13 -50.61 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.558 ' O ' HD23 ' A' ' 159' ' ' LEU . 0.8 OUTLIER -66.54 -31.17 71.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.013 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 156' ' ' VAL . 11.1 t -70.87 -28.77 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.18 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 74' ' ' MET . 61.0 t -79.29 -49.42 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.222 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.417 ' O ' HG22 ' A' ' 162' ' ' ILE . 39.7 mm -68.92 -11.14 14.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.569 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.9 m -66.66 -13.96 61.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.59 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.409 ' C ' ' H ' ' A' ' 166' ' ' PHE . 21.1 mm-40 -141.38 74.71 23.8 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.554 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.13 -7.03 0.59 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 111.99 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 164' ' ' GLN . 47.1 p90 -163.22 179.35 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.494 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 122.34 11.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.46 102.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -64.98 100.15 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.598 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -46.79 131.82 11.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.462 ' HD2' ' H ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -86.5 31.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.453 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.449 ' O ' ' O ' ' A' ' 173' ' ' LEU . 62.3 t0 -69.74 -73.16 0.17 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.587 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 172' ' ' ASP . 10.8 mp 54.05 165.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.302 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -60.27 112.12 1.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.33 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 165.94 119.77 0.49 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.535 ' N ' ' CD ' ' A' ' 176' ' ' ARG . 0.9 OUTLIER 46.8 56.29 6.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.639 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -98.42 -1.27 57.93 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -149.77 157.72 43.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.606 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -65.72 -81.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.529 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -177.68 141.02 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.669 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -78.03 -98.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.589 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.488 ' CD2' ' H ' ' A' ' 182' ' ' HIS . 19.9 m-70 -49.88 120.88 4.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.549 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 67.2 t60 . . . . . 0 C--O 1.219 -0.517 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.51 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.589 ' O2 ' H3M2 ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tpt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.42 -46.92 29.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.347 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.501 ' HA ' ' HE ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -50.09 -45.69 52.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' O ' ' N ' ' A' ' 7' ' ' GLN . 26.2 m-85 -63.03 -43.6 98.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.277 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -48.01 -42.36 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.262 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.8 -24.05 64.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.081 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 4' ' ' PHE . 52.1 tt0 -77.98 -48.19 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.51 -37.55 87.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.75 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 11' ' ' GLY . 8.2 m -76.72 -37.32 56.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.768 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' CG ' ' O ' ' A' ' 10' ' ' GLN . 6.2 tt0 -66.24 1.87 1.4 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.545 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -99.12 149.5 19.05 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.6 mtt85 -70.92 -49.03 50.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.681 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -42.83 -45.63 5.87 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.78 -47.41 83.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.096 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -59.46 -47.17 86.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.058 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 16' ' ' LEU . 4.2 mm? -59.27 -28.22 66.53 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 21' ' ' THR . 0.9 OUTLIER -70.9 -27.73 64.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.439 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.5 mmt -74.24 -34.44 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.47 -53.61 22.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.712 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -53.13 -52.71 57.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.485 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 17' ' ' LEU . 16.2 p -44.74 -54.12 6.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.727 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.29 -22.2 62.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.804 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.73 -41.26 15.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.634 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -53.28 -39.92 64.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.955 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.0 mm? -73.11 -27.78 61.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.835 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.44 -38.74 90.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.589 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.1 mt -79.18 -41.4 28.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.783 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 2.5 m -48.06 -43.33 30.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.49 -32.28 32.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.104 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tp -57.06 -21.33 30.56 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.65 0.262 . . . . 0.0 110.682 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -90.22 -38.94 13.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.545 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -49.08 -45.54 43.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.563 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -71.25 -25.26 62.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.081 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 -21.24 51.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.393 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG13 ' N ' ' A' ' 36' ' ' MET . 7.6 p -107.19 -38.67 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.483 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.431 ' N ' HG13 ' A' ' 35' ' ' VAL . 12.4 mtp -98.68 5.73 47.47 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.107 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.4 mm? 47.22 45.0 16.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.36 . . . . 0.0 110.616 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 46.9 mt -80.01 153.28 28.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.503 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.8 mttt -121.2 126.86 26.41 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.415 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.92 153.4 32.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.218 1.945 . . . . 0.0 111.934 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.421 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 5.8 t -100.15 -174.77 2.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.6 t -65.98 -41.74 90.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 110.822 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.65 -36.47 65.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.4 t -57.69 -47.73 81.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.717 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 124' ' ' PHE . 25.5 pt -66.72 -36.36 77.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.089 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -55.06 -48.29 73.68 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.27 -36.15 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.123 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.0 ttt85 -60.79 -37.01 80.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.176 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.87 84.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.504 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -58.92 -47.9 83.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.632 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -77.72 -49.71 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.331 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -46.6 -43.32 17.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 109.851 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.11 -45.44 93.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' ALA . 55.1 t -58.31 -46.7 88.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.242 0.544 . . . . 0.0 110.006 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.6 tp -48.0 -42.95 29.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.543 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.62 -24.15 72.45 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -75.87 -32.05 59.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.489 -0.355 . . . . 0.0 110.584 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.08 -23.09 41.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.3 tp -79.63 -42.3 25.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.388 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.72 -36.9 17.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.679 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -69.71 -33.7 71.62 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.19 6.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.763 0.316 . . . . 0.0 110.655 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 61' ' ' GLY . 91.9 mt -79.64 -25.56 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.381 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ILE . . . 176.76 68.38 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.409 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.85 14.42 1.28 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.674 2.249 . . . . 0.0 111.995 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -8.81 19.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.197 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.27 162.47 20.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.813 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -42.04 -12.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.418 2.079 . . . . 0.0 112.246 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.7 mp -50.35 -29.3 9.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 164' ' ' GLN . 26.7 ptt180 -37.9 -57.89 0.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.715 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.455 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.6 OUTLIER -52.72 -35.01 55.07 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.108 179.661 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 69' ' ' LEU . 18.2 t -64.02 -44.71 97.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.58 -33.89 47.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.203 0.525 . . . . 0.0 110.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.51 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 8.3 mmt -62.59 -20.06 64.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.575 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 71' ' ' TYR . 3.4 t -51.78 -39.03 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.457 0.646 . . . . 0.0 110.342 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.74 -30.07 5.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.766 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.499 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 15.0 t-105 -66.95 -51.16 58.63 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.123 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 81' ' ' ALA . 5.2 tp -67.29 -50.31 60.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.617 ' CE2' ' NE ' ' A' ' 83' ' ' ARG . 63.6 t80 -42.36 -42.49 3.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.967 0.413 . . . . 0.0 110.267 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.4 p -79.12 -23.23 44.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.803 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 78' ' ' LEU . . . -60.05 -58.95 6.32 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.256 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -74.71 -51.87 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.199 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.617 ' NE ' ' CE2' ' A' ' 79' ' ' TYR . 47.5 ttp85 -65.56 -42.33 91.93 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 88' ' ' THR . . . -62.77 -46.53 93.46 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 81' ' ' ALA . 70.7 t -66.8 -36.68 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.647 0.261 . . . . 0.0 111.057 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -72.09 -29.18 63.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.774 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -84.53 -48.2 9.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 110.391 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 84' ' ' GLY . 18.7 p -50.85 -54.6 22.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.028 0.442 . . . . 0.0 110.395 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -51.69 -34.74 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.385 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -57.98 -39.8 79.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 109.987 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -68.09 -38.51 82.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.408 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.0 p -65.08 -50.57 65.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.44 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.416 ' O ' ' N ' ' A' ' 97' ' ' TYR . 31.8 ttm -50.09 -39.58 43.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.79 -45.44 78.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.957 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.492 ' NE2' ' OE1' ' A' ' 141' ' ' GLU . 19.0 tt0 -59.72 -44.92 93.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.342 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 mt -80.15 -19.21 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.111 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.416 ' N ' ' O ' ' A' ' 93' ' ' MET . 0.9 OUTLIER -133.13 92.62 24.73 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.59 169.05 20.39 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.425 2.083 . . . . 0.0 112.422 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.21 162.04 57.65 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.144 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 102' ' ' ALA . 25.7 Cg_endo -63.37 99.84 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.491 2.127 . . . . 0.0 111.985 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -48.01 -17.73 0.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.692 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 100' ' ' PRO . . . 54.89 -106.66 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.628 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -80.34 -104.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.575 -179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.534 ' N ' ' OG1' ' A' ' 103' ' ' THR . 7.2 t -116.6 -94.03 0.49 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.489 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.14 -154.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.569 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.588 ' CB ' HH12 ' A' ' 109' ' ' ARG . 66.5 m-85 -134.18 159.61 40.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -95.91 154.37 17.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.43 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 108' ' ' VAL . 28.6 m -45.74 112.53 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.658 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.588 HH12 ' CB ' ' A' ' 106' ' ' PHE . 10.8 ptt-85 -114.63 103.5 11.06 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.507 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 111' ' ' PRO . 53.0 m-85 -137.2 149.47 66.1 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.424 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' O ' ' O ' ' A' ' 110' ' ' PHE . 87.1 Cg_exo -37.54 160.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.561 2.174 . . . . 0.0 112.263 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -100.28 -4.95 28.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.709 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -100.6 12.24 37.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.846 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 116' ' ' LEU . 3.9 mt -121.69 79.39 39.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.062 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 119' ' ' TRP . 53.4 Cg_exo -48.66 -5.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.534 2.156 . . . . 0.0 111.968 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.1 tp -54.19 -31.8 53.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.32 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 118' ' ' LYS . 32.3 p-10 -97.0 -42.79 7.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.268 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.499 ' N ' ' OD1' ' A' ' 117' ' ' ASP . 26.0 ttpp -72.29 -45.78 58.58 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.895 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.403 ' N ' ' O ' ' A' ' 115' ' ' PRO . 57.9 t-105 -71.1 -18.82 62.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.182 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t -133.26 75.14 71.25 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -80.4 -26.65 3.93 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.779 2.319 . . . . 0.0 111.952 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -61.62 -54.35 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.013 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.5 t -98.09 59.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.748 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -169.37 -34.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 125' ' ' VAL . 10.6 p -60.96 127.47 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.418 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.4 160.58 14.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.875 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -166.14 99.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.521 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 141.79 -174.99 22.82 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.421 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.1 OUTLIER -88.55 154.06 20.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.787 0.327 . . . . 0.0 110.421 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.682 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 5.4 m -101.4 133.16 46.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 88.12 -4.14 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.928 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.489 ' CD ' ' N ' ' A' ' 133' ' ' ARG . 12.4 tm-20 -67.93 150.95 47.87 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' N ' ' CD ' ' A' ' 132' ' ' GLU . 19.6 ttm180 -85.82 126.84 34.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.849 0.357 . . . . 0.0 110.538 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -121.25 -26.09 5.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.422 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -175.55 135.48 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 4.1 p30 -135.43 159.55 41.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.366 0.603 . . . . 0.0 112.135 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.553 ' CE2' HD13 ' A' ' 138' ' ' LEU . 12.8 t80 -123.54 137.79 54.69 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.062 179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.553 HD13 ' CE2' ' A' ' 137' ' ' PHE . 3.1 mp 54.38 17.1 1.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.521 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.35 13.78 61.16 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.72 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.434 ' HB2' ' NE1' ' A' ' 145' ' ' TRP . 13.8 mt -119.12 145.0 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 141' ' ' GLU . 4.0 mp0 -75.9 148.09 38.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.448 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.4 mtt -50.18 -57.28 13.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 142' ' ' MET . 87.1 Cg_exo -37.34 -38.67 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.351 2.034 . . . . 0.0 111.923 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -73.07 -46.81 49.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.204 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' O ' ' N ' ' A' ' 148' ' ' GLY . 55.5 m95 -60.77 -57.52 12.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.093 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 tt -43.55 -41.01 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.668 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.5 tt -57.38 -34.95 69.39 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -58.35 -43.66 95.56 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.612 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.685 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -72.85 -38.35 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.91 -46.98 64.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.141 0.496 . . . . 0.0 109.707 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.48 -49.49 83.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.504 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -57.72 -48.82 78.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.43 ' O ' ' NE1' ' A' ' 77' ' ' TRP . 2.0 m-85 -59.15 -44.65 92.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.444 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.77 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.3 OUTLIER -69.64 -30.71 68.48 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.298 -179.158 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.24 -36.69 37.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.722 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.454 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.2 t -62.12 -43.31 97.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.411 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.51 ' HB1' ' SD ' ' A' ' 74' ' ' MET . . . -61.71 -48.42 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 154' ' ' LEU . 83.3 t -52.17 -39.24 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.038 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.18 -41.42 25.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.217 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.7 t -59.26 -27.52 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.312 . . . . 0.0 110.91 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.86 -44.66 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.293 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 162' ' ' ILE . 88.2 mt -69.17 -8.92 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.509 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.7 m -66.72 -11.13 53.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.616 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.491 ' O ' ' NH1' ' A' ' 70' ' ' ARG . 4.1 pt20 -165.15 78.97 1.29 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 166' ' ' PHE . 73.0 Cg_endo -81.47 24.57 0.69 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.71 2.273 . . . . 0.0 111.944 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 165' ' ' PRO . 2.8 m-85 51.67 103.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.505 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -81.62 171.75 14.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.421 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -168.51 102.2 0.42 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.464 ' CD ' ' H ' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -68.56 119.02 12.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.564 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -94.91 -165.84 1.37 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.326 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 60.7 mmt-85 -82.27 108.22 15.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.796 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -99.49 57.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.282 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 16.4 mt -120.3 145.4 47.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.619 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -82.2 -2.69 53.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.393 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -44.7 -72.47 0.35 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -104.7 173.8 6.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.458 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 179' ' ' HIS . . . -95.51 123.23 7.56 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -47.49 -18.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 110.651 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.409 ' N ' ' C ' ' A' ' 177' ' ' GLY . 6.1 m80 -105.84 147.25 28.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.483 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.438 ' O ' ' C ' ' A' ' 181' ' ' HIS . 17.2 m80 -83.73 -159.91 0.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.073 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 180' ' ' HIS . 26.0 m80 -34.42 103.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.936 0.398 . . . . 0.0 110.791 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -53.84 141.26 27.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.586 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.494 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 12.4 mt -58.94 -38.94 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.115 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -38.86 70.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.401 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.38 -42.42 98.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.281 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -53.22 -42.0 65.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.396 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.695 HD21 ' NE2' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -65.37 -32.08 73.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.238 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -74.29 -50.08 20.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.642 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.9 -29.89 71.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.514 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.8 m -76.8 -37.36 55.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.695 ' NE2' HD21 ' A' ' 6' ' ' ASN . 0.7 OUTLIER -73.22 6.94 2.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -103.45 144.65 16.0 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.8 mtm-85 -69.71 -49.15 56.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.732 0.301 . . . . 0.0 110.727 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.16 -46.12 6.42 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.05 -47.26 85.5 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -59.19 -42.31 90.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 tp -64.84 -28.95 69.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.051 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.54 -33.99 71.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.623 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.3 mtt -69.96 -33.35 71.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -51.8 35.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.669 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -50.05 -44.05 51.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.851 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -60.25 -62.0 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' O ' ' OE1' ' A' ' 26' ' ' GLU . . . -50.56 -29.45 10.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.77 -37.5 35.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.418 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 28' ' ' THR . . . -53.38 -36.2 61.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.746 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.0 mp -66.68 -37.37 84.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.716 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 3.1 mp0 -66.45 -46.02 77.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.497 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tp -68.45 -56.73 7.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.762 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 24' ' ' ALA . 34.3 p -46.97 -44.81 20.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.722 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.71 -42.79 60.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.961 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.9 tt -52.38 -19.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.953 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -92.36 -36.25 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.748 0.309 . . . . 0.0 110.48 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.8 -44.07 58.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.133 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.93 -29.98 70.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.555 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -76.69 -13.02 60.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.587 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.03 -51.82 7.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.3 mmt -89.36 8.91 28.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.028 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER 46.95 49.06 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 110.254 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.3 mt -82.45 155.25 24.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.415 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -124.34 95.58 43.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.579 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.36 140.02 15.96 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.389 2.059 . . . . 0.0 112.08 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.523 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 4.9 t -95.78 -168.13 1.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 ' CB ' ' A' ' 126' ' ' ALA . 59.2 t -65.67 -44.86 93.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.98 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mt -70.84 -50.13 38.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.745 -178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 p -50.05 -51.17 44.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.46 -39.27 83.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.308 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -57.2 -45.36 83.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.123 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.85 -36.86 75.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.168 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -64.01 -33.81 76.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.022 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.66 80.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.92 -48.89 77.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.383 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.416 HD12 ' HB1' ' A' ' 22' ' ' ALA . 1.5 mm? -76.51 -49.21 17.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.056 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -46.31 -40.1 11.19 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.296 -0.562 . . . . 0.0 109.496 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.61 -45.36 85.43 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 72.3 t -62.17 -45.45 98.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.187 0.518 . . . . 0.0 109.729 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -44.7 -46.73 10.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.586 179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.15 -36.72 93.59 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 54' ' ' VAL . . . -61.13 -44.91 96.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.629 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.89 69.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.434 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tp -78.17 -29.9 48.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.5 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.9 mt -83.3 -40.18 15.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.584 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' ILE . . . -70.77 -34.19 66.36 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.72 4.68 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.736 0.303 . . . . 0.0 110.631 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 61' ' ' GLY . 97.9 mt -87.46 -25.07 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.508 ' HB1' ' OG1' ' A' ' 67' ' ' THR . . . -175.51 67.45 0.26 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.39 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.2 15.92 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.679 2.253 . . . . 0.0 112.116 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -115.65 -4.05 12.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.111 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -114.12 163.17 19.71 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.664 179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -39.97 -15.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.505 2.136 . . . . 0.0 112.255 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' THR . 3.6 mm? -41.81 -34.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -40.79 -70.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.536 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.497 ' O ' HG23 ' A' ' 75' ' ' VAL . 2.2 m-85 -48.35 -36.21 14.03 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.792 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -65.65 -45.7 91.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.63 -33.36 41.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.265 0.555 . . . . 0.0 110.295 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.488 ' SD ' ' HB1' ' A' ' 157' ' ' ALA . 10.4 mmt -65.62 -20.51 66.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.558 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 71' ' ' TYR . 2.1 t -53.36 -34.67 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.239 0.543 . . . . 0.0 110.0 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.3 mt -89.31 -32.25 5.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.205 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.517 ' CD1' ' CB ' ' A' ' 157' ' ' ALA . 6.3 t-105 -63.64 -51.41 65.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.997 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 tp -69.11 -44.54 72.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.704 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -45.79 -46.51 15.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.959 0.409 . . . . 0.0 110.174 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.8 p -78.5 -19.72 52.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.669 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.787 ' O ' HG22 ' A' ' 85' ' ' VAL . . . -60.75 -59.45 5.37 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.331 -0.547 . . . . 0.0 111.087 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -74.72 -49.76 19.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.618 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -71.83 -40.23 69.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.814 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.47 -49.16 81.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 81' ' ' ALA . 33.5 m -72.74 -47.4 50.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.746 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.55 ' N ' HG23 ' A' ' 85' ' ' VAL . 21.1 tt0 -50.72 -24.9 3.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 0.0 109.945 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.4 tt -81.44 -40.56 23.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.434 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.614 ' CG2' HD21 ' A' ' 147' ' ' LEU . 66.7 p -53.95 -25.64 21.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.912 0.387 . . . . 0.0 110.085 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -52.07 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.174 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -56.95 -32.82 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.33 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.462 ' C ' ' ND1' ' A' ' 91' ' ' HIS . 7.2 t-80 -71.73 -44.58 63.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.402 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -65.99 -52.22 51.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.648 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.616 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -57.45 -50.9 71.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.619 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 tt -53.59 -33.4 54.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.823 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -65.6 -42.02 92.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 109.911 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 96' ' ' LEU . 11.2 mp -96.51 -5.51 39.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.203 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.616 ' N ' ' O ' ' A' ' 93' ' ' MET . 34.5 t80 -133.76 69.57 75.77 Favored Pre-proline 0 C--N 1.334 -0.105 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.552 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -46.85 100.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.781 2.321 . . . . 0.0 112.151 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.446 ' OG ' ' CD2' ' A' ' 97' ' ' TYR . 23.6 m -140.6 78.52 21.25 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.594 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -46.41 -27.3 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.624 2.216 . . . . 0.0 112.082 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.2 t80 41.24 90.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.594 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 52.96 68.12 0.89 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.504 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.439 ' HG1' ' N ' ' A' ' 104' ' ' SER . 70.6 p 50.54 -101.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.531 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.439 ' N ' ' HG1' ' A' ' 103' ' ' THR . 14.4 p 57.97 9.29 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.75 -26.81 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.588 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -133.65 83.74 2.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.296 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.579 ' O ' ' N ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -60.18 -62.52 1.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.545 -179.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.726 ' O ' HG22 ' A' ' 108' ' ' VAL . 11.0 p 38.94 20.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.188 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 107' ' ' MET . 9.1 mmm180 -111.45 113.7 26.31 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.038 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -94.6 147.9 33.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.56 160.31 50.25 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.814 2.343 . . . . 0.0 111.932 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 1.8 pm0 -105.57 -10.89 16.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.642 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.559 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -101.21 -6.27 24.45 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.645 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.593 ' C ' ' H ' ' A' ' 116' ' ' LEU . 5.2 mt -123.61 78.91 55.56 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.333 -0.394 . . . . 0.0 109.986 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 45.5 Cg_exo -52.22 1.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.612 2.208 . . . . 0.0 112.194 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.593 ' H ' ' C ' ' A' ' 114' ' ' LEU . 2.0 tp -62.4 -29.31 70.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.258 0.551 . . . . 0.0 110.069 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' OD2' ' CE1' ' A' ' 124' ' ' PHE . 0.4 OUTLIER -97.43 -41.18 8.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.443 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -75.29 -45.73 37.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.952 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.473 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.7 t90 -68.62 -17.67 64.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.203 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 116' ' ' LEU . 4.3 p -161.13 79.42 2.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.996 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.02 -2.05 11.54 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.043 2.495 . . . . 0.0 111.785 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.409 ' O ' ' NE2' ' A' ' 122' ' ' GLN . 0.0 OUTLIER -49.05 -47.96 44.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.776 -179.25 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.96 54.99 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.64 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 117' ' ' ASP . 0.2 OUTLIER -157.15 -41.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.408 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 125' ' ' VAL . 14.3 p -54.43 128.9 14.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.66 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -97.78 150.41 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.776 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.4 t -167.82 110.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.476 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.02 -172.81 21.27 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 1.2 m-20 -87.08 139.1 30.91 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.884 0.373 . . . . 0.0 110.211 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.688 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 28.6 m -93.16 131.09 38.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 87.38 -1.9 0.56 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.326 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -68.01 128.48 36.69 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.035 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -80.17 129.23 34.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.306 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -122.49 -15.49 7.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.62 144.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.067 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -143.02 159.26 42.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.26 0.553 . . . . 0.0 112.0 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.418 ' C ' ' N ' ' A' ' 139' ' ' GLY . 1.9 t80 -112.23 136.85 51.13 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.919 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tp 48.82 16.84 0.12 Allowed 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.38 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.429 ' O ' HD12 ' A' ' 140' ' ' LEU . . . 92.71 22.52 28.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 139' ' ' GLY . 4.7 mp -122.89 133.83 54.4 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.902 0.382 . . . . 0.0 109.977 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -66.85 146.37 54.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.672 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.416 ' N ' ' HD2' ' A' ' 143' ' ' PRO . 3.5 mtt -46.96 -52.65 31.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.722 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 142' ' ' MET . 77.0 Cg_exo -44.45 -35.63 8.83 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.329 2.019 . . . . 0.0 112.232 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.446 HE21 ' N ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -70.51 -52.51 21.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.061 0.457 . . . . 0.0 109.995 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.632 ' O ' ' N ' ' A' ' 148' ' ' GLY . 83.0 m95 -59.35 -56.97 15.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.125 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tt -43.26 -38.21 2.48 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.614 HD21 ' CG2' ' A' ' 88' ' ' THR . 0.5 OUTLIER -60.47 -34.06 73.49 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -59.96 -41.9 98.07 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.437 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.07 -27.93 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.92 0.391 . . . . 0.0 110.086 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.513 ' O ' HD13 ' A' ' 154' ' ' LEU . 10.4 t80 -61.49 -48.47 80.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.617 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 tp -69.15 -37.2 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -52.69 -47.26 67.34 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.025 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.1 -41.17 99.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.864 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 150' ' ' PHE . 6.5 mp -51.93 -32.41 32.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.813 0.34 . . . . 0.0 110.683 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 30.1 mm -82.08 -38.7 15.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.094 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.569 ' O ' HG23 ' A' ' 160' ' ' VAL . 79.0 t -52.11 -36.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.976 0.417 . . . . 0.0 110.319 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.517 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -80.27 -47.16 15.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.19 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 154' ' ' LEU . 72.0 t -58.67 -37.67 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.097 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -80.01 -40.23 28.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.015 -179.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 156' ' ' VAL . 45.3 t -68.48 -26.26 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.855 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 157' ' ' ALA . 43.3 t -79.32 -49.0 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 162' ' ' ILE . 74.7 mt -65.8 -13.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 83.2 p -52.9 -10.65 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.99 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 162' ' ' ILE . 1.0 OUTLIER -47.54 152.28 1.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.302 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 166' ' ' PHE . 27.4 Cg_endo -63.67 -12.5 31.64 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.489 2.126 . . . . 0.0 111.804 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 165' ' ' PRO . 80.5 t80 37.58 91.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -58.75 108.43 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.549 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.56 113.26 24.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.56 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 49.47 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.574 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -170.99 -57.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.522 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 172' ' ' ASP . 50.6 ttt-85 -86.74 -5.1 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.543 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 171' ' ' ARG . 11.0 m-20 56.35 114.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.631 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.6 mp -80.43 131.28 35.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.524 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.12 12.69 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.276 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -169.92 -112.34 0.27 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -141.31 -14.02 0.89 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.879 0.371 . . . . 0.0 110.533 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 171.09 178.05 41.35 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.543 ' ND1' ' N ' ' A' ' 178' ' ' HIS . 1.2 p-80 -168.68 77.5 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 0.0 110.711 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -58.62 2.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.375 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.525 ' CG ' ' H ' ' A' ' 181' ' ' HIS . 0.0 OUTLIER -62.66 -116.43 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.498 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.525 ' H ' ' CG ' ' A' ' 180' ' ' HIS . 1.7 t60 44.22 72.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.579 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.528 ' CG ' ' N ' ' A' ' 183' ' ' HIS . 1.7 t60 -73.52 -109.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.623 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.528 ' N ' ' CG ' ' A' ' 182' ' ' HIS . 11.9 p80 . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.591 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.528 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.4 tp -53.75 -38.39 64.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.042 0.449 . . . . 0.0 110.06 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.468 ' O ' ' OD1' ' A' ' 6' ' ' ASN . 19.1 ttp180 -57.49 -27.93 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.202 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.4 -42.64 58.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.074 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.3 mm? -50.76 -41.19 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.498 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.509 ' C ' ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -71.98 -26.41 62.23 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.512 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -77.77 -49.46 14.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.623 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.94 -34.03 77.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.755 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.6 p -76.74 -32.63 57.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.752 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -70.1 2.25 3.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.607 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.88 149.75 19.16 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -71.98 -49.72 34.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.448 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -43.15 -45.49 6.27 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.97 87.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.357 . . . . 0.0 110.16 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -58.82 -45.32 90.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.026 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.7 -28.28 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.99 -30.75 68.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.387 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.439 ' O ' ' OG1' ' A' ' 21' ' ' THR . 27.2 tpp -72.13 -33.56 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.906 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -51.81 53.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.618 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -51.41 -52.03 49.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.421 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 18' ' ' MET . 24.5 p -49.66 -47.76 49.88 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.675 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.07 -43.31 86.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mt -68.34 -41.3 80.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.489 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 28' ' ' THR . . . -49.89 -35.32 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.378 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' OG1' ' A' ' 28' ' ' THR . 35.4 mt -75.71 -39.6 57.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.487 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -64.82 -52.73 55.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.781 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -57.33 -42.04 81.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.644 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 24' ' ' ALA . 11.7 p -60.67 -42.25 96.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.04 -35.11 61.93 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.124 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.1 tt -65.95 -19.82 65.99 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.294 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -94.46 -37.7 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.744 0.307 . . . . 0.0 110.843 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -55.41 -46.7 76.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.404 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 tm0? -71.62 -40.45 69.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.693 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 34' ' ' HIS . 45.7 t-80 -61.38 -15.02 32.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.474 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.1 t -108.84 -44.77 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.42 5.34 27.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.98 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.7 mt 48.34 48.98 18.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.715 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.4 mt -85.06 154.83 21.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.574 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -116.15 119.15 37.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -179.92 5.9 Favored 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.245 1.964 . . . . 0.0 112.022 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.447 ' SG ' ' C ' ' A' ' 129' ' ' ASP . 3.9 t -127.19 -177.21 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.527 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.412 HG12 ' SG ' ' A' ' 130' ' ' CYS . 2.8 p -66.57 -34.93 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 0.0 110.401 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.52 -48.5 55.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.306 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 p -48.46 -50.77 30.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.248 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 84.1 mt -61.56 -38.43 80.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -60.52 -44.3 96.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.838 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 1.4 tp10 -61.75 -47.88 83.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.054 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 37.0 ttt85 -50.6 -42.79 56.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.917 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -61.09 -33.92 74.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.189 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 47' ' ' GLU . . . -56.26 -44.62 79.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.928 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.41 -50.83 8.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.043 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -39.49 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.25 -45.4 80.85 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -62.32 -43.74 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.559 . . . . 0.0 109.533 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -45.03 -49.42 11.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.362 179.078 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.67 -37.12 92.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.6 -29.3 70.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.409 -0.396 . . . . 0.0 110.285 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -71.5 -37.29 71.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.479 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 mp -74.06 -23.76 59.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.357 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 95.8 mt -84.19 -46.81 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.608 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.49 -27.39 73.82 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.05 5.42 5.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.742 0.306 . . . . 0.0 110.726 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 97.8 mt -80.44 -32.86 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.595 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . 176.69 72.95 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.573 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.63 27.6 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.547 2.165 . . . . 0.0 111.68 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 64' ' ' ALA . 16.5 tttm -113.34 -10.71 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.933 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -110.42 162.6 19.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.654 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -39.05 -14.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.705 2.27 . . . . 0.0 112.665 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' THR . 44.4 mt -45.07 -28.71 0.75 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.699 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' SD ' ' A' ' 74' ' ' MET . 0.2 OUTLIER -40.87 -70.26 0.11 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.547 -179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.566 ' O ' HG23 ' A' ' 75' ' ' VAL . 43.3 m-85 -51.03 -33.26 24.52 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.909 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 t -66.22 -45.45 89.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.64 -36.13 26.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.251 0.548 . . . . 0.0 110.235 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.625 ' N ' ' SD ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -62.73 -23.68 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.402 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 71' ' ' TYR . 1.7 t -53.01 -31.66 17.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.407 0.622 . . . . 0.0 109.873 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 88.2 mt -88.86 -34.32 6.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.395 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.587 ' CD1' HD13 ' A' ' 154' ' ' LEU . 2.9 t-105 -65.34 -53.15 47.87 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 81' ' ' ALA . 4.8 mt -63.2 -47.96 80.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.666 0.27 . . . . 0.0 110.607 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -42.73 -43.31 3.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 0.0 110.256 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.659 ' OG ' HD11 ' A' ' 154' ' ' LEU . 19.0 p -77.66 -21.27 52.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.831 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 154' ' ' LEU . . . -59.7 -60.61 3.57 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.872 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.45 -53.66 15.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -71.01 -48.41 53.24 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.581 ' O ' HG23 ' A' ' 88' ' ' THR . . . -55.89 -47.26 80.51 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.42 -0.895 . . . . 0.0 110.97 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.88 -32.43 34.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.542 0.211 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -72.06 -47.07 54.23 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.062 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.48 -49.91 43.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.674 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 84' ' ' GLY . 13.2 p -46.39 -48.42 18.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.441 . . . . 0.0 110.203 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 92' ' ' THR . 50.4 t80 -57.29 -44.94 84.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.296 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -43.71 -42.06 5.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.931 0.396 . . . . 0.0 109.987 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -70.02 -34.68 73.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.97 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 89' ' ' TYR . 10.1 m -62.24 -50.1 73.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.302 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' TYR . 18.9 ttt -56.48 -36.78 69.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.933 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tp -70.13 -36.9 75.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.52 ' NE2' ' OE2' ' A' ' 141' ' ' GLU . 48.5 tt0 -63.93 -37.52 87.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.509 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.19 -15.73 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 93' ' ' MET . 20.9 t80 -139.93 75.56 29.8 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.667 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.04 -170.26 0.93 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.625 2.217 . . . . 0.0 111.949 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.443 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -179.18 -55.34 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.733 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 99' ' ' SER . 60.7 Cg_endo -74.4 172.3 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.229 1.952 . . . . 0.0 111.972 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -153.37 -13.36 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 104' ' ' SER . . . -157.49 -76.78 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.475 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.2 p 43.41 21.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.525 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 102' ' ' ALA . 14.8 m 55.32 49.58 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -46.45 122.89 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.535 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.73 108.04 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.463 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 16.1 ptt? -113.15 173.42 6.4 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.599 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 108' ' ' VAL . 39.6 t 55.27 20.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.46 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -83.92 106.43 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.586 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -118.64 151.11 49.44 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.35 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.13 140.75 91.0 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.504 2.136 . . . . 0.0 112.003 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.6 11.5 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -124.62 -1.01 8.02 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.624 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 116' ' ' LEU . 53.3 mt -126.59 85.58 60.16 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.46 5.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.872 2.381 . . . . 0.0 112.745 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.619 ' H ' ' C ' ' A' ' 114' ' ' LEU . 11.0 mt -58.04 -31.41 66.99 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.78 -40.08 8.72 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.997 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.0 ttmt -63.5 -45.54 90.24 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.39 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -79.6 -13.01 59.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.856 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.81 68.93 24.45 Favored Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.907 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.451 ' O ' HG23 ' A' ' 125' ' ' VAL . 7.5 Cg_exo -69.98 -20.04 34.29 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.813 2.342 . . . . 0.0 111.508 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -57.64 -53.49 57.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.344 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.54 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 4.0 t -101.94 54.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.038 0.447 . . . . 0.0 111.269 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 123' ' ' VAL . 6.3 m-85 -161.22 -46.52 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 121' ' ' PRO . 77.2 t -55.32 129.44 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.727 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -97.74 152.18 19.4 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.662 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 101.78 1.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.733 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.79 176.41 14.92 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 0.9 OUTLIER -83.13 160.47 21.86 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.663 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 1.8 m -107.84 128.96 55.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.971 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 97.4 -8.19 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.726 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE2' ' N ' ' A' ' 129' ' ' ASP . 8.0 pt-20 -67.87 148.91 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.933 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -85.54 136.51 33.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.919 0.39 . . . . 0.0 110.575 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -125.59 -31.17 3.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.407 ' C ' ' OD1' ' A' ' 136' ' ' ASP . 39.8 t-105 -174.82 141.25 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.602 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' C ' ' A' ' 135' ' ' TRP . 3.6 m-20 -134.62 161.28 35.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.325 0.583 . . . . 0.0 112.161 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.415 ' C ' ' N ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -118.98 136.67 53.98 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.517 178.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 49.13 16.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.479 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.415 ' N ' ' C ' ' A' ' 137' ' ' PHE . . . 93.85 19.75 33.25 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.227 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.1 144.05 51.13 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 117.06 0.43 . . . . 0.0 110.109 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.52 ' OE2' ' NE2' ' A' ' 95' ' ' GLN . 50.8 mt-10 -70.38 145.95 50.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.558 ' SD ' ' C15' ' A' ' 201' ' ' UQ2 . 2.1 mmt -44.03 -61.93 1.76 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.339 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 142' ' ' MET . 86.4 Cg_exo -34.97 -36.45 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.618 2.212 . . . . 0.0 112.238 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -69.57 -58.32 4.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.014 0.435 . . . . 0.0 110.045 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 148' ' ' GLY . 80.9 m95 -55.31 -57.38 12.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.6 tt -43.45 -35.52 1.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.126 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.37 -35.13 78.19 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.57 -48.27 85.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.677 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.9 mp -71.87 -33.28 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -58.02 -44.08 87.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.347 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.46 -43.33 98.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.47 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 156' ' ' VAL . . . -60.65 -49.99 75.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.11 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -57.37 -48.24 79.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 0.0 111.058 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.659 HD11 ' OG ' ' A' ' 80' ' ' SER . 4.5 mm? -66.98 -34.93 78.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.607 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 -36.73 37.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.199 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 152' ' ' ALA . 14.9 t -54.66 -48.74 71.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 77' ' ' TRP . . . -61.19 -48.69 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 154' ' ' LEU . 76.7 t -48.9 -39.43 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 33.5 mt -78.38 -24.6 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.04 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 156' ' ' VAL . 56.1 t -77.92 -22.7 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.0 110.718 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.24 -49.59 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.439 ' C ' ' N ' ' A' ' 164' ' ' GLN . 77.7 mt -64.48 -25.69 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.72 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 39.6 m -52.54 -11.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 0.0 110.403 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.626 ' NE2' ' CZ ' ' A' ' 166' ' ' PHE . 13.7 mt-30 -56.2 152.01 24.42 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.316 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.73 20.98 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.547 2.165 . . . . 0.0 111.918 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.626 ' CZ ' ' NE2' ' A' ' 164' ' ' GLN . 42.1 p90 -161.16 155.51 23.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -159.62 0.82 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.5 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . 53.67 -166.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.349 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -78.39 -27.91 46.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.281 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -156.67 -57.21 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.605 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 25.8 ttm-85 -174.23 -50.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.808 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -147.76 139.1 23.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 0.0 110.63 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 173' ' ' LEU . 0.6 OUTLIER -162.21 0.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.15 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.405 ' H ' ' H ' ' A' ' 173' ' ' LEU . 11.9 m-85 -64.56 101.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.566 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 176' ' ' ARG . . . 163.84 17.54 0.02 OUTLIER Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 175' ' ' GLY . 15.0 mmt180 -136.9 93.65 2.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.773 0.321 . . . . 0.0 110.387 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -173.23 18.95 0.05 OUTLIER Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.704 ' CD2' ' H ' ' A' ' 179' ' ' HIS . 42.2 t60 -76.4 -139.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 0.0 110.472 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . 0.704 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 49.1 t-80 38.98 -120.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.812 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . 0.52 ' N ' ' ND1' ' A' ' 179' ' ' HIS . 17.7 m-70 54.25 166.9 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.47 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -45.01 -30.94 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.67 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -46.34 129.91 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.529 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 17.9 m170 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.589 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.558 ' C15' ' SD ' ' A' ' 142' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.01 -44.75 94.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.375 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -51.3 -39.34 56.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.391 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' O ' ' N ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -66.1 -44.92 82.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.2 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.88 -39.65 12.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -69.45 -24.96 63.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.315 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PHE . 1.5 tm0? -80.39 -48.22 13.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.573 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.13 -33.56 69.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.522 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 p -76.79 -34.48 57.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.684 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.418 ' OE1' ' O ' ' A' ' 65' ' ' PRO . 1.9 tp-100 -70.96 6.37 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.78 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.99 141.08 15.15 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -66.75 -20.64 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.738 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.43 -44.2 74.59 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.3 -51.33 66.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -53.76 -43.9 69.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mt -70.26 -30.28 67.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.53 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.2 tp -69.05 -36.64 77.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.604 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.58 -34.49 75.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.27 37.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.394 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -50.63 -36.87 37.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.728 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.11 -56.72 14.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.778 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.71 65.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.658 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' O ' HD23 ' A' ' 23' ' ' LEU . 1.1 tt -84.21 -42.39 15.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.484 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.3 -31.27 61.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.795 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.3 mt -75.55 -34.61 60.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.591 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.35 -52.84 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -53.83 -52.28 60.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.508 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 p -51.23 -38.9 55.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.982 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.15 -34.14 68.29 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.46 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mp -64.28 -22.75 67.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.756 0.312 . . . . 0.0 110.426 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 13.4 t90 -85.03 -28.81 25.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.087 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -45.56 94.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.99 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.413 ' HA ' ' H ' ' A' ' 38' ' ' LEU . 11.1 pt20 -66.95 -27.46 67.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -83.17 -13.34 55.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.981 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.0 t -109.32 -33.13 2.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.132 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.422 ' CG ' ' O ' ' A' ' 36' ' ' MET . 14.3 ttm -109.21 6.63 24.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.153 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.1 mt 48.92 51.35 16.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.046 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 33' ' ' GLN . 8.6 mt -81.81 154.54 25.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.509 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 127' ' ' SER . 42.3 mttp -120.24 93.76 48.28 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.599 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -49.5 131.11 27.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.509 2.139 . . . . 0.0 112.022 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.59 ' SG ' ' N ' ' A' ' 130' ' ' CYS . 0.1 OUTLIER -89.8 -171.14 3.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 43' ' ' LEU . 8.6 p -62.22 -41.65 92.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.872 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HG13 ' A' ' 42' ' ' VAL . 2.8 mp -58.89 -45.44 90.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.802 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -48.45 -42.54 32.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -62.48 -42.22 94.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 0.0 110.12 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -65.83 -46.45 78.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.503 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -50.36 67.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.366 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -58.76 -30.77 67.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.72 68.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HB1' ' CZ ' ' A' ' 150' ' ' PHE . . . -59.22 -48.81 80.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.399 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 mp -80.62 -52.78 7.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.246 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -44.66 -40.19 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.26 -43.74 87.93 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.44 -46.36 93.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.9 mt -44.05 -46.09 8.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.427 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.19 -41.64 98.26 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.31 -44.38 84.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.512 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.3 -32.61 73.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.46 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' O ' ' CD1' ' A' ' 63' ' ' ILE . 8.6 mt -73.33 -26.45 61.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.148 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mm -82.08 -35.33 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.351 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.95 -19.16 80.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.81 5.71 12.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.706 0.289 . . . . 0.0 110.695 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 1.5 mp -82.85 -35.12 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.426 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 66' ' ' LYS . . . -179.83 73.23 0.18 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.206 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 53.0 Cg_endo -72.56 23.3 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.533 2.155 . . . . 0.0 112.055 -179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' ALA . 12.1 ttpt -113.8 -6.49 13.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.114 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -114.12 159.44 36.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.894 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -38.15 -18.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.628 2.219 . . . . 0.0 112.442 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' THR . 7.5 mp -41.34 -32.6 0.32 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.572 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 161' ' ' VAL . 34.8 mtp180 -39.76 -65.86 0.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.663 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -53.02 -32.49 46.92 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 t -66.0 -45.23 91.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.819 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.29 63.0 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.657 0.742 . . . . 0.0 109.129 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.533 ' SD ' ' O ' ' A' ' 74' ' ' MET . 11.0 tmm? -56.96 -11.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.238 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -63.14 -44.17 99.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.29 0.567 . . . . 0.0 111.394 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.8 mt -82.05 -32.83 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.442 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.776 ' CE2' ' HB3' ' A' ' 157' ' ' ALA . 9.9 t90 -61.22 -53.17 60.31 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.588 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' N ' ' CE3' ' A' ' 77' ' ' TRP . 20.9 tp -58.31 -53.67 55.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.813 0.34 . . . . 0.0 110.869 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -43.82 -46.07 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.667 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.7 p -80.71 -27.31 36.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.01 -60.84 3.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.004 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -73.47 -55.69 6.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.255 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -66.93 -45.48 77.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.37 -46.04 93.51 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -69.91 -53.18 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.826 0.346 . . . . 0.0 110.531 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -47.6 -25.71 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.421 . . . . 0.0 109.948 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.3 tp -78.09 -39.67 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.32 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 73.4 p -54.58 -29.52 51.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.918 0.39 . . . . 0.0 110.355 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.44 ' O ' ' OG1' ' A' ' 92' ' ' THR . 0.5 OUTLIER -70.77 -52.46 20.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.856 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -52.09 -32.61 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -75.22 -34.97 61.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.772 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.462 HG22 HE22 ' A' ' 144' ' ' GLN . 17.6 p -72.05 -47.75 49.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -53.62 -53.87 45.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.554 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.8 tt -61.72 -43.97 97.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.617 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -55.47 -38.72 69.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.203 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -97.55 -9.46 27.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.353 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' MET . 32.5 t80 -130.97 79.23 71.93 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.814 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.83 111.93 3.04 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.53 2.154 . . . . 0.0 111.9 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.4 t -160.84 75.71 2.61 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.574 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.8 114.48 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.636 2.224 . . . . 0.0 112.043 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -61.14 -44.42 97.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.642 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.63 35.21 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.579 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.6 m 52.0 84.61 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.593 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.9 p -101.58 53.49 0.82 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.49 87.19 2.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.509 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -73.07 92.82 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.493 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.55 ' C ' ' H ' ' A' ' 109' ' ' ARG . 22.9 ptt? -101.98 164.52 11.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.699 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 108' ' ' VAL . 49.0 t 58.31 -1.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' A' ' 107' ' ' MET . 45.4 ttt-85 -100.2 102.47 13.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.591 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.421 ' CG ' ' OD1' ' A' ' 117' ' ' ASP . 0.1 OUTLIER -109.73 158.88 33.6 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.268 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.76 130.06 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.709 2.272 . . . . 0.0 111.802 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -87.73 -17.27 32.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.653 ' CD1' ' N ' ' A' ' 113' ' ' TRP . 0.0 OUTLIER -85.09 -6.21 59.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 110.36 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.613 ' C ' ' H ' ' A' ' 116' ' ' LEU . 12.0 mt -120.35 83.41 33.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.865 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.41 ' O ' ' CB ' ' A' ' 119' ' ' TRP . 39.1 Cg_exo -54.0 11.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.79 2.326 . . . . 0.0 112.802 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 114' ' ' LEU . 3.1 mt -75.16 -29.15 60.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.542 ' OD2' ' CD1' ' A' ' 124' ' ' PHE . 1.1 t70 -96.24 -40.22 9.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.805 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -67.87 -40.61 83.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.41 ' CB ' ' O ' ' A' ' 115' ' ' PRO . 5.4 t90 -81.67 -16.02 52.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.301 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t -142.45 74.15 20.2 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.68 -17.27 11.22 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.856 2.371 . . . . 0.0 111.841 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -51.71 -52.44 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.779 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.7 m -112.66 60.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.641 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.542 ' CD1' ' OD2' ' A' ' 117' ' ' ASP . 2.0 t80 -164.92 -40.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.329 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.4 125.81 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.522 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.81 146.56 23.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.554 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 39' ' ' LYS . 16.2 p -155.1 144.79 21.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.88 -175.71 38.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.477 ' C ' ' SG ' ' A' ' 41' ' ' CYS . 6.1 m-20 -84.64 144.76 28.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.744 0.307 . . . . 0.0 110.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 131' ' ' ALA . 32.8 m -92.72 132.65 36.75 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.963 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 130' ' ' CYS . . . 89.88 -3.27 0.34 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.452 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -67.92 128.3 36.01 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.826 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -76.93 134.95 38.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.164 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -128.06 -19.63 3.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.881 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.586 ' NE1' ' SD ' ' A' ' 142' ' ' MET . 6.7 p90 -172.95 149.6 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.228 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.11 166.89 24.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.28 0.562 . . . . 0.0 111.87 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -122.8 138.41 54.65 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.38 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.57 17.04 0.51 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.411 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 88.2 21.65 44.51 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.0 mt -126.34 137.67 53.49 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 143.7 55.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.25 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.586 ' SD ' ' NE1' ' A' ' 135' ' ' TRP . 0.0 OUTLIER -48.1 -53.36 33.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.3 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 142' ' ' MET . 80.3 Cg_exo -40.95 -35.81 1.85 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.33 2.02 . . . . 0.0 111.863 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.462 HE22 HG22 ' A' ' 92' ' ' THR . 73.6 mm-40 -71.71 -49.64 37.6 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.619 ' O ' ' N ' ' A' ' 148' ' ' GLY . 79.5 m95 -59.17 -56.73 18.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.908 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 30.2 tp -43.91 -38.54 3.45 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 147' ' ' LEU . 1.0 OUTLIER -58.74 -35.19 72.32 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.619 ' N ' ' O ' ' A' ' 145' ' ' TRP . . . -61.08 -47.04 93.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.583 ' N ' HD12 ' A' ' 149' ' ' ILE . 1.7 mp -65.96 -43.67 92.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.52 ' CZ ' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -49.04 -40.27 30.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 179.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 96.3 mt -65.38 -38.51 82.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.715 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 149' ' ' ILE . . . -52.99 -49.71 65.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.991 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -61.08 -45.71 93.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.563 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 158' ' ' VAL . 13.2 tp -47.97 -32.64 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.391 0.615 . . . . 0.0 109.844 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 46.0 mt -83.0 -37.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.292 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 160' ' ' VAL . 53.0 t -52.61 -46.35 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.213 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.776 ' HB3' ' CE2' ' A' ' 77' ' ' TRP . . . -79.88 -44.17 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.548 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 154' ' ' LEU . 43.0 t -50.16 -40.66 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.11 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 tt -85.24 -42.15 14.93 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.477 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 156' ' ' VAL . 55.6 t -64.68 -38.26 82.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.208 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.539 ' O ' ' NH2' ' A' ' 70' ' ' ARG . 63.8 t -71.75 -53.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.074 0.464 . . . . 0.0 109.945 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.502 ' CD1' ' N ' ' A' ' 162' ' ' ILE . 1.3 mp -66.46 -5.05 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.7 p -52.46 -13.71 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.185 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.403 ' N ' ' C ' ' A' ' 162' ' ' ILE . 13.1 mt-30 -40.46 154.29 0.2 Allowed Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.218 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 167' ' ' LYS . 13.0 Cg_endo -57.24 -14.97 16.9 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.39 2.06 . . . . 0.0 111.934 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.471 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 31.8 t80 40.39 27.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.654 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . 10.2 mtpt 55.21 89.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.408 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 169' ' ' LYS . . . -147.59 -149.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 168' ' ' ALA . 17.9 mttm 60.48 129.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.528 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -101.78 -6.07 24.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.542 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -46.97 138.3 6.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.493 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.27 155.43 6.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.566 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.6 mp -100.44 -130.7 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.523 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 55.03 107.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.551 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.97 -36.55 3.03 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 70.1 ttt-85 -74.03 94.58 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 0.0 110.593 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 67.28 92.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -160.27 -10.19 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.48 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -64.24 -5.39 4.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.563 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -167.49 68.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.507 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.543 ' CG ' ' N ' ' A' ' 182' ' ' HIS . 2.0 p80 -62.96 -136.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.557 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.543 ' N ' ' CG ' ' A' ' 181' ' ' HIS . 13.6 t60 -158.58 -62.94 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.012 -0.995 . . . . 0.0 110.61 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' UQ2 . . . . . 0.543 H5M1 ' H71' ' A' ' 201' ' ' UQ2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_